Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.5152237556561355,-2.0647261582439276,0.0,0.08801493359788512,0.069,51/87,25.05%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;SEC61B;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPLP2;RPS6;RPS15A;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;RPL22;RPS9;RPS14;RPS25
prerank,cellular response to zinc ion (GO:0071294),-0.7692393955021368,-2.0616053754684165,0.0,0.04682845826041323,0.072,11/15,16.01%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;GLRA2;P2RX4;MT2A
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.7575043760595882,-2.0404065390508923,0.0,0.042879070214354296,0.097,6/14,2.58%,PRKG1;LRP1;SLIT2;TPM1;IGFBP3;IGFBP5
prerank,blood vessel diameter maintenance (GO:0097746),-0.6010435511110377,-2.008626201175179,0.0,0.0629081095907961,0.181,17/34,19.17%,ROCK2;ECE1;NOS3;GCLM;NPR1;ACE;BDKRB2;AGTR1;KLF2;EDNRA;EDN1;EDN3;ACE2;NOS1;PER2;GCLC;AGT
prerank,somite development (GO:0061053),0.9053804116888448,1.998324746860542,0.0,0.39512051657995007,0.278,2/11,0.06%,PTCH1;MEOX2
prerank,smoothened signaling pathway (GO:0007224),0.7443056736727449,1.9948784795985883,0.0,0.21116892216268116,0.292,6/32,5.28%,PTCH1;PTCH2;GLI1;GLI2;STIL;HIPK1
prerank,heart trabecula morphogenesis (GO:0061384),-0.7122892124832759,-1.9948321739138706,0.0,0.06341588805386081,0.22,8/18,2.84%,ENG;TEK;ADGRG6;TGFBR3;RBPJ;FKBP1A;RBP4;TGFBR1
prerank,protein targeting to ER (GO:0045047),-0.48699662698915536,-1.9913798230470756,0.0,0.05453916825509976,0.227,53/99,22.61%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;SGTA;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;SEC62;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;ZFAND2A;RPS12;RPL18A;RPS21;SPCS1;RPS18;RPLP2;RPS6;SGTB;RPS15A;RPL14;RPS2;RPL10A;GET3;RPL39;RPL34;RPL5;RPL22
prerank,dopamine metabolic process (GO:0042417),-0.7039459049130549,-1.9806364656362785,0.0,0.05674222825358161,0.256,8/18,12.75%,SNCAIP;MOXD1;MAOA;COMT;ATP7A;GCH1;MAOB;TGFB2
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.6828286964477555,-1.9792918917594895,0.0,0.050354697587251585,0.258,7/20,4.89%,IGF1;PDGFRB;LRP1;SLIT2;IGFBP3;IGFBP5;ACE
prerank,cellular response to sterol (GO:0036315),0.8651128436682486,1.9763522233084072,0.0,0.20491206520971283,0.389,4/13,4.10%,PTCH1;RORA;GPLD1;GRAMD1B
prerank,regulation of cell morphogenesis (GO:0022604),0.7441977152408539,1.9730636985595418,0.004418262150220913,0.16189617365805556,0.408,5/30,2.67%,NTNG2;NTNG1;EFNA5;FMNL2;CAPZB
prerank,dorsal/ventral pattern formation (GO:0009953),0.8071769089562751,1.9636425443694803,0.0,0.1589867351749253,0.463,5/20,4.27%,PTCH1;FBXL15;GLI2;BMPR1B;NBL1
prerank,basement membrane organization (GO:0071711),0.8527627074642186,1.9503369295774748,0.0,0.16893513773014493,0.538,5/14,1.47%,NTNG2;NTNG1;PXDN;NID1;LAMB2
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.48398598438161605,-1.9475761228934731,0.0,0.06569775670269488,0.349,42/91,16.50%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;SSR1;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;SEC62;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPLP2;RPS6;RPS15A
prerank,negative regulation of cell activation (GO:0050866),-0.7359529366446869,-1.9432958215893252,0.002512562814070352,0.0629645294200255,0.364,6/14,6.95%,PDGFRA;NOS3;THBD;LDLR;APOE;CD200
prerank,regulation of glucose import (GO:0046324),-0.5908041606270759,-1.9375326506729504,0.003205128205128205,0.06267730119849395,0.39,10/30,2.90%,PRKAG2;IGF1;OSBPL8;INSR;PID1;ENPP1;GRB10;PIK3R1;CREBL2;APPL2
prerank,response to zinc ion (GO:0010043),-0.6238155157050901,-1.9230463489216587,0.0,0.0733457779982376,0.47,13/25,17.57%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;GLRA2;P2RX4;MT2A;SLC30A4;D2HGDH
prerank,cellular response to copper ion (GO:0071280),-0.7062401465107723,-1.9225594730580848,0.0,0.06822459349895237,0.471,8/16,3.81%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,cell-substrate junction assembly (GO:0007044),0.7160002258600373,1.922519946406571,0.002890173410404624,0.23919070294490363,0.705,8/33,5.16%,ITGB4;ITGA6;DLC1;SORBS1;LAMC1;PEAK1;SRC;FN1
prerank,regulation of smoothened signaling pathway (GO:0008589),0.6789793681366906,1.917711973149295,0.0,0.22559879851046438,0.738,10/50,7.03%,PTCH1;RORA;GPC3;PTCH2;GLI1;GLIS2;INTU;KIF7;IFT81;PDCL
prerank,angiogenesis involved in wound healing (GO:0060055),-0.7797138397461818,-1.911242807925311,0.0,0.07415177555865779,0.527,7/11,9.15%,ADIPOR2;NDNF;PRCP;KDR;CD34;GATA2;MCAM
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5984177210946162,-1.9073249714440386,0.0,0.0728944193644023,0.548,15/31,17.56%,OSR1;PDGFRA;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;TBX1;HOXC4;HOXA9;FUZ;MEGF8;HOXD4;HOXD3
prerank,regulation of Golgi organization (GO:1903358),-0.6760170289122145,-1.9061839821808513,0.0,0.06904376601949481,0.551,7/17,7.55%,PDE4DIP;MYO5A;STX18;USP6NL;PDCD10;RBSN;MAP2K2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.4540442920896086,-1.8982712225672191,0.0,0.07215100514396766,0.585,23/91,7.18%,BMP6;SLC30A10;ABCG2;SLC39A10;FTH1;TFRC;SCARA5;SLC39A8;ATP7A;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SLC31A1;FTL;SLC31A2;SLC11A2;SLC39A14;NEDD8
prerank,smooth muscle contraction (GO:0006939),-0.7185386337205102,-1.89800759756971,0.0,0.06833068206673418,0.587,8/14,11.69%,ROCK2;MYLK;SLC8A1;BDKRB2;MYH11;PIK3C2A;ACTA2;EDNRA
prerank,positive regulation of embryonic development (GO:0040019),-0.6696207050341,-1.8964704487977748,0.002688172043010753,0.06610028413930238,0.595,5/19,6.20%,PLCB1;OSR1;WNT4;CFL1;ZBED3
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.6573227831141558,-1.8961388318229484,0.002631578947368421,0.06313378890771375,0.596,9/21,9.68%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;CCN3;JAK2;TGFB3;SLC2A10
prerank,extracellular matrix assembly (GO:0085029),0.7519233931748331,1.8885068894807815,0.0031746031746031746,0.3341161612885089,0.865,5/23,1.47%,NTNG2;NTNG1;TNXB;PXDN;LAMB2
prerank,manganese ion transport (GO:0006828),-0.7174368477934748,-1.8883712610272576,0.0,0.06641419897862394,0.634,7/14,6.86%,SLC30A10;TRPC3;SLC39A8;TRPC1;SLC11A2;ATP2C1;SLC39A14
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.8043862313469549,1.886169526580325,0.0033112582781456954,0.3116853291121174,0.871,3/16,1.37%,CLDN1;CLDN11;CLDN19
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6172619965311347,-1.8821173940879168,0.0,0.06842186562912514,0.667,12/26,6.86%,SLC30A10;SLC39A10;SLC39A8;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SLC39A14
prerank,hemidesmosome assembly (GO:0031581),0.8813405304904687,1.8787520911964906,0.0017699115044247787,0.3168813644089688,0.891,3/11,1.46%,ITGB4;ITGA6;LAMC1
prerank,regulation of cholesterol efflux (GO:0010874),0.7067336000031943,1.8721807181220005,0.004424778761061947,0.3213678152468359,0.913,2/30,0.24%,PTCH1;CAV1
prerank,positive regulation of cholesterol efflux (GO:0010875),0.7476753787447447,1.8623156298392216,0.00463678516228748,0.3482662839359911,0.933,2/21,0.24%,PTCH1;CAV1
prerank,positive regulation of cholesterol transport (GO:0032376),0.7131067366810185,1.8590907944369373,0.0014992503748125937,0.34041771007685556,0.939,2/27,0.24%,PTCH1;CAV1
prerank,actin filament-based transport (GO:0099515),-0.6152345915127893,-1.8581892898079642,0.0,0.08875084441392095,0.774,5/21,2.67%,MYO1D;SYNE2;MYO1B;MYO5A;MYO6
prerank,erythrocyte differentiation (GO:0030218),-0.5230016956244113,-1.8574236881562645,0.0,0.08571112390435073,0.776,21/44,28.46%,TGFBR3;LYN;MFHAS1;KIT;CEBPG;UBA5;JAK2;RPS19;CASP3;SLC25A38;TAL1;ID2;CDK5RAP3;ABCB10;INHBA;ALAS1;NCKAP1L;RPS14;JAK3;KMT2E;ALAS2
prerank,regulation of histone modification (GO:0031056),-0.7170433808335273,-1.8545576117741145,0.0,0.08584841215547565,0.793,8/13,16.53%,SETD5;IGF2;PARG;UBE2N;CDK9;MTHFR;MYOCD;AKAP8L
prerank,metanephros development (GO:0001656),0.7235216852489715,1.8543729176000183,0.002967359050445104,0.33912164685088353,0.948,3/26,3.23%,PTCH1;FOXD1;NF1
prerank,negative regulation of smoothened signaling pathway (GO:0045879),0.7536909808224732,1.8459969354207193,0.0015408320493066256,0.35775534896394234,0.97,6/23,5.68%,PTCH1;GPC3;PTCH2;GPR161;GLIS2;KIF7
prerank,embryonic axis specification (GO:0000578),0.8006278462835176,1.838375972693135,0.0,0.3740864357057066,0.981,3/15,3.46%,PTCH1;COBL;STIL
prerank,skin development (GO:0043588),0.6086499854176798,1.8381719105656549,0.0012787723785166241,0.3539295416395753,0.981,12/65,6.65%,ITGB4;CLDN1;ITGA6;WNT10A;JAG1;COL5A3;WNT16;ALOXE3;LSR;WNT5A;TMEM79;COL3A1
prerank,embryonic appendage morphogenesis (GO:0035113),0.8374946458462458,1.8351563317083774,0.005366726296958855,0.34982416532306615,0.983,1/12,0.01%,PTCH1
prerank,zinc ion homeostasis (GO:0055069),-0.5955867421565837,-1.8327355581492033,0.0,0.10906386988732016,0.877,12/28,6.86%,SLC30A10;SLC39A10;SLC39A8;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;SLC39A14
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),0.7293506346067931,1.8326954925310666,0.006134969325153374,0.34378300528084493,0.985,6/20,5.62%,SMOC2;SULF1;SPRY1;SPRY4;CREB3L1;APLN
prerank,establishment of skin barrier (GO:0061436),0.7611339884620201,1.8253590898236625,0.005050505050505051,0.3427762201165946,0.988,5/15,9.28%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,regulation of water loss via skin (GO:0033561),0.7611339884620201,1.8253590898236625,0.005050505050505051,0.3427762201165946,0.988,5/15,9.28%,CLDN1;ALOXE3;LSR;TMEM79;SFN
prerank,regulation of wound healing (GO:0061041),0.649085738277185,1.8080341586851807,0.0028735632183908046,0.40870877765824437,0.994,10/42,8.23%,CLDN1;CAV1;PRKCE;CLDN19;AJAP1;CASK;TNFAIP3;EPHB2;KANK1;OCLN
prerank,copper ion transport (GO:0006825),-0.7286609104146604,-1.8031480156051112,0.0,0.14794532997935103,0.938,5/11,6.14%,STEAP3;ATP7A;SLC31A1;SLC31A2;SLC11A2
prerank,regulation of neuroinflammatory response (GO:0150077),-0.6373250123647296,-1.8028674387347732,0.002617801047120419,0.14310486685260534,0.938,7/19,7.37%,IGF1;NUPR1;IL18;TNFRSF1B;IL33;CD200;DAGLA
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.7471133880447973,1.8010413514587316,0.003246753246753247,0.42640480134479175,0.996,4/18,5.19%,CAV1;NEDD4L;CAMK2D;ATP1A2
prerank,synaptic membrane adhesion (GO:0099560),0.7969755565528079,1.7984225960734848,0.0050335570469798654,0.42128669235726357,0.996,3/14,2.28%,NTNG1;PTPRF;GPC6
prerank,inositol phosphate-mediated signaling (GO:0048016),0.7507238183591796,1.79696513267282,0.009345794392523364,0.41179744684305414,0.996,4/19,1.39%,HRH1;NFATC2;PLCE1;NFATC1
prerank,regulation of neuron projection arborization (GO:0150011),0.7853176414356017,1.792540824627532,0.008,0.41781900319266296,0.998,3/15,4.96%,NTNG2;NTNG1;WNT5A
prerank,regulation of cell projection organization (GO:0031344),0.8253558113042416,1.7858472422795995,0.003355704697986577,0.43510853628472446,0.998,2/13,0.08%,NTNG2;NTNG1
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.6331113841743576,1.7842233217539023,0.003989361702127659,0.4282279200086739,0.998,14/46,10.07%,NTNG2;NTNG1;PARVA;PXN;LAMC1;LAMB2;PEAK1;FN1;FER;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2
prerank,muscle tissue development (GO:0060537),0.7745391845222563,1.7807295537126475,0.01015228426395939,0.4317231297548148,0.998,4/13,4.33%,PTCH1;STRA6;NF1;CSRP3
prerank,response to cholesterol (GO:0070723),0.7623782534505582,1.780107459161318,0.011608623548922056,0.42082408861093445,0.998,3/17,4.10%,PTCH1;GPLD1;GRAMD1B
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.7121104913803604,-1.7796864670150478,0.0024271844660194173,0.17933723649542552,0.974,7/13,8.02%,RBPMS;BMP6;DAB2;BMP4;TGFBR1;JAK2;TGFB3
prerank,neural tube development (GO:0021915),0.777075493786974,1.7795745282474098,0.008460236886632826,0.41037160540281037,0.998,3/15,4.94%,PTCH1;STIL;DACT1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.5909116375892679,1.7769142013486787,0.004993757802746567,0.4102507343025826,0.998,18/70,10.52%,NTNG2;NTNG1;PARVA;PXN;LAMC1;LAMB2;SPI1;OPHN1;PEAK1;FN1;FER;POF1B;LAMA5;ITGB7;SRCIN1;NTN4;FERMT2;RELN
prerank,cytoplasmic translation (GO:0002181),-0.4408335853085231,-1.7733346385602962,0.0,0.1861854364570647,0.98,47/91,22.61%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;RPS18;RPS6;RPS15A;GSPT2;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;RPL22
prerank,transition metal ion transport (GO:0000041),-0.5358291420777048,-1.7723133495346832,0.0035714285714285713,0.1821086487966167,0.982,11/35,6.32%,SLC30A10;TRPC3;FTH1;TFRC;SLC39A8;ATP7A;TRPC1;SLC31A1;SLC31A2;SLC11A2;ATP2C1
prerank,digestive tract development (GO:0048565),0.667903887249373,1.769704531317895,0.00430416068866571,0.4324408280523612,0.999,10/32,8.48%,STRA6;PKDCC;GLI1;RARB;COBL;PCSK5;GLI2;CHD8;CCDC39;CLMP
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.7631915431550764,1.7681625455978214,0.004885993485342019,0.42657463031922943,0.999,5/16,8.29%,RORA;FOXK1;PDK4;BCKDK;FOXK2
prerank,melanocyte differentiation (GO:0030318),-0.7233374259537942,-1.7635781949322125,0.0024096385542168677,0.19387263818957226,0.988,4/11,3.98%,ENPP1;LRMDA;KIT;MITF
prerank,limb morphogenesis (GO:0035108),0.7361511572890836,1.7607426448942085,0.005050505050505051,0.4492423292231261,1.0,3/20,4.10%,PTCH1;PCSK5;BMPR1B
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.552308001161718,-1.7591360059471695,0.005988023952095809,0.1965119748978422,0.988,8/27,11.17%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3;AMBRA1
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5704567435843741,-1.7583758267747351,0.0028653295128939827,0.19209292445873266,0.988,7/25,10.37%,ANK2;ACTN2;DMD;SLC6A9;ATP1B1;ANK3;ATP1B2
prerank,camera-type eye development (GO:0043010),0.6728500834588977,1.7572088456532173,0.007751937984496124,0.4546029336936422,1.0,5/25,6.15%,ALDH1A3;STRA6;EFEMP1;NF1;SHROOM2
prerank,mesoderm formation (GO:0001707),0.7425664635479022,1.7545851784634412,0.008319467554076539,0.4554333245239579,1.0,1/17,0.03%,ITGB4
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.7058109891477824,1.7519814167280152,0.011217948717948718,0.45586015869261187,1.0,7/21,11.20%,CAV1;FZD2;AXIN1;GSK3B;CSNK1A1;APC;DVL3
prerank,embryonic digestive tract development (GO:0048566),0.7252877794154913,1.7488833013159073,0.012698412698412698,0.459198552849537,1.0,5/18,2.92%,STRA6;PKDCC;RARB;PCSK5;GLI2
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7127233822020388,1.7467209334736218,0.01361573373676248,0.4584368568186467,1.0,6/21,9.63%,CNKSR3;CAV1;PDE4D;NCK2;NLRP2B;RASSF2
prerank,positive regulation of wound healing (GO:0090303),0.6284117381466896,1.7401800364281084,0.010309278350515464,0.478493135478253,1.0,10/36,10.37%,CLDN1;SMOC2;ST3GAL4;PRKCE;PLPP3;RREB1;KANK1;OCLN;FERMT2;ADRA2A
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.7206104405144069,1.737457288442944,0.0144,0.4806793977042612,1.0,4/19,2.50%,LBP;PRKCE;PIK3AP1;TNIP3
prerank,integrin-mediated signaling pathway (GO:0007229),0.5749916975100484,1.7359280191111635,0.0012515644555694619,0.47643121670966126,1.0,20/73,10.56%,ITGB4;TEC;ITGBL1;CEACAM1;ADAMTS1;DOCK1;CDH17;TXK;PLPP3;SRC;FN1;ADAM10;LAMA5;COL3A1;ITGB7;CUL3;PLEK;FERMT2;LAT;ZYX
prerank,actin cytoskeleton reorganization (GO:0031532),0.5834252374219914,1.735573531435098,0.0076824583866837385,0.46759577628516663,1.0,11/63,5.71%,GAB1;FGF7;CXADR;SIPA1L1;PARVA;CLDN19;PDLIM4;MINK1;TRPV4;THSD7A;FER
prerank,regulation of melanin biosynthetic process (GO:0048021),-0.7220136582605101,-1.7310165532923,0.002277904328018223,0.24985924373025994,0.997,4/10,10.34%,ZEB2;RAPGEF2;ATP7A;CTNS
prerank,negative regulation of locomotion (GO:0040013),-0.6942185758645468,-1.728907424047694,0.009501187648456057,0.24818455991027577,0.998,6/12,13.86%,FBLN1;FRMD5;DUSP3;CCDC125;CRK;SPOCK3
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),0.7231420721383905,1.728554594233321,0.022257551669316374,0.49083002516595364,1.0,3/19,4.67%,THBS4;RIPOR2;RAC2
prerank,cellular response to amyloid-beta (GO:1904646),-0.5216415893143225,-1.7264845750760678,0.0031545741324921135,0.24711885202483128,0.998,8/35,9.43%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;GRIN1;LGMN
prerank,regulation of glucose metabolic process (GO:0010906),0.6502642442016611,1.7259808125619667,0.006925207756232687,0.4930869215095117,1.0,9/34,9.58%,RORA;OGT;GPLD1;FOXK1;PDK4;BCKDK;SELENOS;FOXK2;SIRT7
prerank,smooth muscle tissue development (GO:0048745),0.7867312015757534,1.7255589824654265,0.015254237288135594,0.4848868611770676,1.0,3/10,3.23%,PTCH1;STRA6;NF1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),-0.7126610444441697,-1.7235383786899616,0.013921113689095127,0.24842541649119665,0.998,4/11,15.22%,RAPGEF2;LYN;ANXA1;LGALS9
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.66975957724788,1.7233323188873233,0.01455604075691412,0.48550656135869774,1.0,6/27,9.35%,NTNG2;NTNG1;BRSK1;ULK4;FRMD7;GSK3B
prerank,ventricular septum morphogenesis (GO:0060412),-0.5518411501252435,-1.721509312045043,0.00906344410876133,0.2470031190417966,0.999,9/27,12.75%,ROBO1;TGFBR3;SLIT2;BMP4;TGFBR1;BMPR2;CITED2;PROX1;TGFB2
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.5000765623033395,-1.720533146630577,0.003289473684210526,0.24339514329568998,0.999,11/34,11.17%,FLT1;TEK;PDGFRB;PDGFRA;PIK3R1;KIT;PIK3R3;EPHA8;TNFAIP8L3;RUBCN;AMBRA1
prerank,vasoconstriction (GO:0042310),-0.6893411104037384,-1.7204591626605603,0.019559902200488997,0.23756876385770617,0.999,6/11,15.95%,SLC8A1;PIK3C2A;ACTA2;EDNRA;EDN1;EDN3
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.6958159627340801,-1.7200864368472382,0.009950248756218905,0.2328526952053939,0.999,5/11,2.18%,IGF1R;PLCB1;IGF1;GHR;PIK3R1
prerank,embryonic organ development (GO:0048568),0.5872805068494168,1.7181864970841365,0.006720430107526882,0.5008926833698797,1.0,10/61,3.53%,ALDH1A3;STRA6;PKDCC;RARB;COBL;PBX1;PCSK5;GLI2;STIL;KMT2A
prerank,chordate embryonic development (GO:0043009),0.5924513346449737,1.715699163516559,0.010666666666666666,0.5025176259256064,1.0,10/55,6.14%,PTCH1;FGFR1;SULF1;KIAA1217;PCSK5;STIL;BMP5;DACT1;WNT5A;ADAM10
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),0.7311319255995902,1.712681597808094,0.019261637239165328,0.5061737112865293,1.0,3/17,4.67%,THBS4;RIPOR2;RAC2
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.46519128690058537,-1.7105918378127887,0.0,0.24816852326630873,1.0,8/49,6.94%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18;JAK2
prerank,positive regulation of vasoconstriction (GO:0045907),0.7700463687169985,1.7102958623336324,0.008389261744966443,0.5085408055905978,1.0,3/13,3.83%,CAV1;SMTNL1;SMTNL2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.7579922517999995,1.7078131624231092,0.02058319039451115,0.5013278193306998,1.0,7/12,17.54%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.7579922517999995,1.7078131624231092,0.02058319039451115,0.5013278193306998,1.0,7/12,17.54%,HOMER2;ATP2B4;RCAN1;GSK3B;HOMER3;CHP1;DYRK2
prerank,external encapsulating structure organization (GO:0045229),0.503315077971243,1.7068634082983467,0.0,0.496766509668574,1.0,35/205,7.33%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMC1;LAMB2;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;FN1;NCAN;LAMA5;COL3A1;DAG1;ITGB7
prerank,cellular response to alcohol (GO:0097306),0.6035486581822369,1.7052995140084548,0.011267605633802818,0.4955430706750918,1.0,5/42,5.35%,PTCH1;PTGFR;GPLD1;GRAMD1B;ADCY5
prerank,vesicle transport along actin filament (GO:0030050),-0.5758674523589178,-1.702886797410595,0.010101010101010102,0.2605826749091231,1.0,4/19,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.634230044788072,-1.7017902085984211,0.0027624309392265192,0.257675628960646,1.0,11/15,28.27%,MKNK2;CPEB2;VCP;ZC3H12A;HSF1;DHX36;GSTO1;HNRNPA1;GSTO2;ATF3;DDX3X
prerank,limb development (GO:0060173),0.6507046269981114,1.7008141644609736,0.009216589861751152,0.5077601232599825,1.0,5/28,5.12%,PTCH1;LRP4;PCSK5;BMPR1B;INTU
prerank,atrial septum development (GO:0003283),-0.653902094267008,-1.7007708130152963,0.019704433497536946,0.2546251423483967,1.0,6/13,12.75%,NOTCH2;ANK2;NPHP3;BMPR2;DAND5;TGFB2
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.5484403666385073,-1.700047890030897,0.002688172043010753,0.2508401599101756,1.0,4/24,1.71%,PICALM;NUMB;PID1;DAB2
prerank,regulation of store-operated calcium entry (GO:2001256),0.8125700968897559,1.6990486436399486,0.019400352733686066,0.5068372277173143,1.0,3/10,1.76%,HOMER2;EFHB;SLC8B1
prerank,extracellular structure organization (GO:0043062),0.5001235055117167,1.6960922674069128,0.0,0.5120455308885458,1.0,38/204,8.54%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMC1;LAMB2;ADAMTSL5;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;FN1;NCAN;LAMA5;COL3A1;DAG1;ITGB7;ADAMTS2;TEX14;TNR
prerank,regulation of developmental growth (GO:0048638),-0.517106584345496,-1.6940637214202634,0.009009009009009009,0.2607066275642484,1.0,7/29,6.28%,PLCB1;IGF1;INSR;GHR;LATS2;MBD5;APOE
prerank,muscle tissue morphogenesis (GO:0060415),-0.6200252119137128,-1.693578882611889,0.01932367149758454,0.2566065947360633,1.0,6/16,10.52%,MYLK;TGFBR3;BMP4;TBX1;PROX1;BMP2
prerank,regulation of multicellular organism growth (GO:0040014),0.7307712805922292,1.6924596992374148,0.010169491525423728,0.5199448127916683,1.0,1/15,0.01%,PTCH1
prerank,pharyngeal system development (GO:0060037),0.7461766080950964,1.6890790917224963,0.024834437086092714,0.5279374429638471,1.0,3/15,4.65%,PTCH1;FOLR1;BMP5
prerank,cellular response to superoxide (GO:0071451),-0.6978821302905175,-1.688502727405635,0.013605442176870748,0.26359344215982006,1.0,4/10,6.10%,NOS3;ATP7A;SOD3;PRDX2
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.6825385877497246,1.6881332642182276,0.01892744479495268,0.5242054344310705,1.0,2/21,1.22%,NGF;USP50
prerank,nerve growth factor signaling pathway (GO:0038180),0.7951032744003041,1.6849140120225148,0.020761245674740483,0.5308405425949233,1.0,2/10,1.89%,NGF;RAP1A
prerank,vascular process in circulatory system (GO:0003018),-0.6535064381671096,-1.6843800526051276,0.009685230024213076,0.2632419032238521,1.0,6/13,5.71%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,regulation of tube diameter (GO:0035296),-0.6535064381671096,-1.6843800526051276,0.009685230024213076,0.2632419032238521,1.0,6/13,5.71%,ROCK2;NOS3;GCLM;NPR1;ACE;AGTR1
prerank,positive regulation of neutrophil migration (GO:1902624),0.7148391066269469,1.684237897256643,0.019077901430842606,0.5256193007513219,1.0,3/18,4.67%,THBS4;RIPOR2;RAC2
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.6825447522573003,1.6827655719706742,0.015151515151515152,0.5245379146003246,1.0,3/22,1.89%,NGF;NTRK3;RAP1A
prerank,response to alcohol (GO:0097305),-0.5367437310898294,-1.682021126664161,0.0029411764705882353,0.26361899076173523,1.0,8/27,12.93%,TGFBR3;SLIT2;TGFBR1;GRIN3A;GRIN2B;GRIN1;PMVK;ABCA2
prerank,actin filament organization (GO:0007015),-0.3803214512391768,-1.6807955234531446,0.0,0.26231041345067707,1.0,39/151,11.56%,MYO1D;HIP1;RHOBTB1;EPS8;SVIL;NEDD9;MYO1B;ARHGEF2;RUFY3;MYO5A;TPM1;ELMO1;CDC42;DSTN;MYO6;SHROOM3;RHOBTB3;TRIOBP;TMOD3;PLS3;HIP1R;ERMN;ZBED3;RHOC;MARCKS;ARHGAP17;CAPG;ABI1;FLNA;EVL;RHOH;RHOB;PROX1;TPM3;NEBL;AVIL;LMOD1;TPM2;BAIAP2L1
prerank,macrophage differentiation (GO:0030225),-0.6517898535762007,-1.678840512438809,0.015037593984962405,0.2622598825598521,1.0,6/13,19.29%,IL31RA;CDC42;BMP4;CSF1;CASP8;PARP1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.549488639581508,-1.6726124967889833,0.0169971671388102,0.2717622274346787,1.0,11/22,17.26%,KDM2B;APPL2;NES;GATA2;PROX1;SLC16A2;LRRK2;KDM1A;TOX;ID2;TAFA1
prerank,eye morphogenesis (GO:0048592),0.6707594791652925,1.6725993623917872,0.014705882352941176,0.5651482696287476,1.0,5/19,6.15%,ALDH1A3;EFEMP1;MFAP5;NF1;SHROOM2
prerank,long-term synaptic potentiation (GO:0060291),0.6797436261695868,1.6719559983093577,0.021487603305785124,0.5598736815378537,1.0,4/21,2.75%,PLK2;TSHZ3;RGS14;SLC24A1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.773596730893446,1.6710573109023863,0.015901060070671377,0.5557041104641764,1.0,3/12,4.74%,DCN;ADAMTS12;ATP2B4
prerank,cardiac conduction system development (GO:0003161),-0.5346338674325314,-1.670627873199854,0.0182370820668693,0.2718445947292304,1.0,7/24,12.69%,NOTCH2;GJB6;BMP4;GJA1;SMAD5;CACNA1G;GATA6
prerank,negative regulation of T cell activation (GO:0050868),0.6207358601781141,1.6676666041548471,0.019553072625698324,0.563975209006414,1.0,6/35,4.23%,RIPOR2;CEACAM1;ARG1;GLMN;IL4I1;PTPN22
prerank,response to interleukin-6 (GO:0070741),-0.7129706218772938,-1.667108491028318,0.01160092807424594,0.27558168311539405,1.0,3/10,0.98%,ST3GAL6;PTGIS;PID1
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.5047795387060258,1.6666647424444714,0.0010940919037199124,0.5601693530195893,1.0,18/159,4.59%,NTNG1;TENM2;CLDN1;CXADR;CDH13;CLDN11;CEACAM1;CLDN19;CDH11;PTPRF;MPZL2;GPC6;CDH5;CDH17;HMCN1;CDH9;TRO;DSCAM
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.5228301765481356,-1.6659129179287169,0.006006006006006006,0.27364573444557594,1.0,7/31,3.93%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;TGFBR1;FGFR2
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.5307201267245263,1.665820614569203,0.001184834123222749,0.556495285491925,1.0,15/93,11.27%,NGF;CNKSR3;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1;PDE4D;ATP2B4;NCK2;IRGM;NLRP2B;RASSF2;DOCK7;HDAC6
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.7700734016549666,1.6620582979379679,0.01936619718309859,0.566652678497423,1.0,4/12,5.76%,DCN;CSPG4;UST;NCAN
prerank,catecholamine metabolic process (GO:0006584),-0.6295949369097837,-1.659781162037488,0.007751937984496124,0.2833027691706285,1.0,3/14,3.31%,SNCAIP;COMT;ATP7A
prerank,positive regulation of protein export from nucleus (GO:0046827),0.7205809244746645,1.6591646786357017,0.02975206611570248,0.5726292393780813,1.0,10/15,21.77%,GTSE1;RAPGEF3;BAG3;RBM22;GSK3B;TPR;EMD;YWHAE;TCF7L2;XPO4
prerank,iron ion homeostasis (GO:0055072),-0.43347509083863417,-1.6582379552725044,0.004219409282700422,0.2821916376703946,1.0,22/58,23.51%,PICALM;BMP6;ABCG2;FTH1;TFRC;SCARA5;NEO1;B2M;FTL;SLC11A2;NEDD8;BDH2;FXN;SLC40A1;HFE;SMAD4;CUL1;SKP1;CYBRD1;BOLA2;CCDC115;ISCU
prerank,regulation of neuron projection development (GO:0010975),0.5013326105702498,1.658107022073121,0.0033149171270718232,0.5699120724180734,1.0,29/163,10.75%,ROR2;NTNG2;NTNG1;ITGA6;ROR1;SIPA1L1;NTRK3;LPAR1;RAP1A;PPFIA2;RAB29;RTN4R;TRPV4;LZTS3;WNT5A;BRSK1;ULK4;ABL2;EFNB2;SEMA3A;SRCIN1;KANK1;CDH2;FRMD7;GSK3B;HDAC2;RELN;RTN4RL1;S100A9
prerank,dermatan sulfate metabolic process (GO:0030205),0.7559960305087501,1.6578906336781172,0.0189328743545611,0.5633517579028859,1.0,4/13,5.76%,DCN;CSPG4;UST;NCAN
prerank,GPI anchor metabolic process (GO:0006505),0.65605500600288,1.6565497725750524,0.02556390977443609,0.5621907859065804,1.0,5/26,9.37%,PIGU;GPLD1;PGAP3;PIGB;PIGA
prerank,regulation of axon guidance (GO:1902667),-0.6839883851192528,-1.6551591362250486,0.0228310502283105,0.2854843359008325,1.0,8/10,30.43%,ZSWIM6;YTHDF1;ZSWIM4;NRP1;TUBB2B;ZSWIM8;MYCBP2;ZSWIM5
prerank,aortic valve development (GO:0003176),-0.48676854391060836,-1.6520957234557978,0.010067114093959731,0.288690415085615,1.0,10/34,5.38%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1;BMPR2;TNFRSF1B
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),-0.47258182660893955,-1.6491651330968309,0.0,0.29149657395309186,1.0,19/40,25.83%,HIP1;INSR;ANGPT1;DAB2;B2M;HNRNPK;ANXA2;LDLRAP1;HFE;AHI1;EGF;PICK1;CLU;CCL19;C3;NTF3;GREM1;ARRB2;VTN
prerank,glycosaminoglycan catabolic process (GO:0006027),0.5683181774138377,1.648491213073405,0.007989347536617843,0.5943292160286879,1.0,18/55,17.78%,DCN;GPC3;CSPG4;PRELP;GPC6;NCAN;SDC1;HEXA;GPC2;SDC3;CEMIP2;HSPG2;HEXB;HGSNAT;CHP1;GPC5;VCAN;SDC4
prerank,regulation of tissue remodeling (GO:0034103),0.6933328893599895,1.6466862241546993,0.023178807947019868,0.5954191397958604,1.0,3/18,1.54%,THBS4;CEACAM1;LEPR
prerank,maintenance of blood-brain barrier (GO:0035633),0.6241826237154233,1.6434874292318038,0.015503875968992248,0.6036615588223846,1.0,8/30,4.56%,CLDN1;F11R;LAMA2;LAMC1;SLC12A2;CDH5;TJP2;LSR
prerank,regulation of coagulation (GO:0050818),0.7487990759052977,1.6421224252428308,0.03236797274275979,0.6031378367218768,1.0,4/11,11.69%,CAV1;EPHB2;PROC;HS3ST5
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5808419424988837,1.6415245021689997,0.011157601115760111,0.5987583194589974,1.0,10/45,6.40%,GAB1;PLCE1;EFEMP1;EGFR;FAM83A;REPS2;SOX9;SRC;KIF16B;NCK2
prerank,spinal cord development (GO:0021510),0.7265665407578418,1.6398208877054226,0.040780141843971635,0.5994031269034306,1.0,6/12,13.45%,VIT;GLI2;NF1;RELN;PKD1;SOX4
prerank,response to copper ion (GO:0046688),-0.5624138435744157,-1.6389982053593357,0.02,0.3136248107257184,1.0,8/20,3.81%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,positive regulation of neuron differentiation (GO:0045666),0.584905724016519,1.6373598272751388,0.03829787234042553,0.6041442306444706,1.0,7/40,5.24%,NGF;FGFR1;DLX1;ZC4H2;MMD2;NBL1;HEYL
prerank,negative regulation of lipid metabolic process (GO:0045833),0.6645971564104743,1.636133395622691,0.019448946515397084,0.6034407285769857,1.0,4/22,10.37%,APOD;CEACAM1;NCOR1;ADRA2A
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.5154666464889256,-1.6336195450671085,0.028328611898016998,0.3241917581357998,1.0,7/29,10.52%,ENG;TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;BMP2
prerank,negative regulation of signal transduction (GO:0009968),0.47816258563612185,1.632252296908678,0.0,0.615511027333198,1.0,39/249,9.71%,PTCH1;DCN;APOD;GPC3;PTCH2;UBASH3B;VGLL4;NTN1;RGS14;ADAMTS12;SULF1;NFATC1;NRARP;LEPROT;EGFR;SOCS5;SPRY1;GLIS2;SPRY4;BMP5;IRAK3;PIP4K2B;DACT1;PTPRC;CREB3L1;KANK2;APLN;KIF7;TNFAIP3;HIC1;EGFL7;SIAH1;KANK1;PALM;PTPRJ;PLEK;NLRP2B;SLC27A4;PTPRT
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.5508102962596834,-1.6311253944271666,0.015503875968992248,0.32612345468607873,1.0,4/20,1.71%,PICALM;NUMB;PID1;DAB2
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.6307688322924199,-1.629552582408963,0.016018306636155607,0.3253266917772507,1.0,5/12,15.72%,LYN;BST2;IL34;PTK2;CSF1
prerank,negative regulation of developmental growth (GO:0048640),0.6228777359498029,1.6283559610940088,0.027696793002915453,0.6271204573222552,1.0,3/30,4.30%,PTCH1;RTN4R;CDKL3
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.6905590680734685,1.6249178029494362,0.022690437601296597,0.6370689089124039,1.0,7/16,16.06%,CAV1;LEPROT;BCL3;INPP5F;NF2;PIBF1;SOCS1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.3878579400126584,-1.6243676350776044,0.006578947368421052,0.3346104712646465,1.0,58/110,22.82%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;RPS3;RPL23;RPL17;PNRC2;RPL9;RPL38;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;MAGOH;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;NCBP1;CTIF;MAGOHB;RNPS1;GSPT2;RPL14;RPS2;RPL10A;RPL39;RPL34;RPL5;EIF3E;RPL22;PPP2R1A
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.5433972763465789,-1.6217155937184298,0.014044943820224719,0.3371648994749753,1.0,11/22,21.13%,ANK2;AKAP6;VMP1;CALM1;ATP1B1;SLC9A1;CALM3;JPH2;P2RY6;STAC3;GSTO1
prerank,melanosome transport (GO:0032402),-0.5680352785716538,-1.619070655806566,0.02349869451697128,0.33472630907828177,1.0,9/18,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,pigment granule transport (GO:0051904),-0.5680352785716538,-1.619070655806566,0.02349869451697128,0.33472630907828177,1.0,9/18,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6706965513468195,-1.6189501146620535,0.029748283752860413,0.33048108189722236,1.0,4/10,2.90%,PID1;ENPP1;GRB10;APPL2
prerank,negative regulation of anoikis (GO:2000811),0.7068257427875242,1.6180249122257233,0.04631217838765009,0.6634974988041815,1.0,4/14,6.97%,CAV1;SRC;PDK4;MCL1
prerank,regulation of neutrophil chemotaxis (GO:0090022),0.6527398797486214,1.61764633876988,0.02900763358778626,0.6583256324014846,1.0,5/23,7.89%,THBS4;RIPOR2;MPP1;RAC2;DPP4
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.6151941158745486,-1.6174508244773298,0.028639618138424822,0.33002550378708034,1.0,6/13,14.20%,NOS3;CALM1;GCH1;AKT1;QDPR;MTHFD1L
prerank,regulation of amyloid-beta formation (GO:1902003),-0.47728061217595885,-1.6169884685919578,0.01935483870967742,0.3270996019404479,1.0,12/34,15.47%,IGF1;PICALM;ROCK2;EPHA4;APOE;CASP3;RTN1;GSK3A;SP1;ABCA2;ABCG1;GGA3
prerank,amino acid import across plasma membrane (GO:0089718),-0.5253858220217216,-1.6163593100144336,0.014534883720930232,0.3245179493334978,1.0,11/24,17.11%,SLC6A6;SLC47A1;SLC6A9;SLC7A5;SLC22A4;SLC7A1;SLC16A2;SLC1A3;SLC1A1;SLC3A2;SLC22A2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5312297746574839,1.6162164518438158,0.01394169835234474,0.6583107351230251,1.0,6/73,2.19%,NGF;CAV1;NTRK3;EGFR;RAPGEF3;AXIN1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.7500972030437918,1.6154852994791524,0.0273224043715847,0.6548072838540182,1.0,3/11,2.13%,CAV1;LEPROT;BCL3
prerank,regulation of signal transduction (GO:0009966),0.4775877597234252,1.6149282810010521,0.0,0.6506828479944178,1.0,22/190,6.40%,PTCH1;RORA;IGFBP6;MDFIC;UBASH3B;RGS6;GLI1;PXN;RGS14;PLCE1;SULF1;DTX1;AXIN1;SOCS5;CDC42SE2;OGT;CD55;SRC;NUP62;INTU;IFT81;NCK2
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7394454976261552,1.613807064531529,0.04674457429048414,0.6494018456409034,1.0,2/11,0.82%,CAV1;NEDD4L
prerank,SNARE complex assembly (GO:0035493),0.7626585503471788,1.6129756049104151,0.02901023890784983,0.6463893056459447,1.0,1/10,0.06%,STXBP6
prerank,peptide biosynthetic process (GO:0043043),-0.37049005943401736,-1.6125965428508542,0.0,0.3303124547612938,1.0,69/153,22.69%,DMD;RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;RPL41;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;RPLP1;RPS17;RPS3;RPL23;RPL17;RPL9;FURIN;RPL38;DHPS;RPL36;RPS26;RPS8;RPS12;RPL18A;RPS21;MRPL32;MRPL18;CARNS1;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;MRPL9;MRPL28;GSPT2;MRPS11;MRPS16;RPL14;MRPS18B;RPS2;MRPL42;RPL10A;RPL39;RPL34;RPL5;MRPS12;RPL22;MRPL55
prerank,action potential (GO:0001508),0.5770560099972603,1.6119148058516393,0.026350461133069828,0.6447202273084414,1.0,5/44,4.79%,GNA14;SCN10A;SLC4A3;GNAQ;CACNA1H
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.5992011693345604,-1.611220578703323,0.02512562814070352,0.3290433373905156,1.0,4/14,10.37%,ANK2;ACTN2;ATP1B1;ATP1B2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.520227191826646,1.6101482252233075,0.009400705052878966,0.6472944280725484,1.0,16/100,5.16%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PTPN13;CEACAM1;PIK3AP1;EGFR;WNT16;SOX9;SRC;PIP4K2B;FN1
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),-0.5571540121873843,-1.6092776218175304,0.023376623376623377,0.329934591232968,1.0,7/20,3.53%,ENG;TGFBR3;RBPJ;BMP4;TBX3;TGFBR1;ACVRL1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.5571042364438142,1.6090725535534762,0.01540436456996149,0.6459279044492678,1.0,16/51,14.73%,NGF;EPB41L3;MINK1;KIF20B;GAS7;NBL1;CNTNAP1;TRIO;GPM6A;SLC9A6;PLXNB1;SNX2;SGK1;CTTN;DICER1;CNTNAP2
prerank,tube closure (GO:0060606),0.6088938400113272,1.60833424855337,0.03762662807525326,0.6428351713997417,1.0,7/31,5.28%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,glycolipid biosynthetic process (GO:0009247),0.5914624380722318,1.6077466174636774,0.030428769017980636,0.6392130200291505,1.0,9/38,12.82%,PIGU;ST3GAL4;A4GALT;PGAP3;PIGB;PIGA;ST8SIA5;ST8SIA3;SCCPDH
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.6321334179036064,-1.6073007597742335,0.014925373134328358,0.3309022984305104,1.0,6/13,12.93%,PLCB1;IGF1;IL33;SLC2A10;GOLGA2;ABCA2
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.6291026742781797,1.6063839478813697,0.03816793893129771,0.6389056287004315,1.0,5/25,4.59%,ITGA6;GLMN;EGFR;SRC;DSCAM
prerank,cell cycle checkpoint signaling (GO:0000075),0.7297966279478194,1.6051740006235302,0.03541315345699832,0.638355830626594,1.0,5/12,14.75%,PLK2;WEE1;CHFR;ZWILCH;ZW10
prerank,response to ethanol (GO:0045471),-0.6100305862654357,-1.6044524774261562,0.028985507246376812,0.3349387541142691,1.0,5/14,11.74%,ADCY7;GRIN3A;GRIN2B;GRIN1;GLRA2
prerank,response to amyloid-beta (GO:1904645),-0.46574672157179065,-1.6037943749991899,0.0035211267605633804,0.33280818778374793,1.0,9/44,9.43%,IGF1R;IGF1;LRP1;GJA1;EPHA4;VCAM1;MMP2;GRIN1;LGMN
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.5846498682352087,1.6026513825066475,0.041193181818181816,0.6444319676821344,1.0,5/35,4.99%,PIGU;CAV1;LEPROT;BCL3;PTPRC
prerank,negative regulation of cell migration (GO:0030336),-0.3561417219440043,-1.602346512978659,0.0,0.3329857535701267,1.0,36/137,11.62%,ROBO1;PHLDB2;PTPRG;MCC;ENG;AFDN;CLDN5;LIMCH1;LRP1;SLIT2;TPM1;RECK;DACH1;CLIC4;IGFBP3;IGFBP5;GJA1;EPHA4;PTPRK;ACVRL1;CYP1B1;MITF;PODN;SRGAP1;DUSP10;DUSP3;BST2;TMEFF2;CITED2;EVL;RHOB;SINHCAF;ATP1B2;TRIB1;ARID2;FUZ
prerank,cell-matrix adhesion (GO:0007160),0.5130412069328967,1.602173216888257,0.00834326579261025,0.6406449980021751,1.0,13/95,7.33%,ITGB4;ITGBL1;DLC1;SORBS1;ECM2;ADAMTS12;PPFIA2;ITGA7;PEAK1;SRC;FN1;COL3A1;ITGB7
prerank,sodium-independent organic anion transport (GO:0043252),-0.6692035883914419,-1.6016849450208475,0.020224719101123594,0.33078139879644736,1.0,4/10,10.86%,SLCO3A1;SLCO1C1;SLCO2A1;SLC16A2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.5626839624228239,-1.5996790114328123,0.022670025188916875,0.33181497213863326,1.0,4/18,4.03%,IGF1;IGFBP2;IGF2;IL18
prerank,skeletal muscle organ development (GO:0060538),0.6260232941443982,1.5989843920409885,0.02245508982035928,0.6498282247682151,1.0,3/26,4.33%,STRA6;CAV1;CSRP3
prerank,regulation of cell-cell adhesion (GO:0022407),0.5666444286176741,1.5982302080642161,0.036061026352288486,0.6472659490893352,1.0,7/39,4.48%,MAGI1;EFNA5;CEACAM1;JAG1;MINK1;FLOT2;SRC
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.5345217361953141,1.5964304507700602,0.014925373134328358,0.6499178590473945,1.0,12/72,5.16%,ROR2;GAB1;DCN;ROR1;NTRK3;FGFR1;HCST;PIK3AP1;WNT16;SOX9;SRC;FN1
prerank,regulation of small molecule metabolic process (GO:0062012),0.6201137722039205,1.596357427326258,0.03851851851851852,0.6442650844155084,1.0,6/28,10.99%,RORA;FOXK1;PDK4;BCKDK;FOXK2;NCOR2
prerank,negative regulation of lymphocyte migration (GO:2000402),0.7510304190648351,1.594742455542881,0.04601769911504425,0.6462070380554219,1.0,2/10,1.06%,APOD;RIPOR2
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.5776013239235909,1.5939653706661796,0.039492242595204514,0.64388177292642,1.0,5/37,7.34%,TENM2;CXADR;HMCN1;AMIGO2;CRTAM
prerank,epithelium development (GO:0060429),0.4978454306222699,1.5927193859806248,0.012941176470588235,0.6437883043999483,1.0,12/107,7.23%,PTCH1;MEOX2;CDHR2;RIPK4;STIL;SOX9;DACT1;MTHFD1;KANK2;ANXA4;DAG1;TBX2
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.5173971077594776,1.5895847146402777,0.01649746192893401,0.652285717066082,1.0,11/75,8.17%,NTNG2;NTNG1;LRP4;PARD6B;MINK1;OPHN1;S100A6;BRSK1;RAB3A;S100B;ISL1
prerank,intestinal absorption (GO:0050892),0.7077815633752704,1.5883738283629498,0.03833333333333333,0.652667698776315,1.0,5/13,14.92%,F11R;TJP2;SLC2A2;ADRA2A;SLC46A1
prerank,negative regulation of potassium ion transport (GO:0043267),0.7054665584397692,1.5882832701068565,0.03367003367003367,0.6473377134367103,1.0,2/13,0.82%,CAV1;NEDD4L
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),-0.48709430558246125,-1.588110891695255,0.03133903133903134,0.35872514677492234,1.0,9/28,17.34%,STMN2;STMN4;CAMSAP1;GBA2;STMN1;MAP1B;MAPT;SKA2;ARL2
prerank,aortic valve morphogenesis (GO:0003180),-0.4924942662469899,-1.5875666315938075,0.023178807947019868,0.35576917603742836,1.0,8/30,2.87%,ROBO1;ROCK2;ELN;SMAD6;SLIT2;NOS3;BMP4;TIE1
prerank,ganglioside biosynthetic process (GO:0001574),-0.6001371938966797,-1.586555204247169,0.032418952618453865,0.35457298132994164,1.0,4/15,2.25%,ST3GAL5;ST3GAL1;ST8SIA4;ST6GALNAC3
prerank,respiratory tube development (GO:0030323),0.6146129612936088,1.5859407793066738,0.04093567251461988,0.6524160763489492,1.0,5/28,2.92%,STRA6;FGF7;FGF1;PCSK5;GLI2
prerank,tight junction assembly (GO:0120192),0.5499209259782046,1.5849925589315208,0.02702702702702703,0.6515977132296432,1.0,13/49,11.15%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;LSR;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6781446677602068,1.5830845531130209,0.0496,0.6549966636380463,1.0,5/17,7.53%,CAV1;CEACAM1;AJAP1;SOX9;MAFG
prerank,aorta morphogenesis (GO:0035909),-0.5735375935054123,-1.5829487291465631,0.03864734299516908,0.360199404136548,1.0,8/17,10.38%,ENG;PDGFRB;LRP1;MYLK;RBPJ;ACVRL1;TBX1;PROX1
prerank,amino acid import (GO:0043090),-0.5454566225704958,-1.5821542265506312,0.03428571428571429,0.3581405382084884,1.0,11/21,17.11%,SLC6A6;SLC47A1;SLC7A5;SLC22A4;SLC7A1;SLC25A38;SLC16A2;SLC1A3;SLC6A1;SLC1A1;SLC22A2
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.6310688421676734,-1.582064456359732,0.027972027972027972,0.354390927335525,1.0,6/11,13.97%,NOS3;CALM1;GCH1;AKT1;QDPR;DHFR
prerank,embryonic eye morphogenesis (GO:0048048),0.7241614752895879,1.581851348606443,0.05201342281879195,0.6554746972983382,1.0,5/11,11.10%,ALDH1A3;EFEMP1;MFAP5;TBX2;RARG
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),0.7047840227437127,1.5818455787642336,0.03741496598639456,0.65001382733161,1.0,5/14,5.62%,SULF1;SPRY1;SPRY4;CREB3L1;APLN
prerank,digestive tract morphogenesis (GO:0048546),0.6794414098430271,1.5793904379267318,0.050488599348534204,0.6561487675865976,1.0,2/14,0.56%,STRA6;GLI1
prerank,lymphocyte mediated immunity (GO:0002449),0.7157076034773895,1.5789501148596445,0.047619047619047616,0.6527582362697799,1.0,3/12,7.45%,JAG1;CD55;MSH2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),0.6113320745359555,1.5787547783893099,0.04192546583850932,0.6484232160353455,1.0,5/26,3.90%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,positive regulation of lipid transport (GO:0032370),-0.6205055377171778,-1.5786257378479611,0.028708133971291867,0.3602406096298055,1.0,3/12,6.28%,LRP1;DBI;APOE
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.6808862643864337,1.577568245282871,0.0391156462585034,0.6483935078480937,1.0,4/15,5.76%,DCN;CSPG4;UST;NCAN
prerank,monoacylglycerol metabolic process (GO:0046462),0.7148273376431233,1.5762575221746191,0.04452054794520548,0.6492876698109535,1.0,4/13,8.30%,MOGAT2;MOGAT3;AWAT2;ABHD12
prerank,positive regulation of behavior (GO:0048520),0.7604043805315762,1.5744264571808533,0.04326123128119801,0.6520671069533287,1.0,4/10,11.65%,STRA6;NPAS2;SGIP1;CFAP20
prerank,negative regulation of cellular component movement (GO:0051271),-0.5913805833964876,-1.5732679396110194,0.029339853300733496,0.3711696765498902,1.0,6/15,7.14%,FBLN1;TGFBR3;FRMD5;SP100;CCDC125;CRK
prerank,response to axon injury (GO:0048678),0.6524858759968782,1.5730666487703586,0.0583596214511041,0.6530966876622181,1.0,4/18,10.73%,APOD;FOLR1;SARM1;RTN4RL1
prerank,protein localization to centrosome (GO:0071539),0.6593607883608339,1.5729030314757941,0.06396255850234009,0.6486931929112915,1.0,10/17,19.16%,STIL;CEP131;NEDD1;SNX10;GOLGB1;C2CD3;HOOK3;PCM1;PIBF1;DCTN2
prerank,glucan catabolic process (GO:0009251),-0.5792545342289807,-1.5725242983709282,0.03007518796992481,0.369309797072959,1.0,10/15,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,negative regulation of hemostasis (GO:1900047),-0.6101014148744004,-1.5718531701591587,0.0345679012345679,0.3673584165068004,1.0,5/12,6.50%,TFPI;THBD;SERPINE2;APOE;CD34
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.716246660491954,1.5708440526887804,0.04679376083188908,0.6530325595338496,1.0,3/11,4.99%,CEACAM1;IL4I1;PTPRC
prerank,Rap protein signal transduction (GO:0032486),0.7366283363024297,1.570747074263031,0.05641025641025641,0.6483849902889972,1.0,3/10,1.89%,PLK2;RAPGEF3;RAP1A
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6135051772626186,1.5705914913776153,0.04154302670623145,0.6440616028710124,1.0,7/26,7.28%,ITPR2;ITPR3;SLC8B1;ERO1A;PTPRC;IBTK;CHERP
prerank,bicellular tight junction assembly (GO:0070830),0.5506496479025081,1.5695689689408208,0.03099730458221024,0.6438090874403738,1.0,12/46,11.15%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC
prerank,cell junction maintenance (GO:0034331),0.6841810928539945,1.5694919386907384,0.056666666666666664,0.639265918910662,1.0,1/14,0.18%,CLDN1
prerank,protein localization to microtubule organizing center (GO:1905508),0.6790671001228612,1.5692165632307842,0.06035889070146819,0.6356731444029622,1.0,9/15,19.16%,STIL;CEP131;NEDD1;SNX10;C2CD3;HOOK3;PCM1;PIBF1;DCTN2
prerank,negative regulation of complement activation (GO:0045916),0.7381613415246959,1.5690873017972289,0.05114638447971781,0.6314546107933945,1.0,3/10,8.44%,SERPING1;CD55;SUSD4
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),0.6186771095988866,1.5687983315145757,0.04285714285714286,0.6280980612553665,1.0,5/24,3.90%,RORA;SULF1;CXCL17;IL1A;EIF2AK3
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.5614771795755196,1.5680531134786595,0.033527696793002916,0.6267783449485462,1.0,6/38,8.41%,RORA;PPM1N;TNIP3;PPM1A;TNFAIP3;TNIP1
prerank,positive regulation of nuclear division (GO:0051785),-0.5018588997074813,-1.5667002407945185,0.015015015015015015,0.378071626492518,1.0,5/25,3.56%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,neuron projection morphogenesis (GO:0048812),0.4797363797166565,1.5665478200868237,0.003424657534246575,0.6288209743466233,1.0,27/137,13.06%,NGF;NTNG2;NTNG1;LRP4;EPB41L3;PARD6B;MINK1;KIF20B;GAS7;S100A6;NBL1;DIP2A;CNTNAP1;TRIO;BRSK1;EPHB2;RAB3A;S100B;ISL1;GPM6A;POU4F1;DOCK7;SLC9A6;PLXNB1;SGK1;PTEN;CTTN
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.7091742883566685,1.5656796221177565,0.054187192118226604,0.6281000259689024,1.0,3/12,2.99%,CAV1;CAMK2D;PDE4D
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5181696185871598,1.5650752194569377,0.016560509554140127,0.6263834023671282,1.0,4/76,1.21%,GNA14;HRH1;LPAR1;PLCE1
prerank,cardiac atrium morphogenesis (GO:0003209),-0.587382512730136,-1.5646104526086684,0.020202020202020204,0.3797577990091144,1.0,6/16,12.75%,NOTCH2;ENG;BMPR2;PROX1;BMP2;TGFB2
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.6865583132313534,1.5640778441975725,0.050933786078098474,0.6261259098753097,1.0,1/15,0.03%,NGF
prerank,response to sterol (GO:0036314),0.7291575924892942,1.5636145508594652,0.057391304347826085,0.6237553883645344,1.0,1/11,0.04%,RORA
prerank,regulation of anoikis (GO:2000209),0.6444489652787533,1.5616756966368674,0.05601317957166392,0.6275583461454327,1.0,5/19,6.97%,CAV1;MYBBP1A;SRC;PDK4;MCL1
prerank,cellular glucan metabolic process (GO:0006073),-0.6357601643766494,-1.561633563121345,0.02534562211981567,0.38423055130316935,1.0,4/11,12.73%,PRKAG2;GBE1;UGP2;PPP1R3C
prerank,peripheral nervous system development (GO:0007422),0.6136051568933948,1.5581491853605673,0.05,0.6380943990161465,1.0,3/23,6.12%,NGF;NF1;ARTN
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.7517434675099552,1.5568345735233016,0.06306306306306306,0.6392813240508871,1.0,1/10,0.15%,DCN
prerank,response to organic cyclic compound (GO:0014070),-0.42578061550848095,-1.556699706246421,0.011538461538461539,0.39457407035633085,1.0,23/52,28.88%,PAQR7;IGFBP5;CYP1B1;IL18;ALPL;ARL6IP5;ANXA1;HLCS;LRRK2;ESR1;FGFR4;ABCA2;SLC1A1;DHFR;TRPM2;TLR3;ABCB4;KYNU;GGT5;STAT3;STRN3;CDKN2D;SFRP1
prerank,acylglycerol homeostasis (GO:0055090),0.6435204572376911,1.5563910021026088,0.048494983277591976,0.6367301265872624,1.0,1/20,0.04%,RORA
prerank,heterotypic cell-cell adhesion (GO:0034113),0.609107603649716,1.5562597074817601,0.05446293494704992,0.6328767952742858,1.0,6/25,9.01%,CXADR;PARVA;ITGAX;ITGA7;ITGB7;CD200R1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.6986037773588927,1.5561216282272698,0.06451612903225806,0.6291525048126104,1.0,3/12,10.34%,APOD;PTPRJ;CBLB
prerank,retinal metabolic process (GO:0042574),0.7211427599317323,1.5551575881433477,0.044850498338870434,0.6291502184542368,1.0,3/12,5.83%,ALDH1A3;RDH10;BCO1
prerank,positive regulation of mitochondrial fission (GO:0090141),0.6488968713806962,1.5551344825800093,0.05536912751677853,0.6249844234101581,1.0,10/18,20.64%,DCN;DDHD1;FIS1;MIEF1;BNIP3;RALBP1;PINK1;RALA;PRKN;MUL1
prerank,regulation of chondrocyte differentiation (GO:0032330),0.6170412075647859,1.554286425275228,0.044374009508716325,0.6244593513340512,1.0,7/24,4.10%,PKDCC;MBOAT2;ADAMTS12;EFEMP1;PTHLH;SOX9;BMPR1B
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.611413257317376,-1.5532957156552343,0.05555555555555555,0.4007387630506785,1.0,4/12,12.26%,NUPR1;IL18;IL33;TTBK1
prerank,regulation of steroid metabolic process (GO:0019218),0.6090076230783426,1.553244702325294,0.05239520958083832,0.6247927465065254,1.0,1/23,0.04%,RORA
prerank,cellular response to cadmium ion (GO:0071276),-0.4984820176263506,-1.5526564467612602,0.05120481927710843,0.39864798941860075,1.0,9/24,8.19%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;AKT1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.6415435890443257,-1.5524778357874178,0.026128266033254157,0.39525962324268943,1.0,4/10,7.55%,LYN;FAS;NBR1;MAP2K2
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6160331513688386,-1.551288620657339,0.03695150115473441,0.39467587724637904,1.0,3/12,5.50%,IGF1R;INSR;UVRAG
prerank,positive regulation of DNA replication (GO:0045740),0.6697093717931074,1.551117815553181,0.043478260869565216,0.6298143976151404,1.0,4/16,5.81%,GLI1;EGFR;GLI2;STN1
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.5706823614818108,1.549904281650246,0.033093525179856115,0.6306114366039248,1.0,13/37,17.15%,DYNLL1;DYNC2I1;CEP131;IFT81;KIF3C;CLUAP1;DYNLL2;IFT74;TTC21B;TRIP11;PCM1;DYNC2LI1;DYNC2H1
prerank,extracellular matrix organization (GO:0030198),0.4471421529644146,1.547239484534985,0.0010395010395010396,0.6377179562489211,1.0,40/276,7.33%,ITGB4;TGFBI;DCN;VIT;ITGA6;ADAMTS14;SMOC2;F11R;LAMA2;ECM2;PXDN;MMP28;LAMA4;ADAMTS12;NID1;LAMC1;LAMB2;ADAMTSL5;KLK2;COL6A3;ADAMTS1;MFAP5;ADAM19;ITGAX;MMP15;NF1;COL5A3;SH3PXD2A;ITGA7;ADAMTS19;SERPINH1;CREB3L1;FN1;NCAN;SH3PXD2B;ADAM10;LAMA5;COL3A1;DAG1;ITGB7
prerank,response to cadmium ion (GO:0046686),-0.48950255014587357,-1.5469967744867015,0.0380952380952381,0.4033583791216688,1.0,9/26,8.19%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;AKT1
prerank,activation of phospholipase C activity (GO:0007202),0.598979651874568,1.546377804376148,0.035036496350364967,0.637357761025548,1.0,5/29,4.47%,LPAR1;EGFR;ITK;TXK;GNAQ
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.6291456208625319,1.5462015920761534,0.06349206349206349,0.6340482252628196,1.0,2/18,0.33%,APOD;MDFIC
prerank,positive regulation of cellular metabolic process (GO:0031325),-0.3681483236020362,-1.545046761234935,0.0,0.4045785354285203,1.0,34/98,24.32%,INSR;PDGFRB;ECE1;PID1;ANGPT1;PPARD;SLCO1C1;IL10RB;NR1H3;XDH;ANXA2;AGTR1;KLF4;APOE;NR1H2;AKT1;ZC3H12A;ACLY;THBS1;GHITM;CSF1;EIF4G1;AHI1;EGF;ACE2;IFNAR1;AGT;ROMO1;PICK1;INHBA;GRB2;RIPK1;NTF3;GREM1
prerank,positive regulation of lipid kinase activity (GO:0090218),-0.4786425975339249,-1.543287126769207,0.015151515151515152,0.40575437941666537,1.0,7/29,7.83%,FLT1;TEK;PDGFRB;PDGFRA;KIT;EPHA8;TNFAIP8L3
prerank,electron transport chain (GO:0022900),0.6865803906922181,1.5431174827033303,0.04582651391162029,0.6436691774626099,1.0,2/15,0.66%,PPARGC1A;POR
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.6850116158412328,1.5401696724971983,0.05161290322580645,0.6522119967521866,1.0,4/15,6.93%,RIPOR2;RAPGEF3;CD53;EHD2
prerank,regulation of neuron migration (GO:2001222),0.5967966599195902,1.537481639261031,0.05373134328358209,0.6595140417095325,1.0,6/26,7.12%,NTNG2;NTNG1;KIF20B;ULK4;COL3A1;SEMA3A
prerank,phosphate ion homeostasis (GO:0055062),-0.6406081551628362,-1.5364578809354874,0.035555555555555556,0.4221996005980506,1.0,2/10,12.13%,ENPP1;FGFR4
prerank,cell-cell junction organization (GO:0045216),0.5000333115495351,1.5359900099192394,0.026415094339622643,0.6616567569730076,1.0,11/79,3.53%,CLDN1;CXADR;CDH13;TLN2;CDH11;PARD6B;CDH5;CDH17;CDH9;TRPV4;TJP2
prerank,transepithelial transport (GO:0070633),0.681244330614639,1.535674086607411,0.05564924114671164,0.6589344776950447,1.0,5/15,9.81%,CXADR;SLC12A2;GPLD1;ABCC1;BEST1
prerank,chondroitin sulfate catabolic process (GO:0030207),0.6963457271848508,1.5343279325851509,0.05423728813559322,0.6606314000563747,1.0,3/13,5.76%,DCN;CSPG4;NCAN
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5914549137718212,1.5338913234821407,0.04685212298682284,0.6585418714250124,1.0,4/28,7.49%,NGF;SPI1;TRADD;BAG3
prerank,icosanoid secretion (GO:0032309),-0.63112918833617,-1.5329915781222188,0.05084745762711865,0.4281951595016768,1.0,4/12,7.39%,ABCC4;ACE;BDKRB2;ANXA1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.6897825327155438,1.532904979604411,0.06440677966101695,0.6587669188573139,1.0,2/13,0.33%,APOD;MDFIC
prerank,neurotrophin signaling pathway (GO:0038179),0.6222110338270177,1.530219498484644,0.05736434108527132,0.6658433408313389,1.0,2/21,1.89%,NGF;RAP1A
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.44106537744689844,-1.5288371574939703,0.02364864864864865,0.4371242732499058,1.0,15/36,21.66%,SGMS1;TGFBR1;MADD;FAS;MAZ;NR4A2;BCL2L12;RPS3;BDNF;CSNK2A1;DEPTOR;TPD52L1;STYXL1;QARS1;TMBIM6
prerank,mesoderm development (GO:0007498),-0.5510702031800117,-1.5279056756738445,0.03836317135549872,0.4358585680233731,1.0,7/18,13.61%,TBX3;TIE1;TBX1;BMX;JAK2;MEST;MESD
prerank,regulation of keratinocyte migration (GO:0051547),0.6938862344331963,1.5244809697652164,0.04521739130434783,0.6864375147955942,1.0,4/12,12.83%,FGF7;ARF6;PTEN;MAPRE2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.5694569857684609,1.5227921299137266,0.04721030042918455,0.6894925230438553,1.0,6/32,4.48%,APOD;DLC1;JAG1;AJAP1;CASK;SRC
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6914022531790653,1.5219614927690164,0.05821917808219178,0.6892933499990628,1.0,3/13,9.71%,PIGU;PTPRC;PTPRT
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.6038407114476003,1.5217487458963823,0.05945121951219512,0.6861254525496189,1.0,3/25,1.42%,CAV1;CXADR;CAMK2D
prerank,negative regulation of intracellular protein transport (GO:0090317),0.6124575926509973,1.5216379943280145,0.050078247261345854,0.6825642055034051,1.0,4/22,9.04%,APOD;MDFIC;GDI1;SIAH3
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6554982760477867,1.5212848953324247,0.06643952299829642,0.6799886274833846,1.0,3/14,8.07%,MEOX2;CARD10;STARD13
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5587444540593736,1.5210021809430896,0.041968162083936326,0.6773666061868453,1.0,5/35,3.26%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,regulation of urine volume (GO:0035809),-0.6332319722079895,-1.5202645814060334,0.05934065934065934,0.45641100412846486,1.0,5/10,28.03%,NPR3;NPR1;ADM;ADCY6;HAS2
prerank,catecholamine biosynthetic process (GO:0042423),-0.6338530860529491,-1.5200165492745878,0.06490384615384616,0.45305122871219067,1.0,3/11,12.75%,MOXD1;GCH1;TGFB2
prerank,retinoid metabolic process (GO:0001523),0.500015247304963,1.5191799380203508,0.021601016518424398,0.6812740718096211,1.0,16/71,12.14%,ALDH1A3;STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;CYP2S1;BCO1;OPN1MW;SDC1;SCPEP1;AKR1B10;RDH13;GPC2;SDC3
prerank,regulation of peptide hormone secretion (GO:0090276),0.5021009492781101,1.5186557576614825,0.02574002574002574,0.6796402988317833,1.0,17/67,13.40%,ITPR2;ITPR3;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;TFR2;PRKCA;RAPGEF4;SLC2A2;DPP4;RASL10B;KCNS3;ADRA2A;ENSA;GCK
prerank,negative regulation of proteolysis (GO:0045861),-0.45071410097688425,-1.5176983466932565,0.03460207612456748,0.45621173773008616,1.0,9/34,12.02%,TIMP3;PTPN3;DNAJC1;EPHA4;GAS1;SERPINE2;AKT1;LRRK2;CAMK2N1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.672547598027539,1.5174666988097767,0.050434782608695654,0.6808246941132202,1.0,1/14,0.10%,GAB1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.6898577737104332,1.517099734861107,0.056218057921635436,0.6746588570066767,1.0,3/12,7.57%,EFNA5;SPRY4;KANK1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.6898577737104332,1.517099734861107,0.056218057921635436,0.6746588570066767,1.0,3/12,7.57%,EFNA5;SPRY4;KANK1
prerank,regulation of monooxygenase activity (GO:0032768),0.6078450864038397,1.5167811017991324,0.05625,0.6721024346586009,1.0,6/23,8.37%,CAV1;POR;EGFR;IL1A;DDAH2;NOS1AP
prerank,muscle cell development (GO:0055001),-0.469027670922032,-1.5162990176205136,0.02857142857142857,0.4563968256033384,1.0,11/30,12.01%,MYOF;IGF1;ENG;ANK2;DMD;SLC8A1;DYSF;MYH11;RAMP2;NEBL;KDM1A
prerank,neural tube closure (GO:0001843),0.564138821719986,1.5140417476213408,0.05555555555555555,0.680323086934737,1.0,7/34,5.28%,DLC1;PRICKLE1;COBL;FOLR1;STIL;LMO4;MTHFD1
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.6291942365586977,-1.5140163057412013,0.04185022026431718,0.4600521936087449,1.0,6/10,27.51%,LYN;KIT;CD40;CD24;BTLA;FGR
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.41069886395856814,-1.5137506577245199,0.014336917562724014,0.4569811616447223,1.0,18/47,18.82%,SOX13;TMEM64;PPARD;CREBL2;NAPEPLD;AKT1;CMKLR1;CREB1;ASXL2;ZC3H12A;BMP2;NOCT;ID2;CEBPB;ZFP36;LRP5;RARRES2;PIM1
prerank,sulfur compound catabolic process (GO:0044273),0.5440553348171361,1.513579913666715,0.05255878284923928,0.6784570696476602,1.0,9/38,15.30%,DCN;CSPG4;PRELP;NCAN;ACAT1;HEXA;HEXB;TXN2;GGT1
prerank,ERBB signaling pathway (GO:0038127),0.5139691442832405,1.5134354856296512,0.03835978835978836,0.6752946202316664,1.0,11/64,6.40%,GAB1;PLCE1;EFEMP1;EGFR;FAM83A;REPS2;SOX9;PRKCA;SRC;KIF16B;NCK2
prerank,epidermis development (GO:0008544),0.5163350157574278,1.5132504590206801,0.038910505836575876,0.6723989767676758,1.0,6/56,4.00%,FGF7;GLI1;WNT10A;EMP1;FLOT2;PTHLH
prerank,sprouting angiogenesis (GO:0002040),-0.40503583838767543,-1.5124769553232846,0.015384615384615385,0.45671128430066293,1.0,22/51,14.97%,ROBO1;ENG;TEK;CCBE1;RSPO3;ANGPT1;RNF213;SLIT2;RECK;BMP4;PIK3R3;ACVRL1;KDR;AKT1;VEGFC;RAMP2;FLT4;VEGFD;THBS1;ESM1;BMPER;NRP1
prerank,neutral amino acid transport (GO:0015804),-0.4762564224386141,-1.5124183413537216,0.04105571847507331,0.4530512287121907,1.0,14/28,24.62%,SLC6A6;SLC6A9;SLC7A5;CTNS;SLC43A2;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC1A4;SLC6A17;SLC38A1;SLC7A10;SLC1A5
prerank,negative regulation of cell motility (GO:2000146),-0.3460982236929891,-1.5107271037779353,0.0,0.45467744731939147,1.0,31/108,11.62%,ROBO1;ENG;AFDN;CLDN5;FBLN1;LIMCH1;SLIT2;FRMD5;TPM1;RECK;DACH1;CLIC4;IGFBP5;EPHA4;PTPRK;ACVRL1;CYP1B1;MITF;PODN;SRGAP1;DUSP10;DUSP3;CCDC125;CRK;BST2;TMEFF2;CITED2;RHOB;SINHCAF;ARID2;FUZ
prerank,primary neural tube formation (GO:0014020),0.5769630581998012,1.5076027511067895,0.05891016200294551,0.6927827932605091,1.0,6/30,5.28%,DLC1;PRICKLE1;COBL;STIL;LMO4;MTHFD1
prerank,epithelial structure maintenance (GO:0010669),0.6875966675954592,1.5064132413735671,0.06368330464716007,0.6941591735758802,1.0,1/11,0.29%,CXADR
prerank,regulation of T cell migration (GO:2000404),0.6353058892663015,1.5056533945424977,0.064,0.693714640799796,1.0,2/18,1.06%,APOD;RIPOR2
prerank,axon development (GO:0061564),0.4878982959181318,1.505584258988411,0.03656998738965952,0.690297835040994,1.0,13/78,10.91%,NTNG2;NTNG1;FOLR1;PARD6B;S100A6;BRSK1;EPHB2;RAB3A;S100B;ISL1;POU4F1;RTN4RL1;DOCK7
prerank,fructose 6-phosphate metabolic process (GO:0006002),0.699061026463308,1.5047369225462528,0.08070175438596491,0.6900493470485847,1.0,2/10,3.18%,HK2;PFKP
prerank,apical junction assembly (GO:0043297),0.5128567170790561,1.5032336316267991,0.045931758530183726,0.6921598082490208,1.0,15/53,14.75%,CLDN1;F11R;CLDN11;CLDN19;PARD6B;CDH5;POF1B;OCLN;PDCD6IP;CLDN10;STRN;APC;PATJ;FBF1;CTNNA1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5655967710002658,1.5032102951278175,0.06432748538011696,0.6886167652690296,1.0,2/33,1.68%,NGF;CEL
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),-0.6134398566193362,-1.5029791264293682,0.06074766355140187,0.4742838911121933,1.0,9/10,34.40%,ACER2;CYP1B1;NEXMIF;WNK1;PDE3B;JAM3;SNAI2;HRG;SERPINE1
prerank,cellular response to estradiol stimulus (GO:0071392),0.6213820976660321,1.5020796033134955,0.06924315619967794,0.6898481168082199,1.0,9/18,18.67%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;GPER1;CCDC62;RUVBL2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.6095679494592953,-1.5006033221787083,0.06697459584295612,0.47782466281928776,1.0,3/11,3.02%,PID1;OMA1;TFRC
prerank,monocyte differentiation (GO:0030224),-0.636132508541328,-1.4996989754325039,0.04975124378109453,0.4769417891875309,1.0,6/10,18.52%,IL31RA;BMP4;MT1G;PIR;PDE1B;MYH9
prerank,negative regulation of synaptic transmission (GO:0050805),0.5870726190268958,1.499286911792992,0.06097560975609756,0.6977296358927263,1.0,2/23,2.75%,PLK2;SLC24A1
prerank,protein localization to cell-cell junction (GO:0150105),0.6342370156872443,1.497412128948702,0.08482871125611746,0.7020926726654643,1.0,5/15,7.93%,F11R;CDH5;TJP2;LSR;CGNL1
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.5928320303050578,-1.4970240570828337,0.06473214285714286,0.48149507920419016,1.0,5/12,11.39%,CYP26B1;TRIM16;SNW1;KLF2;CTBP2
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.6752468398669541,1.4961430832066407,0.06944444444444445,0.6968309718189699,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.6752468398669541,1.4961430832066407,0.06944444444444445,0.6968309718189699,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.6752468398669541,1.4961430832066407,0.06944444444444445,0.6968309718189699,1.0,6/12,18.29%,CUL3;ANAPC5;ANAPC7;ANAPC11;ANAPC4;CDC23
prerank,regulation of Ras protein signal transduction (GO:0046578),0.47846678812903637,1.4953684108348149,0.03225806451612903,0.6965701384808443,1.0,20/85,8.07%,NGF;DLC1;ARHGEF28;PLCE1;OGT;AKAP13;LZTR1;SPRY1;OPHN1;MMD2;MFN2;SPRY4;NUP62;KANK2;LRRC59;EPHB2;RDX;KANK1;ARF6;STARD13
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5866314274595023,1.4932390411561567,0.07165109034267912,0.702581514427958,1.0,5/23,9.04%,UBASH3B;CAMK2D;ATP1A2;NOS1AP;CASQ2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.5823955860987726,-1.4924249681686834,0.04477611940298507,0.49290910807103444,1.0,3/13,4.50%,ENPP1;ENTPD1;ENPP3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.49536563831399333,1.4921455503819245,0.034220532319391636,0.703588304404435,1.0,9/64,4.40%,EFNA5;CDH13;UTRN;JAG1;MINK1;AJAP1;CASK;NF1;PEAK1
prerank,cardiac cell development (GO:0055006),0.6820708268899017,1.4910169358992182,0.09457092819614711,0.7047358950513707,1.0,2/11,2.29%,CXADR;JAG1
prerank,cardiac myofibril assembly (GO:0055003),-0.5647219483535235,-1.4888128277255837,0.049738219895287955,0.5005567249233569,1.0,6/15,11.13%,PDGFRB;PDGFRA;OBSL1;MEF2A;PROX1;NEBL
prerank,lipid modification (GO:0030258),0.5445759878046572,1.4887746792040075,0.069164265129683,0.7109306786383118,1.0,5/37,4.15%,DGKA;MBOAT2;PLPP2;DGKZ;PLPP3
prerank,calcineurin-mediated signaling (GO:0097720),0.7149242890174112,1.4879374751582117,0.07777777777777778,0.7073949814309064,1.0,2/10,1.39%,NFATC2;NFATC1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.7149242890174112,1.4879374751582117,0.07777777777777778,0.7073949814309064,1.0,2/10,1.39%,NFATC2;NFATC1
prerank,regulation of metal ion transport (GO:0010959),-0.5493831353324566,-1.4875090582880397,0.06382978723404255,0.500990172500294,1.0,5/16,15.44%,ANK2;SLC30A10;ORAI1;EPB41;SRI
prerank,regulation of RNA splicing (GO:0043484),0.4882489131602853,1.4873981463723127,0.02956298200514139,0.7061387044667129,1.0,21/69,15.02%,AHNAK;AHNAK2;CLK1;QKI;SLC38A2;CELF1;ZNF326;SON;CLK4;RBM22;SRPK1;DYRK1A;RPS13;PTBP3;KHDRBS2;SRPK2;PTBP2;ERN1;RBM38;TRA2B;SF1
prerank,regulation of nuclear division (GO:0051783),0.5948755529216675,1.4873656210666149,0.08607198748043818,0.7028106585023927,1.0,5/20,7.63%,FBXO43;KIF20B;CAV2;CDK13;FBXO5
prerank,positive regulation of ruffle assembly (GO:1900029),-0.5822866623188365,-1.487274902676707,0.0425531914893617,0.49772062894067526,1.0,10/13,38.40%,EPS8;EPS8L2;PFN1;HRAS;P2RY12;DEF8;PLEKHM1;FAM98A;CARMIL2;NLGN1
prerank,positive regulation of neuron projection development (GO:0010976),0.4800416506260916,1.4866106949641333,0.033498759305210915,0.7024084961042679,1.0,9/85,6.49%,ROR2;ITGA6;ROR1;NTRK3;COBL;RAP1A;BMP5;WNT5A;ABL2
prerank,ear morphogenesis (GO:0042471),-0.5138677989821495,-1.4852912219259076,0.06299212598425197,0.500258757700239,1.0,6/20,11.87%,OSR1;CHD7;MYO6;FGFR2;TBX1;ZIC1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.5212565606684062,-1.4838883997378405,0.06684491978609626,0.5011830287641051,1.0,7/18,17.04%,SMAD3;HIF1A;CD34;CD200;TGFB2;LGALS9;SMAD4
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6579770532318083,1.4837941934430137,0.07226890756302522,0.7106711253805857,1.0,3/14,3.49%,CAV1;SPRED1;SPRY1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.6007171637390814,-1.4837471549978007,0.06387665198237885,0.4977878133042518,1.0,5/11,15.22%,CD34;CD200;GATA6;THBS1;LGALS9
prerank,negative regulation of cartilage development (GO:0061037),0.6613911930056047,1.4819368613670911,0.07880910683012259,0.715072604592319,1.0,6/13,12.74%,ADAMTS12;EFEMP1;PTHLH;SOX9;CHADL;WNT9A
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4867572156594397,-1.4808345236176974,0.05042016806722689,0.5038247681614698,1.0,9/22,14.28%,PICALM;ROCK2;LYN;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5991776365113084,1.4798858742071452,0.060995184590690206,0.7202710229894579,1.0,8/21,10.01%,ARHGAP12;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;CGNL1;MAPKAP1
prerank,regulation of chemotaxis (GO:0050920),-0.45449973138935557,-1.4796085487446795,0.025495750708215296,0.5040940772468616,1.0,19/30,32.87%,PDGFRB;PDGFRA;DUSP3;CYRIB;ZSWIM6;YTHDF1;THBS1;ZSWIM4;P2RX4;RARRES2;ZSWIM8;CCL19;MYCBP2;P2RY12;PPM1F;CXCR4;ZSWIM5;AIF1;TREM2
prerank,GPI anchor biosynthetic process (GO:0006506),0.5718519904594569,1.479351849540722,0.06342182890855458,0.7190296186430306,1.0,4/30,9.37%,PIGU;PGAP3;PIGB;PIGA
prerank,regulation of membrane repolarization (GO:0060306),0.6812224392137385,1.4792008380867983,0.07679465776293823,0.7162671072416632,1.0,2/13,0.82%,CAV1;NEDD4L
prerank,vesicle organization (GO:0016050),0.5267848455384583,1.477565752353305,0.053061224489795916,0.719709056356664,1.0,10/46,6.96%,CAV1;USP50;HOOK2;PI4K2B;CAV2;PHETA2;DNM1;ZFYVE16;USP8;SNX10
prerank,carboxylic acid transport (GO:0046942),-0.3976569022343371,-1.4771758426439554,0.02608695652173913,0.5084571978524441,1.0,21/55,23.03%,SLC16A12;SLC13A3;SLC6A6;SLC6A9;SLC7A5;SLC17A5;SLC7A1;SLC7A6;SLC16A6;SLC16A4;SLC15A4;SLC16A2;SLC16A7;SLC1A1;LLGL2;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1
prerank,amide biosynthetic process (GO:0043604),0.5106184517013198,1.4769545222409863,0.060209424083769635,0.7188774477246294,1.0,7/47,5.64%,SGMS2;CERS6;ARG1;ASS1;PCSK5;ALOXE3;CLN8
prerank,regulation of activated T cell proliferation (GO:0046006),-0.44960660295932814,-1.472375631299302,0.04361370716510903,0.5201066167948505,1.0,9/30,18.95%,IGF1;IGFBP2;IGF2;IL18;RPS3;LGALS9;RC3H1;CD24;ICOSLG
prerank,regulation of filopodium assembly (GO:0051489),0.5312708241362061,1.471786843339326,0.05196629213483146,0.7371943424156848,1.0,8/38,9.20%,TENM2;RIPOR2;ARAP1;CAPZB;FXR2;ARF6;PALM;GPM6A
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.6771854058286336,1.4704653731792279,0.09797297297297297,0.7392227969912922,1.0,2/10,8.21%,APOD;PTPRJ
prerank,modulation of chemical synaptic transmission (GO:0050804),0.4646977558584633,1.4704574741761092,0.03241296518607443,0.7358369344123343,1.0,13/107,8.60%,NGF;CLSTN2;CEL;SLC12A2;DGKZ;OPHN1;CLSTN3;NPTX2;ATP1A2;RIMS2;CPLX1;CDH2;GRID1
prerank,diacylglycerol metabolic process (GO:0046339),0.5937331158495356,1.4695499336015163,0.08837209302325581,0.7364537885621258,1.0,4/23,3.58%,DGKA;PLCE1;MOGAT2;DGKZ
prerank,metanephric mesenchyme development (GO:0072075),-0.6201204855326827,-1.4685416434331502,0.0696629213483146,0.5293099415973099,1.0,2/10,3.04%,OSR1;WNT4
prerank,positive regulation of positive chemotaxis (GO:0050927),0.6376710657309874,1.4673709384971794,0.08401976935749589,0.7426053033350202,1.0,2/15,0.50%,NTRK3;CDH13
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.44635189727596214,1.466910073993708,0.019165727170236752,0.7412179849098196,1.0,20/142,9.49%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;SLC8B1;CD55;TRPV4;FKBP1B;CAV2;ATP2B4;FIS1;WNT5A;ATP1A2;ADCY5;ABL2;PTGER4;HCRTR2;HMGB1
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4293939454695487,-1.4668662343320085,0.06159420289855073,0.5309105930487814,1.0,5/36,1.08%,PDGFD;ENG;EPHA7;ERRFI1;ENPP1
prerank,regulation of cholesterol esterification (GO:0010872),-0.6105701973675495,-1.4666332681450969,0.06280193236714976,0.5279742909874258,1.0,5/10,19.17%,AGTR1;APOE;ABCA2;ABCG1;AGT
prerank,presynapse assembly (GO:0099054),0.6331219507146554,1.466365975665414,0.09313725490196079,0.7402118906469192,1.0,3/16,4.96%,LRP4;CEL;WNT5A
prerank,sulfation (GO:0051923),0.6751245310058219,1.4654236488701184,0.08455882352941177,0.740912826150464,1.0,3/11,11.69%,UST;SULT1A1;HS3ST5
prerank,protein maturation (GO:0051604),0.4677369645942696,1.4649938534842442,0.0364963503649635,0.7393693887438769,1.0,16/95,12.32%,PTCH1;PCSK5;ADAM19;OGT;APH1B;CPE;NCSTN;ADAM10;NAA35;PCSK7;LMF1;MME;TASP1;XPNPEP3;TSPAN14;MMP16
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.585296170223005,1.4647216493212114,0.07473841554559044,0.7371761220290499,1.0,8/23,12.70%,CAV1;SOCS5;PTPRC;TSG101;SRCIN1;CBLB;SOCS4;MVP
prerank,mesonephric tubule development (GO:0072164),-0.5553848659128036,-1.4645045796374698,0.07008086253369272,0.531450260980541,1.0,4/15,3.93%,OSR1;SLIT2;BMP4;FGFR2
prerank,clathrin coat assembly (GO:0048268),-0.5365348000807674,-1.4644405834348577,0.07881773399014778,0.5277892370288232,1.0,6/15,10.53%,PICALM;HIP1;HIP1R;EPS15;PIK3C2A;NSG1
prerank,positive regulation of cell projection organization (GO:0031346),0.4548086687837151,1.4643588140800825,0.03368176538908246,0.7354654771669296,1.0,10/115,4.96%,NGF;ROR2;ITGA6;ROR1;NTRK3;TIAM2;RAP1A;CDKL3;PLXNA3;WNT5A
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.5329174232684725,-1.464157009783809,0.07012987012987013,0.5248091915164006,1.0,10/16,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4798503132350834,-1.4640057701583054,0.061971830985915494,0.5216153261480773,1.0,10/24,10.23%,ARHGAP24;COL5A1;DDR1;ACVRL1;PDCD10;ARHGAP35;RHOC;TMEFF2;FLNA;CCN1
prerank,secondary palate development (GO:0062009),-0.5666248820662743,-1.4635033507640518,0.07434052757793765,0.5194279658323726,1.0,7/14,17.78%,LEF1;TGFBR3;CHD7;TGFB3;TGFB2;SMAD4;WNT11
prerank,positive regulation of filopodium assembly (GO:0051491),0.5709568281707925,1.462171203991486,0.09627329192546584,0.7411903472123107,1.0,3/24,2.02%,TENM2;RIPOR2;ARAP1
prerank,type I interferon signaling pathway (GO:0060337),-0.4286594758995414,-1.4614734107975662,0.032679738562091505,0.5191878063088922,1.0,19/41,26.32%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;GBP2;ISG15;IFIT1;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;MYD88;IRF8
prerank,cellular response to type I interferon (GO:0071357),-0.4286594758995414,-1.4614734107975662,0.032679738562091505,0.5191878063088922,1.0,19/41,26.32%,SP100;IFNAR2;ADAR;SAMHD1;IRF2;IFIT2;IFIT3;BST2;IRF1;GBP2;ISG15;IFIT1;IFNAR1;RSAD2;PSMB8;XAF1;IRF5;MYD88;IRF8
prerank,positive regulation of keratinocyte migration (GO:0051549),0.6925552752444784,1.46147149785055,0.08602150537634409,0.7408619180870741,1.0,3/10,12.83%,FGF7;ARF6;MAPRE2
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6853579691523839,1.46126436283602,0.10996563573883161,0.7383811019904299,1.0,3/10,13.05%,CAV1;KCNAB1;KCNRG
prerank,cholesterol homeostasis (GO:0042632),0.48558104784007544,1.4607566602374005,0.05949367088607595,0.7372410446488202,1.0,4/64,4.10%,RORA;CAV1;CYP7B1;GRAMD1B
prerank,glycosaminoglycan biosynthetic process (GO:0006024),0.46623899398944496,1.460084257823083,0.036585365853658534,0.7366172992610066,1.0,23/95,12.14%,DCN;GPC3;CSPG4;ST3GAL4;PRELP;UST;XYLT2;GPC6;GLCE;B4GAT1;CHST7;NCAN;NDST1;SDC1;SLC35D2;GCNT2;CHST2;HEXA;CHST12;HS3ST6;HS3ST5;GPC2;SDC3
prerank,regulation of muscle contraction (GO:0006937),0.5639016007256793,1.4599088858795533,0.0598159509202454,0.7342244037931941,1.0,4/26,5.19%,CAV1;MYBPH;PLCE1;ATP1A2
prerank,embryonic limb morphogenesis (GO:0030326),0.5459177741280823,1.4595958860568903,0.08017492711370262,0.732386869325649,1.0,2/34,1.15%,PTCH1;AFF3
prerank,protein processing (GO:0016485),0.46275548591214977,1.4583976450643361,0.030878859857482184,0.7342177860660819,1.0,10/102,6.14%,PTCH1;KLK2;PCSK5;ADAM19;OGT;APH1B;CD5L;CPE;NCSTN;ADAM10
prerank,response to histamine (GO:0034776),0.6942627952933773,1.4582775540480115,0.10973451327433628,0.7315344546460145,1.0,3/10,12.26%,HRH1;GABRG2;GABRB3
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4584429106619986,-1.4577290450109133,0.03498542274052478,0.5275137302269001,1.0,11/28,15.04%,SHANK3;EPHA4;ADCY1;SQSTM1;APOE;LGMN;EIF2AK4;NSG1;YTHDF1;CALB1;ZDHHC2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),0.6422605149698148,1.4575306899773126,0.09233449477351917,0.7315044528456185,1.0,6/14,12.74%,ADAMTS12;EFEMP1;PTHLH;SOX9;CHADL;WNT9A
prerank,gland development (GO:0048732),0.48637166351251016,1.456973587108322,0.062087186261558784,0.7307647948550493,1.0,10/59,6.10%,STRA6;CAV1;COBL;WNT10A;GLI2;NF1;SOX9;LSR;IGSF3;GFER
prerank,aminoglycan biosynthetic process (GO:0006023),0.5108881428298397,1.4562769468496088,0.06793478260869565,0.7307343297986907,1.0,19/49,17.78%,GPC3;XYLT2;GPC6;B3GALT1;B4GAT1;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;GPC2;SDC3;HSPG2;EXT1;EXT2;GPC5;SDC4
prerank,superoxide anion generation (GO:0042554),-0.562594147310626,-1.454993281510867,0.07600950118764846,0.5328891514436759,1.0,4/13,11.33%,NOX4;CYBA;NOX1;NCF2
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.6180004261092704,1.4549655571525522,0.09344262295081968,0.732859557116862,1.0,2/15,0.70%,SMOC2;FGFR1
prerank,negative regulation of MAPK cascade (GO:0043409),0.46539304303228113,1.4546549561759987,0.048327137546468404,0.7310741345938876,1.0,15/87,8.41%,CNKSR3;CAV1;RGS14;STK38;SPRED1;NF1;SPRY1;SPRY4;IRAK3;PTPRC;EPHB2;DAG1;PIK3R2;PTPRJ;TNIP1
prerank,lipid translocation (GO:0034204),0.5921772898369831,1.453495123634612,0.08373590982286634,0.73256096174116,1.0,12/21,15.78%,ATP8B3;ATP8B1;ABCC1;RFT1;ATP9B;ATP11C;ATP9A;ATP8B2;ABCA1;ATP10B;TMEM30A;ATP8B4
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.5525113024401785,1.4531621945044095,0.07946026986506746,0.7308938286848727,1.0,5/27,5.76%,DCN;CSPG4;XYLT2;CHST7;NCAN
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.6173016001232532,1.4525282703347109,0.10276073619631902,0.727211637028909,1.0,3/16,4.48%,APOD;DLC1;SRC
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.6173016001232532,1.4525282703347109,0.10276073619631902,0.727211637028909,1.0,3/16,4.48%,APOD;DLC1;SRC
prerank,B cell receptor signaling pathway (GO:0050853),0.5406256758421144,1.4518104199775503,0.08739255014326648,0.7273130821771332,1.0,4/32,4.99%,TEC;NFATC2;ITK;PTPRC
prerank,negative regulation of cell differentiation (GO:0045596),0.434802965962588,1.4507548994492059,0.01533406352683461,0.7288890747044051,1.0,33/181,13.50%,PTCH1;RORA;CAV1;TRIB2;ADAMTS12;EFEMP1;EGFR;DTX1;JAG1;SPRED1;SPRY1;PTHLH;SOX9;BMP5;LEO1;WNT5A;TRIO;ANKRD2;PAF1;LDLRAD4;NELFB;RORB;ABCA1;SDHAF2;FERMT2;MEN1;CHADL;SEMA4D;HOPX;WNT9A;PTEN;ZFP36L2;SPRED2
prerank,regulation of ion transmembrane transport (GO:0034765),0.5431059323913506,1.450727669514052,0.09,0.7260518351079727,1.0,11/33,16.76%,NEDD4L;KCNJ4;SCN10A;KCNJ16;ANO6;KCNJ13;CASQ2;NEDD4;CHRM3;WWP2;YWHAE
prerank,triglyceride homeostasis (GO:0070328),0.5602201702052615,1.450486953272131,0.10492845786963434,0.7240766862466333,1.0,1/26,0.04%,RORA
prerank,regulation of insulin secretion (GO:0050796),0.45558313612000106,1.4504481871653765,0.04316546762589928,0.7212782610368175,1.0,17/101,10.37%,EFNA5;INHBB;ITPR2;ITPR3;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;PRKCA;ADCY5;RAPGEF4;SLC2A2;DPP4;ISL1;KCNS3;ADRA2A
prerank,regulation of DNA replication (GO:0006275),0.5002729607980589,1.4502263886565236,0.07191316146540028,0.7192776361232788,1.0,20/49,20.50%,GLI1;EGFR;GLI2;CDAN1;SMC3;STN1;ORC5;FBXO5;ORC3;OBI1;FAF1;CDC6;NUCKS1;BRPF3;GMNN;USP37;DSCC1;DHX9;PPP2CA;ATR
prerank,negative regulation of fat cell differentiation (GO:0045599),0.531513815645176,1.4481832414546052,0.07868383404864092,0.7242412840108471,1.0,4/34,5.05%,RORA;TRIB2;WNT5A;TRIO
prerank,triglyceride metabolic process (GO:0006641),0.5050166161789769,1.4474608199819012,0.07323568575233022,0.7243103453157304,1.0,5/48,3.74%,CAV1;MOGAT2;MOGAT3;GPAT3;AGMO
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.6060617698744191,1.447100613100666,0.09523809523809523,0.7227796014929957,1.0,2/19,0.38%,DCN;SMOC2
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.5584753058213908,1.4464678419762806,0.07863501483679525,0.7226146298622597,1.0,5/27,4.74%,UTRN;SLMAP;NEDD4L;CAMK2D;ATP2B4
prerank,sterol homeostasis (GO:0055092),0.4770869930057227,1.4462729850875522,0.06491885143570537,0.7205999806815938,1.0,4/65,4.10%,RORA;CAV1;CYP7B1;GRAMD1B
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.5075225649285237,-1.4462674894294867,0.06914893617021277,0.5588940607298463,1.0,8/18,14.28%,PICALM;ROCK2;EPHA4;CASP3;GSK3A;SP1;ABCA2;ABCG1
prerank,regulation of calcium ion import (GO:0090279),-0.48614582163946807,-1.4462223375032268,0.06318681318681318,0.5552321140274069,1.0,9/21,32.00%,PDGFRB;CXCL12;EGF;PLPP4;PLN;TRIM27;PSEN2;STC1;CCL2
prerank,acylglycerol metabolic process (GO:0006639),0.5242665172759693,1.4462022786600153,0.08502024291497975,0.7180373985358435,1.0,6/37,10.46%,CAV1;DGKA;AWAT2;DGKZ;ABHD12;LMF1
prerank,miRNA metabolic process (GO:0010586),0.5926449921805821,1.4453756489130745,0.09344262295081968,0.7185840094066039,1.0,8/20,17.20%,DDX17;DIS3L2;LIN28B;DGCR8;DICER1;RAN;PRKRA;XPO5
prerank,protein kinase B signaling (GO:0043491),-0.4837099244071161,-1.445067139929613,0.05621301775147929,0.555640653766721,1.0,4/23,8.19%,IGF1;PIK3R3;KDR;AKT1
prerank,regulation of centriole replication (GO:0046599),0.6210026851372947,1.4449170117428423,0.0932475884244373,0.7174001767150788,1.0,3/17,4.94%,PLK2;STIL;NUP62
prerank,embryonic digit morphogenesis (GO:0042733),-0.5050601351117597,-1.4448927223993997,0.05630026809651475,0.5523802187315475,1.0,7/18,9.26%,ECE1;OSR1;MAP3K20;GLI3;TBX3;HDAC1;WDPCP
prerank,regulation of protein export from nucleus (GO:0046825),0.5861339003240106,1.4447930476560953,0.07981220657276995,0.7150854271818625,1.0,9/23,12.96%,GTSE1;RAPGEF3;PTPN14;BAG3;RBM22;GSK3B;SIRT7;TPR;EMD
prerank,negative regulation of lipid storage (GO:0010888),-0.5052410122531618,-1.4446982367706347,0.050666666666666665,0.5493946258433449,1.0,5/19,8.19%,OSBPL8;PPARD;NR1H3;ABHD5;NR1H2
prerank,negative regulation of secretion by cell (GO:1903531),0.5155041042475002,1.4436263264033276,0.08368794326241134,0.7171234514990061,1.0,1/38,0.06%,STXBP6
prerank,acylglycerol biosynthetic process (GO:0046463),0.5778219507654659,1.44359908998608,0.08497723823975721,0.7144566721708366,1.0,6/23,3.74%,PLCE1;MOGAT2;MOGAT3;GPAT3;AWAT2;AGMO
prerank,ERBB2 signaling pathway (GO:0038128),0.5487740384151358,1.4431712534308365,0.08011444921316166,0.7133360475733094,1.0,4/31,4.48%,GAB1;EGFR;PRKCA;SRC
prerank,positive regulation of synaptic transmission (GO:0050806),0.4814829722642818,1.4413297940300838,0.05188067444876784,0.7180681882074105,1.0,8/72,6.58%,CLSTN2;PLK2;TSHZ3;RGS14;SLC24A1;CLSTN3;EPHB2;RIMS2
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.40113180736186793,-1.4410164070035658,0.03296703296703297,0.5581851262841584,1.0,19/47,26.51%,PDGFRB;PID1;XDH;AGTR1;PLCG2;CYBA;GRIN1;ZC3H12A;THBS1;MAPT;ACE2;ADGRB1;AGT;ROMO1;GRB2;RAB27A;RIPK1;ITGB2;ITGAM
prerank,regulation of establishment of protein localization (GO:0070201),-0.5629956692264221,-1.4408626758196925,0.0948905109489051,0.5550531173602175,1.0,7/13,17.39%,DNAJA1;CORO2B;CEP135;CTSD;CEP120;SCFD1;GAPVD1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5056422963624375,-1.4405995137694236,0.08651399491094147,0.5524820186658455,1.0,8/18,13.39%,AKT3;HDAC7;HDAC9;KDR;ANXA1;PIK3C2A;GATA2;SRPX2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.6327299501743296,1.4378285830215922,0.11036789297658862,0.7293229793436722,1.0,5/14,8.36%,ADAM19;APH1B;NCSTN;ADAM10;DYRK1A
prerank,sodium ion homeostasis (GO:0055078),0.578582376848297,1.4376376017366521,0.09283387622149837,0.7273023060623885,1.0,5/21,9.40%,NEDD4L;SLC12A2;SLC12A3;ATP1A2;ATP1B3
prerank,aminoglycan catabolic process (GO:0006026),0.5574914590740334,1.4374896720255776,0.08734939759036145,0.7252184910267998,1.0,9/28,17.78%,GPC3;GPC6;SDC1;GPC2;SDC3;HSPG2;HGSNAT;GPC5;SDC4
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5286816004979996,1.4373345790865337,0.0893939393939394,0.7229407155595345,1.0,12/35,10.01%,DLC1;RIPOR2;SCAI;LZTR1;SPRY1;MFN2;SPRY4;EPHB2;ABL2;KANK1;CUL3;MAPKAP1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.61223223912914,1.4370217956479112,0.09621451104100946,0.7215726183705966,1.0,3/15,8.30%,PRODH;HOGA1;ABHD12
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.6256455494957986,1.436979122514828,0.10217755443886097,0.7190575243105752,1.0,7/15,15.81%,MGAT3;CHST7;EXTL2;CHST2;NAGK;GNPDA2;OGA
prerank,positive regulation of growth (GO:0045927),-0.3813680209123171,-1.436172976629057,0.038135593220338986,0.5633610948281506,1.0,23/64,17.05%,PLCB1;INSR;ADNP2;CDC42;TGFBR1;CXCL16;RFTN1;AKAP6;AKT1;SLC25A33;TGFB2;CSNK2A1;MFSD2A;SPHK1;CDKN2AIP;FXN;LGI1;PABIR1;ZPR1;HDGFL2;EIF4G1;NCBP1;DERL2
prerank,regulation of neurotransmitter transport (GO:0051588),-0.5230453298098096,-1.4357745486113294,0.08244680851063829,0.561153068178035,1.0,7/16,21.08%,SNCAIP;MCTP2;SYN1;CAMK2A;CPLX2;FLOT1;RIMS1
prerank,canonical Wnt signaling pathway (GO:0060070),0.47015802620858044,1.4356803942265777,0.05290322580645161,0.7216229968796223,1.0,25/68,19.42%,CAV1;WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;WNT5A;GSK3B;CSNK1A1;RARG;APC;DVL3;WNT9A;PTEN;BCL9;FZD7;FZD9;FZD3;PPP1CA;WNT6;CDH3;RAB5A;TCF7L1;SCYL2
prerank,retinoic acid metabolic process (GO:0042573),0.6114049436848497,1.43460146190407,0.10362694300518134,0.7229821555636073,1.0,3/14,8.34%,ALDH1A3;CYP2S1;SCPEP1
prerank,mitotic chromosome condensation (GO:0007076),-0.4623890178450235,-1.4344979182935673,0.05167173252279635,0.5620564949552354,1.0,13/26,30.75%,PHF8;SMC4;NCAPD3;MCPH1;CSNK2A1;AKAP8L;CSNK2B;NCAPG2;NCAPD2;NUSAP1;NCAPH;TTN;NCAPG
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6442150059689784,1.4342222030750769,0.11783960720130933,0.7218086954597956,1.0,3/13,2.99%,CAV1;CAMK2D;PDE4D
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.42593200165916856,-1.4340862944966961,0.06060606060606061,0.5597775487127421,1.0,10/35,9.40%,IRAG1;KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;APOE;ADCY2;PDE2A
prerank,superoxide metabolic process (GO:0006801),-0.4440695792760677,-1.433647092923904,0.069164265129683,0.5577472703105458,1.0,9/29,11.33%,NOS3;ATP7A;SOD3;PRDX2;NOX4;NRROS;CYBA;NOX1;NCF2
prerank,regulation of embryonic development (GO:0045995),-0.43429873039531364,-1.4330697208509173,0.02857142857142857,0.5562148864581733,1.0,8/34,9.26%,PLCB1;PHLDB2;INSR;NPHP3;CFL1;ZBED3;SOX17;WDPCP
prerank,regulation of B cell apoptotic process (GO:0002902),-0.5485365299201778,-1.4319263595071552,0.06796116504854369,0.5568952535292845,1.0,4/12,13.34%,FOXP1;LYN;FNIP1;NOC2L
prerank,positive regulation of sodium ion transport (GO:0010765),0.6581842340475554,1.4318133594935536,0.11960132890365449,0.7286978929641756,1.0,1/12,0.20%,CNKSR3
prerank,regulation of hydrolase activity (GO:0051336),0.474691547761082,1.4316604212209711,0.055341055341055344,0.7266669797914649,1.0,16/71,8.85%,CAV1;EFNA5;SIPA1L1;ARHGAP12;ARHGAP9;CFAP73;TDG;NF1;VAV2;PLXNA3;ARHGEF5;RAB3GAP2;RDX;PAFAH1B1;RAPGEF6;OCRL
prerank,regulation of platelet aggregation (GO:0090330),0.601124935836242,1.431616013881198,0.10104529616724739,0.7241782850597909,1.0,4/17,4.28%,F11R;CEACAM1;CD9;PRKCA
prerank,negative regulation of response to external stimulus (GO:0032102),0.44870918325601766,1.4315723676486767,0.03588516746411483,0.7216528171881029,1.0,22/105,11.15%,RORA;CLDN19;CDH5;CXCL17;AJAP1;CASK;RTN4R;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;MAPK7;PTGER4;ISL1;ACOD1;INPP5F;TRAFD1;SHARPIN;RTN4RL1;PROC
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.44630407457183685,-1.430290830993226,0.058823529411764705,0.5592040925956799,1.0,9/28,12.48%,PID1;ENPP1;GRB10;APPL2;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,myeloid leukocyte differentiation (GO:0002573),-0.3697601195305534,-1.4291207625007727,0.0211864406779661,0.559788546132278,1.0,21/65,19.29%,LEF1;IL31RA;FOXP1;CDC42;BMP4;KIT;CBFA2T3;EP300;MT1G;DEK;CAMK4;TNFRSF11A;CDK4;PIR;LGALS9;PDE1B;CSF1;CASP8;SBNO2;MYH9;PARP1
prerank,positive regulation of cell aging (GO:0090343),-0.5655477375811235,-1.4279761196986154,0.10386473429951691,0.5603452307857852,1.0,5/11,19.73%,B2M;YPEL3;LMNA;EEF1E1;CGAS
prerank,regulation of mitochondrial fission (GO:0090140),0.559452667036537,1.4269371291335586,0.10759493670886076,0.7370086532843084,1.0,11/24,20.64%,DCN;DDHD1;FIS1;MIEF1;STAT2;BNIP3;RALBP1;PINK1;RALA;PRKN;MUL1
prerank,negative regulation of cellular senescence (GO:2000773),-0.5612569868610062,-1.4259809643928067,0.0819277108433735,0.5637195785915827,1.0,5/13,7.77%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,protein localization to cell surface (GO:0034394),0.563877232400476,1.4258217595449718,0.09785932721712538,0.7388130818375658,1.0,3/26,2.89%,PIGU;FGF7;RIC3
prerank,postsynaptic membrane organization (GO:0001941),0.6008097079771801,1.4253503784520463,0.11214953271028037,0.7379724743424675,1.0,3/17,1.81%,LRP4;CEL;MUSK
prerank,endocrine system development (GO:0035270),0.5845897378801591,1.4248508678206422,0.10789049919484701,0.737270075613308,1.0,3/21,3.23%,STRA6;GLI2;NF1
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6661081869462175,1.4242665647416952,0.12037037037037036,0.7369643463389686,1.0,4/10,5.19%,NEDD4L;PRKCE;CAMK2D;ATP1A2
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.5229480563691317,-1.424223209421967,0.08373205741626795,0.5661288021135515,1.0,10/15,35.07%,JMY;ARPC3;IQGAP2;ACTR2;ARPC1A;ARPC5;TRIM27;WASHC1;ARPC5L;ARPC1B
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.4520913647136445,-1.4240768413291394,0.0443213296398892,0.5632253036223945,1.0,11/26,14.68%,PRKAG2;LPGAT1;ADIPOR2;NR1H3;ERLIN1;WDTC1;NR1H2;PRKAB2;SLC45A3;ERLIN2;MID1IP1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),-0.40308069998608576,-1.423193431043639,0.04150943396226415,0.5629691460144947,1.0,13/43,8.52%,IGF1;PDGFRB;IL6R;FOXP1;MEF2D;IGFBP5;BMP4;GJA1;IL18;AKT1;MMP2;LDLRAP1;NOX1
prerank,regulation of interleukin-13 production (GO:0032656),-0.5505294509240524,-1.422509353177205,0.0875,0.5617612227475395,1.0,5/13,15.22%,LEF1;IL18;TNFRSF21;PRKCZ;LGALS9
prerank,positive regulation of ERAD pathway (GO:1904294),0.6292960897081388,1.4223240971953781,0.11492281303602059,0.7419993204918793,1.0,6/13,18.42%,CAV1;USP13;NFE2L2;RNF185;UBQLN1;TMEM259
prerank,regulation of Rho protein signal transduction (GO:0035023),0.46684440174408093,1.4220428793401254,0.06753246753246753,0.7403884080912405,1.0,15/72,8.07%,DLC1;ARHGEF28;F11R;LPAR1;RIPOR2;SCAI;RTN4R;AKAP13;OPHN1;KANK2;ABL2;COL3A1;KANK1;CUL3;STARD13
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5968443245547983,-1.4220300398593015,0.09176470588235294,0.5600099496772224,1.0,9/10,35.85%,PARD3;PLPP1;GAP43;PRKD3;PICK1;HTR2B;F2R;CHRM1;DGKH
prerank,fatty acid elongation (GO:0030497),0.6418736549126863,1.4204712214989592,0.11816578483245149,0.744015997450426,1.0,7/13,13.29%,ELOVL5;HACD4;ELOVL1;ELOVL2;HACD2;ABCD1;ELOVL6
prerank,regulation of axonogenesis (GO:0050770),0.4995965320465497,1.419646336228513,0.06460296096904442,0.7444361809026113,1.0,8/51,5.95%,NGF;SIPA1L1;LRP4;TIAM2;RTN4R;PLXNA3;BRSK1;GDI1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),0.662759802361433,1.419411793861082,0.09717314487632508,0.7427707237474681,1.0,2/10,3.53%,RAPGEF3;KMT2A
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.5212866301882124,-1.4193564076068927,0.07073170731707316,0.565405874603958,1.0,7/16,13.97%,NPR3;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,regulation of stem cell proliferation (GO:0072091),-0.5072352754253628,-1.418739631963027,0.10164835164835165,0.5640474020531729,1.0,5/17,12.01%,FBLN1;GJA1;ACE;AGO3;KDM1A
prerank,regulation of establishment of planar polarity (GO:0090175),0.45337129433943185,1.4185348402603215,0.04924242424242424,0.7436318550975769,1.0,28/88,18.75%,ROR2;PRICKLE1;PRICKLE2;FZD2;SPEF1;SAPCD2;PSME3;DACT1;WNT5A;PSMB5;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,negative regulation of neuron differentiation (GO:0045665),0.5756543861504626,1.4184305961504766,0.10361067503924647,0.7414342558441404,1.0,4/22,9.35%,DLX1;DTX1;SOX9;GSK3B
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5840076800065335,1.4176784666728017,0.11942675159235669,0.7417361716449571,1.0,2/19,2.89%,CHRNB3;RIC3
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.47676897782847366,1.4167349393856081,0.07042253521126761,0.7427946546595774,1.0,6/67,2.16%,VIT;CDH13;UTRN;DOCK5;ECM2;DOCK1
prerank,diterpenoid metabolic process (GO:0016101),0.4826108730761311,1.416053854002439,0.06200527704485488,0.7429039997750992,1.0,13/55,13.34%,STRA6;GPC3;RDH10;GPC6;RDH5;AWAT2;BCO1;OPN1MW;SDC1;AKR1B10;GPC2;SDC3;HSPG2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.5284416573276586,-1.4160061790815381,0.09438775510204081,0.5702381491573073,1.0,5/15,19.17%,PRKCH;IL18;AGTR1;CSF1;AGT
prerank,glycogen catabolic process (GO:0005980),-0.5192961927618848,-1.4159761937294189,0.08888888888888889,0.5670517089448184,1.0,10/15,35.47%,PGM2L1;CALM1;AGL;PHKG1;PYGB;PYGL;PHKA2;PHKB;STBD1;PYGM
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5237332759954804,1.4156796196240122,0.10186513629842181,0.7417882793164984,1.0,9/33,8.91%,GLI1;EGFR;CCND3;ADAMTS1;UBE2E2;FAM83D;RDX;PAF1;DDRGK1
prerank,phosphatidylcholine biosynthetic process (GO:0006656),-0.43299428164838827,-1.4153800303997097,0.060790273556231005,0.5658360793369092,1.0,11/32,13.12%,CHKA;GPAT4;CHPT1;LPIN2;PCYT1A;SLC44A5;ABHD3;CEPT1;LPIN3;CSNK2A1;MFSD2A
prerank,cyclooxygenase pathway (GO:0019371),-0.5977616809371997,-1.414183661178675,0.07621247113163972,0.5666410144459998,1.0,5/10,17.61%,PTGIS;PTGS1;PTGDS;TBXAS1;HPGDS
prerank,regulation of endothelial cell proliferation (GO:0001936),0.46066232035010346,1.413782933347934,0.06273062730627306,0.7466997813778815,1.0,13/88,6.83%,THBS4;CAV1;CDH13;NR2F2;SULF1;NRARP;NRP2;NF1;CAV2;PRKCA;WNT5A;NRAS;EGFL7
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4442175648459069,1.4131021615677921,0.04470588235294118,0.7468171558327014,1.0,16/113,7.32%,THBS4;CLDN1;FGF7;CDH13;LAMC1;NRARP;EGFR;FGF1;NRP2;SOX9;PRKCA;BMP5;WNT5A;NRAS;EGFL7;RREB1
prerank,negative regulation of transport (GO:0051051),-0.3820810578104594,-1.4122175602372848,0.02973977695167286,0.5701144054607903,1.0,19/51,23.77%,EPHA3;CTTNBP2NL;DYSF;NR1H3;SIRPA;PIP4P2;ARL6IP5;BST2;NR1H2;SCAMP5;RUBCN;CRYAB;PXK;EGF;YRDC;RACK1;RAB7A;PRKD1;ERBB3
prerank,cellular iron ion homeostasis (GO:0006879),-0.3748620916006106,-1.412112587746567,0.03225806451612903,0.5673235704750457,1.0,19/55,23.51%,BMP6;ABCG2;FTH1;TFRC;SCARA5;FTL;SLC11A2;SLC39A14;NEDD8;FXN;SLC40A1;HFE;SMAD4;CUL1;SKP1;CYBRD1;BOLA2;CCDC115;ISCU
prerank,protein neddylation (GO:0045116),-0.5393491400072613,-1.410725618103524,0.09836065573770492,0.5688505642462368,1.0,7/13,25.21%,RBX1;UBA3;NEDD8;NAE1;DCUN1D4;UBE2F;DCUN1D3
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5741994596483437,-1.4105345583285496,0.09832134292565947,0.56642374111374,1.0,4/11,1.89%,RSPO3;NKD1;DAB2;WNT5B
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.3744420703469876,-1.4103890392866878,0.03862660944206009,0.5637681300602315,1.0,8/57,6.94%,IGF1;IL31RA;GHR;IL6R;LYN;KIT;IL18;JAK2
prerank,heart development (GO:0007507),0.4288558283375033,1.4102659892526832,0.03471444568868981,0.7553869115170978,1.0,39/150,15.69%,STRA6;CXADR;GPC3;DLC1;NTRK3;PLCE1;SGCD;PCSK5;PDLIM4;GLI2;NF1;AKAP13;SMYD4;SGCG;SOX9;CSRP3;BMP5;FN1;MTHFD1;APLN;SH3PXD2B;COL3A1;TBX2;ISL1;POU4F1;LEFTY1;TAB2;POPDC3;NDUFV2;PTEN;KDM6B;PKD1;SOX4;FLRT2;ERBB4;FOXF1;TNNI3;POU6F1;FOXC2
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5584419346396832,1.4085311868125396,0.11229135053110774,0.7596059239970048,1.0,6/24,7.28%,ITPR2;ITPR3;ERO1A;PTPRC;IBTK;CHERP
prerank,sympathetic nervous system development (GO:0048485),0.6246632132356188,1.408524575334885,0.12080536912751678,0.757041384021701,1.0,5/15,14.91%,NRP2;NF1;SEMA3A;SOX4;FZD3
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.5941951206008457,1.4083204168059684,0.09983361064891846,0.7553659487945924,1.0,10/16,25.38%,LEPROT;CHMP5;CHMP4A;CHMP4B;CHMP4C;LEPROTL1;VPS36;SNF8;TMEM50B;STAM
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.5127974405219253,-1.4082233616044653,0.09725685785536159,0.5679058810720682,1.0,6/16,22.64%,LRP1;APOE;HDAC1;MYOCD;CLU;SRF
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.573066471748648,-1.407835627007495,0.09360730593607305,0.566023458354453,1.0,4/11,12.75%,TGFBR3;TGFBR1;BMP2;TGFB2
prerank,positive regulation of phospholipase C activity (GO:0010863),0.5138508414153212,1.406760867352608,0.09876543209876543,0.7590317884024337,1.0,8/40,6.49%,NTRK3;FGFR1;LPAR1;EGFR;ITK;TXK;GNAQ;ABL2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.31024451727400104,-1.4067455265100834,0.011235955056179775,0.5667003890686573,1.0,50/182,15.25%,IGF1;ROBO1;SLC24A3;PICALM;NOTCH2;ENG;ROCK2;CLDN5;FOXP1;BMP4;SLC7A5;WNT4;ACVRL1;ANKRD13A;LDLR;HIF1A;RBL1;XDH;KLF4;PDCD10;KDR;MYADM;APOE;CD34;HDAC1;HINFP;RBMS3;SUB1;MAP2K2;CRKL;CITED2;GATA2;LGMN;SLC2A10;AGO3;ZC3H12A;BMP2;ESR1;TTBK1;NOCT;TGFB2;MOV10;ID2;MAPT;AGO4;SH3GL2;PARP10;TLE5;LGALS9;RBL2
prerank,xenobiotic transport (GO:0042908),-0.5104204558403764,-1.4060901637290344,0.112,0.5657719480715612,1.0,6/16,5.65%,SLC47A1;ABCG2;SLC7A5;GJA1;SLC22A4;SLC15A2
prerank,skeletal system morphogenesis (GO:0048705),-0.4043532803124477,-1.4060752662128841,0.040892193308550186,0.562760496646031,1.0,20/42,19.28%,PDGFRA;CYP26B1;HOXA3;TGFBR1;FGFR2;HOXB4;DSCAML1;HOXB9;LRP6;HOXC4;SPEF2;HOXA9;FUZ;MEGF8;HOXD4;ANKRD11;HOXD3;LRP5;WWOX;RFLNB
prerank,RNA splicing (GO:0008380),0.44206085003990275,1.4058100117823584,0.06183115338882283,0.7603282008786889,1.0,24/95,17.58%,DHX8;PPARGC1A;HNRNPC;SF3B2;SF3B1;RBM8A;RNPC3;SRSF4;ZRSR2;SNRPF;PRPF3;SRPK1;SRPK2;DBR1;TCERG1;SNRPA1;SFPQ;PPIG;DHX16;TRA2B;PDCD7;SYNCRIP;YJU2;SLU7
prerank,negative regulation of response to wounding (GO:1903035),0.5719635041223246,1.4056836462877516,0.14009661835748793,0.7581893385909276,1.0,6/19,10.73%,CLDN19;AJAP1;CASK;RTN4R;INPP5F;RTN4RL1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.4996099839145011,1.4053576313230918,0.08744710860366714,0.7568871726336921,1.0,9/41,7.28%,ITPR2;ITPR3;SLC24A1;TRPV4;ERO1A;ATP2B4;PTPRC;IBTK;CHERP
prerank,detection of mechanical stimulus (GO:0050982),0.5810652264416707,1.4050286180748623,0.1085899513776337,0.7556750269232266,1.0,5/19,13.09%,PIEZO2;CSRP3;CDH2;PIEZO1;PKD1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.5602585672012752,1.40488850902985,0.10790273556231003,0.7537163708606953,1.0,7/23,16.15%,PLK2;WEE1;CHFR;CHMP4C;ZWILCH;ZW10;INTS3
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6088185121963864,1.404493522182806,0.10499139414802065,0.7527340762565684,1.0,5/15,8.91%,GLI1;FAM83D;PAF1;CUL3;DDRGK1
prerank,negative regulation of coagulation (GO:0050819),-0.5206185543968652,-1.4044263972522006,0.08354430379746836,0.5649525680859725,1.0,5/14,6.50%,TFPI;THBD;SERPINE2;APOE;CD34
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.6118651928526295,1.4038733092868372,0.12095400340715502,0.752637942363348,1.0,3/13,4.81%,TDG;UPP2;NTHL1
prerank,negative regulation of growth (GO:0045926),-0.32494584289902245,-1.4027114178546476,0.006211180124223602,0.567325391339723,1.0,23/121,7.81%,NOTCH2;SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;JADE1;BST2
prerank,protein localization to cell periphery (GO:1990778),0.43144468844740735,1.4026941441928047,0.05239179954441914,0.7548054061338292,1.0,18/133,9.40%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;RABEP1;RDX;EHD2;RAB3A;EFR3A;RAPGEF6;ZDHHC23;ATP1B3
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.5395003973190334,-1.4023882603572881,0.1024390243902439,0.5653445999356219,1.0,4/12,6.28%,PICALM;ROCK2;FKBP1A;APOE
prerank,toxin transport (GO:1901998),0.663640346008403,1.4023521364942204,0.12780656303972365,0.753644574270563,1.0,5/10,12.51%,RAB29;SLC29A4;SLC22A3;ADAM10;RAB40B
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5925790457083304,-1.40226225426139,0.09027777777777778,0.562808582816274,1.0,2/10,4.03%,ROCK2;IL18
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6232258292657721,1.4020563845077765,0.11091549295774648,0.7523195726861254,1.0,7/13,17.74%,CDH13;CD9;ABCA1;CD81;SYK;PPARG;LPL
prerank,transition metal ion homeostasis (GO:0055076),-0.4409426042312272,-1.4014469359682713,0.07210031347962383,0.562425941637714,1.0,7/28,7.56%,PICALM;NEO1;COMMD1;B2M;FTL;SLC39A14;BDH2
prerank,negative regulation of chemokine production (GO:0032682),0.6117102265077844,1.4008399017151607,0.11452991452991453,0.7547970594566192,1.0,1/14,0.19%,APOD
prerank,positive regulation of response to wounding (GO:1903036),0.5382853023144081,1.3998502688156682,0.1045958795562599,0.7560822508014059,1.0,5/24,10.37%,CLDN1;PRKCE;KANK1;OCLN;ADRA2A
prerank,muscle cell migration (GO:0014812),0.657944718005294,1.3995235915859805,0.1559633027522936,0.7549748360332423,1.0,1/10,0.16%,THBS4
prerank,actin nucleation (GO:0045010),-0.4788515670782459,-1.3989305911301158,0.06571428571428571,0.5675423425890871,1.0,14/21,38.93%,JMY;ARPC3;IQGAP2;ACTR2;LMOD1;ARPC1A;ARPC5;TRIM27;WASHC1;ARPC5L;ARPC1B;SPIRE2;SPIRE1;SCIN
prerank,negative regulation of centrosome duplication (GO:0010826),-0.5618888488962062,-1.3986915970893434,0.11851851851851852,0.5653325354931515,1.0,8/11,32.77%,NPM1;TRIM37;KAT2B;KAT2A;CCNF;BRCA1;CDK5RAP2;MDM1
prerank,regulation of cellular senescence (GO:2000772),-0.44178535562319066,-1.398020024121467,0.07741935483870968,0.5644135019520207,1.0,11/28,19.73%,SLC30A10;AKT3;B2M;ZKSCAN3;RBL1;CDK6;YPEL3;NUAK1;EEF1E1;VASH1;CGAS
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.40143783468992233,-1.3964720593044981,0.06343283582089553,0.5663509257785807,1.0,10/40,13.08%,SLC7A11;SLC13A3;SLC7A5;SLC5A6;SLC38A11;SLC7A6;SLC25A30;SLC25A11;SLC16A7;SLC38A7
prerank,sterol metabolic process (GO:0016125),-0.37551283056493534,-1.3961463898337279,0.03773584905660377,0.564514934192872,1.0,17/60,14.98%,PRKAG2;CYP26B1;PPARD;INSIG2;CYP1B1;ARV1;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;PMVK;ABCG1;FDXR;LIPA
prerank,myelin assembly (GO:0032288),0.6655024848075252,1.3954771042856928,0.10849909584086799,0.7679555215320939,1.0,5/10,14.63%,EPB41L3;CD9;CNTNAP1;NCMAP;DICER1
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5090950378488779,1.3953366932000275,0.09620991253644315,0.7659992332065909,1.0,6/33,9.49%,MEOX2;ATP2B4;CARD10;STARD13;MECP2;HMGB1
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4479490216565396,1.3952305050262237,0.06257521058965103,0.7639441853316074,1.0,9/86,5.33%,THBS4;EFNA5;FGF7;TEC;CSPG4;EGFR;SRC;PTPRC;BANK1
prerank,negative regulation of TOR signaling (GO:0032007),-0.40966061290929845,-1.3946377773679668,0.046822742474916385,0.5666097388023164,1.0,15/36,27.54%,UBR1;FNIP1;DEPDC5;RNF152;TMEM127;GSK3A;SPAAR;DEPTOR;TNFAIP8L1;CASTOR2;CASTOR1;FLCN;PRKAA1;ATM;TSC1
prerank,regulation of cellular localization (GO:0060341),0.4868201846010207,1.3933953228544897,0.10252808988764045,0.7688497787657422,1.0,10/46,11.20%,EFNA5;CAMK2D;PARD6B;ADCY5;GOSR1;BRSK1;FER;TRIM46;WWC1;DVL3
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6362589162343973,1.392905203579579,0.11896551724137931,0.7683260927876882,1.0,3/11,8.37%,CAMK2D;SESTD1;NOS1AP
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.5584746194245132,1.3919888023151616,0.10944527736131934,0.7696053230378723,1.0,5/24,7.17%,PPARGC1A;LEPR;SDHAF4;LYRM7;COX15
prerank,morphogenesis of an epithelium (GO:0002009),0.5451031801854767,1.3913630497171472,0.09190031152647975,0.7695429147555158,1.0,7/25,9.11%,RIPK4;WNT10A;ARHGAP12;SOX9;LAMA5;DAG1;TBX18
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.5335773376360112,1.3913302766789524,0.10428571428571429,0.7672456035288094,1.0,1/31,0.01%,PTCH1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.5033838702692753,-1.3910079163445248,0.09574468085106383,0.5756703242374495,1.0,7/17,23.52%,LYN;PDCD10;ARL6IP5;TAOK2;TGFB2;NOD2;STK25
prerank,aspartate family amino acid metabolic process (GO:0009066),0.5877051024263077,1.3909962838184853,0.11181102362204724,0.7661934527576426,1.0,8/18,14.34%,ASS1;NAALAD2;SLC25A12;NIT2;MTHFD1;SLC25A13;GOT1;SMS
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.6340863842584307,1.3898416101320858,0.15034965034965034,0.7682576937464616,1.0,1/11,0.50%,CDH13
prerank,phospholipid translocation (GO:0045332),0.5369696096704573,1.3897295059535815,0.09800918836140889,0.7663232198232798,1.0,11/28,9.88%,ATP8B3;ATP8B1;ANO6;ABCC1;ATP9B;ATP11C;PLSCR1;ATP9A;ATP8B2;ABCA1;ATP10B
prerank,regulation of cellular respiration (GO:0043457),-0.5070813542048698,-1.389707512512573,0.09141274238227147,0.576854479112231,1.0,6/17,17.34%,CBFA2T3;IL10RB;PRDM16;VCP;NOA1;IFNAR1
prerank,regulation of mitochondrial depolarization (GO:0051900),0.6625663373714235,1.38949434261188,0.13074204946996468,0.7647487267239511,1.0,2/10,4.48%,DCN;SRC
prerank,respiratory system development (GO:0060541),0.5273780048078822,1.3894395619206643,0.11891117478510028,0.762606905471503,1.0,4/32,2.92%,STRA6;FGF7;FGF1;GLI2
prerank,positive regulation of GTPase activity (GO:0043547),0.41689158776601554,1.3879386744758644,0.03820960698689956,0.7660368759997334,1.0,31/188,11.43%,ARHGAP42;ITGA6;SIPA1L1;DOCK9;NTRK3;F11R;RGS6;TIAM2;GRTP1;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ARHGEF5;ZC3H15;RAPGEF6;PKP4;TBC1D16;GSK3B;FOXJ1;SLC27A4;TBC1D2;FERMT2;TBC1D8;DOCK7;RIC1;DVL3;PLXNB1
prerank,histone H2A monoubiquitination (GO:0035518),-0.4933862271192059,-1.3874717276505801,0.0891089108910891,0.581462760038336,1.0,12/17,29.65%,PCGF5;KDM2B;PCGF2;BMI1;RYBP;TRIM37;SKP1;RNF2;PCGF6;RING1;DDB1;BCOR
prerank,androgen metabolic process (GO:0008209),0.5751503363231956,1.3866207447182373,0.1266025641025641,0.7685621824950783,1.0,2/18,7.98%,HSD17B3;HSD17B4
prerank,mesenchyme development (GO:0060485),-0.5137484616047994,-1.3855100751228686,0.09660574412532637,0.5846385508239159,1.0,5/15,10.52%,BMP4;TGFBR1;BMPR2;FGFR2;BMP2
prerank,organic hydroxy compound transport (GO:0015850),0.5105486155129173,1.3851667793873594,0.09285714285714286,0.7716495046691878,1.0,3/36,1.94%,STRA6;CEACAM1;ATP8B1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6318102081194669,1.3850835935478147,0.13787085514834205,0.7696020419808374,1.0,1/12,0.24%,CAV1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5003069532644845,1.3844135365576813,0.10659186535764376,0.7699378193593047,1.0,5/39,1.42%,UTRN;SLMAP;NEDD4L;PRKCE;CAMK2D
prerank,endothelial tube morphogenesis (GO:0061154),-0.5754223899960194,-1.383562415540153,0.12356979405034325,0.5880454458565478,1.0,5/10,16.70%,RBPJ;BMP4;ACVRL1;RHOB;CSNK2B
prerank,regulation of neuron differentiation (GO:0045664),0.4587351839488054,1.3833479492131475,0.08450704225352113,0.7716106693089352,1.0,7/76,5.24%,NGF;FGFR1;DTX1;ZC4H2;MMD2;NBL1;HEYL
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4402144300841452,-1.382929584819704,0.08868501529051988,0.587238705314423,1.0,8/27,19.17%,PRKCH;IL18;NR1H3;AGTR1;NR1H2;ABCG1;CSF1;AGT
prerank,response to progesterone (GO:0032570),0.5734178184523879,1.3828534464708024,0.11885895404120443,0.7712222799811282,1.0,4/18,8.58%,CAV1;SRC;CATSPERD;ACOD1
prerank,cellular response to gamma radiation (GO:0071480),-0.49016805575904254,-1.382836304769657,0.11049723756906077,0.5846643087793147,1.0,6/17,14.74%,MAP3K20;WRN;RPL26;KDM1A;CRYAB;HSF1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.5055073887993632,-1.3827084653358652,0.11165048543689321,0.5821865851645475,1.0,9/16,33.90%,AGTR1;PDCD10;GATA2;THBS1;APLNR;DLL4;PPP1R16B;HMOX1;JCAD
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5986771304553674,1.3826773774334564,0.1444805194805195,0.7695535888526767,1.0,1/16,0.38%,TRIB2
prerank,organophosphate ester transport (GO:0015748),-0.4479470547621728,-1.3824936598673065,0.09116809116809117,0.5799520232517852,1.0,10/24,14.16%,OSBPL8;PLTP;PITPNB;LDLR;TNFAIP8L3;OSBPL5;SCP2;EPG5;PRELID2;PRELID3A
prerank,long-chain fatty acid transport (GO:0015909),-0.44049736115880184,-1.3820275359882774,0.0778816199376947,0.5787911312165644,1.0,12/30,14.68%,PRKAG2;ACSL1;ACSL3;APOE;RPS6KB1;ABCD4;CPT2;PRKAB2;ABCD2;MFSD2A;CPT1A;MID1IP1
prerank,glycogen metabolic process (GO:0005977),-0.4309133286514152,-1.3817263222549148,0.07100591715976332,0.5769849785916091,1.0,10/27,17.91%,PRKAG2;PGM2L1;CALM1;GBE1;UGP2;AGL;PPP1R3C;PHKG1;PYGB;PER2
prerank,regulation of NMDA receptor activity (GO:2000310),-0.41638683965808027,-1.3809368177106698,0.06229508196721312,0.5767780245529425,1.0,8/32,9.11%,DAPK1;ACTN2;SLC6A9;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1
prerank,vascular transport (GO:0010232),-0.3473929796610997,-1.3804468281799,0.0427807486631016,0.5755521112619212,1.0,27/81,13.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;INSR;SLCO3A1;ABCC4;LRP1;SLC6A9;ABCG2;SLC7A5;SLCO1C1;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2;SLC2A10;ATP1B2;SLC16A2;SLC16A7;SLC1A3;ABCA2;SLC6A1;MFSD2A;SLC1A1
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5573479295766702,1.3802275399079826,0.12558869701726844,0.7768294319268759,1.0,4/21,5.76%,DCN;CSPG4;CHST7;NCAN
prerank,presynaptic endocytosis (GO:0140238),0.5500857494545817,1.3798888805670915,0.11649016641452345,0.7758012626859112,1.0,11/24,22.13%,CEL;STX1A;OPHN1;STON1;STON2;SNCG;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5300754474113015,1.379774289161528,0.10267229254571027,0.7739055633853937,1.0,10/30,16.06%,CAV1;PTPRC;SRCIN1;INPP5F;SEMA4D;NF2;MVP;PTPN6;PIBF1;SOCS1
prerank,protein lipidation (GO:0006497),0.47218360630401496,1.3793981409815588,0.09195402298850575,0.773094622474116,1.0,15/59,14.87%,PIGU;GPLD1;PGAP3;ZDHHC1;ATG5;ZDHHC7;PIGB;ZDHHC23;PIGA;ZDHHC13;ATG7;ZDHHC20;GLUL;ZDHHC8;PIK3C3
prerank,transport across blood-brain barrier (GO:0150104),-0.34355776120290604,-1.3793825379373892,0.04891304347826087,0.5761988701889984,1.0,27/83,13.71%,SLC24A3;SLC16A12;SLC13A3;SLC22A8;SLC6A6;INSR;SLCO3A1;ABCC4;LRP1;SLC6A9;ABCG2;SLC7A5;SLCO1C1;TFRC;ABCC9;SLC5A6;SLC7A1;SLC15A2;SLC2A10;ATP1B2;SLC16A2;SLC16A7;SLC1A3;ABCA2;SLC6A1;MFSD2A;SLC1A1
prerank,circulatory system development (GO:0072359),0.4271205228858556,1.378099409668373,0.05930232558139535,0.7756616226002373,1.0,34/118,17.02%,STRA6;CXADR;NTRK3;PLCE1;PCSK5;PDLIM4;CDH5;GLI2;NF1;AKAP13;SMYD4;SOX9;FN1;MTHFD1;SH3PXD2B;COL3A1;ISL1;POU4F1;TAB2;POPDC3;PTEN;NXN;KDM6B;PKD1;HSPG2;SOX4;ERBB4;FOXF1;TNNI3;POU6F1;FOXC2;FGF12;FBXW7;PDLIM2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.44717620816736603,-1.3759957053399057,0.0855614973262032,0.5816487070811484,1.0,8/23,17.04%,ZEB2;DAB2;EP300;CITED2;SNW1;SLC2A10;THBS1;SMAD4
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.44717620816736603,-1.3759957053399057,0.0855614973262032,0.5816487070811484,1.0,8/23,17.04%,ZEB2;DAB2;EP300;CITED2;SNW1;SLC2A10;THBS1;SMAD4
prerank,positive regulation of integrin activation (GO:0033625),0.6317789766273119,1.3744900338696286,0.13582342954159593,0.7874868988047096,1.0,5/11,10.07%,CDH17;SRC;PIEZO1;PLEK;FERMT2
prerank,iron ion transmembrane transport (GO:0034755),-0.5754512400134147,-1.374312210036336,0.11246943765281174,0.5843301528546869,1.0,5/10,15.49%,SCARA5;SLC39A8;SLC11A2;SLC39A14;SLC40A1
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6256287079576416,1.3742680485464192,0.14189189189189189,0.7860357568992256,1.0,1/12,0.24%,CAV1
prerank,positive regulation of glucose metabolic process (GO:0010907),0.5993096676510007,1.374165801441753,0.12845528455284552,0.7841850250174043,1.0,2/14,2.89%,PPARGC1A;GPLD1
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.5428537232197342,1.3736947067478582,0.125,0.783809759398066,1.0,6/25,4.10%,SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.6657871346574047,1.373265478642874,0.13405797101449277,0.7831965483316758,1.0,2/10,4.23%,LBP;PTPN22
prerank,regulation of glycogen metabolic process (GO:0070873),-0.5323504222152882,-1.3731406324364985,0.10858585858585859,0.5855381086333721,1.0,9/12,40.86%,AKT1;PPP1R3B;PPP1R3C;RUBCNL;KHK;PPP1R3E;PPP1R3F;PPP1R3D;GCGR
prerank,dicarboxylic acid metabolic process (GO:0043648),0.4796094155423046,1.3726353157955722,0.09370816599732262,0.7832805091566494,1.0,22/52,18.96%,ASS1;FOLR2;MDH1B;AADAT;NIT2;MTHFD1;HOGA1;ALDH18A1;OGDH;ALDH5A1;MDH1;DLST;ACOT8;L2HGDH;GOT1;SLC46A1;GGT1;PHYH;ME2;ALDH1L2;SLC19A1;GPT2
prerank,central nervous system neuron development (GO:0021954),-0.5022286521820848,-1.372152126261182,0.11290322580645161,0.5861811294605587,1.0,5/15,14.31%,RAPGEF2;ATP7A;ARHGAP35;GBA2;MAPT
prerank,negative regulation of defense response (GO:0031348),0.4480643863103893,1.3719403584112349,0.07440100882723834,0.7838551971381645,1.0,16/77,11.15%,RORA;CDH5;CXCL17;PCBP2;FNDC4;IRAK3;TNFAIP3;TRIM21;SELENOS;MAPK7;PTGER4;ISL1;ACOD1;TRAFD1;SHARPIN;PROC
prerank,response to interferon-gamma (GO:0034341),-0.34978380500108125,-1.3714405991772158,0.03902439024390244,0.5858666267087866,1.0,25/67,28.12%,DAPK1;SP100;CXCL16;SIRPA;GBP3;GBP4;GCH1;BST2;RPL13A;GAPDH;GBP6;CCL13;GBP7;LGALS9;GBP2;CD40;PDE12;DAPK3;SHFL;CCL19;AQP4;KYNU;IRF8;CASP1;CIITA
prerank,Golgi to endosome transport (GO:0006895),-0.4914758604906462,-1.3714383473079321,0.0906801007556675,0.5831843412495014,1.0,11/16,27.01%,AP2A1;VPS13C;WIPI1;DOP1B;EPS15;SORT1;MON2;SYS1;AP1AR;CORO7;KLHL20
prerank,regulation of centrosome duplication (GO:0010824),0.5300243776953603,1.3714134768818211,0.12099125364431487,0.7835783013754346,1.0,8/29,12.90%,PLK2;STIL;CEP131;CHMP5;PDCD6IP;CHMP4B;CHMP4C;GEN1
prerank,positive regulation of glucose import (GO:0046326),-0.4616535001819816,-1.3711370049558007,0.0830945558739255,0.5814488482996218,1.0,5/21,2.55%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2
prerank,regulation of smooth muscle contraction (GO:0006940),0.5682859935203389,1.3710994857708427,0.13848631239935588,0.7825009009612499,1.0,2/20,1.21%,CAV1;PLCE1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.45625447383409223,1.3705827604827996,0.08919597989949749,0.7821860099261005,1.0,9/69,4.09%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;NF1;PLCL1;TPTE
prerank,cognition (GO:0050890),0.48683772987501456,1.3701863488532853,0.10780141843971631,0.7814362249217491,1.0,4/42,3.23%,STRA6;ST3GAL4;MGAT3;NF1
prerank,linoleic acid metabolic process (GO:0043651),0.5733912758821355,1.369146488384988,0.15384615384615385,0.7832872669238419,1.0,6/17,12.76%,ELOVL5;ALOXE3;ELOVL1;ELOVL2;ABCD1;PNPLA8
prerank,cell-cell junction assembly (GO:0007043),0.45361283445128187,1.3688113770026908,0.09948320413436693,0.7823390543356773,1.0,11/63,4.42%,CLDN11;TLN2;CDH11;EPB41L3;PARD6B;CDH5;CDH9;TRPV4;CD9;PRKCA;CNTNAP1
prerank,modulation by symbiont of entry into host (GO:0052372),0.5728302300665039,1.3669112318914483,0.1590909090909091,0.7874012447892692,1.0,4/16,15.72%,CAV1;TRIM21;HS3ST5;TRIM5
prerank,cellular response to chemical stress (GO:0062197),0.43429290520765085,1.3667596766009675,0.06755126658624849,0.7857950893764624,1.0,19/96,13.79%,CAV1;PPARGC1A;LRRC8D;GPX8;MGAT3;ETV5;TRPV4;ERO1A;FOXO3;KEAP1;FANCC;SELENOS;SLC4A11;LONP1;STX2;NFE2L2;ATG7;BRF2;HTRA2
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.6416545332896175,1.3666169679862377,0.17055655296229802,0.7841285652135388,1.0,3/10,4.10%,PKDCC;SOX9;BMPR1B
prerank,response to gamma radiation (GO:0010332),-0.4438609714965204,-1.365710615809857,0.0915032679738562,0.5959780433764487,1.0,13/24,27.27%,MAP3K20;WRN;RPL26;KDM1A;CRYAB;HSF1;TRIM13;HRAS;FANCD2;LIG4;DCUN1D3;PRKAA1;ATM
prerank,amino acid transport (GO:0006865),-0.3819761212921889,-1.365454161033486,0.06324110671936758,0.5940369784494922,1.0,18/49,24.62%,SLC7A11;SLC6A6;SLC7A5;SLC7A1;SLC38A11;SLC7A6;SLC43A2;SLC38A7;SLC25A47;SLC3A2;SLC38A5;SLC25A29;SLC1A4;SLC6A17;SLC38A1;SLC38A9;SLC7A10;SLC1A5
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.5345089618870341,1.3653955082707459,0.12463343108504399,0.7866228989758755,1.0,10/25,17.84%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ADPGK;ENO3;GCK;PGK1;ENO2
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.4834871728349206,1.3651200087807944,0.11854951185495119,0.7853622799692358,1.0,7/44,12.99%,NGF;SRC;SFN;RPS6KA3;USP47;DHCR24;AQP1
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.5353176274325455,1.3650516113952997,0.13541666666666666,0.7834009098808077,1.0,3/27,2.99%,CAV1;CAMK2D;PDE4D
prerank,negative regulation of leukocyte activation (GO:0002695),-0.5176574348565431,-1.3646526885252275,0.12,0.5938263269408247,1.0,11/15,34.98%,IL31RA;NR1H3;CD200;ZC3H12A;GRN;FCGR2B;MILR1;CD300LF;CD300A;LRFN5;CD84
prerank,myofibril assembly (GO:0030239),-0.40230089228438876,-1.3628852198979873,0.05555555555555555,0.5969369734703063,1.0,10/42,11.30%,PGM5;PDGFRB;ACTN2;PDGFRA;TPM1;OBSL1;TMOD3;CFLAR;CSRP2;LMOD1
prerank,negative regulation of nuclear division (GO:0051784),0.6294475395737201,1.3628622257941077,0.15505226480836237,0.789720215912125,1.0,4/11,9.46%,FBXO43;TOM1L1;FBXO5;TOM1L2
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.5848135028943928,1.3627989867485355,0.1353135313531353,0.7877681686282073,1.0,4/15,3.42%,TEC;EGFR;ITK;TXK
prerank,glycine transport (GO:0015816),-0.5814426514169031,-1.3626528551770472,0.13665943600867678,0.5949873991021868,1.0,4/10,22.37%,SLC6A9;SLC25A38;SLC38A5;SLC6A17
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5085072610693595,-1.361529132879448,0.12771739130434784,0.5957382306073604,1.0,8/15,29.81%,IGF1;AKT1;FXN;GHITM;OPA1;CLU;PSMD10;TRIAP1
prerank,negative regulation of cell aging (GO:0090344),-0.5053882221796249,-1.3590486661642451,0.10696517412935323,0.6012106988496789,1.0,5/16,7.77%,SLC30A10;AKT3;ZKSCAN3;RBL1;CDK6
prerank,histone H3-K4 trimethylation (GO:0080182),0.6348657106990561,1.3589900619707285,0.13944954128440368,0.8002651489421138,1.0,3/11,3.72%,OGT;KMT2A;BEND3
prerank,regulation of protein neddylation (GO:2000434),-0.5714691046185834,-1.3585154655015057,0.140625,0.6001280302386465,1.0,9/10,40.78%,HIF1A;EPAS1;DCUN1D4;RPL5;DCUN1D3;RPL11;DCUN1D5;COPS9;DCUN1D1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),0.4968914636687537,1.3585033566398619,0.12395543175487465,0.7998753694596873,1.0,10/35,15.72%,NR3C2;RBFOX2;PGR;SRC;UBR5;DDX17;TMF1;NEDD4;GPER1;YAP1
prerank,platelet degranulation (GO:0002576),-0.32363573031313636,-1.3578683797608984,0.020134228187919462,0.5995596677190617,1.0,29/118,14.24%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;SPARC;LYN;CDC37L1;IGF2;NHLRC2;CALM1;PROS1;TGFB3;VEGFC;CYRIB;QSOX1;SYTL4;PHACTR2;FLNA;MANF;TGFB2;VEGFD;THBS1;TMSB4X;F5;LGALS3BP
prerank,negative regulation of cytokine production (GO:0001818),0.41007569928142096,1.357804722686251,0.06408839779005525,0.8000681328616583,1.0,26/163,10.19%,APOD;TRIB2;INHBB;HOMER2;CEACAM1;UBE2L6;BCL3;PCBP2;PTPN22;IRAK3;PTPRC;FN1;CHID1;TNFAIP3;ANXA4;N4BP1;SELENOS;RARA;PTGER4;ACOD1;CD200R1;FOXJ1;HMGB1;NPLOC4;AXL;TAX1BP1
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.5050326039268617,1.357608475687231,0.125,0.798729502426094,1.0,8/32,9.83%,MYBBP1A;PPP1R13B;BCL3;FHIT;PHLDA3;HIPK1;MSH2;POU4F1
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5957250410690038,1.3572394074572616,0.14285714285714285,0.7979858434907421,1.0,4/15,5.71%,CDH13;CEACAM1;EGFR;FER
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.5815312460519306,1.3570734380941014,0.1342281879194631,0.7963570244107505,1.0,2/15,2.06%,SMOC2;FGF1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4356132866437936,-1.3570701611382001,0.0851063829787234,0.5997058284886466,1.0,6/26,3.66%,IGF1;OSBPL8;INSR;PIK3R1;CREBL2;C2CD5
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.640942611317661,1.356901277776534,0.15992970123022848,0.7948302567514368,1.0,1/10,0.21%,ETV4
prerank,myotube differentiation (GO:0014902),-0.4808232281700987,-1.3563041608102913,0.12668463611859837,0.5993552050122204,1.0,8/17,21.03%,IGF1;ADAMTS5;KCNH1;ADAMTS15;SORT1;MYEF2;NOS1;ADAM12
prerank,myeloid cell differentiation (GO:0030099),-0.377830767160398,-1.3561895847228305,0.07326007326007326,0.5970829927592793,1.0,22/47,32.34%,LYN;SNRK;MFHAS1;KIT;UBA5;JAK2;RPS19;CASP3;SLC25A38;TAL1;TET2;INHBA;RPS14;JAK3;RASGRP4;KMT2E;ALAS2;CEBPA;KAT6A;UFL1;EPO;CDKN2B
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.5946344455089646,-1.3552997585240893,0.12529550827423167,0.5972914404042156,1.0,4/10,21.43%,ADGRV1;PDZD7;TSKU;PLS1
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4684890008392351,1.3541489316134974,0.1039136302294197,0.8033469138845999,1.0,9/54,11.37%,CAV1;NEDD4L;KCNJ4;KCNJ16;KCNIP4;GABBR2;NOS1AP;KCNAB1;NEDD4
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6313884101586709,1.3538924932976313,0.15808823529411764,0.8021513460665369,1.0,3/10,1.42%,NEDD4L;PRKCE;CAMK2D
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.5329258043254586,-1.3534279817027524,0.12771084337349398,0.5979199902258695,1.0,4/12,8.51%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.5329258043254586,-1.3534279817027524,0.12771084337349398,0.5979199902258695,1.0,4/12,8.51%,IGF1;CAMTA1;AKAP6;SLC9A1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.580951022975938,-1.3522065696278551,0.11190476190476191,0.5994426792340414,1.0,6/10,32.00%,KDR;IL33;JAK2;NOD2;NAMPT;CCL2
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.4841298244346554,1.351506872198672,0.11310344827586206,0.8090500683033521,1.0,10/46,11.28%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,negative regulation of platelet activation (GO:0010544),-0.48140807829575116,-1.3507996913995775,0.12064965197215777,0.6014066915367876,1.0,6/16,6.28%,PRKG1;PDGFRA;NOS3;THBD;SERPINE2;APOE
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.4716717058548316,-1.3505889726747626,0.0968586387434555,0.5995166292750459,1.0,6/17,10.37%,GJC1;GJD3;GJA1;SLC8A1;ATP1B1;ATP1B2
prerank,regulation of protein kinase activity (GO:0045859),0.4221349033859284,1.3499790682375687,0.07268464243845252,0.8128628955329076,1.0,19/106,11.08%,TRIB2;UBASH3B;PLCE1;CEACAM1;RAP1A;SPRED1;NF1;PRKAG1;MMD2;GNAQ;PTPRC;LCP2;SFN;RASSF2;LAT;CEP85;RELN;RTRAF;TAB2
prerank,regulation of dopamine secretion (GO:0014059),-0.4339252386686765,-1.3496525656640124,0.11078717201166181,0.599984583976792,1.0,18/25,43.50%,SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;FGF20;SYT8
prerank,cellular response to increased oxygen levels (GO:0036295),0.615749605896653,1.3494574695413335,0.15726495726495726,0.8127657181905862,1.0,1/11,0.24%,CAV1
prerank,cell junction organization (GO:0034330),0.4448981641642121,1.3492479682763514,0.09873417721518987,0.8114253264774908,1.0,7/71,3.66%,CLDN1;CXADR;LRP4;RAB8B;PPFIA2;TJP2;OPHN1
prerank,copper ion homeostasis (GO:0055070),-0.4831245437211747,-1.3486758341693137,0.08333333333333333,0.6004439014149896,1.0,4/17,5.15%,ATP7A;COMMD1;SLC31A1;SLC31A2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.38517322695703554,1.3484727423976197,0.016359918200409,0.8122482592101514,1.0,43/390,7.09%,NGF;ROR2;GAB1;ROR1;EFNA5;FGF7;SIPA1L1;NTRK3;ARHGEF28;UBASH3B;SORBS1;FGFR1;PXN;SH2D2A;RGS14;SULF1;EGFR;MUSK;EFNB1;CYFIP2;FGF1;NRP2;DOCK1;GPLD1;RBFOX2;SPRED1;GIGYF2;APH1B;CAV2;EIF2AK3;VAV2;SRC;DNM1;ATP6V0D2;KIF16B;PDK4;FER;NCSTN;EPHB2;NCK2;SHB;LCP2;EFNB2
prerank,lipid oxidation (GO:0034440),0.6086128382378037,1.3474005950510595,0.14612676056338028,0.8142152514927631,1.0,1/12,0.58%,PPARGC1A
prerank,regulation of gastrulation (GO:0010470),-0.5044322547342852,-1.347237363673256,0.12709832134292565,0.6026107926944945,1.0,2/14,1.09%,PHLDB2;OSR1
prerank,2-oxoglutarate metabolic process (GO:0006103),0.6047404290562471,1.3471149507010995,0.16554054054054054,0.8131037903001418,1.0,8/13,22.42%,AADAT;OGDH;DLST;L2HGDH;GOT1;PHYH;GPT2;IDH2
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.2797694497200326,-1.347070387341922,0.0,0.600616004472258,1.0,122/306,25.06%,RPL37A;RRBP1;CREBL2;WRN;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;TOP3A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RBMS1;BLM;RPS24;APOE;RPLP0;ATRIP;MEF2A;HARS1;PTMA;MCM6;RPS19;HBS1L;RPL31;RPL41;RPL13A;RPL30;ORC2;RPL29;MRPS6;RPS16;RPL3;NR4A2;RPLP1;RRAGC;RPS17;EEF1D;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;POLR3A;RPS8;POLA1;RPS12;MMS19;RPL18A;RPS21;MRPL32;CLSPN;CDC7;MRPL18;TOPBP1;RAD1;GCNT1;EEF1B2;BARD1;RPS18;RPLP2;EIF4G1;TIPIN;RPS6;RPS15A;MRPL9;MRPL28;PWP1;RNPS1;HOXD3;RAD17;POLR2F;GSPT2;RFC2;MRPS11;POLR2A;POLR2J;RAD9B;GAL3ST2;POLR2D;MRPS16;POLR2K;RPL14;MRPS18B;TIMELESS;RPS2;TOP1MT;MRPL42;RPL10A;THAP1;INHBA;THRB;ALAS1;RPL39;RPL34;RPL5;MRPS12;FUT9;RPL22;MRPL55;POLD2;EEF2;RPS9;RMI2;CDC45;MRPL36;RPS14;POLA2;CDK2;BRCA1;RPS25;PCLAF
prerank,regulation of leukocyte activation (GO:0002694),-0.5172723500071373,-1.34618076762847,0.11547911547911548,0.6008385417226256,1.0,6/14,13.76%,LYN;MFHAS1;CD200;GPR137B;MYO18A;PJA2
prerank,dendritic spine organization (GO:0097061),-0.4386074839255959,-1.3452431263600586,0.12215909090909091,0.6015468261618039,1.0,6/26,9.43%,IGF1R;INSR;SHANK3;CDC42;ITGA3;LGMN
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.4332158350694383,1.3444714829851279,0.08173690932311622,0.8212124750770935,1.0,25/85,18.75%,ROR2;PRICKLE1;PRICKLE2;FZD2;PSME3;WNT5A;PSMB5;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,negative regulation of viral life cycle (GO:1903901),-0.5059629219804562,-1.3441741583787783,0.12433862433862433,0.6024435371898116,1.0,3/15,7.81%,LY6E;MID2;BST2
prerank,amyloid-beta metabolic process (GO:0050435),0.5625795698543354,1.3439936185786716,0.16965742251223492,0.8208812297089952,1.0,6/16,10.88%,MGAT3;APH1B;NCSTN;DYRK1A;BACE2;MME
prerank,regulation of synapse assembly (GO:0051963),0.48231624494003894,1.3436914155678588,0.1248303934871099,0.8198059336340661,1.0,5/46,6.39%,CLSTN2;MUSK;GPC6;CLSTN3;EPHB2
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.5626155899467022,1.343368249013566,0.14686468646864687,0.8189659971817458,1.0,6/17,16.38%,CEACAM1;DGKZ;PTPN22;PTPRJ;SH2D1A;EZR
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5504212120855363,1.3432754654474552,0.15016501650165018,0.8171496671670493,1.0,6/18,7.68%,DLC1;RIPOR2;SCAI;ABL2;KANK1;CUL3
prerank,positive regulation of cell communication (GO:0010647),0.5148005623886229,1.3432598197906083,0.16172106824925817,0.8150350702759088,1.0,3/28,6.58%,CLSTN2;CLSTN3;RIMS2
prerank,neurotransmitter uptake (GO:0001504),0.6166135677873033,1.3431884423512543,0.14361702127659576,0.8131445964678173,1.0,5/12,6.69%,SLC1A7;SLC29A4;SLC22A3;ATP1A2;SLC1A6
prerank,collagen fibril organization (GO:0030199),0.42906396137978997,1.343024190659425,0.10024752475247525,0.8116691216825134,1.0,8/88,4.90%,ITGB4;ITGA6;ADAMTS14;PXDN;COL6A3;NF1;COL5A3;SERPINH1
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.48151643166198155,-1.3429359520312647,0.13136729222520108,0.6039362748730235,1.0,4/17,6.63%,ITGA1;PDGFRB;PPP1R12A;CALM1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.4462925024031392,-1.3421165282824143,0.11797752808988764,0.6038618909402117,1.0,8/22,17.34%,AEBP1;HSPA8;APOE;CAMSAP1;GBA2;MAP1B;MAPT;ARL2
prerank,negative regulation of biomineral tissue development (GO:0070168),-0.4445747249961315,-1.3420314879986601,0.12021857923497267,0.6016775051684762,1.0,4/21,8.56%,ROCK2;ENPP1;NOS3;ASPN
prerank,response to ATP (GO:0033198),-0.4799665923526309,-1.3407307251902976,0.14673913043478262,0.6032781240079605,1.0,7/18,27.70%,TRPC3;ABCC9;P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,positive regulation of calcium ion import (GO:0090280),-0.5351152641491534,-1.340276558873158,0.15566037735849056,0.6023553173633451,1.0,2/12,6.45%,PDGFRB;CXCL12
prerank,regulation of dendritic cell apoptotic process (GO:2000668),-0.568614332679942,-1.340274900129691,0.1480637813211845,0.5999458960938918,1.0,3/10,6.45%,RAPGEF2;LYN;CXCL12
prerank,regulation of MAPK cascade (GO:0043408),0.40370127643284487,1.3400891207316774,0.06349206349206349,0.8210030920688248,1.0,25/157,9.49%,ROR2;CAV1;ROR1;NTRK3;FGFR1;LPAR1;CEACAM1;EGFR;PELI2;MINK1;SPRED1;NF1;CAV2;FAM83D;PTPRC;FN1;STYX;ULK4;ARHGEF5;DAG1;PHLPP1;PIK3R2;PTPRJ;STK3;HMGB1
prerank,small GTPase mediated signal transduction (GO:0007264),0.42203230053099344,1.3398442407447546,0.09112426035502959,0.8197408033566111,1.0,21/103,11.23%,PLK2;NTN1;TIAM2;ARHGAP31;PLCE1;USP50;ARHGAP18;ARHGAP32;RGL1;MRAS;NF1;NUCB1;USP8;NRAS;KRAS;RREB1;RAPGEF6;KSR2;LAT;ADRA2A;PLD1
prerank,positive regulation of cytokinesis (GO:0032467),0.4928953193132351,1.339078895089388,0.1476121562952243,0.8205778043391748,1.0,10/32,13.55%,PRKCE;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT
prerank,cellular sodium ion homeostasis (GO:0006883),0.5788840982096419,1.338754127448338,0.1579861111111111,0.8196262640761262,1.0,4/15,9.40%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,lung development (GO:0030324),0.5007694011900677,1.3381782181623199,0.1518624641833811,0.8196620746788773,1.0,4/33,2.92%,STRA6;FGF7;FGF1;GLI2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5436618470303477,1.3381738492420194,0.14592933947772657,0.8175507549069495,1.0,9/23,15.79%,TPTE;MTMR7;MTMR6;OCRL;INPP5F;MTMR3;PTEN;MTMR12;MTMR1
prerank,positive regulation of immune system process (GO:0002684),-0.4861636557710092,-1.3380339659266054,0.11282051282051282,0.6047441440726279,1.0,5/16,22.17%,ANXA1;TGFB2;LGALS9;RSAD2;NCKAP1L
prerank,regulation of membrane depolarization (GO:0003254),0.5706576171896607,1.337990627516574,0.14263074484944532,0.8161657621627031,1.0,6/18,13.19%,NEDD4L;CAMK2D;SCN10A;SCN2B;ABCD1;FHL1
prerank,response to iron ion (GO:0010039),-0.5344864165657185,-1.3379524851214124,0.17258883248730963,0.6026309426335049,1.0,6/12,16.13%,BMP6;B2M;HIF1A;SLC11A2;FXN;HFE
prerank,carboxylic acid catabolic process (GO:0046395),0.6160641301856703,1.3378623265009546,0.1576271186440678,0.8146040730685201,1.0,5/12,14.46%,IL4I1;BCKDK;NAGK;ACOT8;GNPDA2
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.45116172221301293,1.337669420086933,0.11224489795918367,0.8132699661738139,1.0,8/61,6.65%,NGF;F11R;LPAR1;RTN4R;AKAP13;MMD2;LRRC59;COL3A1
prerank,mononuclear cell differentiation (GO:1903131),-0.4401600312412671,-1.3359968361378818,0.1072463768115942,0.6061942695292466,1.0,8/24,18.52%,IL31RA;LYN;BMP4;MT1G;PIR;PDE1B;TRPM2;MYH9
prerank,aorta development (GO:0035904),-0.5013920920244036,-1.3358237771935098,0.12098765432098765,0.6042741410719732,1.0,5/14,9.40%,ROBO1;PDGFRB;LRP1;TBX1;PDE2A
prerank,phospholipid dephosphorylation (GO:0046839),0.48945556740111185,1.3355984070101132,0.12465753424657534,0.8190851437130842,1.0,12/37,15.79%,PLPP2;TPTE;PLPP3;MTMR7;MTMR6;OCRL;INPP5F;MTMR3;PTEN;MTMR12;PLPPR1;MTMR1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5185735906377156,1.3354661189577561,0.14086687306501547,0.8175231697816796,1.0,8/25,15.24%,LEO1;CDK13;ELL;NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5
prerank,neuron migration (GO:0001764),-0.37340029078385906,-1.3344480302366408,0.07575757575757576,0.6061259693097192,1.0,17/48,14.97%,NAV1;RAPGEF2;MARK1;ADGRL3;CEP85L;NDNF;SPOCK1;ELP3;DCX;NR4A2;CDKL5;DCDC2;TUBB2A;MDGA1;MAP1B;CDK5R1;NRP1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3897997185214191,1.3338457046875323,0.061068702290076333,0.8216051247736318,1.0,26/190,9.13%,RORA;CAV1;VGLL4;PPM1N;ARHGAP12;TNIP3;PDE4D;SPRED1;NF1;PHLDA3;SPI1;SRC;ATP2B4;PPM1A;UACA;BANK1;TNFAIP3;NDUFS3;MCL1;DAG1;CGNL1;PHLPP1;PIK3R2;PTPRJ;TNIP1;PLEK
prerank,phosphatidic acid metabolic process (GO:0046473),0.47433487640798944,1.333664330795904,0.12602739726027398,0.820152152753766,1.0,10/48,11.28%,DGKA;DDHD1;GPAT3;ACP6;DGKZ;SLC27A1;AGPAT4;LCLAT1;PLD1;AGPAT5
prerank,purine-containing compound salvage (GO:0043101),-0.5385421833279456,-1.3333130522582657,0.1407766990291262,0.6072536744748315,1.0,2/12,3.33%,ADK;HPRT1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.41047076224450396,-1.3332943825748453,0.0915032679738562,0.6049435074886068,1.0,6/30,6.22%,FLT1;BMP4;KIT;HOXB4;ACE;KDR
prerank,positive regulation of protein catabolic process (GO:0045732),0.4312757318976497,1.3331175285872954,0.08782936010037641,0.820147697770757,1.0,22/84,17.81%,PLK2;GPC3;VGLL4;NEDD4L;AXIN1;GPLD1;DACT1;WNT5A;TNFAIP3;RDX;GSK3B;ADRA2A;APC;NEDD4;FAF1;ATG7;WWP2;FZR1;EZR;ITCH;VPS11;STX5
prerank,megakaryocyte differentiation (GO:0030219),-0.5379304796882164,-1.3326251418343553,0.14719626168224298,0.604649997762573,1.0,3/11,13.79%,KIT;UBA5;TAL1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.40685840747678714,-1.3317554629963464,0.10963455149501661,0.6050645469792241,1.0,9/33,15.54%,IGF1;OMA1;TFRC;AKT1;ACAA2;FXN;MAPT;GHITM;OPA1
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.49244876249973385,1.3313897625961004,0.13876967095851217,0.8245602895505361,1.0,10/34,15.20%,UBASH3B;PTPN13;PTPRF;PTPN22;PTPRJ;PTPRT;PTPN18;DUSP8;PTPRO;PTPN6
prerank,regulation of blood coagulation (GO:0030193),0.5231743105061102,1.33075808005032,0.15160796324655437,0.8249523691194358,1.0,3/27,1.69%,CAV1;ST3GAL4;FAP
prerank,regulation of catabolic process (GO:0009894),0.5565815348470223,1.3305742405815753,0.15294117647058825,0.8235717987190565,1.0,5/18,12.13%,NEDD4L;FAP;FAM83D;ZDHHC7;FAF1
prerank,regulation of astrocyte differentiation (GO:0048710),-0.5252627171677984,-1.3303377918627646,0.16705336426914152,0.6071685022326294,1.0,6/12,25.08%,EPHA4;SERPINE2;BMP2;ID2;CLCF1;NOTCH1
prerank,translation (GO:0006412),-0.2926166295393421,-1.3296808396066933,0.0,0.6069217216002706,1.0,85/208,25.05%,RPL37A;RRBP1;RPL19;RPL8;RPL37;RPS15;RPS29;FARSB;RPL35A;RPS7;RPS20;RPL32;EEF1A1;RPS27;RPL26;RPL27;RPS24;RPLP0;HARS1;RPS19;HBS1L;RPL31;QRSL1;RPL41;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;RPLP1;YARS1;RPS17;EEF1D;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;RPS8;RPS12;RPL18A;ABCE1;RPS21;MRPL32;MRPL18;APEH;RARS1;NOA1;EEF1B2;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;MRPL9;MRPL28;PPA1;EEF1E1;GSPT2;MRPS11;MRPS16;RPL14;MRPS18B;QARS1;RPS2;MRPL42;GATC;RPL10A;RPL39;RPL34;RPL5;MRPS12;RPL22;MRPL55;EEF2;MRPS34;RPS9;MRPL36;RPS14;TRMT112;RPS25
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.623922616457457,1.3294424475382594,0.18783542039355994,0.8259239826871553,1.0,2/10,4.99%,CEACAM1;PTPRC
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.4395283647613963,1.3289096996302108,0.10723192019950124,0.8260203756830585,1.0,10/75,6.83%,THBS4;CDH13;FGFR1;NRARP;NRP2;PRKCA;WNT5A;APLN;NRAS;EGFL7
prerank,BMP signaling pathway (GO:0030509),-0.3534341177591954,-1.3288552470584385,0.05726872246696035,0.6071678065095445,1.0,15/62,13.17%,ENG;SMAD3;BMP6;SMAD6;TGFBR3;BMP4;SMAD9;ACVRL1;BMPR2;SMAD5;TGFB3;SLC33A1;BMP2;TGFB2;MEGF8
prerank,cellular response to nitrogen compound (GO:1901699),-0.4515917598526672,-1.328591065376052,0.10410958904109589,0.6056486322321858,1.0,10/20,21.44%,ROCK2;BLM;EPG5;HSF1;DDI2;NSMCE3;PDE12;TIMELESS;NR1H4;RIOK3
prerank,female gonad development (GO:0008585),0.557964627557572,1.3281794555445685,0.15619967793880837,0.8268718021910532,1.0,2/19,0.77%,INHBB;NR2F2
prerank,regulation of acrosome reaction (GO:0060046),-0.5620939306519962,-1.3277119258027956,0.16273584905660377,0.6059190463174918,1.0,1/10,0.08%,PLCB1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",0.5658345900080181,1.327559584345074,0.1752411575562701,0.8272181215638703,1.0,7/16,19.33%,CDK13;DDX17;CELF4;HNRNPM;SFPQ;SLU7;DHX9
prerank,positive regulation of cellular component organization (GO:0051130),-0.3136820728624741,-1.327412624830484,0.043209876543209874,0.604479921313777,1.0,33/107,12.75%,ASAP1;IGF1R;TRABD2B;INSR;ATP10A;SHANK3;LRP1;DAB2;TGFBR1;TFRC;BCL2L11;FNIP1;TMED9;FNIP2;APOE;FRMPD4;RHOC;SLF2;TGFB3;SH3GLB1;NOX1;SURF4;VCP;SLF1;RPS3;AR;AJUBA;CLIP3;BID;MMP1;MPP7;NRXN1;TGFB2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),-0.39316642688846487,-1.3271154258939786,0.07692307692307693,0.6031449428321238,1.0,11/39,9.43%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;SH3KBP1;EPS15;LGMN
prerank,positive regulation of MAP kinase activity (GO:0043406),-0.34548511073969645,-1.326875910379685,0.06018518518518518,0.6016974042606211,1.0,23/66,19.53%,FLT1;PDGFD;ROBO1;SASH1;PDGFRB;KIT;PDCD10;TRAF6;PIK3R6;MAP3K10;IL34;RPS3;LRRK2;TNFRSF11A;EDN1;EDN3;DVL2;EGF;CD40;DIRAS2;TPD52L1;CD24;MST1R
prerank,histone deubiquitination (GO:0016578),0.5427500958446678,1.3268300584306618,0.14444444444444443,0.8279292577090672,1.0,5/18,13.25%,BRCC3;TAF10;UIMC1;TRRAP;USP15
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.3271682276949756,-1.3263553613759365,0.061452513966480445,0.6011827534845211,1.0,37/84,20.32%,SASH1;TEK;ETS1;ANXA3;ROCK2;ANGPT1;NOS3;SPARC;FOXP1;BMP4;AKT3;BMPR2;HIF1A;KDR;AKT1;GATA2;LGMN;AAMP;ZC3H12A;RHOB;PROX1;SP1;FLT4;THBS1;MAP2K3;TMSB4X;EDN1;NRP1;P2RX4;RIN2;EGF;HSPB1;CD40;AGT;BCAR1;MET;GFUS
prerank,autonomic nervous system development (GO:0048483),0.5690212679567037,1.325857662355517,0.16720257234726688,0.829465937003143,1.0,5/17,13.45%,NF1;FN1;SEMA3A;KIF26A;SOX4
prerank,ion homeostasis (GO:0050801),0.5013997504486406,1.3258165932310269,0.15340086830680175,0.827587035279672,1.0,5/30,7.04%,NEDD4L;CAMK2D;SLC4A3;SLC4A4;SLC4A11
prerank,regulation of execution phase of apoptosis (GO:1900117),0.6140769428668984,1.3254066274843703,0.18716577540106952,0.8269965917269487,1.0,2/11,1.69%,DLC1;FAP
prerank,negative regulation of mRNA catabolic process (GO:1902373),0.5085949546326949,1.3246467026132667,0.16055045871559634,0.8277867981710253,1.0,6/29,13.03%,DHX34;DND1;TENT5C;AXIN2;TENT5D;TAF15
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.5352699821301637,1.324596708874962,0.15981012658227847,0.8259420132627954,1.0,4/21,2.40%,SULF1;EXTL3;XYLT2;GLCE
prerank,calcium import into the mitochondrion (GO:0036444),-0.5420916761221025,-1.3244296877374346,0.16778523489932887,0.6048331536878402,1.0,5/10,20.55%,SMDT1;SLC25A23;MICU1;MICU2;MAIP1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.5181714252295174,-1.3243081712138611,0.155902004454343,0.6029482668582186,1.0,7/12,28.70%,NOTCH2;DOCK11;LFNG;MFNG;FCGR2B;DLL1;DOCK10
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.37438324841557774,-1.3241131688699785,0.07518796992481203,0.6012521712839916,1.0,15/45,17.04%,ENG;RBPMS;BMP6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;HFE;CSNK2B;TWSG1;SMAD4
prerank,positive regulation of mitochondrion organization (GO:0010822),0.4484173734798791,1.3240260278490303,0.1222366710013004,0.8261857562286806,1.0,18/57,20.64%,DCN;PPARGC1A;DDHD1;CIDEB;FIS1;MIEF1;GSK3B;HTRA2;HTT;GPER1;BAD;BNIP3;RALBP1;PINK1;BAX;RALA;PRKN;MUL1
prerank,cellular metal ion homeostasis (GO:0006875),0.4203992841473859,1.3238204591754092,0.09824561403508772,0.8249069272877091,1.0,12/102,5.19%,CAV1;STC2;NEDD4L;CTRC;SLC12A2;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4;ATP1A2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5229593349715281,1.3235019070823244,0.1651376146788991,0.824087577150116,1.0,3/26,4.23%,CAV1;LBP;PTPN22
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.47291106420870577,1.323068043987735,0.1499312242090784,0.8238202599823087,1.0,5/41,8.28%,MAGI1;ADAM19;PLPP3;PIEZO1;GCNT2
prerank,striated muscle tissue development (GO:0014706),0.5122020900095421,1.3224087178146071,0.1635036496350365,0.8242490249502634,1.0,8/29,12.65%,CAV1;SGCD;SGCG;CSRP3;BMP5;TBX2;POPDC3;NDUFV2
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5238872843438035,1.321727612406481,0.15905511811023623,0.8248529659385904,1.0,1/22,0.14%,AHNAK
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.5798274582331502,1.3214065452218882,0.1523972602739726,0.8240235267516154,1.0,5/14,12.75%,EHHADH;DECR2;HSD17B4;ACOT8;ABCD1
prerank,sterol biosynthetic process (GO:0016126),-0.4085358186568827,-1.3211827264972165,0.11945392491467577,0.6081144917222656,1.0,11/33,19.79%,PRKAG2;INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7
prerank,membrane lipid biosynthetic process (GO:0046467),0.4491110873543101,1.3208096972283636,0.12582781456953643,0.8242474276183765,1.0,14/58,13.29%,SGMS2;ST3GAL4;CERS6;ACER3;ELOVL5;PLPP2;PLPP3;HACD4;ELOVL1;ELOVL2;CERT1;HACD2;SCCPDH;ELOVL6
prerank,iron ion transport (GO:0006826),-0.3705924969573284,-1.3205861346959384,0.08679245283018867,0.6076725607069539,1.0,16/47,19.98%,STEAP3;FTH1;TFRC;SCARA5;ATP6V0A4;SLC11A2;ARHGAP1;SLC39A14;ATP6V0C;ATP6V1C1;SLC40A1;HFE;ATP6V1D;TTYH1;RAB11B;ATP6V1F
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.5007720964816083,-1.3200436134857891,0.13202933985330073,0.6072832742939984,1.0,4/14,9.97%,DMD;ATP1B1;SLC9A1;ANK3
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.48260436434419657,1.3198704535835561,0.13817663817663817,0.8256614613431704,1.0,11/39,15.22%,EFNA5;JAG1;AJAP1;CASK;SPRY4;KANK1;GCNT2;NF2;FZD7;PTPRO;PLG
prerank,inositol lipid-mediated signaling (GO:0048017),0.4629243105536844,1.319806605512295,0.14285714285714285,0.823949287327025,1.0,7/50,3.86%,NGF;FGFR1;PLCD3;PLCE1;PLCB3;OGT;PLCL1
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),-0.39317775482667816,-1.3196926572592604,0.10810810810810811,0.6063223626118924,1.0,20/33,34.40%,ACER2;LYN;CYP1B1;EPHA8;RET;NEXMIF;TGFB2;PTK2;NCKAP1L;FERMT3;CIB1;RAC3;PLAU;PDE3B;P2RY12;JAM3;ADA;SNAI2;HRG;SERPINE1
prerank,negative regulation of cell junction assembly (GO:1901889),0.51551332834086,1.3194594597076936,0.1635036496350365,0.8233387586420914,1.0,3/25,4.48%,APOD;DLC1;SRC
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.29455173732818224,-1.3184947280888613,0.039603960396039604,0.607886864406129,1.0,72/168,22.82%,CNOT6L;RPL37A;RPL19;RPL8;RPL37;RPS15;RPS29;RPL35A;RPS7;RPS20;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;TENT2;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;PABPC1;RPLP1;RPS17;ZC3H12A;RPS3;RPL23;RPL17;PNRC2;RPL9;RPL38;RPL36;RPS26;NBAS;RPS8;RPS12;RPL18A;RPS21;CNOT11;MAGOH;TUT7;MTPAP;RPS18;RPLP2;EIF4G1;RPS6;RPS15A;NCBP1;CTIF;MAGOHB;RNPS1;ZFP36;CNOT9;RC3H1;GSPT2;PDE12;POLR2D;RPL14;RPS2;RPL10A;NBDY;DCP2;RPL39;RPL34;RPL5;EIF3E;RPL22;PPP2R1A
prerank,negative regulation of angiogenesis (GO:0016525),0.42548795733131256,1.3184365645670686,0.12438423645320197,0.8251345836181367,1.0,9/84,5.10%,DCN;THBS4;SULF1;SLC12A2;ADAMTS1;SPRED1;ATP2B4;AMOT;CREB3L1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),-0.4407616200236397,-1.3181639049842813,0.10569105691056911,0.6066292627817579,1.0,10/22,25.47%,PAXIP1;MED17;SUB1;MED24;ESR1;DHX36;MED14;MED30;SRF;PSMC5
prerank,regulation of chromatin organization (GO:1902275),-0.5008652894483783,-1.317901955199058,0.1488833746898263,0.6051493467614414,1.0,5/14,7.05%,SETD5;IGF2;PARG;SETD1A;CDK9
prerank,nitric oxide mediated signal transduction (GO:0007263),-0.4778319044752372,-1.3178959278174,0.1640625,0.6030086637124473,1.0,4/16,6.28%,NOS3;NDNF;DDAH1;APOE
prerank,regulation of endocytosis (GO:0030100),0.4415146429319973,1.3172355798135027,0.1211340206185567,0.8276749144728021,1.0,13/61,10.09%,GPC3;CDH13;NEDD4L;OPHN1;TFR2;SRC;LRSAM1;ZFYVE16;STON1;ABL2;PACSIN2;STON2;CALY
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.5250099946284068,-1.3162702058696383,0.14321608040201006,0.6061786752286211,1.0,6/11,19.17%,EP300;SIK1;C1QTNF3;PGP;CLK2;CRY1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.5470619576538661,-1.316246083894637,0.16397228637413394,0.6041138156066173,1.0,4/10,21.90%,UBE2J1;OS9;DERL2;SVIP
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.5479196090420669,-1.3160219472262358,0.17105263157894737,0.6025917860144349,1.0,3/10,6.94%,GHR;LYN;JAK2
prerank,regulation of protein import into nucleus (GO:0042306),0.4815201433831924,1.3158248803352448,0.1404494382022472,0.8309366116669442,1.0,6/36,8.05%,APOD;MDFIC;UBR5;BAG3;RBM22;PIK3R2
prerank,regulation of proteolysis (GO:0030162),0.45581198444779125,1.3157569375449525,0.14725568942436412,0.8292144317062806,1.0,10/48,11.48%,CAV1;CYFIP2;OGT;CLN8;LTBP4;PERP;HDAC2;IST1;HDAC6;SPOPL
prerank,cGMP-mediated signaling (GO:0019934),-0.5126194796964754,-1.3144328429466343,0.15668202764976957,0.6053429013272321,1.0,3/13,9.40%,IRAG1;APOE;PDE2A
prerank,regulation of myoblast fusion (GO:1901739),0.6141346844034787,1.3143524506246367,0.16753022452504318,0.8325080987464416,1.0,3/11,6.93%,RIPOR2;CD53;EHD2
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.306500222391185,-1.3139077968314195,0.03424657534246575,0.6047411047911028,1.0,26/110,12.42%,TRABD2B;CDC42;TFRC;BCL2L11;EP300;PREB;NAPA;FNIP1;HSPA8;FNIP2;APOE;RHOC;SLF2;SH3GLB1;VCP;SLF1;RPS3;ANKRA2;GFAP;AJUBA;PRKCZ;BID;MMP1;MPP7;CRYAB;SAR1B
prerank,high-density lipoprotein particle remodeling (GO:0034375),-0.4913406147747452,-1.3137887298230628,0.14563106796116504,0.6029003155023822,1.0,7/15,35.58%,PLTP;APOE;ABCG1;SCARB1;LCAT;APOC1;LIPC
prerank,negative regulation of response to stimulus (GO:0048585),-0.3474146355692919,-1.3133144493783406,0.05240174672489083,0.6022441953192567,1.0,17/60,8.46%,SLIT2;SLC30A10;LYN;IGFBP3;APPL2;DDAH1;BRAP;AKT3;NR1H3;ZKSCAN3;RBL1;KLF4;CD34;VPS13C;CDK6;NR1H2;AQP11
prerank,epithelial cell-cell adhesion (GO:0090136),0.6070069912018712,1.3124966358666532,0.19614147909967847,0.8375503976607701,1.0,1/11,0.16%,THBS4
prerank,regulation of cell motility (GO:2000145),0.4084183246047735,1.3124820661245205,0.08620689655172414,0.8356393150090025,1.0,20/121,8.86%,FGF7;NTN1;CEACAM1;ARHGAP18;LDB2;EGFR;KIF2A;FGF1;PARD6B;AMOTL1;MGAT3;MINK1;LMO4;PLXNA3;CAVIN1;AMOT;ABL2;SRCIN1;FGF18;INPP5F
prerank,negative regulation of heart contraction (GO:0045822),0.6098923138777431,1.3120529829106558,0.18525179856115107,0.8353168406450171,1.0,3/11,5.19%,PDE4D;FKBP1B;ATP1A2
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3671794773518544,-1.3116573209884925,0.11152416356877323,0.605009290719314,1.0,9/39,10.78%,SNCAIP;RAPGEF2;ROCK2;MSN;TIE1;HSPA8;APOE;ANKRA2;GFAP
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.4831167907141564,1.3116560485730715,0.1511627906976744,0.8349189481305045,1.0,12/33,16.95%,GLI1;FAM83D;PSME3;ATP2B4;PAF1;DDRGK1;INO80;PTEN;PKD1;PTPN6;FBXW7;E2F1
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.5781645565267547,1.3113115762136156,0.1658119658119658,0.8342773186725789,1.0,2/14,4.46%,HNRNPC;HNRNPA0
prerank,positive regulation of cell junction assembly (GO:1901890),0.45845252403790804,1.3110387153649234,0.13971539456662355,0.8333717796031767,1.0,6/56,8.21%,CLSTN2;CAV1;CLDN19;CLSTN3;EPHB2;PTPRJ
prerank,negative regulation of macrophage activation (GO:0043031),-0.48219615413162953,-1.310729555119721,0.12871287128712872,0.6055218991609843,1.0,5/16,10.21%,IL31RA;NR1H3;LDLR;CD200;ZC3H12A
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5303918111533792,-1.3104206098035462,0.1662531017369727,0.6044027892889637,1.0,6/11,35.88%,AGTR1;ABCG1;AGT;PLA2G7;LIPC;PLA2G5
prerank,response to purine-containing compound (GO:0014074),-0.46329617840376347,-1.3103772830612639,0.15151515151515152,0.6024470454889722,1.0,6/17,19.06%,TRPC3;ABCC9;P2RX7;P2RX4;TRPM2;P2RY6
prerank,negative regulation of B cell proliferation (GO:0030889),-0.5332270609904118,-1.3097896350338425,0.15254237288135594,0.6019084530677468,1.0,6/11,32.84%,LYN;TNFRSF21;RC3H1;ATM;FCGR2B;CD300A
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.41321718547120817,-1.3095007678547628,0.11461318051575932,0.6007900294840887,1.0,8/27,12.48%,PID1;ENPP1;GRB10;RPS6KB1;PIP4K2A;PRKCZ;GSK3A;PIP4K2C
prerank,macrophage chemotaxis (GO:0048246),0.6159622824458211,1.3091956135147989,0.189419795221843,0.8384202867807686,1.0,1/10,2.64%,CXCL17
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.5589641080206982,1.3090863519906364,0.15146579804560262,0.8369170408583491,1.0,2/16,4.99%,CEACAM1;PTPRC
prerank,cellular glucose homeostasis (GO:0001678),0.477659962446284,1.3089873318132867,0.14507042253521127,0.8353859940913869,1.0,15/41,15.57%,PPARGC1A;LRRC8D;HK2;ZBTB20;FOXK1;PIK3R2;FOXK2;ERN1;GCK;SOX4;NUCKS1;UNC13B;TRA2B;GPER1;ADCY8
prerank,endosome organization (GO:0007032),0.47447753034877815,1.3089823044016724,0.15331491712707182,0.8334740362028238,1.0,14/41,17.52%,USP50;HOOK2;PI4K2B;PHETA2;DNM1;USP8;SNX10;HOOK3;LAPTM4B;PI4K2A;ANXA8;ANXA8L1;ALS2;VPS11
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.5445779960032772,1.3078406139062941,0.178060413354531,0.8356472170682444,1.0,3/18,4.23%,ASS1;IL4I1;PTPN22
prerank,establishment of melanosome localization (GO:0032401),-0.4522955714549023,-1.307776490764813,0.14520547945205478,0.6041235052375709,1.0,9/19,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),-0.520155304970528,-1.3069086169701263,0.19,0.6046670459944712,1.0,7/12,26.39%,DMD;ATP1B1;ANK3;ATP1B2;NOS1;WNK1;WNK2
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.4322020625415031,-1.3064092420751003,0.14484679665738162,0.6040670299251982,1.0,4/21,6.47%,ERRFI1;ROCK2;BMP4;CTSL
prerank,positive regulation of developmental growth (GO:0048639),0.4544846227162438,1.306408713833056,0.13756613756613756,0.8392343806385225,1.0,3/49,0.85%,NGF;NEDD4L;NTN1
prerank,lipoprotein catabolic process (GO:0042159),-0.5438123586859328,-1.3061584394947374,0.16985645933014354,0.602735322948199,1.0,6/11,14.11%,APOE;LYPLA1;NOTUM;CTSD;ABHD17B;LYPLAL1
prerank,regulation of RNA metabolic process (GO:0051252),0.4404400798946302,1.3060982045841778,0.138996138996139,0.8384891495855304,1.0,13/59,14.85%,AHNAK;AHNAK2;CLK1;PCBP2;CELF1;ZNF326;SON;CLK4;IGF2BP2;PTBP3;PTBP2;RBM38;TRA2B
prerank,RNA processing (GO:0006396),0.39069426899590887,1.306038518608261,0.07057546145494029,0.8367658474066346,1.0,37/176,15.00%,DHX8;PPARGC1A;HNRNPC;NUFIP1;SF3B2;SF3B1;PIWIL2;RBM8A;RNPC3;CELF1;SRSF4;HNRNPA0;TSEN54;ZRSR2;SNRPF;SON;PABPC4;HNRNPR;TUT1;FASTKD2;PRPF3;DDX17;CSTF3;SRPK1;RBM5;LIN28B;CELF2;SUPT4H1;SRPK2;TSEN34;TCERG1;SNRPA1;SFPQ;PPIG;DICER1;DHX16;PDCD7
prerank,positive regulation of cell migration (GO:0030335),0.38179364467005966,1.3059397403546917,0.05783385909568875,0.8352732611474285,1.0,32/253,7.63%,ROR2;GAB1;CLDN1;ITGA6;CAV1;NTRK3;CDH13;DOCK5;PRKCE;EGFR;GTSE1;FGF1;DOCK1;SEMA4B;SH3RF2;CDH5;KIF20B;ITGAX;SOX9;PRKCA;SRC;PTPRC;FN1;FER;TRADD;ADAM10;EPHB2;RDX;RIPOR1;SEMA3A;RREB1;FBXO5
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),-0.5056150213532058,-1.3056638854072984,0.14285714285714285,0.6021344535638791,1.0,6/13,9.87%,NUPR1;USP19;NR1H3;NR1H2;AQP11;MANF
prerank,regulation of sodium ion transport (GO:0002028),0.48213503994791596,1.3055216180436118,0.14407988587731813,0.8349333775568715,1.0,3/34,4.74%,CNKSR3;SLMAP;ATP2B4
prerank,protein localization to cilium (GO:0061512),0.4862659084895606,1.3053798508899255,0.1476121562952243,0.8335882537274759,1.0,14/32,23.18%,ZNF423;RAB29;RABEP1;SNX10;TCTN2;TTC21B;NPHP4;INVS;EHD1;BBS1;TCTN1;TULP2;IFT140;ARL3
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.5873643588448949,1.3053407752499135,0.1909722222222222,0.8318342346186801,1.0,6/13,13.29%,ELOVL5;HACD4;ELOVL1;ELOVL2;HACD2;ELOVL6
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.41697378426198783,-1.3052405483335752,0.11490683229813664,0.6013672214025866,1.0,7/26,8.78%,ROCK2;SHANK3;SYNPO2;CDC42;ASAP3;SLC9A1;ACTG1
prerank,positive regulation of chemotaxis (GO:0050921),0.46166153083334394,1.3044387907826056,0.13966480446927373,0.8333836189869626,1.0,4/43,4.59%,SMOC2;NTRK3;CDH13;DSCAM
prerank,canonical glycolysis (GO:0061621),0.5169151340508834,1.3040515802189314,0.16863905325443787,0.8310627971719693,1.0,11/24,22.51%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,glucose catabolic process to pyruvate (GO:0061718),0.5169151340508834,1.3040515802189314,0.16863905325443787,0.8310627971719693,1.0,11/24,22.51%,HK2;PFKP;FOXK1;ALDOB;FOXK2;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),0.5347764733406927,1.3032087802569778,0.1777408637873754,0.8324368546401375,1.0,4/20,9.65%,LBP;PRKCE;PTPN22;TICAM1
prerank,heart morphogenesis (GO:0003007),-0.3575728820383773,-1.3026919411441213,0.07446808510638298,0.6068735718209721,1.0,15/50,14.54%,ENG;INSR;TGFBR3;NOS3;CHD7;FKBP1A;TBX3;TGFBR1;ACVRL1;TBX1;SOX17;BMP2;TGFB2;MEGF8;PTK2
prerank,focal adhesion assembly (GO:0048041),0.5332404954056386,1.3026330346923314,0.16346153846153846,0.832813613770495,1.0,4/21,4.48%,DLC1;SORBS1;PEAK1;SRC
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.4996266399158606,-1.3025601498053154,0.14507772020725387,0.6051929402122272,1.0,4/14,6.95%,IGF1;LDLR;TNFRSF1B;CD200
prerank,regulation of oxidative phosphorylation (GO:0002082),-0.4675975578219249,-1.302183441015601,0.12853470437017994,0.6043069801961616,1.0,6/16,20.15%,NUPR1;ATP7A;VCP;SLC25A33;PDE12;COX7A2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.40604990330411617,1.3015221386621507,0.10297482837528604,0.835065744263565,1.0,37/119,20.75%,PIGU;PTPN13;SOCS5;PI4K2B;SLC27A1;PIP4K2B;PIK3R4;PGAP3;SOCS6;PLEKHA4;MTMR7;PIK3R2;EFR3A;PIGB;MTMR6;OCRL;INPP5F;MTMR3;PIGA;SOCS4;SOCS7;PTEN;PLEKHA1;PIK3C3;MTMR12;PI4K2A;MTMR1;SOCS1;PITPNM2;SOCS2;RAB5A;PITPNM3;ITPKA;FIG4;VAC14;PIK3C2B;CISH
prerank,neuropeptide signaling pathway (GO:0007218),0.44050126440071546,1.3014531339397533,0.14209827357237717,0.8334280106438653,1.0,4/58,4.70%,SORCS2;SSTR1;KISS1R;CPE
prerank,glycosaminoglycan metabolic process (GO:0030203),0.45260600045419597,1.3013095307891864,0.14226519337016574,0.8321152921817759,1.0,18/54,17.78%,GPC3;XYLT2;GPC6;NDST1;SDC1;SLC35D2;GCNT2;HEXA;HS3ST6;HS3ST5;GPC2;SDC3;HSPG2;EXT1;HGSNAT;EXT2;GPC5;SDC4
prerank,muscle organ development (GO:0007517),0.4528031233723422,1.3008677777496285,0.1441326530612245,0.8319388135134655,1.0,10/54,5.73%,UTRN;LAMA2;SGCD;COL6A3;MRAS;ITGA7;SGCG;CHD2;CACNA1H;ANKRD2
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.4364777778248566,-1.3006679503985217,0.1553672316384181,0.6067522946182276,1.0,6/23,14.18%,TGFBR3;TPM1;FKBP1A;FGFR2;PROX1;ID2
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.46611717535224656,-1.30046578865942,0.13850415512465375,0.6053084239682935,1.0,5/17,8.19%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,genitalia development (GO:0048806),0.5846960841761009,1.3001655687003055,0.18956521739130436,0.8325101944998202,1.0,2/12,4.96%,STRA6;WNT5A
prerank,inner dynein arm assembly (GO:0036159),0.6118282318850503,1.299879530993058,0.2030716723549488,0.8316774836090493,1.0,3/10,15.14%,CFAP73;CCDC39;CCDC40
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",-0.4354211681397699,-1.2997555958471698,0.13212435233160622,0.6054293096020515,1.0,10/21,25.16%,PAXIP1;MITF;MED17;SUB1;MED24;DHX36;MED14;MED30;SRF;BCLAF1
prerank,regulation of kinase activity (GO:0043549),0.41546142578752715,1.298660821195753,0.11835748792270531,0.8342669305938661,1.0,8/89,1.81%,ROR2;ROR1;NTRK3;FGFR1;PLCE1;LDB2;EGFR;MUSK
prerank,regulation of cell migration (GO:0030334),0.3685723161731381,1.2986005737001916,0.02540650406504065,0.8326360625843962,1.0,48/382,7.57%,ROR2;NTNG2;NTNG1;CLDN1;ITGA6;CAV1;FGF7;DLC1;NTRK3;CDH13;CEACAM1;SULF1;CLDN19;LDB2;EGFR;GTSE1;KIF2A;FGF1;PARD6B;JAG1;AMOTL1;SEMA4B;SCAI;MGAT3;SH3RF2;CDH5;MINK1;ITGAX;NF1;ARPIN;FOXO3;PRKCA;LMO4;SRC;PLXNA3;AMOT;FER;ULK4;TRADD;ADAM10;EPHB2;RDX;DAG1;RIPOR1;SEMA3A;LDLRAD4;SRCIN1;KANK1
prerank,regulation of synapse organization (GO:0050807),-0.41037815641271147,-1.2982079241355828,0.11711711711711711,0.6078468919825695,1.0,8/26,13.93%,EPHA4;SETD5;ARHGAP22;PDLIM5;CDKL5;MDGA1;ABHD17B;YWHAZ
prerank,arachidonate transport (GO:1903963),-0.5618885410013414,-1.2977036727040991,0.16289592760180996,0.6054637921481175,1.0,3/10,7.39%,ACE;BDKRB2;ANXA1
prerank,arachidonic acid secretion (GO:0050482),-0.5618885410013414,-1.2977036727040991,0.16289592760180996,0.6054637921481175,1.0,3/10,7.39%,ACE;BDKRB2;ANXA1
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.3469218030878168,-1.2964273025042732,0.08130081300813008,0.6073118345260664,1.0,17/56,17.04%,ENG;RBPMS;BMP6;SMAD6;DAB2;BMP4;TGFBR1;ACVRL1;BMPR2;TGFB3;BMP2;TGFB2;BMPER;HFE;CSNK2B;TWSG1;SMAD4
prerank,regulation of lymphocyte proliferation (GO:0050670),0.5478894036914986,1.2964256863396921,0.17495987158908508,0.8387804917809719,1.0,2/16,4.23%,TNFSF8;PTPN22
prerank,establishment of epithelial cell polarity (GO:0090162),-0.4495417154821602,-1.2963687453267008,0.1581769436997319,0.6055290125024527,1.0,4/19,2.84%,PARD3;MSN;CDC42;CYTH3
prerank,positive regulation of T cell proliferation (GO:0042102),-0.3521723310250314,-1.2963109568950593,0.08627450980392157,0.6037540525674281,1.0,10/55,11.02%,IGF1;IGFBP2;TFRC;IGF2;IL18;SLC7A1;VCAM1;ANXA1;RPS3;CD80
prerank,sulfur compound biosynthetic process (GO:0044272),0.40617674123677944,1.2956667939353965,0.10600706713780919,0.8398122172757694,1.0,20/104,11.72%,DCN;CSPG4;ST3GAL4;PRELP;UST;GLCE;SLC35B2;B4GAT1;MGST2;CHST7;NCAN;SLC35D2;CHST2;GSTZ1;GSTA4;TPK1;GGTA1;CHST12;GSTA3;GSTK1
prerank,positive regulation of cell division (GO:0051781),0.4641087640991659,1.2947288289860226,0.16246498599439776,0.8415007102538028,1.0,11/38,13.55%,PRKCE;FGF1;KIF20B;RACGAP1;SPAST;OPN1MW;CSPP1;CUL3;PKP4;CDC6;CIT
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5770832795895385,1.2946936568670444,0.18356643356643357,0.8397863237959924,1.0,6/13,15.81%,MGAT3;CHST7;EXTL2;CHST2;NAGK;OGA
prerank,membrane depolarization (GO:0051899),0.4868726919346157,1.2941849481891092,0.1678520625889047,0.8397826629355439,1.0,3/32,4.79%,CAV1;SCN10A;CACNA1H
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.4171362768940718,1.2941045811243268,0.11404561824729892,0.8382814528820498,1.0,5/90,2.59%,EBF2;CAV1;PPARGC1A;LEPR;OGT
prerank,negative regulation of T cell differentiation (GO:0045581),-0.5357776833161916,-1.293258546283297,0.15299334811529933,0.6107963544673416,1.0,4/10,10.52%,GLI3;BMP4;IRF1;ZC3H8
prerank,regulation of muscle cell differentiation (GO:0051147),-0.3994901918116351,-1.2925742106514335,0.12461059190031153,0.6108169845227983,1.0,8/31,7.87%,CDC42;IGF2;FGFR2;HDAC9;MEF2A;MAPK12;CDK9;CDON
prerank,neuromuscular process (GO:0050905),0.5357159066275639,1.2922405618051827,0.1915966386554622,0.8432261608360239,1.0,1/16,0.21%,STRA6
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.44487491284769176,-1.291961884170602,0.14084507042253522,0.6105851256931681,1.0,6/21,10.68%,PRKCH;FOXP1;LYN;SLC39A10;ELF2;LPXN
prerank,positive regulation of catabolic process (GO:0009896),0.429559259827128,1.2917497094002361,0.15544041450777202,0.8431744492714248,1.0,13/65,15.38%,PLK2;GPC3;NEDD4L;AXIN1;DACT1;WNT5A;TNFAIP3;GSK3B;APC;NEDD4;ATG7;WWP2;FZR1
prerank,muscle cell differentiation (GO:0042692),0.48962594923906594,1.291675766831648,0.1746031746031746,0.8416432076566726,1.0,2/32,1.67%,RORA;GLMN
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.5126178307376628,-1.2907187806857665,0.183206106870229,0.612209051434579,1.0,4/12,8.19%,PLCB1;SLIT2;CCN3;AKT1
prerank,intracellular lipid transport (GO:0032365),-0.43068100672040366,-1.2906457093851078,0.15151515151515152,0.610487627741912,1.0,8/21,14.68%,PRKAG2;ARV1;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.4605230197188051,-1.290376121839588,0.15104166666666666,0.6094091440582875,1.0,7/18,23.75%,PRKAG2;C2CD5;CLIP3;SLC2A1;NR4A3;C3;PRKCB
prerank,regulation of transmembrane transport (GO:0034762),0.48974187411041226,1.2901819136260615,0.1783166904422254,0.8453128362606982,1.0,6/31,8.23%,NEDD4L;KCNJ4;SCN10A;KCNJ16;KCNJ13;OCLN
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.465812137252124,-1.2897497973666023,0.15469613259668508,0.6093092384029277,1.0,8/17,22.44%,CDK9;CCNT1;ZC3H3;HSF1;NCBP1;CPSF7;CPEB1;CPSF6
prerank,cellular response to growth factor stimulus (GO:0071363),-0.29152610184734995,-1.2888451610341023,0.008620689655172414,0.6100580327319304,1.0,51/151,19.63%,FLT1;SOX5;RAPGEF2;SMAD3;BMP6;PDE8A;CLEC3B;BMP4;SMAD9;NDNF;TGFBR1;APPL2;WNT4;ACVRL1;GAS1;MT1G;STMN2;BMPR2;DSTYK;SEMA6A;EEF1A1;KLF4;DUSP3;KDR;TBX1;RPS6KB1;ANXA1;CRKL;AKT1;PDE2A;RAMP2;LGMN;BMP2;SOX6;FLT4;MAPKAPK2;MAP2K3;SPHK1;PLK5;MAPT;NRP1;ZPR1;SMAD4;ZFP36;NOS1;HSPB1;WWOX;HAS1;LIMS1;RACK1;BCAR1
prerank,negative regulation of MAP kinase activity (GO:0043407),0.462420961157197,1.2886303596145408,0.1573816155988858,0.8493360379102097,1.0,9/44,10.68%,RGS14;STK38;NF1;SPRY1;PTPN22;SPRY4;IRAK3;PTPRJ;MAPK8IP1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.3208852693838021,-1.2873451086798813,0.04678362573099415,0.6126485995640587,1.0,29/88,16.41%,EXOC6B;MYO1B;CLINT1;MYO5A;ARFGEF2;AP1S2;FTH1;DNAJC6;NAPA;COMMD1;AP2A1;FTL;HSPA8;VPS35L;VPS13C;EXOC6;DOP1B;EPS15;EXOC4;OSBPL5;AP4E1;SORCS1;TXNDC5;VAMP7;SH3GL2;DTNBP1;SORT1;MON2;SCFD1
prerank,negative regulation of protein transport (GO:0051224),0.4999742260029808,1.287315548607465,0.18506998444790046,0.8523591358424331,1.0,1/25,0.23%,PKDCC
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),-0.4342325876477017,-1.2872980820679754,0.14540059347181009,0.6109068584174361,1.0,4/22,3.95%,GHR;KIT;IL10RB;CYP1B1
prerank,regulation of cell-substrate adhesion (GO:0010810),0.46490185958691566,1.286556572010669,0.15818431911966988,0.8533897352507473,1.0,5/42,4.67%,VIT;ECM2;MINK1;NF1;RAC2
prerank,cellular response to mechanical stimulus (GO:0071260),0.45847213360889855,1.2856811770827261,0.15448275862068966,0.8548230271706028,1.0,12/46,16.94%,F11R;PIEZO2;MAP3K1;SOX9;TLR7;PTGER4;PIEZO1;TMEM150C;AQP1;KCNK4;BAD;BNIP3
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.40772075890164583,-1.2851824320273153,0.14328358208955225,0.6150815962253354,1.0,10/28,12.13%,PRKAG2;ADIPOR2;MITF;SIRPA;TNFRSF1B;JAK2;PRKAB2;CTNS;AVIL;FGFR4
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.5806362492482279,1.2849342814754932,0.20567375886524822,0.8557999534060182,1.0,4/13,7.23%,CYFIP2;CIDEB;NLRC4;PERP
prerank,positive regulation of cation channel activity (GO:2001259),-0.36714807544301864,-1.2847703955108487,0.11355311355311355,0.6143383492267097,1.0,13/40,23.26%,ANK2;ACTN2;SHANK3;AKAP6;CALM1;ANK3;TMSB4X;CALM3;JPH2;P2RY6;STAC3;GSTO1;LRRC38
prerank,negative regulation of protein ubiquitination (GO:0031397),0.45017458849703795,1.2846408725124732,0.14754098360655737,0.8550234650540062,1.0,15/50,17.14%,CAV1;SH3RF2;OGT;TNFAIP3;N4BP1;FBXO5;SIRT7;SPOPL;NXN;USP4;SOX4;GNL3L;BAG2;MINAR1;CHP1
prerank,protein modification by small protein conjugation or removal (GO:0070647),-0.5054343048208153,-1.2844466546302882,0.1642512077294686,0.6134145495191495,1.0,6/13,9.58%,ATG10;UBA5;UBA3;UBA2;NAE1;UBA7
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.5510677650325936,-1.2841265670565265,0.17972350230414746,0.61242679816876,1.0,6/10,21.91%,EPHA4;ANXA2;RGP1;FURIN;CDK5RAP3;NELL1
prerank,peptidyl-lysine trimethylation (GO:0018023),0.5064239524080623,1.2839775898733605,0.1686746987951807,0.855710871391342,1.0,12/26,22.65%,OGT;KMT2A;BEND3;KMT5C;SUV39H1;ATPSCKMT;KMT2D;SETD2;SUV39H2;ETFBKMT;VCPKMT;EEF2KMT
prerank,regulation of receptor internalization (GO:0002090),-0.37945764866324183,-1.2837269813318446,0.0935483870967742,0.6117089964895382,1.0,13/35,25.49%,INSR;ANGPT1;ANKRD13A;AHI1;EGF;FLOT1;PICK1;MKLN1;NTF3;GREM1;ANKRD13D;RIN3;ARRB2
prerank,primary alcohol metabolic process (GO:0034308),-0.42855616614062075,-1.2836128676319631,0.13846153846153847,0.6102202585170974,1.0,5/25,4.13%,IGF1;GPD2;RBP4;CYP1B1;NAPEPLD
prerank,fibrinolysis (GO:0042730),0.5878016927480845,1.2826928972638485,0.19269102990033224,0.858773500874203,1.0,1/13,0.68%,SERPINB2
prerank,sensory organ development (GO:0007423),0.4497896803697326,1.2822767158045074,0.15855354659248957,0.8584420967499935,1.0,9/51,8.69%,STRA6;WNT10A;PBX1;BMPR1B;HIPK1;SH3PXD2B;SHROOM2;FREM2;ABCB5
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.4833510477522981,-1.2820025830157589,0.15403422982885084,0.6132956213630096,1.0,4/15,6.34%,PDGFRA;TGFBR1;FGFR2;TBX1
prerank,response to estradiol (GO:0032355),0.4816531595910241,1.2815652716131674,0.16911764705882354,0.8591179401111522,1.0,12/31,20.45%,EGFR;SSTR1;NRIP1;POU4F1;NCOA3;LCOR;GPER1;CCDC62;GGT1;SOCS2;RUVBL2;STAT5B
prerank,negative regulation of histone methylation (GO:0031061),-0.5377277502332766,-1.2812375393865878,0.16173120728929385,0.6137376545443521,1.0,7/10,29.65%,JARID2;KDM1A;DNMT3B;BRCA1;AASS;WDR5;BCOR
prerank,regulation of inclusion body assembly (GO:0090083),-0.5182039830863202,-1.2812350014226388,0.17400881057268722,0.6118859096561879,1.0,7/11,32.18%,SNCAIP;DNAJB2;DNAJA4;HSPA1A;DNAJB1;HSPA1B;HSPA2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5034537275756925,1.2807771529117333,0.19788519637462235,0.8601841318793083,1.0,4/27,3.58%,AHNAK;CAMK2D;PDE4D;FKBP1B
prerank,outflow tract septum morphogenesis (GO:0003148),-0.41783114517387937,-1.2806284050656302,0.13559322033898305,0.6118268863145294,1.0,8/24,6.34%,ROBO1;ENG;SMAD6;BMP4;SEMA3C;BMPR2;FGFR2;TBX1
prerank,cardiac ventricle morphogenesis (GO:0003208),-0.3678388600866289,-1.2805596781006041,0.11683848797250859,0.6101830099059516,1.0,7/41,3.93%,ENG;TGFBR3;RBPJ;TPM1;FKBP1A;BMP4;FGFR2
prerank,neuromuscular junction development (GO:0007528),0.5046183146195236,1.2804905191791036,0.18181818181818182,0.8594377962159161,1.0,4/24,2.68%,LRP4;PDZRN3;MUSK;ZC4H2
prerank,cellular response to alkaloid (GO:0071312),-0.4553839153019824,-1.2797384570381778,0.14588859416445624,0.610778639257335,1.0,4/17,7.29%,TGM2;SLC8A1;BLM;CASP3
prerank,cellular response to interleukin-4 (GO:0071353),-0.5301897772455474,-1.2794924177689468,0.1900647948164147,0.6097306193425216,1.0,1/10,0.70%,LEF1
prerank,negative regulation of cell population proliferation (GO:0008285),0.36700641021460295,1.278973823863786,0.050256410256410255,0.8633636217762886,1.0,66/351,15.22%,NGF;ROR2;ZBTB7C;APOD;IGFBP6;DLC1;CDH13;VGLL4;CLDN19;GLMN;FAP;ADAMTS1;SSTR1;GPLD1;GNRH1;NF1;IL1A;PTPN14;PTHLH;SOX9;TPTE;BMPR1B;CELF1;MFN2;BMP5;MORC3;KLF10;NUP62;WNT5A;ACVR1C;PDS5B;KANK2;TNFAIP3;NCK2;CTCF;PEX2;CHERP;DIS3L2;RBM5;PTPRJ;CNOT7;DLG3;PBRM1;MTSS1;STRN;AXIN2;RARG;APC;PLXNB1;ZBTB49;MEN1;NF2;WNT9A;PTEN;CDC6;EMD;SOX4;CDKN1C;CTNNBIP1;DNAJA3;CLMN;PTPRU;ERBB4;GPER1;PTPN6;PLG
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.4411290481933826,1.2786808147958804,0.16621253405994552,0.8626549896292803,1.0,7/50,12.99%,NGF;SRC;SFN;RPS6KA3;USP47;DHCR24;AQP1
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.49489640388753864,1.278221490890385,0.20287539936102236,0.862533202513779,1.0,7/26,17.54%,EFNA5;GPLD1;ADCY5;ADRA2A;ADCY8;STX4;KLF7
prerank,positive regulation of signaling (GO:0023056),0.46665947904770516,1.276993112542427,0.17897727272727273,0.8653604666836785,1.0,5/37,8.86%,CLSTN2;RAB29;CLSTN3;RIMS2;INPP5F
prerank,mesenchymal cell differentiation (GO:0048762),-0.343770474646599,-1.2766875317256574,0.1087866108786611,0.6159660194367883,1.0,15/51,12.75%,RANBP3L;ENG;LEF1;ROCK2;TGFBR3;RBPJ;TGFBR1;WNT4;FGFR2;HIF1A;LRP6;TRIM28;BMP2;LOXL3;TGFB2
prerank,negative regulation of chemotaxis (GO:0050922),-0.38985255902494165,-1.275722709785369,0.1267123287671233,0.617222826725743,1.0,7/31,6.12%,ROBO1;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A;DUSP3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.362638620698812,-1.27543147488569,0.10588235294117647,0.6162758096667852,1.0,20/48,18.01%,ETS1;ANGPT1;NOS3;AKT3;HIF1A;HDAC7;HDAC9;KDR;ANXA1;AKT1;PIK3C2A;GATA2;SP1;THBS1;MAP2K3;SRPX2;TMSB4X;P2RX4;HSPB1;CD40
prerank,regulation of cytokinesis (GO:0032465),0.4105326263073341,1.2745930699391343,0.15664160401002505,0.8726149614291717,1.0,20/78,13.55%,PLK2;PRKCE;KIF20B;RACGAP1;PIK3R4;SPAST;OPN1MW;CSPP1;KIF13A;CUL3;CCP110;PKP4;KLHL21;ZFYVE26;CHMP4C;MAP9;CETN2;AHCTF1;CDC6;CIT
prerank,activation of GTPase activity (GO:0090630),0.40787409040726,1.274146050493543,0.1395631067961165,0.8726290408551272,1.0,13/89,10.91%,ARHGAP42;SIPA1L1;NTRK3;TIAM2;GRTP1;SGSM2;ARHGEF5;TBC1D16;FOXJ1;SLC27A4;TBC1D2;TBC1D8;DOCK7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.3975132902405888,1.2739197935753068,0.10778443113772455,0.8715937754114298,1.0,29/109,18.75%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,skeletal muscle tissue development (GO:0007519),0.47825697841008485,1.273724495957447,0.17220543806646527,0.8704891017988385,1.0,3/32,4.33%,CAV1;CAV2;CSRP3
prerank,regulation of exocytosis (GO:0017157),0.44513924330747356,1.2731769825418036,0.17466666666666666,0.8706603510727221,1.0,5/46,7.29%,STXBP6;RAB8B;RIMS2;RAB3A;CPLX1
prerank,positive regulation of cellular senescence (GO:2000774),-0.5233137444421008,-1.2716500485571067,0.20238095238095238,0.6256942319752873,1.0,4/10,19.73%,B2M;YPEL3;EEF1E1;CGAS
prerank,protein K11-linked ubiquitination (GO:0070979),0.4872232991995906,1.2716433997417529,0.1961367013372957,0.8746294257487159,1.0,11/27,20.41%,UBE2E2;ANAPC5;ANAPC7;ANAPC11;ANAPC2;UBE2D3;ANAPC4;FZR1;CDC23;UBE2W;PRKN
prerank,lysine metabolic process (GO:0006553),0.5734834978502436,1.2711666763614615,0.21379310344827587,0.8728084663683541,1.0,5/12,14.06%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,lysine catabolic process (GO:0006554),0.5734834978502436,1.2711666763614615,0.21379310344827587,0.8728084663683541,1.0,5/12,14.06%,AADAT;OGDH;GCDH;DLST;HYKK
prerank,mRNA metabolic process (GO:0016071),0.4074126094474569,1.2707903230984312,0.14251781472684086,0.8723594017456987,1.0,19/90,13.67%,PPARGC1A;SF3B2;PCBP2;CNOT10;CELF1;SRSF4;HNRNPA0;SNRPF;SON;DXO;HNRNPR;PRPF3;CSTF3;DIS3L2;SUPT4H1;ZFP36L2;ERN1;TCERG1;SFPQ
prerank,prostaglandin biosynthetic process (GO:0001516),-0.4414840597858958,-1.2707432389990212,0.15079365079365079,0.6264103347610065,1.0,7/18,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;HPGDS;MIF
prerank,ether lipid metabolic process (GO:0046485),0.5544711931806747,1.2699719723185654,0.21875,0.8735478912147179,1.0,4/14,12.01%,AGMO;NCEH1;PAFAH1B1;LIPE
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.4916978848918747,1.2699556467896054,0.1691842900302115,0.8718337610298817,1.0,5/30,6.65%,F11R;LPAR1;RTN4R;AKAP13;COL3A1
prerank,C4-dicarboxylate transport (GO:0015740),0.5614427102554218,1.2693187193351854,0.21166666666666667,0.8725301475614696,1.0,5/14,13.00%,LRRC8D;SLC25A12;SLC1A6;SLC25A13;SLC25A22
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),-0.41625194318420355,-1.2690809189532866,0.1592920353982301,0.6294622210080653,1.0,5/23,6.94%,GHR;KIT;IL10RB;CYP1B1;JAK2
prerank,positive regulation of macroautophagy (GO:0016239),0.4480664191486321,1.2685602224583972,0.1882673942701228,0.8736996362485812,1.0,17/48,22.25%,DCN;LRSAM1;PIP4K2B;SCOC;RAB3GAP2;BAG3;SESN1;IRGM;PAFAH1B2;HTT;TBK1;BNIP3;PINK1;ADRB2;TSC2;GNAI3;RAB3GAP1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.55191111382564,1.268488037425424,0.1891025641025641,0.8721798945540008,1.0,2/15,2.92%,EDA;GLI2
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.41991226791042546,-1.2682608445862134,0.15,0.6301364785958994,1.0,9/23,19.41%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;EGF;ENTPD5;GAPDHS
prerank,cellular amino acid catabolic process (GO:0009063),0.4077937666861507,1.2681416509244836,0.14742014742014742,0.8717830473951454,1.0,22/87,14.06%,PRODH;ARG1;IL4I1;ACAD8;AADAT;HMGCLL1;BCKDK;HOGA1;OGDH;GCDH;ACAT1;ALDH5A1;ABAT;BLMH;DLST;GSTZ1;GLDC;BCKDHB;BCAT2;GOT1;GLUL;HYKK
prerank,heterochromatin organization (GO:0070828),-0.48401781377955816,-1.2678528851910917,0.17708333333333334,0.6296982394945466,1.0,3/14,9.20%,MECOM;PRDM16;BAHD1
prerank,alpha-amino acid catabolic process (GO:1901606),0.49010584121828227,1.2673484891207452,0.19461077844311378,0.8730075190408843,1.0,7/29,10.44%,PRODH;IL4I1;AADAT;HOGA1;ACAT1;BLMH;GSTZ1
prerank,negative regulation of stem cell differentiation (GO:2000737),0.571467597069514,1.2669044082151044,0.21283783783783783,0.872846652038365,1.0,4/12,13.32%,JAG1;N4BP2L2;NELFB;ZFP36L2
prerank,regulation of angiogenesis (GO:0045765),0.37553273720634456,1.2664551512238642,0.09891304347826087,0.8728390833209532,1.0,21/192,5.86%,GAB1;DCN;THBS4;SMOC2;CEACAM1;SULF1;RAPGEF3;HK2;ADAMTS1;FGF1;CDH5;SPRED1;ITGAX;NF1;IL1A;PRKCA;ATP2B4;WNT5A;AMOT;HIPK1;TNFAIP3
prerank,regulation of heart contraction (GO:0008016),0.40918246962241317,1.2662052831847264,0.14765906362545017,0.871949440957837,1.0,16/90,10.60%,CORIN;ITPR2;ITPR3;CAMK2D;SCN10A;PDE4D;FKBP1B;ATP2B4;CACNA1H;ATP1A2;APLN;TBX2;CASQ2;CELF2;ATP1B3;FXYD6
prerank,positive regulation of DNA binding (GO:0043388),0.47601870250589556,1.2661657833796738,0.19264705882352942,0.8703181655010748,1.0,1/31,0.03%,NGF
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.4252282655061607,-1.265337008056257,0.15342465753424658,0.6355743253771706,1.0,6/21,8.47%,IGF1;MEF2D;IGFBP5;GJA1;MMP2;LDLRAP1
prerank,positive regulation of metabolic process (GO:0009893),0.39851704150405476,1.265232969911995,0.1403301886792453,0.8721440399984416,1.0,17/103,13.52%,EBF2;CAV1;PPARGC1A;LEPR;OGT;BEND3;MFN2;ACACA;TSHR;PIGA;KSR2;APC;PRLR;KDM6B;TRPV2;ELOVL6;HCRT
prerank,cAMP-mediated signaling (GO:0019933),-0.4082833700966776,-1.264775211506852,0.1580547112462006,0.6353103056249227,1.0,8/24,9.40%,KSR1;RAPGEF2;PDE7B;ADGRG6;ADCY1;AKAP6;ADCY2;PDE2A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.43889111361819344,-1.264655258123845,0.15833333333333333,0.6338931825056092,1.0,4/19,8.44%,IGF1;PICALM;APOE;RTN1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),0.5224820183532013,1.2644700327606393,0.21553090332805072,0.8731680691178275,1.0,9/21,20.82%,GLI1;KIF7;PDCL;SMO;RAB34;TEDC1;ARMC9;TUBD1;STK36
prerank,actin-myosin filament sliding (GO:0033275),-0.3670557399702722,-1.2640705065841256,0.14482758620689656,0.6319575288201195,1.0,8/38,14.51%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,muscle filament sliding (GO:0030049),-0.3670557399702722,-1.2640705065841256,0.14482758620689656,0.6319575288201195,1.0,8/38,14.51%,ACTN2;DMD;TPM1;MYL6;TPM3;TPM2;DES;VIM
prerank,endothelial cell migration (GO:0043542),0.4645700168867735,1.264051435948522,0.19519094766619519,0.8728576670058837,1.0,6/37,8.07%,CDH13;PXN;FAP;CDH5;DPP4;STARD13
prerank,potassium ion export across plasma membrane (GO:0097623),0.5590854169282307,1.2631067460665888,0.21258503401360543,0.8747160506642023,1.0,2/13,8.17%,KCNA5;KCNK5
prerank,regulation of lamellipodium morphogenesis (GO:2000392),0.581423942974874,1.2630211493498418,0.22487223168654175,0.8732924460849246,1.0,4/11,7.57%,ARPIN;SRC;RREB1;KANK1
prerank,sphingolipid biosynthetic process (GO:0030148),0.4134050713128768,1.2628167123824994,0.17380352644836272,0.872291798286914,1.0,16/71,11.60%,SGMS2;CERS6;ACER3;ELOVL5;A4GALT;PLPP2;PLPP3;ALOXE3;CLN8;HACD4;ELOVL1;ELOVL2;CERT1;ST8SIA5;ST8SIA3;HACD2
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.5080503115335946,1.2622625871033055,0.2113564668769716,0.8726945604969165,1.0,6/19,17.59%,HNRNPC;SRC;STN1;EXOSC10;GNL3L;TERF2
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.37431955809644857,-1.2622549960168823,0.13,0.6354433665642921,1.0,9/37,8.47%,IGF1;PRKG1;TPM1;MEF2D;IGFBP5;GJA1;TGFB3;MMP2;LDLRAP1
prerank,protein-containing complex subunit organization (GO:0043933),0.4024543895189386,1.2622201758057727,0.142018779342723,0.8711410850635017,1.0,14/109,8.39%,MAGI1;PPARGC1A;WIPF1;LAMC1;REPS2;PARD6B;CD3G;KMT2A;SOX9;CARD10;FANCC;TAPBP;OCLN;DARS1
prerank,positive regulation of cilium assembly (GO:0045724),-0.4388224227355433,-1.261836600477534,0.15521628498727735,0.6348203543985392,1.0,6/18,14.46%,ARHGAP35;ENTR1;CEP135;FUZ;CEP120;CROCC
prerank,positive regulation of phosphorylation (GO:0042327),0.3716928393088528,1.261322102807475,0.08472803347280335,0.8726176563123991,1.0,26/240,6.42%,ROR2;ITGA6;ROR1;EFNA5;FGF7;NTRK3;FGFR1;CLDN19;LEPR;GLMN;EGFR;CCND3;MUSK;ZBTB20;PELI2;FGF1;AXIN1;FXR2;SOX9;LMO4;DSCAM;LIMK2;SLC4A4;NBN;EPHB2;KRAS
prerank,positive regulation of mitotic nuclear division (GO:0045840),-0.38060920709721446,-1.2612857508636652,0.11604095563139932,0.6346826634804514,1.0,5/34,3.56%,IGF1;INSR;TGFA;PDGFRB;IGF2
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.5535134917757272,1.2612535565536351,0.21018062397372742,0.8711274715454207,1.0,2/13,0.91%,PPARGC1A;GUCA1A
prerank,motor neuron axon guidance (GO:0008045),0.5485409192831024,1.2606069183976087,0.2222222222222222,0.8718342435715297,1.0,5/15,7.26%,NTN1;RAC2;NTN5;SEMA3A;NTN3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.42843230428706924,-1.2600576390927005,0.15902964959568733,0.6364060017370596,1.0,8/21,14.37%,RAD51B;NPM1;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,negative regulation of neuron projection development (GO:0010977),0.4368714170237799,1.2597508646451292,0.164021164021164,0.8731669955706426,1.0,16/56,17.05%,LRP4;LPAR1;RAB29;RTN4R;TRPV4;GDI1;EFNB2;SEMA3A;KANK1;HDAC2;RTN4RL1;PTEN;RTN4;PTPRO;EFNB3;MINAR1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3771356959664878,1.2588805483333008,0.11348314606741573,0.8746024915854194,1.0,11/152,5.35%,GNA14;LPAR1;ADGRG5;ADGRG2;PTGFR;AKAP12;GPR161;MC5R;PTHLH;GNAQ;ADCY5
prerank,atrial cardiac muscle cell action potential (GO:0086014),-0.4819908289217831,-1.2550005571810912,0.19612590799031476,0.6496960335110159,1.0,5/13,10.42%,ANK2;GJC1;GJA1;CACNB2;KCNN2
prerank,Fc receptor signaling pathway (GO:0038093),0.3903824578542471,1.25460469156902,0.1261904761904762,0.8884396032758448,1.0,29/110,18.75%,TEC;NFATC2;NFATC1;ITK;MAP3K1;MAPK10;VAV2;PSME3;FER;LCP2;PIK3R2;PSMB5;GAB2;LAT;TAB2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;SYK;BTK;PSME4;NFATC3;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.46033548308139,-1.2545654126152357,0.19791666666666666,0.6491101352844028,1.0,2/16,0.63%,IGF1R;INSR
prerank,endodermal cell fate commitment (GO:0001711),0.5770467218179565,1.2544945058914794,0.23801065719360567,0.8870990011773703,1.0,4/10,20.10%,LEO1;PAF1;RTF1;CDC73
prerank,regulation of receptor-mediated endocytosis (GO:0048259),-0.38568168834485567,-1.2544936503006856,0.14335664335664336,0.6474758781912844,1.0,7/35,8.47%,PICALM;HIP1;TNK2;B2M;HNRNPK;HIP1R;LDLRAP1
prerank,positive regulation of nervous system development (GO:0051962),0.45022382701675234,1.2543448739227845,0.19148936170212766,0.8859236543424153,1.0,4/42,6.39%,CLSTN2;RGS14;CLSTN3;EPHB2
prerank,peptide catabolic process (GO:0043171),-0.404595625828602,-1.2539425395138117,0.16666666666666666,0.6471163158955328,1.0,5/23,8.79%,ECE1;CPQ;CTSH;ACE;TPP1
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.3255588622175099,-1.2539052186782007,0.0821917808219178,0.6454015248194214,1.0,21/69,17.43%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;ERLIN2;UBE4B;OS9;RNF103-CHMP3;ANKZF1;SGTB;DERL2;FBXO44
prerank,cellular response to interleukin-12 (GO:0071349),-0.34454193795111865,-1.2537547164476746,0.09652509652509653,0.644035520307083,1.0,9/48,9.16%,PLCB1;MSN;CDC42;SIRPA;CFL1;ANXA2;RPLP0;JAK2;CNN2
prerank,negative regulation of cell communication (GO:0010648),0.4994011584860463,1.2532903085728613,0.20926517571884984,0.8881039639561003,1.0,2/21,2.26%,UBASH3B;SOCS5
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.3976511859235713,-1.252458070772641,0.16049382716049382,0.6458094962551134,1.0,6/30,5.61%,ENG;SMAD3;TGFBR3;LATS2;FKBP1A;ITGA3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.5757905095188068,1.2523088116386845,0.21724137931034482,0.8899279838024632,1.0,3/13,5.73%,PRICKLE1;SOX9;ANKRD2
prerank,regulation of protein localization to membrane (GO:1905475),0.4785374697062965,1.2522132383027944,0.20029895366218237,0.8885713376901331,1.0,10/28,17.60%,GPC3;GPC6;ZDHHC7;VAMP8;SLC5A3;GPC2;CRIPT;MMP14;GPC5;SPTBN1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.5584593404104896,1.251923310646487,0.21453900709219859,0.8879003426411012,1.0,8/13,27.07%,NELFB;SUPT4H1;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,regulation of cellular protein catabolic process (GO:1903362),0.5291297199849033,1.2518924540718999,0.19741100323624594,0.8863060046343422,1.0,8/18,17.56%,VGLL4;DACT1;RDX;RIC1;FAF1;EZR;VPS11;WDR91
prerank,prostanoid biosynthetic process (GO:0046457),-0.46145999947517513,-1.2518900059385387,0.1958762886597938,0.6456067475643752,1.0,6/15,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;MIF
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4904503052106378,-1.251319563311185,0.18673218673218672,0.6455591435255209,1.0,3/13,2.60%,NFIB;PPARD;BMP4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.5020824199703173,1.2510483309144,0.2144,0.8877796796249955,1.0,6/20,11.37%,NEDD4L;PRKCE;CAMK2D;CASQ2;ADRA2A;NEDD4
prerank,negative regulation of bone remodeling (GO:0046851),0.578002121397953,1.2510285149406029,0.23985890652557318,0.8861468064852651,1.0,2/11,5.86%,UBASH3B;TNFAIP3
prerank,regulation of monocyte differentiation (GO:0045655),-0.4813356832059708,-1.2506485087843766,0.2072892938496583,0.6457876342297817,1.0,5/14,19.93%,FOXP1;CDK6;IL34;CSF1;FES
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.5043726165589013,1.250263823946429,0.2106060606060606,0.8873984392897953,1.0,6/22,16.87%,NFATC2;IL4I1;CBFB;SOCS1;LAG3;MDK
prerank,dendrite self-avoidance (GO:0070593),-0.45244604137828504,-1.2502576021710363,0.1968503937007874,0.6451709059333574,1.0,6/16,13.47%,BSG;DSCAML1;NEXN;PALLD;ROBO4;CNTN2
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.404077973037242,1.2496731027007395,0.1497005988023952,0.8878569399932819,1.0,44/94,25.62%,DYNLL1;MKS1;SFI1;CEP89;CEP131;CEP78;NEDD1;TUBG1;CKAP5;CEP162;PAFAH1B1;CCP110;TCTN2;C2CD3;NDE1;CEP290;SSNA1;CETN2;RPGRIP1L;FBF1;PCM1;NPHP4;YWHAG;B9D2;YWHAE;CEP57;OFD1;CEP250;DCTN2;ALMS1;TCTN1;HAUS8;CEP43;CC2D2A;HAUS3;SCLT1;HAUS7;TMEM67;CEP83;DYNC1I2;NPHP1;TTBK2;CSNK1D;RAB3IP
prerank,glutamate receptor signaling pathway (GO:0007215),-0.36473691789562906,-1.2493602763366132,0.13,0.646206540205552,1.0,10/37,9.11%,PLCB1;KCNB1;GRM3;GRIA2;CPEB4;GRIN3A;GRIN2B;DAGLA;GRIK2;GRIN1
prerank,regulation of GTPase activity (GO:0043087),0.38005572120005787,1.2484064908527701,0.11627906976744186,0.8907403110712904,1.0,30/177,11.43%,ITGA6;EFNA5;SIPA1L1;DOCK9;F11R;RGS6;ARHGAP12;RAPGEF3;RAP1A;ARHGAP9;ARAP1;SGSM2;NF1;RTN4R;CAV2;VAV2;PLXNA3;ARHGEF5;ZC3H15;RAB3GAP2;RDX;RAPGEF6;PKP4;OCRL;GSK3B;TBC1D2;FERMT2;RIC1;DVL3;PLXNB1
prerank,cilium organization (GO:0044782),0.3638576003902671,1.248072966847571,0.10228509249183895,0.8902539827676086,1.0,57/209,18.88%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;EHD2;SNX10;CEP162;CLUAP1;CCP110;ARMC2;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;HDAC6;CFAP20;EXOC5;CEP290;FAM161B;PKD1;FBF1;PCM1;PDE6D;IQCG;FAM161A;DNAH5;CFAP298;CFAP70;PIBF1;CFAP61;CFAP410;B9D2;CDC14A;DYNC2H1;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29
prerank,regulation of cholesterol transport (GO:0032374),-0.43235552558334783,-1.2479173415794276,0.1726027397260274,0.6485202916151861,1.0,11/20,32.70%,LRP1;NR1H3;ARV1;NR1H2;ABCA2;NAXE;ABCB4;TSPO;ABCA13;NUS1;APOC1
prerank,positive regulation of protein acetylation (GO:1901985),0.571157698967917,1.2478051748238146,0.21837088388214904,0.8895757473529916,1.0,2/12,4.33%,RAPGEF3;DIP2A
prerank,indolalkylamine catabolic process (GO:0046218),0.5973238145924316,1.2472937038690146,0.2577132486388385,0.8897694126129919,1.0,2/10,3.76%,IL4I1;AADAT
prerank,negative regulation of kinase activity (GO:0033673),0.4259143597359184,1.2468469407118608,0.17539267015706805,0.8896382890920884,1.0,21/62,21.82%,TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SFN;CEP85;RTRAF;CDKN1C;YWHAG;DBNDD1;WARS1;CHP1;IRS2;PDPK1;PPM1E;CEP43;TSC2;GSKIP
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3875996888459037,1.2465849837643108,0.14386792452830188,0.8889014159606606,1.0,23/118,12.28%,EFNA5;SIPA1L1;FMNL2;NEDD4L;CEACAM1;PPFIA2;CAPZB;NF1;LZTS3;BRSK1;TNFAIP3;DAG1;SRCIN1;CDH2;GSK3B;SARM1;ZMYM6;PHLDB1;FERMT2;NEDD4;HTATIP2;SEMA4D;STAT2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.3414952801029524,-1.2464452701543496,0.13636363636363635,0.6511778290259421,1.0,18/47,21.72%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;GHITM;ATP5PF;OPA1;MTX2;ATP5ME;ATP5PO;TIMM10B;TIMM8B;ROMO1;MAIP1;TIMM29;ATP5MC2
prerank,negative regulation of multicellular organismal process (GO:0051241),0.3693613894213367,1.2458090912718334,0.1054945054945055,0.8900567191746412,1.0,30/199,11.88%,PTCH1;LRP4;DLX1;IL18R1;LAMA4;ZNF423;EGFR;SPRED1;SPRY1;SPI1;PLCL1;SOX9;PCTP;BMP5;ATP2B4;ACVR1C;ACOT13;N4BP1;HOXC10;LDLRAD4;PTGER4;LNPEP;TBX18;GSK3B;SDHAF2;DOCK7;WWC1;PROC;HS3ST5;RAB11FIP5
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.5211768646405258,1.2452398660344997,0.22149837133550487,0.8904558079528514,1.0,3/17,7.45%,JAG1;CD55;MSH2
prerank,regulation of protein acetylation (GO:1901983),0.5741553528677494,1.2442422464578715,0.2367066895368782,0.8925230689000533,1.0,3/12,14.15%,RAPGEF3;GSK3B;FAM161A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.35873862496158226,1.243821938143199,0.08842105263157894,0.8923459215965083,1.0,69/259,18.88%,DYNLL1;CDH13;PARVA;NTN1;UBXN10;RAP1A;RAB8B;ABLIM3;EMP1;MKS1;MINK1;SPEF1;ANO6;PTPDC1;DZIP1;OPHN1;DYNC2I1;CYS1;EXOC3;CNGB1;INTU;CEP89;CEP131;IFT81;ABLIM2;CNGA4;EHD2;SNX10;ARF6;CEP162;CLUAP1;RAPGEF6;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;MTSS1;HDAC6;CFAP20;EXOC5;CEP290;ARHGEF6;PKD1;FBF1;PCM1;PDE6D;FAM161A;DNAH5;PTPRO;VSTM5;CFAP298;CFAP70;PIBF1;CFAP410;EZR;B9D2;CDC14A;ARHGEF7;DYNC2H1;S1PR2;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29
prerank,hemopoiesis (GO:0030097),-0.3066675335499207,-1.2423639615321251,0.10614525139664804,0.6617504956549104,1.0,21/87,13.79%,FLT1;MECOM;NOTCH2;TEK;TGFBR3;BMP4;SNRK;KIT;FGFR2;MEIS1;FLT3LG;KDR;CD34;MKNK2;PGM3;KIRREL3;BMI1;TOX;FLT4;TGFB2;TAL1
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.41389431758122813,1.2422995805643529,0.190176322418136,0.8963700509144794,1.0,12/72,14.18%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;SPRED2;FLRT2;TIAL1
prerank,protein K63-linked deubiquitination (GO:0070536),0.46736860400789937,1.2421953474610439,0.19005847953216373,0.8950538734745548,1.0,11/31,18.75%,USP50;BRCC3;TNFAIP3;USP8;OTUB2;UIMC1;USP13;OTUD7B;STAMBPL1;STAMBP;PSMD14
prerank,hexose transmembrane transport (GO:0008645),-0.41101551185383084,-1.242038072379866,0.18075801749271136,0.6609875884049664,1.0,10/21,27.12%,PPARD;SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4
prerank,gene expression (GO:0010467),-0.2564007612002007,-1.2417735957506408,0.06666666666666667,0.6600259117814996,1.0,122/348,22.69%,RBPMS;RPL37A;RRBP1;CREBL2;ADAR;NUP107;RPL19;RPL8;RPL37;SNRNP40;RPS15;RPS29;FARSB;RPL35A;RPS7;HNRNPK;RPS20;RPL32;AAAS;EEF1A1;RPS27;RPL26;SEH1L;RPL27;RBMS1;NUP133;RPS24;NOX4;RPLP0;FYTTD1;MEF2A;HARS1;PTMA;RPS19;HBS1L;THOC2;RBMS2;RPL31;RPL41;GLE1;TSPAN17;RPL13A;RPL30;RPL29;MRPS6;RPS16;RPL3;HNRNPH3;NR4A2;RPLP1;RRAGC;RPS17;RPS3;RPL23;RPL17;RPL9;RPL38;DHPS;RPL36;RPS26;POLR3A;RPS8;ZC3H11A;RPS12;MMS19;RPL18A;RPS21;MRPL32;MAGOH;MRPL18;LMF2;NUP88;CDC40;RPS18;RPLP2;EIF4G1;RPS6;NOL9;ANGPT2;HHEX;RPS15A;NCBP1;MRPL9;DNAJB11;MRPL28;CPSF1;PWP1;DDX20;MAGOHB;RNPS1;HOXD3;POLR2F;GSPT2;CLP1;MRPS11;POLR2A;POLR2J;TSPAN5;POLR2D;MRPS16;POLR2K;RPL14;MRPS18B;U2AF2;NOVA1;HNRNPH1;RPS2;SRRM1;THOC7;MRPL42;NUP54;RPL10A;DUSP11;THAP1;THRB;RPL39;RPL34;RPL5;MRPS12;RPL22;SRSF1;MRPL55
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.5536171437773623,1.2417250036699155,0.22053872053872053,0.8952027160073532,1.0,7/15,20.84%,ATL2;REEP3;LNPK;RTN4;ZFYVE27;RAB18;REEP4
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3713447082188172,1.241651365611352,0.1404494382022472,0.8938605045182098,1.0,45/161,18.75%,CAV1;IGFBP6;LRP4;GLI1;PRICKLE1;DKKL1;AXIN1;MLLT3;SOX9;CHD8;PSME3;DACT1;WNT5A;ZNRF3;CUL3;AMFR;PSMB5;TBX18;STK3;GSK3B;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;KREMEN1;EMD;PSMB2;PSMA2;PTPRU;PTPRO;PSMA6;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7;MDK;INVS;PSME4;PSMC4;PSMB6;PSMD12;RUVBL2;PSMD14
prerank,positive regulation of dendrite extension (GO:1903861),0.5185723370735815,1.2414878357701036,0.2200328407224959,0.8928169888563552,1.0,3/17,9.00%,NEDD4L;RIMS2;CPNE9
prerank,sodium ion transport (GO:0006814),0.3979014405089208,1.241085281450415,0.1777509068923821,0.8926464673374567,1.0,12/85,7.04%,NEDD4L;SCN10A;NALCN;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;SLC4A11
prerank,regulation of protein catabolic process (GO:0042176),0.3908260189260865,1.2400332187405525,0.1764004767580453,0.8947830695496299,1.0,11/99,6.08%,PLK2;GPC3;NEDD4L;EGFR;AXIN1;FAM83D;IRAK3;DACT1;WNT5A;TNFAIP3;AZIN2
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4808202168790595,-1.239875885971873,0.22650602409638554,0.6640521911449969,1.0,5/12,21.80%,PIK3R1;BCL2L11;BOK;XBP1;ATF6
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.45781205899209665,1.2397821323300022,0.19912152269399708,0.8940132526624597,1.0,5/35,3.59%,CAV1;NR2F2;SULF1;NF1;CAV2
prerank,negative chemotaxis (GO:0050919),-0.37814538193495795,-1.239640937398281,0.1696113074204947,0.6628886526584097,1.0,7/33,5.19%,ROBO1;EPHA7;SEMA6D;SLIT2;SEMA7A;SEMA3C;SEMA6A
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.41896437409218634,-1.2394066170897984,0.20512820512820512,0.661853392389003,1.0,7/23,6.84%,ACSL1;ACSL3;FAR2;ACOT7;ELOVL7;ACSL6;HSD17B12
prerank,positive regulation of hemostasis (GO:1900048),0.5879613743181846,1.2389948093218823,0.2422680412371134,0.8936754889460717,1.0,1/10,0.79%,ST3GAL4
prerank,positive regulation of coagulation (GO:0050820),0.5879613743181846,1.2389948093218823,0.2422680412371134,0.8936754889460717,1.0,1/10,0.79%,ST3GAL4
prerank,rRNA transcription (GO:0009303),0.5137675570733236,1.2389523060375258,0.22439024390243903,0.8921607637402165,1.0,6/17,13.76%,CAVIN1;GTF3C6;POLR1E;SIRT7;SPIN1;GTF3C5
prerank,regulation of dendrite extension (GO:1903859),0.5132786789193617,1.238947062734855,0.22564935064935066,0.8905451988282354,1.0,3/18,9.00%,NEDD4L;RIMS2;CPNE9
prerank,histone H4-K16 acetylation (GO:0043984),0.509303314128845,1.2383004710033672,0.22383252818035426,0.8914171503187205,1.0,4/19,7.54%,OGT;KMT2A;KANSL2;MSL3
prerank,C-terminal protein amino acid modification (GO:0018410),0.5739184068039102,1.237764977940823,0.2456445993031359,0.8917354586510832,1.0,7/11,18.81%,GPLD1;AGBL4;ATG5;ATG7;LCMT1;AGBL1;ICMT
prerank,energy reserve metabolic process (GO:0006112),-0.43237326653813557,-1.237466373612597,0.19943019943019943,0.6658087319111837,1.0,4/19,7.21%,PRKAG2;PID1;GBE1;UGP2
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.5222252484278502,1.2369486744326341,0.20833333333333334,0.8929877252104809,1.0,5/19,8.21%,PTGFR;FKBP1B;FIS1;PTPRC;PTPRJ
prerank,maintenance of protein localization in organelle (GO:0072595),0.5122478345094907,1.2366688325358903,0.21815286624203822,0.8924128954467021,1.0,3/19,4.75%,HK2;BCL3;MORC3
prerank,negative regulation of protein phosphorylation (GO:0001933),0.38073937461349494,1.2365874901242397,0.1411111111111111,0.8910699429104113,1.0,28/150,12.80%,CNKSR3;CAV1;TRIB2;NTRK3;UBASH3B;PTPN13;CEACAM1;PDE4D;SPRED1;NF1;PLPP3;GNAQ;PTPRC;IBTK;EPHB2;NCK2;LDLRAD4;OCLN;SFN;NLRP2B;RASSF2;CEP85;SNX25;RTRAF;MEN1;SEMA4D;MVP;PTEN
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.3576327063257083,1.236370839128628,0.10363247863247864,0.8902053545125551,1.0,70/248,18.75%,CAV1;IGFBP6;GPC3;LRP4;GLI1;PRICKLE1;PPM1N;DKKL1;NRARP;FOLR1;EGFR;AXIN1;MLLT3;SOX9;CHD8;GNAQ;PSME3;DACT1;WNT5A;PPM1A;USP8;UBR5;PLEKHA4;FAM53B;KANK1;ZNRF3;CUL3;AMFR;CSNK1G3;PSMB5;RNF220;STK3;GSK3B;USP47;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;COL1A1;KREMEN1;EMD;SOX4;PSMB2;FZD7;CAPRIN2;PSMA2;PTPRU;PTPRO;PSMA6;FZD9;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7;MDK;PPP1CA;INVS;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;RUVBL2;PSMD14
prerank,positive regulation of synapse assembly (GO:0051965),0.49131178884281856,1.2359864619575336,0.2141823444283647,0.8899435969468258,1.0,3/27,6.39%,CLSTN2;CLSTN3;EPHB2
prerank,protein localization to membrane (GO:0072657),0.37053588393029224,1.235740885668449,0.11353711790393013,0.8892532578769944,1.0,23/187,10.07%,PTCH1;CAV1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;RAB29;KCNIP4;FLOT2;CPE;SH3PXD2B;RABEP1;RDX;EHD2;RAB3A;ITGB7;EFR3A;RAPGEF6;ZDHHC23;ATP1B3;DLG3;FERMT2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),-0.37336511021922314,-1.2345066426884175,0.14860681114551083,0.6728549967471903,1.0,6/31,6.38%,PARD3;MSN;CDC42;LIN7A;ERBIN;SYNJ2BP
prerank,regulation of mRNA processing (GO:0050684),0.4603427929485906,1.2333022573002181,0.22458270106221548,0.8963302065332203,1.0,18/32,26.68%,QKI;SON;SRPK1;SLTM;KHDRBS2;SRPK2;SF1;CWC22;SRSF3;DHX9;TIA1;SRSF10;YTHDC1;JMJD6;IWS1;PABPN1;SAFB2;RBM39
prerank,sterol transport (GO:0015918),0.5126043070898494,1.233142783604983,0.2273449920508744,0.8952264872448008,1.0,1/19,0.24%,CAV1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),0.5221389187476422,1.2323358378723246,0.2618296529968454,0.8965487330825785,1.0,2/16,2.06%,FOXD1;FGF1
prerank,regulation of establishment of cell polarity (GO:2000114),0.5220689253258467,1.2323103566703035,0.24183006535947713,0.8950204415823101,1.0,4/16,7.57%,RIPOR2;CDH5;KIF20B;KANK1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4029259240250873,-1.2318908645056021,0.21306818181818182,0.6790497033769604,1.0,4/25,6.00%,ANK2;TRPC1;CACNB2;AKAP6
prerank,anterior/posterior pattern specification (GO:0009952),-0.33902384339099734,-1.2316857857101755,0.13059701492537312,0.6778736883303179,1.0,17/53,17.58%,WLS;HOXA3;TGFBR1;BMPR2;HOXB4;HOXA5;HOXB9;TBX1;HOXC4;BMP2;HOXA9;HOXA6;HOXB7;HOXD4;HHEX;HOXD3;LRP5
prerank,ephrin receptor signaling pathway (GO:0048013),0.39850278408130957,1.2312729495059251,0.17699115044247787,0.8971796568532046,1.0,13/82,8.46%,EFNA5;SIPA1L1;ARHGEF28;EFNB1;APH1B;VAV2;SRC;DNM1;NCSTN;EPHB2;NCK2;EFNB2;KALRN
prerank,positive regulation of epidermal cell differentiation (GO:0045606),0.5343871852312354,1.2312597169078492,0.2315270935960591,0.895623902994494,1.0,1/15,0.21%,ETV4
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.48195921464469027,-1.2312281687707336,0.2169576059850374,0.6774201010629429,1.0,6/12,21.63%,LDLR;APOE;VBP1;CRYAB;PFDN4;CLU
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4260859922001324,-1.230962381945938,0.18082191780821918,0.6765007619533845,1.0,4/20,11.67%,IGF1;EP300;TRAF6;H1-0
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.3758312204427282,1.230086850654471,0.15765247410817032,0.898338813559982,1.0,28/140,8.85%,DLC1;TIAM2;ARHGAP31;PLCE1;ARHGAP18;ARHGAP12;ARHGAP32;ARHGAP9;ARAP1;DEPDC1B;AKAP13;OPHN1;RACGAP1;VAV2;SRC;RAC2;NUP62;TRIO;ARHGEF5;ARHGAP26;RHOJ;ARHGEF1;CGNL1;PIK3R2;STARD13;KALRN;OBSCN;OCRL
prerank,acyl-CoA biosynthetic process (GO:0071616),0.5218304392907254,1.2291085353188431,0.215,0.9002689184530002,1.0,5/16,7.77%,DIP2A;SCD5;ACACA;GCDH;ACAT1
prerank,regulation of integrin activation (GO:0033623),0.5272718314126892,1.2287225702584148,0.2282958199356913,0.9001071147040034,1.0,5/15,10.07%,SRC;PTGER4;PIEZO1;PLEK;FERMT2
prerank,positive regulation of B cell proliferation (GO:0030890),0.4738695123636518,1.2287055729334018,0.22746781115879827,0.898568821477832,1.0,7/29,13.16%,NFATC2;PTPRC;EPHB2;CD320;GPR183;CD81;IL7
prerank,response to interleukin-4 (GO:0070670),-0.52582396262823,-1.2286272332547006,0.2191780821917808,0.6817939777368106,1.0,1/10,0.70%,LEF1
prerank,renal system development (GO:0072001),0.4260585576114466,1.228411736745757,0.1912568306010929,0.898090564894356,1.0,5/52,2.92%,STRA6;LRP4;SULF1;PCSK5;GLI2
prerank,regulation of glycolytic process (GO:0006110),-0.31788813155136864,-1.2279132982979177,0.11162790697674418,0.682133646440508,1.0,12/68,7.30%,PRKAG2;IGF1;INSR;NUPR1;NUP107;CBFA2T3;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,alanine transport (GO:0032328),-0.5265356479708728,-1.227880452161101,0.20714285714285716,0.6804320724058137,1.0,4/10,23.93%,SLC6A6;SLC1A4;SLC6A17;SLC7A10
prerank,potassium ion import across plasma membrane (GO:1990573),0.44329063615793546,1.2274355718445378,0.225,0.9000571489503052,1.0,7/41,5.58%,KCNJ4;SLC12A2;KCNJ16;SLC12A4;SLC12A3;ATP1A2;KCNJ13
prerank,carnitine shuttle (GO:0006853),-0.5049667621218885,-1.227249621746248,0.2347417840375587,0.6807200869763558,1.0,5/11,14.68%,PRKAG2;CPT2;PRKAB2;CPT1A;MID1IP1
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.40095278159964676,1.2270565876455342,0.1905940594059406,0.8998225022436783,1.0,7/75,5.06%,DCN;THBS4;SULF1;ADAMTS1;SPRED1;ATP2B4;AMOT
prerank,lipid phosphorylation (GO:0046834),0.590428278784846,1.2270458163533815,0.2717391304347826,0.8982773794417471,1.0,2/10,3.58%,DGKA;DGKZ
prerank,negative regulation of T cell proliferation (GO:0042130),0.4745512993453154,1.2255220983931263,0.21804511278195488,0.9019868517986112,1.0,4/28,7.34%,ARG1;GLMN;IL4I1;CRTAM
prerank,regulation of interleukin-2 production (GO:0032663),0.4333703358536933,1.2254411257546485,0.198005698005698,0.900698117473397,1.0,6/43,5.86%,HOMER2;GLMN;PDE4D;IL1A;PTPRC;TNFAIP3
prerank,establishment of endothelial barrier (GO:0061028),0.4680948935809953,1.2252271079387493,0.21482602118003025,0.8998765903470657,1.0,7/29,8.67%,F11R;RAPGEF3;RAP1A;PDE4D;TJP2;RDX;RAPGEF6
prerank,"synaptic transmission, glutamatergic (GO:0035249)",-0.43020603542171443,-1.224738137990295,0.193717277486911,0.6863553671705863,1.0,4/18,7.84%,UNC13C;NAPA;GRIA2;GRIK2
prerank,cellular response to chemokine (GO:1990869),0.4351923722461859,1.224262190682391,0.20759837177747625,0.901631104050088,1.0,3/46,1.71%,ACKR3;RIPOR2;SLC12A2
prerank,protein localization to plasma membrane (GO:0072659),0.3776637327852934,1.224010409214256,0.16436781609195403,0.9009808609588477,1.0,15/129,9.40%,PTCH1;F11R;SLMAP;EPB41L3;RAP1A;RAB8B;KCNIP4;FLOT2;RDX;EHD2;RAB3A;EFR3A;RAPGEF6;ZDHHC23;ATP1B3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.37153134541199356,1.2237714990486463,0.15497737556561086,0.9002431072872952,1.0,12/140,7.88%,CAV1;LPAR1;ACKR3;PLCE1;ITPR3;PTGFR;CD55;TRPV4;FIS1;ADCY5;ABL2;PTGER4
prerank,cellular response to dsRNA (GO:0071359),0.5383043476957685,1.2235932638897435,0.22185430463576158,0.8992667655653734,1.0,1/15,0.24%,CAV1
prerank,heterocycle biosynthetic process (GO:0018130),-0.45336208629478536,-1.2225549017895498,0.20581113801452786,0.6911576776491194,1.0,9/14,40.89%,GCH1;NFS1;PYCR2;MOCS3;PYCR3;PYCR1;ALOX5;GPHN;NOXRED1
prerank,vitamin transport (GO:0051180),0.4758117331871957,1.2224631283937153,0.21936459909228442,0.9017616466112212,1.0,11/29,14.92%,FOLR1;FOLR2;SLC27A1;SLC2A2;SLC52A1;TTPA;CD320;CUBN;GC;AMN;SLC46A1
prerank,response to nutrient levels (GO:0031667),-0.4354563821862484,-1.2224177227482216,0.21333333333333335,0.6897095792394223,1.0,8/17,32.24%,KCNB1;RPS6KB1;EIF4G1;ATF4;FAM107A;PRKAA1;MEAK7;ULK1
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),0.5419200572987994,1.2222905017104932,0.24288107202680068,0.9008607485866962,1.0,6/12,18.88%,STX1A;STX2;STX19;STX4;SNAP23;SNAP29
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.5283133098407296,-1.221947466580532,0.22556390977443608,0.6893445260036283,1.0,6/10,36.69%,NOC2L;BRCA1;THAP7;CTBP1;SNCA;KLF15
prerank,positive regulation of cellular respiration (GO:1901857),-0.5081291289055837,-1.2216063774757242,0.2219679633867277,0.6886179375210358,1.0,5/11,23.51%,NUPR1;IL10RB;VCP;IFNAR1;ISCU
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.43510777419938834,-1.2207284763824795,0.19948186528497408,0.6894736996411451,1.0,7/17,36.15%,LPGAT1;PLA2G4F;CRLS1;LPCAT1;PLA2G4B;PLA2G5;LPCAT4
prerank,positive regulation of lipid metabolic process (GO:0045834),0.4807697941971696,1.2196777667902643,0.2286158631415241,0.9088214399978272,1.0,2/22,1.88%,SORBS1;ZBTB20
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.42058262615505293,1.2191103476664358,0.19893190921228304,0.9093759046181777,1.0,15/54,17.14%,CAV1;SH3RF2;OGT;TNFAIP3;TRIM21;N4BP1;SIRT7;SPOPL;NXN;USP4;SOX4;GNL3L;BAG2;MINAR1;CHP1
prerank,positive regulation of catalytic activity (GO:0043085),0.44703987942275947,1.2189669751153753,0.21978021978021978,0.9083599386973228,1.0,6/37,7.45%,CAV1;MSH6;NCSTN;AZIN2;ABL2;MSH2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.32915343184489365,-1.2189458140214746,0.13191489361702127,0.692818008416507,1.0,26/57,28.24%,TGS1;RPS15;RPL35A;RPS7;RPL26;NPM1;HEATR3;RPS24;RPS19;RPS16;RPS17;WDR12;RPL38;RIOK1;NOC2L;RPS6;DHX37;RPL14;RPL5;MRPL36;RPS25;PAK1IP1;RPF2;RPL7;RPL11;NOP16
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.35349127936899477,-1.2186258520107822,0.1444043321299639,0.6919862972601369,1.0,9/41,7.30%,PRKAG2;NUP107;EP300;LACC1;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,protein autophosphorylation (GO:0046777),-0.2727261666349285,-1.2184368812482718,0.030612244897959183,0.6907208471270059,1.0,39/157,13.57%,FLT1;IGF1R;DAPK1;INSR;TEK;PDGFRB;PDGFRA;GRK5;LYN;DDR1;EPHA4;KIT;FGFR2;STK17B;SIK1;KDR;BMX;EPHA8;CDK12;JAK2;MAP2K2;STK10;MKNK2;AKT1;ULK2;CAMK2A;MAP3K10;CDKL5;EIF2AK4;MKNK1;CAMK4;OXSR1;LRRK2;FGFR4;TAOK2;FLT4;MAPKAPK2;PIM3;MAPKAPK3
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4546807279605157,-1.2181151964672419,0.22807017543859648,0.6898669519223584,1.0,4/15,13.37%,OSBPL8;OSBPL11;ABHD5;PLIN3
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),0.37144982581144326,1.2179879312927655,0.14823529411764705,0.9103307592649392,1.0,46/129,21.96%,CAV1;GPC3;PPM1N;NRARP;EGFR;AXIN1;PSME3;DACT1;PPM1A;USP8;UBR5;PLEKHA4;FAM53B;KANK1;CSNK1G3;PSMB5;RNF220;USP47;AXIN2;COL1A1;SOX4;PSMB2;CAPRIN2;PSMA2;PSMA6;FZD9;PSMD13;PSMA7;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;PSMD14;PIN1;TRPM4;RNF146;USP34;CCAR2;PSMB3;GSKIP;GID8
prerank,protein K48-linked deubiquitination (GO:0071108),0.48554105886444165,1.2175402167717837,0.23317683881064163,0.9104386895218334,1.0,6/23,11.06%,USP50;TNFAIP3;USP8;OTUB2;MINDY2;OTUD7B
prerank,membrane fusion (GO:0061025),-0.3704230802016367,-1.2170762332963816,0.17064846416382254,0.6911068340007063,1.0,4/33,3.74%,MYOF;DNM3;DYSF;NAPA
prerank,cardiac ventricle development (GO:0003231),0.5127823030623218,1.2169157597824045,0.23333333333333334,0.9111794355071636,1.0,2/20,5.24%,STRA6;HEYL
prerank,regulation of osteoblast proliferation (GO:0033688),-0.4392022394727853,-1.2168202984301943,0.22010869565217392,0.6901498039233696,1.0,5/17,10.52%,NPR3;FGFR2;MN1;CCN1;BMP2
prerank,regulation of defense response to virus (GO:0050688),0.5374128975015721,1.2166861605469685,0.2495755517826825,0.9104978237959515,1.0,6/14,20.97%,PCBP2;TNFAIP3;ZMPSTE24;ITCH;DHX9;TRAF3
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.4757472805653481,-1.2160284573905291,0.2112676056338028,0.6908227650089632,1.0,6/13,15.04%,SHANK3;ADCY1;SQSTM1;LGMN;EIF2AK4;ZDHHC2
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3923909379197647,1.2153432641262039,0.1972534332084894,0.9138016791661853,1.0,12/80,11.89%,TENM2;RIPOR2;PLCE1;ARAP1;CDC42EP4;RAC2;PALM;CCP110;OCLN;GPM6A;APC;AKIRIN1
prerank,cardiolipin metabolic process (GO:0032048),0.5525324413600364,1.2149203625392528,0.2585034013605442,0.9137478719280292,1.0,5/13,12.76%,SLC27A1;HADHB;PTPMT1;LCLAT1;PNPLA8
prerank,negative regulation of viral release from host cell (GO:1902187),-0.4791468493937452,-1.2148236521894757,0.2109004739336493,0.692720944908306,1.0,7/13,20.69%,MID2;TRIM35;TRIM28;CHMP3;TRIM8;TRIM13;TRIM11
prerank,eye development (GO:0001654),0.4184159795255039,1.2144884451114617,0.21621621621621623,0.9137277665842236,1.0,9/54,8.69%,STRA6;EFEMP1;PBX1;BMPR1B;HIPK1;SH3PXD2B;SHROOM2;FREM2;ABCB5
prerank,glucose metabolic process (GO:0006006),0.41344446429930487,1.2143497908397578,0.21466666666666667,0.9126640347804155,1.0,14/58,17.84%,APOD;PPARGC1A;SLC25A12;ALDOB;PGM1;ADPGK;MDH1;SLC25A13;ENO3;GOT1;HECTD4;PGK1;IRS2;ENO2
prerank,epithelial cell migration (GO:0010631),0.4403602289647786,1.2140440512550705,0.20910384068278806,0.9121924775943996,1.0,7/37,8.07%,CDH13;PXN;FAP;KANK2;KANK1;DPP4;STARD13
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.4815185407896878,1.2137400660037094,0.23711340206185566,0.911771745280132,1.0,7/26,13.79%,FGFR1;EYA1;IL1A;MCL1;MAPK7;PPP2R1B;HTRA2
prerank,positive regulation of protein phosphorylation (GO:0001934),0.3523970692013154,1.2136242614003308,0.09723643807574207,0.9106215869630447,1.0,31/348,5.38%,NGF;THBS4;CAV1;EFNA5;FGF7;TEC;NTRK3;INHBB;CSPG4;CLDN19;LEPR;EGFR;RAPGEF3;CCND3;MUSK;RAP1A;PELI2;FGF1;AXIN1;FXR2;PRKAG1;MMD2;SOX9;SRC;BMP5;ATP2B4;LIMK2;PTPRC;BANK1;TOM1L1;BMP15
prerank,cellular response to interferon-gamma (GO:0071346),-0.3004834243429283,-1.21225217143618,0.12135922330097088,0.6989202743933325,1.0,24/88,19.76%,DAPK1;SP100;IRF2;TRIM25;SIRPA;B2M;VCAM1;GBP3;JAK2;GBP4;RPL13A;CAMK2A;IRF1;GAPDH;GBP6;CCL13;GBP7;LGALS9;GBP2;MT2A;TRIM8;PDE12;DAPK3;ICAM1
prerank,positive regulation of axonogenesis (GO:0050772),0.43752832239032785,1.2122209251269662,0.21293800539083557,0.9140840685004108,1.0,3/43,1.05%,NGF;NTN1;TIAM2
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.428724972439838,1.2120049221477274,0.21940928270042195,0.9133146734362928,1.0,7/46,8.41%,CNKSR3;RGS14;SPRED1;SPRY1;PTPRC;EPHB2;TNIP1
prerank,regulation of peptidase activity (GO:0052547),0.501020651812353,1.211698060708124,0.24378881987577639,0.9129500910924763,1.0,1/19,0.24%,CAV1
prerank,cellular copper ion homeostasis (GO:0006878),-0.44874606458829824,-1.2113913597338464,0.22409638554216868,0.6997740021378862,1.0,3/14,5.15%,ATP7A;SLC31A1;SLC31A2
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.35635609943449964,1.211114663937368,0.14621131270010673,0.9136087204752689,1.0,19/214,6.39%,ROR2;CNKSR3;ROR1;NTRK3;ACKR3;RGS14;CEACAM1;EGFR;RAP1A;SPRED1;SPRY1;PTPN22;PRKCA;FAM83D;PTPRC;FN1;STYX;ARHGEF5;EPHB2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.4829369458800168,1.210767728523526,0.24363057324840764,0.913293601284685,1.0,5/21,9.41%,IL4I1;PTPN22;BANK1;TNFAIP3;FOXJ1
prerank,proteolysis (GO:0006508),0.35434415972245314,1.2104014759168324,0.12172088142707241,0.9130941055422884,1.0,52/252,17.66%,PTCH1;CTRC;ADAMTS12;TINAGL1;FAP;NAALAD2;PCSK5;ADAM19;OGT;SENP6;MMP15;APH1B;CPE;CAPN6;CPA2;RNPEP;NCSTN;ADAM10;LVRN;DPP4;FBXO3;PSMB5;LNPEP;UFSP2;PCSK7;BACE2;LONP1;MMP12;MME;PROC;CELA1;TASP1;XPNPEP3;MMP16;CAPN2;MIPEP;ATG4C;HTRA2;PSMA6;PLG;GGT1;FAM111A;TYSND1;NLN;ZMPSTE24;BACE1;MBTPS1;PM20D2;MMP14;TMPRSS7;BMP1;CTSB
prerank,chondroitin sulfate metabolic process (GO:0030204),0.46022975889409884,1.210399562129542,0.22740524781341107,0.9115775755542627,1.0,4/30,5.76%,DCN;CSPG4;CHST7;NCAN
prerank,T cell mediated immunity (GO:0002456),0.5468602706354581,1.2101492395659914,0.2627118644067797,0.9109999365664272,1.0,3/13,7.34%,JAG1;CD55;CRTAM
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.3440380013994322,-1.209989871388913,0.15827338129496402,0.702408398899146,1.0,10/43,7.71%,ITGA1;TGFA;ERRFI1;PTPN3;RNF115;CDC42;ZFYVE28;DUSP3;SH3KBP1;EPS15
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.44677144856482764,-1.20941912412288,0.21629213483146068,0.7025119289251374,1.0,11/17,29.93%,ATP5PD;VPS9D1;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,positive regulation of epithelial cell migration (GO:0010634),0.3864394774687446,1.2094183431458003,0.1959378733572282,0.9120123787868298,1.0,12/92,4.96%,FGF7;SMOC2;DOCK5;PRKCE;FGF1;NRP2;DOCK1;GPLD1;SOX9;PRKCA;SRC;WNT5A
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.4189292600967088,-1.2084173089917623,0.23604060913705585,0.7039328167164572,1.0,4/16,11.10%,ANK2;SEC16A;SEC16B;LRRK2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.3942229864201306,1.2079618525852662,0.2002551020408163,0.9155439477481702,1.0,11/79,5.62%,DLX1;ADAMTS12;SULF1;CASK;SPRY1;BMPR1B;NBL1;SPRY4;ATP2B4;CREB3L1;APLN
prerank,positive regulation of cell motility (GO:2000147),0.35500776979121274,1.207898160814723,0.13704496788008566,0.9142404203703562,1.0,23/205,7.12%,ROR2;CLDN1;ITGA6;CAV1;NTRK3;CDH13;NTN1;EGFR;GTSE1;FGF1;SEMA4B;SH3RF2;CDH5;ITGAX;PRKCA;CAVIN1;FER;TRADD;ADAM10;EPHB2;RDX;RIPOR1;SEMA3A
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.4960994352054242,1.2075501627592433,0.25040387722132473,0.9139822922947428,1.0,8/23,19.62%,OTOP1;ARG1;TXK;IRGM;SOCS1;PPARG;JAK1;SUMO1
prerank,kidney development (GO:0001822),0.4054460893653523,1.2071977049714517,0.20785804816223066,0.9137653509931256,1.0,7/65,5.45%,STRA6;LRP4;SULF1;PCSK5;GLI2;NF1;KANK2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.46146332606769563,-1.207090307056439,0.24939467312348668,0.7063113791486437,1.0,7/14,16.78%,SEMA7A;KIT;PLCG2;BCL10;CAMK4;LAPTM5;GPRC5B
prerank,axonogenesis (GO:0007409),0.35607100029669103,1.2069719418979112,0.13997879109225875,0.9130907024867089,1.0,36/237,11.18%,NTNG2;NTNG1;GAB1;EFNA5;LAMA2;EFNB1;NRP2;PARD6B;SEMA4B;GLI2;OPHN1;S100A6;PRKCA;SRC;DSCAM;WNT5A;BRSK1;ARTN;LAMA5;EPHB2;RAB3A;DAG1;EFNB2;SEMA3A;NTN3;SIAH1;MAPK7;S100B;ISL1;TNR;NTN4;GAB2;POU4F1;RELN;DOCK7;SLC9A6
prerank,bone development (GO:0060348),-0.3479282884515647,-1.205680735537796,0.17343173431734318,0.7087062179922553,1.0,9/39,7.80%,RANBP3L;GNAS;CYP26B1;TGM2;GJA1;FGFR2;PLS3;NOTUM;LRP6
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.30077201453017943,-1.2055311823048371,0.11794871794871795,0.7074148359231471,1.0,18/85,9.51%,IGF1;MCC;TGFA;OSR1;ANGPT1;BMP6;TGFBR3;NUPR1;BMP4;TIE1;ACVRL1;FGFR2;B2M;DUSP10;TBX1;CDK6;AQP11;LAMB1
prerank,homeostasis of number of cells (GO:0048872),-0.46345840467016053,-1.2051563929651028,0.2327790973871734,0.7068242605962628,1.0,3/12,4.37%,NOS3;NAPEPLD;CCN3
prerank,ganglion development (GO:0061548),0.5663947716312996,1.20514012397837,0.2643478260869565,0.9181159336800714,1.0,3/11,14.91%,NRP2;SEMA3A;FZD3
prerank,thyroid hormone generation (GO:0006590),-0.49360721243707445,-1.2042230050165716,0.25968109339407747,0.7079152384822281,1.0,5/10,34.12%,CPQ;DIO2;FOXE1;TG;CTSK
prerank,melanosome localization (GO:0032400),-0.4027042891444054,-1.2039277649800584,0.23835616438356164,0.707036582916572,1.0,9/21,22.48%,MYO5A;RAB11A;BBS2;MKKS;BLOC1S6;RAB11B;MLPH;BBS5;RAB27A
prerank,regulation of Wnt signaling pathway (GO:0030111),0.3730694772182333,1.203620000483226,0.18500604594921402,0.9218850976326909,1.0,22/108,14.10%,MDFIC;GPC3;VGLL4;SULF1;NFATC1;FOLR1;AXIN1;DEPDC1B;GNAQ;DACT1;TNFAIP3;HIC1;FAM53B;KANK1;TMEM237;KREMEN1;SPIN1;NXN;EMD;CTNNBIP1;CBFB;FZD7
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),-0.4939582773885847,-1.2035683402112427,0.2529002320185615,0.7063345724232702,1.0,6/10,14.68%,LPGAT1;NR1H3;NR1H2;SLC45A3;ABCD2;MID1IP1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5762552887753556,1.2032927080605258,0.26611570247933886,0.9215132824482735,1.0,3/10,9.58%,OGT;SELENOS;SIRT7
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.5488495774607264,1.2029758930544676,0.27101200686106347,0.9211734577576719,1.0,5/12,24.20%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4740567747236094,-1.2029703044588143,0.24105011933174225,0.706412304103608,1.0,6/12,22.77%,LRRK2;TMEM9;CLN5;GRN;CLN6;CCDC115
prerank,plasma membrane bounded cell projection organization (GO:0120036),-0.2834862300997624,-1.202707331922739,0.10569105691056911,0.7054414628209074,1.0,27/124,14.92%,FRY;PTPRM;RAPGEF2;TPM1;LYN;FRYL;STMN2;RASGRF1;GPRIN3;APOE;EPHA8;TBC1D24;STMN4;CAMSAP1;WDPCP;RAB13;LAMB1;MANF;ATP1B2;RAB11A;STMN1;LGI1;MAPT;SH3GL2;DTNBP1;MICALL1;CDK5R1
prerank,regulation of mononuclear cell migration (GO:0071675),-0.3929441597888809,-1.2023496240789437,0.1912568306010929,0.7048229923260394,1.0,10/23,18.75%,MSN;SLIT2;LYN;STK10;CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4250502533877415,-1.2022602988571502,0.2297650130548303,0.703381882722911,1.0,7/18,12.46%,FRS2;CCN3;HDAC1;BMP2;GSK3A;SOX6;BDNF
prerank,amyloid fibril formation (GO:1990000),0.4180739599837466,1.2021590121395043,0.22177954847277556,0.9226641848576252,1.0,6/51,7.41%,TGFBI;UBE2L6;APH1B;NCSTN;ADAM10;SIAH1
prerank,regulation of vasoconstriction (GO:0019229),0.4733114286800677,1.2020605187001139,0.2433234421364985,0.9215230805061648,1.0,3/27,3.83%,CAV1;SMTNL1;SMTNL2
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.499515317992378,-1.201934690991013,0.2611764705882353,0.7026753407940459,1.0,2/10,4.80%,GRB10;HIF1A
prerank,regulation of histone acetylation (GO:0035065),0.45277423919954296,1.2018961400581447,0.22157434402332363,0.9206276037541961,1.0,4/33,3.65%,PPARGC1A;RAPGEF3;KMT2A;SPI1
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.41481346491876636,-1.2016191414433828,0.18618618618618618,0.7001878400053024,1.0,8/20,19.41%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,positive regulation of glycolytic process (GO:0045821),-0.41481346491876636,-1.2016191414433828,0.18618618618618618,0.7001878400053024,1.0,8/20,19.41%,IGF1;INSR;HIF1A;PFKFB3;P2RX7;PFKFB1;ENTPD5;GAPDHS
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4023108772225107,1.2006749713520053,0.21794871794871795,0.9234937436807391,1.0,8/59,11.08%,ALDH1A3;CYP7B1;OSBPL6;HOGA1;ACACA;HSD17B4;ACOT8;GAMT
prerank,negative regulation of protein processing (GO:0010955),-0.48466196468102174,-1.1993826967052803,0.25235849056603776,0.7053623403834971,1.0,4/12,13.20%,GAS1;SERPINE2;LRRK2;THBS1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.418024368948931,-1.1993339383015023,0.20491803278688525,0.7037714332100031,1.0,4/19,6.38%,PARD3;CLIC4;ERBIN;SYNJ2BP
prerank,mRNA stabilization (GO:0048255),0.4353068143076412,1.198449467749622,0.22093023255813954,0.9298086208405517,1.0,11/40,19.35%,HNRNPC;DND1;HNRNPA0;TENT5C;AXIN2;TENT5D;TAF15;SYNCRIP;E2F1;DHX9;YBX3
prerank,positive regulation of JUN kinase activity (GO:0043507),-0.3936809785698481,-1.1982673524643788,0.2084507042253521,0.7052153154661907,1.0,7/23,16.28%,SASH1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,regulation of protein localization to centrosome (GO:1904779),0.5704240443890405,1.1978383811355102,0.2638888888888889,0.9305266729654632,1.0,6/10,26.75%,NUP62;GSK3B;APC;CEP250;NSFL1C;MARK4
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.569590839302366,1.197432643630171,0.28222996515679444,0.9304620650469697,1.0,2/10,4.65%,ARHGAP12;BMP5
prerank,L-glutamate transmembrane transport (GO:0015813),0.5754173340539668,1.1965361870344768,0.2870036101083033,0.9319892162366377,1.0,5/10,13.00%,SLC25A12;PRAF2;SLC1A6;SLC25A13;SLC25A22
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.40318858356261267,1.1964600261095026,0.23249669749009247,0.9307337525748433,1.0,6/63,5.90%,ITGA6;CAV1;FGFR1;SRC;PSME3;TRADD
prerank,T cell activation (GO:0042110),0.3981682733893557,1.1963619588923855,0.21858638743455497,0.9295534853144071,1.0,10/69,7.89%,CXADR;LEPR;ITK;CD3G;RAB29;PTPN22;PTPRC;NCK2;CRTAM;DPP4
prerank,triglyceride biosynthetic process (GO:0019432),0.5006737233468438,1.1962147810804695,0.2680577849117175,0.9285780245446835,1.0,4/18,3.74%,MOGAT2;MOGAT3;GPAT3;AGMO
prerank,cellular response to lipid (GO:0071396),0.3529213306075905,1.1959545557674318,0.16776315789473684,0.9280312068145903,1.0,43/191,16.18%,RORA;LBP;EGFR;SSTR1;TNIP3;GPLD1;IL1A;SOX9;WNT5A;ATP1A2;PDK4;ADCY5;TNFAIP3;NRIP1;ABL2;SELENOS;PAF1;BRINP1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;RORB;TICAM1;POU4F1;AXL;NCOA3;NFKBIB;WNT9A;AQP1;HTRA2;KCNK4;FZD7;LCOR;GPER1;CCR5;CCDC62;ADCY8;ADCY3;TICAM2;PLAA;TESC
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.3834022522117707,-1.1951129201635617,0.21098265895953758,0.7131466414597871,1.0,6/25,7.06%,SLC7A5;KIT;LACC1;B2M;TRAF6;PLCG2
prerank,regulation of phosphate metabolic process (GO:0019220),-0.4322697999449241,-1.1950526260054641,0.24585635359116023,0.7116322144646817,1.0,7/16,18.52%,IGBP1;PGAM1;SRPX2;IKBKB;BARD1;RAD17;CD24
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",0.38009593741121306,1.1949749041984863,0.20073891625615764,0.9299070359608586,1.0,35/84,24.14%,FXR2;RBFOX2;QKI;RBM8A;CELF1;SRSF4;RBM15B;SON;DDX17;SRPK1;RBM5;CELF2;CELF4;KHDRBS2;SRPK2;SFSWAP;RBMXL1;NSRP1;FXR1;TRA2B;SF1;CWC22;SRSF3;PRDX6;MBNL2;SAP18;SRSF12;TIA1;SRSF10;YTHDC1;JMJD6;ZBTB7A;RBMX;REST;PUF60
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.36401643133347283,1.1945706824081224,0.17660550458715596,0.9298321134014845,1.0,8/138,1.81%,NGF;ROR2;ROR1;NTRK3;FGFR1;EGFR;PTPRF;MUSK
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.4758825419643111,-1.1944363967373115,0.24523809523809523,0.7119670765336542,1.0,2/12,4.03%,LY6E;MID2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),0.5024068747650395,1.1943562196590216,0.2516025641025641,0.9291402542244598,1.0,7/18,17.52%,VGLL4;DACT1;RDX;FAF1;CD81;EZR;VPS11
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),0.45336879585816336,1.1940574437015903,0.23367198838896952,0.928792433747348,1.0,4/29,5.57%,NGF;MMD2;SRC;LRRC59
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3076313940357344,-1.1932825083441219,0.15104166666666666,0.7137162130691508,1.0,20/79,14.84%,IGF1;ST3GAL6;ST3GAL5;ST8SIA4;CSGALNACT1;CHST11;ATP7A;COG7;BMPR2;CSGALNACT2;ST6GALNAC2;ALG5;FAM20B;B4GALT7;ALG1;GOLGA2;B3GALT2;ST8SIA2;CHST9;GCNT1
prerank,sensory perception of mechanical stimulus (GO:0050954),0.38756523853859837,1.1921676378099701,0.20812807881773399,0.9339406801316498,1.0,5/85,2.95%,ROR1;HOMER2;PIEZO2;RIPOR2;EYA1
prerank,positive regulation of cell differentiation (GO:0045597),-0.25546682305622187,-1.1919167475451913,0.057692307692307696,0.7162906062904808,1.0,47/237,10.52%,TCF4;PLCB1;IGF1;RANBP3L;SOX5;SLC6A6;RAPGEF2;SMAD3;LEF1;PRKCH;BMP6;ARHGEF2;DAB2;IL6R;CCN2;TMEM64;PPARD;CDC42;CREBL2;IGFBP3;BMP4;GJA1;TGFBR1;WNT4;ACVRL1;BMPR2;IL18;HOXB4;HOXA5;BRINP3;AGTR1;KDR;CD34;MEF2A;MAPK12;GLIPR2;CDON;TGFB3;AKT1;CMKLR1;CREB1;ASXL2;LRRC8A;ZC3H12A;CCN1;AR;BMP2
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.4194878025801272,-1.191346342221052,0.232,0.7163045475413008,1.0,9/19,36.26%,ADK;HPRT1;CDA;POLD2;APRT;ADA;POLL;TYMS;GMPR
prerank,substrate-dependent cell migration (GO:0006929),0.515239213095691,1.1911879588803562,0.2847457627118644,0.9358041201207445,1.0,3/14,4.99%,NTN1;OPHN1;PTPRC
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.38405288057661424,-1.1909157090490574,0.2245508982035928,0.7158649301588307,1.0,9/22,23.51%,CIAPIN1;NFS1;MMS19;NFU1;CIAO3;FXN;ISCA2;GLRX5;ISCU
prerank,hydrogen peroxide catabolic process (GO:0042744),0.5460048746466413,1.190758700297255,0.27065026362038663,0.9358382934016403,1.0,1/11,0.87%,PXDN
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.5773817514394175,1.1906205754501376,0.2864963503649635,0.933431336421203,1.0,9/10,32.36%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG;ALKBH5
prerank,DNA dealkylation (GO:0035510),0.5773817514394175,1.1906205754501376,0.2864963503649635,0.933431336421203,1.0,9/10,32.36%,MGMT;ALKBH1;ASCC2;ASCC1;ALKBH2;ALKBH3;FTO;MPG;ALKBH5
prerank,lamellipodium organization (GO:0097581),0.44824241528412273,1.1905665662078413,0.2631578947368421,0.9321622899965055,1.0,10/29,16.89%,CDH13;ABLIM3;SPEF1;ABLIM2;SNX2;ARHGEF6;CTTN;PTPRO;SNX1;ARHGEF7
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3794346545961553,-1.190515213939054,0.2238372093023256,0.7154885966353477,1.0,8/25,15.98%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,glutamine family amino acid catabolic process (GO:0009065),0.5211496381946131,1.1900882219573672,0.28596491228070176,0.9324244007472945,1.0,2/13,1.44%,PRODH;ARG1
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35250185659262834,1.1898420214948906,0.18211920529801323,0.9318182118960843,1.0,41/186,15.71%,CAV1;IGFBP6;LRP4;VGLL4;GLI1;PRICKLE1;DKKL1;NFATC1;AXIN1;MLLT3;SOX9;CHD8;PSME3;DACT1;WNT5A;HIC1;ZNRF3;CUL3;AMFR;PSMB5;STK3;GSK3B;CSNK1A1;SDHAF2;AXIN2;APC;DVL3;KREMEN1;NXN;EMD;CTNNBIP1;PSMB2;PSMA2;PTPRU;PTPRO;PSMA6;BICC1;TMEM170B;PSMD13;NPHP4;PSMA7
prerank,ceramide metabolic process (GO:0006672),0.4211667821568796,1.1885513377047758,0.23024523160762944,0.934876410615143,1.0,8/49,6.26%,SGMS2;CERS6;ACER3;PLPP2;PLPP3;ALOXE3;CLN8;CERK
prerank,synaptic vesicle membrane organization (GO:0048499),0.4955959874147924,1.1882247821019971,0.25210084033613445,0.9345737371353545,1.0,7/17,18.88%,STX1A;SYNGR2;STX2;STX19;STX4;SNAP23;SNAP29
prerank,regulation of focal adhesion assembly (GO:0051893),0.4125732883343684,1.1879467297178334,0.2454780361757106,0.9340171231673873,1.0,5/54,4.48%,APOD;EFNA5;DLC1;PEAK1;SRC
prerank,nitric oxide metabolic process (GO:0046209),-0.4438088625645229,-1.1878284967365431,0.25569620253164554,0.7219215843117031,1.0,4/14,8.19%,NOS3;CYP1B1;GCH1;AKT1
prerank,actomyosin structure organization (GO:0031032),0.38711246061047333,1.1872864086749877,0.23038605230386053,0.9349288888001289,1.0,12/75,8.79%,F11R;SORBS1;EPB41L4A;EPB41L2;EPB41L3;TMOD2;CSRP3;SRC;KRT19;CUL3;TMOD1;OBSCN
prerank,response to exogenous dsRNA (GO:0043330),0.49850922837686984,1.1870474600491503,0.26324237560192615,0.9343426175189682,1.0,3/18,9.65%,CAV1;IRAK3;TICAM1
prerank,early endosome to Golgi transport (GO:0034498),-0.4979699076113173,-1.1870276726641866,0.26265060240963856,0.7227221195191453,1.0,4/11,8.88%,TRAPPC10;TMED9;RBSN;SURF4
prerank,artery morphogenesis (GO:0048844),0.4524449413603739,1.1869021099105843,0.24610591900311526,0.9334223610912881,1.0,4/30,3.23%,STRA6;FOLR1;JAG1;NF1
prerank,hexose metabolic process (GO:0019318),0.43053583334703766,1.1867628157492223,0.25337331334332835,0.9324303036607456,1.0,10/39,19.41%,APOD;ALDOB;PGM1;ADPGK;GALK1;GALK2;PMM1;HECTD4;IRS2;SLC37A4
prerank,regulation of cell cycle process (GO:0010564),0.37311107555587125,1.1859770996606025,0.21696969696969698,0.9337204115157374,1.0,20/104,12.39%,PLK2;FBXO43;KIF20B;CAV2;RACGAP1;SOX9;PIK3R4;RPRD1B;CDK13;KIF13A;FBXO5;CCP110;E4F1;CEP85;APC;KLHL21;ZFYVE26;MAP9;CETN2;AHCTF1
prerank,thymus development (GO:0048538),-0.4536427095149782,-1.1859561293034082,0.25240384615384615,0.7243645419318648,1.0,4/13,16.72%,TGFBR1;TBX1;ZBTB1;EPHB3
prerank,natural killer cell activation (GO:0030101),0.47791163001741344,1.185674156263527,0.26697530864197533,0.9332973045348051,1.0,6/23,18.48%,PBX1;PTPRC;IL21R;AXL;ULBP1;RABL3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.44747088778436495,-1.185603046295783,0.24371859296482412,0.7237794064729752,1.0,2/15,5.90%,MOXD1;SAT1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.44158225148216723,1.1855395318015958,0.2608089260808926,0.932372728402702,1.0,3/38,1.84%,CAV1;CAMK2D;KCNA5
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4516985171651057,1.1853104645209256,0.2674591381872214,0.931785688266167,1.0,5/30,8.91%,OGT;FHIT;STYX;N4BP1;DDRGK1
prerank,endothelial cell differentiation (GO:0045446),-0.4791711246982611,-1.1852945535585429,0.2803030303030303,0.7230549629845983,1.0,6/12,10.38%,TIE1;ACVRL1;BMPR2;KDR;SCUBE1;PROX1
prerank,cardiac muscle cell differentiation (GO:0055007),0.48328129428667527,1.1850685633118672,0.2677165354330709,0.9311932014385461,1.0,2/21,3.33%,CXADR;AKAP13
prerank,positive regulation of multicellular organismal process (GO:0051240),0.34017479718305016,1.1842574118499265,0.14953271028037382,0.9326551239802028,1.0,39/308,11.50%,EBF2;ETV4;CAV1;INHBB;PPARGC1A;LBP;SMTNL1;FOXD1;LEPR;GLMN;ITK;OGT;ITGAX;TXK;IL1A;SMTNL2;SOX9;BMPR1B;MFN2;KMT5C;SLC27A1;WNT5A;RREB1;CRTAM;FBXO5;PTGER4;GCNT2;TSHR;FOXJ1;ABCA1;KSR2;FERMT2;HILPDA;ADRA2A;AXIN2;APC;COL1A1;VAMP8;PRLR
prerank,receptor internalization (GO:0031623),0.41679718765209545,1.1842257647728938,0.23783031988873435,0.9313288124097854,1.0,5/44,4.57%,CAV1;ACKR3;CEACAM1;CD9;DNM1
prerank,positive regulation of cell adhesion (GO:0045785),0.38989413752886204,1.184198852027228,0.22959183673469388,0.9300065880861182,1.0,3/74,0.80%,MAGI1;VIT;ECM2
prerank,tryptophan catabolic process (GO:0006569),0.5458340662386858,1.1840951256270786,0.3024054982817869,0.9289165667754241,1.0,2/11,3.76%,IL4I1;AADAT
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.37302070832051304,-1.1836198189911988,0.22478386167146974,0.7262885254030849,1.0,8/26,15.98%,INSR;SMAD3;DDAH1;KLF4;AKT1;KLF2;EDN1;P2RX4
prerank,neuron differentiation (GO:0030182),0.35675341331730565,1.1834524631407868,0.18659217877094972,0.9297329014083696,1.0,13/165,5.56%,TENM2;WNT10A;PBX1;FZD2;BHLHE22;NEUROD6;RUNX2;GLI2;WNT2B;OPHN1;WNT16;WNT5A;BRSK1
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.4740101301839558,1.1832986923175477,0.26881720430107525,0.9288496074808879,1.0,6/22,16.38%,CEACAM1;DGKZ;PTPN22;PTPRJ;SH2D1A;EZR
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.3889322607188952,1.1829623096121415,0.23354037267080746,0.9286114725833472,1.0,13/78,12.27%,CAV1;TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;CDC20;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B;NFE2L2
prerank,DNA unwinding involved in DNA replication (GO:0006268),-0.43162893186126977,-1.1828858099197161,0.23184357541899442,0.7268130687719699,1.0,9/16,32.05%,WRN;BLM;MCM6;SSBP1;MCMDC2;TWNK;RAD51;MCM7;MCM2
prerank,regulation of cilium assembly (GO:1902017),-0.3136367083306362,-1.182828422124873,0.15695067264573992,0.7252560085110631,1.0,18/62,14.46%,TBC1D1;RABGAP1;TBC1D30;USP6NL;TBC1D2B;ARHGAP35;ENTR1;TBC1D24;SGSM3;CDKL5;DCDC2;EVI5L;FUZ;CEP97;TBC1D22B;CEP120;TCHP;CROCC
prerank,purine nucleotide metabolic process (GO:0006163),0.4670720325721818,1.182815394821635,0.2696296296296296,0.9277297244656426,1.0,8/24,11.63%,FHIT;MTHFD1;PPAT;NT5E;PRPSAP2;NT5C2;PRPS1;PRPS1L1
prerank,diol metabolic process (GO:0034311),-0.40579745101738474,-1.1827463243037486,0.21957671957671956,0.7238234100673118,1.0,7/19,13.41%,NOS3;PLPP1;DEGS2;CALM1;GCH1;AKT1;SPHK1
prerank,positive regulation of dendrite development (GO:1900006),0.5644733160902897,1.1825517322573986,0.27886323268206037,0.9271888255576638,1.0,2/10,4.65%,COBL;BMP5
prerank,negative regulation of signaling (GO:0023057),0.45983771713657207,1.1823839128623659,0.2531446540880503,0.9263562855620513,1.0,2/25,2.26%,UBASH3B;SOCS5
prerank,cellular response to insulin stimulus (GO:0032869),0.36074602724455934,1.1818497070471694,0.20457142857142857,0.9268233635222765,1.0,19/124,9.63%,GAB1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;CAV2;ATP6V0D2;SLC27A1;PDK4;FER;SELENOS;ZDHHC7;SYAP1;PIK3R2;ATP6V0A1;GSK3B;SLC27A4
prerank,Notch signaling pathway (GO:0007219),0.39828364912822994,1.181658137776023,0.25126262626262624,0.926105163600184,1.0,15/59,13.12%,ZNF423;NRARP;PBX1;DTX1;JAG1;MAML2;APH1B;HEYL;NCSTN;ADAM10;POFUT1;DTX4;WWC1;GMDS;CREBBP
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.4464609260860924,1.1816096738160267,0.26857142857142857,0.9248493826190142,1.0,3/31,3.05%,ARG1;GLMN;IL4I1
prerank,retina homeostasis (GO:0001895),-0.39885482421556007,-1.1816019646645726,0.25396825396825395,0.7257930031819929,1.0,8/23,21.96%,B2M;ACTB;POTEF;ACTG1;ATP1B2;POC1B;HSPB1;TULP1
prerank,steroid metabolic process (GO:0008202),0.389741925252498,1.1814637772473306,0.2417721518987342,0.9239699744260472,1.0,13/72,15.05%,HSD17B3;CYP7B1;SULT1A1;RDH5;DHRS4;HSD17B4;CUBN;GC;PRLR;MSMO1;DHCR24;STARD3;LSS
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),-0.40335925544129947,-1.1813471136760796,0.23546511627906977,0.7248689958638201,1.0,3/21,2.21%,OSBPL8;OSBPL10;PLA1A
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.3566577571552412,1.181297378314314,0.2048331415420023,0.9231386626472412,1.0,17/136,10.19%,PTCH1;SPI1;GLIS2;HDAC4;IRAK3;KEAP1;HEYL;BHLHE40;TNFAIP3;ANXA4;TRIM21;ZNF431;ACOD1;FOXJ1;NLRP2B;HDAC2;TAX1BP1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.43579630595259655,1.1812651156991456,0.2669491525423729,0.9218420158297427,1.0,5/36,8.91%,OGT;FHIT;OPHN1;N4BP1;DDRGK1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.4437539461975074,1.1811089917167938,0.2722063037249284,0.9209668761220539,1.0,5/29,4.69%,SORBS1;ZBTB20;ELOVL5;GPLD1;SLC27A1
prerank,monocyte chemotaxis (GO:0002548),-0.3576454177854555,-1.180996790509388,0.2181208053691275,0.7243348488799135,1.0,6/32,13.49%,FLT1;IL6R;RPS19;ANXA1;CCL13;TNFRSF11A
prerank,lung epithelium development (GO:0060428),0.5558661399662428,1.180613214259902,0.2950257289879931,0.9212604658230176,1.0,1/10,0.21%,STRA6
prerank,positive regulation of organelle assembly (GO:1902117),-0.32772470978235213,-1.1805254185143097,0.16783216783216784,0.7240329572506891,1.0,13/44,14.46%,ASAP1;CNOT6L;G3BP2;STX18;ARHGAP35;ENTR1;SH3GLB1;CAPG;PIP4K2A;FUZ;PIP4K2C;CEP120;CROCC
prerank,actin filament bundle assembly (GO:0051017),-0.35407791573246933,-1.1804946604436517,0.20655737704918034,0.7224829638856956,1.0,5/33,5.73%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.48849403298246485,1.1802778023268343,0.2875605815831987,0.921077557330937,1.0,2/19,0.56%,VGLL4;GLI1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5505217604726617,1.1802110154812435,0.29116117850953205,0.9199045290960538,1.0,3/12,9.04%,UBASH3B;FKBP1B;CASQ2
prerank,secretion (GO:0046903),-0.45675949320972364,-1.1800391760099316,0.25116279069767444,0.7222894812123622,1.0,4/14,5.70%,SLC22A6;SLC22A4;NPR1;FBLN5
prerank,peptidyl-tyrosine modification (GO:0018212),0.4077785908490746,1.1798720302266537,0.24091520861372812,0.919735458658028,1.0,9/56,6.49%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;SRC;FER;EPHB2;ABL2
prerank,regulation of intracellular protein transport (GO:0033157),0.45680122435568254,1.1796325716611697,0.258493353028065,0.9192156487067386,1.0,10/32,13.86%,RAB29;KIF20B;PTPN14;CEP131;RIPOR1;SIRT7;GCC2;TPR;CEP290;PCM1
prerank,regulation of feeding behavior (GO:0060259),0.5615675473412198,1.1795941801145515,0.2830508474576271,0.9179580735503226,1.0,4/11,16.33%,LEPR;SGIP1;CFAP20;AGRP
prerank,gastrulation (GO:0007369),0.5135023087838926,1.1795332743049816,0.2896890343698854,0.916775692581971,1.0,1/15,0.41%,GPC3
prerank,regulation of DNA binding (GO:0051101),0.4200904014947092,1.1791824331981904,0.25718194254445964,0.9166332734798771,1.0,18/44,23.03%,NGF;BCL3;HJURP;HMGB1;SMO;TXN;E2F1;PPARG;SUMO1;NME1;PRKN;HABP4;MAPK8;RSF1;FOXC1;JUN;SIRT2;ZBTB7A
prerank,response to reactive oxygen species (GO:0000302),0.41136668900983603,1.1791396613517673,0.2348993288590604,0.9154019147568115,1.0,5/54,5.71%,APOD;PXN;EGFR;MPV17;FER
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),0.5352182483824619,1.1791077349547954,0.2821869488536155,0.9141602699000411,1.0,3/12,15.49%,SORBS1;C1QTNF12;SNX5
prerank,organic substance transport (GO:0071702),-0.2748421165133219,-1.1788969144862689,0.125,0.7240305394256794,1.0,30/120,19.21%,SLC47A1;PLTP;CHKA;TXNIP;ABCG2;TOM1;CALCRL;SLC22A6;SLC22A4;ABCA4;SPNS2;TCN2;ARL6IP5;TAP2;ABCA9;SLCO2A1;RAMP2;SCAMP5;ABCD2;SLC35F3;ABCA2;MFSD2A;ARRDC4;ABCG1;CHMP3;ARRDC2;SLC22A2;CHMP2B;MYH9;RCN3
prerank,nitric oxide biosynthetic process (GO:0006809),-0.4498961274779925,-1.1788015535091765,0.24812030075187969,0.7226906760641277,1.0,4/13,8.19%,NOS3;CYP1B1;GCH1;AKT1
prerank,positive regulation of calcium ion transport (GO:0051928),-0.34319603386516584,-1.1783621933563033,0.20327868852459016,0.7224597426828143,1.0,9/36,9.11%,PDGFRB;ANK2;MYLK;TRPC3;CACNB2;ORAI1;CXCL12;CAMK2A;GRIN1
prerank,regulation of protein polymerization (GO:0032271),-0.3490643978690807,-1.177707402406283,0.21305841924398625,0.7228844747394281,1.0,13/35,23.90%,ARHGAP28;ESAM;FCHSD2;CAMSAP1;HAX1;GBA2;TTBK1;DBN1;MAPT;ARL2;PFN1;DBNL;TPPP3
prerank,positive regulation of cyclase activity (GO:0031281),0.5177061672939749,1.17762642201416,0.27168576104746317,0.9177514147712347,1.0,2/14,3.23%,GUCA1A;NF1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.48268581574496855,1.1770021969285864,0.2718600953895072,0.9186108816449672,1.0,2/17,1.76%,EGFR;CCND3
prerank,axonal fasciculation (GO:0007413),-0.47117326732945264,-1.1762993372397008,0.2230769230769231,0.7256352469027304,1.0,6/12,16.72%,EPHA3;EPHA4;ARHGAP35;MEGF8;CDK5R1;EPHB3
prerank,vasodilation (GO:0042311),-0.44873730697238623,-1.175718026784455,0.28672985781990523,0.7258227190471057,1.0,4/13,17.44%,NOS3;KCNMA1;KLF2;NOS1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.44375356402307553,1.175408689249305,0.28313253012048195,0.9228095782067495,1.0,4/33,5.62%,KLF5;SPI1;FOXO3;APLN
prerank,cytoskeleton organization (GO:0007010),-0.2739432543735105,-1.17537637455861,0.1069182389937107,0.7252098587587038,1.0,31/114,12.85%,RHOBTB1;NEDD9;MARK1;TPM1;FGD5;MAST4;OBSL1;PLD2;DST;RHOBTB3;CFL1;SYNE3;ARAP3;SEMA6A;WASF3;PRPF40A;APOE;RHOC;SH3KBP1;CAMSAP1;CNN2;WDPCP;DIAPH1;PALLD;RHOH;RHOB;AJUBA;PAK5;DES;CECR2;CCL13
prerank,response to metal ion (GO:0010038),0.3969746878552628,1.1752085997530624,0.24025157232704403,0.9221438031386472,1.0,6/67,4.18%,CAV1;NEDD4L;ITPR3;SLC25A12;IL1A;TFR2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3907668897613342,-1.1744187067894576,0.2219020172910663,0.726588949766124,1.0,5/22,11.15%,TIMP3;PTPN3;TNFRSF1B;APOE;FURIN
prerank,PERK-mediated unfolded protein response (GO:0036499),0.5392502002725473,1.1740406163316168,0.30303030303030304,0.9247869900753122,1.0,5/10,24.33%,EIF2AK3;NFE2L2;QRICH1;DDIT3;HSPA5
prerank,cellular response to interleukin-7 (GO:0098761),0.5007788941983079,1.1736684689890042,0.284329563812601,0.9234140928367299,1.0,9/17,20.75%,IL7;IL2RG;SOCS1;BRWD1;IRS2;JAK1;SOCS2;STAT5B;CISH
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.5007788941983079,1.1736684689890042,0.284329563812601,0.9234140928367299,1.0,9/17,20.75%,IL7;IL2RG;SOCS1;BRWD1;IRS2;JAK1;SOCS2;STAT5B;CISH
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.5431393341054489,1.1733425975328555,0.29304029304029305,0.9232075123844238,1.0,4/11,13.08%,PRODH;MAP3K5;STK24;DIABLO
prerank,unsaturated fatty acid metabolic process (GO:0033559),0.426892556563419,1.172893534720017,0.2532005689900427,0.9233373162801872,1.0,11/41,12.76%,EPHX1;ELOVL5;ALOXE3;DECR2;ELOVL1;SCD5;ELOVL2;HSD17B4;ACOT8;ABCD1;PNPLA8
prerank,cobalamin metabolic process (GO:0009235),0.48359374985128795,1.1728549154347332,0.28046744574290483,0.9221297147878431,1.0,6/17,12.76%,CTRC;ABCC1;CD320;CUBN;MMAB;AMN
prerank,maturation of 5.8S rRNA (GO:0000460),0.4908185326972984,1.1723493721017522,0.2823529411764706,0.9224569277061887,1.0,5/17,11.38%,RRP15;C1D;PES1;EXOSC10;RPF1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.3254056237801606,-1.1720005108563232,0.21455938697318008,0.7323419771096693,1.0,8/46,9.16%,PLCB1;MSN;CDC42;CFL1;ANXA2;RPLP0;JAK2;CNN2
prerank,cilium assembly (GO:0060271),0.33790288693459386,1.1717198874476715,0.16579770594369134,0.9232956081416507,1.0,103/296,24.51%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;GORAB;DYNC2I1;CYS1;EXOC3;SFI1;CNGB1;INTU;CEP89;CEP131;IFT81;CEP78;CNGA4;NEDD1;KIF3C;EHD2;SNX10;TUBG1;CCDC39;CKAP5;BBOF1;CEP162;PAFAH1B1;CLUAP1;CCP110;OCRL;UNC119B;TCTN2;TMEM237;FOXJ1;DYNLL2;IFT74;C2CD3;HDAC6;CFAP20;NDE1;EXOC5;CEP290;SSNA1;CETN2;RPGRIP1L;TTC21B;PKD1;TRIP11;FBF1;PCM1;PDE6D;FAM161A;DNAH5;CCDC40;NPHP4;CFAP298;CFAP70;PIBF1;YWHAG;DYNC2LI1;CFAP410;B9D2;YWHAE;CDC14A;CEP57;DYNC2H1;EHD1;OFD1;ARMC9;BBS1;CEP250;SNAP29;TMEM80;DCTN2;ALMS1;TCTN1;HAUS8;STK36;IFT57;CEP43;CPLANE2;IFT140;WDR90;RILPL1;CC2D2A;HAUS3;CEP19;SCLT1;ARL3;HAUS7;TMEM67;FHDC1;CEP83;CFAP52;ARF4;SPATA6;MAK;DYNC1I2;TRAPPC14;NPHP1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.5181910520685913,1.1712023801675415,0.2937181663837012,0.9236940458735945,1.0,4/13,11.54%,KPNA7;KPNA2;CBLB;RANBP2
prerank,rRNA metabolic process (GO:0016072),-0.2584828422972219,-1.1706936003706412,0.12844036697247707,0.7346364392210661,1.0,62/160,25.05%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;DIS3L;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;MAPT;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;WDR3;RPS14;RPS25
prerank,negative regulation of innate immune response (GO:0045824),0.43005104315410003,1.1706536530360674,0.2759124087591241,0.92423886527537,1.0,10/34,13.25%,SERPING1;IRAK3;TNFAIP3;TRIM21;SUSD4;ACOD1;TRAFD1;CNOT7;STAT2;USP15
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.554634966609778,1.1704027077446035,0.30708661417322836,0.9237371694115936,1.0,3/10,6.72%,CEACAM1;CD9;RDX
prerank,negative regulation of vascular permeability (GO:0043116),-0.4477624294746718,-1.1703523878535051,0.24349881796690306,0.7340244858226359,1.0,6/12,9.43%,ANGPT1;CLDN5;SLIT2;DDAH1;PDE2A;RAMP2
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4060527819865512,1.1701941174925645,0.26116373477672533,0.9231279570141335,1.0,22/52,23.04%,LEPROT;PPP1R13B;ABLIM3;RAC2;SFN;HTRA2;UBE2J2;UBE2D3;BAD;NMT1;YWHAG;FBXW7;YWHAE;E2F1;VPS11;CSNK2A2;PINK1;UBL5;MAPK8;TFDP1;YWHAB;SAE1
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.5650044076997077,1.170080999865256,0.3111111111111111,0.9221886249939434,1.0,6/10,21.05%,SESTD1;FKBP1B;ATP1A2;ADRA2A;YWHAE;CBARP
prerank,negative regulation of axonogenesis (GO:0050771),0.4600867405605285,1.16992863012153,0.272863568215892,0.921371534906922,1.0,9/27,18.52%,LRP4;RTN4R;CDKL3;GDI1;TRIM46;PTEN;RTN4;EFNB3;RHOA
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.36311240939000344,1.16952098388479,0.21967963386727687,0.9214397284349749,1.0,42/125,23.11%,PLK2;DYNLL1;KIF2A;STIL;TUBG1;DSN1;CKAP5;PAFAH1B1;EML1;CDC20;NUP160;MECP2;DYNLL2;NUP37;RANBP2;BUB3;MAP4;WDR62;NDE1;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;RAN;TBCE;CENPH;B9D2;CENPK;SETD2;MAD1L1;DCTN2;DYNC1LI2;CENPL;DYNC1I1;NUP43;GPSM2;MIS12;DCTN6;SEC13;SBDS
prerank,"phagocytosis, engulfment (GO:0006911)",0.4264910687596234,1.1694172118649508,0.2524964336661912,0.9204486640876461,1.0,6/36,8.30%,ARHGAP12;XKR7;DOCK1;XKR4;RAC2;XKR8
prerank,epiboly involved in wound healing (GO:0090505),-0.4220557031257366,-1.169219362551737,0.261455525606469,0.7358546844791288,1.0,7/16,10.23%,DDR1;PDCD10;ARHGAP35;RHOC;TMEFF2;FLNA;CCN1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.5256936252339948,1.169080829473718,0.2892857142857143,0.9202096558519696,1.0,7/12,27.07%,NELFB;HEXIM1;TCERG1;RECQL5;EAPP;HNRNPU;NELFA
prerank,positive regulation of interleukin-2 production (GO:0032743),0.44777458212866683,1.1690361523488086,0.27395209580838326,0.9190692676879244,1.0,4/25,4.99%,GLMN;PDE4D;IL1A;PTPRC
prerank,positive regulation of kinase activity (GO:0033674),0.36410062417257816,1.168968804605016,0.22130177514792898,0.9179618226334668,1.0,14/107,7.00%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;RAP1A;PRKAG1;MMD2;LMO4;PTPRC;NBN;EPHB2;LCP2
prerank,mitochondrion distribution (GO:0048311),-0.4543394533403106,-1.1686752836341092,0.24819277108433735,0.7359192822664556,1.0,3/12,14.31%,MEF2A;LRRK2;MAPT
prerank,T-helper cell differentiation (GO:0042093),-0.4516251728509538,-1.1684973968304717,0.2995391705069124,0.7348950533362556,1.0,3/14,3.31%,LEF1;FOXP1;ATP7A
prerank,cation transport (GO:0006812),0.3516428621858269,1.1683133943452686,0.2052689352360044,0.91886253237177,1.0,21/166,8.17%,PIEZO2;NEDD4L;KCNJ4;TRPM3;SLC12A2;SLC8B1;KCNA5;KCNJ16;ANO6;SLC29A4;KCNS2;SLC12A3;KCNK1;SLC22A3;CNGB1;ATP1A2;KCNJ13;SLC4A4;SLC4A11;PIEZO1;KCNK5
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),-0.3556972064843678,-1.1671809371389228,0.23986486486486486,0.7374220807586277,1.0,5/33,8.57%,IGF1R;IGF1;PIK3R1;AKT1;PIK3C2A
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.49778366773461513,1.1670396886135586,0.30293159609120524,0.9218609214289898,1.0,2/16,5.65%,APOD;CHID1
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.4303527800081556,1.1668292902052784,0.2658959537572254,0.9212550526662932,1.0,8/33,16.38%,CEACAM1;RAB29;DGKZ;PTPN22;PTPRJ;CD81;SH2D1A;EZR
prerank,positive regulation of Wnt signaling pathway (GO:0030177),0.3490525400999611,1.1660927728937058,0.22388059701492538,0.9224730010855791,1.0,51/152,21.96%,CAV1;GPC3;PPM1N;SULF1;NRARP;EGFR;AXIN1;DEPDC1B;PSME3;DACT1;PPM1A;TNFAIP3;USP8;UBR5;PLEKHA4;FAM53B;KANK1;CSNK1G3;PSMB5;RNF220;USP47;AXIN2;COL1A1;SPIN1;SOX4;PSMB2;CAPRIN2;PSMA2;PSMA6;FZD9;PSMD13;PSMA7;GPC5;PSME4;CSNK1G1;FGF10;PSMC4;CDH3;PSMB6;PSMD12;ATP6AP2;PSMD14;PIN1;CDC73;TRPM4;RNF146;USP34;CCAR2;PSMB3;GSKIP;GID8
prerank,lipoprotein transport (GO:0042953),-0.49541933405702426,-1.1659976451630503,0.2981651376146789,0.7392411224774527,1.0,3/10,6.59%,LRP1;ZDHHC17;VMP1
prerank,iron-sulfur cluster assembly (GO:0016226),-0.3688298989229131,-1.1655190652841216,0.22865853658536586,0.7390205771800831,1.0,10/24,23.51%,CIAPIN1;NFS1;MMS19;NFU1;CIAO3;FXN;ISCA2;GLRX5;BOLA2;ISCU
prerank,Ras protein signal transduction (GO:0007265),0.3591181108437242,1.1652353022543183,0.23772321428571427,0.9239512265749388,1.0,23/137,10.37%,PLK2;CDH13;NTN1;PLCE1;USP50;RAPGEF3;RAP1A;CDC42EP4;MRAS;NF1;RAC2;USP8;GDI1;NRAS;KRAS;RIPOR1;ARHGEF1;RREB1;RAPGEF6;CTNNAL1;KSR2;LAT;ADRA2A
prerank,ERAD pathway (GO:0036503),-0.2919227085516279,-1.1651739250622168,0.16145833333333334,0.7383688977214264,1.0,25/83,20.74%,UBXN4;USP19;TRIM25;ERLIN1;DNAJB2;UBE4A;STT3B;SGTA;SEC61B;SYVN1;VCP;UBE2J1;FBXO17;UBXN6;ERLIN2;UBE4B;OS9;RNF103-CHMP3;ANKZF1;SGTB;DERL2;FBXO44;RCN3;TRIM13;RNF121
prerank,dopaminergic neuron differentiation (GO:0071542),-0.41065041945190245,-1.165091202423365,0.2717391304347826,0.7370228233402346,1.0,11/19,47.90%,LRP6;NR4A2;MANF;LMX1B;LMX1A;WNT2;SHH;FOXA1;EN1;FOXA2;CDNF
prerank,secondary alcohol biosynthetic process (GO:1902653),-0.3698074590782056,-1.1649883259565068,0.24092409240924093,0.7357194899122697,1.0,16/30,33.80%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7;TM7SF2;MVD;PLPP6;SQLE;EBP;LBR
prerank,microglial cell activation (GO:0001774),-0.3997513496398603,-1.1649396136734218,0.27548209366391185,0.7342967183126567,1.0,12/21,36.29%,JAK2;MAPT;C1QA;CLU;GRN;ITGB2;ITGAM;AGER;AIF1;TREM2;IFNGR1;SNCA
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.413672081546708,-1.1646552564000747,0.25067385444743934,0.7334798094167823,1.0,6/16,8.51%,IGF1;ROCK2;TRPC3;AKAP6;MEF2A;SLC9A1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.32903422082776695,-1.1645517858413308,0.1975806451612903,0.7321828383868022,1.0,9/47,7.55%,IGF1R;TGFBR3;FOXO1;FAS;PDCD10;ARL6IP5;IGBP1;NBR1;MAP2K2
prerank,positive regulation of protein secretion (GO:0050714),-0.30034242275355416,-1.1640111606559018,0.19523809523809524,0.732183154898705,1.0,14/69,14.28%,IGF1;MYRIP;BMP6;WLS;RBP4;C1QTNF3;TGFB3;MYH10;NNAT;SYTL4;LRRC8A;TGFB2;MYO18A;ABCG1
prerank,synaptic vesicle recycling (GO:0036465),0.4401288670240149,1.1639221021416155,0.27521613832853026,0.9271579086749514,1.0,13/31,22.13%,CEL;STX1A;OPHN1;STON1;RAB3A;STON2;SNCG;RAB5A;PACSIN1;AMPH;VAMP2;NLGN3;NLGN2
prerank,heart process (GO:0003015),0.5143504371538485,1.163917749626261,0.29442508710801396,0.9258577400987442,1.0,2/14,3.80%,SGCD;SGCG
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.27330552834510696,-1.1635697417104587,0.1,0.731881915786658,1.0,29/113,16.25%,ASAP1;TRABD2B;TFRC;BCL2L11;FNIP1;RASIP1;RBX1;FNIP2;RHOC;SLF2;SH3GLB1;MED25;CAPG;VCP;SLF1;RPS3;AJUBA;BID;MMP1;ESR1;MPP7;TTBK1;DHX33;ERCC2;TAL1;XPA;ISG15;EIF4G1;SKAP1
prerank,tetrapyrrole metabolic process (GO:0033013),0.4710300689900067,1.1635594239238312,0.29296235679214405,0.9257717537017225,1.0,6/18,12.76%,CTRC;ABCC1;CD320;CUBN;MMAB;AMN
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.5546713545483508,1.163362867061603,0.3069852941176471,0.9251082504042125,1.0,2/10,2.89%,PRKCE;GPLD1
prerank,anterior/posterior axis specification (GO:0009948),-0.4301257153575138,-1.1633436977089917,0.24770642201834864,0.7309704541776384,1.0,2/15,2.75%,WLS;TBX3
prerank,regulation of cation transmembrane transport (GO:1904062),0.44198220406320227,1.1631109691516575,0.3025335320417288,0.9246340665559242,1.0,8/29,21.41%,SLMAP;KCNIP4;ATP2B4;KCNAB1;FGF12;KCNIP1;SNTA1;CD63
prerank,negative regulation of cell adhesion (GO:0007162),0.3870580577901299,1.1630667775601666,0.2468354430379747,0.9234935015345029,1.0,18/72,15.39%,TGFBI;CDH13;RIPOR2;JAG1;DSCAM;PLXNA3;PTPRC;ADAM10;EPHB2;GCNT2;PLXNB1;SEMA4D;NF2;FZD7;PTPRO;SIPA1;PLG;CDH1
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.4872953613155311,1.1630544605123017,0.2908805031446541,0.9222222723142194,1.0,3/17,3.82%,F11R;CDH5;ADD1
prerank,mammary gland development (GO:0030879),0.475368938961241,1.1624879589674963,0.2745709828393136,0.9226794565634676,1.0,3/21,5.62%,CAV1;GLI2;APLN
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.5259004023907864,1.1623160729660382,0.30244755244755245,0.9219496345148,1.0,3/11,8.67%,F11R;TJP2;RAPGEF6
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),-0.38504927935000666,-1.1616082899655804,0.2520775623268698,0.7346079696340486,1.0,6/23,16.54%,IGF1;AKAP6;PROX1;EDN1;MYOCD;ATP11A
prerank,endocardial cushion development (GO:0003197),-0.3990775802210969,-1.1615597239471638,0.2556179775280899,0.7331847418366405,1.0,5/21,3.88%,ENG;NOS3;BMP4;ACVRL1;BMPR2
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),-0.32870177979818754,-1.1607529262559366,0.20640569395017794,0.7339834006136586,1.0,12/41,19.17%,TGFA;NEDD9;EPHA4;ACE;DOCK3;NOX4;LRP8;IL34;BDNF;GPRC5B;EGF;AGT
prerank,regulation of microtubule polymerization (GO:0031113),-0.3302668154528188,-1.160590310632632,0.21071428571428572,0.7328851608200477,1.0,14/40,20.23%,CLIP1;STMN2;EML2;CAMSAP1;RPS3;CLIP3;GBA2;STMN1;MAPT;CDK5R1;TUBB4A;ARL2;FES;MET
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),-0.3981104243207182,-1.1604755929116404,0.24802110817941952,0.7317123665419597,1.0,11/20,25.08%,RBPJ;SMAD9;EP300;SMAD5;HIF1A;BMP2;SMAD4;ATF4;XBP1;SMAD1;NOTCH1
prerank,regulation of phosphorylation (GO:0042325),0.35792224932213756,1.1601482466619015,0.2315668202764977,0.9281387283720821,1.0,23/120,14.10%,ITGA6;DYNLL1;LDB2;GLMN;EGFR;CDH5;OGT;PRKAG1;DSCAM;NUP62;FN1;FER;NUP160;NUP37;TPR;NUP50;RANBP2;STAT2;NUP210;NUP153;GCK;CDKN1C;FZD7
prerank,positive regulation of ERBB signaling pathway (GO:1901186),-0.37508322018037743,-1.1600359041659645,0.2455621301775148,0.7315603487828135,1.0,13/25,24.04%,HIP1;RBPJ;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,mismatch repair (GO:0006298),0.451622441525666,1.1597852021836197,0.2791728212703102,0.9280636860597968,1.0,8/27,21.54%,TDG;MSH6;MSH2;ERCC1;SETD2;MLH3;MLH1;RPA3
prerank,camera-type eye morphogenesis (GO:0048593),0.5499922935978423,1.1597524917705302,0.30141843971631205,0.9268778891814229,1.0,3/10,7.23%,NF1;SHROOM2;TBX2
prerank,ion transport (GO:0006811),0.35861011400022547,1.1592067920301745,0.2394705174488568,0.9274988608670233,1.0,20/111,13.00%,VDAC2;PIEZO2;TRPM3;SLC12A2;SLC8B1;SLC26A9;ANO6;SLC24A1;SLC1A7;SLC12A4;SLC12A3;CNGB1;SLC1A6;PIEZO1;SLC9A7;SLC9A6;PANX2;SLC25A26;ANO10;SLC25A22
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.3802787829093709,-1.1590963935095067,0.24848484848484848,0.7328290335803702,1.0,7/24,10.58%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,ceramide catabolic process (GO:0046514),0.5064365625757115,1.1588994480778623,0.30537974683544306,0.9272005690632671,1.0,6/14,18.22%,ACER3;NAGA;NEU1;HEXA;HEXB;ASAH1
prerank,negative regulation of amyloid-beta formation (GO:1902430),-0.4152107766528215,-1.1588877151843888,0.26109660574412535,0.7319142861341125,1.0,3/17,8.44%,IGF1;APOE;RTN1
prerank,myeloid cell development (GO:0061515),-0.40678515003786486,-1.1588681303457213,0.2821917808219178,0.7304344389224031,1.0,7/18,22.17%,FOXP1;KIT;ANXA2;NRROS;ABCB10;ALAS1;NCKAP1L
prerank,odontogenesis (GO:0042476),0.43057369801029594,1.1588175320853107,0.2861111111111111,0.9261585794539448,1.0,4/35,3.17%,EDA;WNT10A;GLI2;TUFT1
prerank,metal ion export (GO:0070839),0.4385233178406114,1.1587903269399424,0.2916666666666667,0.9249519487368422,1.0,6/31,9.40%,KCNA5;ATP2B4;ATP1A2;SLC4A4;KCNK5;ATP1B3
prerank,regulation of nervous system process (GO:0031644),-0.40174291896886427,-1.1587469436103643,0.2775,0.7292601446877076,1.0,3/18,2.30%,ROCK2;NOS3;SLC8A3
prerank,positive regulation of ATPase activity (GO:0032781),0.41568546971725057,1.1585508232108441,0.2712100139082058,0.924403557659642,1.0,13/41,19.80%,DYNLL1;MSH6;ALDOB;MSH2;PLSCR1;DNAJC9;ATP1B3;DYNLL2;AHSA1;FGF10;DNAJC24;DHX9;PFN2
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),-0.31886642596476295,-1.1582976221093992,0.2170212765957447,0.7290081993326445,1.0,21/54,18.40%,ETS1;ANGPT1;NOS3;AKT3;ACVRL1;PRCP;HIF1A;KDR;APOE;AKT1;GATA2;SP1;THBS1;MAP2K3;TMSB4X;P2RX4;ANGPT2;CSNK2B;HSPB1;CD40;VASH1
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.4267771224990366,-1.158219799049054,0.23684210526315788,0.7276880540498586,1.0,3/16,2.56%,PLCB1;RANBP3L;IGFBP3
prerank,negative regulation of peptidase activity (GO:0010466),-0.3130779624386902,-1.1581206711143908,0.22265625,0.7264371702698958,1.0,10/47,10.66%,TIMP3;SPOCK2;LRP1;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.4924550351564537,1.1580165257439858,0.28792569659442724,0.9248892039393596,1.0,4/18,9.03%,POR;SIRT3;ABL2;PDP2
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.4745607460252522,1.1578301181656014,0.2848297213622291,0.9242446599263691,1.0,6/20,13.51%,NR2F2;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,cellular response to lipopolysaccharide (GO:0071222),0.3633674147263952,1.1570927281716294,0.25,0.9253891433440161,1.0,16/101,9.89%,LBP;PRKCE;TNIP3;IL1A;PTPN22;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,negative regulation of stress fiber assembly (GO:0051497),0.45447741612698633,1.1561243085407047,0.27105666156202146,0.9274221885533879,1.0,3/24,2.02%,DLC1;F11R;ARAP1
prerank,cellular calcium ion homeostasis (GO:0006874),0.3590185866797344,1.1557261023901317,0.23129251700680273,0.9274102898742592,1.0,12/133,4.74%,CAV1;STC2;CTRC;CAMK2D;SLC8B1;CDH5;SLC24A1;TRPV4;FKBP1B;CAV2;CSRP3;ATP2B4
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.47950095053668096,-1.1549631252109434,0.3013698630136986,0.734350603167259,1.0,5/11,25.28%,ARHGEF2;NUPR1;CASP8;RIPK1;BIRC3
prerank,cellular component maintenance (GO:0043954),0.5139604278984476,1.1547740470992323,0.31369150779896016,0.9293091852139973,1.0,1/12,0.18%,CLDN1
prerank,regulation of complement activation (GO:0030449),0.416982706812062,1.1545068433792807,0.29243937232524964,0.9289439011080542,1.0,6/40,13.20%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,negative regulation of catalytic activity (GO:0043086),-0.37833870446119894,-1.1543945439958463,0.23893805309734514,0.7345626683047854,1.0,11/24,33.72%,PPP1R12A;NES;CAMK2A;IFIT1;NOS1;PLN;OXA1L;NOTCH1;NOSIP;TIMP1;APBA3
prerank,negative regulation of protein kinase activity (GO:0006469),0.37676462008209544,1.1543589683993605,0.24907521578298397,0.9281478484550976,1.0,13/88,10.78%,CAV1;TRIB2;UBASH3B;CEACAM1;SPRED1;NF1;GNAQ;PTPRC;SRCIN1;SFN;PTPRT;CEP85;RTRAF
prerank,response to organophosphorus (GO:0046683),-0.4150852018797852,-1.1543438392545975,0.28428927680798005,0.7331528079324873,1.0,5/16,15.98%,TRPC3;ABCC9;TRIM16;P2RX7;P2RX4
prerank,regulation of actin polymerization or depolymerization (GO:0008064),-0.36365872016488593,-1.1542486437002846,0.22551928783382788,0.7319384244151605,1.0,8/28,14.16%,ARHGAP28;ESAM;ARHGAP35;CXCL12;FCHSD2;HAX1;GBA2;DBN1
prerank,regulation of interleukin-4 production (GO:0032673),-0.40013784495776283,-1.1540711556336334,0.25625,0.7309767092311694,1.0,5/21,15.22%,LEF1;SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.39477060214891413,1.1538915370234553,0.2934051144010767,0.92840353694481,1.0,23/52,25.64%,FXR2;RBFOX2;RBM8A;CELF1;RBM15B;DDX17;RBM5;CELF2;CELF4;KHDRBS2;NSRP1;FXR1;TRA2B;MBNL2;SAP18;SRSF12;YTHDC1;ZBTB7A;RBMX;REST;PUF60;FMR1;THRAP3
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.37156802164063407,-1.1538142492928558,0.25835866261398177,0.7302800846418928,1.0,8/24,12.73%,IGF1;INSR;ENPP1;IGF2;AKT1;PPP1R3B;GSK3A;PPP1R3C
prerank,nuclear transport (GO:0051169),0.49875213962067044,1.1538043335362391,0.28501628664495116,0.9274312164374574,1.0,2/16,5.19%,RGS14;RBM15B
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2923351284720919,-1.153715729997869,0.19680851063829788,0.729030277507177,1.0,29/72,21.63%,SHANK3;PLEKHH2;ARHGEF2;SLIT2;KANK3;STMN2;LDLR;HSPA8;HIP1R;TWF1;MYADM;APOE;EML2;CYRIB;CAMSAP1;VBP1;CLIP3;STMN1;APC2;CRYAB;MID1IP1;TUBB4A;SMAD4;PFN1;SSH2;SSH3;KATNB1;PFDN4;CLU
prerank,mitotic recombination (GO:0006312),0.4915468868762011,1.1534015065257028,0.30655737704918035,0.9275764684393029,1.0,4/15,12.90%,SMC5;ERCC1;TEP1;GEN1
prerank,carbohydrate biosynthetic process (GO:0016051),0.4592033897451709,1.1523081673360078,0.2911392405063291,0.9299300787052251,1.0,2/21,2.69%,ST3GAL4;B3GALT1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.407569950367075,-1.1518393439819115,0.2619047619047619,0.7331884507564248,1.0,7/18,14.37%,RAD51B;CDC25B;CDC25A;RAB11A;CDK4;CDC7;RAD51C
prerank,regulation of T cell proliferation (GO:0042129),0.3953556590919315,1.1517878217874538,0.293213828425096,0.930360391659042,1.0,6/61,6.40%,TNFSF8;ARG1;GLMN;IL4I1;PTPRC;NCK2
prerank,cellular response to oxidative stress (GO:0034599),0.3579238786764075,1.151783859129848,0.24767441860465117,0.9290945360887044,1.0,16/118,7.04%,PPARGC1A;PXN;EGFR;GPX8;MGAT3;ETV5;ERO1A;MPV17;FOXO3;WNT16;KEAP1;FANCC;FER;ANKRD2;SELENOS;SLC4A11
prerank,epithelial to mesenchymal transition (GO:0001837),-0.32150170740662465,-1.151536085612481,0.23228346456692914,0.7325888914418819,1.0,9/47,4.80%,ENG;LEF1;ROCK2;TGFBR3;RBPJ;TBX3;TGFBR1;WNT4;HIF1A
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.4211865512763203,-1.151532013328829,0.254278728606357,0.7311038707137063,1.0,8/17,25.08%,TNFRSF1B;SERPINE2;IL34;BMP2;ID2;PTN;CLCF1;NOTCH1
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.35229074957678913,1.151336312196079,0.24330616996507567,0.929382691127708,1.0,29/124,18.75%,ROR2;PRICKLE1;PRICKLE2;NFATC1;PLCB3;FZD2;PSME3;WNT5A;PSMB5;AGO1;DVL3;VANGL1;PSMB2;FZD7;PSMA2;PSMA6;FZD9;FZD3;PSMD13;PSMA7;AP2A2;CELSR1;PSME4;CELSR2;PSMC4;PSMB6;PSMD12;RHOA;PSMD14
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.44043913641656085,1.1512104973960349,0.2880597014925373,0.9285192766861551,1.0,10/26,17.54%,HOMER2;EFHB;ATP2B4;CHERP;RCAN1;GSK3B;HOMER3;STIMATE;CHP1;DYRK2
prerank,positive regulation of leukocyte activation (GO:0002696),0.4862733970597074,1.1511782817969385,0.2897350993377483,0.9273734608348146,1.0,3/18,10.36%,LBP;WNT5A;KARS1
prerank,negative regulation of interleukin-2 production (GO:0032703),0.4835409906154974,1.1511130251160397,0.3015075376884422,0.9263314974109135,1.0,3/18,5.86%,HOMER2;PTPRC;TNFAIP3
prerank,regulation of postsynapse organization (GO:0099175),0.43901158627115255,1.1510308227709694,0.3094170403587444,0.9253483931223414,1.0,5/28,7.43%,SIPA1L1;PPFIA2;LZTS3;WNT5A;SRCIN1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.4088923309766934,-1.1509559876648388,0.25510204081632654,0.7312102170511102,1.0,13/17,34.81%,ANK2;SLC8A1;KCNJ2;CACNB2;CACNA1G;SCN4B;SCN1B;HCN2;CACNA1D;SCN5A;CACNA2D1;CACNA1C;HCN4
prerank,response to cytokine (GO:0034097),-0.2639350559629276,-1.1504360132176976,0.15702479338842976,0.7313783062764918,1.0,24/141,8.47%,TIMP3;ALDH1A2;IL1R1;SMAD3;LEF1;PID1;OSMR;IL6R;SP100;IFNAR2;YTHDC2;ADAR;CXCL16;LIFR;AKAP6;TRAF6;JAK2;CDK9;IGBP1;CASP3;ANXA1;GCH1;BST2;LDLRAP1
prerank,cellular response to ionizing radiation (GO:0071479),-0.3226051625289109,-1.1504342135857564,0.2265625,0.7299002282248553,1.0,17/47,24.88%,MAP3K20;WRN;RPL26;BLM;EEF1D;RHOB;NET1;KDM1A;CRYAB;RAD1;HSF1;RAD9B;KDM4D;HRAS;GRB2;RAD51;LIG4
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),-0.4099719310937944,-1.1496935545749645,0.2722222222222222,0.7306390820098984,1.0,9/17,32.36%,ANK2;SCN4B;SCN1B;KCNE4;KCNH2;SCN5A;GJA5;KCNQ1;CACNA2D1
prerank,regulation of protein secretion (GO:0050708),0.35546121743128023,1.149658039519064,0.23406720741599074,0.9285150283827144,1.0,15/119,7.89%,ITPR2;ITPR3;SLC12A2;RAPGEF3;SLC8B1;KCNA5;RAP1A;STX1A;IL1A;PRKCA;FRMD4A;RAPGEF4;SLC2A2;ARF6;DPP4
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4710817427900966,-1.1492039358697144,0.291358024691358,0.7305372241163828,1.0,6/11,24.51%,ATG10;APOE;WIPI1;WIPI2;WDR45B;WDR45
prerank,mitotic DNA replication (GO:1902969),-0.4744443823069241,-1.148815438858912,0.2768878718535469,0.730145684744212,1.0,7/10,32.05%,MCM6;POLA1;MCMDC2;CDC45;GINS1;MCM3;MCM2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.33356438254798526,1.1488031413768656,0.22160970231532526,0.9301402059680461,1.0,25/208,11.08%,RORA;ROR1;PLK2;LPAR1;PPM1N;PELI2;TNIP3;AKAP13;SLC35B2;REL;NUP62;WNT5A;PPM1A;TNFAIP3;TRADD;TRIM21;S100B;TNIP1;TFG;TICAM1;TMED4;CANT1;SHARPIN;OTUD7B;TAB2
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.36078491822773767,1.1487445362204707,0.25551684088269455,0.9290823799886873,1.0,15/102,8.77%,CAV1;INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;GPLD1;SRC;ADCY5;FER;SELENOS;SYAP1;PRKAR2A;PIK3R2;TSHR
prerank,positive regulation of intracellular protein transport (GO:0090316),0.34750306531798625,1.1484924074989094,0.2396788990825688,0.9287062907852761,1.0,55/144,23.12%,LEPROT;GTSE1;RAPGEF3;PPP1R13B;ABLIM3;RAB29;KIF20B;RAC2;FIS1;CEP131;UBR5;RIPOR1;BAG3;RBM22;PIK3R2;MIEF1;SFN;GSK3B;TPR;CEP290;CD81;EMD;HTRA2;TMEM30A;PCM1;UBE2J2;UBE2D3;RAN;BAD;CDH1;NMT1;ERBB2;YWHAG;FBXW7;YWHAE;E2F1;CHP1;VPS11;CSNK2A2;PINK1;TM9SF4;HDAC3;UBL5;CEMIP;AKT2;MAPK8;VAMP2;TCF7L2;TENM1;XPO4;TFDP1;YWHAB;OAZ2;SAE1;PRNP
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.3465897465551662,-1.1484450871595173,0.21656050955414013,0.7298058783086175,1.0,8/33,10.58%,TEK;ANGPT1;NUPR1;NDNF;KDR;GATA2;RAMP2;SCG2
prerank,glutamate metabolic process (GO:0006536),0.4666392196085663,1.1482488973666034,0.29747899159663865,0.9282414100075492,1.0,7/19,15.30%,PRODH;AADAT;ALDH18A1;ALDH5A1;GOT1;GLUL;GGT1
prerank,positive regulation of cartilage development (GO:0061036),0.4909896279936082,1.148248820094131,0.3344262295081967,0.9269920945162873,1.0,3/17,4.10%,PKDCC;SOX9;BMPR1B
prerank,positive chemotaxis (GO:0050918),0.4819494847833003,1.1477465922012988,0.31918505942275044,0.9274137916120633,1.0,1/17,0.26%,FGF7
prerank,glucose transmembrane transport (GO:1904659),-0.41164028581274836,-1.1476549755072916,0.29190751445086704,0.7306731884107307,1.0,10/18,28.09%,PPARD;SLC2A10;SORT1;SLC2A8;SLC2A9;SLC2A1;SLC45A1;SLC2A3;SLC2A4;RAB4B
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.31940742226577434,1.1475332595337224,0.03,0.9268592947663209,1.0,269/1668,15.37%,PTCH1;EBF2;RORA;MEOX2;TENM2;ZBTB7C;DCN;KLF5;ETV4;ITGA6;CAV1;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;PAX9;FOXD2;NR2F2;TSHZ3;NEDD4L;NR3C2;DLX1;POU4F3;RARB;FOXP2;FOXD1;NFATC1;CAMK2D;ZBTB32;KLF12;LDB2;PBX1;ZSCAN25;EGFR;BHLHE22;ZBTB20;NPAS3;NEUROD6;FGF1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;ZSCAN18;HIVEP2;HOXB6;GLI2;TEF;IL4I1;ZKSCAN7;IRF2BP1;CHD3;CRTC1;MAML2;TXK;LMO1;LMO7;KLF3;KMT2A;SPI1;FOXK1;BEND3;PHF21A;ZNF418;FOXO3;SOX9;UBE2I;BMPR1B;PGR;FOXP4;NPAS2;TFR2;ZBTB8A;GLIS2;CHD8;CSRP3;ZNF585B;ZNF585A;SLC30A9;KAT6B;HDAC4;REL;CHD2;SATB1;BMP5;ZBTB3;ATP2B4;CHD1;KLF10;DACT1;WNT5A;POU5F2;CREB3L1;N4BP2L2;PPM1A;HEYL;ZFP3;ZNF697;ATAD2;ZFP1;SP3;KANK2;BHLHE40;MED18;ZFP90;RPRD1B;TARBP1;CDK13;ANKRD2;ARID3A;ONECUT1;ANXA4;NRIP1;ZFP14;RCOR3;MED12L;NCK2;SIN3B;TEAD3;CDK7;CTCF;NFE2L1;NRF1;HIC1;PEX2;PAF1;ZNF431;NCOR1;PAX3;NCOA5;HOXC10;ZFP62;TBX2;DDX17;ONECUT3;RREB1;DBX2;PIAS2;MAPK7;RARA;SUV39H1;MAFG;USF2;RPAP2;LHX6;KCTD1;PIK3R2;MYPOP;ISL1;PKNOX2;E4F1;FOXK2;TNIP1;MED7;ZNF462;AATF;ZBTB6;AGO1;DDRGK1;TCF20;PLSCR1;TBX18;MED13;TET1;SLTM;MECP2;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;RPRD1A;HDAC2;BAZ2B;LEFTY1;DBP;TLX3;TMF1;CTDSP1;TFEB;TPR;FHOD1;ZHX1;PAXBP1;RTRAF;SIX5;MMP12;WWC1;NCOR2;OTUD7B;RARG;FBXL19;EN2;DVL3;PHF20L1;EGR1;MZF1;MED23;ZBTB49;HEXIM1;ZNF148;HTATIP2;JMJD1C;ERF;AKIRIN1;MEN1;INO80;SEMA4D;NCOA3;NFE2L2;STAT2;CD81;HOPX;PEG3;PTEN;TTC21B;KDM6B;CRLF3;PKD1;CREBBP;NCOA2;NFATC4;BCL9;GTF2H1;ARID4A;SOX4;GMEB1;NUCKS1;DPF3;TCERG1;SFPQ;ZFP57;CBFB;DNAJA3;KAT8;TIAL1;UBE2D3;UBE2D1;CAMTA2;CAPRIN2;RAI1;PPIL4;RIPPLY2;EPC2;DICER1;FOXJ2;ZNF182;FOXF1;ZNF260;BRD8;WWP2;COPS5;NR5A1;LCOR;GPER1;MED8;CCDC62;TADA2A;MED12;ZMYM5;POU6F1;TOX4
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.4705598487621419,-1.1471059565700341,0.32387706855791965,0.7307083066142948,1.0,5/11,30.46%,TIMM10B;TIMM8B;ROMO1;TIMM29;TIMM10
prerank,regulation of endothelial cell migration (GO:0010594),0.3665516814801996,1.1465066860167012,0.24053724053724054,0.9288928993656013,1.0,10/85,4.96%,DCN;SMOC2;NR2F2;CEACAM1;FGF1;NRP2;GPLD1;NF1;PRKCA;WNT5A
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.4309186594213572,1.1463180567763556,0.29235382308845576,0.9282662924247986,1.0,4/32,8.07%,MEOX2;CARD10;RHOJ;STARD13
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.42696261381099043,1.1462115061949791,0.28905109489051095,0.9273778702699095,1.0,7/33,12.80%,APOD;MFN2;APLN;TNFAIP3;TAFA5;EFEMP2;PTEN
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),-0.44024055716670896,-1.146048593042561,0.2879177377892031,0.7324811957896902,1.0,9/14,37.06%,FLNA;SLC2A10;LOXL3;LIMS2;LIMS1;PRKD1;TIMP1;BST1;PHACTR4
prerank,response to chemokine (GO:1990868),0.5152682911357263,1.1457940164588654,0.29845626072041165,0.9275531470738779,1.0,2/13,1.71%,RIPOR2;SLC12A2
prerank,positive regulation of dephosphorylation (GO:0035306),0.4454000126133177,1.1451050022652298,0.3074670571010249,0.9285175718205003,1.0,3/27,4.48%,DLC1;CDH5;SRC
prerank,signal transduction by p53 class mediator (GO:0072331),0.43117483699982784,1.1450851854914448,0.27366863905325445,0.927353679788104,1.0,6/30,9.83%,MYBBP1A;PPP1R13B;BCL3;FHIT;NBN;POU4F1
prerank,anion transport (GO:0006820),0.41806478285510007,1.145020707935562,0.2895125553914328,0.9263538807957403,1.0,4/33,4.89%,VDAC2;LRRC8D;SLC26A9;SLC22A3
prerank,receptor clustering (GO:0043113),0.4430901060759729,1.1448901362220345,0.31626506024096385,0.9255200138579727,1.0,4/27,10.00%,LRP4;MUSK;ITGB7;DLG3
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.38529084290595417,1.1447498111968042,0.2709677419354839,0.9247269454861291,1.0,11/67,6.49%,PKDCC;TEC;FGFR1;EFEMP1;EGFR;ITK;TXK;SRC;FER;EPHB2;ABL2
prerank,phosphatidylcholine metabolic process (GO:0046470),-0.2959772501908153,-1.1447160107262269,0.19617224880382775,0.7348394439366513,1.0,15/70,13.12%,CHKA;ENPP2;GPAT4;CHPT1;NR1H3;LPIN2;DBI;PCYT1A;SLC44A5;NR1H2;ABHD3;CEPT1;LPIN3;CSNK2A1;MFSD2A
prerank,positive regulation of signal transduction (GO:0009967),-0.2528373034227101,-1.1446504010794447,0.08571428571428572,0.733509686225267,1.0,62/238,14.97%,IGF1;ROBO1;SASH1;VWF;TEK;PTGIS;CCBE1;RSPO3;SHANK3;BMP6;WLS;RBPJ;GRB10;NOS3;PIK3R1;TGFBR1;IGF2;EP300;MBD5;FGFR2;MN1;CCN3;F3;HIF1A;FAS;DSTYK;RSPO2;PDCD10;CUX2;SLC39A14;JAK2;JAG2;CITED2;GRIN1;TRIM16;ATP6V0C;ASXL2;FLNA;SNW1;TXNDC15;DCDC2;TM2D3;RPS3;MACF1;BMP2;KLF2;CD80;LRRK2;PRKCZ;CTBP2;TTC23;NRXN1;LOXL3;BDNF;TGFB2;CSNK2A1;CDKN2AIP;MAML3;ILK;RWDD3;ESM1;NRP1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.46090017929562344,1.1441582276207654,0.29505582137161085,0.9254711868987637,1.0,8/20,17.79%,PSMG2;PFDN6;PSMG1;LONP1;CCT2;HOPX;PSMG3;HSPA4
prerank,response to peptide hormone (GO:0043434),0.4068854704480542,1.1441267585747568,0.2723521320495186,0.9243587482505711,1.0,5/43,4.69%,CAV1;OGT;EIF2B3;SRC;SLC27A1
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4589519173868539,1.1440041673304546,0.30392156862745096,0.9235096066582764,1.0,2/22,3.14%,FGF7;CASK
prerank,endothelial cell proliferation (GO:0001935),-0.417512188400168,-1.143766962516087,0.28,0.7345366262179405,1.0,5/17,6.50%,TEK;BMP4;ACVRL1;BMPR2;CD34
prerank,endoderm development (GO:0007492),0.5136664717949021,1.1435668613975698,0.31810490693739424,0.9237151452040927,1.0,2/13,5.22%,LAMC1;KIF16B
prerank,lipid transport (GO:0006869),-0.2742005535684452,-1.1432403792285994,0.1724137931034483,0.734570441953235,1.0,24/97,14.28%,OSBPL8;SLCO3A1;ACSL1;PLTP;CHKA;ABCC4;PITPNB;PPARD;SLCO1C1;LDLR;ABCA4;SPNS2;APOE;TNFAIP8L3;ABCA9;SLCO2A1;OSBPL5;SCP2;ABCD2;ABCA2;MFSD2A;PRELID2;PRELID3A;ABCG1
prerank,inhibitory synapse assembly (GO:1904862),0.5348996191129652,1.1430893094354848,0.30948419301164726,0.9240203013189299,1.0,4/11,12.26%,WNT5A;GABRG2;PLXNB1;GABRB3
prerank,positive regulation by host of viral transcription (GO:0043923),-0.4279991742543032,-1.143016677288711,0.29876543209876544,0.733747169961326,1.0,5/15,12.56%,LEF1;EP300;CCNT1;SNW1;SP1
prerank,engulfment of apoptotic cell (GO:0043652),0.49833853378091364,1.1429953078657056,0.2961730449251248,0.9231033323795534,1.0,4/15,8.30%,XKR7;XKR4;RAC2;XKR8
prerank,positive regulation of autophagy (GO:0010508),0.3699061450633545,1.1429092359299546,0.26574307304785894,0.9221678075303853,1.0,13/81,11.10%,DCN;PLK2;TPCN1;FOXO3;SCOC;TRIM21;SESN1;IRGM;GSK3B;HMGB1;TICAM1;TFEB;PAFAH1B2
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.37501716379770494,-1.1424548919918045,0.27807486631016043,0.7338719731731473,1.0,11/22,38.21%,SLC7A5;RFTN1;IL18;SPHK1;NR1H4;NOD2;MYD88;PRKCQ;TGFB1;LY9;SLAMF6
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.41556099687834813,1.1423767795528645,0.2805232558139535,0.9227496857750769,1.0,6/36,8.37%,CAV1;EGFR;IL1A;ATP2B4;DDAH2;NOS1AP
prerank,phospholipid catabolic process (GO:0009395),-0.3711977352546551,-1.1418445165976598,0.2710843373493976,0.7342465403672467,1.0,3/24,8.38%,GPCPD1;ENPP2;PNPLA6
prerank,response to tumor necrosis factor (GO:0034612),-0.27421254234479414,-1.1415060782415116,0.16853932584269662,0.7338324254887215,1.0,26/91,18.63%,PID1;ARHGEF2;YTHDC2;CXCL16;GSDME;ERBIN;TNFRSF21;ZFAND6;GBP3;JAK2;IGBP1;CASP3;GCH1;AKT1;ZC3H12A;RPS3;BAG4;CCL13;SPHK1;TNFRSF11A;IKBKB;GBP2;ZFP36;CASP8;CD40;CACTIN
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.47805532147312163,1.1413326720920562,0.327718223583461,0.9250767105132061,1.0,6/20,14.09%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,spliceosomal complex assembly (GO:0000245),0.40760905023325866,1.1410744779015165,0.2946058091286307,0.9247184148303405,1.0,10/46,11.36%,SF3B1;CELF1;ZRSR2;SMN1;SRPK1;RBM5;CELF2;CELF4;SRPK2;LUC7L2
prerank,protein heterooligomerization (GO:0051291),-0.40734365112829507,-1.1407708819695836,0.2875318066157761,0.7345683714926512,1.0,7/17,26.98%,FARSB;GRIN2B;GRIN1;TMEM120A;CPSF7;CPSF6;HSD17B8
prerank,oligosaccharide biosynthetic process (GO:0009312),0.4602557741357416,1.140443185992265,0.3022151898734177,0.9256504591344049,1.0,2/20,2.69%,ST3GAL4;B3GALT1
prerank,protein N-linked glycosylation (GO:0006487),-0.29793280808254735,-1.1400895730319807,0.21844660194174756,0.7350815160125611,1.0,18/66,17.65%,MGAT4C;ST3GAL1;MGAT4A;SLC39A8;DPM1;ALG5;STT3B;GAL3ST1;PGM3;UBE2J1;B4GALT1;B4GALT7;ALG1;RPN2;FUT8;OST4;ENTPD5;ASGR1
prerank,regulation of myoblast differentiation (GO:0045661),-0.35398653092137317,-1.1399306780718106,0.25573770491803277,0.7340873765050147,1.0,5/32,2.75%,PLCB1;RANBP3L;IGFBP3;BMP4;TBX3
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.4663396263239219,-1.1395735764674542,0.296127562642369,0.7336856718416164,1.0,6/12,23.71%,PLCG2;CYBA;GRIN1;ADGRB1;RAB27A;ZNF205
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.4409877133495619,1.1392385960177085,0.3097744360902256,0.928448550356724,1.0,7/29,13.50%,SPRED1;SPRY1;BMP5;LDLRAD4;SDHAF2;PTEN;SPRED2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),-0.365023243805402,-1.1392185173430147,0.24477611940298508,0.7332811229828318,1.0,3/24,4.80%,GRB10;TMEM204;HIF1A
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.49195410601188816,1.1387068290889617,0.3194675540765391,0.9290270121291222,1.0,4/15,7.64%,GPC3;SPEF1;DACT1;ZNRF3
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.45741008097420116,-1.138695001530731,0.31880733944954126,0.7335018579739615,1.0,11/12,54.29%,ZBTB1;CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,defense response to protozoan (GO:0042832),-0.45527106416255003,-1.1382538375738012,0.30193236714975846,0.7333280033771309,1.0,8/12,33.93%,GBP4;GBP6;GBP7;GBP2;CD40;MYD88;SLC11A1;BATF2
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.46341519244563745,1.1378433151482215,0.31001589825119236,0.9305424960335996,1.0,5/21,9.34%,ADAM19;NCSTN;ADAM10;DAG1;BACE2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.35315833497591237,1.1377145226621246,0.26136363636363635,0.9297425000575216,1.0,5/121,0.71%,THBS4;EFNA5;FGF7;TEC;CSPG4
prerank,fatty acid transmembrane transport (GO:1902001),-0.3930196569736678,-1.1376286297946299,0.30494505494505497,0.7336553591508836,1.0,7/19,14.68%,PRKAG2;ABCD4;CPT2;PRKAB2;ABCD2;CPT1A;MID1IP1
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.519713825805803,1.1373196477429577,0.3234782608695652,0.929862389775976,1.0,6/12,12.75%,ELOVL5;ELOVL1;ELOVL2;HSD17B4;ACOT8;ABCD1
prerank,response to retinoic acid (GO:0032526),-0.30793007783859194,-1.1367312189908074,0.2260536398467433,0.7348885430304073,1.0,14/59,12.69%,EPHA3;CTSH;ACER2;WNT5B;LYN;ADNP2;RBP4;BRINP3;TBX1;CREB1;TRIM16;SNW1;RET;GATA6
prerank,response to lipid (GO:0033993),-0.2703061879058593,-1.1365470547762788,0.17857142857142858,0.7340307255350158,1.0,26/105,15.22%,CTSH;ACER2;SMAD6;NOS3;FOXP1;PAQR7;PPARD;RBP4;FOXO1;ERBIN;ALPL;JAK2;ANXA1;GCH1;TRIM16;TRIB1;ESR1;FGFR4;NOCT;GATA6;MAPKAPK2;ABCA2;TNFRSF11A;MAPKAPK3;ABCG1;LGALS9
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.2770532878396921,-1.1364935890692751,0.21390374331550802,0.7327680830370571,1.0,20/95,10.51%,ENG;ZEB2;SMAD3;SMAD6;DAB2;TGFBR3;LATS2;FKBP1A;SKIL;TGFBR1;EP300;ITGA3;PRDM16;LEMD3;VASN;ASPN;CITED2;SNW1;SLC2A10;HTRA3
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),-0.3372343933273986,-1.1364112434767544,0.2535211267605634,0.7316105207087644,1.0,7/35,8.04%,ITGA1;PDGFRB;FKBP1A;PPP4R4;PPP1R12A;CALM1;PPP1R11
prerank,toll-like receptor signaling pathway (GO:0002224),0.3696158601912897,1.135875173738832,0.2725030826140567,0.9333599408786535,1.0,20/84,17.66%,LBP;PIK3AP1;SCARA3;TNIP3;MAP3K1;IRAK3;PIK3R4;TLR7;TNIP1;RPS6KA3;HMGB1;TICAM1;S100A9;TAB2;UBE2D3;UBE2D1;PIK3C3;TICAM2;BTK;CTSB
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.44348624148549576,-1.1357831467437016,0.30788804071246817,0.7321228368167938,1.0,7/13,23.14%,PDE8A;GPR37;LRRK2;GPR37L1;RACK1;MET;NR4A3
prerank,negative regulation of protein metabolic process (GO:0051248),0.4027542573617525,1.135781756431459,0.29747675962815406,0.9324451273637755,1.0,5/48,6.08%,INHBB;EGFR;FLOT2;IRAK3;AZIN2
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4634812889789655,-1.1355053342131358,0.32175925925925924,0.7314678960053232,1.0,7/11,40.83%,SP100;MAD2L2;RPS27L;KAT5;TFAP4;MUC1;FOXM1
prerank,embryonic organ morphogenesis (GO:0048562),0.40976909953632246,1.1352678634294877,0.28415300546448086,0.9329544361656097,1.0,4/42,3.74%,ALDH1A3;EFEMP1;MFAP5;DYNC2I1
prerank,regulation of response to DNA damage stimulus (GO:2001020),0.40686669957132704,1.13524755365157,0.2900552486187845,0.9318121222742243,1.0,12/40,15.15%,FXR2;WDR76;NPAS2;UBE2V2;MCL1;FBXO5;SIRT7;ARMT1;RFWD3;ETAA1;FXR1;NEK4
prerank,positive regulation of vasculature development (GO:1904018),0.36083914801217504,1.1351254826820252,0.28136419001218027,0.930976718437112,1.0,11/94,5.28%,GAB1;SMOC2;RAPGEF3;HK2;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,negative regulation of blood coagulation (GO:0030195),-0.3288791547868012,-1.135053158300617,0.2527881040892193,0.7313720872550085,1.0,8/38,6.50%,PDGFRA;TFPI;NOS3;THBD;F3;SERPINE2;APOE;CD34
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),-0.3170381123137587,-1.1347883810862844,0.2596899224806202,0.730785944391282,1.0,9/48,7.30%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PRDM16;PGAM1
prerank,acidic amino acid transport (GO:0015800),0.4918805783425338,1.1344938633494388,0.315,0.9318645065127389,1.0,7/17,13.00%,LRRC8D;SLC25A12;PRAF2;SLC6A13;SLC1A6;SLC25A13;SLC25A22
prerank,negative regulation of interleukin-6 production (GO:0032715),0.42924528925236305,1.1341315583117049,0.30257186081694404,0.9318670436989909,1.0,6/27,9.41%,PTPN22;IRAK3;TNFAIP3;SELENOS;CD200R1;FOXJ1
prerank,cellular respiration (GO:0045333),0.4071991943947637,1.1333926849535938,0.30492676431424764,0.9330361001997101,1.0,5/41,7.17%,PPARGC1A;SDHAF4;LYRM7;SIRT3;COX15
prerank,regulation of immune effector process (GO:0002697),0.40647726588361965,1.1333142914186287,0.3202797202797203,0.9321190797251357,1.0,6/41,13.20%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,cellular response to acid chemical (GO:0071229),-0.3699951497905605,-1.1333114769093564,0.28391167192429023,0.7338720288241369,1.0,15/27,31.64%,CPEB4;LAMTOR3;RRAGC;KLF2;GLRA2;SPAAR;RRAGD;CPEB1;XBP1;LAMTOR2;SLC38A9;NSMF;LAMTOR4;SH3BP4;GLRA1
prerank,actin crosslink formation (GO:0051764),-0.4622626148417799,-1.1331585976324035,0.3069544364508393,0.7329237296904334,1.0,3/12,11.56%,EPS8;FLNA;BAIAP2L1
prerank,aspartate family amino acid catabolic process (GO:0009068),0.4717003380792567,1.1330706671766662,0.3107255520504732,0.9316905202406883,1.0,6/19,14.06%,AADAT;OGDH;GCDH;DLST;GOT1;HYKK
prerank,vesicle transport along microtubule (GO:0047496),0.45839216688888657,1.1328456610433264,0.3235747303543914,0.9312594531164714,1.0,8/23,22.15%,KIF13A;PAFAH1B1;NDE1;KIF5A;KIF5B;HTT;DYNC1I1;FBXW11
prerank,negative regulation of organelle assembly (GO:1902116),-0.3425402005468925,-1.1317715018499586,0.2627986348122867,0.7356866319027913,1.0,16/35,21.65%,NUPR1;TBC1D30;EVI5L;LRRK2;CEP97;TCHP;TRIM37;FEZ2;SCFD1;SMAD4;KAT2B;KAT2A;TESK1;STYXL1;SEC22B;NBDY
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.31654540629603967,-1.1316192247602757,0.24907063197026022,0.734755650578718,1.0,6/43,3.88%,IGF1;BMP6;IL6R;BMP4;WNT4;BMPR2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.34408882982950106,1.1312788182231004,0.2765714285714286,0.9352616955105988,1.0,22/138,13.35%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;TAF4B;TEAD3;CDK7;NCOR1;RARA;MED7;RORB;NRBF2;NCOR2;RARG;MED23;GTF2F2;TAF15;CREBBP;GTF2H1
prerank,intestinal lipid absorption (GO:0098856),0.5278652415375863,1.1311111953555444,0.3467600700525394,0.9346150107706439,1.0,1/11,1.68%,CEL
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.44583134398551977,1.1308920903852222,0.3265625,0.9340968686263934,1.0,6/26,9.33%,PCBP2;IRAK3;TNFAIP3;TRIM21;ACOD1;TRAFD1
prerank,neuromuscular synaptic transmission (GO:0007274),-0.3922871575734024,-1.130755316653708,0.26944444444444443,0.7357852317612137,1.0,3/18,8.30%,KIF1B;TBC1D24;FCHSD2
prerank,protein heterotetramerization (GO:0051290),-0.43680597191568055,-1.1306690217637487,0.319047619047619,0.7346545642387574,1.0,6/13,26.98%,FARSB;GRIN2B;GRIN1;CPSF7;CPSF6;HSD17B8
prerank,ceramide transport (GO:0035627),-0.4428326234415888,-1.1300257793908421,0.3159144893111639,0.7351962359680839,1.0,8/12,33.90%,PLTP;ABCA2;PLEKHA3;ABCB4;PLEKHA8;ABCA13;PSAP;CPTP
prerank,cellular response to amino acid stimulus (GO:0071230),-0.34376176746026793,-1.129958254433542,0.2554517133956386,0.7340028168232338,1.0,14/33,24.17%,UBR1;CPEB4;LAMTOR3;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;CASTOR2;CASTOR1;XBP1;LAMTOR2;SLC38A9;NSMF
prerank,ovarian follicle development (GO:0001541),0.5151606085706157,1.1297531336933802,0.31333333333333335,0.936622791993078,1.0,1/13,0.54%,INHBB
prerank,regulation of cation channel activity (GO:2001257),0.3659875006414537,1.1297523626738257,0.26627218934911245,0.935433548055537,1.0,8/89,4.22%,AHNAK;SLMAP;CAMK2D;MINK1;PDE4D;GRIA3;FKBP1B;KCNS2
prerank,positive regulation of blood coagulation (GO:0030194),0.48395769289524504,1.1294916326896327,0.3232963549920761,0.9350713710951882,1.0,2/17,2.66%,ST3GAL4;ANO6
prerank,nucleotide metabolic process (GO:0009117),0.45362852453106445,1.1294637646692214,0.32975460122699385,0.9339645310460538,1.0,9/23,20.01%,AK5;RNASEH2B;FHIT;NMNAT3;REXO2;CTPS2;DCK;AK7;NUDT5
prerank,response to insulin (GO:0032868),0.3674225410039889,1.1291093474124139,0.2838002436053593,0.933863259110736,1.0,12/80,8.05%,INHBB;SORBS1;OTOP1;CEACAM1;RAB8B;OGT;GPLD1;SLC27A1;FER;SELENOS;SYAP1;PIK3R2
prerank,T cell proliferation (GO:0042098),-0.4430072345507312,-1.1287016028199732,0.315136476426799,0.7363095845332563,1.0,2/13,1.74%,MSN;CTPS1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4567596570333069,1.12757040971326,0.32866043613707163,0.9377052514512483,1.0,1/23,1.14%,MBOAT2
prerank,positive regulation of macrophage activation (GO:0043032),0.4846526255785248,1.1275585759946574,0.3226837060702875,0.9365482595847242,1.0,3/17,10.36%,LBP;WNT5A;KARS1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.4526180345192911,1.127492103205971,0.32171156893819336,0.9355683860004551,1.0,6/23,17.56%,GUCA1A;CNGB1;FNTA;FNTB;NMT1;CAMKMT
prerank,regulation of plasminogen activation (GO:0010755),-0.4515263764698582,-1.1274174641304509,0.3241525423728814,0.7387731217887261,1.0,3/12,13.20%,CLEC3B;SERPINE2;THBS1
prerank,regulation of histone deacetylation (GO:0031063),0.49781641265417753,1.1273068969525326,0.335,0.9349661584379795,1.0,3/13,15.59%,CAMK2D;PRMT6;SAP30BP
prerank,regulation of programmed cell death (GO:0043067),-0.25064830974842967,-1.127008207638147,0.18095238095238095,0.7385874327487125,1.0,28/161,11.36%,MECOM;DAPK1;HIP1;ACTN2;OMA1;TPT1;ACER2;STEAP3;TGM2;IGFBP3;BCL2L11;WRN;GAS1;MADD;FAS;PRDX2;USP42;LRP8;JAK2;AKT1;HS1BP3;NAE1;VCP;HAX1;RPS3;LRRK2;USP36;BID
prerank,activin receptor signaling pathway (GO:0032924),0.4893287038113038,1.126770394843388,0.3360927152317881,0.9355415635648684,1.0,2/15,5.04%,INHBB;ACVR1C
prerank,positive regulation of developmental process (GO:0051094),0.33872471397081566,1.126384209473955,0.2823920265780731,0.9356397638954546,1.0,24/164,9.72%,DCN;FGFR1;DLX1;COBL;FOXD1;RAPGEF3;DDHD1;SOX9;BMPR1B;SRC;KMT5C;BMP5;FIS1;WNT5A;TMEM79;LLPH;DAG1;RREB1;FBXO5;ISL1;CDC20;MIEF1;RPS6KA3;PHLDB1
prerank,respiratory electron transport chain (GO:0022904),0.5074884841573302,1.1263715263132477,0.34271523178807944,0.9345044249589781,1.0,2/14,1.98%,PPARGC1A;SLC25A12
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.36468293090776815,-1.1261516458966818,0.3149847094801223,0.73953928816673,1.0,10/23,19.17%,NUPR1;CBFA2T3;EP300;SIK1;C1QTNF3;GSK3A;PGP;CLK2;PFKFB1;CRY1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.408586583229165,1.1260130444682015,0.30140845070422534,0.9344906328150623,1.0,5/37,9.65%,APOD;IL17RA;CHID1;PLD3;TICAM1
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.4647568379760164,1.1259440492778854,0.31100478468899523,0.9335101202726339,1.0,8/19,17.31%,EXTL3;XYLT2;GLCE;NDST1;HS3ST5;HS6ST3;EXT1;EXT2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.37314128455870677,-1.1257920877287604,0.2992125984251969,0.7391271818877466,1.0,12/24,25.67%,B2M;ACE;TAP2;SEC23A;SAR1B;HFE;TAPBPL;ERAP1;SEC31A;PDIA3;MFSD6;TAP1
prerank,negative regulation of metabolic process (GO:0009892),0.3831826639759248,1.1257502795061078,0.30707610146862485,0.9329619762806469,1.0,10/54,8.81%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;FIS1;ACOT13;HOXC10;ZDHHC7;LNPEP
prerank,response to amino acid (GO:0043200),-0.3501978674637324,-1.125295964496826,0.28792569659442724,0.7391839716056596,1.0,17/31,31.64%,CPEB4;LAMTOR3;GRIN1;RRAGC;GLRA2;SPAAR;RRAGD;CPEB1;XBP1;LAMTOR2;TMBIM6;SLC38A9;NSMF;LAMTOR4;SH3BP4;MEAK7;GLRA1
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.43466222437891977,1.1245908879305575,0.2859237536656892,0.9356273165868702,1.0,5/26,6.72%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX
prerank,positive regulation of cellular catabolic process (GO:0031331),0.34588548838891997,1.1244923531984024,0.2896551724137931,0.9346806930887799,1.0,20/132,10.54%,DCN;PLK2;VGLL4;ZBTB20;TPCN1;GPLD1;FOXO3;DACT1;DXO;SLC4A4;TRIM21;RDX;IRGM;LIN28B;GSK3B;HMGB1;TICAM1;CNOT7;ADRA2A;TFEB
prerank,cellular response to fluid shear stress (GO:0071498),0.5188403776466093,1.1242998148511991,0.3486394557823129,0.9341296292383527,1.0,4/12,12.27%,ASS1;MAPK7;MTSS1;NFE2L2
prerank,regulation of platelet activation (GO:0010543),0.45989737152610344,1.1242911103794795,0.3235772357723577,0.9329908739085441,1.0,3/21,4.28%,TEC;TXK;PRKCA
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.32386904782252446,-1.1241974118654054,0.25263157894736843,0.740927891450181,1.0,8/41,7.30%,PRKAG2;NUP107;EP300;HIF1A;AAAS;SEH1L;NUP133;PGAM1
prerank,MAPK cascade (GO:0000165),-0.24058341861462032,-1.123844008472852,0.07142857142857142,0.7405868134229254,1.0,43/295,8.53%,IGF1;KSR1;RAPGEF2;TEK;TGFA;PDGFRB;PTPN3;ACTN2;SHANK3;PDGFRA;MAP3K20;ANGPT1;IL31RA;CTSH;NRK;PIK3R1;RASGRP3;KL;PSMA1;KIT;BRAP;FRS2;FGFR2;NEFL;IL18;RBX1;LAMTOR3;FLT3LG;RASGRF1;GRIN2B;KDR;LYPLA1;PSMD11;CALM1;MEF2A;MAPK12;JAK2;RASGRF2;MAP2K2;PSMD7;RGL2;CAMK2A;PSMD4
prerank,lipoprotein localization (GO:0044872),-0.45617474410095493,-1.1238352107694467,0.30985915492957744,0.7392274664148905,1.0,3/11,6.59%,LRP1;ZDHHC17;VMP1
prerank,response to calcium ion (GO:0051592),0.3567946936204425,1.1235794851705079,0.2986857825567503,0.9340868749030772,1.0,8/102,4.96%,CAV1;GUCA1A;ITPR3;CAMK2D;SLC25A12;GPLD1;ADD1;WNT5A
prerank,pulmonary valve morphogenesis (GO:0003184),0.49003872275902977,1.1232711764226844,0.3444976076555024,0.9338883645590111,1.0,4/17,5.24%,STRA6;NFATC1;JAG1;HEYL
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.40257020197230375,1.123147898998831,0.31932773109243695,0.9330825156557273,1.0,6/42,11.55%,CDH13;UTRN;PTPRJ;GSK3B;FERMT2;EFEMP2
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.4033276581896935,-1.1228500269733774,0.3143631436314363,0.7407547445627136,1.0,4/17,2.58%,IGF1;DOCK4;PDGFRB;IGFBP5
prerank,positive regulation of leukocyte migration (GO:0002687),-0.35279354456966544,-1.1224854161556845,0.26740947075208915,0.7405472808899832,1.0,10/27,31.49%,IL6R;CSF1;EDN3;PTN;ICAM1;NCKAP1L;ADAM8;JAM3;ADAM17;AIF1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.41020097032645175,1.122283111864284,0.3290414878397711,0.9347279093909185,1.0,5/36,9.49%,DCN;NR2F2;ATP2B4;MECP2;HMGB1
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.509163804361922,1.122272636412332,0.32538330494037476,0.9336012680947872,1.0,5/12,21.62%,PPARGC1A;ABCD1;IRS2;AKT2;TWIST1
prerank,actin filament depolymerization (GO:0030042),-0.4666306818682948,-1.122227689165981,0.3187066974595843,0.7399117087872166,1.0,3/11,6.07%,DSTN;CFL1;TWF1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3502295006576543,1.1220583386202763,0.26490825688073394,0.9331131520447941,1.0,22/137,12.06%,ITGA6;DOCK9;F11R;RGS6;RAPGEF3;RAP1A;ARAP1;SGSM2;NF1;RTN4R;CAV2;ZC3H15;RAPGEF6;PKP4;GSK3B;TBC1D2;FERMT2;FNTA;RIC1;DVL3;PLXNB1;SEMA4D
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.4187443951223073,-1.1219150592360985,0.3106267029972752,0.7394904416491528,1.0,10/16,29.93%,ATP5PD;DMAC2L;ATP5MC3;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,positive regulation of translational initiation (GO:0045948),-0.39844445743005763,-1.1215576553857856,0.2931937172774869,0.7390914658716072,1.0,8/18,28.27%,RPS6KB1;YTHDF1;YTHDF2;POLR2D;KHDRBS1;YTHDF3;RPS6KB2;DDX3X
prerank,endomembrane system organization (GO:0010256),0.3363397761498463,1.1214830648032657,0.2661555312157722,0.93370612838261,1.0,50/178,18.40%,ATP8B3;USP50;HOOK2;ATP8B1;RAB29;PI4K2B;A4GALT;CAV2;LMAN2;PHETA2;EIF2AK3;DNM1;RAB30;USP8;SNX10;ATL2;GOLGB1;SYNGR2;ATP8B2;NPLOC4;LYSMD3;TMED4;SUN1;CSNK1A1;REEP3;LNPK;HOOK3;TRIP11;OTOF;HTT;LAPTM4B;ZW10;FBXW8;NUP93;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;ANXA8;ANXA8L1;OSBPL2;TBC1D20;ARHGEF7;DYNC2H1;ALS2;VPS11;SPTBN1;LEMD2;COG3
prerank,calcium ion homeostasis (GO:0055074),0.359888147696395,1.1213843059561457,0.2845238095238095,0.9328800129599034,1.0,9/95,4.74%,CAV1;STC2;CTRC;SLC8B1;CDH5;SLC24A1;TRPV4;CSRP3;ATP2B4
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.36340016451564455,-1.1213500344023128,0.26666666666666666,0.7383419773090617,1.0,14/27,36.22%,ETS1;SIRPA;TRAF6;CYRIB;SKAP1;NR4A3;ITGB2;PYCARD;HAS2;CCR2;HSPD1;CCL2;PRKCQ;THY1
prerank,protein-containing complex disassembly (GO:0032984),0.3815247910476938,1.1210637785872135,0.2998678996036988,0.9327471146548406,1.0,16/54,19.51%,CAV1;FZD2;AXIN1;TSG101;GSK3B;CSNK1A1;APC;DVL3;VAMP8;LIX1;PYM1;UBQLN1;PPP1CA;SNAP29;MAP1LC3B;LAMP2
prerank,protein autoprocessing (GO:0016540),-0.41525128393002203,-1.120959902939329,0.3181818181818182,0.7380312994726578,1.0,5/17,17.69%,OMA1;CTSL;SPRTN;FXN;CASP4
prerank,regulation of vesicle-mediated transport (GO:0060627),0.3556537934307007,1.1205459027201121,0.28878281622911695,0.9332713978227741,1.0,37/91,23.05%,CDH13;RAB8B;OPHN1;SRC;PTPRC;ZFYVE16;STON1;ABL2;PACSIN2;RIMS2;RAB3A;CPLX1;RINT1;INPP5F;ATP9A;STON2;PLD1;RUFY2;MBTPS1;SYK;RAB33B;RAB21;STX4;SNX12;DENND10;RAB5A;PACSIN3;NSF;SNX17;PACSIN1;RALA;CPLANE2;VAMP2;TSC2;HCK;AP2S1;MAPK1
prerank,diol biosynthetic process (GO:0034312),-0.4044284773633228,-1.1204533256677705,0.3189873417721519,0.7380538816102784,1.0,6/15,13.97%,ACER2;GCH1;QDPR;ABCA2;SPHK1;DHFR
prerank,mRNA processing (GO:0006397),0.3244072505181415,1.1201963123842462,0.23834745762711865,0.933169475786024,1.0,81/287,22.78%,DHX8;PPARGC1A;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;CELF1;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;SON;RPRD1B;HNRNPR;SF3B5;PPIE;CDK7;PRPF3;CSTF3;CHERP;DDX46;RBM22;RBM5;ELAVL2;DNAJC8;SNU13;SUPT4H1;RPRD1A;HNRNPM;DBR1;UPF3B;SRRM2;GTF2F2;ERN1;GTF2H1;TCERG1;SNRPA1;SFPQ;THOC3;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;CMTR1;PSPC1;THOC5;SYNCRIP;PRMT9;CWC22;SLU7;SYMPK;GTF2H3;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,positive regulation of viral transcription (GO:0050434),0.43113516267040075,1.120156900211916,0.34841628959276016,0.9321569129721011,1.0,4/25,12.47%,MDFIC;NELFB;SUPT4H1;GTF2F2
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4661990982112173,1.1200458597152991,0.3256172839506173,0.9314102180037199,1.0,5/17,15.35%,PTPRC;N4BP2L2;LTBP3;FERMT2;PDCD2
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.38639876012174046,1.119879188161564,0.3074829931972789,0.9307951596513605,1.0,8/49,7.60%,CAV1;EIF2AK3;SRC;FIS1;NDUFS3;MCL1;SIAH1;PTPMT1
prerank,brain development (GO:0007420),0.3425174929319099,1.1197529451391492,0.28308400460299193,0.9300404816240895,1.0,12/136,9.41%,PTCH1;APOD;PBX1;NF1;CHD8;SHROOM2;AMIGO2;PAFAH1B1;CDH2;EML1;COL4A1;FOXJ1
prerank,regulation of gluconeogenesis (GO:0006111),0.43469210114241585,1.1195833644061015,0.3088023088023088,0.9294297436400174,1.0,6/27,13.40%,PPARGC1A;OGT;SELENOS;SIRT7;C1QTNF12;GCK
prerank,regulation of neutrophil migration (GO:1902622),0.5345055347016145,1.1194875694552175,0.34459459459459457,0.9285904413130623,1.0,2/10,4.67%,MPP1;RAC2
prerank,negative regulation of programmed cell death (GO:0043069),-0.228688522063668,-1.1190812647118207,0.06896551724137931,0.7406811654180249,1.0,68/355,14.08%,IGF1R;IGF1;MECOM;NOTCH2;TEK;LEF1;OSR1;ANGPT1;GRK5;IL31RA;CTSH;TPT1;SMAD6;DAB2;PIK3R1;DNAJC3;NUPR1;BMP4;TBX3;FOXO1;TFRC;SQSTM1;CFL1;HNRNPK;CAT;FAS;DSTYK;GPX4;ZFAND6;AREL1;NPM1;NAA15;PDCD10;PRDX2;KDR;RPS6KB1;DNAJA1;HDAC1;IFIT3;TRAF6;PTMA;RNF144B;CASP3;ANXA1;ATF5;AKT1;UFM1;CFLAR;CITED2;SERPINB9;ARHGDIA;FLNA;CIAPIN1;UBE2O;HAX1;BID;BABAM2;TXNDC5;BAG4;CRYAB;FLT4;GATA6;THBS1;SPHK1;MYO18A;PIM3;YWHAZ;FXN
prerank,positive regulation of cation transmembrane transport (GO:1904064),-0.3190231291607605,-1.118360808623222,0.2651006711409396,0.7415435944883327,1.0,10/41,10.42%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;KCNJ10;FLNA;ANK3;KCNN2
prerank,negative regulation of cyclase activity (GO:0031280),-0.41507813215993117,-1.1182369027961059,0.3333333333333333,0.7405769366160511,1.0,2/14,2.36%,ADGRV1;GRM3
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.4098002585683346,-1.118100977156939,0.3157894736842105,0.7396608893375808,1.0,8/16,25.40%,SHLD2;POLQ;UBQLN4;CGAS;MAD2L2;RMI2;SMCHD1;PARPBP
prerank,regulation of aerobic respiration (GO:1903715),-0.41642772210940454,-1.1176414112418074,0.344,0.739592414312719,1.0,4/15,11.80%,ATP7A;CBFA2T3;VCP;SLC25A33
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.5079243847361562,1.1175697458791523,0.3344887348353553,0.9333694938413373,1.0,2/12,4.76%,B3GALT1;B4GAT1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.39617492555738737,1.1175156116239902,0.30434782608695654,0.932404130409534,1.0,6/47,7.57%,EFNA5;DOCK5;DOCK1;SPRY4;RREB1;KANK1
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),0.4228361869980898,1.1175135103361447,0.3251908396946565,0.9312803200789556,1.0,11/30,19.96%,LEPROT;ABLIM3;RAC2;HTRA2;UBE2J2;UBE2D3;FBXW7;VPS11;CSNK2A2;PINK1;UBL5
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.39144257217161466,1.11739057023387,0.3035479632063075,0.9305328264750123,1.0,11/48,13.79%,BCL3;MSH6;PHLDA3;CIDEB;HIPK1;HIC1;MCL1;MSH2;SFN;CDIP1;HTRA2
prerank,fat cell differentiation (GO:0045444),-0.2971394065017498,-1.1173696584521677,0.24680851063829787,0.7390222238995047,1.0,16/57,12.88%,OSBPL8;PID1;SMAD6;WNT5B;FOXO1;EP300;KLF4;OSBPL11;PRDM16;ATF5;C1QTNF3;NR4A2;CLIP3;CTBP2;TMEM120A;BBS2
prerank,regulation of protein localization to cell periphery (GO:1904375),-0.38965028775004096,-1.1166915742467995,0.33076923076923076,0.7396680348314909,1.0,7/18,15.04%,STX8;ACTB;LDLRAP1;VPS4A;AR;ABCA2;ZDHHC2
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.3536618482544327,1.1164680857241123,0.30701754385964913,0.9323433554446516,1.0,17/80,16.76%,NGF;SRC;FIS1;ACVR1C;UACA;MAP3K5;SFN;RPS6KA3;HMGB1;USP47;DHCR24;AQP1;HTRA2;GPER1;BAD;SYK;YWHAE
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.4713831852903003,-1.116280232713606,0.3425925925925926,0.7394921602761741,1.0,6/10,29.40%,BMP6;NEXMIF;MAD2L2;NOTCH4;NOTCH1;PPM1F
prerank,Wnt signaling pathway (GO:0016055),0.3517230240679898,1.116140933868841,0.30966952264381886,0.9322883507444562,1.0,23/92,14.91%,WNT10A;FZD2;AXIN1;WNT2B;WNT16;PLPP3;CPE;WNT5A;CSNK1G3;GSK3B;CSNK1A1;FERMT2;STRN;RARG;APC;DVL3;WNT9A;PTEN;NXN;BCL9;FZD7;FZD9;FZD3
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.4012892541037141,-1.1158498454533197,0.30927835051546393,0.7394346287982256,1.0,5/16,6.00%,IGF1;TGFBR3;RBPJ;FGFR2;AKAP6
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.3565856244827479,-1.1157641018401088,0.2923076923076923,0.738340070411205,1.0,14/27,20.33%,SLC47A1;SLC6A9;SLC7A5;SLC7A1;ARL6IP5;SLC25A38;SLC1A3;SLC1A1;SLC3A2;SLC22A2;SLC38A5;SLC25A18;SLC25A29;SLC1A4
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.3670201620000363,-1.1155623777724204,0.2915451895043732,0.7375810786131564,1.0,8/23,20.72%,BCL2L11;SAMM50;TIMM10B;TIMM8B;COX18;ROMO1;MAIP1;TIMM29
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.3108458012084784,1.1154487957805401,0.16032064128256512,0.9333411016274712,1.0,125/834,13.67%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;CDH13;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;NFATC1;LDB2;PBX1;EGFR;FGF1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;GLI2;IL4I1;CRTC1;MAML2;TXK;LMO1;LMO7;KMT2A;SPI1;FOXO3;SOX9;BMPR1B;PGR;NPAS2;TFR2;GLIS2;CHD8;CSRP3;SLC30A9;KAT6B;HDAC4;REL;BMP5;KLF10;LEO1;WNT5A;HEYL;ATAD2;SP3;RPRD1B;APLN;CDK13;ONECUT1;NRIP1;NCK2;CDK7;NRF1;PAX3;HOXC10;DDX17;RREB1;MAPK7;RARA;USF2;PIK3R2;ISL1;E4F1;FOXK2;ELL;TNIP1;ZNF462;AATF;AGO1;DDRGK1;TCF20;PLSCR1;MED13;TET1;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;HDAC2;DBP;TMF1;TFEB;FHOD1;PAXBP1;RTRAF;MMP12;WWC1;RARG;DVL3;EGR1;MZF1;ZBTB49;HTATIP2;AKIRIN1;MEN1;INO80;NCOA3;NFE2L2;CD81;PEG3;KDM6B;CRLF3;PKD1;CREBBP;NCOA2;BCL9;SOX4;DPF3;TCERG1;SFPQ
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.3343309699647837,1.115090852215499,0.29304446978335236,0.9333507671189525,1.0,12/149,6.99%,EDA;CAV1;ROR1;IL18R1;RIPK4;FLOT2;IRAK3;WNT5A;FER;TRADD;TRIM21;NLRC4
prerank,inorganic anion transport (GO:0015698),-0.3009077970130972,-1.114779007906924,0.2422907488986784,0.7384154579998157,1.0,10/53,9.30%,SLC26A7;ENPP1;SLC4A10;ANO1;CLIC4;ANO4;ENPP3;CLIC5;SLC25A30;SLC25A11
prerank,mitochondrion localization (GO:0051646),-0.39053184927728907,-1.1147292857319249,0.3054054054054054,0.7372580584797572,1.0,4/19,11.10%,MARK1;ZBED3;MEF2A;LRRK2
prerank,regulation of lipid metabolic process (GO:0019216),0.35735972762574136,1.114597708353282,0.30413625304136255,0.9338030687133395,1.0,7/88,7.02%,RORA;CAV1;CHD9;SC5D;SIN3B;NCOR1;ACACA
prerank,positive regulation of transferase activity (GO:0051347),0.3390619611357616,1.1145011113223962,0.28125,0.9329663478816982,1.0,13/142,6.39%,ROR2;ROR1;NTRK3;FGFR1;EGFR;MUSK;AXIN1;UBE2I;LMO4;NEK7;RFC3;NBN;EPHB2
prerank,regulation of macrophage activation (GO:0043030),-0.34508644862459775,-1.1141777435517268,0.30448717948717946,0.7375268464540731,1.0,11/30,13.76%,IL31RA;MFHAS1;NR1H3;IL33;CD200;ZC3H12A;GPR137B;THBS1;SPHK1;MYO18A;PJA2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.40744964151035384,-1.1141086723825973,0.30434782608695654,0.7364153034149357,1.0,6/15,21.63%,LDLR;APOE;VBP1;CRYAB;PFDN4;CLU
prerank,acute inflammatory response (GO:0002526),0.4359568234336514,1.1138524508997436,0.32416787264833574,0.9339612632488951,1.0,4/23,13.60%,LBP;ANO6;PLSCR1;CTNNBIP1
prerank,B cell differentiation (GO:0030183),-0.30651678196733706,-1.113776691883166,0.2542372881355932,0.7360352542413112,1.0,10/46,9.83%,KLF6;KIT;CEBPG;FNIP1;VCAM1;HDAC9;PLCG2;NHEJ1;SYVN1;DCAF1
prerank,oligodendrocyte development (GO:0014003),0.47542092123398305,1.1137746937219835,0.3396825396825397,0.9330868822587498,1.0,4/15,13.10%,EIF2B3;CNTNAP1;EIF2B4;NSUN5
prerank,regulation of cellular component organization (GO:0051128),0.3437738860442556,1.113726095372401,0.2951739618406285,0.9321233391437564,1.0,21/135,9.45%,PTCH2;CDH13;PLCE1;CEACAM1;CAMK2D;RAP1A;MLLT3;OPHN1;IRAK3;WNT5A;ZFYVE16;STON1;HJURP;ANGPTL7;ABL2;PACSIN2;LTBP4;STK38L;EBAG9;IRGM;STON2
prerank,actin filament bundle organization (GO:0061572),-0.34015936123411766,-1.1134611510202903,0.28524590163934427,0.7355085007256437,1.0,5/33,5.73%,EPS8;NEDD9;MYO1B;PAWR;PLS3
prerank,response to fatty acid (GO:0070542),0.46517989903081575,1.113341413115443,0.33060556464811786,0.9321985392832988,1.0,7/17,17.74%,FOXO3;SOX9;PDK4;GLDC;KCNK4;SCD;LPL
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.540916078758885,1.1132652145673847,0.3470790378006873,0.9313114270479426,1.0,3/10,11.94%,FAP;DPP4;CHADL
prerank,mRNA catabolic process (GO:0006402),0.3987680792463806,1.1131586195319527,0.3240223463687151,0.9305387012704395,1.0,8/44,13.35%,DHX34;CNOT10;DXO;DIS3L2;AGO1;EXOSC10;ZFP36L2;ERN1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3747279582507828,1.1130906640896934,0.31375,0.9296444788523521,1.0,2/69,0.58%,NGF;PPARGC1A
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.2704820724917931,-1.1127199041424538,0.20833333333333334,0.7363896139402089,1.0,22/87,13.40%,ENG;PARD3;SMAD3;CLDN5;SMAD6;TGFBR3;FKBP1A;SMAD9;TGFBR1;APPL2;PTPRK;ACVRL1;SMAD5;NRROS;TGFB3;LPXN;ZFYVE9;FURIN;PRKCZ;TGFB2;FMOD;ITGB5
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.3990051105184017,-1.11233766054831,0.321256038647343,0.7361531725307211,1.0,5/17,10.52%,NOTCH2;RBPJ;BMP4;GALNT11;BMP2
prerank,regulation of cardiac conduction (GO:1903779),0.3870629230839316,1.1120780918080115,0.3149100257069409,0.9318042883249117,1.0,9/54,10.60%,CORIN;ITPR2;ITPR3;FKBP1B;ATP2B4;ATP1A2;CASQ2;ATP1B3;FXYD6
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.4561086381742763,1.1110363187282644,0.34441087613293053,0.933999219857782,1.0,9/21,18.05%,FBXO5;CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,female gamete generation (GO:0007292),0.42342372406615736,1.1105387814376306,0.3323170731707317,0.934424715161633,1.0,7/29,18.82%,PIWIL2;DIAPH2;BMP15;MEI4;KMT2D;MDK;USP9X
prerank,synapse organization (GO:0050808),0.3444766180364884,1.1104042501426445,0.29871645274212366,0.9336952883441844,1.0,9/125,2.70%,NTNG1;LRP4;PDZRN3;PTPRF;MUSK;GPC6;PPFIA2;ZC4H2;RAB29
prerank,regulation of cell adhesion (GO:0030155),0.3433351681152772,1.1100985376716075,0.2975495915985998,0.9335862204281246,1.0,13/129,6.49%,TGFBI;EFNA5;CDH13;RIPOR2;MINK1;PRKCA;SRC;DSCAM;RAC2;PLXNA3;ADAM10;EPHB2;ABL2
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3318282680127799,1.1100754936898574,0.2888402625820569,0.9325611491253368,1.0,27/166,13.35%,RORA;PPARGC1A;NR3C2;RARB;MAML2;PGR;TAF10;CAVIN1;TAF4B;TEAD3;CDK7;POLR1E;NCOR1;RARA;MED7;RORB;NRBF2;TFB2M;NCOR2;RARG;MED23;NAT14;GTF2F2;TAF15;CREBBP;BRF2;GTF2H1
prerank,muscle contraction (GO:0006936),-0.2600071898597293,-1.1100168429401376,0.1951219512195122,0.7413545659570606,1.0,28/126,15.17%,MYOF;ITGA1;ROCK2;ACTN2;MYLK;DMD;TPM1;GJC1;SLC8A1;DYSF;SNTB1;TMOD3;BDKRB2;CALM1;MYL9;MYL6;MYH11;TPM3;LMOD1;ACTA2;TPM2;EDNRA;CRYAB;DES;ITGB5;SLC6A8;VIM;TLN1
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.4636616973124379,-1.1100047421660455,0.3431151241534989,0.7400871099168321,1.0,6/10,23.66%,PDE8A;GPR37;LRRK2;GPR37L1;RIPK1;STK26
prerank,negative regulation of apoptotic process (GO:0043066),-0.2202763680758901,-1.1097959447165184,0.09090909090909091,0.7393635181702561,1.0,85/444,13.50%,IGF1R;IGF1;NOTCH2;TEK;LEF1;OSR1;PRKCH;ANGPT1;GRK5;IL31RA;RNF213;CTSH;TPT1;SMAD6;DAB2;SLC30A10;PIK3R1;DNAJC3;NUPR1;BMP4;TBX3;NDNF;KDM2B;FOXO1;TFRC;FNIP1;CPEB4;SQSTM1;CFL1;HNRNPK;CAT;FAS;DSTYK;ZFAND6;AREL1;NPM1;NAA15;KLF4;PDCD10;PRDX2;KDR;APOE;TBX1;RPS6KB1;DNAJA1;HDAC1;MAZ;IFIT3;TRAF6;PTMA;IGBP1;RNF144B;CASP3;ANXA1;ATF5;UNC5B;TGFB3;AKT1;UFM1;CFLAR;CITED2;SERPINB9;MERTK;ARHGDIA;LGMN;NR4A2;FLNA;CIAPIN1;UBE2O;ZC3H12A;HAX1;BID;FOXQ1;BABAM2;TXNDC5;BAG4;CRYAB;BDNF;FLT4;GATA6;CSNK2A1;THBS1;SPHK1;MYO18A;PIM3
prerank,regulation of viral release from host cell (GO:1902186),-0.3802597610917632,-1.1097245988293398,0.3062330623306233,0.7383118649392364,1.0,10/21,20.69%,MID2;TRIM25;VPS4A;TRIM35;TRIM28;CHMP3;CHMP2B;TRIM8;TRIM13;TRIM11
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.43513015323400234,-1.109102437256936,0.3383838383838384,0.7388171697151314,1.0,3/14,4.18%,TFRC;PAXIP1;SHLD2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),-0.3561944025841729,-1.1087327269627139,0.3023255813953488,0.7385099192361008,1.0,7/26,12.18%,SHANK3;SLC8A3;CUX2;GRIN1;LRRK2;PRKCZ;NRXN1
prerank,regulation of DNA repair (GO:0006282),0.39157203976973737,1.1085988229100692,0.3215258855585831,0.9360487815106904,1.0,11/44,10.79%,EGFR;BRCC3;EYA1;NPAS2;UBR5;UBE2V2;UIMC1;WRAP53;SIRT7;ERCC6;AXIN2
prerank,positive regulation of lyase activity (GO:0051349),0.48761040028791025,1.1084809315183437,0.35206611570247937,0.935253133864604,1.0,2/14,3.23%,GUCA1A;NF1
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.35706240415741514,1.1074006637373486,0.3199513381995134,0.9373526088370677,1.0,13/87,14.18%,FGF7;FGFR1;FGF1;RBFOX2;SPRED1;KIF16B;FGF18;HNRNPM;GTF2F2;ZFP36L2;SPRED2;FLRT2;TIAL1
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.3033505019533586,-1.1069521665527458,0.30313588850174217,0.7423333182140328,1.0,26/50,28.01%,CCNT2;BLM;MNAT1;ACTB;CNPPD1;CDC25A;CCNT1;CAMK2N1;TTBK1;SERTAD1;CDK5R1;CCNE2;CCNH;CCNJL;CDK5RAP3;BCCIP;CDC37;STOX1;CCND2;CCNF;CDKN2C;CDKN1B;CCNK;CDKN2D;CCND1;CCNB2
prerank,modulation by host of symbiont process (GO:0051851),-0.3381728944334881,-1.1067983074230066,0.32786885245901637,0.7414764727847027,1.0,7/31,12.56%,LEF1;EP300;NAPEPLD;HDAC1;CCNT1;SNW1;SP1
prerank,sodium ion transmembrane transport (GO:0035725),0.35334745676227275,1.10644092301765,0.3118811881188119,0.9391756511732071,1.0,14/84,11.18%,SCN10A;NALCN;SLC12A2;ANO6;SLC24A1;SLC12A3;KCNK1;ATP1A2;SLC6A13;SLC4A4;ATP1B3;SCN2B;SLC9A7;SLC9A6
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),0.47284045712570244,1.1061512982231596,0.3593220338983051,0.9390066612595802,1.0,2/15,2.99%,HSPH1;CD55
prerank,autophagosome maturation (GO:0097352),-0.3410867747062659,-1.106076132284381,0.30976430976430974,0.7423299207805039,1.0,14/32,21.76%,UVRAG;GABARAPL1;VMP1;CALM1;VCP;GABARAP;STX17;TECPR1;EPG5;VAMP7;CHMP3;MAP1LC3A;WIPI2;VTI1B
prerank,positive regulation of cell death (GO:0010942),0.37444268565373573,1.1060480223239002,0.3165374677002584,0.938196907417707,1.0,15/59,12.13%,PRODH;CIDEB;CELF1;WNT5A;SLC6A13;EFNB2;MAP3K5;GSK3B;SARM1;AXIN2;RARG;APC;EGR1;HTATIP2;FAF1
prerank,positive regulation of DNA recombination (GO:0045911),-0.3479480712610388,-1.1059664232027044,0.3008595988538682,0.7413781053148246,1.0,10/27,20.59%,TFRC;PAXIP1;SHLD2;ACTR2;ARID2;MMS19;ERCC2;PARP1;TIMELESS;MAD2L2
prerank,organelle disassembly (GO:1903008),-0.3397657814817681,-1.1059423918067657,0.28938906752411575,0.7401870913299813,1.0,9/33,13.99%,UBA5;KLC1;ULK2;UFM1;VCP;EIF2D;GOLGA2;MTIF2;PLK5
prerank,regulation of protein processing (GO:0070613),-0.3672544389956569,-1.1051866575063762,0.30547550432276654,0.7409348715376928,1.0,5/21,14.64%,CCBE1;GAS1;SERPINE2;LRRK2;NKD2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.39180007062496797,-1.105042244810216,0.32625994694960214,0.7400293745993565,1.0,8/19,17.70%,CUX1;OBSL1;CUX2;LRP8;CDKL5;DBN1;PTPRD;DHX36
prerank,organelle fusion (GO:0048284),0.4378301399882893,1.104733058682104,0.3280757097791798,0.9411663602265393,1.0,9/22,22.21%,MFN2;FIS1;MIEF1;MIGA1;STX4;VPS11;BAX;CHCHD3;THG1L
prerank,purine nucleotide biosynthetic process (GO:0006164),0.508031743432348,1.1047127552334985,0.36203866432337434,0.940140915130662,1.0,7/12,20.46%,MTHFD1;PPAT;PRPSAP2;PRPS1;PRPS1L1;GART;ADSL
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.4439812253245031,-1.1046820401695046,0.34382566585956414,0.7397437271630738,1.0,3/12,6.47%,CTSH;LMO2;CTSL
prerank,negative regulation of bone mineralization (GO:0030502),-0.41743473726121727,-1.1043945781981912,0.3234567901234568,0.7392881526965481,1.0,6/13,34.96%,ENPP1;RFLNB;GREM1;RFLNA;BCOR;AHSG
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.3731243724039654,-1.1043573040636012,0.32791327913279134,0.7381264723804664,1.0,10/23,18.07%,PREB;TMED9;SEC61B;SURF4;SYVN1;SEC16A;VCP;OS9;DERL2;TECPR2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.36904125600094206,1.1043434777009218,0.30062111801242236,0.9402139287089893,1.0,11/67,8.05%,PXN;SH2D2A;SULF1;CYFIP2;NRP2;DOCK1;VAV2;SRC;NCK2;SHB;PIK3R2
prerank,neuron maturation (GO:0042551),-0.39051192640407684,-1.1043051831594237,0.29201101928374656,0.7370229712496342,1.0,10/18,31.82%,EPHA8;LGI4;CLN5;C1QA;PICK1;C3;SCARF1;ACTL6B;RND1;MTCH1
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.42093312629093993,-1.1042653516326881,0.33495145631067963,0.7358517583527611,1.0,2/13,2.36%,ADGRV1;GRM3
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3353834904011779,1.1040278792539826,0.28460686600221485,0.9401184301018215,1.0,9/151,4.99%,ROR2;ROR1;NTRK3;ACKR3;EGFR;RAP1A;PTPN22;PRKCA;PTPRC
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.35294506111619617,1.103644886469311,0.3170441001191895,0.940205585751496,1.0,21/94,17.01%,PRODH;MYBBP1A;PPP1R13B;MSH6;FHIT;ERO1A;CIDEB;HIC1;MCL1;CUL3;MAP3K5;STK24;SFN;POU4F1;DIABLO;ERN1;HTRA2;BAD;BNIP3;E2F1;QRICH1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.28080485469440836,-1.102876630645297,0.25961538461538464,0.7384150094223622,1.0,17/78,11.25%,PICALM;NUMB;PID1;EPHA3;PRKCH;LRP1;DAB2;PIK3R1;SQSTM1;STX8;ITGA3;ACTB;AKT1;LDLRAP1;VPS4A;AR;CLIP3
prerank,actin polymerization or depolymerization (GO:0008154),-0.3068658746383861,-1.1022463787032517,0.2894736842105263,0.7389283852670436,1.0,12/50,11.27%,SVIL;DSTN;ARHGAP6;CFL1;WASF3;TWF1;JAK2;CAPG;DIAPH1;ABI1;EVL;AVIL
prerank,lamellipodium assembly (GO:0030032),0.42216796311743077,1.102143810642788,0.33433734939759036,0.9437338088524385,1.0,4/26,6.47%,CDH13;ABLIM3;SPEF1;ABLIM2
prerank,negative regulation of gene expression (GO:0010629),-0.22807086930960452,-1.1016234406304959,0.10810810810810811,0.7394630796932002,1.0,88/302,21.78%,IGF1;ROBO1;SLC24A3;DAPK1;PICALM;NOTCH2;ENG;ROCK2;CLDN5;LGR4;FOXP1;IGFBP5;BMP4;SLC7A5;WNT4;ACVRL1;RPS6KA5;HIF1A;RBL1;XDH;KLF4;PDCD10;HDAC9;KDR;MYADM;APOE;CD34;HDAC1;HINFP;RBMS3;MAP2K2;CRKL;PPP1R11;PAIP2;RPL13A;JARID2;CITED2;GATA2;LGMN;SLC2A10;AGO3;ZC3H12A;RPS3;BMP2;GAPDH;BMI1;ESR1;RPS26;TTBK1;NOCT;NUDT12;TGFB2;NCL;DHFR;MOV10;ID2;MAPT;AGO4;SH3GL2;PARP10;TLE5;LGALS9;RBL2;SUZ12;DNMT3B;TWSG1;ASB1;ZFP36;CNOT9;TNRC6C;DHX36;KAT2B;METTL16;YTHDF2;ANXA7;EED;RACK1;DAPK3;MIF;ZC3H10;TASOR;DNMT3A;HRAS;CILP;RIDA;TMBIM6;DCP2;APLNR
prerank,cellular response to metal ion (GO:0071248),-0.25493884607538647,-1.1016214475019366,0.20175438596491227,0.7382131655888552,1.0,26/123,11.74%,ADGRV1;BMP6;CLIC4;ADCY1;ADCY7;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;B2M;SYT9;SYT7;KCNH1;RASGRP2;MEF2A;PLCG2;SLC41A1;AKT1;LGMN;ANK3;LRRK2;GLRA2
prerank,mitotic spindle organization (GO:0007052),0.3360050184140725,1.1012603763728683,0.3005586592178771,0.9453887918859136,1.0,49/153,23.11%,PLK2;DYNLL1;KIF2A;STIL;SMC3;SPAST;TUBG1;DSN1;CKAP5;PAFAH1B1;EML1;CDC20;NUP160;MECP2;DYNLL2;NUP37;RANBP2;BUB3;MAP4;WDR62;NDE1;MAP9;AHCTF1;PTPA;TUBG2;ZWILCH;ZW10;CENPU;ARHGEF10;RAN;PIBF1;TBCE;CENPH;B9D2;CENPK;MAD1L1;OFD1;RHOA;DCTN2;DYNC1LI2;CENPL;DYNC1I1;NUP43;GPSM2;PRC1;MIS12;DCTN6;SEC13;SBDS
prerank,insulin receptor signaling pathway (GO:0008286),0.3609971972671573,1.1010633932831808,0.33290816326530615,0.9449493047273827,1.0,10/69,9.35%,GAB1;SORBS1;GPLD1;CAV2;ATP6V0D2;PDK4;FER;PIK3R2;ATP6V0A1;GSK3B
prerank,leukotriene metabolic process (GO:0006691),0.4518779050634758,1.1009698919817805,0.33974358974358976,0.9441651834834743,1.0,5/19,15.30%,MGST2;ABCC1;ABCC10;LTA4H;GGT1
prerank,nuclear pore complex assembly (GO:0051292),0.5212183926571088,1.1005118866698635,0.36684303350970016,0.9444907667623068,1.0,5/10,15.46%,TPR;AHCTF1;NUP153;RTN4;NUP93
prerank,regulation of organelle organization (GO:0033043),-0.2749495096475739,-1.1004652724667017,0.25888324873096447,0.7402147490041805,1.0,17/80,9.40%,ZEB2;PDE4DIP;MSN;MYO5A;CLIC4;EP300;PREB;SQSTM1;TMED9;STX18;USP6NL;PDCD10;RBSN;NEXN;SURF4;DIAPH1;PDE2A
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),0.3823706370861405,1.10044005055575,0.3452054794520548,0.9436140580733018,1.0,12/53,14.11%,EGFR;FXR2;BRCC3;EYA1;SPRED1;NPAS2;HIC1;UIMC1;WRAP53;ERCC6;SPRED2;FXR1
prerank,cellular defense response (GO:0006968),0.3939775449860723,1.1004319932016788,0.33055555555555555,0.9425464479502393,1.0,3/40,3.98%,LBP;ITK;CD5L
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4022228802247249,1.0998964188935871,0.3389121338912134,0.9430611349687775,1.0,15/39,20.75%,SOCS5;PI4K2B;PIP4K2B;SOCS6;PIK3R2;EFR3A;SOCS4;SOCS7;PIK3C3;PI4K2A;SOCS1;SOCS2;ITPKA;PIK3C2B;CISH
prerank,regulation of isotype switching (GO:0045191),-0.4348616692374073,-1.0998290567553104,0.3105134474327628,0.7407904452456157,1.0,4/14,8.40%,TFRC;PAXIP1;SHLD2;SLC15A4
prerank,protein-DNA complex disassembly (GO:0032986),-0.41072117174173206,-1.0995900308455362,0.345,0.7401766083769041,1.0,4/16,10.95%,SMARCE1;SMARCD1;RPL23;ARID2
prerank,cellular response to organic substance (GO:0071310),-0.260556509601212,-1.099471058435635,0.23972602739726026,0.7392274699512082,1.0,22/116,11.10%,SMAD3;LEF1;PID1;GHR;CLEC3B;SLIT2;IGFBP5;TGFBR1;ACVRL1;BMPR2;CYP1B1;IL18;KLF4;AKAP6;RPS6KB1;TRAF6;ARL6IP5;CDK9;LDLRAP1;RAMP2;HAX1;LRRK2
prerank,epidermal cell differentiation (GO:0009913),0.3964837026282614,1.099399970100258,0.3333333333333333,0.9435724541644617,1.0,4/41,4.96%,GLI1;JAG1;WNT16;WNT5A
prerank,positive regulation of isotype switching (GO:0045830),-0.40914308353676904,-1.0990228126842962,0.3333333333333333,0.7392596032309589,1.0,8/15,26.08%,TFRC;PAXIP1;SHLD2;CD40;MAD2L2;CLCF1;TNFSF13;HMCES
prerank,in utero embryonic development (GO:0001701),-0.3580653096010781,-1.0988762075585015,0.3181818181818182,0.738436782420433,1.0,7/25,10.52%,CHD7;TGFBR1;IGF2;FGFR2;HINFP;TGFB3;BMP2
prerank,positive regulation of innate immune response (GO:0045089),0.4163178401173525,1.0987201993057527,0.34789156626506024,0.9445833555591117,1.0,6/30,12.75%,LBP;SPI1;WNT5A;POLR3G;PLSCR1;POLR3D
prerank,B cell activation involved in immune response (GO:0002312),0.4920236656705287,1.0986789320459016,0.36923076923076925,0.9436280621959349,1.0,4/13,16.40%,MSH6;MSH2;GPR183;BATF
prerank,cardiac muscle cell development (GO:0055013),-0.38514858536013513,-1.098274194426844,0.3125,0.7387242628654039,1.0,7/20,8.74%,SORBS2;PDGFRB;PDGFRA;SLC8A1;OBSL1;MYH11;PDLIM5
prerank,regulation of JUN kinase activity (GO:0043506),-0.3263178725947955,-1.0981259399923686,0.3258064516129032,0.7379088879863476,1.0,9/33,16.28%,SASH1;DUSP10;DNAJA1;TRAF6;MAP3K10;RPS3;TNFRSF11A;EDN1;DVL2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3650931367001309,1.0980433594369008,0.33039092055485497,0.9445953821870596,1.0,20/67,19.63%,CAV1;ATP8B1;CAPZB;FXR2;FER;ATG5;RDX;ARF6;TBC1D16;TBC1D2;TBC1D8;PLD1;EVI5;FXR1;DYNC2LI1;TBC1D20;TBC1D5;RAB5A;ATG3;TBC1D10A
prerank,positive regulation of protein modification process (GO:0031401),0.32878342695993573,1.097798793612024,0.3019271948608137,0.9442690468244177,1.0,23/203,8.84%,EFNA5;FGF7;DLC1;NTRK3;CLDN19;LEPR;EGFR;RAPGEF3;CCND3;MUSK;PELI2;FGF1;AXIN1;CDH5;FXR2;SOX9;LIMK2;KRAS;RAB3GAP2;DYRK1A;NOS1AP;FGF18;IRGM
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.42641371907967507,1.097637001957204,0.3476923076923077,0.9437185625375735,1.0,4/24,9.57%,HNRNPC;SRC;STN1;EXOSC10
prerank,regulation of biosynthetic process (GO:0009889),-0.44350991714787846,-1.0973337240516494,0.3613636363636364,0.7386933889259429,1.0,11/11,55.69%,SLC25A33;MID1IP1;SNCA;ALOX5;SPHK2;THRSP;GSTP1;CCN6;PIKFYVE;UCP1;PCK1
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.40269410066126493,-1.0966313117327307,0.33156498673740054,0.7393563882155247,1.0,3/16,1.14%,PDGFD;PDGFRB;PDGFRA
prerank,sphingosine metabolic process (GO:0006670),0.45773228411162176,1.0962563213299839,0.3610223642172524,0.94686837885851,1.0,3/17,4.15%,ACER3;PLPP2;PLPP3
prerank,DNA packaging (GO:0006323),0.46381565902531663,1.0961321654762601,0.3637873754152824,0.9461856413335548,1.0,3/16,4.87%,HAT1;CDAN1;BANF2
prerank,regulation of JNK cascade (GO:0046328),-0.2575662827836823,-1.0958240194968485,0.22758620689655173,0.7403242333226503,1.0,13/101,6.74%,IGF1R;PLCB1;MECOM;TNFRSF19;TGFBR3;CCN2;MFHAS1;SIRPA;SH3RF3;DUSP10;DUSP3;ANKRD6;TRAF6
prerank,protein sumoylation (GO:0016925),0.37364561340960967,1.0956863219294781,0.3425559947299078,0.9465356676325355,1.0,12/49,13.02%,STX1A;EYA1;UBE2I;NUP62;PIAS2;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.35948313246449665,1.0956460776856136,0.32273838630806845,0.9455750410767435,1.0,24/82,21.11%,DYNLL1;GTSE1;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;PAFAH1B1;CCP110;NDE1;CEP290;SSNA1;CETN2;PCM1;YWHAG;YWHAE;CEP57;OFD1;CEP250;DCTN2;ALMS1;HAUS8;CEP43
prerank,carbohydrate homeostasis (GO:0033500),-0.28496485959826157,-1.0948758082273762,0.2719298245614035,0.7417195236425365,1.0,7/67,3.87%,IGF1R;INSR;KCNB1;ADIPOR2;RBP4;APPL2;MBD5
prerank,aggrephagy (GO:0035973),0.4309901297296026,1.0948730954380392,0.34718100890207715,0.9469150963971579,1.0,5/27,11.27%,DYNLL1;WDR81;ATG5;DYNLL2;HDAC6
prerank,carboxylic acid metabolic process (GO:0019752),-0.33142103595521677,-1.0947152823151023,0.326984126984127,0.7409416215567002,1.0,12/33,25.69%,PTGIS;ST3GAL1;DDO;CSGALNACT1;TBXAS1;SLC2A1;AGXT;MIF;GSTO1;CYB5A;GSTO2;SLC2A3
prerank,cyclic purine nucleotide metabolic process (GO:0052652),-0.37555146739677514,-1.094424328922795,0.3118279569892473,0.7405130702554494,1.0,5/21,7.59%,ADCY1;ADCY7;NPR1;ADCY4;ADCY2
prerank,calcium ion import across plasma membrane (GO:0098703),0.4758650919003099,1.0940691197869572,0.359106529209622,0.948342287057351,1.0,3/14,4.74%,SLC24A1;TRPV4;ATP2B4
prerank,early endosome to late endosome transport (GO:0045022),0.4482737214258699,1.0934313974881265,0.3269537480063796,0.9491848641728623,1.0,9/20,21.66%,HOOK2;WDR81;KIF16B;HOOK3;PIK3C3;LMTK2;WDR91;RAB5A;AKTIP
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5056897236732343,1.0926043080725207,0.3763440860215054,0.9506426322547039,1.0,4/10,17.11%,RARB;RARA;RARG;PPARG
prerank,regulation of humoral immune response (GO:0002920),0.3890741674294986,1.092330538118734,0.35492957746478876,0.9504351205607672,1.0,6/44,13.20%,C2;SERPING1;CD55;SUSD4;CD81;CFH
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),-0.44611478967625307,-1.0916581811876394,0.357630979498861,0.747099589437846,1.0,6/11,17.04%,FOXO1;LMNA;GSK3A;MLIP;P2RX4;SMAD4
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),-0.35975294085790877,-1.0913323826304602,0.32142857142857145,0.7467706178329985,1.0,6/25,24.76%,IGF1;TRAF6;H1-0;PER2;MAD2L2;TRIM6
prerank,glycerolipid metabolic process (GO:0046486),0.5098775646182356,1.0909623218177753,0.3564356435643564,0.953722443525459,1.0,2/11,3.58%,DGKA;DGKZ
prerank,regulation of erythrocyte differentiation (GO:0045646),-0.3239180138821657,-1.0908139909881065,0.2966666666666667,0.7469966738791136,1.0,14/35,26.38%,ETS1;LYN;HOXA5;HIF1A;CDK6;TAL1;ZFP36;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.41756751523738816,1.090502167606127,0.35988200589970504,0.9541696176046409,1.0,3/27,2.02%,DLC1;F11R;ARAP1
prerank,response to interferon-alpha (GO:0035455),-0.3922113822673163,-1.090291409958923,0.36272040302267,0.7472387422307882,1.0,5/16,18.78%,IFNAR2;ADAR;BST2;IFNAR1;PDE12
prerank,negative regulation of cellular process (GO:0048523),0.3086991627314226,1.0902664356375442,0.2639029322548028,0.953768966671031,1.0,87/521,15.22%,NGF;ROR2;ZBTB7C;TGFBI;IGFBP6;DLC1;CDH13;VGLL4;RIPOR2;CLDN19;GLMN;ADAMTS1;DCBLD2;PPP1R13B;SSTR1;SPEF1;GPLD1;GNRH1;CASK;PIWIL2;IL1A;PTPN14;WNT16;EIF2AK3;PTHLH;CD9;TPTE;CELF1;NPAS2;DSCAM;BMP5;PLXNA3;KLF10;NUP62;PDS5B;KANK2;ADAM10;EPHB2;NCK2;ATG5;NDUFS3;CTCF;CHERP;FBXO5;BRINP1;DIS3L2;RBM5;PTPRJ;PLSCR1;NLRP2B;SIRT7;CNOT7;DLG3;PBRM1;FERMT2;CHMP4B;STRN;AXIN2;RARG;APC;VAMP8;PLXNB1;ZBTB49;MEN1;SEMA4D;TEX15;NF2;HOPX;WNT9A;PTEN;CDC6;CRLF3;FHL1;SOX4;HTRA2;NAIF1;DNAJA3;CLMN;RTN4;CAPRIN2;PTPRU;ERBB4;SIPA1;NDRG3;GPER1;PTPN6;PLG
prerank,regulation of actomyosin structure organization (GO:0110020),-0.4296721454200093,-1.089757346774869,0.35645933014354064,0.7475562308843817,1.0,5/13,8.78%,ROCK2;CDC42;ASAP3;SLC9A1;ACTG1
prerank,myotube cell development (GO:0014904),-0.4545416369131442,-1.0894530194553362,0.3825503355704698,0.7471934101181289,1.0,2/10,7.43%,IGF1;SELENON
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.5063815267397916,1.0892081674748786,0.3652173913043478,0.9560314078267371,1.0,3/10,7.45%,IRAK3;PTPRC;MAPK7
prerank,cell projection assembly (GO:0030031),0.428879002063114,1.0889883292367755,0.36391912908242613,0.9556082726990072,1.0,3/22,7.01%,PARVA;RAC2;RHOJ
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),-0.3626533802794335,-1.08895665269412,0.34324324324324323,0.7473598482486581,1.0,11/22,19.29%,IGF1;ROCK2;MEF2A;SLC9A1;MLIP;EDN1;P2RX4;SMAD4;LMCD1;AGT;PARP1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),0.48188585333337947,1.0883861004641664,0.36006825938566556,0.9564743140880443,1.0,3/13,15.49%,SORBS1;C1QTNF12;SNX5
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.4640692893034743,-1.0882690021935209,0.3632075471698113,0.7481380345648228,1.0,4/10,25.00%,JARID2;KDM1A;DNMT3B;BRCA1
prerank,endocardial cushion morphogenesis (GO:0003203),-0.3825987613783391,-1.0881747804088822,0.3577023498694517,0.7471943001070365,1.0,6/18,12.75%,ENG;NOS3;BMP4;ACVRL1;BMP2;TGFB2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.4393368693889223,1.0880708276675548,0.3669724770642202,0.9563945591451168,1.0,5/19,12.88%,BCL3;PHLDA3;HIPK1;MSH2;CDIP1
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.43695566904044836,1.0879072534310088,0.3450920245398773,0.9558451899257614,1.0,6/22,13.51%,NR2F2;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,regulation of BMP signaling pathway (GO:0030510),0.35516048858188276,1.0874517457135244,0.33290978398983484,0.9561773285592574,1.0,8/73,4.27%,DLX1;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;NBL1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.3079147664836343,-1.087415596980288,0.2847682119205298,0.7480992788029895,1.0,20/42,33.28%,C2CD5;SEC61B;TIMM44;SEC62;PAM16;PEX26;TIMM17B;PEX6;PEX1;PEX10;ROMO1;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;PEX5;TIMM23;TIMM21;RTN2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.3919696489402531,1.0874148965977104,0.36689655172413793,0.9552040895482001,1.0,10/39,16.76%,UTRN;NEDD4L;FXYD6;SCN2B;NEDD4;FHL1;CHRM3;WWP2;FGF12;YWHAE
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.3733501581352768,1.0872239359211164,0.3638814016172507,0.9547033636898827,1.0,7/52,7.65%,SORBS1;EPB41L2;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,response to thyroid hormone (GO:0097066),-0.4264831563280159,-1.0870127527697333,0.3740648379052369,0.7479281316160602,1.0,3/13,6.47%,CTSH;LMO2;CTSL
prerank,regulation of macrophage cytokine production (GO:0010935),-0.43153657494838643,-1.0868210272288639,0.3640661938534279,0.7473017726073001,1.0,7/13,16.78%,SEMA7A;PLCG2;TGFB3;CUEDC2;TGFB2;LAPTM5;GPRC5B
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.4847358856362975,1.086508313941648,0.3493975903614458,0.955900294547234,1.0,2/13,4.76%,B3GALT1;B4GAT1
prerank,Golgi inheritance (GO:0048313),-0.4420852859075811,-1.086293563819466,0.34236453201970446,0.7476113592563823,1.0,8/11,37.67%,PDCD10;GOLGA2;YWHAZ;PLK5;STK25;PLK3;VRK1;CDK1
prerank,regulation of MAP kinase activity (GO:0043405),0.34658713926933604,1.0850400770015263,0.3506024096385542,0.9593607130192758,1.0,11/92,5.46%,TRIB2;FGFR1;RGS14;EGFR;FGF1;STK38;NF1;SPRY1;SPRY4;IRAK3;TSG101
prerank,keratan sulfate biosynthetic process (GO:0018146),0.4217358483016018,1.0850242951847326,0.3632286995515695,0.9583377099246305,1.0,5/26,9.26%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2
prerank,response to hexose (GO:0009746),0.42543028291803453,1.0850067706967845,0.3654434250764526,0.9573085832625475,1.0,8/25,21.70%,GPLD1;EIF2B3;SELENOS;EIF2B4;IRS2;LPL;VAMP2;TCF7L2
prerank,positive regulation of DNA metabolic process (GO:0051054),0.3678591767930396,1.0849005836508407,0.3341902313624679,0.9565529152985656,1.0,11/61,10.74%,SMOC2;EGFR;BRCC3;EYA1;NPAS2;NBN;UIMC1;WRAP53;MECP2;HMGB1;ERCC6
prerank,adherens junction organization (GO:0034332),0.38114005077199875,1.0848044557371816,0.33923705722070846,0.9557768918944559,1.0,5/48,3.26%,CDH13;CDH11;CDH5;CDH17;CDH9
prerank,cellular response to peptide (GO:1901653),-0.29135298966230627,-1.0847795883570124,0.31451612903225806,0.7507079595880054,1.0,11/56,10.49%,IGF1R;IGF1;LRP1;ARHGEF2;GJA1;EPHA4;VCAM1;NOD1;GRIN1;LGMN;RPL23
prerank,mitochondrial fusion (GO:0008053),0.4489667585901187,1.0845187848014857,0.35714285714285715,0.9555762060990608,1.0,8/18,22.21%,MFN2;FIS1;MIEF1;MIGA1;BAX;CHCHD3;STOML2;THG1L
prerank,T cell homeostasis (GO:0043029),-0.4563754013899475,-1.0844565428309223,0.3615023474178404,0.7503197192204698,1.0,5/10,25.45%,FAS;AKT1;ZC3H8;NCKAP1L;JAK3
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.3234596417135169,1.0842604117583285,0.3210412147505423,0.9553403544567131,1.0,56/184,19.16%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;CUL3;PAFAH1B1;CCP110;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;NDE1;CEP290;INO80;SSNA1;CETN2;CDC6;PKD1;ZFP36L2;ANAPC2;PCM1;PSMB2;UBE2D1;PSMA2;PSMA6;ZW10;ANAPC4;PTPN6;FZR1;PSMD13;PSMA7;YWHAG;NEK11;YWHAE;CDC14A;RGCC;E2F1;CEP57;PSME4;ANAPC16;KLHL18;OFD1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;CEP250;DCTN2
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.34769438945543696,1.084236008816476,0.3416666666666667,0.9543516947345038,1.0,14/100,11.57%,TRIB2;PRICKLE1;GLMN;SOCS5;SH3RF2;OGT;FHIT;KEAP1;N4BP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B
prerank,histone H3-K36 demethylation (GO:0070544),-0.4487305724796952,-1.0841093666534545,0.3673469387755102,0.7500349848229535,1.0,3/10,12.83%,PHF8;KDM2B;KDM7A
prerank,retinol metabolic process (GO:0042572),0.47357599618228075,1.083950012275727,0.3815126050420168,0.9541501310648517,1.0,1/14,0.63%,RDH10
prerank,B cell homeostasis (GO:0001782),-0.4589639483683776,-1.0839214937064037,0.3595505617977528,0.7492772073831143,1.0,2/10,2.16%,DOCK11;LYN
prerank,cellular response to organic cyclic compound (GO:0071407),0.3287712640150368,1.083910836782446,0.33030646992054485,0.9531984017722425,1.0,23/141,15.58%,RORA;HRH1;FOLR1;EGFR;RAPGEF3;RAP1A;SSTR1;ATP1A2;ADCY5;NRIP1;GABRG2;POU4F1;EGR1;NCOA3;GABRB3;AQP1;CTNNA1;LCOR;GPER1;CCDC62;CDH1;ADCY8;ADCY3
prerank,regulation of cell communication (GO:0010646),0.40828989993211917,1.0837972823474307,0.3477051460361613,0.9524834195693535,1.0,6/35,9.11%,CXADR;CAMK2D;CDC42SE2;NUP62;CASQ2;TBX18
prerank,negative regulation of blood pressure (GO:0045776),-0.4144473402256211,-1.083411535465129,0.3611111111111111,0.7494646315331079,1.0,5/13,18.48%,NOS3;BMPR2;PRCP;NOS1;GPR37L1
prerank,phosphorylation (GO:0016310),0.31202182668932,1.0830590794453012,0.30439223697650664,0.9535960405853195,1.0,52/384,9.94%,TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;DGKA;PRKCE;CAMK2D;MINK1;STK38;MAP3K1;TXK;MAPK10;DGKZ;PRKAG1;EIF2AK3;BMPR1B;PRKCA;CDKL3;PEAK1;MORC3;LIMK2;IRAK3;ACVR1C;PDK4;HIPK1;PIK3R4;BRSK1;NEK7;FER;CDK13;BCKDK;COQ8A;ADAM10;CERK;EPHB2;GMFB;CDK7;BMP2K;STK38L;RARA;MAP3K5;SRPK1;DYRK1A;NRBP2;STK24;STK3;GSK3B;CSNK1A1;TYK2
prerank,blood circulation (GO:0008015),0.38403460058817496,1.0830405240534675,0.35497237569060774,0.9526085520839804,1.0,4/49,3.80%,MEOX2;SGCD;SERPING1;SGCG
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.29746695484387226,-1.0828686809373946,0.30656934306569344,0.7498040854170879,1.0,21/47,29.79%,NR1H3;AGTR1;KLF4;APOE;NR1H2;AKT1;EIF2A;TCOF1;EDN1;CSF1;EIF4G1;AGT;RBM4B;INHBA;GEMIN5;TSC1;MTPN;NANOS3;RBM3;VPS35;GRM5
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.4222365125372633,1.0826301741747952,0.36377245508982037,0.9528361663363729,1.0,9/26,16.76%,NEDD4L;KCNS2;CASQ2;ATP1B3;KCNAB1;NEDD4;FHL1;WWP2;YWHAE
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.30724758463130586,1.0825722434681673,0.29022403258655805,0.9519544844467628,1.0,95/366,21.51%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;FOXO3;KAT6B;SMC3;TOM1L1;SP3;BHLHE40;ONECUT1;ORC5;TGFBRAP1;PPIE;HIC1;ZNF431;LIN54;RREB1;MSL3;FBXO5;ELAVL2;ZNF628;FOXK2;POFUT1;MLF2;ACTR8;RORB;EIF4E;SUPT4H1;ORC3;TRRAP;TFEB;OBI1;USP13;ATXN2;WWC1;SAP30L;EIF2B4;MZF1;MED23;JMJD1C;SPIN1;CREBBP;NCOA2;SOX4;NUCKS1;SFPQ;BAZ2A;FZD7;REXO4;TAF5;KMT2D;SRRT;DMTF1;PSPC1;E2F1;GMNN;ESRRA;HP1BP3;MAGED1;USP37;DSCC1;MTF2;BACH1;CREM;CELSR2;FOXO4;RABL3;ASCC2;SPTY2D1;FADS1;ASCC1;PPP2CA;TCF7L1;TCF3;HNRNPD;ZNF22;HCFC2;HMG20A;GZF1;DDIT3;RNF14;ARNT2;ATXN1L;ZSCAN21;DAXX;CCAR2;SRSF10;FOXC1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.37629283808833836,1.0825662962184346,0.3507362784471218,0.9509274901932645,1.0,3/53,3.10%,HRH1;SSTR1;MC5R
prerank,granulocyte differentiation (GO:0030851),-0.38919262774991176,-1.0822766972230708,0.34594594594594597,0.7502385973576838,1.0,6/18,13.79%,LEF1;CBFA2T3;EP300;DEK;CDK4;TAL1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.5108219927187249,1.0822448902870532,0.3932980599647266,0.9508692609718574,1.0,6/11,17.26%,THTPA;TPK1;CTPS2;NT5C3A;SLC25A19;DCK
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.30389291951114566,1.0821295739543237,0.23947895791583165,0.9501499476484669,1.0,105/807,12.06%,PTCH1;TENM2;CAV1;MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;NEDD4L;PHC2;DLX1;RARB;FOXP2;ZNF423;FOXD1;ZBTB32;KLF12;LDB2;ATP8B1;MYBBP1A;BCL3;ETV5;RUNX2;RBFOX2;GLI2;IRF2BP1;CHD3;SFMBT2;CIART;SPI1;L3MBTL3;FOXK1;BEND3;PHF21A;FOXO3;SOX9;UBE2I;FOXP4;GLIS2;CHD8;KAT6B;HDAC4;LANCL2;SATB1;KLF10;DACT1;WNT5A;CREB3L1;N4BP2L2;PPM1A;RBM15B;HEYL;SP3;KANK2;BHLHE40;ZFP90;ANKRD2;NRIP1;RCOR3;SIN3B;CTCF;HIC1;PEX2;PAF1;ZNF431;NCOR1;NCOA5;TBX2;RREB1;RARA;SUV39H1;KCTD1;MYPOP;ISL1;E4F1;FOXK2;UIMC1;TSC22D4;MECP2;FOXJ1;HMGB1;SIRT7;RORB;USP47;SUPT4H1;POU4F1;HDAC2;CNOT7;LEFTY1;TPR;ZHX1;WWC1;NCOR2;ILF3;OTUD7B;RARG;HDAC6;MZF1;HEXIM1;ZNF148;ERF;MEN1;KDM8;SEMA4D
prerank,estrogen metabolic process (GO:0008210),0.46582686825431585,1.0820168283005747,0.37037037037037035,0.9494518575287798,1.0,3/15,11.26%,SULT1A1;HSD17B4;HSD17B2
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.39653122771807203,-1.081931062184516,0.35038363171355497,0.7500323500394663,1.0,4/16,2.58%,IGF1;IGFBP2;IGFBP3;IGFBP5
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.26225875744972843,-1.0817716650869957,0.3076923076923077,0.749251715510892,1.0,19/88,11.84%,TRABD2B;SMAD3;SYNPO2;TFRC;BCL2L11;FNIP1;STX18;FNIP2;RHOC;SLF2;SH3GLB1;VCP;VPS4A;SLF1;RPS3;AJUBA;BID;MMP1;MPP7
prerank,body fluid secretion (GO:0007589),-0.4039074299662979,-1.081709682296088,0.34299516908212563,0.7482370670886793,1.0,3/15,4.51%,GPAT4;SLC22A4;NPR1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4255314451147372,1.0807417764852443,0.37859424920127793,0.9522554263098888,1.0,4/23,5.25%,SLC12A2;SLC12A4;SLC12A3;PDK4
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.4232991448560565,-1.0804800159630084,0.3657957244655582,0.7504342001639293,1.0,6/12,20.32%,CSGALNACT1;PARG;UGP2;FUT8;SLC35A3;GFUS
prerank,interleukin-15-mediated signaling pathway (GO:0035723),-0.4225985854999325,-1.079994641589044,0.38141809290953543,0.7494206386726343,1.0,2/13,7.60%,PLCB1;IL15RA
prerank,cellular response to interleukin-15 (GO:0071350),-0.4225985854999325,-1.079994641589044,0.38141809290953543,0.7494206386726343,1.0,2/13,7.60%,PLCB1;IL15RA
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),0.37877213034185075,1.0799223155296598,0.37720488466757124,0.9537945863437942,1.0,17/46,21.77%,GTSE1;RAPGEF3;UBR5;BAG3;RBM22;PIK3R2;GSK3B;TPR;NEDD4;EMD;RAN;CDH1;YWHAE;DHX9;HDAC3;TCF7L2;XPO4
prerank,negative regulation of transmembrane transport (GO:0034763),-0.4525829908900044,-1.0797495065155618,0.3788235294117647,0.74901494243317,1.0,3/10,13.20%,CTTNBP2NL;AKT1;THBS1
prerank,positive regulation of rRNA processing (GO:2000234),0.5172215865149618,1.079745673620967,0.4017543859649123,0.9532833242757237,1.0,3/10,9.58%,BUD23;UTP15;SIRT7
prerank,histone H2A ubiquitination (GO:0033522),-0.38975839025165315,-1.079627596408416,0.3492063492063492,0.7482039531266859,1.0,9/17,29.65%,KDM2B;RYBP;RNF8;TRIM37;SKP1;RNF2;RING1;DDB1;BCOR
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.38757129617565966,1.079449229849869,0.36412315930388217,0.9531313061298913,1.0,13/45,17.36%,PLK2;WEE1;TOM1L1;CHFR;BRINP1;TOM1L2;ZFP36L2;CDKN1C;ZWILCH;ZW10;FZD3;RGCC;SCRIB
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.3291235437003382,1.0793597724265707,0.3427922814982974,0.9524060186624028,1.0,23/151,11.72%,SGMS2;ST3GAL4;CERS6;ARG1;ASS1;PCSK5;ACER3;ELOVL5;PLPP2;PLPP3;PCTP;SLC27A1;MGST2;HACD4;ELOVL1;ELOVL2;TNIP1;CERT1;GSTZ1;GSTA4;GSTA3;HACD2;GSTK1
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.4286404936264776,1.0793255849153087,0.37732919254658387,0.9514687362693153,1.0,8/26,23.62%,ST3GAL4;TNIP1;SCCPDH;GK;GBGT1;TKT;GOLPH3;RRM2B
prerank,microtubule polymerization (GO:0046785),0.4227334387748172,1.0789554168253195,0.35154061624649857,0.9515961425486622,1.0,17/28,29.89%,TRPV4;TUBG1;CKAP5;TUBGCP5;NDE1;TUBG2;SLAIN2;TUBGCP6;PIN1;MAP7D3;FGF13;CSNK1D;CLASP2;CCDC57;HDGFL3;NDEL1;CLASP1
prerank,regulation of cell junction assembly (GO:1901888),0.41995290454824996,1.0787186580047263,0.38152011922503726,0.9512908917781383,1.0,3/27,1.89%,F11R;CLDN19;RAP1A
prerank,atrial septum morphogenesis (GO:0060413),-0.4524990510572406,-1.0783399089502803,0.37748344370860926,0.7507056168418909,1.0,3/10,12.75%,NOTCH2;BMPR2;TGFB2
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.36070827972994757,1.0778830104517063,0.3539253539253539,0.9528306125844175,1.0,8/66,4.05%,CAV1;NR2F2;CEACAM1;SULF1;CASK;NF1;CAV2;SOX9
prerank,endothelial cell development (GO:0001885),-0.35046614590961206,-1.0778823151848387,0.34782608695652173,0.7507461725908701,1.0,8/25,9.92%,RAPGEF2;COL22A1;MSN;PECAM1;COL15A1;MYADM;PDE2A;ROBO4
prerank,negative regulation of G0 to G1 transition (GO:0070317),-0.3220566318806932,-1.0778641492741938,0.34519572953736655,0.7496065077229529,1.0,16/36,30.27%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;RAD51;L3MBTL2;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.4328710350246794,1.077739096372553,0.3626373626373626,0.9522537561141385,1.0,2/20,1.76%,EGFR;CCND3
prerank,pulmonary valve development (GO:0003177),0.4602759980358243,1.077296981658864,0.39285714285714285,0.9526381298324439,1.0,4/18,5.24%,STRA6;NFATC1;JAG1;HEYL
prerank,cristae formation (GO:0042407),-0.3391645445554687,-1.0770158117354955,0.34662576687116564,0.7508091022270937,1.0,13/27,29.93%,IMMT;ATP5PD;DMAC2L;ATP5MC3;MICOS13;SAMM50;ATP5PF;ATP5ME;ATP5PO;ATP5MC2;ATP5MF;ATP5MC1;ATP5F1E
prerank,protein-containing complex assembly (GO:0065003),0.3143384414934718,1.0769960699944265,0.32774869109947646,0.9525248599117809,1.0,47/259,15.77%,CLDN1;MAGI1;PPARGC1A;WIPF1;LAMC1;FOLR1;REPS2;AXIN1;PARD6B;CD3G;ANO6;KMT2A;SOX9;LEO1;FN1;CARD10;FANCC;SH3PXD2B;TRADD;TAPBP;CNIH1;ADAM10;TRAPPC9;CUL3;OCLN;DARS1;GSK3B;TFG;CSNK1A1;GRIA1;FERMT2;TRRAP;AXIN2;APC;PYGO1;MEN1;CREBBP;BCL9;GSDMD;ZW10;MDN1;BAD;TMED2;SEC23IP;ADCY8;YAP1;KMT2D
prerank,receptor signaling pathway via STAT (GO:0097696),-0.34430103117698646,-1.0769941319528908,0.3313953488372093,0.7496782587605204,1.0,4/25,6.94%,IL31RA;GHR;IFNAR2;JAK2
prerank,positive regulation of neurogenesis (GO:0050769),0.3557806456794526,1.0769743920833836,0.35173299101412064,0.9515599251463179,1.0,5/68,4.73%,NGF;RGS14;TIAM2;CDKL3;PLXNA3
prerank,negative regulation of TORC1 signaling (GO:1904262),-0.4124883859676153,-1.0769667445817817,0.33495145631067963,0.7485793587409386,1.0,6/13,27.27%,DEPDC5;RNF152;SPAAR;CASTOR2;CASTOR1;ATM
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.37770290888769925,-1.076948664925168,0.35142118863049093,0.7474502519159125,1.0,6/18,12.66%,TNFRSF21;OPALIN;TNFRSF1B;IL34;SLC45A3;DAAM2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.3853100709460413,1.0768821612475872,0.37376586741889983,0.950797615101561,1.0,17/42,21.53%,HNRNPC;CHD3;CHD8;SMARCAD1;ACTR8;SMARCD2;HDAC2;PBRM1;ERCC6;INO80;INO80B;ACTR6;SPTY2D1;ZNHIT1;RBBP4;ARID1B;ARID1A
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.3397803103086445,-1.0767489228464893,0.3282674772036474,0.7468358235024789,1.0,7/26,13.41%,ACER2;NOS3;CYP1B1;GCH1;AKT1;ABCA2;SPHK1
prerank,amyloid precursor protein metabolic process (GO:0042982),0.45783859616829226,1.076471991757828,0.37381703470031546,0.9509917545930068,1.0,4/18,6.14%,ADAM19;APH1B;NCSTN;ADAM10
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.40265518175215603,-1.0764033433112554,0.35786802030456855,0.7466912760776883,1.0,3/15,6.01%,DAB2;TNK2;HIP1R
prerank,RNA metabolic process (GO:0016070),0.33221445664934035,1.0763922682573006,0.34902411021814006,0.9502083478319676,1.0,22/127,14.63%,DHX8;HNRNPC;RNASEH2B;NUFIP1;RBFOX2;PCBP2;HNRNPA0;WDR74;PABPC4;HNRNPR;FASTKD2;DDX17;RBM5;SIDT2;AGO1;CELF2;HNRNPM;ATXN2;GTF2F2;ALKBH1;FASTKD1;DICER1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4509310445194224,1.0762959999207418,0.36995153473344106,0.9494560590614878,1.0,4/18,19.17%,IL4I1;CRTAM;ZFP36L2;XRCC6
prerank,metal ion homeostasis (GO:0055065),0.3850335718997038,1.0755705623348242,0.35684647302904565,0.9506625210404338,1.0,4/40,4.35%,CAV1;SLC12A2;SLC12A4;SLC12A3
prerank,positive regulation of vasculogenesis (GO:2001214),0.5118415192112875,1.0752604402717054,0.3778966131907308,0.9505502127607102,1.0,2/10,1.89%,CEACAM1;RAP1A
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.3663987384102262,1.0751650112186844,0.3704188481675393,0.9498232485137976,1.0,17/51,26.88%,HNRNPC;SRC;NEK7;STN1;NAF1;EXOSC10;CCT2;GNL3L;TERF2;ATR;CCT3;SMG6;MAPK1;TENT4B;TNKS;HNRNPU;SMG5
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.3123040368327055,1.074661653340203,0.3155080213903743,0.9503677420784846,1.0,74/264,22.78%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;HNRNPR;CDK13;SF3B5;PPIE;PRPF3;DDX17;CSTF3;CHERP;SMN1;DDX46;RBM22;SRPK1;RBM5;ELAVL2;DNAJC8;SNU13;CELF4;HNRNPM;SRPK2;DBR1;UPF3B;SRRM2;GTF2F2;SNRPA1;SFPQ;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;PSPC1;SYNCRIP;CWC22;SLU7;SYMPK;STRAP;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;DCPS;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.2990287460641612,1.0746154746599879,0.172,0.9494992351929461,1.0,279/1646,16.44%,EBF2;RORA;MEOX2;ZBTB7C;BNC2;KLF5;ETV4;FGF7;MDFIC;CDK15;NFATC2;VGLL4;ETV1;GLI1;PPARGC1A;PRICKLE1;PAX9;FOXD2;NR2F2;TSHZ3;PHC2;NR3C2;DLX1;POU4F3;RGS14;FOXP2;ZNF423;FOXD1;NFATC1;CAMK2D;ZBTB32;EFEMP1;KLF12;PBX1;ZSCAN25;FZD2;EGFR;BHLHE22;ZBTB20;NPAS3;ATP8B1;MYBBP1A;NEUROD6;BCL3;AXIN1;ETV5;OGT;RUNX2;NFIA;ZSCAN18;HIVEP2;RBFOX2;HOXB6;GLI2;TEF;ZKSCAN7;IRF2BP1;CHD3;SFMBT2;MLLT3;KLF3;KMT2A;CIART;SPI1;L3MBTL3;FOXK1;ZNF418;FOXO3;SOX9;UBE2I;PGR;FOXP4;NPAS2;ZBTB8A;GLIS2;CHD8;ZNF585B;ZNF585A;KAT6B;HDAC4;REL;LANCL2;CHD2;SATB1;ZBTB3;ATP2B4;CHD1;KLF10;NUP62;WNT5A;POU5F2;CREB3L1;PPM1A;RBM15B;HEYL;ZFP3;ZNF697;ATAD2;ZFP1;ZNF326;SP3;BHLHE40;MED18;ZFP90;TARBP1;RGMB;ANKRD2;ARID3A;ONECUT1;ANXA4;ZFP14;RCOR3;TGFBRAP1;PPIE;MED12L;TEAD3;CTCF;NFE2L1;NRF1;HIC1;ZNF431;NCOR1;PAX3;LIN54;HOXC10;ZFP62;TBX2;DDX17;ONECUT3;RREB1;DBX2;PIAS2;RARA;SUV39H1;MAFG;MSL3;USF2;FBXO5;MAP3K5;POLR3G;ILF2;LHX6;KCTD1;ELAVL2;MYPOP;ISL1;PKNOX2;ZNF628;E4F1;FOXK2;DYRK1A;MED7;UIMC1;TSC22D4;AATF;ZBTB6;POFUT1;TCF20;MLF2;TBX18;MED13;SLTM;MECP2;FOXJ1;RPS6KA3;ACTR8;HMGB1;SMARCD2;RORB;USP47;SUPT4H1;POU4F1;HDAC2;CNOT7;BAZ2B;DBP;TRRAP;TLX3;KARS1;CTDSP1;TFEB;ZHX1;USP13;ERCC6;SIX5;WWC1;NCOR2;ILF3;SAP30L;FBXL19;EN2;DVL3;HDAC6;COL1A1;TASP1;PHF20L1;EGR1;MZF1;MED23;ZBTB49;HEXIM1;ZNF148;HTATIP2;JMJD1C;ERF;MEN1;BICRA;KDM8;CEP290;NAT14;NFE2L2;STAT2;SPIN1;HOPX;PEG3;TTC21B;CDC6;CRLF3;TAF15;CREBBP;NCOA2;NFATC4;BRF2;GTF2H1;ARID4A;SOX4;GMEB1;CDKN1C;NUCKS1;DPF3;SFPQ;MBD1;ZFP57;BAZ2A;CBFB;FZD7;KAT8;TIAL1;CAMTA2;RAI1;SFMBT1;ERBB4;EPC2;REXO4;FOXJ2;ZNF182;FOXF1;ZNF260;WWP2;NR5A1;LCOR;NEK4;MED8;TADA2A;MED12;SCML2;POU6F1;TOX4;CDH1;PRMT6;SNX5;TAF5;FOXC2;YAP1;SCML4;KMT2D;ERBB2;GBX1;RELB;TESC;PBX4;MED29;PCGF3;SRRT;DMTF1;PCBD2;BATF;ARHGEF11;PSPC1
prerank,regulated exocytosis (GO:0045055),-0.24731788545370184,-1.0744495386883361,0.28125,0.7508068774704206,1.0,54/173,23.83%,IGF1;TIMP3;VWF;ACTN2;ABCC4;PECAM1;PCDH7;CLEC3B;SPARC;LYN;CDC37L1;IGF2;NHLRC2;SYT9;SYT7;CALM1;PROS1;TGFB3;VEGFC;CYRIB;ARHGAP17;QSOX1;SYTL4;PHACTR2;FLNA;MANF;TGFB2;VEGFD;THBS1;VAMP7;TMSB4X;F5;LGALS3BP;TLN1;DNAJC5;CPLX2;EGF;RAB11FIP1;FAM3C;RAB11B;MYH9;RARRES2;SYT13;TUBA4A;SYT6;RIMS1;CLU;VTI1B;SNAP25;RAB10;A2M;RIMS3;TAGLN2;PCYOX1L
prerank,chromosome condensation (GO:0030261),-0.31504109096823474,-1.0743326208086812,0.3424657534246575,0.7499753231230807,1.0,16/36,28.61%,PHF8;SMC4;NCAPD3;MCPH1;H1-0;CSNK2A1;AKAP8L;CSNK2B;NCAPG2;NCAPD2;NUSAP1;TOP2A;AIFM1;BANF1;NCAPH;TTN
prerank,positive regulation of receptor internalization (GO:0002092),-0.35595591923456044,-1.0740920015323638,0.3259668508287293,0.7494785508056191,1.0,8/22,25.49%,INSR;ANGPT1;AHI1;EGF;PICK1;NTF3;GREM1;ARRB2
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.3436857056118241,1.0737716216408983,0.3524590163934426,0.9509431283441441,1.0,11/107,4.74%,CAV1;STC2;CTRC;SLC8B1;SLC39A13;CDH5;SLC24A1;TRPV4;CSRP3;SLC30A9;ATP2B4
prerank,secondary alcohol metabolic process (GO:1902652),-0.30726587514789305,-1.0736040685300923,0.32413793103448274,0.7496975653537289,1.0,21/42,35.53%,PPARD;APOE;SCAP;OSBPL1A;LDLRAP1;OSBPL5;GBA2;NSDHL;ABCG1;TSKU;CLN6;PIP4P1;CH25H;LCAT;IDH3G;SOAT2;RXRA;SQLE;EBP;IDH3A;SULT2B1
prerank,supramolecular fiber organization (GO:0097435),0.3073645028339675,1.0736006884304379,0.32642487046632124,0.9504031444242307,1.0,35/333,9.18%,ITGB4;TGFBI;ITGA6;TNXB;ADAMTS14;PXDN;UBE2L6;ARHGAP12;HOOK2;KIF2A;COL6A3;BFSP1;NCKAP5L;NF1;TRPV4;COL5A3;APH1B;FIGNL2;TMOD2;RAC2;SERPINH1;NCSTN;ADAM10;SHROOM2;POF1B;SPAST;COL3A1;CKAP5;SIAH1;ADAMTS2;CGNL1;TMOD1;LTBP3;LTBP2;COL4A1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.31431475411026466,-1.0735712482303812,0.358974358974359,0.7486438253218581,1.0,8/35,9.63%,PLXNA2;PLXNA4;SEMA6D;SEMA7A;SEMA3C;SEMA6A;ARHGDIA;FLNA
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.4180745190703433,-1.0734809649419845,0.37317073170731707,0.7477333088664695,1.0,8/12,45.79%,INSIG2;OS9;TAPT1;GPAA1;ANKRD13C;KDELR1;KDELR2;RER1
prerank,regulation of cell cycle phase transition (GO:1901987),0.33892247203005094,1.0734020066965602,0.35315533980582525,0.9500101772316132,1.0,28/91,18.75%,GTSE1;PSME3;ATP2B4;FBXO5;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;PSMB2;UBE2D1;PSMA2;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;NEK11;FBXW7;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.41411502630208014,1.073230090296056,0.37853949329359166,0.9495125424130596,1.0,4/26,9.70%,SMOC2;PRKCA;CUL3;EIF4E
prerank,cell junction assembly (GO:0034329),0.34104711193233117,1.0729211264096432,0.34963325183374083,0.949409451400358,1.0,16/100,10.07%,ITGA6;TLN2;CDH11;PARD6B;CDH5;RAB29;CDH9;TRPV4;OPHN1;DSCAM;FN1;CDH2;PKP4;GPM6A;POU4F1;FERMT2
prerank,negative regulation of endopeptidase activity (GO:0010951),-0.2950171706656074,-1.0727571919037637,0.3225806451612903,0.7485810890061613,1.0,10/47,10.66%,TIMP3;SPOCK2;RECK;SERPIND1;SERPINI1;SPOCK1;SERPINE2;AKT1;SERPINB9;GAPDH
prerank,ribosome biogenesis (GO:0042254),-0.2357044388742146,-1.072501952503118,0.2558139534883721,0.748104263007681,1.0,69/187,25.28%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;NPM1;HEATR3;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;EIF2A;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;ABCE1;RIOK1;NOC2L;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;DHX29;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;MRPL36;WDR3;RPS14;RPS25;PAK1IP1
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",0.5064283808485421,1.0720485206413026,0.39451114922813035,0.9509800893622306,1.0,4/10,21.16%,HMGB1;CBFB;SOCS1;RUNX1
prerank,non-motile cilium assembly (GO:1905515),0.40423241721145126,1.0718739779842519,0.37037037037037035,0.9504459523411541,1.0,11/30,20.84%,GORAB;CEP89;C2CD3;CEP290;RPGRIP1L;PCM1;PIBF1;BBS1;CEP250;TMEM80;IFT57
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.5074749259036566,1.0717555138449515,0.3848797250859107,0.9498138984206009,1.0,5/10,19.37%,INPP5F;NF2;PIBF1;SOCS1;PPP2CA
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.4874152227578742,1.0710445576243226,0.41442953020134227,0.9509313125825314,1.0,3/13,5.70%,PIK3AP1;PIK3R4;TLR7
prerank,ribosome assembly (GO:0042255),-0.3010182352838216,-1.070973928698571,0.311284046692607,0.7511534066684655,1.0,25/47,29.48%,RPS15;RPS27;NPM1;RPLP0;RPS19;RPL3;EIF2A;RRP7A;MRPL20;DHX37;MRPS11;DHX29;NLE1;PPAN;RPS27L;RPL5;C1QBP;PWP2;RPS14;ERAL1;RPF2;RPL11;DDX3X;MRPS2;RPL24
prerank,central nervous system development (GO:0007417),0.3105710342879585,1.0707587286213311,0.3443145589798087,0.9507753419960651,1.0,23/250,9.42%,PTCH1;APOD;VIT;PBX1;NF1;SOX9;NPAS2;GLIS2;CHD8;LSR;NCAN;SHROOM2;AMIGO2;TAGLN3;CDH2;ALDH5A1;S100B;EML1;JRKL;PTS;COL4A1;FOXJ1;RPS6KA3
prerank,cytosolic calcium ion transport (GO:0060401),-0.34292345193845,-1.0706603066001024,0.33865814696485624,0.7508844656022962,1.0,10/28,15.72%,SLC8A1;SLC35G1;JPH1;SMDT1;SLC25A23;MICU1;MICU2;ATP2B3;JPH2;JPH4
prerank,protein modification process (GO:0036211),0.3559915280636984,1.070380010903316,0.3670731707317073,0.9509019596336435,1.0,17/76,14.88%,SLC35A1;UBE2L6;DUSP12;STK38;MMP15;ERO1A;UBE2I;CDKL3;CPE;ABL2;CSNK1G3;MANBA;FBXO11;LCMT1;UBE2D3;CHRM3;WWP2
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.31141323084030703,1.0701612706171408,0.33762057877813506,0.9505500773392808,1.0,66/241,22.78%,DHX8;HNRNPC;CSTF1;SF3B2;SF3B1;PCBP2;RBM8A;RBM10;RNPC3;SRSF4;HNRNPA0;ZRSR2;SNRPF;RBM15B;HNRNPR;SF3B5;PPIE;PRPF3;CSTF3;CHERP;DDX46;RBM22;RBM5;ELAVL2;DNAJC8;SNU13;HNRNPM;DBR1;UPF3B;SRRM2;GTF2F2;SNRPA1;SFPQ;DDX42;DHX16;TRA2B;PDCD7;SF1;SUGP1;CTNNBL1;SRRT;PSPC1;SYNCRIP;CWC22;SLU7;SYMPK;PLRG1;SRSF3;LSM3;MTREX;DHX38;DHX9;HNRNPD;UBL5;NUDT21;SRSF12;SRSF11;SRSF10;ELAVL1;CWC25;YTHDC1;HNRNPA3;PCF11;LSM2;CPSF2;RBM6
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3244452373038885,-1.0701610330111675,0.3475409836065574,0.7510625026966986,1.0,14/33,24.04%,HIP1;TGFA;AFAP1L2;HIP1R;AKT1;BCAR3;SHKBP1;EGF;CNOT9;AGT;NEU3;PLAUR;PDE6H;DOK1
prerank,glutathione derivative biosynthetic process (GO:1901687),0.4338180860910667,1.069857816652492,0.3738019169329074,0.9494130879538986,1.0,5/20,11.72%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1
prerank,glutathione derivative metabolic process (GO:1901685),0.4338180860910667,1.069857816652492,0.3738019169329074,0.9494130879538986,1.0,5/20,11.72%,MGST2;GSTZ1;GSTA4;GSTA3;GSTK1
prerank,gluconeogenesis (GO:0006094),0.3881672926096452,1.0695639682816014,0.36439499304589706,0.949269480714512,1.0,13/39,21.47%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,sulfate transport (GO:0008272),-0.4073076272938918,-1.0691122242493036,0.3712737127371274,0.7528554546031553,1.0,4/14,9.30%,SLC26A7;SLC26A2;SLC25A30;SLC25A11
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.44445732203208255,-1.0691041566863675,0.3665158371040724,0.751726728367213,1.0,6/10,40.83%,SP100;RPS27L;KAT5;TFAP4;MUC1;FOXM1
prerank,calcium-mediated signaling (GO:0019722),0.34253564179822776,1.0684026228900751,0.36341756919374246,0.9517314370779297,1.0,13/93,10.18%,ACKR3;PLCE1;PTGFR;EGFR;FKBP1B;EIF2AK3;FIS1;PTPRC;RCAN1;PTPRJ;IRGM;KSR2;LAT
prerank,regulation of ERAD pathway (GO:1904292),-0.43766239651180733,-1.0683859261204085,0.3938053097345133,0.7526474339974644,1.0,3/11,8.46%,USP19;RNFT1;AQP11
prerank,positive regulation of programmed cell death (GO:0043068),0.3105092859513141,1.0681157128579226,0.35115303983228513,0.95152423965448,1.0,60/272,17.01%,NGF;ITGA6;DKKL1;TIAM2;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;FOXO3;VAV2;ACVR1C;TRIO;TRADD;ARHGEF5;NCSTN;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;RBM5;KALRN;OBSCN;STK3;HMGB1;NLRP2B;RASSF2;SLC27A4;RARG;APC;HDAC6;HTATIP2;ARHGEF6;FAF1;PTPA;ADAMTSL4;DIABLO;ATG7;SOX4;HTRA2;HTT;UNC13B;FZD9;GPER1;BAD;PDCD2;AIFM2;CTNNBL1;PLEKHG2;ARHGEF11;SYK;ARHGEF7;BNIP3;E2F1;QRICH1
prerank,cell projection organization (GO:0030030),0.4051803457249437,1.0679808446589463,0.38235294117647056,0.9509571160761933,1.0,5/30,9.13%,PARVA;RAC2;PACSIN2;RHOJ;PLEK
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.35403326338526414,-1.0679483091938733,0.356353591160221,0.7527578475591411,1.0,2/22,1.30%,ALDH1A2;RBP1
prerank,negative regulation of cell division (GO:0051782),-0.44445785189945375,-1.0677721924876808,0.39952153110047844,0.7521116398570658,1.0,3/11,9.80%,TXNIP;BLM;VPS4A
prerank,L-serine metabolic process (GO:0006563),-0.4461019820120894,-1.067764904334351,0.3946078431372549,0.7509874897286246,1.0,6/10,34.20%,SERINC3;PSPH;CBS;PHGDH;SHMT2;SHMT1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.38610656320306064,1.067676657679239,0.3852573018080668,0.9509262181974746,1.0,7/38,12.70%,CAV1;PTPRC;NCK2;SRCIN1;DLG3;RELN;MVP
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.38347580115288393,-1.0673043256683872,0.36548223350253806,0.7511359931409256,1.0,6/16,13.12%,NR1H3;LDLR;CTDNEP1;ABHD5;NR1H2;MFSD2A
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.3840096266945291,-1.066955302836384,0.3626373626373626,0.7509273483823771,1.0,3/18,2.16%,SLIT2;IL6R;LYN
prerank,negative regulation of interleukin-8 production (GO:0032717),0.4493305332691937,1.0666693901075146,0.3864734299516908,0.9529077881479529,1.0,4/17,11.06%,BCL3;PTPN22;ANXA4;OTUD7B
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.3158970397733059,-1.0664734030178895,0.3217993079584775,0.7511422715235408,1.0,13/39,20.66%,ENG;SLIT2;BMP4;TIE1;RASIP1;KDR;LRP6;BMP2;NRP1;SALL1;LRP5;MET;NOTCH4
prerank,proteoglycan biosynthetic process (GO:0030166),-0.32633357869411617,-1.0652894492492893,0.3323442136498516,0.7532731078844639,1.0,10/31,11.44%,IGF1;CSGALNACT1;NDST3;CHST11;BMPR2;CSGALNACT2;PXYLP1;FAM20B;B4GALT7;HS3ST3B1
prerank,acute-phase response (GO:0006953),0.4871703907249591,1.0650778168311867,0.40809443507588533,0.9568372511773424,1.0,2/12,8.99%,LBP;PLSCR1
prerank,positive regulation of phosphatase activity (GO:0010922),-0.36027470302157394,-1.0649820730369326,0.3785310734463277,0.7529768216588999,1.0,5/21,14.44%,ITGA1;PDGFRB;CALM1;BMP2;CALM3
prerank,inorganic cation import across plasma membrane (GO:0098659),0.34982920855555794,1.0645927007860883,0.37275064267352187,0.9573119298451822,1.0,10/75,5.58%,KCNJ4;SLC12A2;KCNJ16;SLC24A1;TRPV4;SLC12A4;SLC12A3;ATP2B4;ATP1A2;KCNJ13
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.3426643701015805,1.0645818763699002,0.37218045112781956,0.9563369497050387,1.0,9/76,5.90%,NR3C2;EGFR;BCL3;SPI1;PTPN22;PPM1A;UACA;TLR7;TRADD
prerank,epithelial tube morphogenesis (GO:0060562),-0.3249644066416916,-1.064523334986815,0.36789297658862874,0.753097335039213,1.0,8/32,13.17%,SLIT2;BMP4;ACVRL1;RASIP1;SOX17;PODXL;RHOB;MEGF8
prerank,ncRNA processing (GO:0034470),-0.23219371976015565,-1.064280183697819,0.2692307692307692,0.7525571260943662,1.0,73/200,25.42%,SMAD3;RPL37A;INTS9;SSB;ADAR;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;AGO3;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;PUS10;INTS1;AGO4;TUT7;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;UTP4;RPL39;RPL34;RPL5;RPL22;SMAD1;PWP2;RPS9;MRPL44;WDR3;RPS14;RPS25;TRPT1;INTS5
prerank,smooth muscle cell differentiation (GO:0051145),-0.4174208814994123,-1.0641855898465593,0.3724137931034483,0.7516922609351352,1.0,5/12,21.78%,BMP4;TMEM204;GATA6;MYOCD;APLNR
prerank,vesicle cytoskeletal trafficking (GO:0099518),-0.311964795158122,-1.0637845992401436,0.34615384615384615,0.7516478722933327,1.0,4/39,2.67%,MYO1D;MYO1B;MYO5A;MYO6
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.30399271570394126,-1.0633873331197903,0.34408602150537637,0.751573119745766,1.0,17/40,29.81%,IGF1;BCL2L11;AKT1;BID;MLLT11;FXN;GHITM;OPA1;TNFSF10;BBC3;PLAUR;CLU;PYCARD;PSMD10;BIK;BMF;TRIAP1
prerank,ureteric bud morphogenesis (GO:0060675),-0.39084795047339044,-1.063121886851345,0.3962765957446808,0.7512025352683527,1.0,5/16,24.58%,BMP4;BMP2;SALL1;WNT11;NPNT
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.3891212457460259,1.0630444247942774,0.3855932203389831,0.959862851102808,1.0,12/38,21.60%,PHLDA3;BANK1;DAG1;PHLPP1;PTPRJ;PTEN;PLEKHA1;GPER1;DDIT3;MUL1;TSC2;PPP2R5C
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.26263500685833957,-1.0630418979377905,0.328042328042328,0.7503330522578803,1.0,14/94,8.53%,PLCB1;IL1R1;IL1RAP;PSMA1;RPS6KA5;SQSTM1;IRAK4;RBX1;PSMD11;TRAF6;UBE2N;NOD1;PSMD7;PSMD4
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.3271793016879224,-1.0624174324178297,0.3333333333333333,0.7508880494967783,1.0,18/29,31.33%,RPS19;RPS16;RPS8;NOP9;RPS21;HEATR1;TSR1;DHX37;MRPS11;KRI1;TBL3;UTP4;PWP2;RPS14;RRP36;WDR46;UTP6;ABT1
prerank,triglyceride catabolic process (GO:0019433),-0.3623970602648699,-1.0623407261016966,0.3802083333333333,0.749974474467536,1.0,9/19,43.45%,PNPLA3;FABP7;FABP3;FABP5;LIPH;LIPC;FABP4;PNPLA2;FABP12
prerank,long-chain fatty acid metabolic process (GO:0001676),0.3541871432007569,1.0621301152302103,0.36548223350253806,0.961597672806084,1.0,14/64,13.29%,AIG1;EPHX1;ELOVL5;ALOXE3;ELOVL1;ELOVL2;HSD17B4;SLC27A4;ACOT8;ACOT2;LTA4H;ABCD1;PNPLA8;ELOVL6
prerank,protein transmembrane import into intracellular organelle (GO:0044743),-0.32780342355664793,-1.0617079690285924,0.3560830860534125,0.7505754384540958,1.0,16/31,33.15%,TIMM44;PAM16;PEX26;TIMM17B;PEX6;PEX1;PEX10;ROMO1;GRPEL1;DNLZ;AIFM1;TIMM50;HSPD1;PEX5;TIMM23;TIMM21
prerank,chondrocyte differentiation (GO:0002062),0.4067077968815327,1.061459840505235,0.4024024024024024,0.9626043525552802,1.0,7/32,4.10%,SULF1;RUNX2;GPLD1;WNT2B;EIF2AK3;SOX9;BMPR1B
prerank,excitatory postsynaptic potential (GO:0060079),-0.36995452869257434,-1.061368673540839,0.3867403314917127,0.7504424994066474,1.0,5/19,11.97%,GRIN2B;AKT1;GRIN1;LRRK2;GSK3A
prerank,glutamine family amino acid metabolic process (GO:0009064),0.3903486940995643,1.0609919520113569,0.4029197080291971,0.9630391426044247,1.0,10/33,15.30%,PRODH;AADAT;NIT2;DDAH2;ALDH18A1;ALDH5A1;CAD;GOT1;GLUL;GGT1
prerank,tyrosine metabolic process (GO:0006570),0.48872224248619434,1.060972532065879,0.3915343915343915,0.962093642707259,1.0,2/11,10.44%,IL4I1;GSTZ1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.2953580176660301,1.0609047866636674,0.298,0.9613145284148996,1.0,154/1082,13.67%,RORA;MEOX2;DCN;KLF5;ETV4;ITGA6;FGF7;MDFIC;CDH13;NFATC2;ETV1;GLI1;PPARGC1A;FOXD2;NR2F2;DLX1;POU4F3;RARB;ZNF423;NFATC1;LDB2;PBX1;FZD2;EGFR;NPAS3;FGF1;BCL3;AXIN1;JAG1;TNIP3;ETV5;OGT;RUNX2;NUFIP1;NFIA;GLI2;IL4I1;CRTC1;MAML2;MLLT3;TXK;LMO1;LMO7;KMT2A;SPI1;FOXK1;FOXO3;EIF2AK3;SOX9;BMPR1B;PGR;NPAS2;TFR2;GLIS2;CHD8;CSRP3;SLC30A9;KAT6B;HDAC4;REL;BMP5;KLF10;NUP62;WNT5A;PPM1A;HEYL;ATAD2;SP3;ZFP90;RPRD1B;RGMB;ONECUT1;NRIP1;NCK2;CDK7;CTCF;NRF1;UTP15;PAX3;HOXC10;DDX17;RREB1;MAPK7;RARA;USF2;MAP3K5;ILF2;PIK3R2;ISL1;E4F1;FOXK2;ELL;DYRK1A;TNIP1;ZNF462;AATF;AGO1;DDRGK1;TCF20;PLSCR1;MED13;TET1;FOXJ1;RPS6KA3;HMGB1;SIRT7;SMARCD2;RORB;SUPT4H1;POU4F1;HDAC2;DBP;KARS1;TMF1;TFEB;FHOD1;ERCC6;PAXBP1;RTRAF;MMP12;ILF3;RARG;DVL3;COL1A1;TASP1;EGR1;MZF1;ZBTB49;HTATIP2;AKIRIN1;MEN1;BICRA;KDM8;CEP290;INO80;NCOA3;NAT14;NFE2L2;CD81;SPIN1;PEG3;KDM6B;CRLF3;TAF15;PKD1;CREBBP;NCOA2;BCL9;GTF2H1;SOX4;CDKN1C;DPF3;TCERG1;SFPQ
prerank,activation of protein kinase B activity (GO:0032148),0.40756255122932905,1.0605078757241226,0.381021897810219,0.9615058724711268,1.0,6/29,10.37%,NTRK3;PRR5;FGF1;WNT5A;MAPKAP1;ADRA2A
prerank,peptidyl-proline modification (GO:0018208),0.42279685706878617,1.0602900776704105,0.3914327917282127,0.9611753050496797,1.0,6/25,14.09%,FKBP5;FKBP1B;PPIE;PPIL6;PPIC;PPIG
prerank,blood vessel endothelial cell migration (GO:0043534),-0.34820258841588225,-1.0601441559844431,0.3706896551724138,0.7527713019108638,1.0,5/22,8.19%,ROBO1;SLIT2;PIK3R3;KDR;AKT1
prerank,neurotransmitter transport (GO:0006836),0.34936281399154057,1.0597622607199058,0.36398467432950193,0.9617702950019904,1.0,12/73,7.29%,PPFIA2;STX1A;CASK;SLC38A2;SLC1A7;SLC29A4;SLC22A3;ATP1A2;BRSK1;SLC1A6;RAB3A;CPLX1
prerank,regulation of actin filament-based process (GO:0032970),0.35390236978095113,1.059550750522043,0.38107416879795397,0.961393359296276,1.0,6/70,5.91%,EFNA5;DLC1;F11R;ARHGAP18;RAC2;ARHGEF5
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.4913804547884119,1.0593480951528058,0.41263940520446096,0.9609899454496997,1.0,6/11,24.14%,LANCL1;P4HB;UBQLN1;PINK1;PRKN;REST
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.3692142995223332,1.0590607235728375,0.38,0.9608664948357848,1.0,5/47,4.74%,CAV1;DKKL1;CEACAM1;SLC27A1;ATP2B4
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.39314874644598213,1.0589601305047145,0.382183908045977,0.9601428747205115,1.0,3/35,1.75%,NTRK3;F11R;RAPGEF3
prerank,DNA replication checkpoint signaling (GO:0000076),-0.3901333660245226,-1.0586603953234788,0.38315217391304346,0.7556339538094623,1.0,8/16,24.14%,NAE1;CLSPN;TOPBP1;TIPIN;RAD17;RAD9B;TIMELESS;CDC45
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.47566155369321916,1.0586267584611977,0.4088586030664395,0.9601409044698668,1.0,3/13,9.49%,FGFR1;APLN;HMGB1
prerank,regulation of dephosphorylation (GO:0035303),0.44515811246982684,1.0584806591320781,0.402555910543131,0.9595804750247643,1.0,7/15,26.88%,SRC;MTMR3;SMG7;MTMR1;SMG6;PPP1R16A;SMG5
prerank,positive regulation of angiogenesis (GO:0045766),0.33124411099028395,1.0583268215914894,0.3927272727272727,0.9590599444450983,1.0,11/108,5.28%,GAB1;SMOC2;RAPGEF3;HK2;FGF1;CDH5;ITGAX;IL1A;PRKCA;WNT5A;HIPK1
prerank,pseudouridine synthesis (GO:0001522),0.46182656904847724,1.0578032804862862,0.40816326530612246,0.9596705915966894,1.0,3/13,6.98%,RPUSD2;PUS7;PUS3
prerank,skeletal system development (GO:0001501),0.32300555859342545,1.0574934890056207,0.38738738738738737,0.9595618278299372,1.0,17/148,5.78%,PKDCC;FGFR1;SULF1;PRELP;CDH11;KIAA1217;PCSK5;GLI2;AKAP13;EIF2AK3;PTHLH;SOX9;BMPR1B;BMP5;WNT5A;NCAN;SH3PXD2B
prerank,Rac protein signal transduction (GO:0016601),0.4452498034932698,1.0574717238075075,0.3905996758508914,0.9586441449361739,1.0,2/18,4.67%,CDH13;RAC2
prerank,regulation of ossification (GO:0030278),0.3881386655203716,1.0569292784090563,0.3734087694483734,0.9593083172522069,1.0,5/36,6.92%,LRP4;SGMS2;SOX9;WNT5A;BMP2K
prerank,nucleic acid-templated transcription (GO:0097659),-0.2964217461676182,-1.0567576353057142,0.33559322033898303,0.7597201656770156,1.0,17/42,21.82%,CREBL2;MEF2A;PTMA;NR4A2;RRAGC;POLR3A;MMS19;PWP1;RNPS1;HOXD3;POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;THAP1;THRB
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.31413583005986623,-1.0566228622141713,0.3375796178343949,0.7589668873872251,1.0,22/38,35.58%,ARHGEF2;SP100;NOS3;MADD;FAS;CFLAR;FEM1B;THBS1;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;SFRP1;TRAF2;RFFL;HMOX1;FAIM2;SERPINE1;PMAIP1
prerank,positive regulation of RNA metabolic process (GO:0051254),0.37363543385453607,1.0564996423982085,0.3975409836065574,0.9596251999465262,1.0,9/45,9.58%,EGFR;SLC38A2;BUD23;DXO;UTP15;RBM22;DYRK1A;LIN28B;SIRT7
prerank,glucose homeostasis (GO:0042593),0.34394393139877166,1.0564677397100795,0.35670356703567035,0.9587353031232051,1.0,20/83,17.88%,PPARGC1A;LRRC8D;LEPR;SLC8B1;HK2;FOXK1;PDK4;PIK3R2;FOXK2;BACE2;ADRA2A;GCK;SOX4;NUCKS1;BAD;ADCY8;HECTD4;PPARG;KLF7;WFS1
prerank,cellular response to interleukin-6 (GO:0071354),-0.3472472784283475,-1.056300165241365,0.3562874251497006,0.7587058619075504,1.0,4/26,1.80%,ST3GAL6;PTGIS;PID1;IL6R
prerank,regulation of protein transport (GO:0051223),-0.33793596075620796,-1.0558011957796678,0.38109756097560976,0.7590064761033414,1.0,7/27,17.39%,DNAJC1;HSPA8;DNAJA1;RHBDF2;LLGL2;SCFD1;GAPVD1
prerank,mitochondrial transcription (GO:0006390),0.49977501535107083,1.0555972656803525,0.426056338028169,0.9603974119244103,1.0,4/10,14.07%,FOXO3;TFB2M;MTERF2;TEFM
prerank,membrane assembly (GO:0071709),0.3869282737013733,1.0548295770085114,0.3868312757201646,0.9616382473031143,1.0,13/34,22.13%,LRP4;CEL;FLOT2;SPAST;CHMP4B;STX2;PTEN;STX4;SPTBN1;S100A10;CHMP2A;NLGN3;NLGN2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.4578971245884552,1.0543808639574732,0.3958664546899841,0.9619975143627026,1.0,6/17,16.67%,MAPK7;NFE2L2;SFPQ;HTRA2;P4HB;UBQLN1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.45650395477072775,1.0541273615913982,0.3918918918918919,0.9617645540013344,1.0,3/16,6.94%,CEACAM1;SOX9;NCOR1
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.4913778329941789,1.0538517140026058,0.4086206896551724,0.9615722917211155,1.0,3/12,6.74%,ATIC;PFAS;PPAT
prerank,nucleotide biosynthetic process (GO:0009165),0.427064659340878,1.053756158882333,0.38486312399355876,0.9608963281991334,1.0,6/18,11.63%,MTHFD1;PPAT;NMNAT3;PRPSAP2;PRPS1;PRPS1L1
prerank,glial cell differentiation (GO:0010001),-0.32893391382442516,-1.0532607723025051,0.39644970414201186,0.7646889390606785,1.0,3/28,2.30%,NFIB;ADGRG6;SLC8A3
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.40720166226853943,-1.0531520082499726,0.3771289537712895,0.7638464956493833,1.0,6/13,25.47%,KDR;IL33;JAK2;EDN1;NOD2;NAMPT
prerank,histone H3-K4 methylation (GO:0051568),0.40895668679138275,1.0530196006648536,0.3913713405238829,0.962180991398212,1.0,6/26,15.77%,OGT;KMT2A;BEND3;MEN1;DYDC2;KMT2D
prerank,ncRNA transcription (GO:0098781),0.4673068016974097,1.052982452836655,0.40863787375415284,0.9613215153824134,1.0,4/13,12.39%,CAVIN1;RPAP2;SIRT7;SPIN1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.47124942500633127,1.0522832110482756,0.40978077571669475,0.9623942555484774,1.0,6/13,22.77%,VDAC2;BAD;BNIP3;BAX;BLOC1S2;RHOT2
prerank,regulation of transposition (GO:0010528),0.4641627010509252,1.051270173982282,0.4016806722689076,0.9643509409577972,1.0,3/13,12.29%,PIWIL2;SIRT7;TEX15
prerank,response to estrogen (GO:0043627),0.3968322907846215,1.051133981146663,0.41409691629955947,0.9637764837176864,1.0,3/31,7.46%,CAV1;KRT19;RARA
prerank,protein transport (GO:0015031),-0.2165626911811495,-1.0504993894720205,0.2692307692307692,0.7700967010960557,1.0,95/332,22.35%,TBC1D4;STXBP3;VAMP5;TXNIP;LRP1;WLS;STEAP3;ARHGEF2;TBC1D1;MYO6;RABGAP1;TOM1;TFRC;CALCRL;RAB6B;RAB3C;COG7;TBC1D12;PREB;NAPA;TMED9;ATP6V0A4;AP2A1;STX8;TBC1D30;USP6NL;TBC1D2B;NPM1;ZDHHC17;ARHGAP1;APOE;VMP1;ARL6IP5;SGSM3;RAMP2;ATP6V0C;COPZ1;RAB13;SCAMP5;ANK3;COPZ2;EIF2D;STX17;EVI5L;MACF1;SCG2;RAB5C;ATP6V1C1;TMED3;TBC1D22B;SAR1B;RAB24;BBS2;VPS26B;ARRDC4;STX12;HERC2;SVBP;PREPL;ABCG1;CTSA;GGA3;TMED1;CHMP3;RAB3B;STX6;ARF5;HFE;LAPTM5;ARRDC2;SCFD1;ATP6V1D;STX16;SYS1;SEC31A;CHMP2B;RAB11B;MYH9;RCN3;RAB32;SLC10A7;SYNDIG1;ATP6V1F;TMED7;TBC1D17;PICK1;MON1A;ARF3;RAB7A;OPTN;CLU;RAB10;ATP6V1E1;ARL4C;ARL5B
prerank,lymphocyte proliferation (GO:0046651),-0.34661862937158805,-1.050396522115576,0.3746556473829201,0.7692587261661311,1.0,2/22,1.74%,MSN;CTPS1
prerank,blood vessel morphogenesis (GO:0048514),0.35989967860671723,1.0502067254798881,0.359504132231405,0.9654444385243867,1.0,9/54,10.33%,STRA6;CAV1;GLMN;NF1;EGFL7;EFNB2;CDH2;COL4A1;AGGF1
prerank,regulation of osteoblast differentiation (GO:0045667),0.3410305447939189,1.050190347907814,0.3888888888888889,0.9645128645684524,1.0,4/82,4.10%,PTCH1;RUNX2;SOX9;BMPR1B
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.43817509890402556,1.0496047506511217,0.3967479674796748,0.9652647443294148,1.0,4/18,7.57%,RIPOR2;CDH5;KIF20B;KANK1
prerank,nucleoside catabolic process (GO:0009164),0.49029629721589074,1.0495355815799385,0.3993055555555556,0.9644954473086975,1.0,5/11,15.08%,DPYS;UPP2;NT5E;DERA;NT5C3A
prerank,positive regulation of apoptotic process (GO:0043065),0.30374303544864134,1.049301494888818,0.37122002085505734,0.9642343756810347,1.0,62/293,17.01%,NGF;ITGA6;DLC1;DKKL1;TIAM2;FAP;MYBBP1A;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;FOXO3;VAV2;ACVR1C;TRIO;TRADD;ARHGEF5;NCSTN;PHLDA1;NLRC4;ARHGEF1;SIAH1;MAP3K5;RBM5;KALRN;OBSCN;STK3;HMGB1;NLRP2B;RASSF2;SLC27A4;SRPK2;RARG;APC;ARHGEF6;FAF1;PTPA;ADAMTSL4;DIABLO;ATG7;SOX4;HTRA2;HTT;UNC13B;FZD9;GPER1;BAD;PDCD2;AIFM2;CTNNBL1;BACE1;PLEKHG2;ARHGEF11;ARHGEF7;BNIP3;E2F1;QRICH1
prerank,long-chain fatty acid import into cell (GO:0044539),-0.4378607535763305,-1.0491237437343222,0.39952718676122934,0.7716150969921135,1.0,3/10,6.35%,ACSL1;ACSL3;RPS6KB1
prerank,mitochondrial genome maintenance (GO:0000002),-0.4291149294342487,-1.0486444694814743,0.4149184149184149,0.7717176828913981,1.0,6/11,19.29%,AKT3;TOP3A;MEF2A;SLC25A33;OPA1;PARP1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.31898521345144465,-1.0485284593552018,0.3735632183908046,0.7708826588221729,1.0,8/29,8.99%,SHANK3;PLEKHH2;SLIT2;KANK3;HIP1R;TWF1;MYADM;CYRIB
prerank,regulation of neurotransmitter secretion (GO:0046928),-0.31612794588277265,-1.04843265954998,0.3901639344262295,0.7700023673290198,1.0,8/32,16.66%,SNCAIP;MCTP2;SYN1;CAMK2A;LRRK2;PREPL;DTNBP1;CPLX2
prerank,monocarboxylic acid transport (GO:0015718),-0.28813213316169206,-1.0477835560501072,0.33460076045627374,0.7706406648177606,1.0,11/51,11.94%,SLC16A12;SLCO3A1;ABCC4;ABCG2;SLCO1C1;SLC5A6;SLC16A6;SLC16A4;SLCO2A1;SLC16A2;SLC16A7
prerank,keratan sulfate catabolic process (GO:0042340),0.4888073871587917,1.0476497990821172,0.4200680272108844,0.9681394969141008,1.0,3/11,14.23%,PRELP;HEXA;HEXB
prerank,cellular response to UV (GO:0034644),-0.26711275004690277,-1.0475175817633313,0.3645833333333333,0.7702339959943277,1.0,20/76,19.92%,USP28;PTPRK;EP300;RPL26;NPM1;MMP2;CDC25A;EIF2AK4;MFAP4;MMP1;KDM1A;NOC2L;XPA;POLK;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,oogenesis (GO:0048477),0.45392168234071495,1.0473052457962542,0.411663807890223,0.9681692213292435,1.0,4/15,16.87%,PIWIL2;MEI4;KMT2D;MDK
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",-0.42824926554577214,-1.0467597567775586,0.42431761786600497,0.7711239527674929,1.0,6/11,35.97%,UQCRC2;CYC1;UQCRQ;UQCRFS1;UQCR10;UQCR11
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.44476446338436376,1.046250923583111,0.4166666666666667,0.9703289869355876,1.0,4/17,13.18%,COX5A;COX15;COX7C;COX5B
prerank,calcium ion import into cytosol (GO:1902656),0.45335670689080143,1.045682601221143,0.4103448275862069,0.9710808630915647,1.0,3/15,4.74%,SLC24A1;TRPV4;ATP2B4
prerank,tryptophan metabolic process (GO:0006568),0.48993393075788205,1.0454349697036927,0.4275491949910555,0.970834278453618,1.0,2/11,3.76%,IL4I1;AADAT
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.3447260785863156,1.0453789989775104,0.38257575757575757,0.9700290250240631,1.0,11/74,9.35%,ITGA6;EYA1;IL1A;SRC;PSME3;BMP5;TNFAIP3;TRADD;MCL1;MAPK7;GSK3B
prerank,protein import into nucleus (GO:0006606),0.34686112334763863,1.0452479371761716,0.3833116036505867,0.9694181692479776,1.0,16/66,16.49%,PRICKLE1;KPNA7;IPO8;NUP62;KPNA2;FAM53B;CBLB;TPR;MMP12;NUP50;RANBP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,regulation of ruffle assembly (GO:1900027),0.4212157571973116,1.045208796637904,0.39603960396039606,0.968552061639388,1.0,3/23,7.57%,CAV1;RDX;KANK1
prerank,cholesterol transport (GO:0030301),0.37157176496902744,1.045096936741688,0.394109396914446,0.9678810231258623,1.0,6/45,14.27%,CAV1;CEL;SOAT1;ABCA1;STARD3;STARD5
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.35860075981061623,-1.043826023041722,0.3872832369942196,0.7781079422273232,1.0,4/21,7.55%,IGF1;CTSH;KDR;MAP2K2
prerank,rRNA processing (GO:0006364),-0.2347004861509496,-1.0438040421706896,0.3402061855670103,0.7770357702230744,1.0,75/172,30.26%,RPL37A;RPL19;RPL8;RPL37;RPS15;RPL35A;RPS7;RPL32;RPS27;RPL26;RPL27;RPS24;RPLP0;RPS19;RPL31;RPL41;RPL13A;RPL30;RPL29;RPS16;RPL3;RPLP1;RPS17;WDR12;RPL23;RPL17;RPL9;RPL38;RPL36;RRP7A;ESF1;RPL18A;RIOK1;EXOSC3;IMP4;HEATR1;TEX10;LAS1L;RPLP2;POP5;RPS6;NOL9;HELQ;DIS3;DHX37;EXOSC1;FBL;RPL14;TBL3;RPS2;RPL10A;RIOK3;UTP4;RPL39;RPL34;RPL5;RPL22;PWP2;RPS9;WDR3;RPS14;RPS25;NOB1;RPL36A;NHP2;RPL7;NAT10;RPL11;PIH1D2;SART1;RPL24;RRP36;RRP9;WDR46;UTP6
prerank,regulation of stress fiber assembly (GO:0051492),0.33880849576582667,1.043387010681607,0.3970037453183521,0.9719911640218888,1.0,6/74,2.02%,DLC1;F11R;LPAR1;PXN;RAPGEF3;ARAP1
prerank,regulation of intracellular signal transduction (GO:1902531),0.2982760231004296,1.0433852534257824,0.36585365853658536,0.9710220496152233,1.0,59/420,10.01%,DLC1;NTRK3;TIAM2;ARHGAP31;PRR5;PTPN13;CEACAM1;ARHGAP18;ARHGAP12;ARHGAP32;AKAP12;EGFR;ARHGAP9;ARAP1;FGF1;PPP1R13B;BCL3;MINK1;DEPDC1B;SPRED1;GPAT3;CHD3;AKAP13;OPHN1;RACGAP1;PRKAG1;TPTE;PTPN22;FAM83D;VAV2;RAC2;TAF10;PIP4K2B;WNT5A;TRIO;HIPK1;TAF4B;RFC3;ULK4;ARHGEF5;NBN;ARHGAP26;CCNG1;RHOJ;ARHGEF1;PTPMT1;PHLPP1;PRKAR2A;PIK3R2;STARD13;KALRN;OBSCN;OCRL;STK3;DIPK2A;RASSF2;POU4F1;HDAC2;MAPKAP1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.43134244620832163,1.0431222121235832,0.3996710526315789,0.9708605237472309,1.0,4/20,9.40%,NEDD4L;SLC12A2;ATP1A2;ATP1B3
prerank,positive regulation of interferon-gamma production (GO:0032729),0.3636104001002216,1.0428420297796241,0.3874488403819918,0.9707273633254779,1.0,7/48,8.17%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;ISL1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.43763274936793506,-1.0428172227502137,0.4227467811158798,0.7787306163617239,1.0,1/10,1.02%,SHANK3
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3301504555510049,-1.0427653681580458,0.40522875816993464,0.7777518236916902,1.0,13/29,27.09%,IFNAR2;SAMHD1;UBE2K;USP18;ABCE1;ISG15;YTHDF2;CACTIN;CDC37;YTHDF3;TRIM6;ZBP1;TTLL12
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.42179751420136347,-1.0423294185104772,0.4119047619047619,0.7767541133941966,1.0,5/11,20.66%,AGO3;AGO4;ZFP36;TNRC6C;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),-0.42179751420136347,-1.0423294185104772,0.4119047619047619,0.7767541133941966,1.0,5/11,20.66%,AGO3;AGO4;ZFP36;TNRC6C;NOTCH4
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.30133785323208795,-1.0422274985092541,0.3979933110367893,0.7759088376991279,1.0,21/39,26.21%,RPS15;RPS7;RPS27;NPM1;RPS24;RPS19;RPS16;RPS17;RRP7A;RIOK1;RPS6;MRPS11;RIOK3;UTP4;RPS27L;PWP2;WDR3;RPS14;ERAL1;RPS25;NOB1
prerank,positive regulation of binding (GO:0051099),0.3392636162782549,1.0417703704573629,0.41119221411192214,0.9727899709886081,1.0,10/84,9.49%,NGF;CAV1;ADD1;DACT1;TRIM21;RARA;AMFR;STK3;GSK3B;HMGB1
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.35616360550378917,1.0415496610551191,0.4259012016021362,0.9714758344265381,1.0,21/51,22.93%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,mitotic nuclear membrane organization (GO:0101024),0.35616360550378917,1.0415496610551191,0.4259012016021362,0.9714758344265381,1.0,21/51,22.93%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,positive regulation of DNA repair (GO:0045739),0.37129905964038024,1.0413510518153632,0.41192411924119243,0.9710893382580853,1.0,10/46,12.86%,EGFR;FAM168A;BRCC3;EYA1;NPAS2;UIMC1;WRAP53;HMGB1;ERCC6;MGMT
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.30942562734568974,1.041263589143671,0.42444444444444446,0.970404097591623,1.0,34/163,18.75%,TEC;NFATC2;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PIK3R2;PTPRJ;PSMB5;LAT;TAB2;EIF2B4;CD276;PSMB2;PSMA2;PSMA6;PLEKHA1;PSMD13;PSMA7;NFKBIZ;SYK;BTK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,positive regulation of protein processing (GO:0010954),-0.3591377334585374,-1.0410652828091531,0.4141689373297003,0.77800758947262,1.0,2/19,1.69%,CCBE1;CLEC3B
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.331699577166573,-1.0406897171967553,0.375,0.7779356814605667,1.0,6/26,12.14%,SLC30A10;PLCG2;CYBA;GRIN1;SLC25A33;ABCD2
prerank,regulation of interleukin-12 production (GO:0032655),-0.2832782946123627,-1.0406828458444082,0.38671875,0.7768372835890369,1.0,13/47,25.45%,PLCB1;FOXP1;PLCG2;CMKLR1;THBS1;LGALS9;LAPTM5;CD40;TLR3;C1QBP;CCL19;IRF5;JAK3
prerank,high-density lipoprotein particle assembly (GO:0034380),0.48792528879110214,1.040580556291862,0.41695501730103807,0.9713779711845145,1.0,4/10,17.49%,ABCA1;PRKACB;ZDHHC8;BMP1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.43506421398331074,-1.0405748207580898,0.4079822616407982,0.7760305711237705,1.0,7/10,33.39%,DNAJB2;DNAJA4;HSPA1A;DNAJB1;HSPA1B;HSPA2;SORL1
prerank,cortical actin cytoskeleton organization (GO:0030866),0.42512944138817244,1.0405416100259088,0.3984375,0.9705443415496965,1.0,4/20,10.63%,FMNL2;ARF6;PLEK;FHOD1
prerank,rRNA pseudouridine synthesis (GO:0031118),0.490182514400061,1.0397929048560455,0.45604395604395603,0.9717572758441906,1.0,3/10,18.26%,RPUSD2;NAF1;RPUSD4
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.44723886865648554,1.0394312005360757,0.4169329073482428,0.9718282397769753,1.0,2/15,9.52%,USP50;NLRP2B
prerank,regulation of B cell activation (GO:0050864),0.3988702054342663,1.039333952207312,0.42272727272727273,0.9711410214567643,1.0,5/25,13.32%,IL4I1;BANK1;TNFAIP3;FOXJ1;ZFP36L2
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.29290251930970895,1.039147726028887,0.3693239152371342,0.9707418014468522,1.0,60/509,11.43%,ROR2;GAB1;DCN;CAV1;ROR1;FGF7;PLK2;NTRK3;CDH13;FGFR1;LPAR1;NR3C2;HCST;PIK3AP1;EGFR;PELI2;FGF1;AKAP13;CAV2;WNT16;SOX9;SLC35B2;SRC;REL;RAC2;WDR24;NUP62;FIS1;WNT5A;PTPRC;FN1;PPM1A;MIOS;TLR7;TRADD;TRIM21;SIAH1;PIK3R2;S100B;PTPRJ;GCNT2;NOS1AP;FGF18;HMGB1;TFG;TICAM1;TMED4;GAB2;AXL;CANT1;FERMT2;SHARPIN;ADRA2A;RELN;STRN;S100A9;WWC1;TAB2;NEDD4;PLXNB1
prerank,cation transmembrane transport (GO:0098655),0.3683313208405557,1.0390404330531107,0.40440165061898214,0.9700810227103883,1.0,6/44,5.22%,TRPM3;SFXN2;SLC29A4;CACNA1H;ATP1A2;SLC25A20
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.3960240862964995,1.0389986114695724,0.4120300751879699,0.9692498951523758,1.0,1/32,0.24%,CAV1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.3624582616965288,1.038668071289008,0.39783491204330174,0.9692695014285171,1.0,9/46,10.91%,IL18R1;LAMA4;ZNF423;PLCL1;PCTP;ACOT13;HOXC10;LNPEP;DOCK7
prerank,regulation of protein phosphorylation (GO:0001932),0.30618074632422687,1.038430182094171,0.4045881126173097,0.9690017081777192,1.0,24/256,6.42%,EFNA5;FGF7;NTRK3;PLCE1;PTPN13;CLDN19;LEPR;EGFR;CCND3;MUSK;PELI2;FGF1;AXIN1;CDH5;FXR2;EIF2AK3;SOX9;PLPP3;LIMK2;IBTK;FN1;FER;EPHB2;KRAS
prerank,mammary gland epithelium development (GO:0061180),-0.38945251360569444,-1.0383600714467178,0.4177545691906005,0.7812448119462448,1.0,4/14,14.18%,WNT4;JAK2;AKT1;ID2
prerank,fatty acid oxidation (GO:0019395),0.3514452010320428,1.0378967179758947,0.3820816864295125,0.9696610069163796,1.0,8/57,8.66%,PPARGC1A;EHHADH;HADHB;PEX2;ACAT1;HSD17B4;ADH5;ACADS
prerank,defense response to tumor cell (GO:0002357),0.4782405059219387,1.0376406736455603,0.4154676258992806,0.9694439121483198,1.0,2/10,3.65%,DLEC1;SPI1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.3851823309851486,1.0375545727732536,0.41228070175438597,0.968737774793319,1.0,2/33,0.77%,DCN;NR2F2
prerank,vasculogenesis (GO:0001570),0.3848260149969715,1.0372937222413117,0.3848396501457726,0.9685761351627891,1.0,4/32,6.83%,CAV1;GLMN;SPRED1;EGFL7
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.40250992711243083,-1.0371865116242538,0.400990099009901,0.7834351398228583,1.0,5/13,15.12%,RPS15;NPM1;NOP9;ABCE1;NUP88
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.353599842983958,1.0371229551614467,0.4105263157894737,0.9681178549378712,1.0,13/54,19.72%,PLK2;GTSE1;CNOT10;ARID3A;SFN;CNOT7;SOX4;RGCC;TNKS1BP1;E2F1;CNOT8;CNOT1;BAX
prerank,negative regulation of endocytosis (GO:0045806),0.41585340945077764,1.037082804685617,0.4131455399061033,0.9672978764275323,1.0,3/24,7.65%,CAV1;LRSAM1;ARF6
prerank,regulation of T cell activation (GO:0050863),0.3704308179925422,1.036542998511501,0.40827586206896554,0.9678863743850984,1.0,5/42,10.18%,TNFSF8;IL4I1;PTPN22;CRTAM;LAT
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),-0.3944094389744178,-1.0356459269273903,0.3898305084745763,0.7867139254732071,1.0,2/14,1.72%,RAPGEF2;PKIG
prerank,response to laminar fluid shear stress (GO:0034616),0.4832812563897475,1.0352497061674766,0.4175257731958763,0.9706048349193278,1.0,4/10,12.27%,ASS1;MAPK7;ABCA1;NFE2L2
prerank,melanosome organization (GO:0032438),0.4016485889853657,1.0350053579191631,0.4101796407185629,0.970405646647075,1.0,4/26,7.55%,RAB29;HPS1;SHROOM2;KIF13A
prerank,negative regulation of developmental process (GO:0051093),-0.26102687384042095,-1.0348769766650858,0.37333333333333335,0.7876961493373227,1.0,20/69,18.40%,NFIB;ROCK2;OMA1;NOS3;BMP4;TFRC;GRIN3A;TBX1;CDK6;WDR77;SINHCAF;BMP2;FUZ;ARHGEF15;DCC;MAPT;SUZ12;RC3H1;WNT11;VASH1
prerank,neuron development (GO:0048666),-0.23485249510707512,-1.0348490819437934,0.30952380952380953,0.7866572773987518,1.0,36/141,14.92%,FRY;PTPRM;RAPGEF2;LYN;PBX3;FRYL;ATP7A;STMN2;RASGRF1;GPRIN3;APOE;EPHA8;TBC1D24;STMN4;THOC2;DCX;VSX1;CAMSAP1;RAB13;LAMB1;MANF;LGI4;RP1;MYT1L;GBA2;RAB11A;STMN1;HS6ST1;TGFB2;LGI1;MAPT;SH3GL2;DTNBP1;CLN5;MICALL1;CDK5R1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),0.45307136609496423,1.0344562840442975,0.3925549915397631,0.971034100517675,1.0,4/14,16.49%,CD55;PTPN22;CD81;SYK
prerank,organic anion transport (GO:0015711),0.3419703122774345,1.0344471210029167,0.4200743494423792,0.9701195959393387,1.0,11/76,7.50%,LRRC8D;SLC35A1;SLC4A3;SLC26A9;SLC35B2;SLC22A3;SLC4A4;SLC35C2;SLC2A2;SLC4A11;SLC52A1
prerank,negative regulation of ossification (GO:0030279),0.41260375222130313,1.0340170141269407,0.41467065868263475,0.9703656886881857,1.0,2/23,4.05%,LRP4;SOX9
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.40652835308224367,-1.0338947386415256,0.4153498871331828,0.7881770228576791,1.0,8/12,32.67%,UNC13C;SYT7;UNC13A;RIMS1;RIMS3;SYT1;SYT5;DOC2B
prerank,negative regulation of hippo signaling (GO:0035331),0.47317841958611506,1.033802450055136,0.42598684210526316,0.9700274524544082,1.0,3/12,13.55%,VGLL4;WWC1;CIT
prerank,alcohol catabolic process (GO:0046164),0.482527766347624,1.0337790343612587,0.43327556325823224,0.9691465602707626,1.0,1/10,1.68%,CEL
prerank,positive regulation of response to cytokine stimulus (GO:0060760),0.45550695678279995,1.033677404115223,0.4357638888888889,0.9685060885814708,1.0,7/13,28.83%,WNT5A;AXL;IL7;DHX9;IFIH1;TRIM44;MAVS
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.29107051044550436,1.0334724449659822,0.40826612903225806,0.9681733498302411,1.0,73/572,12.06%,PTCH1;TENM2;CAV1;NR2F2;NEDD4L;DLX1;RARB;FOXP2;ZBTB32;KLF12;LDB2;ETV5;GLI2;IRF2BP1;CHD3;SPI1;BEND3;PHF21A;FOXO3;SOX9;UBE2I;FOXP4;GLIS2;CHD8;HDAC4;SATB1;KLF10;DACT1;N4BP2L2;PPM1A;KANK2;BHLHE40;ZFP90;ANKRD2;NRIP1;SIN3B;CTCF;HIC1;PEX2;PAF1;ZNF431;NCOR1;NCOA5;TBX2;RREB1;RARA;BAG3;SUV39H1;KCTD1;MYPOP;ISL1;E4F1;MECP2;FOXJ1;HMGB1;SIRT7;SUPT4H1;POU4F1;HDAC2;LEFTY1;TPR;ZHX1;WWC1;NCOR2;OTUD7B;RARG;NEDD4;MZF1;HEXIM1;ZNF148;ERF;MEN1;SEMA4D
prerank,nucleotide catabolic process (GO:0009166),-0.3744785145981436,-1.0332545741761212,0.4090909090909091,0.7888529548874534,1.0,6/16,18.92%,SAMHD1;XDH;NUDT3;VCP;NT5C;NT5C1A
prerank,"regulation of gene expression, epigenetic (GO:0040029)",0.33892067436559437,1.0332016445096435,0.41794871794871796,0.9680142833079735,1.0,12/73,11.27%,GLMN;MYBBP1A;TDG;SF3B1;SPI1;HDAC4;POLR1E;CTCF;MECP2;PPHLN1;ERCC6;HDAC6
prerank,macrophage activation involved in immune response (GO:0002281),0.4644788844766371,1.0331495394689554,0.44240400667779634,0.9672509555189336,1.0,1/13,0.73%,LBP
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.3272332606480494,1.0329427823544968,0.40836408364083643,0.9668751791204678,1.0,14/95,9.89%,LBP;TNIP3;IL1A;WNT5A;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;HMGB1;TICAM1;AXL
prerank,signal transduction in response to DNA damage (GO:0042770),-0.28780906428331615,-1.0328574368168506,0.38910505836575876,0.7888878715295448,1.0,10/49,14.63%,MAP3K20;ACER2;USP28;MYO6;PAXIP1;ATRIP;HINFP;BID;CLSPN;RAD1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3085913592205632,1.0328528098499792,0.40859030837004406,0.9662237163106985,1.0,15/166,5.81%,SMOC2;GLI1;PPARGC1A;SORBS1;ASS1;EGFR;BCL3;ELOVL5;FXR2;GPLD1;GLI2;PIWIL2;SLC27A1;DDAH2;STN1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.39941545940888085,1.032315472592915,0.41384388807069217,0.9668477392973313,1.0,10/30,13.29%,ELOVL5;HACD4;ELOVL1;PEX2;ELOVL2;SLC27A4;ACOT2;HACD2;ABCD1;ELOVL6
prerank,regulation of B cell differentiation (GO:0045577),0.436372045554624,1.0319211722217034,0.42549668874172186,0.9670837922638902,1.0,6/17,16.92%,IL4I1;ZFP36L2;PPP2R3C;SYK;BTK;MMP14
prerank,clathrin-dependent endocytosis (GO:0072583),-0.3261031749130405,-1.03129067035377,0.3895705521472393,0.7921089378600162,1.0,6/26,16.04%,PICALM;DNAJC6;AP2A1;FCHSD2;LMBRD1;FNBP1L
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.3994374538590831,-1.031235159921524,0.4317073170731707,0.7911617563108703,1.0,6/13,20.02%,ERLIN1;APOE;SCAP;BMP2;ERLIN2;DKK3
prerank,nucleic acid metabolic process (GO:0090304),0.3488225387892119,1.0312152627279174,0.43112244897959184,0.9682110843394539,1.0,14/69,15.26%,HNRNPC;RBFOX2;PCBP2;HNRNPA0;WDR74;DXO;HNRNPR;KPNA2;NT5E;HNRNPM;ATXN2;GTF2F2;RECQL5;RAN
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),-0.2983378120680168,-1.0310130193674807,0.4158415841584158,0.7906505053252838,1.0,11/44,10.42%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;ATP1B1;KCNJ10;FLNA;ATP1B2;KCNN2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.37187751534318536,1.030933246855012,0.4248927038626609,0.968066546733093,1.0,5/43,5.62%,KLF5;SPI1;FOXO3;SOX9;APLN
prerank,membrane repolarization during action potential (GO:0086011),-0.4006002879414309,-1.0305495635663429,0.4219948849104859,0.7908316748633657,1.0,6/13,30.78%,KCNJ2;ATP1B1;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,negative regulation of hormone secretion (GO:0046888),-0.42488179948719973,-1.0304214814289552,0.423963133640553,0.7900390348101458,1.0,3/10,17.29%,GJA1;RAB11FIP3;RAB11FIP1
prerank,myeloid cell activation involved in immune response (GO:0002275),0.4364794664262124,1.030366173812913,0.4230769230769231,0.9687385541384249,1.0,3/18,10.36%,LBP;DOCK2;KARS1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),-0.2600531538381281,-1.0303156612466224,0.391304347826087,0.789213846514973,1.0,13/74,12.75%,PHLDB2;SMAD3;LEF1;EPHA3;DAB2;TGFBR1;MCRIP1;GLIPR2;TGFB3;VASN;BMP2;USF3;TGFB2
prerank,peptidyl-lysine acetylation (GO:0018394),-0.43010868292272736,-1.0302557270800015,0.4418604651162791,0.7882820722229522,1.0,3/10,18.03%,EP300;KAT2B;KAT2A
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4157039598251926,1.0301488024396608,0.41033434650455924,0.9675143599431907,1.0,10/22,22.43%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4157039598251926,1.0301488024396608,0.41033434650455924,0.9675143599431907,1.0,10/22,22.43%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC20;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7
prerank,positive regulation of cellular protein localization (GO:1903829),0.3439197521638622,1.0299032605063756,0.4360613810741688,0.9672724362194448,1.0,19/69,20.41%,GTSE1;RIC3;EIF2AK3;LIMK2;NUP62;CARD10;DDRGK1;GSK3B;FERMT2;APC;SLC5A3;RTN4;YAP1;GNL3L;STX4;TM9SF4;CEP250;LAMTOR5;PRKN
prerank,negative regulation of receptor binding (GO:1900121),0.48529360530987076,1.0297875103389331,0.44165170556552963,0.9666808170635959,1.0,1/10,1.78%,PTPRF
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.29550106090388223,-1.0297804825542876,0.41353383458646614,0.7884986329387242,1.0,6/36,7.19%,MECOM;FOXO1;SIRPA;DUSP10;DUSP3;IGBP1
prerank,regulation of mRNA metabolic process (GO:1903311),0.47044284338945885,1.0297483578292108,0.4372822299651568,0.9658666536775995,1.0,6/11,25.72%,SRPK1;SLTM;SRPK2;DHX9;IWS1;SAFB2
prerank,establishment of protein localization to organelle (GO:0072594),0.33502159281163674,1.02962555691854,0.41959798994974873,0.965293589316633,1.0,28/72,26.58%,PRICKLE1;HK2;IPO8;LRSAM1;NUP62;FAM53B;LAMP1;TPR;MMP12;NUP50;CSE1L;NUP153;RAN;NUP93;SYK;PINK1;LAMP2;RPAIN;RALA;TSC2;SEC13;SPRN;IPO13;PTTG1IP;CD68;NUP188;RANBP17;TNPO1
prerank,positive regulation of actin nucleation (GO:0051127),-0.4171211344282926,-1.0295302668045692,0.41414141414141414,0.7880819320806663,1.0,2/11,8.30%,WASF3;FCHSD2
prerank,bone morphogenesis (GO:0060349),-0.39162818985076364,-1.0294355252801282,0.43099273607748184,0.7872200623809557,1.0,4/14,7.80%,CYP26B1;BMPR2;FGFR2;LRP6
prerank,regulation of neuron apoptotic process (GO:0043523),0.32651241982503043,1.0294272586130955,0.4154761904761905,0.9649368251531657,1.0,10/96,10.90%,NGF;PPARGC1A;NF1;FOXO3;EGLN3;MSH2;ISL1;NRBP2;POU4F1;SRPK2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),-0.3977661207994809,-1.0290021496036696,0.39577836411609496,0.7873759900798929,1.0,6/13,28.04%,MMS19;NFU1;ISCA2;GLRX5;BOLA2;CIAO2B
prerank,regulation of phospholipase activity (GO:0010517),0.4819937523890462,1.0287860069166783,0.44658493870402804,0.9658761227508045,1.0,1/10,0.70%,FGFR1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3392896546957437,1.0287342765469973,0.4093789607097592,0.9651050330625729,1.0,14/66,13.19%,EGFR;CCND3;ADAMTS1;UBE2E2;WEE1;PSME3;DACT1;KANK2;RDX;APC;INO80;PTEN;PKD1;FHL1
prerank,vasculature development (GO:0001944),0.4445686670799283,1.0280877718775454,0.4169381107491857,0.9660486218335474,1.0,2/16,2.58%,STRA6;CDH5
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.351576454172925,1.0278929550225244,0.43544303797468353,0.9657191826752226,1.0,10/59,9.71%,CDH13;CEACAM1;MPZL2;CDH17;HMCN1;TRO;DSCAM;AMIGO2;CDH2;PTPRT
prerank,autophagosome organization (GO:1905037),-0.2812304146708308,-1.0272117308503201,0.404,0.7914793054749134,1.0,16/50,24.51%,ATG16L2;BECN1;GABARAPL1;VMP1;WIPI1;ULK2;GABARAP;AMBRA1;STX12;ATG13;MAP1LC3A;RAB7A;WIPI2;ATG12;WDR45B;WDR45
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.3614700995640118,-1.02689366896148,0.4109947643979058,0.7912204167978876,1.0,4/17,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.2983579493335957,-1.0262401430731087,0.4124087591240876,0.7919077853383548,1.0,11/40,9.11%,CREBL2;BMP4;WNT4;LARP6;APOE;PLCG2;CYBA;TGFB3;AKT1;CREB1;GRIN1
prerank,cholesterol metabolic process (GO:0008203),-0.2683319737775718,-1.0262343693921083,0.3681592039800995,0.7908265236287048,1.0,25/68,26.09%,PPARD;INSIG2;ARV1;APOE;HMGCS1;SCAP;OSBPL1A;LDLRAP1;OSBPL5;ACAA2;GBA2;ACLY;NSDHL;PMVK;ABCG1;MVK;ACAT2;DHCR7;TSKU;CLN6;PIP4P1;TM7SF2;SCARF1;CH25H;LCAT
prerank,nuclear membrane reassembly (GO:0031468),0.3485420602973428,1.0261508680097151,0.4297082228116711,0.9697968300644728,1.0,21/54,22.93%,UBE2I;SPAST;NUP160;IST1;NUP37;REEP3;CHMP4A;CHMP4B;CHMP4C;AHCTF1;EMD;RAN;NUP93;LEMD2;PPP2CA;SUMO1;REEP4;CHMP2A;NUP43;SEC13;SIRT2
prerank,ventricular septum development (GO:0003281),-0.30270887612322145,-1.025963162422866,0.3959731543624161,0.7904184291218063,1.0,10/37,12.75%,ROBO1;TGFBR3;SLIT2;TGFBR1;BMPR2;CITED2;PDE2A;PROX1;DAND5;TGFB2
prerank,protein dephosphorylation (GO:0006470),0.3143932712825566,1.0259365704426748,0.42081447963800905,0.9695070882005162,1.0,30/135,14.48%,UBASH3B;PTPN13;PTPRF;DUSP12;EYA1;PTPN14;TPTE;PTPN22;PTPRC;PPM1A;RPRD1B;PPM1M;MTMR7;RPAP2;PTPRJ;MTMR6;MTMR3;PDP2;PTPRT;RPRD1A;SDHAF2;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;CTDSP2;PTPRU;PTPRO
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.47639558079771005,1.0257977676879937,0.4489795918367347,0.9689952374702538,1.0,1/10,0.24%,CAV1
prerank,chemical homeostasis (GO:0048878),0.3514543546154087,1.0255896901451569,0.41751269035532995,0.9686766675665069,1.0,14/61,18.05%,NEDD4L;SLC4A3;ZBTB20;CLN8;SLC4A4;SLC4A11;USF2;TLCD3A;THADA;PNPLA8;FBXW7;PPARG;IRS2;VGF
prerank,positive regulation of immune effector process (GO:0002699),0.39453391580114555,1.0254577239038034,0.4175491679273828,0.9681479725180302,1.0,4/27,12.38%,LBP;PTPRC;PTPRJ;CD81
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.40332540870015765,-1.0251258821238787,0.42789598108747046,0.7915772079295418,1.0,9/12,32.05%,MCM6;CDC7;MUS81;MCMDC2;CDC45;MCM3;MCM7;MCM5;MCM2
prerank,leukotriene biosynthetic process (GO:0019370),0.4570601501937184,1.0249874800748338,0.4498327759197324,0.9685632254590697,1.0,4/14,15.30%,MGST2;GGTA1;LTA4H;GGT1
prerank,protein homotetramerization (GO:0051289),0.36049860255813626,1.0249650945178865,0.4342629482071713,0.9677192550940487,1.0,4/49,7.02%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,positive regulation of B cell activation (GO:0050871),0.3568982309342282,1.024808066907595,0.4295212765957447,0.9672450442239836,1.0,13/50,17.63%,NFATC2;KMT5C;PTPRC;EPHB2;CD320;GPR183;CD81;IL7;PPP2R3C;SYK;BTK;MMP14;IRS2
prerank,negative regulation of neuron death (GO:1901215),0.33024507778619255,1.0245329498844757,0.42823250296559906,0.9671466068994937,1.0,10/93,10.71%,NGF;PPARGC1A;MSH2;ISL1;NRBP2;CD200R1;GSK3B;POU4F1;CHMP4A;CHMP4B
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.41977205617569285,1.024414562198282,0.4353312302839117,0.9665812932810018,1.0,1/22,0.41%,DYNLL1
prerank,keratan sulfate metabolic process (GO:0042339),0.39248475948834677,1.0242439685218032,0.43909774436090226,0.9661367775134271,1.0,6/31,10.86%,ST3GAL4;PRELP;B4GAT1;SLC35D2;CHST2;HEXA
prerank,protein import into peroxisome membrane (GO:0045046),0.4157798603195088,1.0238161647454622,0.44607843137254904,0.9664354736687959,1.0,7/22,19.84%,RAB8B;FIS1;PEX2;PXMP2;ABCD1;SLC25A17;PEX13
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.49320132521045557,1.0229849541605023,0.4555160142348754,0.9678417420154976,1.0,3/10,16.06%,CD55;CD81;SOCS1
prerank,dicarboxylic acid transport (GO:0006835),0.39321577336158997,1.022865974617203,0.4279475982532751,0.9672594564792846,1.0,6/28,6.69%,FOLR1;FOLR2;SLC25A12;SLC1A7;PRAF2;SLC1A6
prerank,positive regulation of gene expression (GO:0010628),0.2914909601180039,1.0221530291113083,0.4338461538461538,0.9683412968201712,1.0,61/442,11.60%,NGF;FGF7;NTRK3;PPARGC1A;FOXD1;CLDN19;GLMN;EGFR;MUSK;MYBBP1A;FGF1;BCL3;ITK;ADAM19;SLC26A9;CDH5;FXR2;SF3B1;SLC38A2;ITGAX;PIWIL2;TXK;IL1A;PRKAG1;WNT16;EIF2AK3;SOX9;CELF1;TFR2;PTPN22;WNT5A;FN1;EPHB2;KRAS;RIMS2;UBR5;POLR1E;RDX;CTCF;CRTAM;PTGER4;RBM22;OCLN;DYRK1A;NOS1AP;FGF18;AGO1;DDRGK1;PLSCR1;GSK3B;TICAM1;POU4F1;HILPDA;ADRA2A;METTL5;ERCC6;SRPK2;PLD1;UPF3B;EGR1;MED23
prerank,regulation of cell differentiation (GO:0045595),0.3104794760816745,1.0219818258488638,0.4333706606942889,0.9679015945147939,1.0,15/148,9.72%,NGF;FGFR1;DLX1;MBOAT2;RUNX2;NF1;FLOT2;PTHLH;BMPR1B;LTBP4;DAG1;DDX17;ISL1;RPS6KA3;PHLDB1
prerank,regulation of sprouting angiogenesis (GO:1903670),0.3828454604421476,1.021867804142073,0.4484848484848485,0.9673305130999257,1.0,10/33,18.55%,CEACAM1;FGF1;CREB3L1;RHOJ;FGF18;CEMIP2;GLUL;ITGA5;JAK1;PDPK1
prerank,bile acid and bile salt transport (GO:0015721),0.40143851968194877,1.0212771530098552,0.45606060606060606,0.9680585169791496,1.0,2/24,1.94%,CEACAM1;ATP8B1
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4398175546112779,1.0211531302253845,0.4276422764227642,0.9675119472132804,1.0,2/15,2.68%,PPARGC1A;ELOVL5
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3262047882452413,1.0211336179280264,0.4528763769889841,0.9666564616397707,1.0,26/84,18.75%,PSME3;FBXO31;FBXO5;CUL3;CDC20;PSMB5;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;PSMB2;UBE2D1;PSMA2;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.3507691181693951,1.020909234734491,0.42207792207792205,0.9664270888988777,1.0,11/56,10.95%,EGFR;CCND3;ADAMTS1;UBE2E2;RDX;FBXO5;CUL3;ANAPC5;ANAPC7;MECP2;ANAPC11
prerank,negative regulation of DNA recombination (GO:0045910),-0.28723661124522426,-1.0208474544168762,0.4131944444444444,0.8024391811079912,1.0,19/43,26.75%,SHLD2;BLM;H1-0;POLQ;UBQLN4;ZRANB3;POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;CGAS;MAD2L2;ACD;RMI2;SMCHD1;PARPBP;POLR2I;PARP3
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.38256575919997354,1.0205006329017334,0.4287856071964018,0.966686142090697,1.0,7/31,14.31%,SIPA1L1;PPFIA2;LZTS3;SRCIN1;RELN;PTEN;CAPRIN2
prerank,regulation of hormone secretion (GO:0046883),-0.37980613542678454,-1.0203185253500522,0.422279792746114,0.8027618183571364,1.0,8/15,40.26%,ANXA1;EDN1;EDN3;SCG5;NMB;IL11;VAMP3;LIF
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.38872625019000007,1.0202732144563926,0.4371165644171779,0.9664232131826948,1.0,11/29,21.16%,AXIN1;KANK2;ISL1;DDRGK1;UFSP2;CBFB;YAP1;KMT2D;VPS11;CNOT1;RUNX1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3410151164532951,1.0198844485017813,0.4363143631436314,0.966605246223961,1.0,10/57,9.49%,USP50;CYFIP2;CIDEB;FIS1;ACVR1C;UACA;NLRC4;PERP;MAP3K5;HMGB1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.3495781984603478,-1.019680941088923,0.4233983286908078,0.8034013182784552,1.0,1/19,0.12%,IGF1
prerank,regulation of response to external stimulus (GO:0032101),0.31399216077787745,1.0196640060641557,0.43458475540386804,0.9663142018638899,1.0,12/121,7.09%,CAV1;GUCA1A;ADAMTS12;PIK3AP1;CD55;CELF1;PTPN22;WNT5A;CNGB1;EPHB2;N4BP1;EFNB2
prerank,isotype switching (GO:0045190),0.4838217882984611,1.0195884103510484,0.44727891156462585,0.965632135964366,1.0,3/10,16.40%,MSH6;MSH2;BATF
prerank,endodermal cell differentiation (GO:0035987),0.3816220335929172,1.0190031550745802,0.4363103953147877,0.96640336111169,1.0,9/31,17.35%,MMP15;ITGA7;LEO1;FN1;PAF1;MMP14;ITGA5;RTF1;SETD2
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3377112027539818,1.0189903600359718,0.43821656050955415,0.9655439527308223,1.0,15/63,19.72%,PLK2;GTSE1;CNOT10;ARID3A;FBXO31;SFN;CNOT7;RFWD3;SOX4;RGCC;TNKS1BP1;E2F1;CNOT8;CNOT1;BAX
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.3343510585291583,1.0186261212507546,0.4330413016270338,0.9656878620076569,1.0,14/75,13.51%,NR2F2;RGS14;STK38;NF1;SPRY1;SPRY4;IRAK3;PRKAR2A;PTPRJ;APC;HEXIM1;MEN1;PTEN;CDKN1C
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.39690955663338323,-1.0184151588899513,0.4368932038834951,0.8058253047001476,1.0,7/13,38.12%,UBE2J1;OS9;DERL2;SVIP;BCAP31;EDEM1;UBAC2
prerank,cellular protein modification process (GO:0006464),0.28554717641677835,1.0182422413620593,0.423,0.9658046909127083,1.0,209/982,18.42%,PIGU;TEC;PLK2;FAM20C;TRIB2;CDK15;GPC3;STC2;FGFR1;ST3GAL4;HCST;SLC35A1;PRKCE;PTPN13;UBE2L6;CAMK2D;LAMC1;LAMB2;CEL;PTPRF;FBXL15;UST;UBE2E2;SOCS5;CD3G;DUSP12;MINK1;B3GALT1;ASB6;STK38;MAP3K1;MMP15;TXK;LMO7;MAPK10;PTPN14;ERO1A;SCG3;PRKAG1;EIF2AK3;UBE2I;TPTE;BMPR1B;PTPN22;PRKCA;CDKL3;SPSB4;PEAK1;PSME3;NUCB1;CPE;MORC3;LIMK2;IRAK3;PTPRC;ACVR1C;KEAP1;FN1;PPM1A;EGLN3;PDK4;HIPK1;PIK3R4;BMP15;SUMF1;BRSK1;NEK7;FER;CDK13;BCKDK;COQ8A;ADAM10;SOCS6;PTP4A2;SIRT3;ATG5;PPM1M;ABL2;GOLM1;GMFB;COL3A1;CDK7;BMP2K;RAB3A;STK38L;RARA;FBXO31;CUL3;MTMR7;MAP3K5;RCN1;CDH2;SRPK1;PTPRJ;GCNT2;DYRK1A;NRBP2;CSNK1G3;MTMR6;PSMB5;DCAF13;MTMR3;PDP2;STK24;STK3;GSK3B;SIRT7;PTPRT;CSNK1A1;SDHAF2;TYK2;CTDSP1;SRPK2;ST8SIA5;ILF3;MANBA;FBXL19;PROC;PRKCSH;PPP2R1B;ST8SIA3;KLHL21;HS3ST5;FBXL5;PTPN18;MEN1;SGK1;LIPE;HUNK;FBXO11;PARP6;OARD1;DAD1;MAP3K21;PTEN;PTPRA;DUSP8;PRKACB;ATG7;SIK3;ERN1;FBXO21;LCMT1;PSMB2;P4HB;UBE2D3;STT3A;PSMA2;KLHL22;CTDSP2;PTPRU;PTPRO;CHM;FNTB;FEM1C;PSMA6;PARP8;CHRM3;CHGB;PIK3C3;WWP2;COPS5;NEK4;PTPN6;PSMD13;FBXW8;SERP2;CDKL2;PSMA7;MAN2A2;OGA;FBXO41;DDB2;ERBB2;TBK1;NEK11;TBCK;FBXL12;MBTPS1;SYK;FBXW7;BTK;FBXL3;PAK3;MAP3K9;PPP1CA;CUL4B;LMTK2;PP2D1;RNF7;DYRK2;PSME4;VCAN;CALU;FSTL1;BTBD6;WFS1;JAK1;PINK1;VGF;DAPK2;PTAR1;SOCS2;PSMC4;FBN1;ILKAP;COG3;PSMB6;PSMD12
prerank,cellular component assembly (GO:0022607),0.2981429643747785,1.018220848509895,0.44783983140147526,0.9649724056391554,1.0,27/253,9.41%,MAGI1;PPARGC1A;PARVA;WIPF1;LAMC1;REPS2;PARD6B;CD3G;SPEF1;KMT2A;OPHN1;ADD1;SOX9;CDAN1;RAC2;WNT5A;CARD10;FANCC;TEX11;TAPBP;SHROOM2;SPAG17;RHOJ;OCLN;DARS1;CALD1;FOXJ1
prerank,transferrin transport (GO:0033572),-0.30326591801967695,-1.018204407718394,0.40298507462686567,0.805347462661871,1.0,11/33,22.14%,STEAP3;TFRC;ATP6V0A4;ARHGAP1;ATP6V0C;ATP6V1C1;HFE;ATP6V1D;RAB11B;ATP6V1F;ATP6V1E1
prerank,stress-activated MAPK cascade (GO:0051403),-0.26919358979732966,-1.0179218808154646,0.40789473684210525,0.8049805260156359,1.0,17/61,19.93%,TNFRSF19;MAP3K20;TRAF6;UBE2N;NOD1;CRKL;MAP3K10;TRIB1;TAOK2;MAP2K3;IKBKB;LGALS9;ZFP36;IRAK2;CUL1;GPS1;SKP1
prerank,regulation of phospholipid metabolic process (GO:1903725),0.47205736852671515,1.01765629607386,0.4663299663299663,0.9657424170437697,1.0,3/10,19.31%,MTMR3;MTMR1;DNAJC19
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.47227422463530133,1.0176395330962682,0.44939965694682676,0.9649108563252473,1.0,2/11,1.53%,NEDD4L;LEPROT
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.29568900742185855,1.017553842107875,0.44228694714131606,0.9642678390550777,1.0,19/234,6.99%,EDA;CAV1;ROR1;PPARGC1A;IL18R1;RIPK4;FZD2;LPAR5;CRTC1;FLOT2;PLPP3;HDAC4;IRAK3;WNT5A;FER;TRADD;ARHGEF5;TRIM21;NLRC4
prerank,heme biosynthetic process (GO:0006783),-0.33518856358886295,-1.0173791399633136,0.430939226519337,0.8054084775037661,1.0,11/22,24.33%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;UROD;HMBS;TSPO;ALAD
prerank,plasma membrane repair (GO:0001778),-0.3962613337305013,-1.0171239667108447,0.4219512195121951,0.8050532347655018,1.0,4/13,9.25%,MYOF;DYSF;SYT7;SYTL4
prerank,pyrimidine nucleoside metabolic process (GO:0006213),0.4484828119274318,1.017052889604331,0.4337152209492635,0.9647591241675286,1.0,4/14,8.59%,DPYS;UPP2;NT5E;CAD
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.36860172467754004,-1.0168450657498185,0.42857142857142855,0.8046851240656782,1.0,4/16,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,intermediate filament organization (GO:0045109),-0.36234533291970206,-1.0166707774013164,0.4469135802469136,0.8040478139407008,1.0,5/17,14.51%,NEFL;BFSP2;GFAP;DES;VIM
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.40392797065926567,1.0165278755685132,0.44478063540090773,0.9644506669230625,1.0,11/23,24.32%,PPP1R13B;SFN;BAD;NMT1;YWHAG;YWHAE;E2F1;MAPK8;TFDP1;YWHAB;YWHAQ
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.40392797065926567,1.0165278755685132,0.44478063540090773,0.9644506669230625,1.0,11/23,24.32%,PPP1R13B;SFN;BAD;NMT1;YWHAG;YWHAE;E2F1;MAPK8;TFDP1;YWHAB;YWHAQ
prerank,zymogen activation (GO:0031638),0.37501944507567125,1.0164151914184947,0.43453237410071943,0.9638619442284277,1.0,6/39,7.23%,KLK2;CYFIP2;CIDEB;CD5L;NLRC4;PERP
prerank,negative regulation of defense response to virus (GO:0050687),0.49092421929910574,1.0161671068791225,0.4444444444444444,0.9636543418170782,1.0,4/10,21.90%,PCBP2;ITCH;MUL1;TSPAN6
prerank,regulation of keratinocyte differentiation (GO:0045616),0.406762570774613,1.0161655901261222,0.44171779141104295,0.9627802919156934,1.0,1/24,0.21%,ETV4
prerank,response to hydroxyurea (GO:0072710),-0.40964635234608304,-1.0160347930244513,0.44146341463414634,0.8047169441876454,1.0,4/11,19.71%,BLM;DDI2;NSMCE3;TIMELESS
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.4183827610349968,1.0159710757748766,0.46199701937406856,0.9606677303685874,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.4183827610349968,1.0159710757748766,0.46199701937406856,0.9606677303685874,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,spindle assembly checkpoint signaling (GO:0071173),0.4183827610349968,1.0159710757748766,0.46199701937406856,0.9606677303685874,1.0,8/20,18.05%,CDC20;TEX14;TPR;APC;BUB3;KLHL22;ZW10;MAD1L1
prerank,negative regulation of cell projection organization (GO:0031345),0.35657508963346396,1.0155748751374722,0.456,0.9608337540582496,1.0,11/48,14.48%,LPAR1;RAB29;RTN4R;TRPV4;EFNB2;SEMA3A;KANK1;HDAC2;RTN4RL1;PTEN;PTPRO
prerank,pyrimidine-containing compound catabolic process (GO:0072529),0.4420324860228082,1.0154888010755816,0.44554455445544555,0.9601855156775944,1.0,6/16,15.08%,DPYS;UPP2;NT5E;DPYSL2;DPYSL5;NT5C3A
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.3592483807825423,1.015357743421154,0.42178770949720673,0.9596748440940622,1.0,6/43,7.46%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,cellular response to osmotic stress (GO:0071470),0.41310887786972006,1.0151526533794761,0.43601895734597157,0.9593609809570317,1.0,3/21,7.04%,LRRC8D;TRPV4;SLC4A11
prerank,intracellular cholesterol transport (GO:0032367),-0.3780042792538808,-1.015012213242244,0.45365853658536587,0.8065708357542127,1.0,5/15,14.28%,LDLR;LRP6;LDLRAP1;VPS4A;ABCG1
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.3710934501117196,-1.0148691020732583,0.4479166666666667,0.8058632274934566,1.0,5/18,6.84%,ACSL1;ACSL3;ELOVL7;ACSL6;HSD17B12
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3322260848008317,1.014598414389155,0.43375,0.9599674959534531,1.0,6/73,6.99%,NGF;DLC1;EIF2AK3;EGLN3;TRADD;NLRC4
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.29997035635890984,-1.0140748029416367,0.40327868852459015,0.8069730465068508,1.0,13/33,26.38%,ETS1;HOXA5;HIF1A;TAL1;FES;RAB7B;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3
prerank,endocytic recycling (GO:0032456),-0.279558797586056,-1.013998387069512,0.4219858156028369,0.8060975476851213,1.0,15/50,22.32%,VPS39;VPS35L;ENTR1;EPS15;RAB13;DENND1A;EIPR1;EHD4;MICALL1;STX6;RAB11FIP3;RAB11B;ANKRD27;RAB7A;ARL4C
prerank,T cell receptor signaling pathway (GO:0050852),0.30682297536561826,1.0138278924405173,0.4489092996555683,0.9612368531256423,1.0,30/138,18.75%,TEC;ITK;CD3G;PDE4D;TXK;EIF2B3;PTPN22;PSME3;PTPRC;LCP2;PIK3R2;PTPRJ;PSMB5;LAT;TAB2;EIF2B4;CD276;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;NFKBIZ;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.3242386574229271,-1.013670873194895,0.4322033898305085,0.8058807397211528,1.0,7/24,11.67%,DACH1;ACVRL1;BMPR2;BLM;SUB1;RPS3;H1-0
prerank,anion transmembrane transport (GO:0098656),0.3423162008198305,1.0135510171130553,0.432258064516129,0.961150053545072,1.0,10/67,6.69%,LRRC8D;SLC35A1;SLC25A12;SFXN2;PRAF2;SLC27A1;ABCC1;SLC6A13;SLC35C2;SLC1A6
prerank,regulation of protein targeting to mitochondrion (GO:1903214),0.3701518265407474,1.0129968145643176,0.4454022988505747,0.9617931889971365,1.0,13/38,20.41%,LEPROT;ABLIM3;RAC2;SIAH3;HTRA2;UBE2J2;UBE2D3;FBXW7;VPS11;CSNK2A2;PINK1;UBL5;PRKN
prerank,response to ketone (GO:1901654),0.40251957224489776,1.0129302972147545,0.4305343511450382,0.9611261398591273,1.0,1/24,0.24%,CAV1
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.43003592752816455,1.0129123834923637,0.43906510851419034,0.960301049865705,1.0,2/16,1.86%,PLCB3;KLK2
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.3957470160549764,-1.012880189073098,0.4684466019417476,0.8068902407371116,1.0,4/12,8.19%,IGF1;INSR;IGF2;AKT1
prerank,regulation of axon regeneration (GO:0048679),0.45254250447028144,1.012800993406433,0.46846846846846846,0.9597584140257946,1.0,4/12,10.73%,RTN4R;INPP5F;STK24;RTN4RL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.41918702746769004,1.0126181997855084,0.44684129429892144,0.9585003627583114,1.0,4/21,7.45%,EYA1;IL1A;MCL1;MAPK7
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),0.41918702746769004,1.0126181997855084,0.44684129429892144,0.9585003627583114,1.0,4/21,7.45%,EYA1;IL1A;MCL1;MAPK7
prerank,regulation of vasculogenesis (GO:2001212),0.450472061806622,1.0124918594574015,0.4417808219178082,0.9579565901845093,1.0,2/14,1.89%,CEACAM1;RAP1A
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3125138553959122,1.0122936523658426,0.45381984036488027,0.9576701403620126,1.0,21/128,10.56%,F11R;INHBB;PXN;CDH5;RUNX2;BMPR1B;SRC;BMP5;ACVR1C;BMP15;ZFYVE16;RGMB;TGFBRAP1;COL3A1;GCNT2;LTBP2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.4337976886611857,1.0122549226496507,0.45,0.956914098055388,1.0,3/17,9.49%,CXCL17;ANO6;HMGB1
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.30383595978434264,1.0121989393111668,0.4619625137816979,0.9562014983602078,1.0,63/173,25.29%,DYNLL1;FOLR1;CAPZB;RAB29;CD55;TRAPPC3L;LMAN2;GOSR1;CNIH1;SPAST;ACTR10;ATL2;CUL3;COG6;GOLGB1;NRBP2;TFG;TMED4;GRIA1;DYNLL2;ANK1;PROC;COPE;GOLT1A;COPG1;TRIP11;TEX261;ZW10;COPA;TMED2;TICAM2;TBC1D20;TRAPPC3;ERGIC1;SPTBN1;ARCN1;STX5;COG3;BET1;DCTN2;SEC24B;NSF;DYNC1LI2;CNIH4;SPTB;USO1;COG5;DYNC1I1;TRAPPC8;SPTBN5;PGAP1;DCTN6;SEC13;F8;VAPA;ARF4;VAPB;DYNC1I2;SAR1A;SPTAN1;PEF1;WHAMM;LMAN1
prerank,regulation of immune response (GO:0050776),0.31083910794671993,1.0114208263640956,0.4554913294797688,0.9575514064232259,1.0,22/135,16.49%,CXADR;HCST;CD3G;CD300LG;IL4I1;PTPN22;N4BP1;COL3A1;ITGB7;CRTAM;PLSCR1;CD200R1;COL1A1;LAIR1;CD276;CD81;ULBP1;SH2D1A;IL15;ZMPSTE24;LAG3;SYK
prerank,response to hydrogen peroxide (GO:0042542),-0.2897813947655869,-1.011256720010817,0.45878136200716846,0.8101553362608105,1.0,14/45,17.52%,CYP1B1;SIRPA;CAT;PDCD10;ANXA1;OSER1;RHOB;RPS3;NET1;GLRX2;FXN;APTX;ANKZF1;TRPM2
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.29537512864424254,-1.0109833822159886,0.4642857142857143,0.8098338488085803,1.0,11/39,13.91%,ROBO1;RBPJ;NOS3;EP300;CCN3;PDCD10;JAG2;SNW1;TM2D3;TGFB2;MAML3
prerank,cellular response to heat (GO:0034605),0.3745082508883469,1.0106376723662087,0.43786127167630057,0.9588131947660055,1.0,12/35,21.75%,FGF1;TRPV4;IL1A;BAG3;TPR;CLPB;HTRA2;YWHAE;SLU7;SUMO1;DAXX;RBBP7
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.28703616616647387,-1.0104885868554367,0.3903345724907063,0.8101115017936886,1.0,16/42,25.40%,SHLD2;ACTR2;ARID2;KDM1A;MMS19;POLQ;UBQLN4;PPP4R2;PARP1;TIMELESS;CGAS;MAD2L2;RMI2;RAD51;SMCHD1;PARPBP
prerank,negative regulation of protein binding (GO:0032091),0.33143053570928155,1.0103292430422264,0.4451530612244898,0.9587639906444404,1.0,5/71,5.27%,CAV1;EFHB;PTPRF;DACT1;STYX
prerank,L-amino acid transport (GO:0015807),0.3889334628509014,1.0102042018209445,0.43536404160475484,0.9582300938601592,1.0,7/28,13.00%,SLC25A12;SLC38A2;PRAF2;SLC1A6;SLC7A2;SLC25A13;SLC25A22
prerank,negative regulation of wound healing (GO:0061045),0.3854135058075364,1.009445091387306,0.44298245614035087,0.9593906916998611,1.0,4/28,3.14%,CLDN19;SLC12A2;AJAP1;CASK
prerank,regulation of defense response (GO:0031347),-0.2522782167897602,-1.0090265687963047,0.4065934065934066,0.8130006636201017,1.0,21/76,17.73%,IL1R1;FOXP1;SEMA7A;APPL2;SAMHD1;LACC1;AREL1;AGTR1;APOE;LRP8;JAK2;ANXA1;USP18;IRF1;CASP12;TMSB4X;ERAP1;ACE2;CASP8;CASP4;SBNO2
prerank,receptor metabolic process (GO:0043112),0.34673327241748186,1.0089994727356726,0.44519621109607577,0.9597011105835569,1.0,7/53,5.29%,CAV1;ACKR3;PHETA2;CD9;DNM1;KIF16B;PIK3R4
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.4220156400631849,1.0088599149187902,0.44603174603174606,0.9592196677565631,1.0,9/19,23.75%,CHD8;POLR3G;ELL;BRF2;RPTOR;TENM1;ICE2;POLR3C;MTOR
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.288041958080454,1.0088389686260781,0.4704081632653061,0.9584281895490514,1.0,80/327,21.51%,RORA;BNC2;NFATC2;PPARGC1A;ZNF423;EFEMP1;MYBBP1A;NFIA;CHD3;SPI1;KAT6B;SP3;BHLHE40;ONECUT1;TGFBRAP1;PPIE;HIC1;ZNF431;LIN54;RREB1;MSL3;ELAVL2;ZNF628;FOXK2;POFUT1;MLF2;ACTR8;RORB;SUPT4H1;TRRAP;TFEB;USP13;WWC1;SAP30L;MZF1;MED23;JMJD1C;SPIN1;CREBBP;NCOA2;SOX4;SFPQ;BAZ2A;FZD7;REXO4;TAF5;KMT2D;SRRT;DMTF1;PSPC1;E2F1;ESRRA;HP1BP3;MAGED1;MTF2;BACH1;CREM;CELSR2;FOXO4;ASCC2;SPTY2D1;FADS1;ASCC1;PPP2CA;TCF7L1;TCF3;HNRNPD;ZNF22;HCFC2;HMG20A;GZF1;DDIT3;RNF14;ARNT2;ATXN1L;ZSCAN21;DAXX;CCAR2;SRSF10;FOXC1
prerank,"base-excision repair, AP site formation (GO:0006285)",0.4213777379496004,1.008683708084779,0.4527363184079602,0.9579954953031015,1.0,2/17,4.81%,TDG;NTHL1
prerank,extracellular transport (GO:0006858),0.44662210223081694,1.0083848161322089,0.4469565217391304,0.9579531639176383,1.0,4/12,15.14%,TSG101;SPAG17;WWP2;CCDC40
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.4148580110571835,1.0083412233676852,0.4481658692185008,0.9572107620940727,1.0,4/22,8.58%,LBP;PTPN22;TNFAIP3;ACOD1
prerank,tricarboxylic acid metabolic process (GO:0072350),0.4567699660520266,1.0082716879105942,0.4714765100671141,0.956541295726,1.0,1/12,1.60%,ASS1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.32345819396155145,-1.008078309641351,0.449685534591195,0.8144394947076468,1.0,12/25,31.32%,ETS1;HIF1A;TAL1;ABCB10;INHBA;NCKAP1L;HSPA1A;ACVR1B;FAM210B;STAT3;HSPA1B;ACVR2A
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.39248962494933454,-1.0080182362394896,0.4580152671755725,0.8135060526668778,1.0,4/13,8.19%,IGF1;INSR;IGF2;AKT1
prerank,negative regulation of protein depolymerization (GO:1901880),-0.32969328356862154,-1.0079717813537687,0.4362017804154303,0.8125329200783294,1.0,6/24,14.68%,PLEKHH2;ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.3616317425083262,1.007812474114174,0.43651925820256776,0.9569579819756019,1.0,6/41,7.46%,LBP;PTPN22;IRAK3;TNFAIP3;SELENOS;RARA
prerank,regulation of catecholamine secretion (GO:0050433),-0.3115801560398104,-1.0074808638221981,0.43373493975903615,0.8127584828896807,1.0,21/29,43.50%,KCNB1;SYT9;SYT7;DTNBP1;SYT13;SYT6;KCNA2;CHRNA4;SYT15;SYT1;SYT5;SYT17;CHRNB2;SNCA;SYT4;SYT3;DRD3;FGF20;HRH3;CHGA;SYT8
prerank,microtubule polymerization or depolymerization (GO:0031109),0.4094785059700185,1.0074357890083145,0.46417445482866043,0.9571503125559816,1.0,4/24,7.38%,KIF2A;NCKAP5L;TRPV4;CKAP5
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.36232127410875176,1.0073656166896887,0.44025974025974024,0.9564992881520694,1.0,14/42,20.18%,RARS2;TARS2;VARS1;CARS2;DARS1;KARS1;AIMP1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;TARS3
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.32722555115599894,1.0070353769364988,0.44599745870393903,0.956514932130341,1.0,25/73,21.63%,LMO1;KMT2A;SPI1;PSME3;PUS7;PSMB5;PSMB2;CBFB;PSMA2;PSMA6;PDCD2;KITLG;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;RUNX1;FOXC1;PSMB3
prerank,eosinophil chemotaxis (GO:0048245),-0.3736335646444794,-1.0069856004859417,0.4396984924623116,0.811980377417887,1.0,11/14,51.71%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil migration (GO:0072677),-0.3736335646444794,-1.0069856004859417,0.4396984924623116,0.811980377417887,1.0,11/14,51.71%,SCG2;CCL13;CCL2;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,mRNA splice site selection (GO:0006376),0.38125963743886915,1.0066205511163395,0.44155844155844154,0.9568033186904786,1.0,11/30,24.14%,CELF1;CELF2;CELF4;LUC7L2;SFSWAP;SF1;SLU7;SRSF12;SRSF10;YTHDC1;PUF60
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.28737565990573255,1.0065596070527358,0.46830265848670755,0.9561104214306979,1.0,57/417,11.94%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;ATP8B1;MYBBP1A;BCL3;RUNX2;RBFOX2;SFMBT2;CIART;SPI1;L3MBTL3;FOXK1;SOX9;UBE2I;GLIS2;CHD8;KAT6B;HDAC4;LANCL2;KLF10;WNT5A;CREB3L1;RBM15B;HEYL;SP3;BHLHE40;RCOR3;CTCF;NCOR1;TBX2;RARA;SUV39H1;KCTD1;FOXK2;UIMC1;TSC22D4;MECP2;RORB;USP47;HDAC2;CNOT7;ZHX1;NCOR2;ILF3;HDAC6;HEXIM1;ZNF148;MEN1;KDM8
prerank,potassium ion transmembrane transport (GO:0071805),0.306124719145652,1.0064950972009163,0.46498277841561425,0.9554303329840748,1.0,18/135,11.18%,KCNJ4;NALCN;SLC12A2;KCNA5;KCNJ16;SLC24A1;SLC12A4;KCNS2;SLC12A3;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6
prerank,regulation of epithelial cell migration (GO:0010632),0.3482647398920754,1.0063818517068746,0.43275632490013316,0.9548721699508117,1.0,8/51,7.32%,DOCK5;PRKCE;CEACAM1;DOCK1;SOX9;SRC;RHOJ;RREB1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.28935084505929104,1.0054764154503524,0.47461139896373056,0.9565051649223144,1.0,52/291,16.38%,RORA;LBP;PXN;FOLR1;EGFR;RAPGEF3;RAP1A;SSTR1;TNIP3;GPLD1;IL1A;MPV17;SOX9;ATP2B4;WNT5A;PDK4;FER;TNFAIP3;NRIP1;ABL2;SELENOS;PAF1;BRINP1;DEFA6;ACOD1;TSHR;IRGM;CHMP5;HMGB1;RORB;TICAM1;POU4F1;AXL;EGR1;NCOA3;NFKBIB;WNT9A;AQP1;CAPN2;RRAGB;HTRA2;KCNK4;FZD7;LCOR;GPER1;CCR5;CCDC62;CPEB3;TICAM2;PLAA;TESC;EZR
prerank,alpha-amino acid metabolic process (GO:1901605),0.35185709791611386,1.0053314211943432,0.44214876033057854,0.9560262808989465,1.0,10/45,13.54%,ASS1;NAALAD2;SLC25A12;AADAT;MTHFD1;DDAH2;ALDH18A1;SLC25A13;GOT1;GLUL
prerank,positive regulation of cell growth (GO:0030307),0.3217343417482218,1.005162309746024,0.4449877750611247,0.9556406068622716,1.0,12/96,12.06%,NGF;NEDD4L;NTN1;EGFR;ADAM10;RIMS2;CPNE9;RPS6KA3;USP47;S100A9;INO80;SEMA4D
prerank,regulation of protein kinase B signaling (GO:0051896),0.29964398595540237,1.0050434139756594,0.46229508196721314,0.9551171791406612,1.0,21/193,10.07%,GAB1;FGF7;NTRK3;FGFR1;PIK3AP1;EGFR;FGF1;PHLDA3;TPTE;SRC;RAC2;BANK1;DAG1;PHLPP1;PIK3R2;PTPRJ;GCNT2;FGF18;GAB2;AXL;FERMT2
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3951197348276655,-1.0050401703072416,0.45774647887323944,0.8161933760404145,1.0,2/13,6.74%,ETS1;TRAF6
prerank,regulation of phospholipase C activity (GO:1900274),0.4455632399463708,1.004987699472318,0.45,0.9544349552068682,1.0,2/15,0.70%,NTRK3;FGFR1
prerank,sensory perception of sound (GO:0007605),0.3255027146119877,1.0047241204738933,0.47515151515151516,0.9542803585433228,1.0,5/88,4.62%,ROR1;HOMER2;RIPOR2;EYA1;TMC2
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.3101700050746886,1.0039235707775411,0.46436781609195404,0.955582313343373,1.0,9/122,3.28%,SMOC2;GLI1;SORBS1;EGFR;BCL3;HSPH1;FXR2;GLI2;PIWIL2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.3048768282892386,-1.0037090080432407,0.4214046822742475,0.8187310391200943,1.0,16/32,37.23%,TRPC1;AKAP6;CALM1;CALM3;JPH2;P2RY6;GSTO1;APLNR;NPSR1;F2R;CASQ1;CXCL10;CAPN3;THY1;SNCA;TRDN
prerank,regulation of gene expression (GO:0010468),0.28095583418659076,1.0035140692590576,0.4994994994994995,0.9558441071741468,1.0,112/903,11.79%,NGF;RORA;BNC2;AHNAK;FGF7;NTRK3;NFATC2;STC2;PPARGC1A;AFF3;ZNF423;FOXD1;CLDN19;EFEMP1;GLMN;MUSK;AHNAK2;MYBBP1A;FGF1;ADAM19;SLC26A9;CDH5;TDG;NFIA;COQ7;CLK1;SLC38A2;ITGAX;CHD3;SFMBT2;TXK;PCBP2;IL1A;SPI1;PRKAG1;WNT16;EIF2AK3;FLOT2;PTHLH;SOX9;CELF1;PGR;PTPN22;DIP2A;KAT6B;HDAC4;REL;ATP2B4;WNT5A;PTPRC;ATXN7L3B;CREB3L1;FN1;ZNF326;SON;SP3;BHLHE40;APLN;ONECUT1;TAPBP;ADAM10;TGFBRAP1;C1D;PPIE;EPHB2;KRAS;TRIM21;RIMS2;UBR5;RDX;CTCF;HIC1;ZNF431;CLK4;LIN54;RREB1;MSL3;IGF2BP2;ELAVL2;OCLN;ZNF628;GCNT2;FOXK2;NOS1AP;ZNF462;FGF18;AGO1;POFUT1;DDRGK1;MLF2;PLSCR1;MECP2;GSK3B;ACTR8;RORB;TICAM1;SUPT4H1;POU4F1;CNOT7;TRRAP;PTBP3;TFEB;USP13;SRPK2;WWC1;SAP30L;HDAC6;EGR1;MZF1;MED23;ZNF148;JMJD1C
prerank,negative regulation of biosynthetic process (GO:0009890),0.4245686064768755,1.003455444009218,0.46434494195688225,0.9551849634062789,1.0,6/16,20.68%,CEACAM1;ABCD1;ABCB7;GPER1;COA8;IL6
prerank,cAMP biosynthetic process (GO:0006171),-0.4204415103528026,-1.0033720806702098,0.45901639344262296,0.8186315454911189,1.0,4/10,7.59%,ADCY1;ADCY7;ADCY4;ADCY2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.33157722190188726,-1.003299481334907,0.46285714285714286,0.8177531840977295,1.0,11/24,27.00%,TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2;RNF34;UBB
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.39372934622807987,1.0031314607614266,0.46536144578313254,0.9551991049595907,1.0,7/25,14.38%,LEPROT;CHMP5;CHMP4A;CHMP4B;CHMP4C;LEPROTL1;LAPTM4B
prerank,negative regulation of lyase activity (GO:0051350),-0.36846051848981687,-1.0030117065197246,0.4458128078817734,0.8173854435208938,1.0,2/16,2.36%,ADGRV1;GRM3
prerank,sphingolipid metabolic process (GO:0006665),0.3174152229688116,1.0027004077927983,0.46054181389870436,0.9555727454197491,1.0,16/108,8.73%,SGMS2;CERS6;ACER3;ELOVL5;PLPP2;TEX2;PLPP3;ALOXE3;SUMF1;CLN8;HACD4;CERK;ELOVL1;NEU1;ELOVL2;CERT1
prerank,response to acidic pH (GO:0010447),-0.3851978101897785,-1.0023100806853138,0.47415730337078654,0.8183123099535053,1.0,6/13,25.96%,SLC9A1;GPR4;LGMN;RAB11B;PKD2L1;PKD1L3
prerank,regulation of protein localization to nucleus (GO:1900180),0.3510871332718842,1.0020677624568304,0.450199203187251,0.9563736772025233,1.0,11/43,15.72%,GTSE1;EIF2AK3;LIMK2;CARD10;GSK3B;FERMT2;TPR;OTUD7B;GLUL;CTNNA1;YAP1
prerank,negative regulation of type I interferon production (GO:0032480),0.36527883315017934,1.001832984143645,0.4442916093535076,0.9562019837478544,1.0,10/40,17.27%,UBE2L6;PCBP2;REL;TNFAIP3;ACOD1;NPLOC4;TAX1BP1;TBK1;RELB;ITCH
prerank,mitochondrial RNA metabolic process (GO:0000959),0.4352287470979213,1.001604667152064,0.46337579617834396,0.955994648979887,1.0,5/14,14.41%,FOXO3;TFB2M;MTERF2;TEFM;FASTKD1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.38027481945366637,-1.0013603328003058,0.4474327628361858,0.8198061357524304,1.0,6/14,18.01%,ADGRV1;MYADM;GPD1L;FLT4;WNT11;CD40
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.35506240807040806,-1.000791637951069,0.4151436031331593,0.8202032674225992,1.0,8/18,24.86%,HIP1R;ACAA2;BID;GSK3A;BOK;CHCHD10;ZNF205;HSPA1A
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.2461009037779581,-1.0000851697591742,0.4858757062146893,0.8211049838128788,1.0,19/93,13.76%,PLCB1;SASH1;TNFRSF19;CCN2;MFHAS1;SH3RF3;XDH;PDCD10;ANKRD6;TRAF6;ARL6IP5;MAP3K10;ZC3H12A;BMP2;TAOK2;FLT4;TGFB2;SPHK1;PJA2
prerank,mitochondrion organization (GO:0007005),0.302118627759969,0.9998888330256342,0.4769736842105263,0.9597547941395652,1.0,38/165,20.71%,CXADR;PPARGC1A;PISD;HK2;RAB29;WDR81;CAV2;MPV17;TOMM34;MFN2;DNM1;FIS1;ATPAF1;SIRT3;NRF1;MIEF1;IMMP2L;TFB2M;LONP1;MTX1;NIPSNAP2;TOMM40;DNAJA3;POLG2;BCS1L;AIFM2;BNIP3;ESRRA;MIGA1;TMEM70;PINK1;GABPA;DNAJC19;BAX;CHCHD3;PRKN;MUL1;ATP5F1D
prerank,cellular response to hydroxyurea (GO:0072711),-0.4136741359574194,-0.9998679921778313,0.4786729857819905,0.8206567732677833,1.0,4/10,19.71%,BLM;DDI2;NSMCE3;TIMELESS
prerank,positive regulation of phagocytosis (GO:0050766),0.3465837812348861,0.9997806527716202,0.45554035567715456,0.9592006329719639,1.0,6/47,8.21%,C2;ANO6;LMAN2;PTPRC;DOCK2;PTPRJ
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.3358788980396183,-0.999766697443052,0.4521276595744681,0.8198533239863894,1.0,8/21,16.19%,SLC8A3;TGM2;RAP1GDS1;SMDT1;SLC25A23;MICU1;MICU2;ANXA6
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.329179022784591,0.9996693092055037,0.4598997493734336,0.9586343987710706,1.0,12/76,12.80%,TRIB2;PRICKLE1;AXIN1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;ZYG11B;PTEN
prerank,myelin maintenance (GO:0043217),0.4766491491648302,0.9995929704390997,0.4614035087719298,0.9580032137084457,1.0,5/10,22.24%,EPB41L3;ABCD1;PTEN;PRX;MYRF
prerank,positive regulation of cell cycle process (GO:0090068),-0.24207123067552083,-0.9992382399451719,0.4228571428571429,0.8202040059020396,1.0,9/91,3.96%,IGF1;INSR;TGFA;PDGFRB;SVIL;MAP3K20;CDC42;IGF2;USP19
prerank,mitotic cytokinetic process (GO:1902410),0.40660125936775116,0.9991552554582497,0.45638629283489096,0.9583929793936359,1.0,6/20,11.97%,CHMP5;PDCD6IP;CNTROB;CHMP4A;CHMP4B;CHMP4C
prerank,regulation of exosomal secretion (GO:1903541),0.4191241195355585,0.999083147975813,0.4692913385826772,0.957771222101515,1.0,9/19,25.38%,TSG101;SDC1;PDCD6IP;ATP9A;SDC4;PRKN;CHMP2A;SNF8;STAM
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.3044782666801913,-0.9986376780525628,0.4672364672364672,0.8207883004884324,1.0,10/33,22.92%,LEF1;TRAF6;IL34;HAX1;ID2;HSF1;CSF1;CASP8;FES;RIPK1
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.3814976293186128,0.9985772501162289,0.45454545454545453,0.9582798598940144,1.0,1/29,0.24%,CAV1
prerank,primary miRNA processing (GO:0031053),-0.4117480253150193,-0.9985430633543324,0.4659090909090909,0.8199524717065076,1.0,5/10,27.65%,SMAD3;PUS10;SMAD1;MRPL44;SMAD2
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.3992083650949334,-0.9982899555195247,0.44711538461538464,0.8196307937316243,1.0,5/11,30.78%,KCNJ2;ATP1B1;KCNH2;ATP1A1;KCNQ1
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.3296893538705343,0.9980475063658588,0.4835443037974684,0.9589247068897745,1.0,9/70,8.13%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.40898238840189904,-0.9978577431796198,0.47072072072072074,0.8197874650353096,1.0,4/11,13.76%,LYN;MFHAS1;CYBA;PJA2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.45832435106067215,0.9977474079101588,0.4540901502504174,0.9588673804108896,1.0,8/12,30.07%,CLCN2;RAN;MBTPS1;MBTPS2;SEC14L2;SREBF2;DGKQ;SREBF1
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.4094802865077857,-0.997261567176807,0.4583333333333333,0.8204308909859079,1.0,4/10,14.20%,MTHFS;MTHFR;DHFR;MTHFD1L
prerank,regulation of organelle assembly (GO:1902115),0.32836656814758014,0.996865723583746,0.4444444444444444,0.9602693663455897,1.0,25/72,21.99%,PLK2;SENP6;STIL;TSG101;ATG5;RDX;MTMR3;PDCD6IP;TBC1D16;TBC1D2;TBC1D8;ATXN2;EVI5;DYNC2LI1;EZR;TBC1D20;VPS11;TBC1D5;RAB5A;ATG3;TBC1D10A;ALMS1;CDKL1;IFT140;HCK
prerank,histone deacetylation (GO:0016575),0.3529234260287956,0.9968419997923142,0.4720744680851064,0.9594981832694349,1.0,18/43,24.14%,HDAC4;SMARCAD1;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;SFPQ;BAZ2A;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;SIN3A;SUDS3;REST
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.4008959257750534,-0.9966574166531871,0.45495495495495497,0.820937824290164,1.0,2/11,1.71%,MSN;DAB2
prerank,regulation of adaptive immune response (GO:0002819),-0.34331681846036366,-0.9966257713088045,0.48737373737373735,0.8199652577020173,1.0,9/18,28.07%,ADCY7;IRF1;EIF2AK4;SAMSN1;AHR;SKAP1;PYCARD;TRIM27;FCGR2B
prerank,regulation of fatty acid metabolic process (GO:0019217),0.4284966950455341,0.9966207642746563,0.47157190635451507,0.9592941942899332,1.0,3/17,6.94%,CAV1;PDK4;NCOR1
prerank,second-messenger-mediated signaling (GO:0019932),0.3214051965388168,0.9962307022528362,0.46706586826347307,0.9595412439549429,1.0,8/82,10.18%,HRH1;ACKR3;PLCE1;EIF2AK3;DDAH2;RCAN1;KSR2;LAT
prerank,icosanoid biosynthetic process (GO:0046456),0.4697064875008919,0.9961667380427502,0.48342059336823734,0.9588937246389438,1.0,4/10,22.81%,MGST2;LTA4H;FADS1;PLA2G4A
prerank,plasma membrane tubulation (GO:0097320),0.4449255396084046,0.9961366005755529,0.4835924006908463,0.9581513686751968,1.0,6/13,19.98%,PACSIN2;EHD2;CHMP4A;CAVIN2;PACSIN3;PACSIN1
prerank,regulation of cell division (GO:0051302),0.32595858892460816,0.9960919996253946,0.4623243933588761,0.9574263992202794,1.0,13/72,12.39%,PLK2;FGF1;MLLT3;PIK3R4;CSPP1;KIF13A;CCP110;SFN;KLHL21;ZFYVE26;NCOA3;CETN2;AHCTF1
prerank,negative regulation of inflammatory response (GO:0050728),0.29844204590326373,0.9959475470900863,0.4709748083242059,0.9569916370430868,1.0,19/182,9.01%,RORA;PLK2;CD3G;CDH5;CXCL17;MC5R;FNDC4;PTHLH;SRC;ADCY5;TNFAIP3;SELENOS;MAPK7;PTGER4;PRKAR2A;ISL1;ACOD1;TSHR;CD200R1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.43665830417066603,0.9959033504504663,0.48494983277591974,0.9562914220609581,1.0,3/15,13.45%,HOMER2;GRM1;HOMER3
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.36325296296074716,-0.9957841651706141,0.47738693467336685,0.8211818445124721,1.0,7/16,22.54%,SOX5;HOXB4;SOX6;TGFB2;DHX36;PTN;SP7
prerank,postreplication repair (GO:0006301),0.3539942955234617,0.9957813603063304,0.4665757162346521,0.9557780225954258,1.0,6/45,7.45%,UBE2L6;USP43;POLI;RFC3;UBE2V2;MSH2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.31930218564625606,0.9957726184769915,0.4682926829268293,0.954988519153516,1.0,9/86,5.38%,INHBB;SULF1;ZNF423;FOXD1;FBXL15;CDH5;BMPR1B;BMP5;BMP15
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.36172228254430017,0.9954291898745589,0.4811188811188811,0.9550562712348599,1.0,14/37,23.98%,RNASEH2B;PABPC4;SIDT2;DFFB;NUDT18;ENTPD2;RNASE3;MTREX;HNRNPD;NUDT5;EXOSC7;NUDT1;RNASEH1;DNASE1L1
prerank,response to steroid hormone (GO:0048545),0.3822291146478503,0.9954050007824259,0.45161290322580644,0.9543007916187078,1.0,3/31,7.19%,CAV1;ATP1A2;CATSPERD
prerank,protein phosphorylation (GO:0006468),0.28404444012446656,0.9953866902054189,0.5085945399393327,0.9535377925019243,1.0,76/478,13.55%,PKDCC;TEC;PLK2;FAM20C;TRIB2;CDK15;FGFR1;HCST;PRKCE;CAMK2D;EFEMP1;EGFR;MUSK;MINK1;STK38;MAP3K1;TXK;MAPK10;PRKAG1;EIF2AK3;BMPR1B;PRKCA;CDKL3;PEAK1;SRC;MORC3;LIMK2;IRAK3;ACVR1C;PDK4;HIPK1;PIK3R4;BRSK1;NEK7;TLR7;FER;CDK13;BCKDK;COQ8A;ADAM10;EPHB2;ABL2;GMFB;CDK7;BMP2K;STK38L;RARA;MAP3K5;SRPK1;DYRK1A;NRBP2;CSNK1G3;CAD;STK24;STK3;GSK3B;RPS6KA3;MASTL;CSNK1A1;TYK2;RELN;SRPK2;ILF3;TOP1;HTATIP2;SGK1;LIPE;HUNK;MAP3K21;PKD1;USP15;PRKACB;SIK3;ERN1;GTF2H1;CIT
prerank,homocysteine metabolic process (GO:0050667),-0.3940742920889422,-0.9950971052767011,0.48729792147806006,0.822043480804807,1.0,6/11,30.82%,NOX4;MTHFR;MTRR;CBS;CTH;MPST
prerank,positive regulation of phospholipid transport (GO:2001140),-0.40564510164476797,-0.9950218343357284,0.49770642201834864,0.8211942591259248,1.0,2/10,6.28%,DBI;APOE
prerank,negative regulation of neurogenesis (GO:0050768),0.36910897269226467,0.9949837077830415,0.4449213161659514,0.9537266245081184,1.0,8/34,14.25%,LRP4;NF1;RTN4R;GDI1;HOOK3;PTEN;PCM1;RTN4
prerank,ganglioside metabolic process (GO:0001573),-0.3427590237198507,-0.9947909023744179,0.453781512605042,0.8207782036823918,1.0,8/20,22.45%,ST3GAL5;ST8SIA4;ST6GALNAC3;ABCA2;ST8SIA2;NEU3;ST6GALNAC4;CLN6
prerank,cellular response to BMP stimulus (GO:0071773),0.3316357596226837,0.9944475439131918,0.4666666666666667,0.9544011870850946,1.0,9/66,5.67%,DLX1;ADAMTS12;RUNX2;SOX9;BMPR1B;BMP5;BMP15;ZFYVE16;RGMB
prerank,negative regulation of macroautophagy (GO:0016242),-0.32251954318953197,-0.9944400263422669,0.4451219512195122,0.8206395032156102,1.0,9/26,16.41%,NUPR1;AKT1;QSOX1;RUBCN;LRRK2;USP36;UBQLN4;FEZ2;SCFD1
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.28605510278239,-0.9943671605201974,0.4426229508196721,0.8197837493230201,1.0,8/40,12.75%,SMAD3;LEF1;DAB2;TGFBR1;GLIPR2;TGFB3;BMP2;TGFB2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.38242518442393886,-0.9943298061531233,0.47512437810945274,0.8188315693893419,1.0,2/13,1.37%,PLXNA2;PLXNA4
prerank,regulation of p38MAPK cascade (GO:1900744),0.3670898903755568,0.9936416165509986,0.4731494920174166,0.955750342021371,1.0,6/35,8.02%,RELL1;MINK1;SPI1;PTPN22;ULK4;PHLPP1
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.32600999299300615,-0.9936206401665661,0.4913294797687861,0.8195679106165467,1.0,11/24,24.86%,NR1H3;NR1H2;AQP11;SYVN1;LRRK2;OPA1;RACK1;XBP1;CLU;TMBIM6;HSPA1A
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3533225308983902,0.9935201393751947,0.46184738955823296,0.9552568565410621,1.0,12/44,21.99%,PRKCE;CDC42EP4;FER;NCK2;ARF6;CTTN;CDC42EP3;BAIAP2;PFN2;NCK1;TENM1;HCK
prerank,aromatic amino acid family catabolic process (GO:0009074),0.42847175715856284,0.9934354516350676,0.4672268907563025,0.9546788888320917,1.0,3/15,10.44%,IL4I1;AADAT;GSTZ1
prerank,DNA modification (GO:0006304),0.39894625515628973,0.9932660577360265,0.4816,0.9543026742031214,1.0,3/22,5.32%,TDG;NTHL1;EXOSC5
prerank,proton transmembrane transport (GO:1902600),0.3646649621755425,0.9931533377231124,0.4617524339360223,0.9537933634198196,1.0,5/36,10.02%,OTOP1;ATP1A2;SLC4A11;COX15;NNT
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.32745473999101776,0.9927701794585045,0.4892541087231353,0.9539744957452468,1.0,9/71,8.13%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,synaptic vesicle endocytosis (GO:0048488),0.37661717348877066,0.9925725352406441,0.48502139800285304,0.9536753287441797,1.0,13/33,22.13%,CEL;STX1A;OPHN1;DNM1;STON1;STON2;SNCG;PACSIN1;AMPH;VAMP2;ITSN1;NLGN3;NLGN2
prerank,negative regulation of peptide hormone secretion (GO:0090278),0.4181953936050585,0.9925065435442636,0.4728171334431631,0.9530265062833523,1.0,1/18,0.54%,INHBB
prerank,pore complex assembly (GO:0046931),0.42147044420990104,0.9924449781378909,0.46794871794871795,0.9523779873866657,1.0,9/19,15.46%,ANO6;ADAM10;TPR;AHCTF1;NUP153;GSDMD;RTN4;BAD;NUP93
prerank,positive regulation of viral process (GO:0048524),0.3376592648031076,0.9922890858876269,0.4888888888888889,0.9519755008865699,1.0,10/60,12.47%,MDFIC;KPNA2;PPIE;SRPK1;NELFB;SUPT4H1;AXL;CNOT7;SRPK2;GTF2F2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.3315081001990071,-0.9920510676945182,0.48097826086956524,0.8228195561703274,1.0,5/21,10.31%,PRKCH;FOXP1;SLC39A10;BCL10;RPS3
prerank,positive regulation of establishment of protein localization (GO:1904951),-0.35472192926883717,-0.9916828113991104,0.4689119170984456,0.8227903802705869,1.0,5/18,12.82%,CCT7;CORO2B;CEP135;CCT8;CEP120
prerank,negative regulation of DNA binding (GO:0043392),-0.3215087108899023,-0.9915827815987381,0.46417445482866043,0.8220354689101709,1.0,6/28,20.59%,LEF1;SP100;JAK2;KDM1A;PER2;MAD2L2
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.30090617257310187,-0.9915488702500931,0.4692556634304207,0.8211095514610832,1.0,8/31,24.68%,PLCB1;PLCG2;LGALS9;LAPTM5;CD40;TLR3;CCL19;IRF5
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.36662826732018455,-0.9914968264781808,0.4433249370277078,0.8202047067039572,1.0,3/16,2.25%,ST3GAL5;ST8SIA4;ST6GALNAC3
prerank,regulation of protein dephosphorylation (GO:0035304),0.3636983404981653,0.9914609390388996,0.4691011235955056,0.953305021447975,1.0,14/37,24.12%,DLC1;CDH5;ENSA;PTPA;HTT;PPP6R3;SYMPK;PIN1;PPP6R1;CALM2;CDCA2;YWHAB;PPP6R2;PRKCD
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.33881088923619607,-0.9910190656129826,0.4520547945205479,0.8204348762120156,1.0,10/20,27.94%,ENTPD1;TXNIP;IL18;P2RX7;P2RX4;ENTPD5;C3;SUGT1;PYCARD;CASP1
prerank,ubiquinone metabolic process (GO:0006743),0.4199907396161419,0.9906980208268918,0.45616883116883117,0.9545025203212132,1.0,5/15,16.95%,COQ7;COQ8A;COQ9;AIFM2;COQ6
prerank,sulfur compound transport (GO:0072348),0.3831756523978163,0.9905093717058123,0.46715328467153283,0.9542091647343737,1.0,5/27,5.54%,LRRC8D;RACGAP1;SLC35B2;SLC27A1;SLC6A13
prerank,positive regulation of cellular protein metabolic process (GO:0032270),0.3164442478909596,0.989979502435868,0.4746376811594203,0.954789260958248,1.0,24/101,16.38%,VGLL4;CYFIP2;BCL3;OGT;FXR2;PIWIL2;DACT1;RDX;PERP;HDAC2;IST1;METTL5;PLD1;UPF3B;FAF1;NSUN5;ATG7;SOX4;FXR1;PYM1;BAD;CPEB3;ERBB2;EZR
prerank,regulation of extracellular matrix organization (GO:1903053),-0.38284972333105977,-0.9899514782445219,0.46437994722955145,0.8223699754954872,1.0,6/15,12.13%,AEBP1;LRP1;DDR1;TIE1;SLC2A10;FGFR4
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.3098179051062447,0.9899165102126501,0.47850678733031676,0.9541654230425964,1.0,41/128,22.51%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;NEDD1;CDK7;PHLDA1;TUBG1;CKAP5;PAFAH1B1;CCP110;MASTL;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;LCMT1;PCM1;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;CEP57;BACH1;OFD1;CEP250;DCTN2;ALMS1;TAF2;HAUS8;CEP43;FBXW11;BORA;HAUS3
prerank,positive regulation of reproductive process (GO:2000243),0.37420850704163716,0.9897942642349774,0.4711964549483013,0.9536940600480178,1.0,3/31,6.64%,INHBB;CACNA1H;LHFPL2
prerank,protein import (GO:0017038),0.3193498932369661,0.9897336491871286,0.4868255959849435,0.9530587929900585,1.0,22/84,19.84%,PRICKLE1;RAB8B;IPO8;NUP62;FIS1;PEX2;FAM53B;PXMP2;TPR;MMP12;NUP50;CSE1L;ABCD1;NUP153;RAN;NUP93;SYK;HSPA4;SLC25A17;LAMP2;RPAIN;PEX13
prerank,regulation of fat cell differentiation (GO:0045598),0.322289399535202,0.9895427661473826,0.4592875318066158,0.952775752663869,1.0,4/74,5.05%,RORA;TRIB2;WNT5A;TRIO
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3651464426941834,0.989260463196237,0.4650817236255572,0.9526678333914818,1.0,4/32,5.25%,SORBS1;CEACAM1;ZBTB20;PDK4
prerank,regulation of protein metabolic process (GO:0051246),-0.2749176749522357,-0.9890199828938142,0.4529616724738676,0.8238671510596288,1.0,11/44,12.04%,ROCK2;FKBP1A;LDLR;ACE;SPOP;KLF4;APOE;NEDD8;KLF2;FURIN;TMEM9
prerank,lymphocyte chemotaxis (GO:0048247),0.37002697951023455,0.9887767884871757,0.47538677918424754,0.9531283998603794,1.0,2/34,2.15%,SLC12A2;CYP7B1
prerank,positive regulation of nervous system process (GO:0031646),0.40640696497423956,0.9885980432787086,0.46865203761755486,0.9528640755765297,1.0,7/18,14.63%,ITGAX;RIMS2;NCMAP;ATPSCKMT;HCRT;UNC13B;DICER1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.39721837979999797,-0.988507300371797,0.4919908466819222,0.8241719871360338,1.0,4/11,13.20%,SEMA6A;SYNJ2BP;KLF2;THBS1
prerank,positive regulation of exosomal secretion (GO:1903543),0.4368595058928582,0.9884392226775985,0.4710884353741497,0.9524793459857852,1.0,7/15,25.38%,TSG101;SDC1;PDCD6IP;SDC4;CHMP2A;SNF8;STAM
prerank,stem cell differentiation (GO:0048863),-0.28349128349016733,-0.9883848508836648,0.4901185770750988,0.8234806588334448,1.0,8/39,8.66%,OSR1;KIT;FGFR2;HOXB4;ACE;PSMD11;LRP6;JARID2
prerank,regulation of interleukin-17 production (GO:0032660),-0.3018934172490466,-0.9883215374095968,0.4831804281345566,0.8225968251145281,1.0,8/31,25.87%,SLC7A5;RFTN1;IL18;SPHK1;NR1H4;NCKAP1L;NOD2;MYD88
prerank,regulation of vasculature development (GO:1901342),-0.3140582555044962,-0.9879631094938783,0.4567901234567901,0.8224998255156638,1.0,3/26,2.71%,ETS1;SP100;EGLN1
prerank,neuron projection regeneration (GO:0031102),0.4559560415003582,0.9877668953069346,0.45161290322580644,0.953418764799112,1.0,2/10,10.73%,FOLR1;RTN4RL1
prerank,positive regulation of neuron migration (GO:2001224),-0.4058411794731429,-0.9877221115929846,0.45754716981132076,0.8221594397845181,1.0,3/11,5.19%,RAPGEF2;ARHGEF2;SEMA6A
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.46368664953640826,0.9872144159808602,0.4607329842931937,0.9532131096388716,1.0,3/10,14.98%,CDC42EP4;APC;CDC42EP3
prerank,regulation of pseudopodium assembly (GO:0031272),0.46368664953640826,0.9872144159808602,0.4607329842931937,0.9532131096388716,1.0,3/10,14.98%,CDC42EP4;APC;CDC42EP3
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.39895723426313456,0.9867893942517674,0.4777777777777778,0.9535137153476088,1.0,8/21,18.94%,CNOT10;SAMD4B;CNOT7;PAN2;TNKS1BP1;CNOT8;PNLDC1;CNOT1
prerank,negative regulation of cellular protein localization (GO:1903828),0.3620045325642826,0.9862245233025265,0.46458923512747874,0.9542045484169247,1.0,4/34,3.65%,NEDD4L;RIPOR2;LEPROT;SPI1
prerank,connective tissue development (GO:0061448),0.3646482606007924,0.9858994576831517,0.49712643678160917,0.9542313279096191,1.0,7/35,13.69%,SULF1;SLC39A13;SOX9;SH3PXD2B;DDRGK1;PKD1;TRIP11
prerank,cellular response to retinoic acid (GO:0071300),-0.2821876421631372,-0.985889159671166,0.4517241379310345,0.8260019523302541,1.0,9/42,11.19%,EPHA3;WNT5B;LYN;ADNP2;BRINP3;TBX1;CREB1;SNW1;RET
prerank,protein monoubiquitination (GO:0006513),0.36840722734750314,0.9857925618884337,0.48813056379821956,0.9537361380305628,1.0,15/36,23.23%,LEO1;TRIM21;PAF1;CUL3;UBE3D;OBI1;UBE2D3;KLHL22;FANCL;UBE2R2;UBE2W;CDC73;PRKN;RNF20;DTX3L
prerank,protein palmitoylation (GO:0018345),0.37548606030518117,0.9855920888166615,0.4699853587115666,0.9534623717041741,1.0,13/30,22.52%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;ZDHHC20;GLUL;ZDHHC8;ZDHHC19;GOLGA7B;ZDHHC3;ZDHHC12;GOLGA7;ZDHHC5
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),-0.3052571608395223,-0.9853919209689872,0.45714285714285713,0.8252553260304848,1.0,9/29,19.96%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),-0.3052571608395223,-0.9853919209689872,0.45714285714285713,0.8252553260304848,1.0,9/29,19.96%,GPAT4;ACOT7;DBI;ACSL6;MLYCD;ACLY;ACOT6;ACOT11;OXSM
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.4381682655857809,0.9852279396845705,0.4787430683918669,0.9536119817524511,1.0,5/12,21.84%,DND1;NCOR1;NCOR2;PPARG;ELAVL1
prerank,histone H4-K8 acetylation (GO:0043982),0.42658555244928364,0.9850665728311417,0.4844827586206897,0.9524501792608185,1.0,3/15,14.16%,OGT;KANSL2;KAT8
prerank,histone H4-K5 acetylation (GO:0043981),0.42658555244928364,0.9850665728311417,0.4844827586206897,0.9524501792608185,1.0,3/15,14.16%,OGT;KANSL2;KAT8
prerank,regulation of interleukin-6 production (GO:0032675),0.31290628973069357,0.9850319989438224,0.4883148831488315,0.9517495199446696,1.0,13/96,9.49%,LBP;IL1A;PTPN22;IRAK3;WNT5A;IL17RA;TLR7;TNFAIP3;SELENOS;ISL1;CD200R1;FOXJ1;HMGB1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.32245935568325335,-0.9848489932736726,0.4604105571847507,0.8256857721850305,1.0,10/26,23.42%,ALPK1;TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),0.4439703376504397,0.9848250989673613,0.4835924006908463,0.9514870681457337,1.0,1/12,1.60%,ASS1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.38041213967197585,0.9847401768515562,0.46476761619190404,0.9509132414950072,1.0,9/26,18.29%,FBXO5;CUL3;ANAPC5;ANAPC7;ANAPC11;CDC6;LCMT1;ANAPC4;CDC23
prerank,regulation of cell population proliferation (GO:0042127),0.27695320526371503,0.9846798883349521,0.5602409638554217,0.9502845623242228,1.0,91/691,12.87%,NGF;ROR2;ZBTB7C;FGF7;IGFBP6;DLC1;NTRK3;CDH13;GLI1;FGFR1;CLDN19;PTGFR;GLMN;FOLR2;EGFR;ADAMTS1;FGF1;JAG1;SSTR1;ACER3;KIF20B;GPLD1;RBFOX2;GNRH1;ITGAX;IL1A;PTPN14;PTHLH;SAPCD2;SOX9;TPTE;CELF1;HDAC4;BMP5;KLF10;NUP62;FN1;EGLN3;PDS5B;KANK2;RPRD1B;FER;CDK13;CEP131;ADAM10;NCK2;KRAS;CTCF;EFNB2;HOXC10;TBX2;CHERP;RARA;FBXO5;CUL3;DIS3L2;DPP4;S100B;RBM5;PTPRJ;GCNT2;FGF18;TSHR;DDRGK1;TET1;MECP2;GAB2;HDAC2;TRNP1;CNOT7;DLG3;PBRM1;HILPDA;ADRA2A;TBC1D8;STRN;AXIN2;SRPK2;RARG;APC;IL6ST;PRLR;ZBTB49;MEN1;SGK1;STAT2;CD81;NF2;WNT9A;PTEN;CDC6
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.32240350392450245,0.9846746102174923,0.51,0.9495121146062525,1.0,9/73,8.13%,WIPF1;PRKCE;CYFIP2;DOCK1;CD3G;VAV2;SRC;PIK3R2;MYH2
prerank,cellular response to ATP (GO:0071318),-0.3759474051543743,-0.9845093742215718,0.48426150121065376,0.8255233316837831,1.0,5/14,27.70%,P2RX7;P2RX4;CIB2;P2RY12;P2RY1
prerank,wound healing (GO:0042060),0.33143825761741685,0.9844021953478084,0.47174770039421815,0.9494218185892118,1.0,8/62,7.05%,CLDN1;AHNAK2;FGF1;DCBLD2;NF1;WNT5A;COL3A1;RAB3A
prerank,microtubule anchoring (GO:0034453),0.4426396109412599,0.9842910997255968,0.47761194029850745,0.9489428081857896,1.0,3/12,13.86%,DAG1;GCC2;PCM1
prerank,regulation of cytoplasmic translation (GO:2000765),-0.3694088562214907,-0.9842711875364419,0.47368421052631576,0.8251308112799225,1.0,5/14,18.05%,CPEB4;CPEB2;UNK;DHX36;CPEB1
prerank,regulation of viral life cycle (GO:1903900),0.40010243444783306,0.9841141908687117,0.45878693623639194,0.9486329806985557,1.0,6/21,15.72%,TSG101;KPNA2;TRIM21;AXL;HS3ST5;TRIM5
prerank,glial cell development (GO:0021782),0.384582308661213,0.9840370158760391,0.47913446676970634,0.9480527552971774,1.0,7/25,16.87%,NF1;EIF2B3;S100A9;EIF2B4;NSUN5;SOX4;MDK
prerank,atrioventricular valve morphogenesis (GO:0003181),-0.3475285038678606,-0.9838873515669692,0.48138297872340424,0.8251417678064942,1.0,7/19,25.08%,SMAD6;BMPR2;BMP2;TGFB2;SMAD4;OLFM1;NOTCH1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.3909198092877563,-0.9838343375557121,0.4987593052109181,0.8242386957082332,1.0,5/12,29.81%,RPL26;KDM1A;MIF;TAF9;TRIAP1
prerank,regulation of dendrite development (GO:0050773),0.3638461946076232,0.9837213860891239,0.48314606741573035,0.948122047525561,1.0,7/37,12.06%,NEDD4L;COBL;BMP5;GSK3B;SARM1;NEDD4;SEMA4D
prerank,cholesterol biosynthetic process (GO:0006695),-0.30696451242012457,-0.9835901538675406,0.4868421052631579,0.823821074512232,1.0,10/31,19.79%,INSIG2;ARV1;HMGCS1;ACAA2;ACLY;NSDHL;PMVK;MVK;ACAT2;DHCR7
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.34576136446386657,0.9834599580768504,0.47050938337801607,0.9480409689408648,1.0,4/46,5.86%,APOD;CDH13;MFN2;TNFAIP3
prerank,negative regulation of immune response (GO:0050777),0.3011249066560671,0.9834187890124005,0.5124434389140271,0.9473694972181294,1.0,18/154,9.33%,PLK2;CD3G;MC5R;PCBP2;SPI1;PTHLH;SRC;IRAK3;ADCY5;FER;TNFAIP3;TRIM21;COL3A1;PTGER4;PRKAR2A;ACOD1;TSHR;TRAFD1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.4009900943038817,0.9834050290931896,0.49149922720247297,0.9466268134137615,1.0,5/20,11.99%,PDE4D;AKAP13;GPR101;ADRA2A;ADCY9
prerank,intraciliary retrograde transport (GO:0035721),0.4395915021509884,0.9833636825288683,0.49572649572649574,0.9459537564791162,1.0,6/12,25.87%,DYNC2I1;TTC21B;DYNC2LI1;DYNC2H1;IFT140;DYNC2I2
prerank,DNA conformation change (GO:0071103),0.41819236112146313,0.9833598466568975,0.47665056360708535,0.945190405941573,1.0,5/17,14.96%,HAT1;TOP3B;HMGB1;TOP1;NAA10
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.3526367461173525,-0.9829132561661656,0.4648648648648649,0.8245722867421663,1.0,9/17,25.21%,PID1;NUPR1;CBFA2T3;PFKFB1;PDE12;PARP1;GIT1;TIGAR;FLCN
prerank,regulation of spindle assembly (GO:0090169),0.38308644093365546,0.9826937118719029,0.4837758112094395,0.9460690020319054,1.0,6/25,11.97%,SENP6;CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C
prerank,7-methylguanosine RNA capping (GO:0009452),-0.30051918383938203,-0.9826765438424722,0.47315436241610737,0.8231161867152771,1.0,14/31,27.73%,MNAT1;ERCC2;RAMAC;NCBP1;CCNH;POLR2F;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.30051918383938203,-0.9826765438424722,0.47315436241610737,0.8231161867152771,1.0,14/31,27.73%,MNAT1;ERCC2;RAMAC;NCBP1;CCNH;POLR2F;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;POLR2I;CMTR2;GTF2H5
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3140545678039186,-0.9825980381774333,0.45786516853932585,0.8222955319593335,1.0,8/26,13.97%,NPR3;ATP7A;HIF1A;APOE;GCH1;AKT1;S100A1;DHFR
prerank,mitotic cell cycle phase transition (GO:0044772),0.2929415484606876,0.9825385223001155,0.5081081081081081,0.9456855898568926,1.0,44/203,17.29%,PLK2;DYNLL1;CCND3;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;SPAST;NEDD1;CCNG1;CDK7;PHLDA1;TUBG1;CKAP5;CUL3;PAFAH1B1;CCP110;CCNJ;ANAPC7;MASTL;EIF4E;CHMP4B;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;CRLF3;LCMT1;PCM1;POLE;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;E2F1;CEP57;USP37;CUL4B
prerank,carnitine metabolic process (GO:0009437),0.4423227026825271,0.9824841111724885,0.4847457627118644,0.9450568708754019,1.0,1/12,1.67%,ALDH9A1
prerank,regulation of macrophage differentiation (GO:0045649),-0.3721219578154592,-0.9824406614468468,0.4892601431980907,0.8216995128937888,1.0,7/15,22.92%,IL34;ID2;HSF1;CSF1;CASP8;INHBA;RIPK1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.32613234708262506,-0.98217023060395,0.4786096256684492,0.821387419662467,1.0,5/23,5.61%,ENG;SMAD3;TGFBR3;LATS2;ITGA3
prerank,positive regulation of cellular component movement (GO:0051272),-0.32844243652976074,-0.9821305522272079,0.48757763975155277,0.8204797804470405,1.0,5/24,7.20%,ETS1;SPOCK2;LYN;TGFBR1;RPS19
prerank,monosaccharide transmembrane transport (GO:0015749),-0.35169314001585006,-0.9820053007722046,0.47368421052631576,0.8197877901263888,1.0,5/16,17.76%,SLC2A12;SLC2A10;SLC45A3;SLC2A8;SLC2A9
prerank,protein prenylation (GO:0018342),0.4628923088571565,0.9811279097559162,0.47593582887700536,0.9477454137911394,1.0,4/10,18.12%,FNTA;CHM;FNTB;PTAR1
prerank,organelle organization (GO:0006996),0.2811428500944146,0.980526235584884,0.5294715447154471,0.9484806170057717,1.0,78/388,17.17%,CAV1;CXADR;FMNL2;PPARGC1A;ATP8B3;PLCE1;ATP8B1;CAPZB;RAB29;PI4K2B;WDR81;CAV2;LMAN2;EIF2AK3;CNTNAP1;RAB30;ZFYVE16;TMEM135;TNFAIP3;CEP78;SIRT3;PACSIN2;NRF1;PEX2;ATL2;RANBP10;GOLGB1;MICAL3;ARMC2;CHMP5;PDCD6IP;ATP8B2;NPLOC4;ZMYM6;LYSMD3;TMED4;CSNK1A1;DIAPH3;HILPDA;TFB2M;LNPK;CHMP4A;CHMP4B;ANK1;LONP1;CHMP4C;DPYSL2;MTX1;FAM161B;NIPSNAP2;ABCD1;TRIP11;HTT;DNAJA3;IQCG;POLG2;FAM161A;RAB34;SPRYD3;SIPA1;ZW10;FBXW8;BCS1L;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;CFAP61;CFAP410;TBC1D20;MDK;ARHGEF7;BRWD1;GEM;ESRRA;DYNC2H1;STX4
prerank,regulation of cellular catabolic process (GO:0031329),-0.25630375322651877,-0.9803126463394645,0.5021459227467812,0.8232084940054425,1.0,16/62,14.68%,DAPK1;ITPR1;ACER2;NUPR1;EP300;DEPDC5;DRAM1;PIP4K2A;USP33;RRAGC;GPR137B;LRRK2;PIP4K2C;BOK;MAPT;RRAGD
prerank,cellular response to interleukin-1 (GO:0071347),-0.22315517446918962,-0.9797391779700072,0.515625,0.8237058535534598,1.0,18/143,8.53%,PLCB1;IL1R1;PTGIS;IL1RAP;PSMA1;RPS6KA5;SQSTM1;SIRPA;IRAK4;RBX1;HIF1A;PSMD11;GBP3;TRAF6;UBE2N;NOD1;PSMD7;PSMD4
prerank,membrane lipid metabolic process (GO:0006643),0.3946305546872566,0.9795036988830785,0.4737631184407796,0.9502318715919277,1.0,5/22,6.26%,AGMO;TEX2;ALOXE3;MGST2;CERK
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.4031242952412405,-0.9794094509250199,0.47368421052631576,0.8235808140960498,1.0,7/11,43.24%,GRK3;ADM;ARRB2;DRD3;ADRB3;ARR3;SAG
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.31703272797216375,0.9793247404360609,0.5060827250608273,0.9498939785064003,1.0,8/87,6.49%,EFNA5;DLC1;F11R;ARHGAP18;RAPGEF3;RAC2;ARHGEF5;ABL2
prerank,cellular response to hormone stimulus (GO:0032870),0.326875393814809,0.9791981046681305,0.493099121706399,0.9494383649834862,1.0,16/69,18.50%,CAV1;SRC;CACNA1H;ATP1A2;RDX;RARA;ADRA2A;NCOA3;NCOA2;GCK;BRD8;GPER1;CTSB;SFR1;SOCS2;LHCGR
prerank,carbohydrate catabolic process (GO:0016052),0.3601937722614244,0.9785955100225717,0.49019607843137253,0.9502246975978272,1.0,11/38,17.84%,HK2;NAGA;NEU1;ALDOB;PGM1;MANBA;ENO3;DERA;GCK;PGK1;ENO2
prerank,phasic smooth muscle contraction (GO:0014821),-0.4068851429375075,-0.9784734665085261,0.47494033412887826,0.825048051343975,1.0,3/10,24.12%,EDN1;EDN3;HTR2B
prerank,oxoacid metabolic process (GO:0043436),-0.3081655003677305,-0.9783236350956164,0.4868035190615836,0.824411535151916,1.0,8/27,20.44%,ENPP1;DDO;BPNT2;TPST1;PPA1;AGXT;MIF;SULT4A1
prerank,regulation of ion transport (GO:0043269),0.3216046114260509,0.9782200319005094,0.4956521739130435,0.9504285059073826,1.0,5/76,2.41%,NEDD4L;KCNJ4;SCN10A;KCNA5;KCNJ16
prerank,regulation of inflammatory response (GO:0050727),0.29442027171778906,0.9781902758360489,0.5186813186813187,0.9497292303008372,1.0,24/190,11.15%,RORA;ADAMTS12;PIK3AP1;CDH5;CXCL17;FNDC4;CELF1;MGST2;WNT5A;ABCC1;IL17RA;TLR7;TNFAIP3;TRADD;SELENOS;MAPK7;PTGER4;ISL1;TNIP1;ACOD1;CD200R1;SHARPIN;S100A9;PROC
prerank,positive regulation of protein localization to membrane (GO:1905477),0.3074735455447168,0.9779403035543855,0.4785801713586291,0.9496250838217254,1.0,33/98,22.52%,SORBS1;PRKCE;EGFR;PPP1R13B;ATP2B4;FIS1;EPHB2;ARF6;MIEF1;SFN;SLC5A3;CD81;KIF5B;ZDHHC8;GPER1;BAD;NMT1;ERBB2;YWHAG;YWHAE;E2F1;CHP1;STX4;SPTBN1;PDPK1;CEMIP;PRKN;AKT2;ITGB1;MAPK8;TFDP1;YWHAB;ZDHHC5
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.2961743305723714,0.9779344197602025,0.5142543859649122,0.948866795818308,1.0,36/172,16.38%,DGKA;PTPN13;PISD;DDHD1;PI4K2B;GPAT3;ACP6;DGKZ;PCTP;SLC27A1;PIP4K2B;AGPAT4;PIK3R4;PLEKHA4;MTMR7;PIK3R2;MTMR6;OCRL;INPP5F;MTMR3;PLSCR1;LCLAT1;ETNK2;PLD1;AGPAT5;CDS2;PTEN;PLEKHA1;PIK3C3;MTMR12;GPD1;STARD10;PI4K2A;MTMR1;PITPNM2;HDHD5
prerank,regulation of G0 to G1 transition (GO:0070316),-0.2920210609397284,-0.9776891385115817,0.4810606060606061,0.8250240476164192,1.0,20/38,37.41%,PCGF2;PHC3;BMI1;RYBP;CDC7;SUZ12;EED;EHMT2;RAD51;L3MBTL2;BRCA1;RNF2;PCGF6;RING1;MAX;E2F6;CDKN2B;EHMT1;DAB2IP;PHC1
prerank,regulation of calcium ion transport (GO:0051924),0.3382103256147913,0.9774978000590976,0.4821664464993395,0.9491712743836968,1.0,3/54,1.76%,HOMER2;EFHB;SLC8B1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.27752135294528885,0.977431333909172,0.5626262626262626,0.9485868072086491,1.0,67/497,11.94%,MDFIC;VGLL4;PRICKLE1;PAX9;NR2F2;TSHZ3;PHC2;FOXP2;ZNF423;FOXD1;ATP8B1;MYBBP1A;BCL3;RUNX2;FXR2;RBFOX2;SFMBT2;GIGYF2;CIART;SPI1;L3MBTL3;FOXK1;EIF2AK3;SOX9;CNOT10;UBE2I;GLIS2;CHD8;CDAN1;KAT6B;HDAC4;LANCL2;KLF10;SAMD4B;WNT5A;CREB3L1;RBM15B;HEYL;SP3;BHLHE40;PUS7;RCOR3;SELENOS;CTCF;NCOR1;TBX2;RARA;SUV39H1;KCTD1;IGF2BP2;FOXK2;UIMC1;TSC22D4;MECP2;GSK3B;RORB;USP47;HDAC2;CNOT7;ZHX1;NCOR2;ILF3;HDAC6;HEXIM1;ZNF148;MEN1;KDM8
prerank,axon guidance (GO:0007411),0.29153225990042764,0.9770508318298881,0.5263724434876211,0.9487864021654371,1.0,25/201,7.45%,GAB1;EFNA5;LAMA2;NTN1;EFNB1;NRP2;SEMA4B;GLI2;OPHN1;PRKCA;SRC;DSCAM;RAC2;PLXNA3;WNT5A;NTN5;ARTN;LAMA5;EPHB2;DAG1;EFNB2;SEMA3A;NTN3;SIAH1;MAPK7
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.46578226057324873,0.9770400250899185,0.5094664371772806,0.9480463889033667,1.0,2/10,6.14%,WNT5A;ADAM10
prerank,positive regulation of p38MAPK cascade (GO:1900745),0.3891515480194266,0.9766919073787566,0.48705501618122976,0.9481613274340112,1.0,3/22,3.65%,RELL1;MINK1;SPI1
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4100843178203145,0.9765909223224571,0.4809917355371901,0.9476551847311184,1.0,8/18,20.68%,SPI1;SRC;FER;IL6ST;YAP1;JAK1;ST18;IL6
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3177053378223411,0.9762416001528841,0.5099009900990099,0.9470213579501154,1.0,22/78,22.90%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3177053378223411,0.9762416001528841,0.5099009900990099,0.9470213579501154,1.0,22/78,22.90%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.2888096854578311,-0.9754904716126408,0.49491525423728816,0.8299522820320935,1.0,8/37,17.04%,PRKAG2;PARD3;CALM1;UBE2K;SPHK1;CALM3;EIF4G1;EGF
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.4478856855132835,0.9754775518907317,0.49566724436741766,0.9481605316171,1.0,1/12,0.98%,IL18R1
prerank,cortical cytoskeleton organization (GO:0030865),0.3510068780352269,0.9753278958727924,0.4694708276797829,0.9477570300317844,1.0,12/41,18.52%,FMNL2;EPB41L3;TRPV4;RAC2;ARF6;PLEK;FHOD1;RND2;PPP2R3C;EZR;LCP1;RHOA
prerank,regulation of lymphocyte migration (GO:2000401),-0.4033810341058486,-0.9752817927565428,0.4896073903002309,0.829571755896082,1.0,3/10,8.19%,MSN;STK10;AKT1
prerank,response to interleukin-1 (GO:0070555),-0.24362122566041838,-0.9751927286120127,0.5339366515837104,0.8287921173428838,1.0,19/73,18.68%,IL1R1;PTGIS;YTHDC2;SIRPA;HIF1A;GBP3;TRAF6;IGBP1;ANXA1;ZC3H12A;CCL13;TNFRSF11A;TLE5;LGALS9;GBP2;RC3H1;CD40;CACTIN;IRAK2
prerank,establishment of spindle localization (GO:0051293),-0.368650170918942,-0.9748403875993826,0.46568627450980393,0.8287721581530921,1.0,6/14,31.25%,CFL1;ZBED3;LLGL2;NUSAP1;TLE6;DYNC1H1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),0.4716864905187484,0.9748369714181674,0.5008944543828264,0.9482475106736787,1.0,3/10,8.54%,DPYS;UPP2;NT5E
prerank,negative regulation of GTPase activity (GO:0034260),0.3978892915588417,0.9747701001235325,0.4953560371517028,0.9476504081741963,1.0,2/22,6.72%,F11R;RDX
prerank,regulation of T cell differentiation (GO:0045580),0.36443597496985897,0.974446740891912,0.4678362573099415,0.947710781334161,1.0,5/33,16.87%,NFATC2;CRTAM;IL7;CBFB;MDK
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.2725696228917153,-0.9737937415446716,0.4810606060606061,0.8305425451522382,1.0,21/51,25.08%,SMAD6;SKIL;SMAD9;BMPR2;SMAD5;CRIM1;GREM2;LEMD3;HTRA3;BMP2;DAND5;CHRDL1;BMPER;SMAD4;VWC2L;SMURF2;FSTL3;BAMBI;SMAD1;GREM1;NOTCH1
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),0.45369793399468944,0.9731463538403925,0.4778761061946903,0.9502537626282902,1.0,2/10,8.40%,NUFIP1;NAF1
prerank,regulation of lipid kinase activity (GO:0043550),-0.39387671173597133,-0.9731170924543403,0.4813895781637717,0.8313245366232923,1.0,5/11,15.25%,PIK3R1;PIK3R3;RBL1;PPP2R5A;RBL2
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3125315847092016,-0.972944942848901,0.4717514124293785,0.8308018902090469,1.0,8/25,13.57%,ARHGAP24;SLIT2;TBC1D30;EVL;EVI5L;CEP97;ARHGAP44;TCHP
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.4249630487722065,0.9728661401576025,0.49093904448105435,0.9502128478935009,1.0,3/16,6.74%,ATIC;PFAS;PPAT
prerank,telomere maintenance via recombination (GO:0000722),0.4483979208263065,0.9727640656967864,0.4973637961335677,0.9497353689840314,1.0,3/11,12.80%,SMC5;ERCC1;TEP1
prerank,purine ribonucleotide transport (GO:0015868),0.40905761094819904,0.9727575605900974,0.4951923076923077,0.9489917868769028,1.0,2/16,4.44%,LRRC8D;SLC35B2
prerank,sphingoid metabolic process (GO:0046519),0.443916827001437,0.9724146049985214,0.5034843205574913,0.9491197589047435,1.0,2/12,4.15%,PLPP2;PLPP3
prerank,response to glucose (GO:0009749),0.34052989996879623,0.9721135378551552,0.5013550135501355,0.9491158035261934,1.0,17/46,21.70%,ZBTB20;GPLD1;EIF2B3;SELENOS;EIF2B4;ERN1;GCK;SOX4;UNC13B;TRA2B;GPER1;ADCY8;IRS2;LPL;PAX2;VAMP2;TCF7L2
prerank,chromatin remodeling (GO:0006338),0.3053237808129761,0.9718609396580784,0.5086633663366337,0.9490400626262363,1.0,33/100,21.53%,HNRNPC;CHD3;SOX9;CHD8;HDAC4;SATB1;SMARCAD1;GATAD1;ACTR8;SMARCD2;HDAC2;BAZ2B;PBRM1;ERCC6;TOP1;INO80;KDM6B;BAZ2A;TADA2A;INO80B;CHD1L;KDM4B;SUV39H2;RUVBL2;NUDT5;HCFC2;RBBP4;CHRAC1;KDM5B;ARID1B;DAXX;RSF1;ARID1A
prerank,ethanol metabolic process (GO:0006067),-0.3841895858251698,-0.9717456890371342,0.5087719298245614,0.8329787939421868,1.0,1/12,0.05%,ALDH1A1
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.21681942380107874,-0.9717073051674233,0.5913978494623656,0.8320610174540918,1.0,30/170,13.88%,IGF1;ROCK2;PRDM6;FOXP1;ADNP2;SLC8A1;PRDM5;NOVA2;SIRPA;LDLR;HNRNPK;HIF1A;ZNF507;APOE;HINFP;PCBP1;ATP1B1;CDK6;TRIM14;PRDM2;ZC3H12A;PROX1;ANKRA2;BMI1;PCBP4;MEGF8;CDK4;AHR;CIAO3;CAVIN4
prerank,positive regulation of potassium ion transport (GO:0043268),-0.28902984199553705,-0.9712295123851479,0.53125,0.8323176305732313,1.0,9/38,10.42%,ANK2;ACTN2;KCNJ6;KCNMA1;KCNJ2;AKAP6;KCNJ10;FLNA;KCNN2
prerank,potassium ion homeostasis (GO:0055075),0.38704873114438093,0.9708599422264221,0.4896,0.9508273019327782,1.0,5/23,9.40%,SLC12A2;SLC12A4;SLC12A3;ATP1A2;ATP1B3
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.27815506235554927,0.9702220749527964,0.5608247422680412,0.951708261195106,1.0,41/348,9.83%,NGF;FGF7;NTRK3;PPARGC1A;FOXD1;CLDN19;MUSK;FGF1;ADAM19;SLC26A9;CDH5;RAB29;SLC38A2;ITGAX;IL1A;PRKAG1;WNT16;EIF2AK3;SOX9;CELF1;PTPN22;WNT5A;FN1;EPHB2;KRAS;RIMS2;UBR5;RDX;CTCF;MAPK7;OCLN;NOS1AP;FGF18;AGO1;INPP5F;DDRGK1;PLSCR1;GSK3B;RESF1;TICAM1;POU4F1
prerank,artery development (GO:0060840),0.3846182473268668,0.9701057754377534,0.47648902821316613,0.9512344885850751,1.0,2/23,3.23%,STRA6;NF1
prerank,modified amino acid transport (GO:0072337),0.42142183643232806,0.9694175056308723,0.514480408858603,0.9522240523900392,1.0,3/15,5.54%,FOLR1;FOLR2;SLC6A13
prerank,adenine nucleotide transport (GO:0051503),0.4016436461847462,0.9694161733801309,0.4960380348652932,0.9514698087429725,1.0,2/17,4.44%,LRRC8D;SLC35B2
prerank,maturation of LSU-rRNA (GO:0000470),0.374815667486305,0.96937290507994,0.48755490483162517,0.9508336122557284,1.0,5/26,11.38%,RRP15;RPL35;SNU13;PES1;RPF1
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.3300753488767792,-0.9692898359664609,0.5039787798408488,0.8364710986918767,1.0,4/19,8.02%,BMP4;WNT4;LARP6;TGFB3
prerank,regulation of actin filament polymerization (GO:0030833),0.32159265097307216,0.9688375458741839,0.4955640050697085,0.9514098843813467,1.0,8/69,7.65%,KANK4;PRKCE;ARHGAP18;CDC42EP4;FER;NCK2;KANK1;ARF6
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.3393572598734654,-0.968827600473821,0.5120643431635389,0.8366767318898948,1.0,6/19,12.24%,ENPP1;BPNT2;PAPSS1;SLC26A2;TPST1;SLC35B3
prerank,phospholipid transport (GO:0015914),0.33536794662486924,0.9684259268881655,0.48313090418353577,0.9516463928016332,1.0,11/52,9.88%,ATP8B3;ATP8B1;PITPNC1;PCTP;ABCC1;ATP9B;ATP11C;ATP9A;ATP8B2;ABCA1;ATP10B
prerank,response to muramyl dipeptide (GO:0032495),-0.3837857890031876,-0.9682060675212755,0.5149253731343284,0.8372975217206463,1.0,7/12,24.68%,ARHGEF2;ERBIN;NOD1;VIM;TRIM41;NOD2;IRF5
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.3248081909765934,-0.9681714066209005,0.4915254237288136,0.8363746264971156,1.0,5/20,13.27%,FAS;CASP3;GSK3A;BOK;DCC
prerank,macrophage migration (GO:1905517),0.43512510709666186,0.9679796156795318,0.4907563025210084,0.9519924180000172,1.0,1/13,2.64%,CXCL17
prerank,regulation of transferase activity (GO:0051338),0.41312156032367925,0.967819668756089,0.4943089430894309,0.9516412334337984,1.0,1/17,1.61%,LDB2
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.29610945904159847,0.9664606669501492,0.5209790209790209,0.9543537947669338,1.0,15/110,10.37%,LPAR1;ADGRG5;ADGRG2;PTGFR;GPR161;MC5R;PTHLH;GNAQ;ADCY5;PTGER4;TSHR;GNAL;GPR101;ABCA1;ADRA2A
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),-0.24764527502103073,-0.9661492090019862,0.5409090909090909,0.8407506214952751,1.0,14/74,12.63%,RBPJ;PSMA1;EGLN1;EP300;RBX1;HIF1A;PSMD11;PSMD7;PSMD4;CITED2;EPAS1;CUL2;HIF3A;PSMB4
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.4006158006142526,0.9659276014276914,0.5082781456953642,0.9549583480616866,1.0,2/20,4.33%,PPARGC1A;DIP2A
prerank,regulation of interferon-gamma production (GO:0032649),0.3207368440121291,0.9657804989127431,0.5,0.9545797495559046,1.0,10/71,9.89%,IL18R1;PDE4D;TXK;PTPN22;TLR7;CRTAM;RARA;ISL1;HMGB1;AXL
prerank,sodium ion export across plasma membrane (GO:0036376),0.4275657290668833,0.9650543111266512,0.464471403812825,0.9556491081466992,1.0,3/13,9.40%,ATP1A2;SLC4A4;ATP1B3
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3839076356867604,-0.9648872707748839,0.5078534031413613,0.8431376564287639,1.0,7/13,27.00%,NEFL;HIF1A;MAPT;OPA1;RHOT1;LRPPRC;UBB
prerank,negative regulation of cell development (GO:0010721),-0.30710278309869354,-0.964772679408069,0.5029585798816568,0.842459262558529,1.0,3/25,4.53%,IGF1;APPL2;B2M
prerank,neuromuscular process controlling balance (GO:0050885),-0.3766781245794625,-0.9647410693918083,0.5123762376237624,0.8415332478193581,1.0,3/12,12.18%,PCDH15;TPP1;NRXN1
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.3959850054497167,-0.9647358181562683,0.5023696682464455,0.8405363920896721,1.0,4/11,19.63%,STMN1;NRP1;MST1R;BCAR1
prerank,steroid hormone mediated signaling pathway (GO:0043401),0.4358056440921599,0.9643002112245658,0.5069686411149826,0.956716782708217,1.0,2/13,4.11%,NR3C2;PGR
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.2463903664934966,-0.9639393228811498,0.5440414507772021,0.8416406065483992,1.0,27/72,27.84%,UVSSA;EP300;RBX1;MNAT1;ERCC2;XPA;POLK;ISY1;LIG3;COPS6;CCNH;POLR2F;RFC2;POLR2A;POLR2J;GTF2H4;POLR2D;POLR2K;GPS1;ERCC4;ERCC5;POLD2;POLR2I;RFC4;UBB;GTF2H5;DDB1
prerank,regulation of blood circulation (GO:1903522),-0.2915653643459849,-0.9635437825544236,0.5357142857142857,0.8417069159720825,1.0,11/34,19.17%,ECE1;TPM1;ACE;BDKRB2;AGTR1;DES;S100A1;SRI;ACE2;PER2;AGT
prerank,microtubule depolymerization (GO:0007019),0.41033110671593787,0.9633491385896283,0.5066445182724253,0.9583808953269043,1.0,3/17,7.38%,KIF2A;NCKAP5L;CKAP5
prerank,positive regulation of CREB transcription factor activity (GO:0032793),-0.3458364025142062,-0.9633283052612328,0.5054347826086957,0.8412432463317391,1.0,6/18,11.85%,ADCY1;RPS6KA5;CRTC3;LRP8;CD200;CRTC2
prerank,cAMP metabolic process (GO:0046058),0.4239865003347909,0.9632965330448684,0.5077989601386482,0.9577764942815803,1.0,6/13,15.58%,PDE4D;PTHLH;ADCY5;ADCY9;ADCY8;ADCY3
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.43748693352890033,0.9631059205586704,0.5034129692832765,0.957455412351762,1.0,2/12,1.97%,DOCK5;ADAMTS1
prerank,negative regulation of DNA replication (GO:0008156),0.4237699644634035,0.9630269551855348,0.49322033898305084,0.956878470320621,1.0,4/13,20.50%,CDAN1;CDC6;GMNN;ATR
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3298233773953454,-0.9629572566273213,0.501432664756447,0.8412304260929861,1.0,4/20,6.87%,SHANK3;APOE;CUX2;LRP8
prerank,regulation of cellular protein localization (GO:1903827),0.34439655114243434,0.9627402069977194,0.49265687583444595,0.9568633421199008,1.0,9/45,17.74%,GPC3;GPC6;TRIM46;DVL3;RAB11FIP5;GPC2;SETD2;GPC5;LCP1
prerank,cell cycle G2/M phase transition (GO:0044839),0.30148989374813223,0.962408853273588,0.5300794551645857,0.956929880788043,1.0,40/129,22.51%,DYNLL1;FBXL15;WEE1;SFI1;BRSK1;CEP131;CEP78;NEDD1;CDK7;PHLDA1;TUBG1;CKAP5;PAFAH1B1;CCP110;MASTL;FBXL17;KDM8;NDE1;CEP290;SSNA1;CETN2;ENSA;LCMT1;PCM1;YWHAG;FBXL12;PPP1R12B;YWHAE;FBXL3;CEP57;OFD1;CEP250;DCTN2;ALMS1;TAF2;HAUS8;CEP43;FBXW11;BORA;HAUS3
prerank,cellular response to inorganic substance (GO:0071241),-0.3251631162748898,-0.9623224343852738,0.5439093484419264,0.8418349594570983,1.0,6/21,19.71%,FOXO1;BLM;MTR;DDI2;NSMCE3;TIMELESS
prerank,regulation of cell development (GO:0060284),-0.2850278094106522,-0.9618912717280408,0.5152542372881356,0.8419705748710139,1.0,5/36,8.19%,NOTCH2;FOXO1;HDAC9;RPS19;AKT1
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.30905694512085286,-0.9618405417200458,0.49577464788732395,0.8410874932117665,1.0,11/24,24.33%,ABCG2;SLC25A38;FECH;CPOX;FXN;ABCB10;ALAS1;UROD;HMBS;TSPO;ALAD
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.35570398848718776,0.961466176783529,0.5007256894049347,0.958490464444808,1.0,1/34,0.10%,GAB1
prerank,regulation of cellular component size (GO:0032535),-0.29899357831696427,-0.9614512167501726,0.5079365079365079,0.8411070821797892,1.0,3/30,1.25%,PICALM;EPS8;MSN
prerank,signal release from synapse (GO:0099643),-0.2761479006236169,-0.9613504592226769,0.5423076923076923,0.840409162550807,1.0,20/43,29.32%,STXBP3;LIN7A;HSPA8;SYN1;GAD1;NRXN1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;SYN2;RIMS1;SNAP25;SLC32A1;PPFIA3;PIP5K1C;PTPRN2;GRM4;SYT1
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),0.40056019812107196,0.9613338694671955,0.5041186161449753,0.9580702053300487,1.0,1/20,0.23%,PKDCC
prerank,fatty acid catabolic process (GO:0009062),0.3215799118094785,0.9606779629081224,0.5130434782608696,0.9589809804346708,1.0,11/67,10.29%,EHHADH;CEL;AIG1;PCCB;HADHB;PEX2;ACAT1;HSD17B4;ACADS;SLC27A4;ACOT8
prerank,negative regulation of small molecule metabolic process (GO:0062014),0.38647139112303514,0.9598136277747935,0.5114854517611026,0.9603288012568497,1.0,5/20,13.40%,DKKL1;BCKDK;NCOR1;C1QTNF12;GCK
prerank,response to glucagon (GO:0033762),-0.3364060349211633,-0.9595892168571685,0.5184135977337111,0.8439778080214629,1.0,8/19,19.17%,ADCY1;ADCY7;ADCY4;ADCY2;CREB1;PRKAR2B;CYSLTR2;CRY1
prerank,Notch signaling involved in heart development (GO:0061314),-0.3887652529521482,-0.9595216097712939,0.5253456221198156,0.8431459402877968,1.0,3/11,7.04%,NOTCH2;RBPJ;GALNT11
prerank,DNA integrity checkpoint signaling (GO:0031570),-0.2889187949286481,-0.9594082209584706,0.5204081632653061,0.8424614235744468,1.0,10/36,19.71%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;TIPIN;RAD17;RAD9B;TIMELESS
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.45026444874315374,0.9592871593355828,0.5154109589041096,0.9609044994090208,1.0,3/11,13.45%,JAG1;ISL1;SOX4
prerank,regulation of lamellipodium assembly (GO:0010591),0.3557096818852938,0.9591583726487012,0.5177809388335705,0.9604697589831683,1.0,6/34,11.89%,PLCE1;CAPZB;RAC2;FER;OCLN;AKIRIN1
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.2497635927637804,-0.9591296536628096,0.544973544973545,0.8421968425883545,1.0,19/69,19.49%,POU2F1;INTS9;CCNT2;CDK9;RPRD2;PHAX;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;POLR2D;POLR2K;TAF6
prerank,regulation of viral transcription (GO:0046782),0.34502092276564744,0.9589940793461073,0.5137481910274964,0.9601271351190621,1.0,6/39,12.47%,MDFIC;TRIM21;NELFB;SUPT4H1;HEXIM1;GTF2F2
prerank,response to X-ray (GO:0010165),0.41566759814417004,0.9588935481305035,0.5090311986863711,0.9596432423378193,1.0,4/14,13.53%,BRCC3;IKBIP;MSH2;NUCKS1
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.3522497098860915,-0.9581797610974149,0.495260663507109,0.8437093118409386,1.0,6/15,13.12%,NR1H3;LDLR;SIK1;CTDNEP1;NR1H2;MFSD2A
prerank,histone lysine demethylation (GO:0070076),-0.30944850978221616,-0.9581101646995047,0.4789156626506024,0.8428737051056324,1.0,5/25,12.83%,KDM5C;PHF8;KDM2B;KDM1A;KDM7A
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.31576975144396313,0.9577959608350465,0.5437017994858612,0.9615856694606104,1.0,23/70,21.63%,LMO1;KMT2A;PSME3;N4BP2L2;PUS7;PSMB5;PSMB2;CBFB;PSMA2;PSMA6;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;RUNX1;FOXC1;PSMB3
prerank,nucleosome disassembly (GO:0006337),-0.3694301939685383,-0.9577543332716568,0.49379652605459057,0.8419071668882399,1.0,3/14,10.95%,SMARCE1;SMARCD1;ARID2
prerank,chromatin disassembly (GO:0031498),-0.3694301939685383,-0.9577543332716568,0.49379652605459057,0.8419071668882399,1.0,3/14,10.95%,SMARCE1;SMARCD1;ARID2
prerank,phospholipid biosynthetic process (GO:0008654),0.35530102408508746,0.9576844791824615,0.523876404494382,0.9610933672215515,1.0,9/36,20.42%,SGMS2;AGPAT4;AGPAT5;DHDDS;DPAGT1;HDHD5;FADS1;DOLK;DOLPP1
prerank,negative regulation of catabolic process (GO:0009895),0.3389266149932144,0.9575160566922465,0.5228848821081831,0.9607600745382792,1.0,7/47,10.37%,EGFR;HDAC4;IRAK3;AZIN2;NCOR1;ZDHHC7;ADRA2A
prerank,response to nitric oxide (GO:0071731),-0.3747469065575857,-0.9574177009307804,0.5358024691358024,0.8417838521028499,1.0,5/13,24.97%,EGLN1;FOXO1;MTR;CCL19;CDK2
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2837458147764043,-0.9573925367577475,0.5559440559440559,0.8408697582693793,1.0,12/36,22.08%,AFDN;VAMP5;GORASP2;ANK3;MACF1;BBS2;PREPL;GGA3;SYS1;RAB7A;OPTN;RAB10
prerank,histone H3 deacetylation (GO:0070932),0.41708724183767987,0.956719283522443,0.5168,0.9620172600118957,1.0,5/15,13.67%,HDAC4;SMARCAD1;SIRT7;HDAC2;SFPQ
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.31196038823358146,0.9566700552330817,0.5329192546583851,0.9613888848093706,1.0,22/79,22.90%,DYNLL1;KIF2A;CAPZB;RACGAP1;KIF3C;ACTR10;DYNLL2;KIF26A;KIF5A;LAG3;AP2A2;KLC2;DCTN2;AP1M1;SEC24B;DYNC1LI2;ACTR1B;DYNC1I1;DCTN6;AP2S1;CLTA;SEC13
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3169618168727407,0.956163894508817,0.5241830065359477,0.9618833528344632,1.0,16/61,18.75%,CAV1;PSME3;PDK4;PSMB5;NCOR2;PSMB2;PSMA2;PSMA6;PANK2;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,response to muscle stretch (GO:0035994),-0.35392028021968513,-0.955952164031347,0.5536159600997507,0.8436706791787189,1.0,4/15,14.54%,DMD;SLC8A1;SLC9A1;PTK2
prerank,motile cilium assembly (GO:0044458),0.43897681696473334,0.9556438772517678,0.5189655172413793,0.9624861015298822,1.0,3/12,15.14%,CCDC39;BBOF1;CCDC40
prerank,positive regulation of histone methylation (GO:0031062),0.3761256718869016,0.9551953184334434,0.5150078988941548,0.9628852473144094,1.0,6/24,17.37%,OGT;KMT2A;PAF1;TET1;AUTS2;MTF2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.3188712542986967,0.955167155522432,0.5,0.9622211262169247,1.0,14/65,18.00%,RORA;EGLN3;SUV39H1;HILPDA;AQP1;P4HB;BAD;PGK1;UBQLN1;RGCC;BNIP3;HP1BP3;SUV39H2;PINK1
prerank,macromolecule catabolic process (GO:0009057),0.36956097554460887,0.9550814976456067,0.5328244274809161,0.9617204971100235,1.0,7/26,11.37%,LRSAM1;KIF16B;PIK3R4;CLN8;SIAH1;SNX25;NEDD4
prerank,protein K48-linked ubiquitination (GO:0070936),0.3291964412813212,0.9549286592152614,0.5267489711934157,0.9613242779180682,1.0,16/54,21.61%,NEDD4L;UBE2E2;TNFAIP3;UBR5;CUL3;AMFR;TTC3;FBXO38;UBE2D3;UBE2D1;UBE2R2;ITCH;KBTBD7;PRKN;RNF146;ZNRF1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4472353026213256,0.9548318949319683,0.4936936936936937,0.9608359759984019,1.0,5/10,21.38%,WDR76;RFWD3;ETAA1;THOC5;CCAR2
prerank,response to lipopolysaccharide (GO:0032496),0.28815296614811303,0.9544165598049632,0.5300113250283126,0.9611335492313458,1.0,21/138,11.08%,LBP;TNIP3;IL1A;PTPN22;HNRNPA0;IRAK3;WNT5A;FER;TNFAIP3;SELENOS;PAF1;DEFA6;ACOD1;IRGM;CHMP5;RPS6KA3;HMGB1;TICAM1;AXL;S100A9;TAB2
prerank,hepaticobiliary system development (GO:0061008),0.3852812635218652,0.9543478323763895,0.5092436974789916,0.9605463647181509,1.0,4/20,6.10%,COBL;NF1;LSR;GFER
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.26501135184195035,-0.953998667231398,0.51171875,0.8477412581646413,1.0,18/48,19.45%,NEDD9;CUX1;CDC42;OBSL1;TRIOBP;MYADM;CUX2;CRK;CRKL;FLNA;CDKL5;ILK;NRP1;PTPRD;CARMIL1;LIMS2;TESK1;LIMS1
prerank,protein polymerization (GO:0051258),0.3302090436622855,0.9538265008519354,0.5305343511450382,0.9610669554911906,1.0,9/55,10.71%,COBL;TRPV4;GAS7;CKAP5;WASHC3;CASQ2;DIAPH3;CHMP4A;CHMP4B
prerank,cardiocyte differentiation (GO:0035051),-0.4040580291816652,-0.9537942339524386,0.5274463007159904,0.847233374860663,1.0,6/10,15.43%,SIK1;BMP2;GATA6;TGFB2;EEF1AKMT4-ECE2;MYOCD
prerank,cilium movement (GO:0003341),0.330995707210359,0.9534025344275826,0.5382513661202186,0.9613607765600084,1.0,13/47,22.54%,CFAP73;SPEF1;SPAG17;CCDC39;DNAH5;CCDC40;CFAP70;CFAP61;ODAD1;ZBBX;TTC29;DNAI4;CFAP100
prerank,mRNA methylation (GO:0080009),-0.36278316033711655,-0.953310796874526,0.528395061728395,0.8475101026820501,1.0,8/15,36.62%,NSUN2;TRMT61B;METTL16;METTL8;METTL14;TRMT6;TRMT61A;TRMT10C
prerank,regulation of exit from mitosis (GO:0007096),0.35312740316727953,0.9530611251331391,0.5177111716621253,0.9614391716888302,1.0,13/38,18.29%,CDC20;ANAPC5;ANAPC7;ANAPC11;BUB3;ANAPC2;UBE2D1;ZW10;ANAPC4;CDC14A;RGCC;ANAPC16;CDC23
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4090618242648508,0.9517462077415879,0.5395189003436426,0.9639740556687268,1.0,2/15,2.89%,PRKCE;GPLD1
prerank,regulation of pH (GO:0006885),-0.39565095169816356,-0.9516669358071018,0.531322505800464,0.8507123887144697,1.0,3/11,8.51%,ATP6V0A4;LACC1;SLC9A1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",-0.39734561836467863,-0.9514321988192832,0.5337837837837838,0.8503749040972705,1.0,5/10,21.72%,ATP5PD;VPS9D1;ATP5MC3;ATP5PO;ATP5MC2
prerank,ncRNA metabolic process (GO:0034660),0.34250017812242406,0.9513237819163898,0.5077793493635078,0.964295941329995,1.0,12/37,25.78%,PIWIL2;DDX17;DGCR8;DICER1;RAN;PRKRA;XPO5;DTD1;TDRD9;MEPCE;TENT4B;AGO2
prerank,regulation of mitochondrial translation (GO:0070129),0.38797897687194516,0.9512981575939593,0.5153374233128835,0.9636154684766143,1.0,9/21,23.15%,RMND1;FASTKD2;MPV17L2;ALKBH1;MTG2;RPUSD4;MALSU1;TSFM;MTG1
prerank,regulation of cellular metabolic process (GO:0031323),0.3397198259463296,0.951134451557594,0.5258855585831063,0.9632769293205997,1.0,11/45,18.00%,COQ7;MPV17;KIF16B;PDK4;ACACA;TBC1D16;NCOR2;ACACB;PANK2;PM20D2;PINK1
prerank,membrane raft organization (GO:0031579),-0.35001403590567104,-0.9509829073740899,0.5202020202020202,0.8505210530990979,1.0,5/15,18.34%,RFTN1;ANXA2;MYADM;NAXE;FLOT1
prerank,protein destabilization (GO:0031648),0.3560127831228587,0.9507160533763861,0.4992636229749632,0.9635598034413208,1.0,15/32,23.12%,TRIM21;PEX2;CUL3;IRGM;KDM8;CREBBP;HTT;FBXL3;SENP2;CDC73;PRKN;MUL1;DERL1;FBXW11;PRNP
prerank,regulation of telomere capping (GO:1904353),0.38598770061721566,0.950351573679122,0.5302114803625377,0.9637302244626227,1.0,8/23,26.71%,NEK7;NBN;TERF2;HNRNPD;SMG6;MAPK1;TNKS;RAD50
prerank,positive regulation of cell-substrate junction organization (GO:0150117),-0.3072398943272811,-0.9502462216498231,0.5371428571428571,0.8513221451837251,1.0,4/24,6.22%,TEK;PIK3R1;DUSP3;KDR
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.3319186988465374,0.9496822941790267,0.496617050067659,0.9646372876640178,1.0,7/46,12.67%,TSHZ3;DGKZ;OPHN1;ATP1A2;CDH2;RELN;GRM1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.3931259161675784,-0.9495417548356703,0.5333333333333333,0.8521318509441148,1.0,7/11,29.36%,SLIT2;CCN3;MIF;DUSP1;GREM1;RIN3;DDT
prerank,brain morphogenesis (GO:0048854),-0.3656888824726783,-0.9495182281152034,0.535377358490566,0.8511928229286868,1.0,4/12,14.89%,SHANK3;SPEF2;BBS2;MKKS
prerank,microvillus organization (GO:0032528),0.41899812866955294,0.9492914782409294,0.5115894039735099,0.9648410402695795,1.0,3/13,8.67%,RAP1A;MINK1;RAPGEF6
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.3157877829226857,0.9492119496634885,0.5353535353535354,0.9642943754021067,1.0,6/70,9.35%,NGF;HIPK1;TRADD;MCL1;BAG3;GSK3B
prerank,barbed-end actin filament capping (GO:0051016),0.3958839297499204,0.9492049407073455,0.534621578099839,0.9628365752759072,1.0,4/18,7.68%,ADD3;CAPZB;ADD1;VILL
prerank,actin filament capping (GO:0051693),0.3958839297499204,0.9492049407073455,0.534621578099839,0.9628365752759072,1.0,4/18,7.68%,ADD3;CAPZB;ADD1;VILL
prerank,cellular response to hexose stimulus (GO:0071331),-0.3081704844821547,-0.9488337167711361,0.5300859598853869,0.851906771000007,1.0,3/23,6.86%,IGF1R;KCNB1;SLC39A14
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.3935340393087373,0.9487009630175813,0.5332302936630603,0.9633105570990285,1.0,5/21,9.04%,CAMK2D;PDE4D;FKBP1B;ATP1A2;CASQ2
prerank,regulation of axon extension (GO:0030516),0.346386152316794,0.948626056722998,0.5334261838440112,0.9627638640949262,1.0,8/37,14.25%,NTN1;RTN4R;CDKL3;SEMA3A;GSK3B;TRIM46;CTTN;RTN4
prerank,regulation of neuron death (GO:1901214),0.3084433724540838,0.9486037366947795,0.5388349514563107,0.9620816839686231,1.0,19/82,17.14%,PPARGC1A;RAB29;WNT5A;EGLN3;EFNB2;MAP3K5;CD200R1;GSK3B;SARM1;CHMP4A;CHMP4B;EGR1;LANCL1;SNCG;DHCR24;HTRA2;TBK1;GPR75;CHP1
prerank,epithelial cell morphogenesis (GO:0003382),-0.33863320045254974,-0.9484661036673004,0.5179063360881543,0.8518859366705397,1.0,5/17,20.23%,COL22A1;COL15A1;COL18A1;DACT2;MET
prerank,cellular protein localization (GO:0034613),0.27469233941105187,0.9484268771239347,0.5805439330543933,0.9617792325783052,1.0,75/285,20.78%,PIGU;FGF7;GRTP1;EPB41L3;EGFR;RAB29;STX1A;RIC3;SGSM2;SIL1;CSRP3;CNTNAP1;MFN2;CPE;ARL11;WNT5A;AMOT;SH3PXD2B;RAB3GAP2;SYNRG;KIF13A;ARF6;OCLN;TBC1D16;ARL4A;FOXJ1;TMED4;TBC1D2;FERMT2;TBC1D8;AXIN2;RIC1;HDAC6;STX2;STX19;RTP3;CTTN;USP4;EVI5;RRAGB;PTPRU;CNTNAP2;ARL5A;COPA;TMED2;SEC23IP;TICAM2;TBCK;AP3B1;SNX1;CELSR1;RAB21;STX4;SLU7;ARCN1;FAM91A1;STX5;SCFD2;FGF10;TBC1D5;EHD1;COG3;RABL3;TM9SF4;TM9SF2;CEP250;RAB5A;NSF;SNX17;TBC1D10A;PACSIN1;PIGK;TBC1D8B;RAB18;USO1
prerank,regulation of DNA metabolic process (GO:0051052),0.3361972636753975,0.9482273019056919,0.5100942126514132,0.9615698818815053,1.0,8/44,9.58%,MPV17;WDR18;SMARCAD1;TOM1L1;KPNA2;NBN;UBE2V2;SIRT7
prerank,generation of neurons (GO:0048699),0.28314366135009983,0.9478573805926497,0.5868852459016394,0.9617467991450015,1.0,26/190,11.16%,FGFR1;WNT10A;FZD2;BHLHE22;NEUROD6;RUNX2;WNT2B;OPHN1;RACGAP1;WNT16;WNT5A;HEYL;BHLHE40;BRSK1;ARTN;SEMA3A;PAFAH1B1;LHX6;EML1;NRBP2;GPM6A;RELN;ERCC6;LRP12;DOCK7;EN2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.3921520459363864,-0.9478346601917217,0.5467625899280576,0.8525010136597075,1.0,2/11,1.57%,ITM2A;NECAB1
prerank,protein hydroxylation (GO:0018126),-0.3607049030360085,-0.947213545163224,0.5272277227722773,0.8531576211371256,1.0,6/15,16.80%,PLOD2;PLOD1;P3H2;JMJD4;P3H3;P3H4
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.35516495621436195,0.9470490712159281,0.5258215962441315,0.9629196118790027,1.0,7/30,17.59%,HNRNPC;SRC;STN1;EXOSC10;MEN1;GNL3L;TERF2
prerank,actin filament polymerization (GO:0030041),0.3691282573682448,0.946711092249555,0.5237388724035609,0.9629786335019171,1.0,4/29,9.93%,COBL;GAS7;WASHC3;DIAPH3
prerank,axonal transport (GO:0098930),-0.2768374465375324,-0.9466753334883289,0.5653710247349824,0.8535501164889195,1.0,9/36,18.23%,KIF1B;DST;NEFL;HIF1A;MAPT;DTNBP1;OPA1;TMEM108;BLOC1S6
prerank,negative regulation of viral transcription (GO:0032897),-0.36536654752902753,-0.9466535944662797,0.5548098434004475,0.8526211339152477,1.0,6/13,20.69%,MID2;TRIM14;UBP1;ZFP36;TRIM13;TRIM11
prerank,DNA damage checkpoint signaling (GO:0000077),-0.3002078269216381,-0.94637360630928,0.5659163987138264,0.8524037500736646,1.0,7/28,17.71%,MAP3K20;USP28;ATRIP;HINFP;CLSPN;RAD1;RAD17
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.3902974742686976,0.9461702170499942,0.521875,0.9635569180481074,1.0,4/20,12.78%,RGS14;GPRASP1;PLEK;RPGRIP1L
prerank,post-translational protein modification (GO:0043687),0.2700812139353049,0.9460819220223792,0.5901981230448383,0.9630339349614253,1.0,77/332,19.44%,FAM20C;GPC3;STC2;LAMC1;LAMB2;FBXL15;SOCS5;ASB6;LMO7;SCG3;SPSB4;PSME3;NUCB1;KEAP1;FN1;BMP15;SUMF1;ADAM10;SOCS6;PTP4A2;ATG5;GOLM1;RAB3A;FBXO31;CUL3;RCN1;CDH2;PSMB5;DCAF13;FBXL19;PROC;PRKCSH;KLHL21;FBXL5;MEN1;FBXO11;FBXO21;PSMB2;P4HB;STT3A;PSMA2;KLHL22;CHM;FEM1C;PSMA6;CHGB;COPS5;PSMD13;FBXW8;PSMA7;FBXO41;DDB2;FBXL12;MBTPS1;FBXW7;FBXL3;DSCC1;CUL4B;RNF7;PSME4;VCAN;CALU;FSTL1;BTBD6;WFS1;VGF;SOCS2;PSMC4;FBN1;PSMB6;PSMD12;PSMD14;ICMT;RAB5A;ZBTB16;DDA1;KBTBD7
prerank,regulation of lipase activity (GO:0060191),0.4226323828090892,0.9460229819524619,0.5210526315789473,0.9624500251800622,1.0,4/13,18.52%,PCSK5;LMF1;LPL;RHOA
prerank,cellular response to glucose starvation (GO:0042149),0.33206532668278615,0.9460014791874203,0.5305832147937412,0.9617769724187959,1.0,8/41,8.96%,MYBBP1A;PRKAG1;FOXO3;EIF2AK3;PIK3R4;BRSK1;SESN1;MTMR3
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.3853468435354968,0.945910121730752,0.5499207606973059,0.9612954745885298,1.0,3/20,10.79%,CAMK2D;FIS1;THADA
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.29432689754704766,-0.9457778716519086,0.540453074433657,0.8529564033605873,1.0,4/31,4.18%,RBP4;TFRC;PAXIP1;SHLD2
prerank,positive regulation of endocytosis (GO:0045807),0.3359152242817477,0.9453481602052743,0.5279672578444747,0.9619499969532447,1.0,7/45,10.09%,GPC3;NEDD4L;ANO6;TFR2;SGIP1;AXL;CALY
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.33951397832286057,0.9453011179309654,0.5370629370629371,0.9613354230691044,1.0,5/38,8.37%,CAV1;ASS1;ATP2B4;DDAH2;NOS1AP
prerank,cellular potassium ion homeostasis (GO:0030007),0.42634447351242516,0.9452796442591794,0.5340314136125655,0.9606617032675082,1.0,3/13,9.40%,SLC12A2;ATP1A2;ATP1B3
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.4177711677582375,0.9451727749000016,0.5140495867768595,0.9601824938198397,1.0,3/15,9.77%,FGFR1;CELF1;CELF4
prerank,leukocyte cell-cell adhesion (GO:0007159),0.3780131711627906,0.945115729948143,0.5292307692307693,0.959614386096939,1.0,6/24,16.49%,F11R;TNIP1;NT5E;SEMA4D;EZR;SYK
prerank,negative regulation of protein secretion (GO:0050709),-0.2760313516598832,-0.9446938968767287,0.5631399317406144,0.8547668829895176,1.0,12/38,18.56%,KCNB1;CCN3;NR1H3;MIDN;APOE;CD200;SERGEF;RHBDF2;RAB11FIP3;RAB11FIP1;RSAD2;OPRM1
prerank,regulation of cardiac muscle contraction (GO:0055117),-0.27600732317998716,-0.9444148161338333,0.5884353741496599,0.8544560171833807,1.0,10/34,17.44%,ANK2;SLC8A1;CALM1;ATP1B1;SLC9A1;ZC3H12A;CALM3;SRI;P2RX4;NOS1
prerank,regulation of B cell proliferation (GO:0030888),0.3330144771920541,0.9435958968571767,0.5185676392572944,0.9625685531741244,1.0,7/44,13.16%,NFATC2;PTPRC;EPHB2;CD320;GPR183;CD81;IL7
prerank,calcium ion transport into cytosol (GO:0060402),0.3826798069522107,0.9434735044492,0.5234493192133132,0.9621559285537954,1.0,3/21,4.74%,ITPR3;TRPV4;ATP2B4
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),-0.33013699569120647,-0.9434408880880695,0.5440414507772021,0.855946907632522,1.0,5/18,19.00%,NUP133;THOC2;ZC3H11A;HHEX;DDX19A
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.36801090195063285,-0.9433750114251671,0.5239179954441914,0.8551363300877951,1.0,6/12,16.52%,LAMA3;ACTB;ACTG1;FUZ;VANGL2;AHI1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.415312127427503,0.9432382212472326,0.5187713310580204,0.9620072461122379,1.0,4/13,17.17%,LAMP1;GAB2;SYK;STX4
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.41484464665195686,0.9432273127593742,0.523102310231023,0.961310021767671,1.0,4/13,11.67%,SOCS5;TSG101;CBLB;SOCS4
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.32425007448611337,-0.9426796252412837,0.5326370757180157,0.8558050813531276,1.0,9/21,20.27%,CYP26B1;PPARD;LPIN2;FAH;LPIN3;ACBD5;AGXT;ACOX1;PLA2G15
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.4197152073037389,0.9426708801427931,0.5215146299483648,0.9619263758788105,1.0,2/13,7.23%,GLI1;TBX2
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.3753687889527316,0.9423874448393195,0.5389408099688473,0.9618955151937435,1.0,6/25,17.58%,SF3B1;SRSF4;PRPF3;DBR1;TRA2B;SLU7
prerank,RNA export from nucleus (GO:0006405),0.29350839323481936,0.9422951607158931,0.5546116504854369,0.9614175483303027,1.0,33/100,23.31%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;RAN;NUP93;THOC5;MCM3AP;XPO5;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.3095901984120266,-0.9422560240847374,0.5567567567567567,0.8558894527377887,1.0,11/22,20.17%,SLIT2;KANK3;HIP1R;TWF1;MYADM;TMSB10;CYRIB;TMSB4X;PFN1;SSH2;SSH3
prerank,quinone biosynthetic process (GO:1901663),0.4098092161414365,0.9422127575082371,0.5257048092868989,0.9608911950212118,1.0,3/14,8.82%,COQ7;COQ8A;COQ9
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.33046313798785026,-0.9418588637283939,0.5555555555555556,0.855913228015109,1.0,4/17,15.99%,PARD3;CALM1;CALM3;EIF4G1
prerank,negative regulation of JNK cascade (GO:0046329),0.3524429956836968,0.9418430903969562,0.5219858156028369,0.9610714518311385,1.0,14/31,24.59%,SH3RF2;PTPN22;DACT1;NCOR1;MAPK8IP1;MEN1;ITCH;PINK1;HDAC3;PRKN;AIDA;TAOK3;PDCD4;CYLD
prerank,visual perception (GO:0007601),0.3020922930006497,0.9414193010188868,0.5603985056039851,0.9613179770723784,1.0,9/84,11.96%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1;CRYBG3
prerank,regulation of cytoskeleton organization (GO:0051493),0.2973083255518543,0.9412352949421805,0.5634638196915777,0.9609797414009845,1.0,8/108,5.91%,EFNA5;DLC1;F11R;ARHGAP18;SPEF1;RAC2;CAPN6;ARHGEF5
prerank,platelet aggregation (GO:0070527),-0.29401274532111954,-0.9411038433166037,0.5335570469798657,0.8568894750958537,1.0,11/33,18.52%,STXBP3;GNAS;PDGFRA;ACTB;MYL9;ACTG1;FLNA;ILK;TLN1;HSPB1;MYH9
prerank,purine-containing compound catabolic process (GO:0072523),-0.367595002904716,-0.9410856391067279,0.54,0.8559554873902018,1.0,5/13,24.17%,DPYD;XDH;NT5C;NT5C1A;GDA
prerank,histone H3-K9 demethylation (GO:0033169),-0.3814748635927596,-0.9407338477576149,0.5433255269320844,0.8558548678557294,1.0,4/11,20.15%,PHF8;KDM1A;KDM7A;KDM4D
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.3795333644011746,0.9403206192530086,0.512,0.9624127655970127,1.0,7/22,16.58%,LEO1;CDK13;ELL;SUPT4H1;ERCC6;TCERG1;THOC5
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.32760706657024385,-0.9400053600172346,0.538860103626943,0.8557910491172012,1.0,9/19,33.50%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.32760706657024385,-0.9400053600172346,0.538860103626943,0.8557910491172012,1.0,9/19,33.50%,POLR2F;POLR2A;POLR2J;POLR2D;POLR2K;ACD;POLR2I;TINF2;POLR2B
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.337167715668146,-0.9399066674764195,0.5275590551181102,0.85510505884127,1.0,1/17,1.51%,LPGAT1
prerank,beta-catenin-TCF complex assembly (GO:1904837),0.3536355620971716,0.9397254081744424,0.5145929339477726,0.9630784369986127,1.0,12/29,21.70%,LEO1;TRRAP;AXIN2;PYGO1;MEN1;CREBBP;BCL9;KMT2D;TCF7L1;CDC73;ASH2L;TCF7L2
prerank,regulation of chemokine production (GO:0032642),-0.27740366727308224,-0.9396478375042489,0.5787671232876712,0.8548324517036143,1.0,5/36,6.53%,IL6R;FOXP1;IL18;HIF1A;IL33
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.34823979194298393,-0.9395854549228321,0.5544041450777202,0.8540039031515232,1.0,5/16,12.91%,ARHGAP24;RASGRF1;ARHGAP17;GABARAP;ARHGAP44
prerank,inorganic cation transmembrane transport (GO:0098662),0.27402627564103643,0.9391419444260382,0.59958071278826,0.9637354364085641,1.0,38/268,13.98%,KCNJ4;OTOP1;SCN10A;NALCN;TRPM3;SLC12A2;KCNA5;SLC39A13;KCNJ16;ANO6;SLC24A1;TRPV4;KCNS2;SLC12A3;KCNK1;ATP2B4;CACNA1H;ATP1A2;SLC6A13;SLC4A4;SLC30A6;SLC4A11;COX15;KCNK5;ATP1B3;NNT;KCNS3;TRPC4AP;KCNAB1;SCN2B;SLC9A7;SLC9A6;PKD1;TRPV2;ABCB7;KCNK10;KCNK4;SLC6A4
prerank,negative regulation of interleukin-1 production (GO:0032692),0.3708251422446695,0.9390186050087937,0.5287713841368584,0.9633336081085341,1.0,3/23,9.52%,CEACAM1;TNFAIP3;NLRP2B
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.43038611619356226,0.9389013842535338,0.5517241379310345,0.9628877514502958,1.0,3/12,10.47%,TET1;RESF1;PPHLN1
prerank,snRNA transcription (GO:0009301),-0.24512831810992405,-0.9387177387320669,0.5913978494623656,0.8552966238294527,1.0,19/70,19.49%,POU2F1;INTS9;CCNT2;CDK9;RPRD2;PHAX;CCNT1;SNAPC1;ZC3H8;SP1;INTS1;NCBP1;POLR2F;POLR2A;POLR2J;SNAPC5;POLR2D;POLR2K;TAF6
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.30366433277910543,-0.9386083033277285,0.5279503105590062,0.8545774295956818,1.0,9/26,20.23%,CLIP1;STMN2;RPS3;MAPT;CDK5R1;ARL2;FES;KATNB1;MET
prerank,stress-activated protein kinase signaling cascade (GO:0031098),-0.28973480238836297,-0.9373843098028132,0.5213414634146342,0.8565964371896275,1.0,12/27,36.82%,MAP3K20;TAOK2;IKBKB;CUL1;SKP1;IKBKG;TNIP2;UBB;MAP3K8;CCDC88C;RPS27A;UBC
prerank,modulation by host of viral genome replication (GO:0044827),-0.36283029521594357,-0.9372771860951544,0.5445544554455446,0.8559052916075063,1.0,7/13,28.83%,YTHDC2;ZC3H12A;EIF2AK4;PPIB;FBXL2;CCNK;IFI27
prerank,regulation of T cell chemotaxis (GO:0010819),0.43522035061569264,0.9369689368907345,0.5389830508474577,0.9667624357568514,1.0,2/11,6.14%,WNT5A;ADAM10
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.278434498989104,0.9369413248805314,0.5772266065388951,0.966102344439911,1.0,18/158,11.08%,ROR1;PLK2;LPAR1;PELI2;AKAP13;SLC35B2;REL;NUP62;PPM1A;TRADD;TRIM21;S100B;TFG;TICAM1;TMED4;CANT1;SHARPIN;TAB2
prerank,midbody abscission (GO:0061952),0.3942217659596207,0.9358737469339669,0.5200642054574639,0.967985398770529,1.0,5/17,11.97%,CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3168978821543025,0.9357212528305877,0.5555555555555556,0.9676437839663956,1.0,13/63,18.02%,NFATC2;PTPRC;EPHB2;NCK2;CD320;IL6ST;GPR183;CD276;CD81;IL7;IL15;IRS2;FGF10
prerank,regulation of biomineral tissue development (GO:0070167),0.36862329269525806,0.9356103941011467,0.5255255255255256,0.96719638704719,1.0,5/26,10.72%,SGMS2;SOX9;BMP2K;FBXO5;ANKH
prerank,covalent chromatin modification (GO:0016569),-0.3478877897018676,-0.9355852562898118,0.539440203562341,0.8592227084101233,1.0,4/14,12.46%,SETD5;HDAC1;HLCS;PARP2
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3106017689353853,-0.9352456336803271,0.5111111111111111,0.8591563524348574,1.0,6/23,17.04%,PRKAG2;CALM1;UBE2K;SPHK1;CALM3;EGF
prerank,myelination (GO:0042552),-0.26120167077416423,-0.9350460085500666,0.5564516129032258,0.858703482861682,1.0,12/46,13.82%,PARD3;ADGRG6;SLC8A3;TNFRSF21;BCAS1;PLLP;CMTM8;GAL3ST1;LGI4;SBF2;ABCD2;DEGS1
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.36632047705363846,-0.9349515785555474,0.5423728813559322,0.8579638474248155,1.0,2/13,4.13%,SOX13;NAPEPLD
prerank,neutrophil chemotaxis (GO:0030593),0.3265079593394915,0.9346398743765633,0.5512649800266312,0.9688405158418822,1.0,1/53,0.29%,CXADR
prerank,hexose biosynthetic process (GO:0019319),0.33615700261177556,0.9345477350900936,0.5643153526970954,0.9683401772321365,1.0,13/42,21.47%,PPARGC1A;SLC25A12;ALDOB;PGM1;MDH1;SLC25A13;ENO3;GOT1;PGK1;ENO2;SLC37A4;SLC25A10;ENO1
prerank,substantia nigra development (GO:0021762),-0.2724256114500163,-0.9342694279288732,0.5947712418300654,0.8587665358954802,1.0,14/37,15.09%,CDC42;CKB;GNB4;CALM1;ACTB;MAOB;COX6B1;SEC16A;CNP;TTBK1;S100A1;CALM3;RAD1;ATP5PF
prerank,import into cell (GO:0098657),0.33762006419534746,0.9341435959555815,0.5470085470085471,0.9685850235059528,1.0,8/41,6.69%,LRRC8D;SLC1A7;SLC12A4;SLC27A1;LRSAM1;ATP1A2;SLC6A13;SLC1A6
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),0.38864064041530166,0.9336223928599159,0.5311973018549747,0.9690947898826473,1.0,1/16,0.79%,ST3GAL4
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.34190363456013995,0.9332285370445181,0.5116279069767442,0.9693484083499759,1.0,11/35,18.99%,AWAT2;HMGCLL1;SCD5;ACACA;GCDH;ACAT1;GGTA1;GGT1;HPGD;SCD;BDH1
prerank,branched-chain amino acid catabolic process (GO:0009083),0.38863191040421113,0.9329000008749161,0.5512422360248447,0.9687031340450525,1.0,5/20,11.48%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,branched-chain amino acid metabolic process (GO:0009081),0.38863191040421113,0.9329000008749161,0.5512422360248447,0.9687031340450525,1.0,5/20,11.48%,ACAD8;BCKDK;ACAT1;BCKDHB;BCAT2
prerank,negative regulation of RNA splicing (GO:0033119),0.37933671385555917,0.9328467573885352,0.5086887835703001,0.9681118742139366,1.0,9/19,24.10%,SRSF4;RPS13;PTBP3;SFSWAP;PTBP2;SAP18;SRSF12;SRSF10;RBMX
prerank,protein kinase A signaling (GO:0010737),0.4260114507866392,0.932822464130207,0.5243506493506493,0.9674538546199188,1.0,4/12,17.74%,RDX;PRKACB;EZR;LCP1
prerank,RNA 3'-end processing (GO:0031123),0.3097253623820451,0.932614022849789,0.5398457583547558,0.9672464130194267,1.0,24/69,25.76%,CSTF1;RBM8A;SRSF4;RPRD1B;TUT1;CSTF3;LIN28B;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;SRSF3;DHX38;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B;PNPT1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.3652742597273064,0.931915089195512,0.5515151515151515,0.9681934869788714,1.0,10/26,22.57%,EGFR;SOX9;SYAP1;ZFP36L2;ERBB2;PDPK1;PTPN12;STAT5B;FOXC1;IQGAP1
prerank,regulation of phagocytosis (GO:0050764),-0.248911145386222,-0.9318793319455915,0.6082089552238806,0.863819069782025,1.0,9/53,9.19%,TGM2;DYSF;SIRPA;SYT7;PIP4P2;IL15RA;CYBA;GATA2;MERTK
prerank,positive regulation of histone acetylation (GO:0035066),0.36280466662768907,0.9318587136667768,0.5083969465648855,0.9676236163521525,1.0,1/23,0.58%,PPARGC1A
prerank,tRNA wobble base modification (GO:0002097),-0.35172527098065137,-0.9314733922886532,0.5230352303523035,0.8638863359280627,1.0,9/14,37.21%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ADAT2;CTU2;CTU1
prerank,positive regulation of telomere maintenance (GO:0032206),0.34867143467612355,0.93142109442261,0.5299860529986054,0.9679731558032088,1.0,12/31,26.71%,NEK7;NBN;NAF1;ERCC1;MRE11;HNRNPD;SLX4;MAPK1;ATRX;TNKS;PML;RAD50
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.3750391586509513,-0.9313572873134512,0.5695364238410596,0.8632334397408474,1.0,5/11,13.12%,NR1H3;LDLR;CTDNEP1;NR1H2;MFSD2A
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.31004042070038573,-0.9311897206723402,0.5558823529411765,0.8626987267290952,1.0,9/25,27.69%,EPHA4;RPS7;SGTA;RPL23;CSNK2A1;HFE;RPL5;ALAD;RPL11
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),-0.28105925511031504,-0.9310233607478953,0.5871559633027523,0.8621489029067025,1.0,6/31,9.71%,STXBP3;KCNB1;SYT9;SYT7;CACNA1G;SCAMP5
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.26313043184838536,0.9310229033909498,0.6737804878048781,0.9682300491709996,1.0,81/476,17.11%,RORA;FGF7;MDFIC;NFATC2;GLI1;PPARGC1A;NR2F2;ZNF423;NFATC1;FZD2;EGFR;NPAS3;BCL3;AXIN1;RUNX2;GLI2;MLLT3;KMT2A;FOXK1;FOXO3;SOX9;NPAS2;GLIS2;CHD8;KAT6B;HDAC4;NUP62;WNT5A;PPM1A;ATAD2;SP3;ZFP90;RGMB;CTCF;PAX3;RREB1;RARA;MAP3K5;ILF2;FOXK2;DYRK1A;MED13;RORB;HDAC2;KARS1;TFEB;ILF3;DVL3;COL1A1;TASP1;EGR1;BICRA;KDM8;CEP290;NAT14;SPIN1;CRLF3;TAF15;CREBBP;GTF2H1;SOX4;CDKN1C;FZD7;KAT8;RAI1;ERBB4;FOXF1;NEK4;MED12;CDH1;SNX5;FOXC2;YAP1;TESC;PBX4;PCBD2;ARHGEF11;TFE3;E2F1;QRICH1;PPARG
prerank,transcription by RNA polymerase II (GO:0006366),0.2674920619549518,0.9309813094241913,0.6288659793814433,0.9676277372200374,1.0,57/305,18.15%,RORA;PPARGC1A;NR3C2;RARB;DTX1;CSTF1;MAML2;MLLT3;PGR;INTS10;TAF10;LEO1;SNRPF;MED18;RPRD1B;TAF4B;CDK13;TEAD3;CDK7;PAF1;NCOR1;CSTF3;RREB1;RARA;RPAP2;ELL;MED7;NELFB;RORB;SUPT4H1;RPRD1A;NRBF2;ERCC6;NCOR2;RARG;MED23;GTF2F2;TAF15;CREBBP;GTF2H1;TRIP11;MBD1;CBFB;NR5A1;TAF5;YAP1;INTS3;SRRT;ELOA;ESRRA;PPARG;RTF1;TCEA1;SETD2;SYMPK;TSC22D1;GTF2H3
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.34071273844162964,-0.9303953875700541,0.5349462365591398,0.8628201200621499,1.0,7/15,19.29%,IGF1;ROCK2;MEF2A;SLC9A1;EDN1;AGT;PARP1
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.3880695536028017,-0.9299085855201653,0.5672645739910314,0.8630494990445529,1.0,2/10,2.52%,MSN;CDC42
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.4090602152368954,0.9298774087127369,0.532258064516129,0.9695473575540765,1.0,2/14,6.14%,WNT5A;ADAM10
prerank,import into nucleus (GO:0051170),0.3043711910076625,0.9298214281074255,0.5679487179487179,0.9689676031743395,1.0,15/73,16.49%,PRICKLE1;IPO8;NUP62;SNRPF;FAM53B;SMN1;TPR;MMP12;NUP50;HTATIP2;CSE1L;NUP153;RAN;NUP93;SYK
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.28375660926905455,-0.9296234264176471,0.5608974358974359,0.8629109850548254,1.0,8/30,17.65%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,negative regulation of insulin secretion (GO:0046676),0.3966971808532063,0.9292268546493561,0.5289256198347108,0.9696055607540524,1.0,1/17,0.54%,INHBB
prerank,ubiquinone biosynthetic process (GO:0006744),0.3959635485300568,0.9288559907684794,0.5450081833060556,0.9697904491706244,1.0,3/15,8.82%,COQ7;COQ8A;COQ9
prerank,glucose import (GO:0046323),0.41944259209893553,0.9287972750893964,0.5557377049180328,0.9692330073775789,1.0,3/13,9.63%,SLC27A1;ZDHHC7;SLC27A4
prerank,inner ear morphogenesis (GO:0042472),-0.3144084469129747,-0.9286605916864221,0.5495978552278821,0.8643692589629607,1.0,4/22,6.34%,CHD7;MYO6;FGFR2;TBX1
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.38773062033443717,-0.9285433318783837,0.5539568345323741,0.8636834737732461,1.0,5/11,25.54%,HIF1A;ATF4;RACK1;NR4A3;FBXO7
prerank,bile acid biosynthetic process (GO:0006699),0.3616399788766819,0.9281920058976839,0.5299401197604791,0.969928889670334,1.0,4/24,10.29%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,telomere maintenance in response to DNA damage (GO:0043247),-0.3918927015437306,-0.928143753140652,0.5369565217391304,0.8636954206598715,1.0,4/10,23.94%,DCLRE1B;DCLRE1C;ACD;TFIP11
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.3976420720273404,0.9276487201098007,0.5555555555555556,0.9704972996069128,1.0,6/17,21.40%,KCNS2;NOS1AP;KCNAB1;KCNRG;SUMO1;VAMP2
prerank,regulation of fatty acid oxidation (GO:0046320),0.40255519663719824,0.9273912980606895,0.5446880269814502,0.9703941143112895,1.0,3/16,5.25%,PPARGC1A;SOX9;PDK4
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.4503231059676033,0.9272083847062337,0.5738539898132428,0.9701108816231236,1.0,2/10,8.66%,GCDH;ACADS
prerank,regulation of osteoclast differentiation (GO:0045670),0.3492280672155588,0.9269814116167518,0.5555555555555556,0.9699296890645179,1.0,1/33,0.50%,UBASH3B
prerank,regulation of cellular component movement (GO:0051270),-0.25307369695545295,-0.9259360064465135,0.6273764258555133,0.8680952736766729,1.0,13/49,13.25%,ETS1;ROCK2;TGFBR3;SP100;LYN;TGFBR1;IGBP1;RPS19;CDK6;DIAPH1;ZSWIM6;YTHDF1;ZSWIM4
prerank,regulation of receptor recycling (GO:0001919),0.3940973409830738,0.9258770297018718,0.555379746835443,0.971871183701155,1.0,4/16,9.12%,RAB29;KIF16B;INPP5F;TBC1D16
prerank,positive regulation of lamellipodium organization (GO:1902745),0.35273671861693423,0.9256803563996777,0.5450581395348837,0.9715949876186836,1.0,8/32,16.89%,PLCE1;SRC;RAC2;RREB1;OCLN;AKIRIN1;AUTS2;ARHGEF7
prerank,phosphatidylinositol metabolic process (GO:0046488),0.29485704506034077,0.9256010012115093,0.6016166281755196,0.9710687363428553,1.0,17/109,9.15%,PTPN13;PLCB3;PI4K2B;TPTE;SLC27A1;PIP4K2B;PIK3R4;PGAP3;PLEKHA4;MTMR7;PIK3R2;MTMR6;OCRL;INPP5F;MTMR3;PLEK;LCLAT1
prerank,negative regulation of phosphorylation (GO:0042326),0.30395544120610263,0.9255745416399467,0.5667915106117354,0.9704249115424468,1.0,9/85,8.23%,DYNLL1;NTRK3;PTPN13;PLPP3;HDAC4;IBTK;EPHB2;NCOR1;OCLN
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.2651253371691377,-0.9255037370311059,0.5946843853820598,0.868239035464871,1.0,9/36,17.04%,TGFA;SHANK3;HIF1A;HDAC1;JAK2;EDN1;NRP1;HFE;EGF
prerank,dephosphorylation (GO:0016311),0.2799681600273464,0.9250672673445687,0.6008869179600886,0.9708822926512559,1.0,31/147,15.20%,PTPN13;PTPRF;DUSP12;PLPP2;ACP6;PTPN14;TPTE;PLPP3;PTPN22;PTPRC;THTPA;PPM1A;PPM1M;MTMR7;PTPRJ;MTMR6;MTMR3;PDP2;PTPRT;SDHAF2;CTDSP1;PPP2R1B;PTPN18;PTEN;PTPRA;DUSP8;CTDSP2;PTPRU;PTPRO;PLPPR1;PTPN6
prerank,myoblast differentiation (GO:0045445),-0.3520702711271185,-0.9246907861601122,0.5600961538461539,0.8693420525185371,1.0,4/14,10.59%,IGF1;HINFP;MAPK12;EPAS1
prerank,regulation of cholesterol metabolic process (GO:0090181),-0.31432800887129764,-0.9246407725968042,0.5218579234972678,0.8685256111613453,1.0,4/20,12.93%,ARV1;APOE;LDLRAP1;ABCA2
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.30118933419684174,0.9244803005034862,0.5768261964735516,0.971598431459911,1.0,8/72,9.99%,PLK2;GTSE1;BCL3;CNOT10;ARID3A;NBN;SFN;CNOT7
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),-0.3249365969326197,-0.9239491930638523,0.5555555555555556,0.869256778827513,1.0,4/18,7.43%,FLT1;AKT3;IGF2;COL4A3
prerank,chromatin organization (GO:0006325),0.2846955907614893,0.923870683097284,0.5969084423305588,0.9722931761008828,1.0,44/132,21.53%,SPI1;SOX9;CDAN1;HDAC4;SATB1;CHD1;SMARCAD1;SUV39H1;GATAD1;SMARCD2;SUPT4H1;HDAC2;BAZ2B;PBRM1;TOP1;INO80;KDM6B;NUCKS1;BAZ2A;TADA2A;CHD1L;KDM4B;MCM3AP;BRWD1;HP1BP3;SETD2;MTF2;SUV39H2;HMGN2;RUVBL2;TCF7L1;HDAC3;NUDT5;HCFC2;RBBP4;HMG20A;CHRAC1;LOXL2;KDM5B;DAXX;SETDB1;RSF1;DDX11;ARID1A
prerank,peptidyl-proline hydroxylation (GO:0019511),0.41773699837666056,0.923498531959769,0.5724258289703316,0.972450517875705,1.0,4/11,14.09%,EGLN3;P4HTM;P4HA1;P4HB
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.4302753559325613,0.9232636537301468,0.5505226480836237,0.9723514853019473,1.0,1/10,5.04%,CNGB1
prerank,nervous system development (GO:0007399),0.2638382582108241,0.9229386492936753,0.6894093686354379,0.97234739649526,1.0,66/429,13.59%,NGF;EFNA5;LPAR1;LDB2;JAG1;ZC4H2;RAB29;RBFOX2;NF1;STIL;OPHN1;TMOD2;NPAS2;GLIS2;NBL1;HDAC4;DSCAM;PCDHB15;DACT1;ACVR1C;INTU;FN1;NTN5;CLN8;NCAN;ARTN;LSAMP;ARHGAP26;EPHB2;GMFB;SCD5;TAGLN3;CHERP;SIAH1;CDH2;ALDH5A1;S100B;IGF2BP2;DYRK1A;JRKL;KALRN;PTS;DOC2A;GPM6A;MPZ;UNC119B;RPS6KA3;BTBD2;POU4F1;AXL;RELN;ERCC6;BPNT1;TMEM223;APC;PRPS1;WDR62;FBXL17;DPYSL2;NDUFV2;PTEN;CHRM2;PKD1;SMO;SDK1;DPF3
prerank,fatty acid transport (GO:0015908),-0.33122089031814195,-0.9228308941672418,0.5413533834586466,0.8711036041477933,1.0,3/17,6.28%,ACSL1;PPARD;APOE
prerank,apoptotic mitochondrial changes (GO:0008637),0.3539935896914091,0.9224344077166083,0.5795620437956205,0.9728453959052124,1.0,12/32,21.38%,HK2;FIS1;SFN;NAIF1;ERBB4;FZD9;BAD;AIFM2;BNIP3;ATG3;BAX;CCAR2
prerank,regulation of interleukin-8 production (GO:0032677),0.3050899568501272,0.9219875328087195,0.5888324873096447,0.9731770152778147,1.0,8/69,11.06%,LBP;BCL3;PTPN22;PTPRC;TLR7;ANXA4;HMGB1;OTUD7B
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.24502817569922672,-0.9219763279618401,0.6235294117647059,0.8722270773729248,1.0,22/54,29.48%,RPL35A;RPL26;NPM1;HEATR3;RPLP0;RPL3;WDR12;NOC2L;LAS1L;MRPL20;RPL14;NLE1;PPAN;RPL10A;RPL5;PAK1IP1;RPF2;NHP2;RPL7;RPL11;NOP16;RPL24
prerank,N-glycan processing (GO:0006491),-0.33102216265511847,-0.9218984303708883,0.5398457583547558,0.8715011761593316,1.0,5/18,14.85%,ST8SIA4;MGAT4A;GANC;ST8SIA2;FUT8
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.34129249298677194,0.921725931357557,0.5449189985272459,0.9730912585886875,1.0,7/33,14.04%,KLK2;AXIN1;DDRGK1;UFSP2;HDAC6;NCOA2;CBFB
prerank,regulation of bone mineralization (GO:0030500),0.3170996771583564,0.9216770805359831,0.5750332005312085,0.9724978745967429,1.0,4/55,4.10%,PKDCC;SGMS2;ANO6;BMPR1B
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.3545630037516206,0.9215822027035019,0.5340393343419062,0.9720288166230171,1.0,9/27,18.67%,KAT6B;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRD8;MORF4L2;RUVBL2
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.2877401799441778,0.9214837909494223,0.5797101449275363,0.9715563872015113,1.0,10/108,7.80%,NGF;DLC1;EIF2AK3;FIS1;ACVR1C;EGLN3;UACA;TRADD;NLRC4;MAP3K5
prerank,regulation of viral entry into host cell (GO:0046596),-0.28583597936995103,-0.9214400023269481,0.5914634146341463,0.8717005436280159,1.0,12/30,32.60%,LY6E;MID2;TRIM25;TRIM14;LGALS9;TRIM11;TRIM6;TRIM27;CIITA;LGALS1;IFITM2;TRIM62
prerank,regulation of microtubule-based movement (GO:0060632),0.4248799257092686,0.9214110508871428,0.568100358422939,0.9710287151308871,1.0,4/11,15.69%,LAMP1;HDAC6;TTC21B;CFAP298
prerank,positive regulation of inflammatory response (GO:0050729),0.2982959108509447,0.9212932544400704,0.6014943960149439,0.9706202944000761,1.0,14/86,12.38%,LBP;MGST2;WNT5A;ABCC1;IL17RA;TLR7;TRADD;PTGER4;TNIP1;KARS1;S100A9;IL6ST;VAMP8;CD81
prerank,positive regulation of MAPK cascade (GO:0043410),0.27034478355373226,0.9212766365206186,0.6215351812366737,0.9699655488421692,1.0,14/245,4.99%,ROR2;ROR1;NTRK3;FGFR1;LPAR1;ACKR3;EGFR;RAP1A;PELI2;FGF1;CAV2;PTPN22;PRKCA;PTPRC
prerank,glycolipid metabolic process (GO:0006664),0.3263732458733559,0.9211051807856593,0.555256064690027,0.969687556111355,1.0,17/47,24.26%,ST3GAL4;NAGA;SUMF1;PGAP3;CERK;NEU1;HEXA;SCCPDH;HEXB;GBGT1;ASAH1;ST6GALNAC6;SUMF2;PGAP1;ESYT2;ARSA;SMPD2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.2987111603578214,0.9210977951735873,0.5900383141762452,0.9690129174367911,1.0,14/78,13.51%,NR2F2;EGFR;CCND3;CCNG1;CDK7;CCNJ;APC;HEXIM1;MEN1;PTEN;CDC6;PKD1;GTF2H1;CDKN1C
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.33400202661866424,0.9210042624066153,0.5772913816689467,0.9685346028561801,1.0,4/48,3.58%,UBASH3B;CAMK2D;PDE4D;FKBP1B
prerank,lipid catabolic process (GO:0016042),0.38444836146710326,0.9207142908221742,0.5595054095826894,0.9684936997913794,1.0,5/18,22.93%,CEL;LIPE;LPL;HSD11B1;SIRT2
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.360236703175199,-0.9207062384579625,0.5609756097560976,0.8725794702449048,1.0,4/12,14.40%,AP2A1;TMEFF2;AR;EDN1
prerank,cochlea morphogenesis (GO:0090103),0.4303774969806262,0.9205572461799796,0.5454545454545454,0.9681565482909696,1.0,4/10,20.87%,SOX9;TBX18;MYO3B;PAX2
prerank,regulation of cell death (GO:0010941),0.29565022517617245,0.9203399424510809,0.5684210526315789,0.9679759645660828,1.0,18/94,13.45%,PRODH;ACER3;SPEF1;RAB29;WNT16;CIDEB;CELF1;NPAS2;ATG5;SARM1;FERMT2;CHMP4B;AXIN2;APC;FAF1;SNCG;DHCR24;SOX4
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.28789880029656756,0.9202952150596586,0.5885225885225885,0.967391308036282,1.0,31/96,23.31%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.3654187883530279,-0.9202698208543033,0.5541871921182266,0.872638177034111,1.0,5/12,18.03%,GCLM;BDH2;CNDP2;GGCT;GCLC
prerank,organelle assembly (GO:0070925),0.26060853382043536,0.9202251882698651,0.6717791411042945,0.9668717035757487,1.0,89/384,19.81%,DYNLL1;PARVA;UBXN10;RAB8B;ABLIM3;MKS1;PTPDC1;DZIP1;DYNC2I1;TMOD2;CYS1;EXOC3;NUP62;CNGB1;INTU;HPS1;CEP89;TSG101;NEK7;CEP131;SH3PXD2B;IFT81;ATG5;CNGA4;EHD2;NCOR1;SNX10;CEP162;CLUAP1;TMOD1;IRGM;OCRL;CHMP5;PDCD6IP;UNC119B;TCTN2;TMEM237;FOXJ1;IST1;DYNLL2;IFT74;TUBGCP5;CHMP4A;CHMP4B;ATXN2;HDAC6;CFAP20;CHMP4C;EXOC5;CEP290;INO80;CDS2;CSDE1;UBAP2L;MAPRE2;PKD1;ATG7;DDX6;FLII;FBF1;PCM1;PDE6D;FAM161A;DNAH5;PIK3C3;CFAP298;CFAP70;PIBF1;CFAP410;B9D2;MRPL22;UBQLN1;CDC14A;DYNC2H1;EHD1;OFD1;ATG2B;ARMC9;BBS1;CEP250;SNAP29;MAP1LC3B;G3BP1;LSM3;ATG3;HDAC3;TUBGCP6;TCTN1;RB1CC1
prerank,positive regulation of natural killer cell activation (GO:0032816),0.4140892787965017,0.9196729190962465,0.5604770017035775,0.96747319102896,1.0,3/13,9.89%,LAMP1;TICAM1;AXL
prerank,regulation of ATP biosynthetic process (GO:2001169),0.39662319077167707,0.9194037375668234,0.5668276972624798,0.9674024904675331,1.0,1/16,0.58%,PPARGC1A
prerank,neuron projection organization (GO:0106027),-0.3465681073414105,-0.9193471868836826,0.5497382198952879,0.8739050498680577,1.0,5/15,21.43%,INSR;LGMN;ABCD2;PICK1;PLS1
prerank,positive regulation of protein metabolic process (GO:0051247),0.2888559834380178,0.9192928222618062,0.6084905660377359,0.9669660912998398,1.0,13/110,11.37%,PLK2;GPC3;NEDD4L;AXIN1;TFR2;DACT1;WNT5A;TNFAIP3;MAPK7;ISL1;GSK3B;APC;NEDD4
prerank,membrane organization (GO:0061024),-0.1994766026598734,-0.9192111311516877,0.7843137254901961,0.8732770447014404,1.0,32/227,9.97%,MYOF;PICALM;HIP1;TGFA;ANK2;DNM3;DAB2;TFRC;DNAJC6;DYSF;NAPA;TRIP10;AP2A1;STX18;LDLR;SYT9;HSPA8;HIP1R;MYADM;ATP2C1;ACTB;SH3KBP1;CTDNEP1;EPS15;SH3GLB1;LEMD3;LDLRAP1;PIK3C2A;ACTG1;ARPC3;VPS4A;ANK3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3273584079682653,-0.9190880579352816,0.556786703601108,0.8725829462719761,1.0,5/18,12.18%,SHANK3;CUX2;GRIN1;PRKCZ;NRXN1
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.371962713874356,0.9189863566639228,0.5576036866359447,0.9669992432082126,1.0,2/21,4.40%,EFNA5;PEAK1
prerank,peptidyl-amino acid modification (GO:0018193),-0.37783217794415414,-0.918838780151437,0.5522727272727272,0.8722848651032029,1.0,1/10,3.31%,ATP7A
prerank,intracellular protein transport (GO:0006886),-0.19028239093120167,-0.9186130927242719,0.8205128205128205,0.8719262376579742,1.0,74/304,20.65%,RANBP3L;TBC1D4;STXBP3;WLS;ARHGEF2;KIF13B;IPO9;TBC1D1;MYO6;RABGAP1;APPL2;RAB6B;COG7;NUP107;TBC1D12;PREB;C2CD5;NAPA;TMED9;AP2A1;STX8;TBC1D30;USP6NL;TBC1D2B;NPM1;HEATR3;AKAP6;NUP133;RANBP6;RASSF9;AKT1;SURF4;SGSM3;COPZ1;SEC16A;GABARAP;COPZ2;EIF2D;STX17;EVI5L;AP4E1;RAB5C;CLIP3;RANBP3;TMED3;TBC1D22B;SAR1B;RAB24;VPS26B;STX12;HERC2;CTSA;NUP88;GGA3;TMED1;STX6;ARF5;LAPTM5;SCFD1;XPO6;STX16;TECPR2;SEC31A;COX18;RAB32;CDC37;SYNDIG1;E2F3;KATNB1;TMED7;TBC1D17;VPS28;MAIP1;PICK1
prerank,gliogenesis (GO:0042063),-0.34944681438705094,-0.9184336742435005,0.5639686684073107,0.8714070131441918,1.0,4/15,12.75%,NFIB;ANXA1;CDK6;TGFB2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.39123391246966205,-0.9183936253248275,0.562929061784897,0.8705518589677266,1.0,6/10,39.53%,CALM1;CALM3;GPR35;CRHR1;GNB5;DRD3
prerank,positive regulation of phospholipase activity (GO:0010518),0.3756630834019712,0.9180464008488648,0.5622188905547226,0.9683694845720769,1.0,2/22,0.70%,NTRK3;FGFR1
prerank,tRNA wobble uridine modification (GO:0002098),-0.350801821787705,-0.917855772223068,0.5634920634920635,0.8708733061094358,1.0,9/14,37.21%,ELP3;TRMT9B;ELP4;GTPBP3;MOCS3;KTI12;ELP1;CTU2;CTU1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.2547780455292379,-0.9176710552299809,0.5985401459854015,0.87038858366508,1.0,11/45,14.53%,IGF1;PDGFRA;FTH1;CDK6;MED25;BMI1;B4GALT7;SPHK1;CDK4;PARP10;NLRC3
prerank,hippo signaling (GO:0035329),0.3518398686462166,0.9173053092899119,0.5488721804511278,0.9693814198655343,1.0,9/26,16.76%,AMOTL1;TJP2;AMOT;TEAD3;STK3;WWC1;NPHP4;YAP1;YWHAE
prerank,negative regulation of establishment of protein localization (GO:1904950),-0.3874206077367914,-0.9171108107799609,0.5857461024498887,0.8708641049678056,1.0,5/10,29.40%,DNAJA1;CORO2B;MAPT;NDFIP2;PPM1F
prerank,regulation of protein localization to cell surface (GO:2000008),0.3425277665767224,0.9168716833506653,0.5584415584415584,0.9696570719093471,1.0,3/33,2.89%,NEDD4L;LEPROT;RIC3
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.2839086617823018,0.9168320102290454,0.5857988165680473,0.9690450213448139,1.0,25/114,22.11%,EDA;TNFSF8;FOXO3;PSME3;TRADD;PSMB5;CDIP1;TNFRSF11B;TXNDC17;PSMB2;PSMA2;PSMA6;TNFRSF14;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;ST18;TRAF3;TRAF5;PSMB3;LTBR
prerank,regulation of telomerase activity (GO:0051972),0.3246742480901063,0.9167792641383429,0.5844686648501363,0.9684949882923768,1.0,6/45,12.07%,SRC;NEK7;NAF1;WRAP53;MEN1;CCT2
prerank,response to light stimulus (GO:0009416),0.31310702255318207,0.9164588271272905,0.5876010781671159,0.9685362163445281,1.0,8/55,11.92%,MSH6;SLC24A1;MAPK10;BRSK1;OPN1MW;OPN1MW3;ERCC6;MEN1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.29311513013490575,-0.9162747794001005,0.5891238670694864,0.872023178247382,1.0,6/27,13.59%,IGF1;PDGFRA;CDK6;BMI1;SPHK1;CDK4
prerank,nuclear membrane organization (GO:0071763),0.3803870105922233,0.9160961870182641,0.5464743589743589,0.9686915493848562,1.0,5/19,15.10%,NEMP1;SPAST;CHMP4B;EMD;GPER1
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.2854069946223736,0.9157815738459382,0.6209677419354839,0.9687226311858832,1.0,18/112,10.56%,F11R;PXN;DLX1;WNT10A;CDH5;SOX9;SRC;WNT5A;TGFBRAP1;COL3A1;MAPK7;GCNT2;LTBP2;CGN;FERMT2;LEFTY1;FNTA;ZYX
prerank,regulation of cellular response to heat (GO:1900034),0.2989370265974378,0.915776762414637,0.5806451612903226,0.9680464586656358,1.0,27/77,23.75%,CAMK2D;HSPH1;NUP62;BAG3;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;CREBBP;NUP93;CHORDC1;DNAJC7;YWHAE;BAG2;CAMK2G;RPTOR;ATR;CCAR2;NUP43;RPA3;SEC13;MAPK1;MTOR
prerank,positive regulation of ossification (GO:0045778),0.32964458398858454,0.9157357569010195,0.5763888888888888,0.967466616741877,1.0,4/39,4.96%,PKDCC;ANO6;BMPR1B;WNT5A
prerank,NAD biosynthetic process (GO:0009435),0.3737425514772075,0.9156791313754652,0.56120826709062,0.966907448682812,1.0,4/20,12.57%,NAPRT;NADSYN1;NMNAT3;NAXD
prerank,protein insertion into membrane (GO:0051205),0.34152221874112165,0.9154030181061821,0.5844155844155844,0.9668596705964545,1.0,13/32,24.81%,EGFR;STX1A;TRAM1;RTP3;EMD;OTOF;UBE2J2;SEC61G;STX5;VAMP2;PRNP;VAPA;SERP1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.30201482300037497,0.915397775612149,0.5844980940279543,0.9661886975383897,1.0,21/71,20.41%,ADAMTS12;FAP;TNFAIP3;SOCS6;CHFR;PDCD6IP;CHMP4B;LONP1;OTUD7B;HDAC6;ZYG11B;FBXL17;CHMP4C;CAPN2;PSMA6;CUL4B;CTSB;USP9X;HM13;UBE2W;PRKN
prerank,regulation of protein localization (GO:0032880),-0.23901147478070445,-0.9153003253707366,0.6652719665271967,0.8735004200433978,1.0,15/58,19.63%,PICALM;AFDN;FKBP1A;TRIM25;TRIM14;WDPCP;VPS4A;CTSD;KDM1A;MMD;STX6;TESK1;PARP1;RACK1;PLEKHM2
prerank,Rho protein signal transduction (GO:0007266),0.31479840645086693,0.915224122160145,0.5704787234042553,0.9658746624330083,1.0,13/53,17.25%,CDH13;NTN1;CDC42EP4;RHOJ;RIPOR1;ARHGEF1;CTNNAL1;ADRA2A;CDC42EP3;ARHGEF11;CELSR1;RTKN;ARHGDIB
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3648774386745896,0.9152038128657101,0.5753012048192772,0.9652462461428353,1.0,1/25,0.24%,CAV1
prerank,embryonic skeletal system development (GO:0048706),0.3391808415208658,0.9149458951251609,0.5645863570391872,0.9651272201121076,1.0,5/35,4.96%,SULF1;KIAA1217;PCSK5;DYNC2I1;WNT5A
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.4226878207034661,0.9145131452289065,0.5629251700680272,0.965438739861299,1.0,3/11,17.17%,SPI1;TICAM1;STX4
prerank,peptidyl-asparagine modification (GO:0018196),-0.27700069237325503,-0.9143684323218334,0.5664556962025317,0.8747827788889223,1.0,8/31,17.65%,DPM1;ALG5;STT3B;UBE2J1;RPN2;FUT8;OST4;ASGR1
prerank,sensory perception of light stimulus (GO:0050953),0.2899597976333173,0.913920688278513,0.5968331303288672,0.966060030771353,1.0,9/87,11.96%,RDH10;POU4F3;EFEMP1;SLC24A1;CNGB1;CRYBB3;BEST1;COL1A1;CRYBG3
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.34939902486501667,0.9135472639582741,0.5449101796407185,0.9662559405509582,1.0,6/28,16.92%,NRARP;EGFR;EGFL7;WWP2;FBXW7;MMP14
prerank,regulation of spindle organization (GO:0090224),0.38097929017523813,0.9133733722166905,0.5784313725490197,0.9659859287973017,1.0,3/18,12.02%,SENP6;NUP62;MAP9
prerank,potassium ion transport (GO:0006813),0.2849958703110121,0.9127586737195256,0.6261904761904762,0.9667461791236888,1.0,18/120,13.89%,KCNJ4;NALCN;KCNA5;KCNJ16;SLC24A1;KCNS2;KCNK1;ATP1A2;KCNJ13;KCNK5;ATP1B3;KCNS3;KCNAB1;SLC9A7;SLC9A6;AQP1;KCNK10;KCNK4
prerank,positive regulation of lipid localization (GO:1905954),-0.36871612148146726,-0.9122912364564559,0.5695067264573991,0.8789591260475239,1.0,2/11,10.21%,LRP1;ZC3H12A
prerank,regulation of interleukin-1 production (GO:0032652),0.38832708919442394,0.9122432429692753,0.5739837398373984,0.9672190124134235,1.0,2/15,9.49%,CEACAM1;HMGB1
prerank,positive regulation of heart rate (GO:0010460),-0.32338903411167036,-0.9121588596813223,0.5752688172043011,0.8783719902855298,1.0,5/17,15.95%,TPM1;ADRA1B;EDN1;ADM;EDN3
prerank,autophagosome assembly (GO:0000045),-0.24789284050185703,-0.9121144984477717,0.6291666666666667,0.8775539028914703,1.0,17/52,24.51%,ATG16L2;BECN1;GABARAPL1;VMP1;WIPI1;ULK2;GABARAP;STX17;AMBRA1;STX12;ATG13;MAP1LC3A;RAB7A;WIPI2;ATG12;WDR45B;WDR45
prerank,protein glycosylation (GO:0006486),-0.21644884183730023,-0.9118894009300176,0.6511627906976745,0.877170079043525,1.0,23/125,11.94%,ST3GAL6;MGAT4C;ST3GAL5;ST3GAL1;ST8SIA4;MGAT4A;EOGT;SLC39A8;COG7;DPM1;ST6GALNAC2;ALG5;PLOD2;STT3B;PLOD1;GAL3ST1;AQP11;PGM3;B4GALT1;B4GALT7;ALG1;GOLGA2;RPN2
prerank,regulation of autophagy (GO:0010506),0.2694266895630709,0.9117073525112942,0.6737513283740701,0.96772531270851,1.0,31/216,11.37%,DCN;PLK2;LEPR;TPCN1;FOXK1;PRKAG1;FOXO3;PTPN22;WDR41;ATP6V0D2;WDR24;PIP4K2B;KEAP1;ABL2;TRIM21;MCL1;RMC1;PIK3R2;FOXK2;ATP6V0A1;IRGM;MTMR3;GSK3B;HMGB1;TICAM1;EIF4E;TFEB;USP13;TAB2;HDAC6;NEDD4
prerank,regulation of cholesterol storage (GO:0010885),-0.3445459080288701,-0.911631279319622,0.5950617283950618,0.8768739687803778,1.0,4/15,14.28%,PPARD;NR1H3;NR1H2;ABCG1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),-0.24416523518362102,-0.9115615273678332,0.6065573770491803,0.8761252037145822,1.0,14/51,19.75%,IL6R;CXCL12;CMKLR1;VEGFC;LGMN;IL34;VEGFD;THBS1;PTK2;LGALS9;CSF1;EDN3;RARRES2;PTN
prerank,cellular response to estrogen stimulus (GO:0071391),-0.34372228687225004,-0.9113871737406771,0.576271186440678,0.8755731278449819,1.0,4/14,13.08%,SERPINB9;AR;NCOA4;ARID5A
prerank,positive regulation of lymphocyte differentiation (GO:0045621),0.37689335411931196,0.9113307523911508,0.5652173913043478,0.9679167508284318,1.0,8/19,19.17%,AXL;IL7;PPP2R3C;SYK;BTK;MDK;MMP14;XRCC6
prerank,protein complex oligomerization (GO:0051259),0.2949211496668531,0.9111894226901343,0.573019801980198,0.9675560772797782,1.0,25/85,24.23%,CLDN1;LRRC8D;BEND3;SPAST;NLRC4;ATL2;PDCD6IP;GSDMD;VSTM5;ADCY8;HGSNAT;GLRA3;ALS2;EHD1;MS4A1;NUDT21;STOML2;CHMP2A;YME1L1;ELAVL1;MPP2;JMJD6;PRMT8;RBMX;DNM1L
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.23062633480698874,-0.9110083471864653,0.6721311475409836,0.87559123932746,1.0,18/80,14.51%,PICALM;ROCK2;EPHA4;LARP6;PRR16;EIF3C;RPL26;NPM1;RPS6KB1;CASP3;ZCCHC4;GSK3A;YTHDF1;SP1;ABCA2;THBS1;ABCG1;VIM
prerank,regulation of acute inflammatory response (GO:0002673),-0.3215147790693254,-0.910986614807287,0.5867346938775511,0.8747236591104635,1.0,1/18,1.18%,OSMR
prerank,mesenchyme morphogenesis (GO:0072132),-0.32826540359856227,-0.910861195327808,0.5781637717121588,0.874076401594349,1.0,5/17,12.75%,ENG;NOS3;ACVRL1;BMP2;TGFB2
prerank,regulation of cell killing (GO:0031341),0.39295687027500215,0.9106140595690049,0.5673400673400674,0.968151464087897,1.0,5/16,14.10%,CD55;WNT5A;NOXO1;CFH;FZD7
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.23740098049291752,-0.9105939553634075,0.6330645161290323,0.8737926619141302,1.0,14/62,14.34%,LYN;EP300;HOXA5;MEIS1;SETD1A;HDAC1;MYL9;CDK6;AGO3;HOXB8;HOXA9;THBS1;MOV10;AGO4
prerank,negative regulation of cell growth (GO:0030308),-0.208372469612421,-0.9105780129886113,0.6818181818181818,0.8728986093052706,1.0,30/121,17.78%,SMAD3;ENPP1;SLIT2;SMARCA2;GJA1;ACVRL1;BMPR2;CCN3;NPR1;DNAJB2;APBB2;SOX17;RNF6;JADE1;BST2;ULK2;GSK3A;TGFB2;DCC;CDKN2AIP;TCHP;SERTAD3;CCDC85B;CGRRF1;BTG1;MAG;SEMA3G;SMAD4;RERG;WNT11
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.24204168240487126,-0.9102489832548183,0.6415770609318996,0.8727591161417175,1.0,25/54,31.67%,MADD;UBE2K;CFLAR;RNF31;CLIP3;SPHK1;IKBKB;PELI3;LAPTM5;CASP8;CASP4;RACK1;TRAIP;IKBKG;RIPK1;SPPL2B;HSPA1A;BIRC3;SPATA2;PYCARD;CASP1;HSPA1B;TRAF2;ADAM17;RFFL
prerank,ncRNA 3'-end processing (GO:0043628),-0.34154054253124255,-0.9100831458199209,0.5817307692307693,0.8722577318989234,1.0,2/14,5.86%,SSB;TRNT1
prerank,fatty acid beta-oxidation (GO:0006635),0.32123301524852066,0.9099702568540311,0.5804289544235925,0.9688664453718074,1.0,9/51,10.29%,EHHADH;DECR2;HADHB;PEX2;GCDH;ACAT1;HSD17B4;ACADS;ACOT8
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.29986566910939044,0.9098675000510982,0.5896805896805897,0.9684228026253482,1.0,8/76,9.13%,NTRK3;PRKCE;CDC42EP4;NUP62;FER;NCK2;ARF6;PLEK
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.3353799117480405,-0.9097435421926678,0.5725806451612904,0.8721335409816648,1.0,4/17,10.46%,SASH1;BMP6;NFKBIL1;TRIB1
prerank,regulation of potassium ion transport (GO:0043266),0.34047972699755646,0.9096677041078839,0.5805022156573116,0.9681843456166568,1.0,7/31,13.61%,KCNA5;KCNIP4;CASQ2;ADRA2A;KCNAB1;FHL1;KIF5B
prerank,apoptotic cell clearance (GO:0043277),0.34975010533540096,0.9095218673452493,0.5861027190332326,0.96783910936856,1.0,6/30,9.49%,XKR7;XKR4;RAC2;RARA;XKR8;HMGB1
prerank,gonad development (GO:0008406),0.32904769886727225,0.9093397833240744,0.5760111576011158,0.9675765887455723,1.0,5/41,7.45%,NR2F2;WNT2B;SOX9;WNT5A;MSH2
prerank,embryonic hemopoiesis (GO:0035162),-0.3485014885127691,-0.9092474376778658,0.5614457831325301,0.8723435989285915,1.0,5/12,18.58%,KIT;FLT3LG;KDR;TAL1;ATF4
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.31390270404837767,-0.9092094321059843,0.5942408376963351,0.8715153743611883,1.0,5/20,11.05%,HOXA5;MEIS1;CDK6;HOXB8;HOXA9
prerank,negative regulation of cell cycle (GO:0045786),-0.22745304629006105,-0.9090937708536453,0.6793478260869565,0.8708674408663835,1.0,13/73,12.02%,SMAD3;PTPN3;LATS2;NUPR1;BMP4;PTPRK;GAS1;BRINP3;CDK6;TRIM35;RHOB;BMP2;CAMK2N1
prerank,regulation of cartilage development (GO:0061035),0.3821395309315202,0.9090318773143194,0.563011456628478,0.9675818386186612,1.0,4/18,4.10%,MBOAT2;PTHLH;SOX9;BMPR1B
prerank,plasma membrane organization (GO:0007009),0.30751101350714494,0.9088915299480216,0.6097560975609756,0.9672514268949699,1.0,21/61,19.98%,EPB41L3;AHNAK2;ANO6;A4GALT;PACSIN2;EHD2;RAB3A;PLSCR1;CHMP4A;STX2;ARL8B;ABCD1;OTOF;OSBPL2;STX4;SPTBN1;CAVIN2;PACSIN3;NSF;FA2H;PACSIN1
prerank,inorganic anion transmembrane transport (GO:0098661),-0.23875517475806657,-0.9087342275617006,0.668141592920354,0.8707951779904889,1.0,23/63,22.15%,ANO1;SLC12A6;ANO4;SLC5A6;ANO3;GABRA2;SLC26A2;SLC25A30;SLC25A11;LRRC8A;GABRB1;SLC12A5;GLRA2;SLC1A3;SLC6A1;SLC1A1;ANO5;SLC12A7;GABRE;GABRA5;SLC37A1;ANO2;SLC12A9
prerank,cartilage development (GO:0051216),0.3197662872068932,0.9082828004965473,0.5879945429740792,0.9679322970047959,1.0,6/49,4.05%,SULF1;RUNX2;GPLD1;WNT2B;TRPV4;SOX9
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.33868255089169663,0.9081520854585821,0.5603576751117735,0.9675350627603958,1.0,7/30,13.12%,KLK2;HEYL;NCOR1;PIAS2;NCOR2;HDAC6;NCOA2
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.37422389490884,0.9080788883598737,0.5828025477707006,0.9670284613259273,1.0,3/20,6.14%,APH1B;NCSTN;ADAM10
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.3532745559727268,-0.9079910975960841,0.5995203836930456,0.8716899249520746,1.0,5/13,14.60%,GREM2;NRROS;BMP2;DAND5;CHRDL1
prerank,protein localization to Golgi apparatus (GO:0034067),-0.285782278151223,-0.9076861469265775,0.5488958990536278,0.871518466624177,1.0,4/27,6.91%,VPS13D;OBSL1;COG7;VPS13C
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.279027873145885,-0.9076751665133437,0.6361031518624641,0.8706278971511227,1.0,6/29,15.04%,SLC4A10;APOE;GRIK2;CAMK2A;DBN1;ZDHHC2
prerank,water-soluble vitamin metabolic process (GO:0006767),0.2990104939912467,0.9075706820725556,0.6138364779874214,0.9675169858426882,1.0,16/68,15.44%,CTRC;FOLR2;PCCB;ACP5;THTPA;MTHFD1;ABCC1;SLC52A1;CD320;CUBN;MMAB;TPK1;AMN;SLC46A1;PANK2;SLC25A19
prerank,regulation of translational initiation (GO:0006446),-0.23885733150654148,-0.9074939603741772,0.6434782608695652,0.8701311161444321,1.0,22/63,23.50%,DNAJC3;NPM1;RPS6KB1;GLE1;PAIP2;EIF2AK4;YTHDF1;MTIF2;CEBPB;EIF4G1;NCBP1;CTIF;HSPB1;YTHDF2;KLHL25;ATF4;DDX1;POLR2D;EIF1B;KHDRBS1;EIF3E;YTHDF3
prerank,defense response to fungus (GO:0050832),-0.3209078538260012,-0.9073915677962718,0.5878048780487805,0.8694484933155703,1.0,4/17,18.75%,PLCG2;BCL10;GAPDH;RARRES2
prerank,positive regulation of intracellular transport (GO:0032388),0.337226639908813,0.9073782275880139,0.5818181818181818,0.9673007754185585,1.0,15/38,22.67%,RAB29;KIF20B;CEP131;EHD2;RIPOR1;TPR;NEDD4;CEP290;PCM1;TBC1D20;EHD1;VAMP2;TENM1;PGAP1;OAZ2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.23324776773881836,-0.907368287322713,0.6834862385321101,0.8686006991016095,1.0,20/76,18.68%,PTGIS;G3BP2;COMMD1;CYP1B1;ERBIN;KLF4;CD200;CMKLR1;NFKBIL1;LRRC14;ZC3H12A;COMMD7;TMSB4X;PARP10;NLRC3;RWDD3;TRIM37;CDK5RAP3;CACTIN;IRAK2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.2834287073754332,-0.9073527137194869,0.6097560975609756,0.8677310718926031,1.0,4/29,6.94%,IL31RA;GHR;IFNAR2;JAK2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.34331792785541876,0.9071714444197245,0.5677321156773212,0.9670991431747842,1.0,8/29,13.29%,ELOVL5;ELOVL1;SCD5;ACACA;GCDH;ELOVL2;HACD2;ELOVL6
prerank,placenta development (GO:0001890),0.4072265938205929,0.906567916134384,0.5804794520547946,0.9677909159539005,1.0,1/12,2.24%,ADAM19
prerank,striated muscle cell differentiation (GO:0051146),0.3875268556828811,0.9064630823083824,0.5779527559055118,0.9673643139031854,1.0,5/16,12.86%,AKAP13;PLD3;SDC1;POPDC3;KDM6B
prerank,determination of heart left/right asymmetry (GO:0061371),-0.2557375475200739,-0.9064348732606842,0.6379928315412187,0.8689302205113931,1.0,11/42,16.59%,ENG;TBX3;NPHP3;SOX17;ZIC3;DAND5;MEGF8;VANGL2;MKKS;AHI1;SOX18
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.36534183697809164,-0.9063310502774428,0.6170212765957447,0.8682528792937346,1.0,2/12,5.95%,FOXP1;KLF4
prerank,chromatin assembly (GO:0031497),0.32988383089186224,0.9057807268073433,0.5923836389280677,0.9681715362485155,1.0,6/38,7.08%,SOX9;CDAN1;KAT6B;CTCF;PAF1;LIN54
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.32114903349233814,-0.9056432666365992,0.5718157181571816,0.8690124499797605,1.0,6/17,14.28%,ERLIN1;APOE;SCAP;ABCA2;ERLIN2;ABCG1
prerank,protein secretion (GO:0009306),0.30973256155614337,0.9053888428462459,0.6056527590847914,0.968376986916229,1.0,7/56,9.72%,TANGO6;PCSK5;RAB8B;RIMS2;RAB3A;LTBP2;ABCA1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),0.38106192099826103,0.9053514373507597,0.5545171339563862,0.9677956273774941,1.0,2/17,3.14%,SULF1;CASK
prerank,RNA modification (GO:0009451),0.3117993638228793,0.9049995884573312,0.5718050065876152,0.9678969884530045,1.0,18/54,23.24%,MRM2;RBM15B;PUS7;PUS3;WDR4;CDKAL1;FTSJ1;NSUN5;ALKBH1;ANKRD16;URM1;TYW5;ADARB1;THG1L;TFB1M;TRMT1;JMJD6;MEPCE
prerank,regulation of neurotransmitter receptor activity (GO:0099601),-0.23823189228557073,-0.9047945809158825,0.672645739910314,0.8701536229003735,1.0,8/57,10.71%,DAPK1;ACTN2;GRIA2;NEFL;GRIN2B;CAMK2A;GRIN1;CACNG7
prerank,microvillus assembly (GO:0030033),0.3975287163606439,0.9047386005412302,0.5612582781456954,0.9678515851091075,1.0,3/14,8.67%,RAP1A;MINK1;RAPGEF6
prerank,prostaglandin metabolic process (GO:0006693),-0.2883114250470861,-0.904675541925247,0.5877192982456141,0.8695323100497698,1.0,8/26,19.84%,PTGIS;PTGS1;PTGDS;TBXAS1;EDN1;HPGDS;ACOX1;MIF
prerank,neuron projection extension (GO:1990138),0.3384930712233609,0.9045405628576046,0.5803698435277382,0.9676158274918396,1.0,11/32,22.57%,NRP2;CDKL3;LLPH;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3;IMPACT;IQGAP1
prerank,regulation of hippo signaling (GO:0035330),0.3836241824099607,0.9042292618817801,0.5643879173290938,0.9676474391749248,1.0,4/17,13.55%,VGLL4;WWC1;NF2;CIT
prerank,membrane protein proteolysis (GO:0033619),0.3280898262038165,0.9042068681498824,0.5788732394366197,0.967034413655873,1.0,6/37,9.34%,ADAM19;APH1B;NCSTN;ADAM10;DAG1;BACE2
prerank,synapse assembly (GO:0007416),-0.23878440921179123,-0.9037163732368998,0.6666666666666666,0.8708734937845435,1.0,6/67,2.92%,FARP1;SHANK3;DNM3;SPOCK2;ADGRL3;OBSL1
prerank,regulation of striated muscle contraction (GO:0006942),0.35084889760387994,0.9036041408635717,0.5849624060150376,0.9677131089680503,1.0,3/27,5.19%,MYBPH;SCN10A;ATP1A2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.3250898777129912,-0.9034088689359145,0.5757575757575758,0.8707015045546194,1.0,4/17,15.22%,SLC7A5;PRKCZ;CEBPB;LGALS9
prerank,lymphocyte migration (GO:0072676),-0.2760985357880593,-0.9032687952858591,0.609271523178808,0.8700991149464082,1.0,24/32,51.86%,MSN;RET;CCL13;CCL19;ADAM8;CCL2;S1PR1;CCL25;MYO1G;CCL5;CCL11;CCL15;ZAP70;CCL4;GATA3;CCL7;CCL8;MSMP;CCR6;CKLF;CCL1;CCL3;TBX21;XCL1
prerank,nuclear body organization (GO:0030575),0.4123954943054509,0.9030789646752699,0.5861486486486487,0.9681971167068043,1.0,3/12,10.90%,USP50;WRAP53;SRPK2
prerank,activation of protein kinase activity (GO:0032147),0.2855199269814075,0.9029577926630956,0.636150234741784,0.9677888910144412,1.0,20/106,15.87%,NTRK3;PRR5;FGF1;AXIN1;MINK1;WNT5A;CARD10;TOM1L1;ADCY5;PRKAR2A;STK3;MAPKAP1;ADRA2A;PRLR;ADCY9;PRKACB;TXN;ADCY8;ADCY3;PIBF1
prerank,protein polyubiquitination (GO:0000209),0.25922795809009097,0.9027449447783067,0.6946484784889821,0.9675920720436336,1.0,81/297,21.66%,NEDD4L;UBE2L6;ZNRF2;FBXL15;PELI2;UBE2E2;IRF2BP1;UBE3C;LMO7;PSME3;LRSAM1;TMEM129;TNFAIP3;TRIM21;UBR5;CHFR;UBE2V2;SIAH1;FBXO31;CUL3;AMFR;PSMB5;BLMH;LNPEP;ANAPC5;ANAPC7;UBE3D;SHARPIN;ANAPC11;FBXL19;LONRF1;NEDD4;FBXL5;FBXL17;TTC3;FBXO11;FBXO21;FBXO38;ANAPC2;PSMB2;ANKRD39;CBFB;UBE2J2;UBE2D3;UBE2D1;PSMA2;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;FBXW8;PSMA7;TRIM5;FBXO41;DDB2;UBE2R2;FBXL12;FBXW7;FBXL3;ITCH;PSME4;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;DDA1;KBTBD7;HECTD2;UBE2W;PRKN;MKRN1;RNF146;RNF14;MUL1;TRAF3;TRAF5;ZNRF1;PSMB3;AKTIP
prerank,cell chemotaxis (GO:0060326),0.30610153523711536,0.9026309599092567,0.5867549668874172,0.9671983094556169,1.0,3/60,0.78%,PARVA;LPAR1;ACKR3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.26206917766854465,-0.9026159935110513,0.6633333333333333,0.8707129002921907,1.0,12/45,19.76%,SP100;IRF2;TRIM25;B2M;VCAM1;JAK2;CAMK2A;IRF1;GBP2;MT2A;TRIM8;ICAM1
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),0.37988734290552134,0.9013659263388878,0.5772230889235569,0.9692547605783081,1.0,4/20,10.48%,ATIC;PFAS;PPAT;NT5C2
prerank,regulation of cell aging (GO:0090342),-0.362631794795673,-0.9013180242842795,0.5831265508684863,0.8728369523147492,1.0,4/11,19.84%,LMNA;NUAK1;VASH1;MIF
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.3829387617397787,0.9011590383565117,0.5864197530864198,0.9690374564417569,1.0,1/17,0.82%,NEDD4L
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.39374141501128734,0.9011585909673617,0.5786963434022258,0.9683755456108541,1.0,4/16,9.04%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,modification-dependent protein catabolic process (GO:0019941),0.2665525647257779,0.9008670195392351,0.6677454153182308,0.9684019384988878,1.0,46/193,18.75%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;UBE2I;SPSB4;KEAP1;CHFR;SIAH1;ZNRF3;CUL3;UBL7;CDC20;AMFR;ANAPC5;ANAPC7;NPLOC4;RCHY1;TRPC4AP;LONP1;ANAPC11;NEDD4;BUB3;TTC3;FBXO11;RNF185;FBXO21;FBXO8;ANAPC2;UBA1;UBE2D1;KLHL15;FEM1C;ANAPC4;FZR1;PSMD13;UBE2R2;UBQLN1;ITCH;RNF7;WDR91;ANAPC16;PINK1;CDC23;PSMD14
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.2964041947783541,-0.900528734326026,0.5616045845272206,0.8737757039777952,1.0,3/22,5.81%,ADGRV1;GRM3;ORAI1
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.37547465352539944,-0.9004703932734969,0.5823665893271461,0.873008264204897,1.0,3/10,15.22%,IL18;PRKCZ;LGALS9
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.36796231267234025,-0.9002079130722496,0.5946601941747572,0.8727361547017727,1.0,3/12,14.28%,NR1H3;NR1H2;ABCG1
prerank,bicarbonate transport (GO:0015701),0.36041707717903404,0.9001852310120705,0.5762195121951219,0.9692099757014918,1.0,4/25,7.04%,SLC4A3;SLC26A9;SLC4A4;SLC4A11
prerank,ceramide biosynthetic process (GO:0046513),0.32319762619513487,0.8997653808722994,0.5906515580736544,0.969457120913992,1.0,4/40,5.64%,SGMS2;CERS6;ALOXE3;CLN8
prerank,regulation of fibrinolysis (GO:0051917),0.4034800128606961,0.8997028618895277,0.5936454849498328,0.9689252320285819,1.0,1/13,1.69%,FAP
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.27343198451111145,0.8996828297806546,0.6515837104072398,0.9683110116708696,1.0,16/150,10.74%,GAB1;FGF7;FGFR1;PIK3AP1;EGFR;FGF1;SRC;RAC2;PIK3R2;PTPRJ;GCNT2;FGF18;GAB2;AXL;FERMT2;STRN
prerank,mesonephros development (GO:0001823),-0.3692028232070689,-0.8993983747047646,0.5776699029126213,0.8737605173782751,1.0,2/11,2.60%,OSR1;BMP4
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.39087096361186824,0.8991857528743564,0.5957095709570958,0.9687229853816508,1.0,1/17,0.47%,NTRK3
prerank,cytoplasmic microtubule organization (GO:0031122),0.30947781147521747,0.8986275277522273,0.6191117092866757,0.9693366515470153,1.0,17/54,21.79%,HOOK2;TRPV4;FIGNL2;LIMK2;SPAST;TUBGCP5;HOOK3;PCM1;SLAIN2;CRIPT;EZR;CHP1;RHOA;KATNAL1;TUBGCP6;CLIP4;CCDC88B
prerank,relaxation of cardiac muscle (GO:0055119),0.3936622411915184,0.8984977278030966,0.5631229235880398,0.9689567604612271,1.0,2/13,5.19%,CAMK2D;ATP1A2
prerank,rRNA methylation (GO:0031167),0.36365586962900887,0.8984847767670787,0.5839753466872111,0.9683301692447595,1.0,6/22,16.72%,MRM2;BUD23;TFB2M;METTL5;NSUN5;MRM1
prerank,heart contraction (GO:0060047),0.32058350569167965,0.8981688328270994,0.6008462623413258,0.9683698029331838,1.0,7/41,12.41%,SGCD;SGCG;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1
prerank,fatty acid biosynthetic process (GO:0006633),0.30185843398615536,0.8979277893154209,0.6172185430463576,0.968266217510056,1.0,15/63,19.24%,ELOVL5;DECR2;HACD4;ELOVL1;SCD5;ACACA;ELOVL2;HACD2;LTA4H;ABCD1;ELOVL6;HPGD;SCD;LPL;FADS1
prerank,amino acid transmembrane transport (GO:0003333),0.3167881949327984,0.8978858931028089,0.5793103448275863,0.9677246652879826,1.0,6/45,6.69%,LRRC8D;SLC25A12;SFXN2;SLC38A2;SLC6A13;SLC1A6
prerank,regulation of TORC1 signaling (GO:1903432),-0.27651352294549847,-0.8976572010434923,0.6698717948717948,0.8770407254085385,1.0,12/33,27.27%,SEH1L;DEPDC5;RNF152;RRAGC;GPR137B;SPAAR;RRAGD;CASTOR2;CASTOR1;PIP4P1;FLCN;ATM
prerank,base conversion or substitution editing (GO:0016553),-0.3662610393994482,-0.8975777634852352,0.5953488372093023,0.8763334516439317,1.0,1/11,3.22%,ADAR
prerank,epithelial cell development (GO:0002064),0.3714890747014258,0.8971311123546366,0.5761904761904761,0.9687317512751573,1.0,4/20,10.12%,BFSP1;POF1B;TMEM79;LRTOMT
prerank,positive regulation of cell cycle (GO:0045787),0.29839382309844026,0.896835301338754,0.6069587628865979,0.9687278260612107,1.0,8/62,10.90%,SMOC2;EGFR;CCND3;PRKCA;TRIM21;RARA;EIF4E;SRPK2
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.3695013037160846,-0.8963250151595108,0.635,0.8783471486279261,1.0,4/11,15.43%,FRS2;BMP2;SOX6;MYOCD
prerank,regulation of endopeptidase activity (GO:0052548),0.30776192888492127,0.8963126251165122,0.6070038910505836,0.9691738160517099,1.0,6/59,6.01%,SERPINB2;SERPING1;APH1B;PSME3;SERPINH1;NCSTN
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.3069319672185105,-0.8961630890242869,0.5617283950617284,0.8778265072805971,1.0,5/22,14.44%,PDGFD;ACE;CALM1;TAOK2;CALM3
prerank,protein import into mitochondrial matrix (GO:0030150),-0.3212463099138228,-0.8961285082639072,0.5978835978835979,0.8770129721386108,1.0,9/18,33.15%,TIMM44;PAM16;TIMM17B;ROMO1;GRPEL1;DNLZ;TIMM50;TIMM23;TIMM21
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.41716466233311633,0.8958914265553458,0.6172413793103448,0.9694156441217593,1.0,2/10,7.80%,EMC9;EMC7
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.31960651980431787,-0.8958381723046577,0.616751269035533,0.876804611266542,1.0,2/18,6.91%,PLCB1;AGRN
prerank,glycerolipid catabolic process (GO:0046503),-0.3183031004054403,-0.8954494640200538,0.6182336182336182,0.8768299789838597,1.0,3/19,12.51%,GPCPD1;PNPLA6;ABHD2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.396272646098256,0.8951681794274199,0.5802047781569966,0.9703345845187958,1.0,1/13,0.88%,NAPRT
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",-0.29000874301047874,-0.8949541894200355,0.6207951070336392,0.8770075937499822,1.0,5/25,11.97%,GRIN2B;AKT1;GRIN1;LRRK2;GSK3A
prerank,phosphate-containing compound metabolic process (GO:0006796),0.2671922573440327,0.8949357890969971,0.6634304207119741,0.9702054644824436,1.0,22/198,7.21%,PLCD3;PLCE1;PLCB3;HK2;DUSP12;PFKP;PLPP2;ACP6;TPTE;PLPP3;LIMK2;PIP4K2B;PTPRC;THTPA;PPM1A;CLN8;BCKDK;COQ8A;CERK;EPHB2;PPIP5K2;ALDOB
prerank,renal filtration (GO:0097205),0.40432890293735146,0.8943376391671702,0.5580985915492958,0.9709004998088607,1.0,2/10,11.52%,SULF1;XPNPEP3
prerank,positive regulation of cell development (GO:0010720),-0.2734502286310958,-0.8940888479628193,0.6180758017492711,0.8780147185379346,1.0,4/31,4.92%,NUMB;TGM2;BMP4;RFX3
prerank,regulation of calcium-mediated signaling (GO:0050848),0.3445349001435742,0.8937555829677514,0.5958395245170877,0.9715231336554899,1.0,4/25,13.97%,CDH13;PLEK;TMBIM4;HTT
prerank,calcium ion import (GO:0070509),-0.27985244832327805,-0.8934156405762488,0.6035502958579881,0.8786801175687138,1.0,7/28,12.84%,SLC8A1;CACNB2;CACNA1G;SMDT1;SLC25A23;MICU1;MICU2
prerank,negative regulation of B cell activation (GO:0050869),-0.3047753792720737,-0.8929999463715141,0.6397849462365591,0.8787621328381646,1.0,11/21,28.88%,LYN;TNFRSF21;SAMSN1;ID2;LAPTM5;RC3H1;INHBA;PARP3;ATM;FCGR2B;SFRP1
prerank,microtubule nucleation (GO:0007020),0.3716701014750105,0.8927650428326778,0.5795620437956205,0.9730885135269838,1.0,11/19,29.89%,TUBG1;TUBGCP5;NDE1;TUBG2;SLAIN2;TUBGCP6;CSNK1D;CLASP2;CCDC57;NDEL1;CLASP1
prerank,RNA transport (GO:0050658),0.2911664578794775,0.892419609109871,0.6104725415070242,0.9732168357879023,1.0,17/71,19.27%,RBM8A;SRSF4;NUP62;CKAP5;SIDT2;EIF4E;TPR;RTRAF;ATXN2;UPF3B;NUP153;THOC3;THOC5;XPO5;SLU7;SRSF3;DHX38
prerank,autophagy of mitochondrion (GO:0000422),-0.2545460632966847,-0.8924074537921907,0.6565656565656566,0.8791887050779187,1.0,16/38,26.21%,SQSTM1;BECN1;GABARAPL1;WIPI1;ULK2;GABARAP;AMBRA1;ATG13;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;FBXO7;CISD2
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4079523476727729,0.8920543607133045,0.6147260273972602,0.9733481412352317,1.0,2/12,6.12%,WDR18;NBN
prerank,regulation of DNA biosynthetic process (GO:2000278),0.34635963804660336,0.8919454013329207,0.6015503875968993,0.9729437791127661,1.0,2/27,5.34%,SMOC2;TOM1L1
prerank,growth hormone receptor signaling pathway (GO:0060396),-0.34055600719125356,-0.8915856636675793,0.6,0.8801860691331816,1.0,4/14,6.94%,GHR;LYN;PIK3R1;JAK2
prerank,response to organonitrogen compound (GO:0010243),-0.25809792807793197,-0.8913884241144279,0.6363636363636364,0.8797216002816445,1.0,12/38,25.13%,HLCS;SYVN1;VCP;RRAGC;GLRA2;UBXN6;DHFR;TRPM2;RCN3;NR1H4;IRF5;KYNU
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.3838748947201636,0.8906241523573112,0.5921052631578947,0.9751765382927753,1.0,4/17,14.75%,CTCF;BUB3;ZWILCH;ZW10
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.40828212875871583,0.8905832528840684,0.6,0.9746083516297489,1.0,1/11,2.26%,SOCS5
prerank,regulation of ATP metabolic process (GO:1903578),0.30308471752521027,0.8902983672087476,0.6185983827493261,0.9746105906573271,1.0,14/54,13.40%,OGT;BEND3;PRKAG1;NUP62;FIS1;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;ABCD1;NUP153;GCK
prerank,embryonic heart tube development (GO:0035050),-0.3348082466284027,-0.8902793221453064,0.597051597051597,0.8813441762201968,1.0,4/14,16.59%,SOX17;CITED2;MEGF8;SOX18
prerank,mitochondrion morphogenesis (GO:0070584),-0.3575805934693996,-0.890184029693195,0.5921375921375921,0.8806792017178616,1.0,2/11,12.89%,PID1;SLIRP
prerank,replicative senescence (GO:0090399),0.3998591558368916,0.8901827347743569,0.5967479674796748,0.9742372894582342,1.0,2/12,10.88%,WNT16;MME
prerank,regulation of mitotic spindle assembly (GO:1901673),0.36573139237726926,0.8901347584832465,0.6009174311926605,0.9736809315061996,1.0,5/19,11.97%,CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C
prerank,cellular modified amino acid biosynthetic process (GO:0042398),-0.30559097236831273,-0.8900643799482022,0.6082191780821918,0.8800624482985789,1.0,8/20,18.80%,MTHFS;GCLM;PLOD2;PTDSS2;CNDP2;GGCT;GCLC;GATM
prerank,negative regulation of phosphatase activity (GO:0010923),0.3551153168771675,0.8899454339125751,0.5804511278195489,0.9734281100157471,1.0,7/25,12.92%,SH3RF2;FKBP1B;BOD1L1;GSK3B;MASTL;SEMA4D;PTPA
prerank,relaxation of muscle (GO:0090075),0.39154520998206455,0.8899350550596508,0.5637583892617449,0.9727977042176881,1.0,2/13,5.19%,CAMK2D;ATP1A2
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.3045045035036509,0.8899277486490349,0.6256476683937824,0.9721624949802636,1.0,12/60,20.69%,SMOC2;NEK7;RFC3;NAF1;WRAP53;CCT2;POLG2;RGCC;DSCC1;ATR;CCT3;HGF
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.2758911291899042,-0.8898504608050184,0.6234567901234568,0.8796536637949329,1.0,7/28,15.19%,SMAD3;PIK3R1;FLNA;ZC3H12A;TRIM28;ZIC1;ZPR1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),0.3959277030475973,0.8895895335319626,0.6026272577996716,0.972235949165324,1.0,2/15,4.62%,PIEZO2;TMC2
prerank,central nervous system neuron differentiation (GO:0021953),-0.2700619770926239,-0.8893825105859499,0.6579804560260586,0.8797990652493581,1.0,9/33,14.31%,ATP7A;SPOCK1;LRP6;NR4A2;PROX1;MDGA1;GBA2;TOX;MAPT
prerank,cellular protein catabolic process (GO:0044257),0.30344666547181415,0.8887961175254727,0.6055045871559633,0.9733117389714407,1.0,16/59,22.86%,ADAMTS12;FAP;PISD;CPA2;LONP1;CAPN2;HTRA2;PSMA6;AP2A2;BNIP3;CTSB;PRKN;TCIRG1;YME1L1;AP2S1;CLTA
prerank,mRNA export from nucleus (GO:0006406),0.2762492028551604,0.8886911283076118,0.6455089820359281,0.9728865765160726,1.0,35/102,24.86%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33;IWS1;SARNP;PABPN1;NXF1
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.3820140118202458,0.888683342031354,0.6,0.9722605101500925,1.0,5/17,13.12%,PBX1;MAML2;HEYL;WWC1;CREBBP
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.29009957208057846,0.8884876318855993,0.6236162361623616,0.9720448290794896,1.0,21/85,20.55%,TRIB2;PRICKLE1;SOCS5;SH3RF2;KEAP1;DDRGK1;GSK3B;CSNK1A1;RCHY1;USP13;ZYG11B;RNF185;FBXW7;BAG2;RNF180;TMEM259;DDA1;SUMO1;TMTC3;PRKN;RNF14
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.30224034145474277,0.8884627142396673,0.6256476683937824,0.9714457757297741,1.0,10/57,15.58%,LPAR1;AKAP12;ADCY5;GNAL;ADRA2A;ADCY9;CHRM2;CHRM3;ADCY8;ADCY3
prerank,arachidonic acid metabolic process (GO:0019369),-0.2672301964060575,-0.8884358410620019,0.6360544217687075,0.8810326767395137,1.0,7/35,10.30%,PTGIS;CYP1B1;GPX4;DAGLA;PTGS1;PTGDS;TBXAS1
prerank,regulation of myotube differentiation (GO:0010830),-0.29185890885586874,-0.8883180685206415,0.6389684813753582,0.880399837743341,1.0,11/24,29.12%,CCN3;SIK1;HDAC9;HDAC1;BDNF;ATP11A;XBP1;DMPK;NOTCH1;RBM24;FBXO22
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.27901989685669754,0.887885567577767,0.6527293844367015,0.9719733791130125,1.0,20/117,16.60%,PLK2;CD3G;MC5R;PTHLH;SRC;ADCY5;PTGER4;PRKAR2A;TSHR;KARS1;ADCY9;CD81;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,rRNA modification (GO:0000154),0.35975799983923057,0.8878845169834151,0.589825119236884,0.9713302403255135,1.0,4/21,10.57%,MRM2;BUD23;TFB2M;METTL5
prerank,regulation of secretion by cell (GO:1903530),-0.2378595905562625,-0.887865229301411,0.6609442060085837,0.8805758971877428,1.0,12/54,16.66%,SNCAIP;DNAJC1;RAB3C;MCTP2;ANXA1;SYN1;CAMK2A;RAB13;RHBDF2;LLGL2;RAB3B;CPLX2
prerank,RNA catabolic process (GO:0006401),0.3146304160531341,0.8873930293853406,0.6095238095238096,0.971784880929786,1.0,15/46,23.68%,RNASEH2B;CNOT10;PABPC4;DXO;DIS3L2;SIDT2;ZFP36L2;ERN1;RNASE3;MTREX;HNRNPD;EXOSC7;LSM2;RNASEH1;RNH1
prerank,regulation of lymphocyte activation (GO:0051249),0.39752909584598783,0.8872233055136839,0.5775127768313458,0.9714617961859434,1.0,2/12,10.18%,CRTAM;LAT
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.23081284875002162,-0.8870314151592675,0.6666666666666666,0.8816436375989254,1.0,17/68,20.44%,ENPP1;GPAT4;HPRT1;ACOT7;BPNT2;DBI;ACSL6;TPST1;MLYCD;LRRK2;ACLY;ACOT6;OPA1;ACOT11;HINT1;OXSM;SULT4A1
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.40912855523982655,0.8869484540467166,0.6092943201376936,0.9714000847858176,1.0,4/12,11.37%,PTPN14;SIRT7;TPR;NEDD4
prerank,regulation of stem cell differentiation (GO:2000736),0.2847557816282738,0.8869213502031111,0.6554726368159204,0.9708125556164692,1.0,27/89,21.63%,JAG1;LMO1;KMT2A;PSME3;PUS7;SLC4A11;NELFB;PSMB5;ZFP36L2;PSMB2;CBFB;PSMA2;PSMA6;PSMD13;PSMA7;YAP1;ITCH;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;TCF3;OCIAD1;NUDT21;RUNX1;PSMB3
prerank,multivesicular body assembly (GO:0036258),0.33701002680004677,0.8868375805212989,0.601823708206687,0.9703520618033541,1.0,7/30,11.97%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4A;CHMP4B;CHMP4C
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.34666283520477276,0.8866103014718116,0.6008836524300442,0.9702041920406925,1.0,9/26,21.19%,FKBP1B;ATP1A2;CASQ2;ADRA2A;THADA;UBQLN1;YWHAE;CBARP;CALM2
prerank,neuron projection development (GO:0031175),0.2650597596264992,0.8864187140357004,0.690968443960827,0.9699770132681225,1.0,25/168,13.06%,NGF;EPB41L3;MINK1;KIF20B;GAS7;OPHN1;NBL1;DIP2A;CNTNAP1;TRIO;EPHB2;GPM6A;GSK3B;HMGB1;POU4F1;ERCC6;LRP12;DOCK7;SLC9A6;NEDD4;PLXNB1;MAP4;SGK1;PTEN;CTTN
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.39621379304845894,0.8860883742159058,0.6030150753768844,0.9700313211274965,1.0,1/14,0.43%,CORIN
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.31576370950486476,0.8857750509444768,0.6123595505617978,0.9700774931727416,1.0,9/43,16.06%,SORBS1;OGT;PIP4K2B;KANK1;SLC27A4;C1QTNF12;NUCKS1;SNX5;SOCS1
prerank,reticulophagy (GO:0061709),-0.3588389455589792,-0.8855811355714504,0.6078886310904872,0.8839488765911419,1.0,3/12,8.62%,UBA5;ULK2;UFM1
prerank,cytokine-mediated signaling pathway (GO:0019221),0.24984765795319738,0.8852213971428358,0.7904858299595142,0.9705941082959293,1.0,35/532,7.15%,RORA;EDA;TEC;SERPINB2;LBP;TNFSF8;ACKR3;IL19;IL18R1;CEACAM1;CAMK2D;LEPR;PELI2;IL17C;SOCS5;STX1A;ITGAX;IL1A;SPI1;FOXO3;SRC;PSME3;SLC27A1;IRAK3;FN1;IL17RA;FER;TRADD;SOCS6;LAMA5;IL21R;ABL2;TRIM21;MCL1;SDC1
prerank,calcium-ion regulated exocytosis (GO:0017156),-0.2765771381658863,-0.8851523386968757,0.6397694524495677,0.8840437217793297,1.0,16/27,38.93%,SYT9;SYT7;ARHGAP17;VAMP7;SYT13;SYT6;RIMS1;RIMS3;SYT15;SYT1;SYT5;DOC2B;SYT17;SYT4;SYT3;SCIN
prerank,protein O-linked mannosylation (GO:0035269),-0.31412513192504987,-0.8850316945373752,0.6236842105263158,0.8834336951141135,1.0,3/18,4.35%,TMTC2;TMTC1;DPM1
prerank,positive regulation of T cell cytokine production (GO:0002726),0.3574644275380163,0.8848788978245266,0.5895765472312704,0.9706956020821685,1.0,2/20,2.99%,IL18R1;CD55
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.29813602999361644,0.884846615420935,0.6313065976714101,0.9701320677399805,1.0,8/65,5.71%,CDH13;CEACAM1;EGFR;ARAP1;SPRY1;NUP62;TSG101;FER
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.2990693870040251,0.8845867632288222,0.607094133697135,0.9700376126171029,1.0,6/52,7.65%,SORBS1;PRKCE;EGFR;ATP2B4;EPHB2;ARF6
prerank,cellular macromolecule catabolic process (GO:0044265),0.30323295916296433,0.8844685249220899,0.6271870794078062,0.9696421861568285,1.0,16/49,26.01%,RNASEH2B;PABPC4;SIDT2;DFFB;MANBA;HTRA2;OGA;RNASE3;MTREX;HNRNPD;PRKN;EXOSC7;RNASEH1;DNASE1L1;PNPT1;UBE2G1
prerank,cellular response to leucine starvation (GO:1990253),0.41104380677874985,0.884395371965434,0.5514834205933682,0.969180551513725,1.0,5/10,23.75%,SESN1;RRAGB;GCN1;IMPACT;MTOR
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.32856012682113594,0.8843046247628105,0.5967976710334789,0.9687355780623336,1.0,4/36,4.96%,NFATC1;PLCB3;FZD2;WNT5A
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.3705453591092317,-0.8842689268101864,0.611764705882353,0.8834497263900869,1.0,5/10,29.21%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.3705453591092317,-0.8842689268101864,0.611764705882353,0.8834497263900869,1.0,5/10,29.21%,KLF4;MYADM;WNK1;MAP2K5;MBP
prerank,cellular response to cAMP (GO:0071320),0.33219231864947996,0.8841013094701078,0.5967741935483871,0.9685361573909895,1.0,2/30,1.89%,RAPGEF3;RAP1A
prerank,mRNA transport (GO:0051028),0.27464284486767443,0.8840061525996403,0.6497584541062802,0.9681020583139167,1.0,34/101,25.00%,RBM8A;SRSF4;NUP62;RBM15B;NUP160;UPF2;EIF4E;NUP37;TPR;NUP50;UPF3B;RANBP2;NUP210;SMG7;NUP153;THOC3;NUP93;THOC5;MCM3AP;SLU7;SYMPK;SRSF3;DHX38;SRSF11;NUP43;DDX25;YTHDC1;SMG6;CPSF2;SEC13;WDR33;SARNP;NXF1;FMR1
prerank,defense response to symbiont (GO:0140546),-0.2167592939944754,-0.8839101847570993,0.7083333333333334,0.8833944644948893,1.0,24/92,21.48%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;IFIT3;AGBL5;BST2;FLNA;IRF1;NDUFAF4;ABCE1;MOV10;ISG15;IFIT1;CD40;RSAD2;PDE12;OPRK1;CGAS;TLR3;BNIP3L;SHFL
prerank,myeloid dendritic cell activation (GO:0001773),0.40246202905628203,0.8838233870113903,0.5907473309608541,0.9678922232284678,1.0,3/12,16.40%,DOCK2;HMGB1;BATF
prerank,positive regulation of acute inflammatory response (GO:0002675),-0.32834282645267837,-0.8837894672977454,0.6271186440677966,0.8827909123833723,1.0,1/14,1.18%,OSMR
prerank,regulation of sister chromatid cohesion (GO:0007063),0.4027074311732318,0.8836899832011312,0.6135986733001658,0.9675508753884127,1.0,2/12,10.79%,CTCF;AXIN2
prerank,aerobic respiration (GO:0009060),-0.29815175879192524,-0.8833160643688348,0.6257309941520468,0.8829630001897725,1.0,8/20,29.17%,SDHB;UQCRC2;MTFR1;ME3;OXA1L;NDUFS8;MTFR2;UQCR10
prerank,neuron apoptotic process (GO:0051402),-0.3118586559265516,-0.8832645062545259,0.6043360433604336,0.8821876571546045,1.0,5/19,11.36%,TNFRSF21;FAS;NAE1;GAPDH;BID
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3743334538476286,0.8829576567943805,0.6056782334384858,0.9684389860375001,1.0,3/17,7.05%,STX1A;CACNA1H;RAB3A
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.3988194571372857,0.8828342849140773,0.5959595959595959,0.9680718962145275,1.0,1/12,1.25%,CEACAM1
prerank,ketone body metabolic process (GO:1902224),-0.3699474778282655,-0.8827461521845467,0.6397228637413395,0.8825197563215506,1.0,4/10,8.90%,HMGCL;BDH2;HMGCS2;ACSS3
prerank,icosanoid metabolic process (GO:0006690),0.31657208129573866,0.8824034828681138,0.5967976710334789,0.9683850596647333,1.0,15/40,24.59%,EPHX1;CYP2S1;ALOXE3;ABCC1;ABCC10;LTA4H;PNPLA8;GGT1;HPGD;FADS1;FAAH;PON3;PLA2G4A;PTGR1;DAGLB
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.31744241428931186,-0.8823015573017603,0.6024096385542169,0.8826297854431803,1.0,3/14,5.81%,ENPP1;ENPP3;CMPK1
prerank,glycerophospholipid catabolic process (GO:0046475),-0.2804360940574031,-0.8822713547720321,0.6406779661016949,0.8818290188550144,1.0,3/27,8.38%,GPCPD1;ENPP2;PNPLA6
prerank,mitotic nuclear division (GO:0140014),0.29730685679366553,0.8820479787364296,0.6552598225602028,0.9684883641096739,1.0,19/71,18.52%,KIF2A;SMC3;NUP62;SPAST;TUBG1;DSN1;CHMP4B;NDE1;MAP9;INO80;TUBG2;KLHL22;ZW10;ARHGEF10;RAN;PIBF1;CENPK;OFD1;RHOA
prerank,contractile actin filament bundle assembly (GO:0030038),0.3788278930006262,0.8819495569339431,0.5943708609271523,0.9674266342250868,1.0,4/15,10.56%,SORBS1;SRC;CUL3;ZYX
prerank,stress fiber assembly (GO:0043149),0.3788278930006262,0.8819495569339431,0.5943708609271523,0.9674266342250868,1.0,4/15,10.56%,SORBS1;SRC;CUL3;ZYX
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.2688061992075854,0.8818689746165246,0.6772009029345373,0.9669547395911765,1.0,37/145,19.70%,DYNLL1;PSME3;SFI1;CEP131;CEP78;NEDD1;TUBG1;CKAP5;FBXO5;PAFAH1B1;CCP110;PSMB5;MECP2;USP47;NDE1;CEP290;SSNA1;CETN2;FHL1;PCM1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;YWHAG;YWHAE;CEP57;PSME4;OFD1;PSMC4;PSMB6;PSMD12;PSMD14;CEP250;DCTN2;ALMS1
prerank,positive regulation of ATP metabolic process (GO:1903580),0.32783488855529286,0.8817956436607732,0.6083333333333333,0.9664614068121762,1.0,4/32,6.02%,PPARGC1A;ZBTB20;BEND3;SLC4A4
prerank,ameboidal-type cell migration (GO:0001667),0.3100849547451719,0.8817285195825242,0.6194805194805195,0.9659564733121708,1.0,6/51,7.33%,GPC3;AMOTL1;SEMA4B;AMOT;SEMA3A;ITGB7
prerank,regulation of protein ubiquitination (GO:0031396),0.274374773165054,0.8816518401505848,0.6615566037735849,0.9654882953865028,1.0,24/108,18.00%,CAV1;PRICKLE1;AXIN1;SH3RF2;OGT;TNFAIP3;N4BP1;CUL3;SIRT7;RCHY1;SPOPL;NXN;USP4;SOX4;UBE2D1;FBXW7;UBQLN1;GNL3L;BAG2;MINAR1;CHP1;WFS1;PHF23;PINK1
prerank,plasma membrane invagination (GO:0099024),0.33877939089002307,0.8813601445536742,0.6024096385542169,0.9654860175110189,1.0,2/29,2.16%,ARHGAP12;DOCK1
prerank,negative regulation of axon extension (GO:0030517),0.3347425655338937,0.8813474431333395,0.6,0.964881275711321,1.0,10/30,18.70%,SEMA4B;RTN4R;CDKL3;SEMA3A;TRIM46;SEMA4D;SEMA6C;RTN4;SEMA4C;SEMA4A
prerank,histone H4 deacetylation (GO:0070933),0.4135058500783133,0.8812597290286704,0.6033613445378151,0.9644360829713272,1.0,6/10,24.14%,HDAC4;SMARCAD1;HDAC2;HDAC3;SIRT2;REST
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.2901373958267941,0.8811410783395094,0.6422136422136422,0.964073239522773,1.0,4/75,1.21%,RGS6;GUCA1A;RGS14;PLCE1
prerank,protein localization to synapse (GO:0035418),-0.3481275577047207,-0.8809819842874553,0.6142131979695431,0.8836377190584431,1.0,3/12,14.93%,BSN;NRXN1;NRXN2
prerank,zinc ion transmembrane transport (GO:0071577),-0.29469687196020466,-0.8804933631558551,0.6379310344827587,0.883787770646337,1.0,4/22,6.86%,SLC30A10;SLC39A10;SLC39A8;SLC39A14
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.2966311438491321,-0.8804778826898401,0.6169590643274854,0.8829445802960306,1.0,3/23,2.70%,WNT5B;BMP4;GJA1
prerank,aerobic electron transport chain (GO:0019646),0.29033848881187724,0.8799540403119533,0.6347381864623244,0.9659361376857228,1.0,14/68,15.67%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,histone H4 acetylation (GO:0043967),0.3062184152876442,0.8797615959763775,0.6419753086419753,0.9657336820082859,1.0,13/47,19.22%,OGT;KMT2A;BEND3;HAT1;KANSL2;MSL3;TRRAP;KAT8;BRD8;MORF4L2;RUVBL2;NAA40;NAA60
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.2809738250463553,-0.8796734383160387,0.6803519061583577,0.8838353569330661,1.0,10/28,23.42%,LACC1;TRAF6;UBE2N;NOD1;AAMP;CASP8;IRAK2;MAP2K6;IKBKG;NOD2
prerank,protein O-linked glycosylation (GO:0006493),0.27783185898199153,0.8796142531325051,0.6335329341317365,0.9654005457822584,1.0,12/96,9.87%,ST3GAL4;GALNTL6;OGT;C1GALT1C1;GCNT4;B4GAT1;FKRP;B3GLCT;POFUT1;TET1;ST6GAL1;GALNT18
prerank,positive regulation of proteolysis (GO:0045862),0.29927807969524656,0.8794559458950092,0.6458885941644562,0.9651074034782431,1.0,9/55,10.37%,CYFIP2;OGT;GPLD1;NLRC4;PERP;TNIP1;HDAC2;IST1;ADRA2A
prerank,protein targeting to membrane (GO:0006612),0.2836541704447514,0.8794161713311102,0.6509661835748792,0.9645603929653215,1.0,23/83,20.37%,RAB8B;SIL1;FIS1;ZDHHC1;PEX2;ZDHHC7;ZDHHC23;PXMP2;TRAM1;CHMP4A;CHMP4B;RTP3;ABCD1;ZDHHC20;CHM;ZDHHC19;GOLGA7B;ICMT;SLC25A17;ATG3;PEX13;ZDHHC3;ZDHHC12
prerank,positive regulation of bone mineralization (GO:0030501),0.3249916590699371,0.8792976483199666,0.5994194484760522,0.964176996228653,1.0,3/35,4.10%,PKDCC;ANO6;BMPR1B
prerank,amino sugar metabolic process (GO:0006040),-0.3679859829044817,-0.8788882055194323,0.6175771971496437,0.8847969892381455,1.0,2/10,2.65%,ST3GAL1;CSGALNACT1
prerank,positive regulation of vacuole organization (GO:0044090),0.42086344582666535,0.8783677365397333,0.6062717770034843,0.9654816247902208,1.0,3/10,6.44%,LRSAM1;PIP4K2B;RAB3GAP2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4010872987451585,0.8783031776960161,0.6041666666666666,0.9649985688560139,1.0,3/11,13.60%,SOX9;WNT5A;CTNNBIP1
prerank,positive regulation of cellular process (GO:0048522),0.24656331128689782,0.8782371502976876,0.8145161290322581,0.9645203841639978,1.0,88/565,14.63%,CAV1;FGF7;PRODH;NTRK3;GLI1;FGFR1;LBP;DLX1;PTGFR;FOLR2;EGFR;FGF1;SMC5;ACER3;FXR2;KIF20B;ITGAX;FKBP1B;LMAN2;CIDEB;PTHLH;SAPCD2;SOX9;BMPR1B;CELF1;PRKCA;HDAC4;BMP5;WNT5A;FN1;DOCK2;RPRD1B;FER;CDK13;CEP131;ADAM10;KRAS;TRIM21;ACACA;EFNB2;HOXC10;TBX2;RARA;CSPP1;FBXO5;CUL3;DPP4;S100B;ISL1;PTPRJ;GCNT2;FGF18;TSHR;DDRGK1;TET1;NCMAP;MECP2;RPS6KA3;USP47;GAB2;HDAC2;CNOT7;HILPDA;ADRA2A;TBC1D8;S100A9;AXIN2;SRPK2;APC;IL6ST;PRLR;INO80;FAF1;NOXO1;CD81;PTEN;CDC6;IL7;SOX4;HBEGF;P4HB;FZD7;CCKBR;FXR1;IL2RG;KLHL22;ERBB4;DICER1
prerank,cellular response to calcium ion (GO:0071277),0.2911012675404982,0.8780332682704965,0.6441326530612245,0.9643368653070672,1.0,5/67,4.96%,GUCA1A;CAMK2D;GPLD1;ADD1;WNT5A
prerank,apoptotic nuclear changes (GO:0030262),0.3451398952962042,0.877709599506947,0.5884146341463414,0.9644044231799576,1.0,6/24,15.10%,ACVR1C;DFFB;HMGB1;EXOG;DICER1;GPER1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3694345744054738,0.8773482961908945,0.5944272445820433,0.9645173065528322,1.0,3/18,9.35%,RAP1A;RIMS2;GSK3B
prerank,hydrogen peroxide metabolic process (GO:0042743),0.3634795926364381,0.8769887225022515,0.5932475884244373,0.9646657459652219,1.0,1/19,0.87%,PXDN
prerank,regulation of type I interferon production (GO:0032479),0.2796499067106748,0.876791926158683,0.654747225647349,0.9644632553301032,1.0,27/84,24.59%,UBE2L6;PCBP2;PTPN22;TNFAIP3;TRIM21;POLR3G;ACOD1;DTX4;NPLOC4;NLRP4;TAX1BP1;POLR3D;CREBBP;TBK1;CRCP;ITCH;MRE11;G3BP1;XRCC6;DHX9;PIN1;TRAF3;IFIH1;DHX58;POLR3C;POLR3K;CYLD
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.3290458142600328,-0.8766387295406558,0.6388140161725068,0.888899711075955,1.0,2/16,4.13%,SOX13;NAPEPLD
prerank,cellular response to organonitrogen compound (GO:0071417),0.27800144958837714,0.8762911425001467,0.6574850299401198,0.9648943660435209,1.0,16/99,16.38%,HRH1;FOLR1;RAPGEF3;RAP1A;SOX9;TSHR;GABRG2;EGR1;GABRB3;AQP1;CAPN2;RRAGB;CTNNA1;CDH1;CPEB3;EZR
prerank,transcription preinitiation complex assembly (GO:0070897),0.39466153554925243,0.876241068895115,0.5884413309982487,0.9643767302744091,1.0,7/12,31.79%,POLR1E;BDP1;TAF1;TBP;GTF2A2;TAF7;TAF1B
prerank,"phototransduction, visible light (GO:0007603)",0.3869964514308447,0.876219014362752,0.6006825938566553,0.9638036296287984,1.0,2/14,5.04%,GNAQ;CNGB1
prerank,negative regulation of phagocytosis (GO:0050765),-0.31402197614992267,-0.8760349056635084,0.6556122448979592,0.8893604863595663,1.0,3/17,6.62%,DYSF;SIRPA;PIP4P2
prerank,innate immune response (GO:0045087),-0.18866951631032755,-0.8750024790965594,0.9102564102564102,0.8907460158497181,1.0,47/217,22.42%,SP100;SERINC3;LYN;MFHAS1;ADAR;CXCL16;TNK2;MID2;TRIM25;B2M;IRAK4;ALPK1;PLCG2;GCH1;NRROS;CYBA;BST2;TRIM14;BCL10;TRIM35;TRIM28;PGLYRP1;MFAP4;NCF2;AKAP1;POLR3A;PJA2;CFP;PTK2;IKBKB;TRIM59;ISG15;IFIT1;MASP1;CYBC1;CD40;TRIM8;RARRES2;COLEC12;TLR3;FES;TRIM13;TRIM11;SHFL;RPL39;IKBKG;RNF187
prerank,reverse cholesterol transport (GO:0043691),-0.33729438991004107,-0.874869297496984,0.6502347417840375,0.8901557877427738,1.0,5/13,26.09%,APOE;ABCG1;CLU;SCARB1;LCAT
prerank,protein deacetylation (GO:0006476),0.3167840627470498,0.8743394407176475,0.6391891891891892,0.967110838616552,1.0,16/41,24.09%,HDAC4;RCOR3;SIRT3;SIN3B;MSL3;SIRT7;HDAC2;HDAC6;BAZ2A;MORF4L2;MTA3;HDAC3;BRMS1L;SIRT2;SIN3A;SUDS3
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.34677043310810834,0.8743047804252422,0.6244343891402715,0.9665499792817273,1.0,4/24,11.89%,PLCE1;RAC2;OCLN;AKIRIN1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.3349932532361305,-0.8740596195653232,0.6348448687350835,0.8910553167619162,1.0,2/13,7.84%,SLC4A10;GRIK2
prerank,Golgi organization (GO:0007030),0.27612785144017843,0.8739933263596928,0.6690140845070423,0.9666313886355461,1.0,29/112,18.79%,ATP8B3;ATP8B1;RAB29;PI4K2B;LMAN2;RAB30;ATL2;GOLGB1;ATP8B2;NPLOC4;LYSMD3;TMED4;CSNK1A1;GCC2;TRIP11;HTT;ZW10;FBXW8;TMED2;SEC23IP;TICAM2;PI4K2A;ATP8B4;TBC1D20;ARHGEF7;DYNC2H1;STX5;COG3;BET1
prerank,acetyl-CoA metabolic process (GO:0006084),-0.31863553552988,-0.8728534386932374,0.6088082901554405,0.892853793194506,1.0,7/15,16.18%,HMGCS1;HMGCS2;MLYCD;ACLY;PMVK;MVK;ACSS1
prerank,neurotransmitter secretion (GO:0007269),-0.24633271919874505,-0.8728331875019215,0.7072243346007605,0.8920124788327527,1.0,20/44,29.32%,STXBP3;LIN7A;HSPA8;SYN1;GAD1;NRXN1;SYN3;NRXN2;DNAJC5;CPLX2;UNC13A;SYN2;RIMS1;SNAP25;SLC32A1;PPFIA3;PIP5K1C;PTPRN2;GRM4;SYT1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),0.36545310382570906,0.8725745472778088,0.6369426751592356,0.9689401185731938,1.0,2/16,7.24%,RBFOX2;DDX17
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.3986666613743443,0.8725250576216663,0.6021505376344086,0.9684309045926905,1.0,1/11,1.73%,EGFR
prerank,positive regulation of protein localization to cell surface (GO:2000010),0.3854644482918639,0.872448927807144,0.6016949152542372,0.9679608221014309,1.0,3/13,18.77%,RIC3;STX4;TM9SF4
prerank,lymphocyte differentiation (GO:0030098),0.2911022495335673,0.8716551525394057,0.6387434554973822,0.9690072874199236,1.0,9/68,9.89%,LEPR;PBX1;TPD52;PTPN22;HDAC4;PTPRC;MSH2;PTPRJ;AXL
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.3400767513654029,0.8713435056014457,0.6174183514774495,0.9690388268835676,1.0,8/26,16.65%,SOCS5;TSG101;NCK2;CBLB;ADRA2A;SOCS4;HBEGF;FBXW7
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.41182812999861274,0.8710510295473323,0.6153846153846154,0.9690205191937643,1.0,2/11,9.57%,EXOSC5;EXOSC10
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3255017868868379,-0.870808577945586,0.6280788177339901,0.8955400890014524,1.0,8/15,31.42%,SAMHD1;USP18;ISG15;YTHDF2;CACTIN;YTHDF3;TTLL12;NLRC5
prerank,purine ribonucleotide biosynthetic process (GO:0009152),-0.24351494666754578,-0.870410420312091,0.6867924528301886,0.8955249852202722,1.0,13/48,15.30%,ADCY1;ADCY7;NPR1;ACOT7;PAPSS1;SLC26A2;ADCY4;ADCY2;PANK1;SLC35B3;PPCDC;IMPDH1;NUDT2
prerank,folic acid metabolic process (GO:0046655),0.3617007516085564,0.8703987018501635,0.6373983739837399,0.9697446619522331,1.0,6/18,17.89%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;PM20D2;SLC19A1
prerank,sensory perception of chemical stimulus (GO:0007606),-0.3206060933345059,-0.8699578389868244,0.6388888888888888,0.8955630120700948,1.0,1/15,1.05%,GNAS
prerank,translesion synthesis (GO:0019985),0.31269763879391954,0.8699208703312954,0.654320987654321,0.9700921088729345,1.0,6/42,10.64%,UBE2L6;USP43;POLI;RFC3;NPLOC4;RCHY1
prerank,regulation of centrosome cycle (GO:0046605),0.3571507302416237,0.8698651956050601,0.6093247588424437,0.9695754504632158,1.0,6/21,12.90%,CEP131;CHMP5;PDCD6IP;CHMP4B;CHMP4C;GEN1
prerank,nucleocytoplasmic transport (GO:0006913),0.3146509401104544,0.8694320924903011,0.6298882681564246,0.96980105619988,1.0,6/40,14.55%,RGS14;SNRPF;RBM15B;SMN1;HTATIP2;LSG1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.320619828581721,-0.8688552151834884,0.6477541371158393,0.8970642328712347,1.0,8/16,29.65%,PAXIP1;SNW1;KDM1A;DNMT3B;SMAD4;BRCA1;WDR5;BCOR
prerank,actin filament network formation (GO:0051639),0.3995992166038877,0.8681966602780037,0.6089193825042881,0.9717604688419138,1.0,2/11,10.63%,COBL;FHOD1
prerank,positive regulation of stress fiber assembly (GO:0051496),0.30783263795986715,0.8681295665435261,0.6377410468319559,0.9712897647717282,1.0,14/44,21.26%,LPAR1;PXN;RAPGEF3;ARHGEF5;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;PPM1E;S100A10
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.2805277971062068,-0.868074898588562,0.6786786786786787,0.8979232383454872,1.0,2/25,4.69%,PICALM;ANKRD13A
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.27275001602477755,0.8680390094294373,0.6917728852838934,0.9708620759368637,1.0,19/116,16.60%,PLK2;CD3G;MC5R;PTHLH;SRC;ADCY5;SELENOS;PTGER4;PRKAR2A;TSHR;ADCY9;PRKACB;GGT1;ADCY8;ADCY3;PTH2R;GPR27;SYK;RXFP1
prerank,histone H2A acetylation (GO:0043968),0.3704616618519819,0.8679393865119625,0.6345514950166113,0.9704540361421036,1.0,6/16,18.84%,MSL3;TRRAP;BRD8;MORF4L2;RUVBL2;NAA40
prerank,granulocyte chemotaxis (GO:0071621),0.303343507461076,0.8677884349148386,0.6500672947510094,0.9701348191724835,1.0,1/55,0.29%,CXADR
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.34377795115860205,-0.8674889618689012,0.6352941176470588,0.8983360445679923,1.0,5/12,29.88%,SEH1L;RMDN1;CENPC;CENPE;NDC80
prerank,positive regulation of heterochromatin assembly (GO:0031453),0.40581686116724014,0.8671731351056691,0.6267361111111112,0.9707587102462787,1.0,3/11,10.62%,RESF1;PPHLN1;TPR
prerank,negative regulation of histone modification (GO:0031057),-0.32431528913504304,-0.867024099569743,0.6356968215158925,0.8984505180851422,1.0,8/14,39.99%,JARID2;NOC2L;BRCA1;AASS;THAP7;CTBP1;SNCA;SPHK2
prerank,organic cation transport (GO:0015695),0.3556928885644415,0.8669987345835064,0.6155088852988692,0.970510616233132,1.0,6/19,17.34%,SLC29A4;SLC22A3;SEC14L1;SLC25A26;SLC25A19;RALBP1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.280244677976462,-0.8668832701799146,0.6584615384615384,0.8978745197919786,1.0,10/26,25.80%,LGR4;APPL2;NFKBIL1;LRRC14;IRF1;FLOT1;CACTIN;TLR3;BIRC3;SMPDL3B
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.28151525090721874,0.8664958516388289,0.6415816326530612,0.9709339802503947,1.0,6/76,8.41%,CAV1;PRICKLE1;AXIN1;HDAC4;CUL3;TNIP1
prerank,ribosomal small subunit assembly (GO:0000028),0.3722882377416465,0.8663416977259283,0.6195826645264848,0.9706420497159064,1.0,1/16,0.72%,RPSA
prerank,regulation of actin nucleation (GO:0051125),0.3908998727216927,0.866340912034474,0.6287215411558669,0.9700287249604647,1.0,1/12,3.44%,ARPIN
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.28941724196369956,0.8657819395684022,0.6560913705583756,0.9706061290159712,1.0,16/64,18.15%,MLLT3;LEO1;CDK13;CDK7;POLR1E;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;RTF1;TCEA1;SETD2;GTF2H3
prerank,snRNA 3'-end processing (GO:0034472),0.35432619980946856,0.8653159953024347,0.622792937399679,0.9709517340769733,1.0,5/19,21.48%,EXOSC5;TUT1;INTS6L;TOE1;EXOSC7
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2841874537789375,0.8651791967416225,0.6624525916561315,0.9706183832020436,1.0,14/69,15.67%,COX5A;NDUFA6;NDUFB10;NDUFS3;COX15;NDUFS6;SDHD;SDHAF2;COX7C;NDUFA3;NDUFV2;COX5B;NDUFV1;NDUFA7
prerank,positive regulation of interleukin-6 production (GO:0032755),0.28849407837256025,0.8648422073569534,0.6658031088082902,0.970740479921418,1.0,7/68,9.49%,LBP;IL1A;WNT5A;IL17RA;TLR7;ISL1;HMGB1
prerank,RNA destabilization (GO:0050779),0.36631546477753557,0.8647511621155053,0.6356589147286822,0.9703074869947811,1.0,4/18,9.07%,GIGYF2;CELF1;DXO;LIN28B
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.2888378748584521,0.8645540933290529,0.674025974025974,0.9701031553527952,1.0,14/66,15.72%,GTSE1;EIF2AK3;LIMK2;CARD10;UBR5;BAG3;RBM22;PIK3R2;FERMT2;TPR;CCT2;RAN;CDH1;YAP1
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.3676048136719821,0.8644212363749866,0.6417391304347826,0.9697534171756168,1.0,1/16,0.78%,ACKR3
prerank,mitochondrion disassembly (GO:0061726),-0.2543928162429327,-0.8641839830209954,0.6840390879478827,0.9029196311906598,1.0,15/34,26.21%,SQSTM1;BECN1;GABARAPL1;WIPI1;ULK2;GABARAP;AMBRA1;USP30;MAP1LC3A;WIPI2;ATG12;WDR45B;WDR45;FBXO7;CISD2
prerank,base-excision repair (GO:0006284),0.30356500775309675,0.8638889175075142,0.6392572944297082,0.9701958925336307,1.0,11/48,17.88%,TDG;NTHL1;RFC3;USP47;APEX2;ERCC6;ADPRS;POLB;PRMT6;POLE;RFC1
prerank,dendritic cell differentiation (GO:0097028),-0.2976415625553292,-0.8638773215222841,0.6542553191489362,0.9027304524408358,1.0,10/22,35.39%,LYN;CAMK4;LGALS9;TRPM2;CCL19;IRF8;PRTN3;TREM2;BATF2;LILRB1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.2870054291071761,0.8637418753023862,0.660574412532637,0.9698642782351299,1.0,8/69,9.49%,LBP;IL1A;WNT5A;PTPRC;EPHB2;ISL1;PTPRJ;HMGB1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.33524688231776645,0.8636814601109879,0.6292307692307693,0.9693729170811247,1.0,9/27,23.67%,CSTF3;POP7;ERN1;DICER1;TOE1;PCF11;RPP30;RNASE1;RNASEH1
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.28286395538244935,-0.8636786814445437,0.638121546961326,0.9022485659764344,1.0,3/22,5.38%,SLC7A5;LACC1;TNFRSF1B
prerank,negative regulation of protein polymerization (GO:0032272),0.32873082512919066,0.8636001955850561,0.6166419019316494,0.9689311975831123,1.0,4/27,8.36%,KANK4;CDH5;KANK1;DYRK1A
prerank,cellular response to glucagon stimulus (GO:0071377),-0.31376123284963353,-0.8635748032199401,0.6301369863013698,0.9015757119421848,1.0,6/17,15.96%,ADCY1;ADCY7;ADCY4;ADCY2;PRKAR2B;CYSLTR2
prerank,regulation of gene silencing by RNA (GO:0060966),0.2965940581710948,0.8635569289235464,0.6533333333333333,0.9678063862158081,1.0,12/50,15.46%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;PUM2;NUP93
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.2965940581710948,0.8635569289235464,0.6533333333333333,0.9678063862158081,1.0,12/50,15.46%,IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;PUM2;NUP93
prerank,"base-excision repair, gap-filling (GO:0006287)",0.3193728878269923,0.8632971411345177,0.6396648044692738,0.9677343485646283,1.0,7/35,17.88%,TDG;NTHL1;RFC3;ADPRS;POLB;POLE;RFC1
prerank,oligosaccharide metabolic process (GO:0009311),0.3018436753035871,0.8632126480739204,0.6581081081081082,0.9673006584024213,1.0,7/46,11.50%,ST3GAL4;B3GALT1;NAGA;NEU1;ST8SIA5;MANBA;ST8SIA3
prerank,positive regulation of interleukin-1 production (GO:0032732),0.29796772441570907,0.8632114189782557,0.6524137931034483,0.9666973525761069,1.0,7/51,13.87%,USP50;WNT5A;NLRC4;ISL1;HMGB1;EGR1;GSDMD
prerank,positive regulation of peptidase activity (GO:0010952),0.36520488810105123,0.8631072821374774,0.6394230769230769,0.966311929912175,1.0,4/20,8.91%,APH1B;PSME3;NCSTN;DDRGK1
prerank,signal peptide processing (GO:0006465),0.40200694572311557,0.8630604750139267,0.6295025728987993,0.9658140845446604,1.0,1/11,2.16%,PCSK5
prerank,cellular response to hypoxia (GO:0071456),0.26544784621420453,0.8628802413967263,0.6706021251475797,0.9655772058867638,1.0,28/126,18.75%,RORA;PSME3;EGLN3;SUV39H1;PSMB5;HILPDA;AQP1;CREBBP;PSMB2;P4HB;PSMA2;PSMA6;BAD;PSMD13;PSMA7;PGK1;UBQLN1;RGCC;BNIP3;HP1BP3;SUV39H2;PSME4;BACH1;PINK1;PSMC4;PSMB6;PSMD12;PSMD14
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.4119836473878612,0.8624467560535335,0.6101398601398601,0.9658780164492117,1.0,5/10,20.61%,LEO1;PAF1;CPEB3;CDC73;NUDT21
prerank,calcium ion transport (GO:0006816),0.2724681521642661,0.8621770330863429,0.6809015421115066,0.9658022176200695,1.0,8/113,4.79%,CAV1;NALCN;TRPM3;ANO6;SLC24A1;TRPV4;ATP2B4;CACNA1H
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.38479862694396266,0.8621624100946768,0.6180904522613065,0.9652326128937386,1.0,3/13,13.50%,SPRED1;HIC1;SPRED2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.29396116711577946,-0.8620231965316442,0.6923076923076923,0.904066961449464,1.0,4/20,5.19%,SEMA6D;SEMA7A;SEMA3C;SEMA6A
prerank,regulation of mitotic nuclear division (GO:0007088),0.2922516245078198,0.8617616591823315,0.6521164021164021,0.9654316600104502,1.0,9/55,9.46%,FBXO43;KIF20B;CAV2;IL1A;NUP62;TOM1L1;CDK13;FBXO5;TOM1L2
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2930317130026846,-0.8617365994922097,0.6639566395663956,0.9038259638298678,1.0,6/20,27.37%,AKR1B1;FDXR;TSPO;STARD3NL;HSD17B10;TSPOAP1
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.29264880787840036,-0.8614838402250846,0.673469387755102,0.903479372728231,1.0,8/22,22.17%,ROCK2;FKBP1A;PPP4R4;PPP1R11;IKBKB;STYXL1;CRY2;NCKAP1L
prerank,regulation of cellular response to stress (GO:0080135),0.2700413772700919,0.861274991301421,0.6890173410404624,0.9658214450864421,1.0,38/115,23.05%,CAMK2D;HSPH1;SLC38A2;NPAS2;NUP62;MCL1;BAG3;AMFR;NUP160;GSK3B;NUP37;TPR;NUP50;RANBP2;NUP210;ARMT1;ABCD1;NUP153;CREBBP;NEK4;NUP93;ADCY8;AIFM2;CHORDC1;DNAJC7;YWHAE;BAG2;CAMK2G;PINK1;RPTOR;PRKN;ATR;CCAR2;NUP43;RPA3;MBTPS2;SEC13;MAPK1
prerank,homotypic cell-cell adhesion (GO:0034109),0.31953252803711935,0.8612426397132532,0.6331938633193863,0.965297391050053,1.0,4/39,5.16%,UBASH3B;TJP2;PLPP3;FN1
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.22809348800599288,-0.8607411798902965,0.7445255474452555,0.9041569837388522,1.0,18/52,22.19%,CNOT6L;EDC3;NT5C3B;HBS1L;EDC4;CNOT11;TUT7;EXOSC3;LSM7;ZFP36;DIS3;CNOT9;RC3H1;EXOSC1;PDE12;POLR2D;DCP2;LSM5
prerank,development of primary male sexual characteristics (GO:0046546),0.32326572616398247,0.8606046944827423,0.6547277936962751,0.9659629493000338,1.0,8/34,15.35%,WNT2B;SOX9;WNT5A;LHFPL2;MSH2;CSDE1;NR5A1;KITLG
prerank,positive regulation of defense response (GO:0031349),0.27658931608478354,0.8603943637068993,0.6804374240583232,0.9657599047623321,1.0,18/89,17.74%,NPAS2;MGST2;LRSAM1;WNT5A;ABCC1;IL17RA;TLR7;TRADD;POLR3G;PTGER4;TNIP1;PLSCR1;S100A9;POLR3D;IL15;NFKBIZ;MDK;LPL
prerank,cellular response to purine-containing compound (GO:0071415),-0.362922484690339,-0.8603495953545347,0.6393034825870647,0.9041719607530693,1.0,5/10,30.95%,SLC8A1;TRPM2;P2RY6;P2RY1;RYR2
prerank,regulation of T cell cytokine production (GO:0002724),-0.32268307250559614,-0.8600751704453321,0.6734177215189874,0.9038511154464347,1.0,3/15,6.74%,B2M;TNFRSF1B;TRAF6
prerank,tRNA export from nucleus (GO:0006409),0.31895018848216433,0.859991983919021,0.6338235294117647,0.9653428932826765,1.0,10/32,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.31895018848216433,0.859991983919021,0.6338235294117647,0.9653428932826765,1.0,10/32,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,positive regulation of myelination (GO:0031643),-0.34573938999008547,-0.859383843084646,0.642512077294686,0.9044131301051764,1.0,2/11,5.38%,PARD3;TNFRSF1B
prerank,positive regulation of macrophage differentiation (GO:0045651),-0.3623213350189613,-0.859160581474048,0.6444444444444445,0.9040077964549191,1.0,6/11,22.92%,IL34;ID2;HSF1;CSF1;CASP8;RIPK1
prerank,regulation of endothelial cell apoptotic process (GO:2000351),-0.24896888256709668,-0.8590756381625368,0.6925925925925925,0.9033064689700837,1.0,8/39,13.20%,TEK;ANGPT1;NDNF;KDR;GATA2;RAMP2;SCG2;THBS1
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.3581265448245825,0.8590135589567965,0.627172195892575,0.9666593017663516,1.0,1/18,0.80%,TSHZ3
prerank,cardiac muscle contraction (GO:0060048),0.31379441291982796,0.8589374219994155,0.6454413892908828,0.9662119268160897,1.0,7/34,15.19%,CAMK2D;CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1;TNNI3
prerank,organonitrogen compound catabolic process (GO:1901565),0.29465850166260305,0.8587065075021126,0.6522875816993464,0.966076395960134,1.0,12/57,15.15%,IL4I1;LRSAM1;CLN8;BCKDK;LVRN;SIAH1;LNPEP;NAGK;LTA4H;PNPLA8;GNPDA2;TXN2
prerank,regulation of mitotic spindle organization (GO:0060236),0.31712712409629773,0.8586989787041269,0.6503496503496503,0.9654907027814067,1.0,7/35,12.02%,NUP62;CHMP5;PDCD6IP;TPR;CHMP4B;CHMP4C;MAP9
prerank,cellular response to interleukin-2 (GO:0071352),0.39880695923893805,0.8582414710183461,0.5964601769911504,0.9652361676505998,1.0,6/11,29.49%,IL2RG;SYK;JAK1;STAT5B;STAT5A;SHC1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.39880695923893805,0.8582414710183461,0.5964601769911504,0.9652361676505998,1.0,6/11,29.49%,IL2RG;SYK;JAK1;STAT5B;STAT5A;SHC1
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.3475211814218881,0.8580919907234509,0.6368,0.9649503892490576,1.0,4/21,13.40%,HK2;RPE;DERA;GCK
prerank,positive regulation of cell killing (GO:0031343),0.3860271478861057,0.8578666973781186,0.6555944055944056,0.9648015308254693,1.0,6/13,23.35%,WNT5A;NOXO1;FZD7;SYK;MAPK8;RAC1
prerank,organophosphate catabolic process (GO:0046434),-0.33924886091502565,-0.8577429560081851,0.6293706293706294,0.9053270241602852,1.0,1/11,2.72%,ENPP2
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.30149455303987177,0.8576915538998805,0.6446499339498019,0.9645639984227822,1.0,13/53,20.41%,GLMN;OPHN1;PSME3;DDRGK1;TMF1;PKD1;FBXW7;BAG2;RHBDF1;PINK1;PSMD14;TMTC3;PRKN
prerank,positive regulation of organelle organization (GO:0010638),0.32157070572855173,0.8576817705548331,0.642754662840746,0.9639808333999406,1.0,7/32,15.89%,PPARGC1A;RAB3GAP2;IRGM;GSK3B;LNPK;HTRA2;SHCBP1L
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.2326938456338232,-0.8576049337223164,0.7021276595744681,0.9047635714768987,1.0,17/48,22.66%,EP300;ATAD2B;ACTB;TAF1D;DEK;SMARCD1;H1-0;SMARCA5;SERTAD1;POLR2F;KAT2B;KAT2A;TAF1C;POLR2K;POLR1C;ZMIZ2;POLR1F
prerank,cellular component disassembly (GO:0022411),0.2998442862962145,0.857503764144428,0.6788124156545209,0.9637330807994258,1.0,13/53,17.74%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;NOXO1;MMP16;CAPN2;PLG;MMP14;BMP1;LCP1
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3594619994544973,0.8571944687658477,0.626984126984127,0.963770844905724,1.0,3/20,4.69%,CEACAM1;BMP5;SLC27A1
prerank,extracellular matrix disassembly (GO:0022617),0.2993414773257722,0.857049873491212,0.6671122994652406,0.9634569038553676,1.0,13/53,17.74%,LAMC1;KLK2;MMP15;SH3PXD2B;ADAM10;MMP12;NOXO1;MMP16;CAPN2;PLG;MMP14;BMP1;LCP1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.28482698745648183,0.8569879137223049,0.6760925449871465,0.962985867258077,1.0,20/62,22.90%,DND1;IPO8;NUP62;NUP160;AGO1;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;FXR1;PUM2;NUP93;PPARG;DHX9;NUP43;PUM1;ELAVL1;SEC13
prerank,multivesicular body organization (GO:0036257),0.32343082439921716,0.8568679174389466,0.6418816388467374,0.9626403943096586,1.0,7/31,11.97%,TSG101;CHMP5;PDCD6IP;IST1;CHMP4A;CHMP4B;CHMP4C
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.30541520455478155,0.8562694176029183,0.6465863453815262,0.963222310270814,1.0,4/42,5.75%,UBE2L6;USP43;POLI;RFC3
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.32232099828837524,-0.8561611438393965,0.6394230769230769,0.9069034997644493,1.0,5/14,19.71%,ACTR2;ARID2;MMS19;PARP1;TIMELESS
prerank,DNA double-strand break processing (GO:0000729),0.35696713314989054,0.8559462172284765,0.6338709677419355,0.9632862786470813,1.0,3/18,6.89%,SMARCAD1;NBN;UBE2V2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.2989932345087385,-0.8555858145718052,0.663013698630137,0.9072795851474597,1.0,4/20,10.59%,TGFBR1;HIF1A;DNAJB2;EPAS1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.34691157780899384,0.8555550441452833,0.6336,0.9634645243862717,1.0,2/19,2.82%,CXCL17;MPP1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.3493925563480372,-0.8555203131859461,0.6519721577726219,0.9065438627997525,1.0,2/11,6.50%,MECOM;CD34
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2860501500805432,-0.855233305299353,0.6426592797783933,0.9062851193236108,1.0,11/21,28.16%,RPS7;UBE2S;RPL23;GOLGA2;CDC14B;SKP1;MAD2L2;RPL5;MAD2L1;RPL11;GORASP1
prerank,positive regulation of ion transport (GO:0043270),0.3064051923371247,0.85519388621915,0.6446629213483146,0.9636015696223705,1.0,2/48,2.66%,CNKSR3;ANO6
prerank,regulation of Notch signaling pathway (GO:0008593),0.2819885381912651,0.8550646275891844,0.6806083650190115,0.9632677400081217,1.0,16/76,16.92%,NRARP;EGFR;DTX1;JAG1;MAML2;SRC;EGFL7;BMP2K;POFUT1;IL6ST;TSPAN14;CREBBP;WWP2;YAP1;FBXW7;MMP14
prerank,steroid hormone biosynthetic process (GO:0120178),0.32755466548003526,0.8544541919111507,0.6421207658321061,0.9638941792410671,1.0,5/29,19.80%,HSD17B3;HSD17B2;STARD3;STAR;HSD17B11
prerank,sensory perception of taste (GO:0050909),-0.35815577636619655,-0.854168966466136,0.6470588235294118,0.9076660155626435,1.0,8/10,49.94%,PKD2L1;PKD1L3;CD36;ASIC1;ASIC3;TAS1R1;TAS1R2;GNAT3
prerank,cellular response to reactive oxygen species (GO:0034614),0.2911588627553826,0.8538685673535057,0.6679586563307494,0.9644835526810897,1.0,10/59,12.99%,PXN;EGFR;MPV17;FER;TNFAIP3;MAPK7;MAP3K5;HDAC6;NFE2L2;AQP1
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.32390770172407857,-0.8537720652786717,0.687041564792176,0.9076105821139172,1.0,5/14,10.09%,CHKA;LPIN2;ETNK1;CEPT1;LPIN3
prerank,establishment of protein localization to extracellular region (GO:0035592),0.31043963788721624,0.8528342208433244,0.6488439306358381,0.9659554562057736,1.0,5/39,9.72%,TANGO6;RAB8B;RAB3A;LTBP2;ABCA1
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.321093766249412,0.8528259926535595,0.6536231884057971,0.9653844997985898,1.0,2/32,2.58%,DLC1;CDH5
prerank,response to molecule of bacterial origin (GO:0002237),0.28196876825871753,0.8525872636255761,0.6808236808236808,0.9652541783473909,1.0,10/69,11.08%,LBP;PTPN22;HNRNPA0;IRAK3;FER;TNFAIP3;ACOD1;RPS6KA3;S100A9;TAB2
prerank,glycoprotein catabolic process (GO:0006516),0.36217837862376234,0.8523070264338207,0.6394779771615008,0.965235513467064,1.0,5/17,18.96%,ADAMTS12;MMP12;MANBA;OGA;EDEM2
prerank,COPII-coated vesicle budding (GO:0090114),-0.2196025068379882,-0.8521727008440431,0.7702702702702703,0.9100060414065961,1.0,20/68,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;SCAP;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,negative regulation of transposition (GO:0010529),0.3593480396236489,0.8520957706476141,0.6217532467532467,0.9650347945975368,1.0,3/16,12.29%,PIWIL2;SIRT7;TEX15
prerank,receptor-mediated endocytosis (GO:0006898),0.2598853352426817,0.8520485885155629,0.7225433526011561,0.9645364030209458,1.0,24/132,16.60%,CAV1;ACKR3;FOLR1;HSPH1;COLEC11;CAV2;CD9;TFR2;DNM1;SGIP1;INPP5F;CUBN;M6PR;NEDD4;CD81;AMN;CTTN;HSPG2;CLEC9A;CLTB;AP2A2;SNX1;SYK;SCARB2
prerank,determination of left/right symmetry (GO:0007368),0.31231696724055413,0.8519344422673181,0.6463932107496464,0.9641694181014114,1.0,8/36,15.14%,ENKUR;STIL;CCDC39;FOXJ1;LEFTY1;SMO;DNAH5;CCDC40
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.3521428064103341,-0.8516700458905554,0.6551724137931034,0.9101788977576364,1.0,3/10,13.13%,PCGF5;IGF2;PRMT7
prerank,peptide cross-linking (GO:0018149),0.3276478149406423,0.8516565127288811,0.613603473227207,0.9641176354664929,1.0,3/25,6.65%,CD3G;FN1;COL3A1
prerank,axonal transport of mitochondrion (GO:0019896),-0.3547954243375523,-0.8514647266961629,0.6716417910447762,0.909740433829603,1.0,4/11,15.54%,NEFL;HIF1A;MAPT;OPA1
prerank,positive regulation of transport (GO:0051050),0.27095549690091536,0.8513972723615153,0.6866585067319462,0.964055602557763,1.0,7/85,5.49%,GPC3;NEDD4L;GPLD1;KMT2A;LMAN2;TFR2;DOCK2
prerank,negative regulation of immune effector process (GO:0002698),0.3750654529162294,0.8513583963827883,0.6476345840130505,0.9635366924608372,1.0,2/13,5.71%,CD55;FER
prerank,cytosolic transport (GO:0016482),-0.20920824491817885,-0.8513332016068319,0.8278145695364238,0.9091265602710779,1.0,33/108,21.76%,MYO1D;DENND5A;RAB6B;RHOBTB3;GOSR2;AP2A1;STX8;BECN1;RBSN;VPS13C;DOP1B;EPS15;UBE2O;RGP1;SNX16;VPS26B;BET1L;PREPL;CLN5;SORT1;MON2;STX6;LAPTM5;HEATR5A;STX16;SYS1;YKT6;PLEKHJ1;TBC1D17;ANKRD27;RAB7A;RNF126;VTI1B
prerank,positive regulation of protein ubiquitination (GO:0031398),0.2775999375596425,0.8510927076904844,0.6874205844980941,0.963455059862973,1.0,4/80,4.37%,CAV1;PRICKLE1;AXIN1;SPSB4
prerank,regulation of mitotic cell cycle (GO:0007346),0.253475361366045,0.8502404152039219,0.7541713014460512,0.9645637021968972,1.0,37/171,18.75%,SMOC2;FBXO43;KIF20B;CAV2;PRKCA;PSME3;NEK7;CDK13;FBXO5;BRINP1;CDC20;PSMB5;ANAPC5;ANAPC7;EIF4E;ANAPC11;BUB3;CDKN1C;ANAPC2;PSMB2;UBE2D1;PSMA2;TTC28;PSMA6;ANAPC4;FZR1;PSMD13;PSMA7;NEK11;SCRIB;PSME4;ANAPC16;PSMC4;CDC23;PSMB6;PSMD12;PSMD14
prerank,glycerol metabolic process (GO:0006071),-0.36003109003345624,-0.8497445850982878,0.6628440366972477,0.9115232703221798,1.0,3/10,13.53%,TPI1;COQ3;PGP
prerank,filopodium assembly (GO:0046847),-0.31336578442705276,-0.849384485321756,0.6875,0.9113936935002122,1.0,3/16,5.88%,DNM3;FGD5;ARHGEF4
prerank,peptidyl-lysine modification (GO:0018205),0.26696410272097737,0.8491550847133484,0.6978155339805825,0.9661465457872541,1.0,32/99,23.45%,STX1A;EYA1;SENP6;UBE2I;HDAC4;NUP62;SIRT3;PIAS2;NUP160;SIRT7;NUP37;TPR;NUP50;HDAC6;RANBP2;NUP210;NUP153;ATPSCKMT;NUP93;SENP3;SUMO1;SENP2;TRPM4;LOXL2;ETFBKMT;NUP43;VIPAS39;VCPKMT;IFIH1;SIRT2;SAE1;BCL11A
prerank,positive regulation of secretion (GO:0051047),-0.3540940420512782,-0.8486775689341787,0.6635730858468677,0.9119662618981393,1.0,2/11,4.51%,ACSL3;NPR1
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.28215774452383874,-0.8486036221064728,0.7287234042553191,0.9112562535896641,1.0,11/22,27.96%,RPL37;RPS15;RPS7;RPS20;RPL23;EEF1E1;CDK5RAP3;PLA2R1;UBB;ATM;MSX1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.2969351194791451,-0.848195327687552,0.6529562982005142,0.9112342553512578,1.0,4/18,12.90%,PIK3R1;BCL2L11;RNFT1;BOK
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.29490561214298877,0.8468694383604182,0.6821282401091405,0.9701637524625052,1.0,11/49,13.64%,SRC;DACT1;PPM1A;LDLRAD4;PTGER4;ISL1;GSK3B;HMGB1;NLRP2B;HDAC6;LCMT1
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.37923966003390963,0.8465906897171174,0.6466302367941712,0.9701119694111274,1.0,4/12,10.99%,HEYL;NCOR1;PIAS2;NCOR2
prerank,respiratory chain complex IV assembly (GO:0008535),0.34539969713418994,0.8464384005412628,0.6761006289308176,0.9698132080661369,1.0,7/21,19.29%,COA5;COX15;COX19;COX16;BCS1L;SURF1;COA8
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.25352467152374647,-0.8462723172673121,0.7445482866043613,0.9141925052860459,1.0,10/30,22.08%,VAMP5;SEC16A;ANK3;MACF1;BBS2;PREPL;GGA3;SYS1;OPTN;RAB10
prerank,regulation of primary metabolic process (GO:0080090),-0.19563500243964604,-0.8458821633943355,0.8333333333333334,0.9141207987175153,1.0,24/126,15.44%,ROCK2;PPARD;PSMA1;TGS1;LDLR;PLPP1;APOE;TBL1XR1;PSMD11;HMGCS1;C1QTNF2;TNFAIP8L3;PSMD7;PSMD4;PRKAB2;NFYB;FGFR4;SP1;PSMB4;PMVK;ID2;CERS2;MVK;NFYC
prerank,mRNA 3'-end processing (GO:0031124),0.27473442707436213,0.8454810236407657,0.6863237139272271,0.9711022115973614,1.0,26/78,25.26%,CSTF1;RBM8A;SRSF4;LEO1;RPRD1B;TUT1;PAF1;CSTF3;RPRD1A;UPF3B;THOC3;THOC5;SLU7;SYMPK;PAPOLG;SRSF3;DHX38;CDC73;NUDT21;SRSF11;PCF11;CPSF2;WDR33;SARNP;PABPN1;TENT4B
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.37361720642252183,0.8449576506022822,0.6442953020134228,0.9715291895627636,1.0,2/13,4.79%,STX1A;CACNA1H
prerank,defense response to virus (GO:0051607),-0.2018536765524518,-0.8449377176055384,0.8385093167701864,0.9151072328153822,1.0,25/100,21.48%,SERINC3;IFNAR2;ABCC9;SAMHD1;IRF2;IFIT2;IFIT3;AGBL5;BST2;FLNA;IRF1;NDUFAF4;AKAP1;ABCE1;MOV10;ISG15;IFIT1;CD40;RSAD2;PDE12;OPRK1;CGAS;TLR3;BNIP3L;SHFL
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.35132324833628525,-0.8447539355824509,0.6788321167883211,0.9146117823767157,1.0,6/10,35.88%,ENPP2;PLA2G15;PLA2G7;PLA2G6;LIPC;PLA2G5
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.29025278632312695,0.8447105353109483,0.6909581646423751,0.9713924183261607,1.0,4/50,5.90%,NR3C2;EGFR;TLR7;TRADD
prerank,regulation of cilium movement (GO:0003352),0.39628932747362056,0.8446726370359503,0.6341030195381883,0.9708756206952498,1.0,3/10,15.69%,CCDC39;CCDC40;CFAP298
prerank,error-prone translesion synthesis (GO:0042276),0.3470579723894426,0.8444652225954242,0.6441176470588236,0.9706865124627967,1.0,10/21,27.70%,POLI;RFC3;REV3L;RFC1;RPA3;POLE2;PRIMPOL;REV1;RPA2;RPA1
prerank,kinetochore organization (GO:0051383),-0.3250542990041497,-0.8444449144574032,0.671604938271605,0.9143738172944293,1.0,9/13,40.07%,CENPT;CENPC;CENPE;NDC80;CENPF;CENPA;DLGAP5;NUF2;CENPW
prerank,snRNA processing (GO:0016180),0.36193595548624247,0.8443418652271506,0.636963696369637,0.970346991239783,1.0,5/16,18.95%,INTS10;TUT1;INTS6L;INTS3;TOE1
prerank,calcium ion transmembrane transport (GO:0070588),0.2733807978691665,0.8443285628210236,0.6918316831683168,0.9697851793712554,1.0,7/86,4.74%,NALCN;TRPM3;SLC8B1;ANO6;SLC24A1;TRPV4;ATP2B4
prerank,regulation of receptor binding (GO:1900120),0.394176119997244,0.8436937202826346,0.6228373702422145,0.9704788252786785,1.0,1/10,1.78%,PTPRF
prerank,protein polyglutamylation (GO:0018095),0.3931624319548785,0.8429516942903418,0.6225749559082893,0.9713129224045893,1.0,3/11,16.93%,TTLL1;CFAP20;TTLL9
prerank,negative regulation of nervous system development (GO:0051961),-0.2952023436845367,-0.8428440678284875,0.701530612244898,0.9168014863037008,1.0,2/17,4.53%,APPL2;B2M
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),-0.35420237706989677,-0.8427499452377448,0.6605080831408776,0.9161305242467394,1.0,4/10,15.44%,CACNB2;CALM1;CALM3;SRI
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.3194854723520741,0.8424485732094732,0.6544117647058824,0.9716571827943847,1.0,3/29,9.49%,CXCL17;ANO6;HMGB1
prerank,histone H2B ubiquitination (GO:0033523),0.4010478936427875,0.8424379752892138,0.6198934280639432,0.971093103059435,1.0,5/10,23.23%,LEO1;PAF1;CDC73;RNF20;DTX3L
prerank,COPII vesicle coating (GO:0048208),-0.22318528156008857,-0.8418560122544665,0.7848101265822784,0.9154114643654073,1.0,19/61,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,vesicle coating (GO:0006901),-0.22318528156008857,-0.8418560122544665,0.7848101265822784,0.9154114643654073,1.0,19/61,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.22318528156008857,-0.8418560122544665,0.7848101265822784,0.9154114643654073,1.0,19/61,21.26%,TGFA;TRAPPC10;PREB;NAPA;GOSR2;ANKRD28;SEC16A;SEC16B;SEC23A;GOLGA2;SAR1B;F5;TRAPPC2;SCFD1;CTSC;SEC31A;TRAPPC6B;TRAPPC6A;SEC22B
prerank,negative regulation of viral process (GO:0048525),-0.22557287476122084,-0.8417334068544416,0.7884615384615384,0.9147919579524162,1.0,18/57,21.48%,MID2;BST2;TRIM14;ZC3HAV1;TRIM35;TRIM28;PROX1;UBP1;PARP10;CHMP3;ISG15;IFIT1;ZFP36;RSAD2;TRIM8;TRIM13;TRIM11;SHFL
prerank,chloride transmembrane transport (GO:1902476),0.30398964634112596,0.8408560107678567,0.6711956521739131,0.9735758155172612,1.0,9/48,12.26%,SLC12A2;ANO6;SLC12A4;SLC12A3;CLCN1;GABRR2;GABRG2;GABRG1;GABRB3
prerank,myoblast fusion (GO:0007520),0.3764880593098582,0.8406493273210223,0.6581196581196581,0.9734080675286033,1.0,3/12,12.38%,CD9;CACNA1H;CD81
prerank,histone acetylation (GO:0016573),0.27591756107331056,0.8406276172940819,0.71484375,0.9728648840628276,1.0,19/69,19.22%,SPI1;BEND3;HAT1;KAT6B;TAF10;MSL3;TRRAP;PHF20L1;CREBBP;KAT8;BRD8;TADA2A;BRPF3;MORF4L2;TAF5;BRD1;RUVBL2;NAA40;NAA60
prerank,DNA duplex unwinding (GO:0032508),-0.22772989507924835,-0.8403682778340783,0.7769230769230769,0.9166620074685368,1.0,21/50,32.05%,WRN;RBX1;BLM;MCM6;ANXA1;SSBP1;ERCC2;XPA;GTF2H4;DDX1;PARP1;MCMDC2;TWNK;RAD51;UBB;GTF2H5;DDB1;ASCC3;MCM9;MCM7;MCM2
prerank,regulation of mitochondrion organization (GO:0010821),0.299936993936822,0.8401511566264305,0.6977715877437326,0.9731969957915506,1.0,15/47,21.24%,PPARGC1A;PISD;FIS1;GSK3B;SIRT7;HDAC6;STAT2;HTRA2;PRMT6;FBXW7;CSNK2A2;PINK1;PRKN;MUL1;GOLPH3
prerank,ureteric bud development (GO:0001657),0.35078976968123127,0.8400437853809133,0.6661367249602543,0.9728314504188579,1.0,1/17,0.41%,GPC3
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.3598690860130068,-0.8398410566745441,0.674364896073903,0.9168592042667907,1.0,3/10,7.68%,CSGALNACT1;CSGALNACT2;PXYLP1
prerank,pyruvate metabolic process (GO:0006090),0.2877238186260267,0.839521176830451,0.682704811443433,0.9732433697668859,1.0,12/52,17.84%,HK2;HOGA1;ALDOB;DLAT;PGM1;SLC16A1;ENO3;GCK;ME2;PGK1;LDHB;ENO2
prerank,Golgi to plasma membrane transport (GO:0006893),0.30035612899907366,0.8394279867763293,0.6938502673796791,0.9728178497475751,1.0,1/47,0.06%,STXBP6
prerank,membrane lipid catabolic process (GO:0046466),0.3993237262152381,0.8393701366375224,0.6459412780656304,0.9723471555864738,1.0,2/10,4.80%,NAGA;MGST2
prerank,negative regulation of hydrolase activity (GO:0051346),0.2973652804177667,0.838384950507897,0.6621803499327052,0.9736537487260847,1.0,4/49,7.45%,F11R;SH3RF2;RDX;MAPK7
prerank,steroid biosynthetic process (GO:0006694),0.28520058554538086,0.8382882929250083,0.685823754789272,0.9732540990342238,1.0,8/56,11.64%,HSD17B3;CYP7B1;OSBPL6;SC5D;HSD17B4;ACOT8;PRLR;MSMO1
prerank,anterograde trans-synaptic signaling (GO:0098916),0.24860713073807972,0.838244737668522,0.7959183673469388,0.9727575290432954,1.0,31/224,14.69%,HRH1;CHRNB3;CEL;MINK1;GRIA3;SLC12A4;NPTX2;SLC1A6;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GABRG2;HCRTR2;MYCBPAP;DOC2A;MPZ;RPS6KA3;GRIA1;SCN2B;GABRG1;GABRB3;SNCG;GRM1;KIF5A;CHRM2;PRKACB;HCRT;UNC13B;CHRM3
prerank,receptor catabolic process (GO:0032801),0.32987144149342706,0.8382122692537868,0.6646616541353384,0.9722407357813195,1.0,6/24,11.37%,KIF16B;PIK3R4;GPRASP1;ZNRF3;SNX25;NEDD4
prerank,nucleosome organization (GO:0034728),0.289297416043542,0.8368427931769942,0.6733601070950469,0.9742409879454696,1.0,17/55,21.53%,SOX9;KAT6B;CTCF;PAF1;LIN54;SMARCD2;INO80;MCM3AP;SETD2;NAP1L1;ACTR6;SPTY2D1;NAA60;ZNHIT1;DAXX;RSF1;ARID1A
prerank,negative regulation of transferase activity (GO:0051348),0.3233344882542965,0.8367887937673834,0.6671779141104295,0.9737610168460421,1.0,6/28,17.63%,SRC;FBXO5;GSK3B;MEN1;CDKN1C;IRS2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3733400464388955,0.8362465207653663,0.6426116838487973,0.9742257653294335,1.0,3/12,17.26%,UPP2;CAD;DCK
prerank,methylguanosine-cap decapping (GO:0110156),-0.35083239934152205,-0.8362255323391133,0.6598173515981736,0.9231782961043482,1.0,3/10,10.58%,EDC3;EDC4;PNRC2
prerank,tRNA transport (GO:0051031),0.3077596278196576,0.8361140393320141,0.6967930029154519,0.9738715520230037,1.0,10/35,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,neuronal action potential (GO:0019228),0.3382630810690884,0.8357510816167038,0.6719653179190751,0.9739721603223109,1.0,2/22,4.79%,SCN10A;CACNA1H
prerank,nuclear pore organization (GO:0006999),-0.32133388195567814,-0.835605375491056,0.683046683046683,0.9235314390631575,1.0,3/14,6.17%,NUP107;SEH1L;NUP133
prerank,zinc ion transport (GO:0006829),0.3401608620574804,0.8349957049656958,0.6515837104072398,0.9749068960142732,1.0,3/21,6.05%,SLC39A13;SLC30A9;SLC30A6
prerank,protein alkylation (GO:0008213),0.33036443136256904,0.8349811271804422,0.6651651651651652,0.974353438139453,1.0,9/22,25.77%,ETF1;LCMT1;METTL22;CAMKMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2538726876170178,0.8349149289455177,0.7692307692307693,0.9738969574872677,1.0,21/153,13.35%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;MASTL;CSNK1A1;SRPK2;TOP1;SGK1;PKD1;ERN1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.24148280904938996,-0.8346045996266606,0.7617647058823529,0.9247057239921452,1.0,5/38,8.40%,SASH1;BMP6;POLR3B;CYBA;SLC15A4
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.39557260733765015,0.8343988697999293,0.6414414414414414,0.9742771343213461,1.0,2/10,12.34%,NPTX2;DLGAP2
prerank,DNA repair (GO:0006281),0.2421047804166387,0.833824046319321,0.8205394190871369,0.9747871781380457,1.0,64/284,19.62%,FAAP24;TDG;MSH6;BRCC3;EYA1;POLI;SLC30A9;KMT5C;FANCC;PDS5B;RFC3;KPNA2;FANCF;NBN;UBE2V2;MSH2;UIMC1;ACTR8;USP47;TRRAP;APEX2;ERCC6;ERCC1;TDP1;MEN1;INO80;CETN2;MDC1;MGMT;RFWD3;ADPRS;GTF2H1;NUCKS1;ALKBH1;RAD51AP2;POLB;EME2;REXO4;RECQL5;FAM111A;PRMT6;POLE;DDB2;FANCL;INTS3;CHD1L;KDM4B;USP45;TNKS1BP1;RHNO1;CUL4B;SETD2;PSME4;TDP2;BRIP1;BACH1;GTF2H3;ERCC6L2;ASCC2;MRE11;ASCC1;MLH3;RPAIN;SUMO1
prerank,aminoglycan metabolic process (GO:0006022),0.3945845284179722,0.8336944151373299,0.6581818181818182,0.9744715589309093,1.0,1/10,2.21%,XYLT2
prerank,cGMP metabolic process (GO:0046068),-0.3344877010100754,-0.8335425823473196,0.6618705035971223,0.9259188698324586,1.0,2/12,9.40%,NPR1;PDE2A
prerank,stabilization of membrane potential (GO:0030322),-0.30513558706847566,-0.8333675977096228,0.6888888888888889,0.9253987751602716,1.0,1/16,0.21%,KCNK2
prerank,peptide metabolic process (GO:0006518),0.2741783318921806,0.8331727823464951,0.7164556962025317,0.9749082555911648,1.0,17/75,16.37%,PCSK5;MGAT3;CPE;LVRN;LNPEP;BACE2;GSTZ1;GSTA4;MME;GSTA3;GSTK1;LTA4H;MIPEP;ABCB9;GGT1;NLN;BACE1
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2553602290807367,-0.8327898080092936,0.7129909365558912,0.9256697367459568,1.0,10/33,17.52%,CYP1B1;SIRPA;ANXA1;OSER1;RHOB;RPS3;NET1;FXN;ANKZF1;TRPM2
prerank,response to cAMP (GO:0051591),0.30347493411116766,0.8324433265420391,0.6595441595441596,0.9757341369805432,1.0,2/37,1.89%,RAPGEF3;RAP1A
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.3220226560340041,0.8321774264979358,0.671664167916042,0.9756785381062199,1.0,10/27,25.12%,SPRED1;HIC1;DYRK1A;SPRED2;YJU2;ATR;KMT5A;TWIST1;PTTG1IP;MDM2
prerank,cellular protein-containing complex assembly (GO:0034622),0.24986856972189417,0.8321440390198913,0.7609427609427609,0.9751607116832613,1.0,30/159,15.46%,STXBP6;PXN;AXIN1;SRC;NCK2;CCDC39;SGIP1;PSMG2;CASQ2;IMMP2L;CALY;PFDN6;PSMG1;TPR;CHMP4A;CHMP4B;LONP1;VAMP8;PRLR;CCT2;AHCTF1;VAMP1;HOPX;NUP153;RTN4;CLTB;POMP;CCDC40;PSMD13;NUP93
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.28373418293197306,0.832029870545129,0.6846254927726675,0.9747973208486036,1.0,12/59,16.08%,BCL3;REL;TLR7;TRADD;AZI2;IRAK1BP1;TICAM1;SHARPIN;TAB2;TICAM2;TBK1;RELB
prerank,bile acid metabolic process (GO:0008206),0.3214529858116227,0.8318712229282044,0.6935724962630793,0.9745206948245251,1.0,4/27,10.29%,CYP7B1;OSBPL6;HSD17B4;ACOT8
prerank,regulation of dendritic spine development (GO:0060998),0.3512211614201294,0.8318473235559793,0.64576802507837,0.9739738602477638,1.0,3/19,7.65%,PPFIA2;LLPH;ARF6
prerank,UV-damage excision repair (GO:0070914),0.3762651562544709,0.8316388386467378,0.6522491349480969,0.9737926263783678,1.0,4/12,17.29%,ERCC1;INO80;DDB2;CUL4B
prerank,regulation of translation (GO:0006417),0.2487115954965209,0.831622856175704,0.7612267250821467,0.9732413110268259,1.0,47/173,22.10%,BCL3;FXR2;PIWIL2;GIGYF2;FOXO3;EIF2AK3;CNOT10;SAMD4B;PUS7;EIF5B;IGF2BP2;RPS6KA3;EIF4E;CNOT7;EIF1;METTL5;ATXN2;ILF3;PLD1;EIF2B4;UPF3B;ETF1;CSDE1;NSUN5;DDX6;SOX4;ALKBH1;MIF4GD;FXR1;PYM1;MTG2;CPEB3;ERBB2;LTN1;SYNCRIP;CNOT8;CNOT1;DHX9;HNRNPD;LARP4;EIF4G2;IL6;MALSU1;TSFM;ELAVL1;IMPACT;DDX25
prerank,nucleus organization (GO:0006997),-0.22900625222600976,-0.8315740461760291,0.7843137254901961,0.9271861539806977,1.0,9/47,11.18%,PITPNB;SYNE1;SEH1L;NUP133;RPS19;CTDNEP1;LEMD3;VPS4A;USP36
prerank,termination of RNA polymerase II transcription (GO:0006369),0.3102560463334765,0.831501286148216,0.6871345029239766,0.9729056932340897,1.0,4/33,7.27%,CSTF1;SNRPF;MED18;CSTF3
prerank,double-strand break repair (GO:0006302),0.2521250106774411,0.8313140622187739,0.7709049255441008,0.9727081975207829,1.0,37/158,19.62%,SMC5;BRCC3;EYA1;PAXX;SMARCAD1;KPNA2;NBN;UBE2V2;PALB2;SWI5;UIMC1;ACTR8;HMGB1;ZSWIM7;ERCC1;TDP1;ZFYVE26;INO80;MDC1;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;POLB;EME2;REV3L;RECQL5;KDM4B;TNKS1BP1;TDP2;BRIP1;SFR1;PSMD14;MRE11;XRCC6;SUMO1
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.2905480786435297,0.8312716017027184,0.7005494505494505,0.9722106728599264,1.0,4/46,4.96%,HK2;TOMM34;MFN2;FIS1
prerank,detection of light stimulus involved in sensory perception (GO:0050962),0.39302565315909843,0.8310177382695185,0.6718213058419243,0.9715283817547268,1.0,2/10,18.84%,CNGB1;CEP250
prerank,detection of light stimulus involved in visual perception (GO:0050908),0.39302565315909843,0.8310177382695185,0.6718213058419243,0.9715283817547268,1.0,2/10,18.84%,CNGB1;CEP250
prerank,positive regulation of telomerase activity (GO:0051973),0.304270292580962,0.8307615969270252,0.6554621848739496,0.9714385393912299,1.0,4/33,12.07%,NEK7;NAF1;WRAP53;CCT2
prerank,positive regulation of biomineral tissue development (GO:0070169),0.2991599352733228,0.8305430110230946,0.6772853185595568,0.9712973085499947,1.0,3/40,4.10%,PKDCC;ANO6;BMPR1B
prerank,positive regulation of protein maturation (GO:1903319),0.38592906746077354,0.8304743879792331,0.6520979020979021,0.9708557601750702,1.0,4/11,16.90%,TFR2;NLRC4;SOX4;BAG2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.3124354521256883,0.8304344874293729,0.656891495601173,0.9703671697506797,1.0,12/31,22.22%,PPP1R13B;SFN;GSK3B;BAD;NMT1;YWHAG;YWHAE;E2F1;BAX;MAPK8;TFDP1;YWHAB
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.26099589791904776,-0.8303753650542973,0.7601156069364162,0.9287123369445701,1.0,16/30,34.40%,ARHGEF2;NOS3;FAS;CFLAR;TNFSF10;CASP8;ICAM1;RIPK1;BRCA1;RNF34;DDX3X;TRAF2;RFFL;HMOX1;FAIM2;SERPINE1
prerank,determination of bilateral symmetry (GO:0009855),-0.26964097373100515,-0.8303739108685693,0.7359050445103857,0.9278521182409718,1.0,6/24,14.89%,NPHP3;TBX1;GALNT11;CITED2;ZIC3;MKKS
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3664666392188426,0.8298292040561916,0.6486013986013986,0.9709486793919242,1.0,2/14,8.64%,AK5;NMNAT3
prerank,cellular protein metabolic process (GO:0044267),0.23748673593392186,0.8294118041725679,0.8596311475409836,0.9711737585440933,1.0,44/396,11.24%,FAM20C;IGFBP6;GPC3;STC2;RPSA;SLC35A1;UBE2L6;LAMC1;LAMB2;PCSK5;DUSP12;STK38;MMP15;APH1B;ERO1A;SCG3;MRPL37;MRPL43;UBE2I;CDKL3;NUCB1;CPE;FN1;BMP15;PABPC4;NCSTN;ADAM10;ABL2;GOLM1;RCN1;CDH2;IGFALS;DARS1;TNIP1;CSNK1G3;RPL35;MRPL41;RPS13;MRPS15;MRPS33;MANBA;PROC;MRPL3;PRKCSH
prerank,mitotic G2/M transition checkpoint (GO:0044818),0.297761808014074,0.8292625065606943,0.6857142857142857,0.9708895591816155,1.0,12/43,19.02%,BRCC3;BRSK1;NBN;CHFR;RINT1;UIMC1;DONSON;CDC6;FZR1;INTS3;ORC1;MRE11
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3249425884276083,0.8292514015408341,0.6599690880989181,0.9703397499667125,1.0,6/26,10.99%,HEYL;KANK2;NCOR1;PIAS2;ISL1;NCOR2
prerank,tRNA aminoacylation (GO:0043039),0.3091227902453927,0.8286934526536515,0.689795918367347,0.9708140351079414,1.0,13/37,22.22%,RARS2;VARS1;DARS1;KARS1;AIMP1;WARS1;WARS2;DARS2;TARS1;SARS2;HARS2;GATB;MARS2
prerank,cellular response to light stimulus (GO:0071482),-0.2124964582694055,-0.8286814456257038,0.7788944723618091,0.9301839897296112,1.0,16/66,19.92%,USP28;PTPRK;EP300;RPL26;NPM1;CDC25A;EIF2AK4;KDM1A;NOC2L;POLK;ZBTB1;NSMCE3;DHX36;ATF4;PARP1;ERCC4
prerank,neutrophil migration (GO:1990266),0.28418644989675995,0.8283721119275361,0.7010443864229765,0.9708231833542876,1.0,1/58,0.29%,CXADR
prerank,phosphatidylserine metabolic process (GO:0006658),0.31549951885516936,0.8283209757838228,0.6918604651162791,0.9703553456765238,1.0,4/32,8.99%,MBOAT2;SLC27A1;ABHD12;PLSCR1
prerank,chemical synaptic transmission (GO:0007268),0.2408092841912306,0.8281067526204986,0.81139896373057,0.9701808997056237,1.0,37/284,13.52%,HRH1;CHRNB3;CEL;PDLIM4;MINK1;STX1A;RIC3;GRIA3;SLC12A4;NPTX2;BRSK1;SLC1A6;RAB3A;CPLX1;GABBR2;PAFAH1B1;PRKAR2A;GABRR2;GRID1;GABRG2;HCRTR2;MYCBPAP;DOC2A;MPZ;RPS6KA3;GRIA1;SCN2B;GABRG1;GABRB3;DLGAP2;SNCG;GRM1;KIF5A;PTEN;CHRM2;PRKACB;HCRT
prerank,negative regulation of cell death (GO:0060548),0.2691005536181754,0.8281046748071713,0.7117224880382775,0.9696149628609632,1.0,14/88,10.71%,PPARGC1A;SPEF1;WNT16;NPAS2;NUP62;KANK2;AMIGO2;ATG5;CD200R1;GSK3B;POU4F1;FERMT2;CHMP4A;CHMP4B
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.36712650555889986,0.8278875143567939,0.6538461538461539,0.9694384059539426,1.0,3/12,10.99%,NCOR1;LIN28B;NCOR2
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.23733105520109063,0.8276746904767059,0.8331606217616581,0.969262055788031,1.0,82/341,20.55%,NEDD4L;UBE2L6;RNF130;WDR81;UBE3C;RNF122;PCBP2;UBE2I;SPSB4;PSME3;KEAP1;TOM1L1;TSG101;TNFAIP3;CHFR;SIAH1;ZNRF3;CUL3;UBL7;CDC20;AMFR;PSMB5;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;SHARPIN;RCHY1;TRPC4AP;ANAPC11;OTUD7B;FBXL19;NEDD4;SPOPL;BUB3;FBXL17;TTC3;FAF1;FBXO11;NFE2L2;RNF185;FBXO21;FBXO8;ANAPC2;PSMB2;UBA1;UBE2D3;UBE2D1;PSMA2;KLHL22;KLHL15;FEM1C;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;PSMA7;PLAA;UBE2R2;FBXW7;UBQLN1;ITCH;RNF7;PSME4;WDR91;ANAPC16;PINK1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;USP9X;KBTBD7;GID4;UBE2W;DDIT3;PRKN;RNF146;RNF14
prerank,positive regulation of focal adhesion assembly (GO:0051894),-0.285226121777244,-0.8276674866744326,0.726775956284153,0.9312858848140664,1.0,11/19,37.82%,TEK;KDR;NRP1;LIMS1;TSC1;SFRP1;PPM1F;MYOC;HRG;THY1;MAP4K4
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.26029875442567335,0.8275284250899985,0.7331701346389229,0.9689832175371582,1.0,7/104,5.17%,CAV1;DLX1;SPRED1;SPRY1;BMPR1B;NBL1;PPM1A
prerank,response to ionizing radiation (GO:0010212),-0.21837369326137276,-0.8275177938052953,0.8215962441314554,0.9307077718383202,1.0,30/70,27.50%,USP28;PAXIP1;BLM;ANXA1;NHEJ1;EEF1D;RHOB;BABAM2;NET1;TOPBP1;RAD1;CLK2;RNF8;EYA3;ABRAXAS1;RAD9B;KDM4D;TRIM13;XRCC4;FANCD2;GRB2;RAD51;NABP1;LIG4;BRCA1;DCUN1D3;PRKAA1;ATM;SMPD1;BRAT1
prerank,activation of adenylate cyclase activity (GO:0007190),-0.24534088575343202,-0.8273839256244621,0.7578616352201258,0.9301129830846029,1.0,7/35,14.82%,LGR4;ADCY1;ADCY7;ADCY4;ADCY2;EDNRA;LGR5
prerank,regulation of interleukin-10 production (GO:0032653),0.29778231103081015,0.8273565595277826,0.6967213114754098,0.9687140358136139,1.0,1/44,0.38%,TRIB2
prerank,regulation of actin filament-based movement (GO:1903115),-0.344687220336355,-0.8271419794058882,0.691764705882353,0.929699712063456,1.0,7/10,31.44%,ANK2;SRI;PLN;PDE4B;SCN5A;PDPN;STC1
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.30352747752619996,-0.8268616100837678,0.7263157894736842,0.9293809768083806,1.0,6/17,16.52%,BMP4;RFX3;VEZF1;BTG1;NKX6-1;AHI1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.3537872632984922,0.8266517334423639,0.6525285481239804,0.9694544571774255,1.0,4/15,13.35%,TSEN54;RTRAF;TSEN34;ERN1
prerank,protein tetramerization (GO:0051262),0.2775974081776255,0.826211348476363,0.7233502538071066,0.9697115923493452,1.0,4/67,7.02%,ALDH1A3;ALDH9A1;ACOT13;ACACA
prerank,protein localization to nucleus (GO:0034504),0.2565818017724677,0.8256478912807862,0.733015494636472,0.9702127844154912,1.0,18/102,16.76%,PRICKLE1;BCL3;IPO8;NOL8;MORC3;NUP62;PAF1;FAM53B;TPR;MMP12;NUP50;COL1A1;CSE1L;NUP153;RAN;NUP93;SYK;YWHAE
prerank,proteoglycan metabolic process (GO:0006029),0.3190505324410104,0.8255997865835334,0.6841294298921418,0.9697474848049232,1.0,5/26,11.13%,ADAMTS12;SULF1;BMPR1B;CANT1;CHST12
prerank,prostanoid metabolic process (GO:0006692),0.36501263564120595,0.8255008622973026,0.6571428571428571,0.9693719290729098,1.0,6/13,25.99%,CYP2S1;PLAA;HPGD;PTGR1;PTGR2;GSTM1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.270988609772088,0.8254866769078759,0.7007672634271099,0.968840936555771,1.0,8/73,9.49%,LBP;IL1A;WNT5A;PTPRC;EPHB2;ISL1;PTPRJ;HMGB1
prerank,protein autoubiquitination (GO:0051865),0.2791952778080322,0.8250532650754825,0.7258278145695364,0.9690971336474453,1.0,14/61,17.27%,SH3RF2;RNF122;LRSAM1;TRIM21;CUL3;AMFR;RNF220;UBE3D;OBI1;RNF185;UBE2D3;WWP2;DDB2;ITCH
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.32271738653064397,0.8249715293528539,0.6831530139103554,0.9686810941256122,1.0,1/24,0.78%,ACKR3
prerank,stem cell development (GO:0048864),0.3538547182744909,0.8249682603681883,0.6683168316831684,0.9681241315010571,1.0,2/16,7.86%,PTPRC;CDH2
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2648407447484059,0.8249311333286194,0.7388613861386139,0.9676174712152562,1.0,14/83,17.83%,PLK2;CDK15;CDK7;FBXO5;CUL3;EIF4E;CDC6;CRLF3;POLE;E2F1;USP37;CUL4B;BACH1;ORC1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.28738761487165515,0.8248555761138678,0.6871657754010695,0.9671970179613053,1.0,16/51,21.68%,LPAR1;PXN;RAPGEF3;ARHGEF5;PLEK;FERMT2;FHOD1;NF2;ARHGEF10L;ARHGEF10;RGCC;RHOA;PFN2;PPM1E;S100A10;CX3CL1
prerank,cellular response to catecholamine stimulus (GO:0071870),-0.26829481106856035,-0.8247547175979428,0.7246376811594203,0.932637473418606,1.0,12/23,36.29%,TGM2;SLC9A1;LRRK2;ATF4;PDE4B;ADCY6;NR4A3;APLP1;KCNQ1;RYR2;GNG2;SNCA
prerank,positive regulation of muscle cell differentiation (GO:0051149),-0.27738036809764627,-0.8245192516069464,0.7401129943502824,0.9322011784292132,1.0,4/24,7.87%,CDC42;MEF2A;MAPK12;CDON
prerank,sphingolipid catabolic process (GO:0030149),-0.30821055167334416,-0.8243117508221636,0.7119047619047619,0.9317407499885763,1.0,4/15,13.41%,ACER2;ENPP2;PDXDC1;SPHK1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.32361302318005747,0.8242436668853792,0.6896551724137931,0.9677482829245648,1.0,4/26,6.01%,USP50;APH1B;PSME3;NCSTN
prerank,response to UV-A (GO:0070141),0.35810389392166103,0.8239263090007657,0.6677908937605397,0.9677656407645103,1.0,2/14,10.88%,EGFR;MME
prerank,peroxisomal membrane transport (GO:0015919),0.3207474948528951,0.8239168005096378,0.6545166402535658,0.9672168127573892,1.0,5/27,12.75%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2852462671734616,0.8237447957855496,0.6980874316939891,0.9669956098577025,1.0,7/48,12.28%,OTOP1;ARG1;IRAK3;PTPRC;NLRP2B;CNOT7;STAT2
prerank,positive regulation of secretion by cell (GO:1903532),-0.21815381119885377,-0.823591445549478,0.8097826086956522,0.932241395786785,1.0,15/70,15.98%,IGF1;BMP6;KCNB1;CADPS;TGFB3;MYH10;SYTL4;BMP2;TGFB2;MYO18A;ABCG1;EDN1;DTNBP1;EDN3;P2RX4
prerank,chromosome organization (GO:0051276),0.2604472366928309,0.823577457097451,0.740395809080326,0.9667333375701453,1.0,23/99,20.27%,MSH6;CDAN1;SATB1;MSH2;SUV39H1;GATAD1;SUPT4H1;HDAC2;AXIN2;CETN2;RFWD3;NUCKS1;COPS5;DDB2;CENPH;BRWD1;GEM;CUL4B;MTF2;HMGN2;TCF7L1;HDAC3;HMG20A
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.19076680080406755,-0.8234608143370054,0.9333333333333333,0.9315888707237124,1.0,55/148,27.75%,PRKAG2;CHD4;WRN;EP300;RPL37;RPS15;TOP3A;RPS20;JMY;BLM;ATRIP;HDAC1;AKT1;BRD7;SMYD2;PRKAB2;PIP4K2A;RPL23;RICTOR;CSNK2A1;NOC2L;TOPBP1;RAD1;CDK5R1;BARD1;CSNK2B;BANP;TP53RK;NUAK1;RAD17;RFC2;CDK5RAP3;RAD9B;TAF6;EHMT2;MAP2K6;RPL5;PIP4P1;RMI2;PRDM1;CDK2;BRCA1;PAK1IP1;RNF34;MLST8;L3MBTL1;PRKAA1;RFC4;RPF2;RMI1;ATM;ING5;TPX2;RPL11;TAF11
prerank,chloride transport (GO:0006821),0.2777761712496081,0.8234497235676677,0.7292191435768262,0.9663990909041072,1.0,13/74,12.51%,SLC12A2;SLC26A9;ANO6;SLC12A4;SLC12A3;CLCN2;CLCN1;GABRR2;GABRG2;BEST1;GABRG1;GABRB3;ANO10
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.3187602982297604,0.823215571332047,0.6602373887240356,0.9662846555949451,1.0,2/26,7.46%,CEACAM1;RARA
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.26616186136319286,-0.8228107906133627,0.7243589743589743,0.9320141317960976,1.0,7/26,18.58%,PDE8A;AKT1;GPR37;LRRK2;HSPB1;GPR37L1;ATF4
prerank,Golgi localization (GO:0051645),-0.34265837871556887,-0.8224775490135565,0.6911764705882353,0.9317791734679988,1.0,3/11,6.04%,CDC42;UVRAG;PDCD10
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.3057468300636699,0.8223349407037868,0.6894586894586895,0.9673509770535821,1.0,1/37,0.26%,EFNA5
prerank,positive regulation of protein deacetylation (GO:0090312),0.35558461709675476,0.8221848540315438,0.662828947368421,0.9670787982224633,1.0,3/14,15.59%,DYRK1A;FNTA;SAP30BP
prerank,liver development (GO:0001889),0.30103493301257145,0.8219472156213342,0.6825633383010432,0.966978807667356,1.0,5/32,7.30%,COBL;NF1;LSR;GFER;CCDC39
prerank,androgen receptor signaling pathway (GO:0030521),0.3773564801642384,0.8216587839589024,0.6683168316831684,0.9669553370346883,1.0,5/11,21.53%,DDX17;TMF1;RNF14;DAXX;ARID1A
prerank,regulation of vacuole organization (GO:0044088),0.33221204383625996,0.8212682033326761,0.6692913385826772,0.9671290223921519,1.0,10/20,27.30%,MTMR3;ENO3;LAPTM4B;SCARB2;ENO2;RAB5A;ENO1;NPRL2;TBC1D14;IFT20
prerank,mitochondrial gene expression (GO:0140053),0.29459132532321475,0.8209573129740084,0.7042640990371389,0.9671428384930504,1.0,13/42,21.18%,FOXO3;FASTKD2;MRPS28;RARS2;PTCD3;TFB2M;MRPS15;TEFM;MRPL16;NDUFA7;MRPL2;GATB;MRPS7
prerank,cellular response to fatty acid (GO:0071398),-0.32508163317435756,-0.8208418778115907,0.7115384615384616,0.9339658891281469,1.0,4/12,21.16%,PID1;ZC3H12A;NR1H4;DGAT2
prerank,regulation of microtubule-based process (GO:0032886),0.30704004796295,0.8206766048592251,0.7186147186147186,0.9671020038648196,1.0,5/36,11.27%,EFNA5;GSK3B;PHLDB1;APC;HDAC6
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.34154275055325645,-0.8206541881407897,0.6643990929705216,0.9334609079496187,1.0,1/10,0.68%,TGFA
prerank,positive regulation of vascular permeability (GO:0043117),0.3704000353036328,0.8202819031275375,0.6779964221824687,0.967294767162746,1.0,3/12,8.23%,TRPV4;TJP2;OCLN
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),-0.2375332856851128,-0.820035252612913,0.7643097643097643,0.9337951472551187,1.0,18/40,27.92%,COMMD1;RPS7;SGTA;RPL23;CSNK2A1;PTK2;UBQLN4;RAD23A;HFE;LAPTM5;FOXF2;CDK5RAP3;CLU;RPL5;UBE3A;RPL11;CCDC22;SMURF1
prerank,cellular response to ketone (GO:1901655),0.29763372014941686,0.8192482763562617,0.7043090638930164,0.9686441246367519,1.0,8/35,15.58%,PTGFR;SRC;ADCY5;PTGER4;ACOD1;AQP1;ADCY8;ADCY3
prerank,positive regulation of protein binding (GO:0032092),0.2800711766401691,0.8185981340961872,0.7263427109974424,0.9692532026161105,1.0,21/56,24.27%,CAV1;ADD1;DACT1;TRIM21;AMFR;STK3;GSK3B;MEN1;PKD1;CAPRIN2;RAN;PPP2CA;PIN1;PRKN;AKTIP;TCF7L2;DERL1;NMD3;DTX3L;RIPK2;HIPK2
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.37286103363134065,0.8184863225562067,0.6774193548387096,0.9688993050071824,1.0,3/14,16.83%,ANO6;GPER1;RGCC
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.30387712160509084,0.8184031501110205,0.6786206896551724,0.9684816274549252,1.0,4/34,6.39%,PTPN22;WNT5A;PTPRC;EPHB2
prerank,regulation of cell size (GO:0008361),0.33527850208638493,0.8182972491776518,0.6786271450858035,0.9681188762311816,1.0,12/23,23.75%,VAV2;RDX;PLEK;RARG;PTEN;EZR;RAP1GAP2;RHOA;LAMTOR5;RPTOR;RAC1;MTOR
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.326290418874412,0.817161725754674,0.6483679525222552,0.9696228232710488,1.0,3/24,3.58%,CAMK2D;PDE4D;FKBP1B
prerank,lysosome organization (GO:0007040),0.30281478676125384,0.8169619036572772,0.7107558139534884,0.9694321394256035,1.0,6/36,11.69%,HOOK2;HPS1;ABCA1;ATP10B;TFEB;HOOK3
prerank,positive regulation of cytokine production (GO:0001819),0.2348499850155959,0.8169204431497583,0.8418259023354565,0.9689618377621303,1.0,44/292,17.74%,RORA;LBP;IL18R1;SULF1;GLMN;ITK;CXCL17;PDE4D;TXK;IL1A;EIF2AK3;PTPN22;WNT5A;PTPRC;IL17RA;TLR7;CRTAM;RARA;POLR3G;PTGER4;ISL1;HMGB1;TICAM1;HILPDA;ADRA2A;IL6ST;EGR1;CD276;POLR3D;CREBBP;IL7;CLEC9A;TNFRSF14;IL15;PIBF1;TBK1;BATF;SYK;CRCP;RGCC;MDK;SCRIB;SPTBN1;LPL
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.27229858355695785,0.8165909361830522,0.7287705956907478,0.9690272246393776,1.0,15/62,18.15%,MLLT3;LEO1;CDK13;CDK7;PAF1;ELL;NELFB;SUPT4H1;GTF2F2;GTF2H1;ELOA;RTF1;TCEA1;SETD2;GTF2H3
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),-0.32347566836746894,-0.8165634370703808,0.7286432160804021,0.9393303330848121,1.0,5/12,25.09%,NAE1;CLSPN;TOPBP1;RAD17;STK33
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.2677610135662297,0.8165496773201408,0.7376654632972323,0.9685464054608479,1.0,21/80,18.40%,KIF2A;LMAN2;RACGAP1;PLPP3;TAPBP;KIF3C;RINT1;ATP9B;ATP9A;COPE;KIF26A;KIF5A;COPG1;HTT;ZW10;COPA;TMED2;ERGIC1;ARCN1;KLC2;COG3
prerank,regulation of lamellipodium organization (GO:1902743),0.3601478486824166,0.8163896022533209,0.6655683690280065,0.9682627603436088,1.0,2/14,5.71%,CAPZB;FER
prerank,amide transport (GO:0042886),0.3200282110263244,0.8162122421775315,0.7053140096618358,0.968040648146353,1.0,6/26,14.92%,FOLR1;FOLR2;SLC27A1;CERT1;ABCB9;SLC46A1
prerank,regulation of fibroblast migration (GO:0010762),0.32900330535294914,0.8159959776329017,0.6942675159235668,0.9678681579332853,1.0,1/20,1.22%,PRKCE
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.3533694111158816,0.8155893902284193,0.6578947368421053,0.9680675221548961,1.0,5/15,24.20%,SOX9;SMO;PAX2;LHX1;SIX1
prerank,apical protein localization (GO:0045176),0.38019392538756946,0.8150292062705472,0.6683673469387755,0.9685325125494696,1.0,2/10,6.15%,ATP8B1;SHROOM2
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.25954777705045884,-0.8144595228924869,0.7417417417417418,0.9423966379807274,1.0,14/28,32.99%,CLIP1;RPS3;MAPT;CDK5R1;ARL2;FES;MET;GIT1;HSPA1A;CDK5RAP2;DCTN1;HSPA1B;NAV3;TOGARAM1
prerank,serine family amino acid biosynthetic process (GO:0009070),-0.31490376169653106,-0.8138154828433304,0.6945812807881774,0.942761962157442,1.0,7/12,29.20%,SERINC3;PSPH;SEPHS1;CBS;SEPHS2;CTH;PHGDH
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.3167473030064207,0.8137672037996635,0.6907993966817496,0.9703442319992476,1.0,1/27,0.73%,LPAR1
prerank,keratinocyte differentiation (GO:0030216),0.31001384097576223,0.8137394959848836,0.6882352941176471,0.9698485199916256,1.0,3/29,4.96%,JAG1;WNT16;WNT5A
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2614103990819142,0.8135652656828412,0.7660098522167488,0.9696053954228535,1.0,22/87,19.29%,SDHAF4;LYRM7;NDUFA6;NDUFB10;COA5;NDUFS3;NDUFS6;IMMP2L;SDHAF2;COX19;NDUFA3;NDUFV2;COX16;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2;SURF1;COA8
prerank,maturation of SSU-rRNA (GO:0030490),-0.24686646540934887,-0.8134300562812103,0.7635782747603834,0.9426071669872376,1.0,18/34,30.26%,RPS19;RPS16;RPS8;RIOK1;HEATR1;TSR1;DHX37;MRPS11;RIOK3;UTP4;PWP2;WDR3;RPS14;NOB1;NAT10;RRP36;WDR46;UTP6
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.321247529148642,0.8133932242920683,0.6979655712050078,0.9693716390787923,1.0,9/22,21.63%,PSMB5;NFE2L2;PSMB2;PSMA2;PSMA6;PSMA7;PSME4;PSMB6;PSMB3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.276585936899058,-0.8129998711228928,0.7219101123595506,0.9425112317402223,1.0,5/20,12.84%,SLC8A3;SMDT1;SLC25A23;MICU1;MICU2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.2961221384112065,0.8128198498853091,0.7048951048951049,0.9698628896919756,1.0,6/37,15.32%,CAV1;FIS1;SIAH1;S100A9;SFPQ;BAD
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.3087132550631994,-0.81265188149659,0.7301980198019802,0.9422409238372598,1.0,4/15,16.13%,TGFB3;CUEDC2;TGFB2;HFE
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.3364573933593929,0.8121226925035968,0.696969696969697,0.9705672472578922,1.0,4/19,15.41%,F11R;OCLN;CBFB;NPHP4
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.286122167720624,-0.8121212538890676,0.7573333333333333,0.9423157812690497,1.0,2/19,1.31%,AFDN;BMP6
prerank,acetylcholine receptor signaling pathway (GO:0095500),-0.28895046070248737,-0.8121194500626228,0.7313829787234043,0.9414629832749395,1.0,2/20,6.91%,PLCB1;AGRN
prerank,response to glucocorticoid (GO:0051384),-0.25621078225579513,-0.8120480766670376,0.7755681818181818,0.9407458708965911,1.0,3/26,7.39%,SLIT2;BCL2L11;ANXA1
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3745600747110087,0.8117797280864799,0.696027633851468,0.970664336826131,1.0,2/11,6.82%,LEO1;PAF1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3694985582155115,0.8117578149544347,0.673202614379085,0.9701439893828153,1.0,5/13,22.62%,PRPF3;USP4;SRSF12;SRSF10;LSM2
prerank,carbohydrate derivative catabolic process (GO:1901136),0.3396140580247943,0.811683356030069,0.6873977086743044,0.9697282179399318,1.0,5/18,15.81%,NAGA;BPGM;MANBA;DERA;OGA
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.36559632681081994,0.8115662304235937,0.6621848739495798,0.9693736752288948,1.0,5/12,22.15%,RBM15B;LRIF1;PCGF3;CDYL;YTHDC1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.2851140811800986,0.8113596669802069,0.7039106145251397,0.9691862542655105,1.0,6/45,13.87%,USP50;WNT5A;NLRC4;ISL1;EGR1;GSDMD
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.31247954930877736,-0.8109137451101125,0.6873508353221957,0.9419032176035895,1.0,2/13,2.60%,DDO;MTHFS
prerank,neuron projection fasciculation (GO:0106030),-0.3465501599765493,-0.8107899827404809,0.7354368932038835,0.9412626408572043,1.0,7/10,31.99%,EPHA4;ARHGAP35;CDK5R1;EPHB3;AMIGO1;SEMA5A;NRCAM
prerank,regulation of monocyte chemotaxis (GO:0090025),0.32255726091499515,0.8105527246203137,0.6897590361445783,0.9700924875670929,1.0,4/24,9.49%,CXCL17;ANO6;NBL1;HMGB1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.3627043849224827,0.8105501967633105,0.6570915619389587,0.9695468048804582,1.0,4/12,20.28%,GPLD1;ADCY8;STX4;TRPM4
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.33712988141118444,0.8105453061544149,0.705511811023622,0.9690075897175322,1.0,9/21,22.93%,AATF;HDAC6;ABCD1;ABCB7;PINK1;COA8;PRKN;PAX2;SIRT2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.31205355777028143,0.8099982621655619,0.7167381974248928,0.969458532299391,1.0,11/29,21.07%,TRAPPC3L;GOSR1;COG6;COPE;COPG1;COPA;RAB33B;TRAPPC3;COG3;NSF;COG5
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.34844961343412384,0.8099205665785374,0.6756756756756757,0.9690485138598942,1.0,7/17,25.21%,ALG9;DHDDS;DPAGT1;DOLK;DOLPP1;ALG12;ALG14
prerank,proteasome assembly (GO:0043248),0.36909927346256444,0.8093479984210746,0.691470054446461,0.9695270578011816,1.0,4/11,15.40%,PSMG2;PSMG1;POMP;PSMD13
prerank,organophosphate biosynthetic process (GO:0090407),0.29533842582714465,0.8092104044864785,0.7072463768115942,0.9692288779741189,1.0,10/37,20.23%,AGPAT4;PPIP5K2;TPK1;AGPAT5;GK;PPIP5K1;MOCS2;FADS1;ITPKA;TKT
prerank,defense response to Gram-negative bacterium (GO:0050829),0.29103953707247976,0.8090879274075651,0.7129120879120879,0.9688986903044203,1.0,6/42,15.16%,LBP;DEFA6;IRGM;AQP1;GSDMD;TNFRSF14
prerank,negative regulation by host of viral process (GO:0044793),-0.34236335703787146,-0.8090528883998499,0.7250554323725056,0.9435233559241435,1.0,2/10,10.27%,ZC3H12A;EIF2AK4
prerank,Golgi to lysosome transport (GO:0090160),-0.3291239590732247,-0.8087274622730364,0.7396313364055299,0.9432364994580696,1.0,3/11,16.29%,RBSN;SORT1;LAPTM5
prerank,response to unfolded protein (GO:0006986),0.28388764880319894,0.808726145280457,0.747638326585695,0.9690097878538464,1.0,14/48,21.89%,HSPH1;DNAJC4;SERPINH1;BAG3;ERN1;HSPA4;ERP44;DNAJB4;BAX;DDIT3;PRKN;DAXX;HSPA9;DERL1
prerank,synaptonemal complex assembly (GO:0007130),0.35481421304562,0.8082352367402321,0.7128712871287128,0.9687869572553659,1.0,3/15,17.96%,TEX11;REC8;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.35481421304562,0.8082352367402321,0.7128712871287128,0.9687869572553659,1.0,3/15,17.96%,TEX11;REC8;SYCP2
prerank,establishment of protein localization to membrane (GO:0090150),-0.20518207628376944,-0.807951971926431,0.8564593301435407,0.9437819332593456,1.0,16/66,18.51%,PARD3;AFDN;RFTN1;GORASP2;SYNE3;AQP11;RABGEF1;BID;RAB11A;TAOK2;MICALL1;ZDHHC2;VPS37C;ZDHHC14;RAB11B;COX18
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.3139353376018694,-0.8077132575837892,0.7264367816091954,0.9433874099138772,1.0,3/13,9.36%,ENPP1;BPNT2;TPST1
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.27067161720299016,0.8075793575029223,0.7513089005235603,0.9693333352057191,1.0,7/62,7.45%,ACKR3;SRC;CREB3L1;SELENOS;NDUFS3;MCL1;MAPK7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.2715652225938362,0.8068380345380193,0.7444589308996089,0.9701233793143484,1.0,15/58,19.62%,SMC5;BRCC3;PAXX;NBN;UBE2V2;UIMC1;HMGB1;ERCC6;ERCC1;MDC1;POLB;PSMD14;MRE11;XRCC6;SUMO1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.25317352975809326,-0.8064387801648951,0.7507163323782235,0.9447904856802876,1.0,8/28,17.39%,FOXP1;APPL2;SAMHD1;LRP8;IRF1;GATA6;ERAP1;CASP8
prerank,striated muscle cell development (GO:0055002),0.35225656145301754,0.8062423043273247,0.6900175131348512,0.9706387962419739,1.0,4/14,13.58%,TMOD2;SDC1;TMOD1;FLII
prerank,cell part morphogenesis (GO:0032990),0.3593125007631647,0.8061661094995497,0.6974789915966386,0.9702129919153275,1.0,2/13,6.56%,FIS1;PACSIN2
prerank,nuclear envelope organization (GO:0006998),0.3302142798655602,0.8057022621587074,0.6959247648902821,0.9704876040434611,1.0,7/20,20.84%,NEMP1;SUN1;REEP3;EMD;NUP93;LEMD2;REEP4
prerank,neural crest cell development (GO:0014032),-0.22969858577965785,-0.8054513626864099,0.8,0.9458108348933926,1.0,21/44,32.90%,SEMA6D;SEMA7A;SEMA3C;SEMA6A;TBX1;RADIL;TCOF1;ANXA6;SEMA3G;SOX10;HTR2B;TAPT1;SEMA4G;SEMA3F;SEMA3D;SEMA5A;SNAI2;NRTN;SEMA4F;NRG1;SEMA5B
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.3040280243884126,-0.8053361531853498,0.7422434367541766,0.945163667367388,1.0,6/15,27.69%,RPS7;RPL23;MAD2L2;RPL5;MAD2L1;RPL11
prerank,synaptic vesicle cycle (GO:0099504),0.3053254692940135,0.8052541621107233,0.7095808383233533,0.970716537318897,1.0,4/30,7.29%,STX1A;BRSK1;RAB3A;CPLX1
prerank,axoneme assembly (GO:0035082),0.3021605475666018,0.8052408089276347,0.7125925925925926,0.9701964995844825,1.0,4/30,9.41%,SPEF1;SPAG17;CCDC39;FOXJ1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3115127722906965,-0.8051925477665439,0.7209876543209877,0.9445704305585151,1.0,7/13,23.59%,ACSL1;C2CD5;CLIP3;P2RX7;CA2;NR4A3;C3
prerank,glycolytic process (GO:0006096),0.3100412315962127,0.8051041921579267,0.7035398230088495,0.9698925754096042,1.0,9/28,22.51%,HK2;ALDOB;PGM1;ENO3;GCK;PGK1;ENO2;ENO1;PKM
prerank,positive regulation of actin filament depolymerization (GO:0030836),-0.3338873793964367,-0.8048521892585648,0.7207207207207207,0.944344253624444,1.0,1/10,1.02%,ACTN2
prerank,polyamine metabolic process (GO:0006595),0.352211163898665,0.8041774425753414,0.6809917355371901,0.9709936251249528,1.0,4/13,14.34%,SAT2;HDAC6;SMOX;SMS
prerank,defense response to bacterium (GO:0042742),-0.1936494700607932,-0.8039877143132947,0.8881987577639752,0.9450483463658845,1.0,23/105,22.04%,ANXA3;IL6R;GBP4;RPS19;NOD1;PPP1R11;RPL30;STAB1;PGLYRP1;GBP6;GBP7;CFP;CEBPB;GBP2;ISG15;MR1;RARRES2;ADGRB1;COLEC12;ROMO1;TLR3;OPTN;RPL39
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),-0.24386365980728392,-0.8038538863741358,0.7879858657243817,0.9444365688392865,1.0,9/32,15.94%,ARHGEF2;STMN2;EML2;CAMSAP1;CLIP3;STMN1;APC2;MID1IP1;TUBB4A
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),0.3740520110469076,0.8037765399555613,0.6690265486725664,0.9711612277573027,1.0,1/10,4.96%,WNT5A
prerank,organic acid transport (GO:0015849),0.2590145666530285,0.803484849797876,0.7611044417767107,0.9711539835950772,1.0,13/94,11.57%,LRRC8D;CEACAM1;FOLR1;FOLR2;ATP8B1;SLC38A2;SLC27A1;SLC6A13;SLC7A14;SLC7A2;SLC27A4;SLC16A1;SLC3A1
prerank,cellular amide metabolic process (GO:0043603),0.2577622835292897,0.803313448144773,0.7664319248826291,0.9709311751671471,1.0,22/102,16.70%,FOLR2;PCCB;PLPP2;PLPP3;CPE;PLAAT5;MTHFD1;ACOT13;CLN8;CERK;NIT1;ST6GAL1;ACSF2;ACOT8;MME;ACOT2;MIPEP;ABCB9;SLC46A1;PANK2;NLN;ALDH1L2
prerank,macroautophagy (GO:0016236),0.24833875144748352,0.8031893675552189,0.784452296819788,0.9706056198312877,1.0,38/118,22.28%,DYNLL1;PRKAG1;SRC;MFN2;PIP4K2B;PIK3R4;TSG101;ATG5;MTMR3;DYNLL2;CHMP4A;CHMP4B;VAMP8;CHMP4C;ARL8B;TOMM40;LIX1;ATG7;PIK3C3;PLAA;EI24;UBQLN1;MTERF3;CSNK2A2;PINK1;TBC1D5;SNAP29;MAP1LC3B;ATG3;LAMP2;RB1CC1;PRKN;VPS16;CHMP2A;ATG14;TCIRG1;VIPAS39;VPS36
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.3310132852874128,0.8031843519422696,0.7049742710120068,0.9700719253119489,1.0,3/18,10.99%,EGFR;NCOR1;NCOR2
prerank,fatty acid metabolic process (GO:0006631),-0.18939912176290896,-0.8030649934236135,0.9299363057324841,0.9449684397854823,1.0,28/115,20.97%,ACSL1;ACSL3;ADIPOR2;PPARD;ACADSB;LPIN2;ACOT7;GPX4;ACSL6;CPT2;ECHDC3;LPIN3;ACBD5;MLYCD;ACLY;ABCD2;CPT1A;ACOT6;HACL1;ACOT11;PER2;PNPLA3;ACOX1;OXSM;PLA2G15;XBP1;SLC27A2;ADIPOR1
prerank,regulation of phosphatase activity (GO:0010921),0.31772039765114907,0.8030164998780654,0.7009063444108762,0.9698332989702562,1.0,8/24,24.04%,SH3RF2;PTPA;HTT;CHP1;PPP6R3;PPP6R1;PPP6R2;URI1
prerank,positive regulation of mRNA catabolic process (GO:0061014),-0.22818275129315935,-0.8027236508184753,0.8239700374531835,0.9447194818102863,1.0,12/44,18.15%,ROCK2;ZC3HAV1;PABPC1;ZC3H12A;YTHDF1;MOV10;ZFP36;TNRC6C;DHX36;RC3H1;METTL16;YTHDF2
prerank,pre-replicative complex assembly (GO:0036388),0.264309715626756,0.8026931410645772,0.7691309987029832,0.9698792783988036,1.0,18/64,18.75%,PSME3;ORC5;PSMB5;ORC3;CDC6;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;GMNN;PSME4;ORC1;ORC6;PSMC4;PSMB6;PSMD12;PSMD14
prerank,inositol phosphate metabolic process (GO:0043647),0.28534568502102275,0.8026104680657112,0.7297297297297297,0.9694748176165986,1.0,3/46,1.51%,PLCD3;PLCE1;PLCB3
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2226243089872765,-0.8022245631623715,0.853448275862069,0.94477375897939,1.0,12/56,13.57%,LACC1;IRAK4;ALPK1;CTSL;TRAF6;PLCG2;NOD1;BCL10;LGMN;S100A1;MAPKAPK2;MAPKAPK3
prerank,cellular response to pH (GO:0071467),0.337657198267733,0.8021877843449924,0.692967409948542,0.9697116909100977,1.0,4/17,17.14%,GPLD1;RAB11FIP5;KCNK4;CHP1
prerank,photoperiodism (GO:0009648),0.30529543777488116,0.8021424041379365,0.7399702823179792,0.9692522594155606,1.0,7/28,17.05%,CRTC1;BHLHE40;FBXL17;PER3;FBXL12;FBXL3;PPP1CA
prerank,protein stabilization (GO:0050821),0.24140082550462735,0.802001379245381,0.825414364640884,0.9689645053870202,1.0,46/168,21.01%,PPARGC1A;PARVA;GTSE1;WDR81;FLOT2;PLPP3;GNAQ;MORC3;CDK7;BAG3;IRGM;STK3;ATP1B3;LAMP1;RASSF2;ZSWIM7;HYPK;USP13;DVL3;CCT2;PTEN;SOX4;RTN4;PER3;TESC;FBXW7;PRKRA;BAG2;RAB21;CHP1;WFS1;PINK1;COG3;RABL3;USP9X;AAK1;COA8;LAMP2;SUMO1;SEL1L;PFN2;PIN1;PRKN;MUL1;CCT3;PDCL3
prerank,endoplasmic reticulum organization (GO:0007029),0.26419532404236973,0.8019839167379696,0.7567917205692108,0.9684651969817596,1.0,26/72,25.93%,STX1A;CAV2;LMAN2;EIF2AK3;ATL2;TRAM1;REEP3;LNPK;EMD;OTOF;UBE2J2;RTN4;SEC61G;STX5;RAB18;REEP4;VAMP2;PRNP;VAPA;VCPIP1;VAPB;DNM1L;SERP1;LMAN1;REEP5;SEC61A1
prerank,photoreceptor cell development (GO:0042461),-0.3031789355193992,-0.8018888464415642,0.7295918367346939,0.9445022268087616,1.0,7/14,32.16%,DCX;RP1;MFSD2A;AHI1;TULP1;MYO7A;CDHR1
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.36252609633655364,0.8017313826686104,0.6991596638655462,0.9683612020398608,1.0,3/14,6.74%,ATIC;PFAS;PPAT
prerank,RNA methylation (GO:0001510),0.2751454889782333,0.8014330682811248,0.7496671105193076,0.9683320498438001,1.0,18/60,23.24%,MRM2;BUD23;RBM15B;TARBP1;TFB2M;METTL5;THADA;FTSJ1;TRMT5;NSUN5;CMTR1;THUMPD3;METTL2B;METTL2A;ZC3H13;TRMO;TFB1M;MEPCE
prerank,cell differentiation in spinal cord (GO:0021515),0.3710540541651656,0.8014330208201068,0.6919104991394148,0.9677931894933027,1.0,3/10,13.45%,ZC4H2;ISL1;SOX4
prerank,positive regulation of protein import (GO:1904591),0.3010891346310507,0.8013628595985949,0.7291361639824304,0.9673713311371199,1.0,8/30,15.39%,ARHGEF5;UBR5;BAG3;RBM22;PIK3R2;TPR;RAN;CDH1
prerank,negative regulation of ATPase activity (GO:0032780),-0.2922365919698089,-0.8013115520956189,0.7754569190600522,0.9446553357331804,1.0,6/16,27.54%,PAM16;PXK;IFIT1;PLN;OXA1L;TSC1
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3068292896048887,0.801036642965085,0.7346326836581709,0.9674043377490403,1.0,7/27,17.05%,CRTC1;BHLHE40;FBXL17;PER3;FBXL12;FBXL3;PPP1CA
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.2179600460834277,-0.8006116891397226,0.8461538461538461,0.9449863393744798,1.0,18/55,19.53%,NUPR1;TGFBR1;BCL2L11;GSDME;FAS;BECN1;TNFSF12;BCL10;RPS3;BID;BOK;TNFSF10;WWOX;TPD52L1;STYXL1;AGT;RACK1;BBC3
prerank,regulation of protein kinase A signaling (GO:0010738),-0.27370940165443436,-0.8004338042592243,0.7674418604651163,0.9444669355993268,1.0,7/20,19.84%,ADGRV1;AKAP6;LRRK2;PRKAR2B;PJA2;TCIM;MIF
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2695093979254537,0.8003659318139779,0.75,0.9680650790012287,1.0,8/68,7.37%,CSTF1;CAVIN1;SNRPF;MED18;CDK7;POLR1E;CSTF3;SMN1
prerank,cellular response to cytokine stimulus (GO:0071345),0.22815679632839322,0.8002001379981161,0.9003083247687564,0.9678407539458754,1.0,44/416,12.28%,RORA;TEC;LBP;IL19;IL18R1;RIPOR2;PTPN13;ADAMTS12;LEPR;SLC12A2;SOCS5;STX1A;ITGAX;IL1A;PTPN14;FOXO3;SOX9;IRAK3;WNT5A;FN1;FER;TRADD;SOCS6;LAMA5;ABL2;MCL1;SDC1;PTPRJ;ACOD1;IRGM;GSK3B;PTPRT;GAB2;POU4F1;AXL;TYK2;TPR;MME;IL6ST;EGR1;PRLR;PTPN18;NFE2L2;STAT2
prerank,protein deubiquitination (GO:0016579),0.23287371441606353,0.8001591495352027,0.8633938100320171,0.9673687646639234,1.0,55/242,18.83%,USP50;TNIP3;OGT;BRCC3;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;USP48;CCP110;FOXK2;TNIP1;CDC20;UIMC1;PSMB5;ACTR8;MINDY2;USP47;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP15;USP4;PSMB2;POLB;UBE2D1;PSMA2;PSMA6;USP35;COPS5;PSMD13;PSMA7;DDB2;INO80B;STAMBPL1;STAMBP;USP45;USP37;PSME4;NFRKB;PSMC4;FOXO4;PSMB6;PSMD12;RHOA;PSMD14;USP9X;KDM1B
prerank,peptidyl-threonine modification (GO:0018210),0.26658785426331716,0.7997996226808394,0.7628865979381443,0.9674672871585043,1.0,23/66,25.71%,CAMK2D;GALNTL6;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;GALNT4;LMTK2;DYRK2;CSNK2A2;PDPK1;CDC42BPG;ACVR1;MAPK8;MAPK1;PRKCD;HIPK2;ROCK1;TNKS;TAF1
prerank,detection of visible light (GO:0009584),0.3473182940673514,0.7992562118453941,0.7075630252100841,0.9678539181718229,1.0,2/16,5.04%,GNAQ;CNGB1
prerank,peptidyl-glutamic acid modification (GO:0018200),0.3189196182917935,0.7992193636503236,0.7154088050314465,0.967384265947626,1.0,5/24,16.93%,TTLL1;AGBL4;CFAP20;NAA10;TTLL9
prerank,negative regulation of signaling receptor activity (GO:2000272),0.3113530225672335,0.799124602135833,0.7425431711145997,0.9670154306189096,1.0,5/25,11.67%,SOCS5;TSG101;EPHB2;CBLB;SOCS4
prerank,carbohydrate derivative transport (GO:1901264),0.3323633887849598,0.7988620004949983,0.7179080824088748,0.966970060937326,1.0,1/18,0.73%,LBP
prerank,histone mRNA catabolic process (GO:0071044),-0.3016140378616755,-0.7984373327726837,0.741424802110818,0.9470402433988206,1.0,4/15,15.02%,SSB;TENT2;TUT7;MTPAP
prerank,embryonic heart tube morphogenesis (GO:0003143),-0.22426603755153413,-0.7982258706151228,0.8432835820895522,0.9465751516482926,1.0,10/43,16.59%,ENG;TBX3;NPHP3;SOX17;ZIC3;MEGF8;VANGL2;MKKS;AHI1;SOX18
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.20186375834556775,-0.798081628459752,0.8771186440677966,0.9459915274443734,1.0,26/72,26.23%,IFNAR2;MADD;LIFR;JAK2;CFLAR;USP18;RNF31;CLIP3;ABCE1;SPHK1;IKBKB;CASP8;CD24;IRAK2;RACK1;CDC37;VRK2;IKBKG;SOCS3;SIGIRR;RIPK1;SPPL2B;BIRC3;SPATA2;PYCARD;ZBP1
prerank,regulation of tumor necrosis factor production (GO:0032680),0.24928357240507468,0.797741806511509,0.7944711538461539,0.9683797721435956,1.0,13/112,9.49%,LBP;IL1A;PTPN22;IRAK3;WNT5A;PTPRC;TNFAIP3;EPHB2;SELENOS;RARA;ISL1;PTPRJ;HMGB1
prerank,cellular response to leucine (GO:0071233),-0.33581001849387265,-0.7976893571588489,0.7213114754098361,0.9449905881656488,1.0,1/10,0.83%,UBR1
prerank,response to leucine (GO:0043201),-0.33581001849387265,-0.7976893571588489,0.7213114754098361,0.9449905881656488,1.0,1/10,0.83%,UBR1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.307695654165619,-0.79768407066492,0.7343358395989975,0.9441658351225939,1.0,9/13,51.86%,CYRIB;MR1;IL12A;IL12RB1;IL23A;IL23R;IL12B;PVR;XCL1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.30813464862003287,0.797526786171447,0.7318181818181818,0.9681962135918948,1.0,3/29,9.55%,SPI1;CRTAM;LAMP1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.30610862883935364,0.7974069916205263,0.7428571428571429,0.967871300799796,1.0,4/27,11.08%,MAP3K1;IRAK3;TNIP1;TAB2
prerank,visual system development (GO:0150063),0.2930321219965702,0.7973872924410992,0.7275449101796407,0.9673793560398412,1.0,6/37,8.69%,PBX1;BMPR1B;HIPK1;SH3PXD2B;FREM2;ABCB5
prerank,regulation of autophagosome maturation (GO:1901096),-0.3039954608306438,-0.7972290069576986,0.7620192307692307,0.9440961401228212,1.0,3/13,14.56%,UVRAG;RUBCN;UBQLN4
prerank,positive regulation of neuron death (GO:1901216),0.27880458514179696,0.7969799314405035,0.7441860465116279,0.9675959942863575,1.0,9/46,11.42%,NF1;FOXO3;WNT5A;EFNB2;MAP3K5;GSK3B;SARM1;SRPK2;EGR1
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3264217763264533,-0.7968971107503322,0.7615571776155717,0.9437749260528568,1.0,6/11,24.51%,WIPI1;STX17;ATG13;WIPI2;WDR45B;WDR45
prerank,positive regulation of axon extension (GO:0045773),0.3182939720084005,0.7966738737757464,0.7058823529411765,0.9676037741328188,1.0,2/22,4.59%,NTN1;DSCAM
prerank,acyl-CoA metabolic process (GO:0006637),0.2968730680629369,0.7962428818500681,0.7162921348314607,0.9677905591149836,1.0,10/35,17.59%,ACOT13;ACACA;OGDH;ACSF2;DLST;ACOT8;ACOT2;ACACB;SUCLG2;SUCLA2
prerank,cilium-dependent cell motility (GO:0060285),-0.2678612815973126,-0.7959597055186769,0.776536312849162,0.9445707042077325,1.0,10/22,36.67%,RFX3;EFHC2;DNAH3;CFAP44;DRC1;CFAP54;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,folic acid-containing compound metabolic process (GO:0006760),0.321579688976579,0.7959461273566781,0.7165354330708661,0.9677615094016263,1.0,5/19,17.89%,FOLR2;MTHFD1;SLC46A1;ALDH1L2;SLC19A1
prerank,cellular senescence (GO:0090398),0.30714740024777726,0.7954668247633659,0.7130044843049327,0.9680343092303983,1.0,3/27,7.23%,SMC5;SPI1;TBX2
prerank,tRNA metabolic process (GO:0006399),0.3312729986456173,0.795244321804274,0.7014446227929374,0.9678884223671269,1.0,8/17,23.14%,KARS1;POP7;ADAT1;DARS2;DTD1;RPP21;THG1L;RPP30
prerank,renal water homeostasis (GO:0003091),0.32101171201709044,0.7952240791543175,0.7235023041474654,0.9673906187312689,1.0,9/23,18.74%,ADCY5;PRKAR2A;ADCY9;AQP1;PRKACB;ADCY8;ADCY3;WFS1;RAB11FIP2
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.2399004153425336,-0.7951394005244473,0.8278145695364238,0.9451607289561148,1.0,14/32,30.58%,PICALM;PGAM1;EIF2A;TCOF1;NR1H4;RBM4B;TIGAR;GEMIN5;TSC1;MTPN;NANOS3;RBM3;GRM5;TMED10
prerank,positive regulation of mitochondrial translation (GO:0070131),0.3538255413043323,0.7943891959849381,0.685025817555938,0.9683282430696838,1.0,4/14,18.26%,RMND1;FASTKD2;MPV17L2;RPUSD4
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.30358009502474664,-0.7941581196042395,0.7136038186157518,0.9459877411133409,1.0,4/13,12.40%,BMP4;ZC3H8;CAMK4;TOX
prerank,negative regulation of microtubule depolymerization (GO:0007026),-0.26993364007543247,-0.7938054442816042,0.7463556851311953,0.9457535571621886,1.0,10/21,31.38%,ARHGEF2;STMN2;CAMSAP1;APC2;MID1IP1;KATNB1;CIB1;TPX2;CAMSAP3;NAV3
prerank,ncRNA catabolic process (GO:0034661),0.30420032494965904,0.793657728217786,0.7359635811836115,0.9691116815696749,1.0,4/28,9.57%,EXOSC5;DIS3L2;LIN28B;EXOSC10
prerank,apoptotic process (GO:0006915),0.23382141906375803,0.7935646928986174,0.85,0.9687490589497185,1.0,16/203,7.41%,EFNA5;DLC1;PRKCE;FAP;HK2;CYFIP2;OGT;MAGI3;IL1A;CIDEB;EGLN3;TRADD;FASTKD2;MAGEH1;PAX3;SIAH1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.2843723581049785,-0.7934556331093299,0.751937984496124,0.9454999022297242,1.0,8/17,27.31%,PODXL;RET;TGFB2;SKAP1;NCKAP1L;CIB1;RAC3;P2RY12
prerank,regulation of programmed necrotic cell death (GO:0062098),0.3261835049432753,0.7933663157727129,0.7003257328990228,0.9685490937042228,1.0,3/20,9.03%,OGT;FLOT2;PDCD6IP
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.3434152560757908,0.7932649091398335,0.7162629757785467,0.9681830589091494,1.0,4/14,13.09%,KEAP1;FAF1;NFKBIB;PKD1
prerank,mucosal immune response (GO:0002385),0.3414661056165754,0.7930842631690149,0.7178631051752922,0.9679609832879092,1.0,3/15,18.92%,DEFA6;OTUD7B;RNASE3
prerank,RNA stabilization (GO:0043489),0.2972035326157839,0.7927015804556643,0.7209302325581395,0.9680893636058407,1.0,8/33,16.95%,DND1;NAF1;TENT5C;AXIN2;TENT5D;TAF15;ZCCHC17;E2F1
prerank,hyaluronan catabolic process (GO:0030214),0.33160213847228803,0.7925565422812987,0.7214170692431562,0.9678125866113535,1.0,7/18,24.71%,HEXA;CEMIP2;HEXB;CHP1;CEMIP;GUSB;FGF2
prerank,cellular response to starvation (GO:0009267),0.2410710336094838,0.7921049837437145,0.8129251700680272,0.9680652228370209,1.0,18/147,9.21%,INHBB;MYBBP1A;PRKAG1;FOXO3;EIF2AK3;ATP6V0D2;KLF10;WDR24;PDK4;PIK3R4;MIOS;BRSK1;ATG5;RIPOR1;MAP3K5;SESN1;MTMR3;STK24
prerank,polyol metabolic process (GO:0019751),0.2810685117911445,0.7919079429230453,0.7469553450608931,0.9678632075129301,1.0,3/46,1.51%,PLCD3;PLCE1;PLCB3
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2473392809511638,-0.7915328640843053,0.7732919254658385,0.9479107428516,1.0,13/30,25.40%,SHLD2;POLQ;UBQLN4;HSF1;TRIP12;CYREN;CGAS;MAD2L2;NUDT16L1;RMI2;TFIP11;SMCHD1;PARPBP
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.29501856486119327,0.7915301306947836,0.7299270072992701,0.967979558360121,1.0,5/31,19.01%,HSD17B3;PRLR;LSS;STAR;MOCS2
prerank,meiosis I (GO:0007127),-0.26004452441362774,-0.7911400969866507,0.7931034482758621,0.947723122300778,1.0,3/23,8.93%,BCL2L11;FOXJ3;MYBL1
prerank,regulation of innate immune response (GO:0045088),0.2662520183640302,0.7911268439899648,0.7563249001331558,0.968125527761299,1.0,9/57,9.33%,PTPN22;IRAK3;TNFAIP3;TRIM21;N4BP1;POLR3G;ACOD1;PLSCR1;TRAFD1
prerank,inositol phosphate biosynthetic process (GO:0032958),0.36208070167801903,0.790573281138089,0.7066895368782161,0.9685317268517255,1.0,6/11,29.25%,PPIP5K2;PPIP5K1;ITPKA;FGF2;IP6K2;ITPKB
prerank,positive regulation of cell population proliferation (GO:0008284),0.22433578462469767,0.7905590543831391,0.9091836734693878,0.9680271302985959,1.0,48/423,10.49%,FGF7;NTRK3;CDH13;GLI1;FGFR1;LAMC1;PTGFR;FOLR2;EGFR;FGF1;ACER3;KIF20B;ITGAX;PTHLH;SAPCD2;SOX9;S100A6;HDAC4;BMP5;WNT5A;PTPRC;FN1;RPRD1B;FER;CDK13;CEP131;ADAM10;KRAS;EFNB2;HOXC10;TBX2;RARA;FBXO5;CUL3;DPP4;S100B;GCNT2;FGF18;TSHR;DDRGK1;TET1;MECP2;GAB2;HDAC2;CNOT7;HILPDA;ADRA2A;TBC1D8
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.19930696690480687,-0.7905067252709017,0.8941798941798942,0.9478491648095618,1.0,24/80,21.76%,DENND5A;TRAPPC10;RAB6B;TMED9;RHOBTB3;GOSR2;RBSN;SURF4;UBE2O;RGP1;VPS26B;BET1L;PREPL;CLN5;STX6;HEATR5A;STX16;YKT6;PLEKHJ1;TBC1D17;RAB7B;RAB7A;RNF126;VTI1B
prerank,cellular response to amino acid starvation (GO:0034198),-0.20049917782454924,-0.7902911834640551,0.8990825688073395,0.947385525094599,1.0,22/71,23.21%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;ATP6V0C;RNF152;RRAGC;EIF2AK4;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,adipose tissue development (GO:0060612),-0.32251225523523885,-0.7890644337700918,0.754880694143167,0.948561843294994,1.0,5/11,25.47%,ARID5B;LRP5;XBP1;DGAT2;NAMPT
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3051653494905835,0.788587983104585,0.7182890855457227,0.9708378872534499,1.0,1/29,1.14%,MBOAT2
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.3270644685572102,0.7884562963134947,0.6913767019667171,0.9705541663228939,1.0,4/20,9.04%,CAMK2D;FKBP1B;ATP1A2;CASQ2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.32634991822218157,-0.7882635275627757,0.7197309417040358,0.9491170143452112,1.0,2/10,6.34%,FGFR2;TBX1
prerank,presynapse organization (GO:0099172),0.37154053515850843,0.7881002215585129,0.6896551724137931,0.9706466775018343,1.0,3/10,22.13%,WNT5A;NLGN3;NLGN2
prerank,neutrophil activation (GO:0042119),0.3481203071517631,0.7876247502463389,0.7198641765704584,0.9709379373631536,1.0,4/12,24.12%,IL15;SYK;PREX1;PRKCD
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),-0.3173268416662246,-0.7874700185514864,0.7380952380952381,0.9488038273891942,1.0,5/11,21.13%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),-0.3173268416662246,-0.7874700185514864,0.7380952380952381,0.9488038273891942,1.0,5/11,21.13%,FKBP1A;CALM1;CALM3;SRI;GSTO1
prerank,protein mannosylation (GO:0035268),-0.2637132234780065,-0.7874055784215462,0.779891304347826,0.9480977484955616,1.0,3/22,4.35%,TMTC2;TMTC1;DPM1
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2450124851175822,-0.7870623271214295,0.7658959537572254,0.9478846670285639,1.0,7/29,16.09%,SMAD3;ADAR;AGO3;PUS10;AGO4;TUT7;ZC3H7A
prerank,regulation of actin filament depolymerization (GO:0030834),-0.3129391192163438,-0.7869921760452122,0.7430555555555556,0.947180622443961,1.0,1/12,1.04%,PLEKHH2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.2628303750424775,0.7867490729086175,0.7713178294573644,0.9718756831339156,1.0,5/65,7.40%,CAV1;SPRED1;SPRY1;PPM1A;LDLRAD4
prerank,regulation of multicellular organismal development (GO:2000026),-0.2564629089062494,-0.7867192479564681,0.793010752688172,0.9467965504684039,1.0,8/25,19.75%,INSR;SOX17;SPAAR;TRIP12;DHX36;KAT2A;CD24;PTN
prerank,positive regulation of response to stimulus (GO:0048584),-0.22956513386508426,-0.7862198684911803,0.839041095890411,0.9467670001952885,1.0,11/40,19.73%,B2M;SELENON;YPEL3;ECHDC3;CD80;TGFB2;CDKN2AIP;ILK;EEF1E1;RSAD2;CGAS
prerank,positive regulation of protein targeting to membrane (GO:0090314),-0.26182819585277706,-0.7861974439502823,0.787292817679558,0.9459832728321665,1.0,10/24,26.51%,KCNB1;C2CD5;ANK3;MTCL1;MIEF2;TCAF2;HRAS;ITGB2;CIB1;ITGAM
prerank,mesenchymal to epithelial transition (GO:0060231),-0.3302423532308558,-0.7860997016652775,0.7297297297297297,0.9453284663479338,1.0,2/10,16.44%,BMP4;SALL1
prerank,protein depolymerization (GO:0051261),0.3033845295562181,0.7846831148630249,0.7342549923195084,0.9748063986917612,1.0,4/27,8.51%,KIF2A;NCKAP5L;CKAP5;MICAL3
prerank,mRNA modification (GO:0016556),0.3177343653729995,0.7846231858859699,0.7184615384615385,0.9743794146607568,1.0,3/22,6.98%,RPUSD2;PUS7;PUS3
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.32433223358951685,-0.7844254245739152,0.76905311778291,0.9470864880227416,1.0,4/10,26.38%,GALNT3;MGAT5B;GALNT2;GALNT13
prerank,protein homooligomerization (GO:0051260),0.24716744574110014,0.7837784288720848,0.8364269141531323,0.9752760159604384,1.0,10/114,9.03%,ALDH1A3;ALDH9A1;BEND3;ACOT13;SPAST;NLRC4;ACACA;CLYBL;ATL2;PDCD6IP
prerank,synaptic vesicle exocytosis (GO:0016079),0.27493166696700727,0.78314272497676,0.7680555555555556,0.9758545521018849,1.0,13/40,22.00%,STX1A;RIMS2;RAB3A;CPLX1;STX2;STX19;OTOF;UNC13B;STX4;SNAP23;SNAP29;VAMP2;SNPH
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.3022110346300483,0.783088773083018,0.7390070921985815,0.9754129184894135,1.0,2/30,1.84%,NEDD4L;KCNA5
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.21788530006099532,-0.7827947924944889,0.8772563176895307,0.9489305930706814,1.0,6/44,12.71%,PRKAG2;INSIG2;OSBPL1A;OSBPL9;SCP2;PMVK
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.30748877345178416,-0.7826872475862425,0.7587006960556845,0.9482651475000379,1.0,5/12,21.75%,SGTA;SEC61B;SEC62;SGTB;GET3
prerank,response to growth factor (GO:0070848),-0.22582801918987622,-0.7822669642263275,0.8637992831541219,0.9480711834270792,1.0,9/41,13.99%,TGFBR1;ACVRL1;BMPR2;KLF4;RPS6KB1;AKT1;GATA6;SPHK1;PLK5
prerank,response to amino acid starvation (GO:1990928),-0.1985601784771856,-0.7818313607383052,0.8867924528301887,0.947948873794658,1.0,22/72,23.21%,FAS;LAMTOR3;SEH1L;DEPDC5;SH3GLB1;ATP6V0C;RNF152;RRAGC;EIF2AK4;ATP6V1C1;ATF2;RRAGD;CEBPB;ATP6V1D;ATF4;CASTOR2;ATP6V1F;CASTOR1;LAMTOR2;ATP6V1E1;PRKD1;SLC38A9
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.29832753023858044,0.7817972811100036,0.7390029325513197,0.9770219626746209,1.0,7/32,15.38%,BRCC3;BRSK1;NBN;RINT1;UIMC1;DONSON;FZR1
prerank,regulation of regulated secretory pathway (GO:1903305),-0.23485671508855718,-0.7815420896439769,0.8295819935691319,0.9476159335021966,1.0,19/34,37.19%,SYT9;SYT7;SYN1;LRRK2;PREPL;DTNBP1;SYT13;SYT6;RIMS1;RAB27A;RIMS3;RAB15;SYT15;SYT1;SYT5;SYT17;UNC13D;SYT4;SYT3
prerank,DNA recombination (GO:0006310),-0.22700167988410241,-0.7808235724577287,0.8344594594594594,0.9479350544016888,1.0,4/37,5.83%,RAD51B;TSN;WRN;BLM
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.24901669316561298,0.7807532537306017,0.8314176245210728,0.978245503275365,1.0,22/87,18.75%,WEE1;PSME3;DACT1;KANK2;FBXO5;PSMB5;USP47;APC;PTEN;FHL1;ZFP36L2;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RGCC;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,eye photoreceptor cell development (GO:0042462),0.3408638985316863,0.7807204791511512,0.7382113821138211,0.9777727706044042,1.0,3/15,12.78%,RORB;CEP290;RPGRIP1L
prerank,negative regulation of protein catabolic process (GO:0042177),-0.22948662144583762,-0.780677353458384,0.8239700374531835,0.9473405778559666,1.0,14/40,26.51%,TIMP3;PTPN3;FLNA;RGP1;CTSA;BANP;TIMP4;CDK5RAP3;ADGRB1;MAD2L2;NELL1;MAD2L1;AGAP2;CST3
prerank,negative regulation of microtubule polymerization (GO:0031115),-0.303526649438788,-0.7806736872051068,0.7586206896551724,0.9465348834479935,1.0,5/12,15.94%,STMN2;EML2;CLIP3;STMN1;TUBB4A
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.2937003255030022,0.7805893120421551,0.7586705202312138,0.9774571409976736,1.0,6/32,17.83%,CDK15;FBXO5;CDC6;E2F1;BACH1;ORC1
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.3031393409116593,0.780345434797423,0.7413010590015129,0.9773435834487465,1.0,3/23,5.26%,SPI1;PPM1A;UACA
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3404829323087698,0.7800469447824285,0.7075630252100841,0.9773266425330756,1.0,6/14,24.10%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,positive regulation of mRNA processing (GO:0050685),0.31100300399043257,0.7799728859724758,0.7366003062787136,0.9769138020059034,1.0,7/21,20.10%,LEO1;PAF1;CELF4;RBMXL1;TRA2B;PRDX6;CDC73
prerank,response to endoplasmic reticulum stress (GO:0034976),0.24586482472282845,0.7795338270370713,0.8103651354534747,0.9771360560129357,1.0,27/107,21.89%,THBS4;ERO1A;EIF2AK3;CREB3L1;SELENOS;MAP3K5;PIK3R2;DDRGK1;GSK3B;ERN1;RNF185;P4HB;MBTPS1;UBQLN1;QRICH1;WFS1;ERP44;TMEM259;TMTC3;BAX;SEL1L;CREB3L2;DDIT3;PRKN;NCK1;JUN;DERL1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.3580550344429323,0.7791729047436671,0.71875,0.9772313102124316,1.0,1/10,2.99%,PDE4D
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.24737115747867278,0.7788628850851442,0.819047619047619,0.9772139597440371,1.0,14/101,10.37%,FGFR1;EGFR;CCND3;FGF1;SRC;SLC27A1;ATP2B4;WNT5A;SYAP1;FGF18;IRGM;DIPK2A;FERMT2;ADRA2A
prerank,lytic vacuole organization (GO:0080171),0.29179943206644515,0.7787536096201777,0.7455357142857143,0.9768826033416494,1.0,5/32,11.69%,HOOK2;HPS1;ABCA1;TFEB;HOOK3
prerank,protein modification by small protein removal (GO:0070646),0.22735459159195623,0.7787336565452329,0.9046087888531619,0.9763865772563086,1.0,58/252,19.65%,USP50;TNIP3;OGT;BRCC3;SENP6;TFPT;FOXK1;PSME3;TAF10;KEAP1;TNFAIP3;USP8;OTUB2;USP48;CCP110;FOXK2;TNIP1;CDC20;UIMC1;PSMB5;ACTR8;USP47;TRRAP;USP13;OTUD7B;APC;INO80;PTEN;USP15;USP4;PSMB2;POLB;UBE2D1;PSMA2;PSMA6;USP35;COPS5;PSMD13;PSMA7;DDB2;INO80B;STAMBPL1;STAMBP;USP45;USP37;PSME4;NFRKB;PSMC4;FOXO4;PSMB6;PSMD12;RHOA;PSMD14;USP9X;KDM1B;SENP3;SENP2;ADRB2
prerank,synaptic vesicle transport (GO:0048489),0.3621282910488666,0.7787319220572219,0.7115716753022453,0.9758627530328361,1.0,4/11,19.71%,KIF5A;KIF5B;TMEM230;SPG11
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.35486320732610516,0.7786849550125675,0.7318339100346021,0.9754178725446023,1.0,2/11,9.65%,SCARA3;TICAM1
prerank,Golgi ribbon formation (GO:0090161),-0.300331450096426,-0.7783882857482967,0.7932816537467701,0.9493716026649597,1.0,5/13,21.37%,GOLGA2;MYO18A;STX6;STX16;OPTN
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.33335634761170196,0.7783836918100231,0.7371900826446282,0.975400029132956,1.0,4/17,11.99%,AKAP13;GPR101;ADRA2A;ADCY9
prerank,dendrite morphogenesis (GO:0048813),0.2885928260975619,0.7783696384963509,0.727810650887574,0.9748952611634106,1.0,4/35,6.39%,LRP4;MINK1;DIP2A;EPHB2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.2992590854376682,-0.7783421042577245,0.7461024498886414,0.9486335810605422,1.0,7/14,28.88%,PAXIP1;SNW1;DNMT3B;SMAD4;BRCA1;KMT2E;WDR5
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.27347040877446416,-0.7777768811432376,0.7837837837837838,0.9487115670100648,1.0,11/18,43.40%,GPR137B;TLR3;FSTL3;TCTA;LILRB3;LILRB1;CARTPT;TMEM178A;LRRC17;TLR4;IL4
prerank,protein localization to organelle (GO:0033365),0.23538920849875086,0.7777640156694262,0.8481439820022497,0.9753992350100035,1.0,45/133,25.32%,ZNF423;STX1A;SCG3;CSRP3;PACSIN2;PAF1;SNX10;RIPOR1;ARF6;OBSCN;DDRGK1;TRAM1;LAMP1;GCC2;COL1A1;TTC21B;EMD;OTOF;TMEM30A;UBE2J2;SEC61G;YWHAE;RAB33B;STX5;EHD1;COG3;BBS1;CEP250;DHX9;LAMP2;TIA1;TULP2;VAMP2;IFT140;ZBTB7A;PRNP;ARL3;VAPA;SIX1;BMP7;SERP1;MDM2;CD68;CSNK1D;CNTLN
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.3043873388505686,-0.7776575490890539,0.7572115384615384,0.9480617340341014,1.0,5/13,21.26%,NUPR1;LRRK2;FEZ2;SCFD1;SEC22B
prerank,negative regulation of protein modification process (GO:0031400),0.2562449091858553,0.7775000175040331,0.7945205479452054,0.975307256368226,1.0,12/79,12.92%,NTRK3;PTPN13;PLPP3;ATP2B4;IBTK;EPHB2;OCLN;GSK3B;MEN1;ENSA;PTEN;PTPA
prerank,glycogen biosynthetic process (GO:0005978),0.35618660292275706,0.7769249884931697,0.7332155477031802,0.9751750078833992,1.0,2/12,7.99%,GYS1;PGM1
prerank,glucan biosynthetic process (GO:0009250),0.35618660292275706,0.7769249884931697,0.7332155477031802,0.9751750078833992,1.0,2/12,7.99%,GYS1;PGM1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.3427312093718702,0.7758509377717566,0.7268128161888702,0.9764238368722332,1.0,6/14,18.52%,OPHN1;FOXJ1;PATJ;EZR;SCRIB;RHOA
prerank,cardiac muscle tissue development (GO:0048738),0.27293215574943386,0.7752200885818213,0.7809139784946236,0.9769422543867313,1.0,9/50,12.86%,SGCD;AKAP13;SGCG;CSRP3;BMP5;TBX2;TBX18;NDUFV2;KDM6B
prerank,phospholipid metabolic process (GO:0006644),0.2539452165667869,0.7746257987612398,0.7895392278953923,0.9773433660261666,1.0,7/71,8.30%,PLPP2;ACP6;PLPP3;PIP4K2B;AGPAT4;CLN8;ABHD12
prerank,positive regulation of double-strand break repair (GO:2000781),-0.22156392416873616,-0.7745501335269358,0.8435374149659864,0.9520884958978469,1.0,13/39,26.75%,SHLD2;SLF2;SLF1;ACTR2;ARID2;MMS19;PARP1;TIMELESS;KDM4D;MAD2L2;SMCHD1;ZCWPW1;PARP3
prerank,negative regulation of autophagy (GO:0010507),0.2732357037310858,0.7739360470986797,0.7842105263157895,0.9778803506623109,1.0,10/54,14.39%,LEPR;FOXK1;PTPN22;MCL1;FOXK2;NRBP2;EIF4E;TAB2;ATG7;KLHL22
prerank,protein targeting to peroxisome (GO:0006625),0.29417383887858434,0.7736406589264792,0.7473363774733638,0.9778522353932598,1.0,5/29,12.75%,RAB8B;FIS1;PEX2;PXMP2;ABCD1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.3215547956757383,-0.7734569662054679,0.7785714285714286,0.9530011377898442,1.0,3/10,35.75%,ABCA2;APOC1;SHH
prerank,negative regulation of RNA metabolic process (GO:0051253),0.321271606684124,0.7732221533807975,0.7604166666666666,0.9780155738744231,1.0,5/18,12.29%,NCOR1;RPS13;PTBP3;NCOR2;PTBP2
prerank,activation of protein kinase A activity (GO:0034199),0.33496490074216506,0.7724172301858278,0.7376,0.978817981461101,1.0,6/16,15.58%,ADCY5;PRKAR2A;ADCY9;PRKACB;ADCY8;ADCY3
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.31290314706408917,0.7723869003844419,0.74079754601227,0.9783347003391621,1.0,3/22,8.28%,FLOT2;MAPK7;GCNT2
prerank,peroxisome organization (GO:0007031),0.3031595416743739,0.7722190678143622,0.7626339969372129,0.9780781658420831,1.0,5/25,12.75%,FIS1;TMEM135;PEX2;ACOT8;ABCD1
prerank,negative regulation of glycolytic process (GO:0045820),-0.32401003787575755,-0.7721717773543848,0.7505882352941177,0.9533133328649186,1.0,2/10,3.46%,NUPR1;CBFA2T3
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.32401003787575755,-0.7721717773543848,0.7505882352941177,0.9533133328649186,1.0,2/10,3.46%,NUPR1;CBFA2T3
prerank,nitrogen compound transport (GO:0071705),0.23504799243907298,0.7720089193832661,0.8495981630309989,0.9778800621035378,1.0,21/141,13.98%,LRRC8D;SLC12A2;CD3G;SLC38A2;SLC29A4;SLC22A3;ABCC1;SLC6A13;SEC14L1;SLC52A1;SLC7A14;CERT1;CD320;SLC7A2;CUBN;SLC3A1;CEP290;AMN;AQP1;TMEM30A;SLC6A4
prerank,protein ubiquitination (GO:0016567),0.2182109013787642,0.7712494327657272,0.9369277721261444,0.9786232038594552,1.0,112/471,22.15%,NEDD4L;PDZRN3;UBE2L6;ZNRF2;FBXL15;DTX1;PELI2;UBE2E2;SH3RF2;IRF2BP1;UBE3C;LZTR1;RNF122;LMO7;SPSB4;PSME3;LRSAM1;LEO1;TMEM129;KEAP1;TRIM21;SELENOS;UBR5;CHFR;PEX2;PAF1;UBE2V2;SIAH1;FBXO31;ZNRF3;CUL3;AMFR;PSMB5;BLMH;RNF220;LNPEP;ANAPC7;DTX4;UBE3D;OBI1;RCHY1;KLHL7;TRPC4AP;ANAPC11;FBXL19;LONRF1;NEDD4;KLHL21;FBXL5;FBXL17;FBXO11;NFE2L2;RFWD3;RNF185;FBXO21;PSMB2;CBFB;UBE2J2;UBA1;UBE2D3;UBE2D1;PSMA2;KLHL22;PSMA6;WWP2;PSMD13;FBXW8;PSMA7;TRIM5;FBXO41;DDB2;FANCL;UBE2R2;FBXL12;FBXW7;FBXL3;RTF1;ITCH;CUL4B;RNF7;VPS11;PSME4;ANAPC16;PINK1;KLHL18;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;USP9X;ATG3;DDA1;PEX13;HECTD2;UBE2W;CDC73;PRKN;MKRN1;RNF146;RNF14;MUL1;CUL7;TRAF7;ZNRF1;PSMB3;AKTIP;DERL1;RNF157;CUL5;MIB2;FBXW11
prerank,regulation of defense response to virus by host (GO:0050691),0.29457861600582114,0.7707655840469239,0.7534246575342466,0.9788957874207117,1.0,3/30,6.13%,PTPN22;TNFAIP3;ZDHHC1
prerank,ether lipid biosynthetic process (GO:0008611),-0.3162240030239155,-0.7707512780271016,0.7561576354679803,0.9547346112527967,1.0,1/10,3.61%,CHPT1
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.36421301644743703,0.7697935538951124,0.7269565217391304,0.9799709601103743,1.0,1/10,2.66%,ANO6
prerank,phosphatidylethanolamine metabolic process (GO:0046337),0.29527552010251934,0.7697626741257165,0.7458646616541353,0.9794976151408106,1.0,7/27,18.23%,PISD;SLC27A1;PLAAT5;ETNK2;PNPLA8;SELENOI;LPIN1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.2857136926053371,0.7693436889198498,0.7563909774436091,0.9796767943640755,1.0,3/30,8.36%,ACKR3;FBXO5;DYRK1A
prerank,regulation of presynapse assembly (GO:1905606),-0.27475879488496086,-0.7689866535188379,0.7587131367292225,0.9557548004708412,1.0,12/18,37.46%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;VPS35;LRFN4;LRFN5;SNCA;WNT7A
prerank,regulation of presynapse organization (GO:0099174),-0.27475879488496086,-0.7689866535188379,0.7587131367292225,0.9557548004708412,1.0,12/18,37.46%,LRRC4B;MDGA1;PTPRD;EIF4G1;IL1RAPL2;SLITRK2;SLITRK3;VPS35;LRFN4;LRFN5;SNCA;WNT7A
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.33199702121969105,0.7689150546387692,0.7645107794361525,0.9798402905504514,1.0,4/18,12.96%,NF1;MORC3;PEX2;EMD
prerank,protein acylation (GO:0043543),0.2781199997578391,0.7684843394419139,0.7552447552447552,0.9800235920318486,1.0,10/38,14.96%,ZDHHC1;ZDHHC7;ZDHHC23;ZDHHC13;CREBBP;ZDHHC20;GLUL;NAT9;ZDHHC8;NAA10
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.2804894972430098,-0.7683101126384952,0.776595744680851,0.9559186130464649,1.0,5/16,21.88%,CEBPG;VAMP7;TUBB4B;PLEKHM2;RAET1E
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.3164089848404209,-0.7681903431383268,0.7757437070938215,0.9552916907918001,1.0,5/11,19.71%,BLM;ZRANB3;LIG3;TIPIN;TIMELESS
prerank,transport along microtubule (GO:0010970),-0.29939792884805505,-0.7674962811775746,0.7610837438423645,0.9554960218167678,1.0,3/13,11.25%,CDC42;BORCS5;CLIP3
prerank,protein insertion into ER membrane (GO:0045048),0.28179326776521246,0.7672566427216133,0.7899280575539568,0.9814597339599639,1.0,8/37,15.12%,STX1A;EMC9;EMC7;TRAM1;EMD;OTOF;UBE2J2;SEC61G
prerank,response to prostaglandin E (GO:0034695),-0.31636275562562755,-0.7668481171431117,0.7598152424942263,0.9556202288395459,1.0,4/10,28.88%,TGFBR3;CCL19;ADCY6;SFRP1
prerank,peptidyl-serine modification (GO:0018209),0.2321727593747398,0.7668120322439865,0.8520971302428256,0.9816704198542134,1.0,19/166,11.96%,PLK2;PRKCE;CAMK2D;STK38;EIF2AK3;PRKCA;MORC3;HIPK1;BRSK1;STK38L;DYRK1A;CSNK1G3;GSK3B;RPS6KA3;MASTL;CSNK1A1;SRPK2;TOP1;SGK1
prerank,apoptotic DNA fragmentation (GO:0006309),0.326454303455103,0.7667616585271646,0.7528830313014827,0.9812295969020897,1.0,4/16,14.63%,DFFB;HMGB1;EXOG;DICER1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.2817066256664127,0.7667329588135158,0.7673410404624278,0.9807643210656095,1.0,4/37,8.91%,OGT;FHIT;N4BP1;DDRGK1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.3124380023960411,-0.766474506504188,0.7867298578199052,0.9553043898625052,1.0,6/11,36.51%,AKAP6;LRRC38;ALG10B;LRRC55;TREM2;RNF207
prerank,endochondral bone morphogenesis (GO:0060350),0.3524381308240713,0.7664285374739136,0.726962457337884,0.9807299471467393,1.0,2/11,4.10%,TRPV4;BMPR1B
prerank,RNA polyadenylation (GO:0043631),0.3009029669980486,0.7662100255199875,0.7631184407796102,0.980040267507259,1.0,12/26,25.76%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,mRNA polyadenylation (GO:0006378),0.3009029669980486,0.7662100255199875,0.7631184407796102,0.980040267507259,1.0,12/26,25.76%,LEO1;TUT1;PAF1;CSTF3;SYMPK;PAPOLG;CDC73;PCF11;CPSF2;WDR33;TENT4B;PNPT1
prerank,negative regulation of histone acetylation (GO:0035067),0.3642802942790712,0.7659187764668776,0.7357512953367875,0.9799948925384829,1.0,1/11,3.65%,SPI1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.31131260604271027,-0.7655982498065433,0.8,0.95580564031696,1.0,4/11,25.92%,FAS;LGALS9;PLAUR;CAAP1
prerank,response to interferon-beta (GO:0035456),-0.2606075932151443,-0.7652822119423868,0.8090185676392573,0.9554537496799892,1.0,4/22,10.10%,IFNAR2;UBE2K;BST2;IRF1
prerank,regulation of steroid biosynthetic process (GO:0050810),0.35490115768090646,0.765236470077834,0.7461928934010152,0.9806151851909681,1.0,5/11,18.69%,BMP5;EGR1;NR5A1;ASAH1;STAR
prerank,peptidyl-lysine dimethylation (GO:0018027),0.3201250485027667,0.7647212543891156,0.7475728155339806,0.9809178379304285,1.0,5/18,17.48%,KMT2A;SUV39H1;KMT2D;SETD2;SUV39H2
prerank,polyol biosynthetic process (GO:0046173),0.3222314064839792,0.76424124909853,0.739413680781759,0.9811854100860342,1.0,2/16,6.92%,ACER3;PPIP5K2
prerank,regulation of rRNA processing (GO:2000232),0.32937335167508963,0.7641777800631149,0.7454844006568144,0.9807717573314167,1.0,3/16,9.58%,BUD23;UTP15;SIRT7
prerank,interstrand cross-link repair (GO:0036297),0.261931544643337,0.7635314153176377,0.8055190538764783,0.9813124479666475,1.0,13/53,21.54%,FAAP24;MSH6;FANCC;FANCF;ERCC1;RFWD3;NUCKS1;RAD51AP2;FANCL;ERCC6L2;ATR;SLX4;RPA3
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.2998766741728044,-0.7631879315926839,0.7488372093023256,0.9575977647171495,1.0,2/12,3.65%,NKD1;PROM1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.3196434158222064,0.7631106652113235,0.7606973058637084,0.98144899511787,1.0,6/18,19.29%,COA5;COX19;COX16;BCS1L;SURF1;COA8
prerank,erythrocyte development (GO:0048821),-0.3209704255921955,-0.7630345536815876,0.7692307692307693,0.9570037669703888,1.0,4/10,28.46%,ABCB10;ALAS1;NCKAP1L;ALAS2
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2080580489698356,-0.763023878141657,0.8682170542635659,0.9562137847313129,1.0,14/52,20.87%,DNAJC3;PREB;GOSR2;SSR1;WIPI1;TPP1;SYVN1;LMNA;GSK3A;TLN1;DNAJB11;SEC31A;XBP1;TATDN2
prerank,regulation of dendrite morphogenesis (GO:0048814),0.28830794176198016,0.7626707964616215,0.7674418604651163,0.9816399060734332,1.0,8/32,15.44%,NEDD4L;CDKL3;GSK3B;SARM1;NEDD4;SEMA4D;CAPRIN2;FBXW8
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.2603350674977829,0.7624446463637555,0.8206451612903226,0.9814943301147109,1.0,21/59,23.89%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED8;MED12;MED31;BAX;MED15;IL6;MED16;TWIST1;TCF7L2;JUN;MED27;MED20
prerank,negative regulation of viral genome replication (GO:0045071),0.2697650897717231,0.7623396825825507,0.775623268698061,0.9811489258967944,1.0,7/40,11.01%,N4BP1;SRPK1;TNIP1;PLSCR1;RESF1;SRPK2;ILF3
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.29933187768258124,0.7612794757822389,0.7476489028213166,0.982308401018642,1.0,8/24,20.35%,NF1;FOXO3;MCL1;SRPK2;BACE1;FBXW7;BAX;DDIT3
prerank,male gonad development (GO:0008584),0.2848522576030057,0.7612420001668598,0.7618364418938307,0.9818581014827208,1.0,7/34,15.35%,WNT2B;SOX9;WNT5A;MSH2;CSDE1;NR5A1;KITLG
prerank,epithelial cell differentiation (GO:0030855),0.24285086586037774,0.7611075332628032,0.8487394957983193,0.9815614851734374,1.0,16/88,17.72%,GLI1;CDHR2;JAG1;ANXA4;ZDHHC7;HDAC2;GSTK1;KDM6B;FZD7;ERBB4;UPK1A;PGK1;PPARG;SCRIB;CTSB;FSTL1
prerank,DNA catabolic process (GO:0006308),0.3488860715415597,0.7609253674071419,0.7361853832442068,0.9813165531805147,1.0,4/11,25.94%,DFFB;REXO4;DNASE1L1;FBH1
prerank,positive regulation of exocytosis (GO:0045921),0.2876689304478148,0.7607617898925163,0.7755102040816326,0.9810511433681188,1.0,14/35,26.17%,TSG101;RAB3A;SDC1;PDCD6IP;SDC4;RAB2B;RAB27B;RAB5A;CHMP2A;RAB9A;SNF8;STAM;ATP6AP1;CLASP2
prerank,regulation of TOR signaling (GO:0032006),-0.19508950453275212,-0.7605218395546737,0.9017857142857143,0.9590969676396129,1.0,12/67,14.68%,UBR1;FNIP1;LAMTOR3;SEH1L;FBXO9;DEPDC5;RRAGC;RICTOR;TMEM127;GSK3A;DEPTOR;RRAGD
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.32403363543054653,0.7601179912727833,0.7491638795986622,0.9815345656373596,1.0,2/16,9.55%,CRTAM;LAMP1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.2882823448043404,-0.7594850527101873,0.7975609756097561,0.9597261160985842,1.0,6/14,18.75%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2
prerank,regulation of chromosome segregation (GO:0051983),0.32320892571853993,0.7589717655110536,0.7406199021207178,0.9828351783846166,1.0,5/16,21.52%,SMC5;CDC6;PUM2;CSNK2A2;PUM1
prerank,T cell migration (GO:0072678),0.3395011146839143,0.7585593910817063,0.7365684575389948,0.9829937972905555,1.0,2/13,11.78%,SLC12A2;GPR183
prerank,positive regulation of macrophage migration (GO:1905523),-0.26159069723851713,-0.7582019278713665,0.8473282442748091,0.9606785076191295,1.0,7/19,18.75%,CMKLR1;IL34;THBS1;PTK2;CSF1;P2RX4;RARRES2
prerank,protein localization to lysosome (GO:0061462),0.2937783945896817,0.7581606614377686,0.7735294117647059,0.9831231823792523,1.0,9/28,19.60%,ZFYVE16;M6PR;GCC2;NEDD4;CD81;RTN4;AP3M1;SCARB2;LAMTOR5
prerank,mitotic spindle assembly (GO:0090307),0.2761142419351811,0.7578321245979902,0.7855153203342619,0.983135238735841,1.0,8/42,18.52%,KIF2A;RACGAP1;SMC3;MAP9;ARHGEF10;PIBF1;OFD1;RHOA
prerank,regulation of macroautophagy (GO:0016241),0.23752221659830042,0.7577740709350794,0.8539458186101295,0.9827082853530379,1.0,25/105,22.04%,DCN;PRKAG1;ATP6V0D2;SCOC;SESN1;NRBP2;ATP6V0A1;PAFAH1B2;HDAC6;NEDD4;ERN1;RRAGB;SNX5;TBK1;UBQLN1;BNIP3;PINK1;ATP6V1G1;LAMTOR5;RB1CC1;RPTOR;CAPN1;MAPK8;TSC2;GNAI3
prerank,regulation of DNA recombination (GO:0000018),0.2853536017527645,0.7576241487832047,0.768688293370945,0.9824357414779429,1.0,4/32,7.45%,MSH6;SMARCAD1;KPNA2;MSH2
prerank,purine nucleotide catabolic process (GO:0006195),-0.29839351724086655,-0.7574917130796587,0.7944162436548223,0.9608601889819014,1.0,5/13,24.17%,XDH;NT5C;HINT1;NT5C1A;GDA
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2941706207112646,0.7574887329656427,0.7492447129909365,0.9821339851225828,1.0,10/25,21.89%,CUL3;LONP1;HDAC6;ZYG11B;FBXL17;RNF185;KLHL15;UBE2W;YME1L1;DERL1
prerank,positive regulation of hormone secretion (GO:0046887),0.31750288611459015,0.7573819586408941,0.7675941080196399,0.9817878295082187,1.0,3/17,11.35%,TFR2;RASL10B;VAMP8
prerank,pyrimidine nucleobase metabolic process (GO:0006206),0.341438240597555,0.7571872063487606,0.7568027210884354,0.9815820051057689,1.0,4/12,14.78%,DPYS;DPYSL2;CTPS2;DPYSL5
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.35067788099422537,0.7570316157867358,0.7486437613019892,0.98131847426019,1.0,11/11,64.96%,NFKBIZ;MALT1;NFKBID;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;PRKCQ
prerank,positive regulation of protein depolymerization (GO:1901881),0.3527273909332391,0.7567343781864937,0.7530224525043178,0.9812794256967949,1.0,3/11,14.21%,TRPV4;PLEK;CFL2
prerank,regulation of stem cell population maintenance (GO:2000036),0.31427225458629116,0.7559637626888858,0.7620689655172413,0.9819519147577155,1.0,8/18,27.18%,NCOA3;CNOT1;ZC3H13;LOXL2;ELAVL1;CNOT2;REST;TAF6L
prerank,negative regulation of telomere maintenance (GO:0032205),0.33077635216481677,0.7557193138069922,0.7818181818181819,0.9818145575509991,1.0,8/15,28.08%,NBN;ERCC1;TERF2;SLX4;SMG6;TNKS;RAD50;TERF2IP
prerank,positive regulation of lymphocyte activation (GO:0051251),-0.23371070137862324,-0.7547430053434286,0.8722741433021807,0.9638811237223245,1.0,12/28,36.22%,SIRPA;SH3KBP1;CYRIB;NCKAP1L;NOD2;PYCARD;TNIP2;CCR2;HSPD1;CCL2;PRKCQ;THY1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3476805925492876,0.7545806393849012,0.7395659432387313,0.9830787686510573,1.0,8/11,31.21%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.29972082669067224,0.75447851888695,0.7456,0.9827358321021532,1.0,4/20,7.98%,SCD5;ACACA;GCDH;HSD17B4
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.2795595439158238,0.7544367891264552,0.7628865979381443,0.9822811973450967,1.0,6/31,13.19%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.28620430264081104,-0.7540604573799694,0.7638190954773869,0.9640407697473893,1.0,3/13,20.59%,TMSB4X;PER2;MAD2L2
prerank,transcription by RNA polymerase I (GO:0006360),-0.22392903030425398,-0.7533140015252984,0.8954248366013072,0.9642780983570254,1.0,12/34,23.85%,MNAT1;TAF1D;ERCC2;TCOF1;CCNH;POLR2F;TAF1C;GTF2H4;POLR2K;POLR1C;POLR1F;RRN3
prerank,T cell differentiation (GO:0030217),0.2714823018724427,0.7531254679139717,0.7828492392807745,0.9838023969051166,1.0,4/40,4.99%,LEPR;SPI1;PTPN22;PTPRC
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.2749424056935371,0.7526206909303004,0.7748976807639836,0.9840813944645558,1.0,8/39,16.83%,ASS1;JAG1;RDX;MAPK7;NF2;PLG;CDH1;RGCC
prerank,establishment of spindle orientation (GO:0051294),0.2910075171747158,0.752615879919129,0.783625730994152,0.9835759587566624,1.0,9/28,22.15%,SAPCD2;PAFAH1B1;MAP4;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,glycoprotein metabolic process (GO:0009100),-0.20666975094780543,-0.7523949244073107,0.9047619047619048,0.9648227719466171,1.0,14/53,19.86%,ST8SIA4;MGAT4A;ST6GALNAC3;HIF1A;GANC;STT3B;B4GALT7;FBXO17;ST8SIA2;GCNT1;FUT8;FBXO44;GAL3ST2;ST8SIA1
prerank,cellular response to interferon-beta (GO:0035458),0.32160904315950717,0.7522139245169452,0.7517123287671232,0.9837034082384305,1.0,3/14,13.79%,ACOD1;IRGM;HTRA2
prerank,sarcomere organization (GO:0045214),-0.24131629339717453,-0.752126871770531,0.8540372670807453,0.964385232402783,1.0,2/27,1.91%,ACTN2;TPM1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.26515408604643026,-0.7520056133789638,0.848,0.9637464547132096,1.0,4/19,17.04%,SLCO1C1;KLF4;KLF2;EGF
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),-0.2552315531725394,-0.7519795278148181,0.8383838383838383,0.9629666342593131,1.0,4/21,12.40%,NES;PROX1;KDM1A;TOX
prerank,maintenance of protein location in nucleus (GO:0051457),0.30808030679753856,0.7516826203015458,0.7584541062801933,0.9839976397600968,1.0,3/20,9.77%,BCL3;MORC3;SUN1
prerank,mitochondrial translation (GO:0032543),0.2371423869140382,0.7514936637324542,0.8615384615384616,0.9837852283032701,1.0,28/104,21.18%,MRPL37;MRPL43;MRPL33;FASTKD2;MRPS28;MRPS35;RARS2;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;NDUFA7;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;GATB;TSFM;MRPS7
prerank,mitotic cytokinesis (GO:0000281),0.26445869766953845,0.7509738334849019,0.8060522696011004,0.9841025138960809,1.0,12/47,17.60%,RACGAP1;SON;USP8;SPAST;PDCD6IP;CNTROB;CHMP4B;APC;CIT;STAMBP;RTKN;SPTBN1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.2994132253576941,-0.7507142982820648,0.7967667436489607,0.9638551577872684,1.0,4/12,26.36%,IL18;CD80;PAEP;IL17D
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.29670947169897144,0.7505255234858026,0.7830045523520486,0.9842835149433737,1.0,6/24,18.75%,PSME3;TMF1;PKD1;RHBDF1;PINK1;PSMD14
prerank,protein targeting (GO:0006605),-0.1759416829264449,-0.7503165367513777,0.9770992366412213,0.9635702861640413,1.0,27/118,20.47%,PARD3;KIF13B;ZFAND6;AKAP6;RASSF9;AQP11;RABGEF1;TIMM44;GABARAP;AP4E1;ZFAND2A;TIMM17B;TAOK2;SPCS1;MICALL1;ZDHHC2;HACL1;PEX6;AIP;VPS37C;PEX1;ZDHHC14;TIMM10B;TIMM8B;CDC37;KATNB1;ZDHHC24
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.32708474535920207,0.750299189349446,0.7504132231404959,0.9841253474032331,1.0,3/14,11.03%,TSEN54;RTRAF;TSEN34
prerank,chemokine-mediated signaling pathway (GO:0070098),0.27051607623200985,0.7494052563013163,0.7950138504155124,0.9849944680169799,1.0,1/42,0.78%,ACKR3
prerank,protein modification by small protein conjugation (GO:0032446),0.2142917709520634,0.7493474768843013,0.9546858908341915,0.9845709336163422,1.0,87/361,22.15%,NEDD4L;PDZRN3;FBXL15;DTX1;STX1A;EYA1;LZTR1;LMO7;UBE2I;SPSB4;LEO1;TMEM129;NUP62;KEAP1;TRIM21;SELENOS;CHFR;PEX2;PAF1;UBE2V2;PIAS2;ZNRF3;CUL3;AMFR;NUP160;RNF220;DDRGK1;ANAPC7;DTX4;NUP37;TPR;RCHY1;KLHL7;TRPC4AP;ANAPC11;NUP50;NEDD4;RANBP2;KLHL21;FBXL5;FBXL17;FBXO11;NFE2L2;NUP210;NUP153;RFWD3;ATG7;UBE2J2;UBA1;UBE2D3;UBE2D1;WWP2;FBXW8;NUP93;TRIM5;UBE2R2;FBXW7;FBXL3;RTF1;URM1;ITCH;CUL4B;RNF7;VPS11;ANAPC16;PINK1;KLHL18;CDC23;USP9X;ATG3;SUMO1;PEX13;UBE2W;CDC73;TRPM4;PRKN;MKRN1;RNF14;MUL1;CUL7;NUP43;TRAF7;DERL1;RNF157;CUL5;MIB2;FBXW11
prerank,mitotic sister chromatid segregation (GO:0000070),0.2370065363799519,0.748652113709757,0.8621103117505995,0.9851719526769711,1.0,28/98,22.27%,NUP62;PDS5B;TUBG1;DSN1;CUL3;DIS3L2;TEX14;CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C;INO80;TUBG2;KLHL22;ZW10;RAN;REC8;PIBF1;CENPK;CSNK2A2;CDC23;DCTN2;RRS1;KMT5A;CHMP2A;PRC1;MIS12
prerank,negative regulation of secretion (GO:0051048),-0.31785361733429485,-0.7485925891092118,0.7775229357798165,0.9650767723892573,1.0,8/10,42.87%,NR1H3;EGF;ERBB3;SPX;NRG1;VAMP3;TIFAB;CD74
prerank,selective autophagy (GO:0061912),0.25850985069345256,0.7484916025256004,0.8226018396846255,0.9849145020760671,1.0,15/56,21.48%,DYNLL1;WDR81;ATG5;DDRGK1;DYNLL2;HDAC6;LGALS8;UBQLN1;ATG2B;MAP1LC3B;DYNC1LI2;RB1CC1;PRKN;DYNC1I1;ATG14
prerank,dendritic spine morphogenesis (GO:0060997),-0.27995501098672676,-0.7481377364565425,0.7866004962779156,0.9648451783676754,1.0,5/15,18.50%,SHANK3;CDC42;EPHB3;CTNND2;EPHB1
prerank,neuron fate commitment (GO:0048663),-0.2820990021112342,-0.7479937836601835,0.8177215189873418,0.9642328075633757,1.0,6/14,28.18%,TGFBR1;MYT1L;ID2;POU3F2;DLL4;DLL1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),0.3372256144735765,0.7479215792568455,0.7564766839378239,0.9852621151072383,1.0,3/12,7.69%,GLI2;EPHB2;PAFAH1B1
prerank,GTP metabolic process (GO:0046039),-0.2783308728109437,-0.7476999015240504,0.8014888337468983,0.9638382779922121,1.0,3/15,15.54%,LRRK2;IMPDH1;OPA1
prerank,piRNA metabolic process (GO:0034587),0.3064403493365723,0.7474708184557497,0.7632850241545893,0.9854739057434043,1.0,2/19,12.29%,PIWIL2;TEX15
prerank,cell proliferation in forebrain (GO:0021846),-0.3071659519884913,-0.7472619405772123,0.776255707762557,0.9636092396242582,1.0,1/10,0.77%,NUMB
prerank,regulation of lipoprotein lipase activity (GO:0051004),-0.2685527726217517,-0.7471556992177161,0.8168316831683168,0.962944847176297,1.0,5/17,15.32%,NR1H3;HDAC9;NR1H2;FURIN;SORT1
prerank,protein deacylation (GO:0035601),0.30016488600578467,0.7470142385757026,0.7907692307692308,0.9856539342613888,1.0,10/23,23.99%,HDAC4;SIRT3;SIRT7;HDAC6;ABHD10;HDAC3;LYPLA2;ABHD17C;SIRT2;SIN3A
prerank,RNA interference (GO:0016246),0.3108780936096549,0.7468594194182849,0.7530647985989493,0.9853773656651885,1.0,6/17,19.33%,CELF1;AGO1;DICER1;TSNAX;PRKRA;DHX9
prerank,ribosomal large subunit assembly (GO:0000027),-0.24234227704275094,-0.7462238312648974,0.8363636363636363,0.9634099586336711,1.0,11/24,33.54%,RPLP0;RPL3;MRPL20;NLE1;PPAN;RPL5;RPF2;RPL11;RPL24;DDX28;NOP53
prerank,DNA metabolic process (GO:0006259),0.215596706394803,0.7461715969282744,0.9287958115183246,0.9859261734725445,1.0,55/270,18.15%,TDG;MSH6;POLI;KMT5C;NTHL1;SMARCAD1;FANCC;PDS5B;RFC3;STN1;KPNA2;ORC5;NBN;UBE2V2;TOP3B;MSH2;NT5E;DFFB;HMGB1;SIRT7;ORC3;TRRAP;AXIN2;LONP1;SRPK2;ERCC1;TDP1;TOP1;MEN1;INO80;MGMT;CDC6;GEN1;ADPRS;GTF2H1;ALKBH1;POLB;REXO4;RECQL5;RAN;POLE;DDB2;FANCL;INTS3;CHD1L;USP45;GMNN;PSME4;TERF2;BACH1;NOC3L;ORC1;RFC1;ORC6;GTF2H3
prerank,microtubule-based transport (GO:0099111),0.33172120516264775,0.7460759814106784,0.7571942446043165,0.985569318433315,1.0,5/12,24.34%,SPAG17;HTT;CCDC40;DYNC1I1;DYNC1I2
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.2323072613015536,-0.7456386380085263,0.880466472303207,0.963360363051341,1.0,10/29,22.19%,EDC3;NT5C3B;HBS1L;EDC4;EXOSC3;LSM7;DIS3;EXOSC1;DCP2;LSM5
prerank,gas transport (GO:0015669),0.34789751066413704,0.7453693866912026,0.7495495495495496,0.9861484545473612,1.0,2/10,12.99%,IPCEF1;AQP1
prerank,positive regulation of locomotion (GO:0040017),0.2882235974382839,0.7453149259074731,0.8055987558320373,0.9857197329150965,1.0,2/27,4.97%,NTN1;CAVIN1
prerank,positive regulation of protein kinase activity (GO:0045860),0.22585781326558066,0.7447599003833646,0.8845726970033296,0.9860253438822711,1.0,21/148,11.42%,RAP1A;AXIN1;MINK1;PRKAG1;MMD2;SRC;SLC27A1;PTPRC;TOM1L1;LCP2;SRCIN1;SYAP1;IRGM;STK3;RASSF2;DLG3;LAT;ADRA2A;RELN;TAB2;EGR1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.304044825576128,-0.7446348489853041,0.7945544554455446,0.9639595372120351,1.0,6/11,42.87%,KDM1A;MIF;TAF9;TRIAP1;MUC1;CD74
prerank,positive regulation of histone deacetylation (GO:0031065),-0.29681132286827994,-0.7446314880777363,0.7752525252525253,0.9631610547951954,1.0,4/12,29.95%,AKAP8L;APLNR;PRKD1;CTBP1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.268690463337968,0.7446295256343158,0.8076923076923077,0.9857064048386902,1.0,12/39,22.13%,TFR2;ISL1;RASL10B;GCK;SOX4;AIMP1;GPER1;BAD;IRS2;GLUD1;TCF7L2;NLGN2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.2685410889875849,0.7440478320770952,0.8131241084165478,0.9860972483796256,1.0,14/38,25.92%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFA7;NDUFS2;NDUFA11;NDUFA12;NDUFS4;NDUFS1;NDUFA9
prerank,protein K63-linked ubiquitination (GO:0070534),-0.2136340469583575,-0.7438606400663809,0.8921568627450981,0.963376081743961,1.0,7/41,9.85%,RNF115;TRAF3IP2;TRAF6;UBE2N;UBE2S;RNF152;UBE2O
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.3136003530085565,0.743852994900442,0.7670549084858569,0.9858848673664293,1.0,2/17,9.55%,CRTAM;LAMP1
prerank,leukocyte tethering or rolling (GO:0050901),0.309615342584246,0.7435637130087751,0.7665615141955836,0.9858088494248058,1.0,6/17,24.54%,ITGB7;PODXL2;ITGB1;CX3CR1;GOLPH3;ROCK1
prerank,vacuolar acidification (GO:0007035),0.3045379396277577,0.7434516140781928,0.7974068071312804,0.9854655858395275,1.0,4/21,11.51%,ATP6V0D2;DMXL1;ATP6V0A1;DMXL2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.28046565351735925,-0.7433436862640163,0.8089330024813896,0.9633023317616473,1.0,4/14,23.24%,ENTPD1;ENTPD5;ENTPD3;NUDT16
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.3484252463582871,0.7430975066688632,0.7651245551601423,0.9854901769700223,1.0,4/11,17.93%,PRKCA;RDX;SYK;JAK1
prerank,neuron cell-cell adhesion (GO:0007158),0.32623717737098734,0.7429497512364972,0.7984,0.9852216635620624,1.0,1/14,1.68%,CEL
prerank,regulation of histone methylation (GO:0031060),0.3268059118594401,0.7428549753385807,0.7736842105263158,0.9848676670669216,1.0,2/13,9.16%,PAF1;TET1
prerank,sister chromatid segregation (GO:0000819),0.2783550503019649,0.7418653546193655,0.8034188034188035,0.9858368341943877,1.0,8/31,17.27%,TUBG1;DSN1;INO80;TUBG2;KLHL22;ZW10;RAN;CENPK
prerank,positive regulation of sprouting angiogenesis (GO:1903672),0.3183497931738913,0.741778760381579,0.7779661016949152,0.9854516010156912,1.0,6/15,24.71%,FGF1;ITGA5;JAK1;PDPK1;PKM;FGF2
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.2839477377300438,-0.7413123341051363,0.8071428571428572,0.9651795389757108,1.0,6/14,35.01%,IL18;CD80;PAEP;IL17D;CD84;RASGRP1
prerank,regulation of apoptotic process (GO:0042981),0.2092259213286107,0.7410100178874809,0.9819277108433735,0.9861188190875221,1.0,101/676,15.35%,NGF;ITGA6;PLK2;DKKL1;TIAM2;EGFR;PPP1R13B;BCL3;SH3RF2;ANO6;TNFAIP8;GPLD1;TFPT;NF1;AKAP13;PHLDA3;RNF122;APH1B;STIL;FOXO3;CIDEB;SOX9;VAV2;SRC;NUP62;WNT5A;ACVR1C;TRIO;EGLN3;DDAH2;SON;ANXA4;TRADD;ARHGEF5;NCSTN;ADAM10;PHLDA1;MCL1;NLRC4;ARHGEF1;PERP;SIAH1;BAG3;MAP3K5;PHLPP1;NAA35;RBM5;KALRN;AATF;OBSCN;DDRGK1;STK3;GSK3B;RPS6KA3;HMGB1;NLRP2B;RASSF2;SLC27A4;USP47;AXL;HDAC2;TAX1BP1;HYPK;RARG;PROC;APC;IL6ST;PRLR;HTATIP2;SGK1;ARHGEF6;SEMA4D;FAF1;LANCL1;FBXO11;TMBIM4;NF2;DHCR24;MGMT;PTPA;AQP1;ADAMTSL4;DIABLO;CREBBP;IL7;ATG7;SOX4;LCMT1;HTRA2;HTT;DNAJA3;DDX42;RTN4;UNC13B;CHM;COPS5;FZD9;GPER1;PTPN6;BAD;PDCD2
prerank,mitochondrial translational termination (GO:0070126),0.23907473892907982,0.7408223329419567,0.8514492753623188,0.9859030790074839,1.0,20/88,18.18%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,protein localization to condensed chromosome (GO:1903083),0.3399904087826952,0.7407729159950991,0.7831125827814569,0.9854732312725591,1.0,4/12,22.27%,BUB3;ZWILCH;ZW10;MIS12
prerank,regulation of megakaryocyte differentiation (GO:0045652),-0.20472255640440157,-0.7407421666765218,0.9323308270676691,0.9651240494499087,1.0,17/49,28.88%,EP300;SETD1A;HDAC1;MYL9;AGO3;THBS1;MOV10;AGO4;TNRC6C;KAT2B;RAB7B;NR4A3;KMT2B;CIB1;L3MBTL1;KMT2E;WDR5
prerank,proteasomal protein catabolic process (GO:0010498),0.21746435031994404,0.7406344924015652,0.9222343921139102,0.9851701454118741,1.0,49/201,22.15%,NEDD4L;RNF122;PCBP2;SPSB4;PSME3;SOCS6;SIAH1;CUL3;PSMB5;SIAH3;UBE3D;SHARPIN;FBXL19;NEDD4;SPOPL;FBXL17;FAF1;NFE2L2;RNF185;PSMB2;UBE2D3;PSMA2;KLHL22;FEM1C;PSMA6;WWP2;PSMD13;PSMA7;PLAA;FBXW7;ITCH;CUL4B;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;KBTBD7;GID4;SEL1L;UBE2W;DDIT3;PRKN;PPP2R5C;ZNRF1;PSMB3;DERL1;GID8;FBXW11
prerank,regulation of protein localization to Cajal body (GO:1904869),-0.30384403867800086,-0.7404303510302593,0.7968036529680366,0.9639260157383448,1.0,2/11,11.04%,CCT7;CCT8
prerank,positive regulation of protein localization to Cajal body (GO:1904871),-0.30384403867800086,-0.7404303510302593,0.7968036529680366,0.9639260157383448,1.0,2/11,11.04%,CCT7;CCT8
prerank,negative regulation of cellular component organization (GO:0051129),0.24014838211800346,0.7403506666020612,0.8443877551020408,0.9850930005163584,1.0,11/74,13.64%,FAP;RAPGEF3;SRC;LRSAM1;IRAK3;RDX;ISL1;GSK3B;HDAC6;SACS;LCMT1
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2131710300339349,0.7396940646973251,0.9494845360824742,0.9855250238590102,1.0,61/336,17.71%,NFATC2;BCL3;UBE2E2;SMC5;MSH6;POLI;CIDEB;WDR76;PAXX;KMT5C;FANCC;PDS5B;BRSK1;RFC3;FANCF;NBN;UBR5;HIC1;MCL1;MSH2;SUV39H1;FBXO31;AATF;BOD1L1;SFN;MASTL;SIRT7;USP47;TRRAP;APC;ERCC1;TDP1;MEN1;INO80;OARD1;MGMT;RFWD3;ADPRS;GTF2H1;CHCHD6;ETAA1;HTRA2;ALKBH1;POLB;UBA1;REXO4;NEK4;RECQL5;FAM111A;YAP1;DDB2;FANCL;INTS3;BATF;CHD1L;USP45;E2F1;CUL4B;DYRK2;PSME4;BACH1
prerank,cellular response to drug (GO:0035690),-0.24089036356494964,-0.7396349838121704,0.8567493112947658,0.964171051250119,1.0,2/25,3.02%,ACER2;TFRC
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.2346198631463175,-0.7395499118734986,0.8589743589743589,0.963494142671735,1.0,8/30,26.38%,CD34;PLCG2;PRKCZ;LGALS9;ISG15;NOD2;PYCARD;STAT3
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.3053106395542561,-0.7393533545563927,0.7943262411347518,0.9613743708531636,1.0,2/10,5.83%,WRN;BLM
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.3053106395542561,-0.7393533545563927,0.7943262411347518,0.9613743708531636,1.0,2/10,5.83%,WRN;BLM
prerank,t-circle formation (GO:0090656),-0.3053106395542561,-0.7393533545563927,0.7943262411347518,0.9613743708531636,1.0,2/10,5.83%,WRN;BLM
prerank,negative regulation of cilium assembly (GO:1902018),0.3298458340798891,0.739315180479286,0.7652027027027027,0.985604117960093,1.0,4/12,15.72%,LIMK2;CCP110;MAP4;YAP1
prerank,receptor recycling (GO:0001881),-0.30581525024971784,-0.7382696485358274,0.8036529680365296,0.9619325485211089,1.0,4/10,18.43%,ARFGEF2;NSG1;PLEKHJ1;RAB11B
prerank,regulation of macrophage chemotaxis (GO:0010758),-0.24873314820810938,-0.7381920662584681,0.8449197860962567,0.9612444888766748,1.0,7/21,19.84%,CMKLR1;IL34;THBS1;PTK2;CSF1;RARRES2;MIF
prerank,response to UV-B (GO:0010224),0.3346045040922122,0.7376565010165067,0.7756521739130435,0.9875798408947982,1.0,2/12,10.88%,MSH2;MME
prerank,negative regulation of reproductive process (GO:2000242),0.30976233026508243,0.7371673097716331,0.7848932676518884,0.9877909911110936,1.0,2/17,5.04%,SULF1;ACVR1C
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.23761513432207138,0.7371636327054196,0.8628158844765343,0.9872922833676553,1.0,13/86,15.10%,PRKCE;CDC42EP4;TRPV4;FER;NCK2;ARF6;OCLN;PLEK;EFEMP2;CTTN;CFL2;CDC42EP3;SLAIN2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.33024153051269334,0.7371440491871382,0.7975567190226877,0.9868160997080839,1.0,2/13,9.18%,NRARP;COL4A1
prerank,cellular response to oxygen levels (GO:0071453),-0.30741093993699126,-0.7370989899179463,0.8048780487804879,0.9618407981659787,1.0,3/10,22.77%,CPEB4;PICK1;CCDC115
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3494874489345068,0.736952020305454,0.7847222222222222,0.9865834047677455,1.0,2/10,10.68%,PTPN22;MAPK8IP1
prerank,UV protection (GO:0009650),0.35019336707450904,0.736660405864367,0.7626527050610821,0.9865488841558125,1.0,1/10,2.10%,SCARA3
prerank,necroptotic process (GO:0070266),-0.26563620554831024,-0.7365469400934372,0.816793893129771,0.9617570521883845,1.0,6/16,25.91%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,glutathione biosynthetic process (GO:0006750),-0.30166951194263647,-0.7361017957366005,0.8094059405940595,0.961554031668168,1.0,4/11,18.03%,GCLM;CNDP2;GGCT;GCLC
prerank,monocarboxylic acid metabolic process (GO:0032787),0.22772088023873904,0.7355250588873887,0.8713105076741441,0.9876980724247855,1.0,22/117,17.74%,ALDH1A3;PCCB;CYP2S1;HOGA1;CKMT2;DLAT;SCPEP1;ABAT;SLC27A4;ACSF2;GAMT;SLC16A1;ACOT2;MSMO1;PNPLA8;AASDH;GGT1;PANK2;ME2;LDHB;PPARG;LPL
prerank,myelination in peripheral nervous system (GO:0022011),0.33485945951300944,0.7354360905989579,0.7843137254901961,0.9873243852157119,1.0,8/13,24.00%,NF1;CNTNAP1;NCMAP;DICER1;ARHGEF10;PRX;SIRT2;SKI
prerank,DNA strand elongation (GO:0022616),0.3073530389791509,0.7352291111111867,0.7741935483870968,0.9871257991364126,1.0,3/18,8.18%,RFC3;NBN;GINS4
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.2833178547346578,0.735093493437154,0.7881481481481482,0.9868014507982525,1.0,5/29,17.96%,TEX11;SIRT7;MEI4;REC8;SYCP2
prerank,regulation of transport (GO:0051049),0.27182997718596036,0.7349756939122231,0.7875354107648725,0.9864755245040481,1.0,10/36,21.40%,CLDN19;LEPR;CLDN10;WWC1;MBTPS1;PINK1;ICA1L;PRKN;MUL1;VAMP2
prerank,pre-miRNA processing (GO:0031054),-0.2794426782394074,-0.7340273305518065,0.8341121495327103,0.9634296284976319,1.0,4/14,14.65%,ADAR;AGO3;AGO4;TUT7
prerank,mitotic sister chromatid cohesion (GO:0007064),0.3122699127657498,0.7338311009499656,0.8081967213114755,0.9876728336325447,1.0,3/16,17.29%,PDS5B;REC8;DSCC1
prerank,dendritic cell chemotaxis (GO:0002407),0.32237446251958335,0.7338228875505145,0.7668918918918919,0.9871790994310496,1.0,4/14,20.28%,HMGB1;GPR183;CCR5;TRPM4
prerank,recombinational repair (GO:0000725),0.23570113004201868,0.7335265454511993,0.8486005089058524,0.9871001330127941,1.0,18/77,19.02%,SMC5;NBN;PALB2;SWI5;ZSWIM7;ZFYVE26;INO80;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;REV3L;RECQL5;RHNO1;SFR1;PSMD14;MRE11
prerank,positive regulation of protein polymerization (GO:0032273),0.2490275421289331,0.7334917210475367,0.8454661558109834,0.9866609697516516,1.0,15/65,21.99%,PRKCE;CDC42EP4;FER;NCK2;ARF6;OCLN;CTTN;CDC42EP3;SLAIN2;PINK1;BAIAP2;PFN2;NCK1;TENM1;HCK
prerank,regulation of protein binding (GO:0043393),0.22727110189528318,0.7329961429735482,0.8928987194412107,0.9868634764359794,1.0,35/114,24.54%,CAV1;EFHB;ADD1;HDAC4;DACT1;STYX;TRIM21;AMFR;STK3;GSK3B;MEN1;PKD1;CTNNBIP1;CAPRIN2;RAN;GNL3L;BAG2;PPP1CA;SYMPK;PPP2CA;BAX;PIN1;PRKN;MAPK8;DDX11;AKTIP;TCF7L2;DERL1;NMD3;DTX3L;PRMT8;PRKCD;RIPK2;HIPK2;ROCK1
prerank,chromatin assembly or disassembly (GO:0006333),0.3387152727529736,0.7325915027146039,0.7815699658703071,0.9869930348526071,1.0,3/11,20.25%,CDAN1;SUV39H2;RBBP4
prerank,regulation of neurogenesis (GO:0050767),0.2477066387227104,0.7325439231391875,0.8491321762349799,0.9865717002575355,1.0,13/55,21.68%,RGS14;HEYL;BHLHE40;MME;DOCK7;HOOK3;PCM1;GPER1;YAP1;NAP1L1;IL6;CX3CR1;CX3CL1
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.32645819649761315,0.7325337052610476,0.776,0.9860814473942048,1.0,6/15,26.21%,CNTNAP4;ZDHHC3;ZDHHC12;NLGN2;USP46;ADRA1A
prerank,membrane depolarization during action potential (GO:0086010),0.29215622360416343,0.7318707352692378,0.7984962406015037,0.9865563288277842,1.0,3/26,5.19%,SCN10A;CACNA1H;ATP1A2
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.28518263883153344,-0.7310015988789292,0.8154205607476636,0.9663288923310424,1.0,1/13,1.43%,GLI3
prerank,inflammatory response (GO:0006954),0.216348590541724,0.7309846805116482,0.907027027027027,0.9873068795480809,1.0,8/195,4.50%,HRH1;F11R;PTGFR;FOLR2;IL1A;HDAC4;HNRNPA0;REL
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.21152173338967117,-0.7304686722957973,0.9083969465648855,0.966202041473422,1.0,7/40,14.31%,PID1;ARL6IP5;AKT1;VCP;LRRK2;SLC25A33;MAPT
prerank,regulation of trophoblast cell migration (GO:1901163),-0.2774706601054806,-0.7302168139684432,0.8054862842892768,0.9657238697678762,1.0,7/14,31.98%,GJA1;SMURF2;C1QBP;YTHDF3;ACVR1B;CALR;TIMP1
prerank,establishment of mitotic spindle orientation (GO:0000132),0.2914125513372266,0.7299055104611172,0.7904191616766467,0.9883331559071329,1.0,8/23,22.15%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.27292850304309146,0.7298820994196729,0.8019525801952581,0.9878704960798096,1.0,7/34,16.89%,DOCK5;DOCK1;RREB1;FERMT2;P4HB;MDK;ARHGEF7
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.300339534424352,0.7298537659373322,0.7829457364341085,0.987410672174934,1.0,7/21,16.76%,FKBP1B;BOD1L1;GSK3B;MASTL;ENSA;PTPA;YWHAE
prerank,neurotransmitter biosynthetic process (GO:0042136),0.31260951817197297,0.7295386145158858,0.7817589576547231,0.9873760650969161,1.0,1/14,1.67%,ALDH9A1
prerank,mitochondrial fission (GO:0000266),0.31307537990177575,0.7294628169281858,0.7733118971061094,0.9869751686199656,1.0,3/16,8.64%,DNM1;FIS1;MIEF1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3323520317696477,0.7284314853118378,0.7762711864406779,0.9879223919070294,1.0,2/12,4.99%,PTPN22;PTPRC
prerank,peptidyl-serine dephosphorylation (GO:0070262),-0.2676114549933713,-0.7278138743326344,0.8386363636363636,0.9678508260810174,1.0,1/14,1.35%,PPP2R2B
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.2773298513807123,0.7276255610337583,0.8212121212121212,0.9885811921207005,1.0,6/30,15.93%,TNIP3;TICAM1;UBE2D3;UBE2D1;TICAM2;TBK1
prerank,O-glycan processing (GO:0016266),0.24909724479221518,0.7272083797211745,0.8371467025572006,0.9886883096145822,1.0,5/54,9.51%,ST3GAL4;C1GALT1C1;GCNT4;POFUT1;ST6GAL1
prerank,dendritic cell migration (GO:0036336),-0.2609750694106657,-0.7270270196274763,0.844059405940594,0.9680122814653428,1.0,1/16,0.58%,EPS8
prerank,response to UV (GO:0009411),0.22991149855626455,0.7267326591371539,0.9036860879904876,0.9888680587947378,1.0,14/95,13.12%,EGFR;SCARA3;BCL3;MSH6;BRSK1;N4BP1;MSH2;USP47;ERCC6;NEDD4;MEN1;INO80;AQP1;CREBBP
prerank,regulation of early endosome to late endosome transport (GO:2000641),0.2976330806542537,0.726652022209085,0.8057784911717496,0.9884650596246142,1.0,7/18,18.46%,SRC;RDX;EZR;RAB21;VPS11;SNX12;DENND10
prerank,ncRNA export from nucleus (GO:0097064),0.2635111222937178,0.7265088905626076,0.8316831683168316,0.9881794868380958,1.0,10/36,15.46%,NUP62;NUP160;NUP37;TPR;NUP50;RANBP2;NUP210;NUP153;RAN;NUP93
prerank,protein mono-ADP-ribosylation (GO:0140289),0.33676866726610044,0.7254132028269209,0.7597955706984668,0.9892062545299928,1.0,4/11,22.08%,PARP11;PARP6;PARP8;TIPARP
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.3353864970408027,0.7252142161741719,0.7539823008849558,0.9890049743400865,1.0,2/11,8.11%,PCBP2;IGF2BP2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.286819167537045,-0.7250467047754942,0.7995226730310262,0.9695632604483302,1.0,6/12,30.04%,WAC;PLK5;RPS27L;CDK2;CCND1;PLK3
prerank,negative regulation of binding (GO:0051100),0.23289001721718006,0.7246018357987112,0.8743781094527363,0.9893179196525563,1.0,20/81,21.86%,CAV1;EFHB;DACT1;STYX;GSK3B;SMO;CTNNBIP1;GNL3L;BAG2;E2F1;PPP1CA;SYMPK;SUMO1;BAX;PIN1;HABP4;MAPK8;RSF1;DDX11;JUN
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.29192847471104477,0.7245113096759742,0.8090614886731392,0.9889373677719302,1.0,5/23,19.24%,ALOXE3;LTA4H;ELOVL6;HPGD;FADS1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.2698674714868169,-0.7241740072472911,0.8176943699731903,0.9698297351143804,1.0,6/15,22.10%,SPHK1;SMPD3;ORMDL1;ORMDL2;RACK1;ORMDL3
prerank,sulfur amino acid metabolic process (GO:0000096),-0.23509758787074492,-0.7237742340372154,0.8904494382022472,0.969525145262221,1.0,11/24,31.64%,NOX4;MTHFR;MTR;MTRR;CBS;GCLC;ADI1;CTH;MSRA;MPST;CDO1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.3016990927254133,0.7235643809370396,0.7900641025641025,0.9897644822987343,1.0,5/20,23.90%,ANO6;GPER1;RGCC;IL6;PDCD4
prerank,positive regulation of interferon-alpha production (GO:0032727),0.3031140057600453,0.7230044185554915,0.8073248407643312,0.9900549360538747,1.0,6/19,24.19%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2
prerank,V(D)J recombination (GO:0033151),-0.2972965114055644,-0.7224450731785349,0.8355855855855856,0.9702686511649188,1.0,4/11,24.88%,DCAF1;LIG3;XRCC4;LIG4
prerank,neuron remodeling (GO:0016322),-0.3041713951711751,-0.7220027944956355,0.8239130434782609,0.9699669519252858,1.0,5/10,31.39%,EPHA8;C1QA;C3;SCARF1;RND1
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2295465764707187,-0.7205419461178236,0.8974358974358975,0.9700803455953716,1.0,14/29,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2295465764707187,-0.7205419461178236,0.8974358974358975,0.9700803455953716,1.0,14/29,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,mesenchymal cell development (GO:0014031),0.3040123498109141,0.7205145125613811,0.7960526315789473,0.9930389013896884,1.0,2/18,7.86%,HEYL;CDH2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.337288457475905,0.7196832334829913,0.7766143106457243,0.9936582829203084,1.0,2/10,8.00%,DPP4;PIEZO1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.23732644713442533,0.7196729526285489,0.8847150259067358,0.9931783366105831,1.0,17/65,18.75%,PSME3;CHFR;PSMB5;USP47;CHMP4C;FHL1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;INTS3;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,regulation of mRNA stability (GO:0043488),0.21961259974967712,0.7193636215669931,0.9264705882352942,0.9931110906276837,1.0,35/145,22.22%,FXR2;DND1;GIGYF2;CELF1;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;TENT5C;AXIN2;TENT5D;TAF15;ZFP36L2;PSMB2;FXR1;PSMA2;PUM2;FASTKD1;PSMA6;PSMD13;PSMA7;E2F1;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;HNRNPD;EXOSC7;PUM1;PSMB3;ELAVL1;YWHAB
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),0.2480192269219177,0.7192112888915677,0.8548812664907651,0.9928163187191033,1.0,12/57,15.99%,BRCC3;BRSK1;NBN;RINT1;FBXO31;UIMC1;MDC1;DONSON;RFWD3;EME2;FZR1;NEK11
prerank,regulation of necroptotic process (GO:0060544),0.2863761831156817,0.7188924698461373,0.8070987654320988,0.9927718342953836,1.0,3/23,9.03%,OGT;FLOT2;PDCD6IP
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.242069290406239,-0.718557661249239,0.8776595744680851,0.9715897265241117,1.0,6/22,18.58%,PHF8;DHX33;NCL;HEATR1;PWP1;ATF4
prerank,regulation of cell growth (GO:0001558),0.2114846316014313,0.7179921837073194,0.932092004381161,0.9935098139610861,1.0,47/204,21.75%,PTCH2;VGLL4;PLCE1;CEACAM1;CAMK2D;EGFR;DCBLD2;ADAM10;NDUFS3;LTBP4;PTPRJ;EBAG9;RPS6KA3;USP47;S100A9;SGK1;INO80;KIF26A;CRLF3;FHL1;NAIF1;RTN4;CAPRIN2;KLHL22;SIPA1;NDRG3;EI24;ERBB2;ARHGEF11;RAB33B;MMP14;MINAR1;ITCH;SOCS2;PPP2CA;EIF4G2;RPTOR;MUL1;CISH;CEP43;FRZB;CCAR2;SERTAD2;OSGIN1;ENO1;TAF9B;RBBP7
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.1846644432232043,-0.7177010602353918,0.9669811320754716,0.9717469744538976,1.0,19/72,22.71%,ENPP1;EDC3;RBX1;EDC4;ZC3H12A;PNRC2;ERCC2;XPA;POLK;SPO11;MUS81;RFC2;PDE12;GTF2H4;DDX1;PARP1;ERCC4;ERCC5;POLD2
prerank,histone mRNA metabolic process (GO:0008334),-0.22943893236483276,-0.7175154252453506,0.8927444794952681,0.9711785046638268,1.0,10/27,27.27%,SSB;TENT2;SNRPE;TUT7;MTPAP;NCBP1;LSM11;DCP2;SLBP;ATM
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.34373000841394585,0.7172449524273629,0.7922535211267606,0.9940240215120741,1.0,2/10,7.87%,CHFR;DIS3L2
prerank,mitochondrial transport (GO:0006839),0.24301546873632462,0.7171855478425666,0.8460526315789474,0.9936090222188693,1.0,9/53,16.94%,TOMM34;MFN2;FIS1;SLC25A13;TOMM40;STARD3;BAD;BCS1L;BNIP3
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),-0.25915796140466163,-0.7171650177563446,0.8316831683168316,0.9708236702651714,1.0,7/16,28.56%,SLC39A14;GSK3A;MRAP2;PDE6H;C3;ACP3;GRP
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.30660755596694245,0.7168579753094898,0.8117647058823529,0.9935483159815511,1.0,6/17,17.11%,APLN;TAFA5;EFEMP2;PTEN;GPER1;PPARG
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.23018530030443302,0.7164711396142777,0.8932853717026379,0.993570481610921,1.0,14/88,14.11%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;CLN8;PUS7;IGF2BP2;CNOT7;RIC1;ILF3;HDAC6;DDX6;FXR1
prerank,regulation of cytokine production (GO:0001817),0.22176980623756753,0.7159705838362393,0.9040462427745665,0.9937651797271309,1.0,15/126,10.37%,GLMN;ITK;TXK;IL1A;PTPRC;TRIM21;N4BP1;PLD3;CRTAM;PTGER4;IGF2BP2;DTX4;NLRP4;HILPDA;ADRA2A
prerank,tRNA processing (GO:0008033),0.24300330412450277,0.7157235576803901,0.8685567010309279,0.9935838985879822,1.0,18/61,23.14%,TSEN54;PUS3;WDR4;CDKAL1;KARS1;POP7;RTRAF;TSEN34;FTSJ1;ADAT1;ANKRD16;URM1;TYW5;PTCD1;RPP21;THG1L;TRMT1;RPP30
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.33656188029961337,0.7156467113974125,0.7841328413284133,0.9931921078367923,1.0,5/10,22.93%,BAG3;NCK1;JUN;IMPACT;SIRT2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.2898982806748235,-0.7154357063938694,0.8144796380090498,0.9720082980387048,1.0,2/11,12.14%,SLC30A10;ABCD2
prerank,fluid transport (GO:0042044),0.32298473596686106,0.7153085245201091,0.7959866220735786,0.993140164763326,1.0,3/12,21.70%,SLC4A11;AQP1;SLC26A6
prerank,positive regulation of histone modification (GO:0031058),0.2666396307645805,0.7152998197754421,0.8363095238095238,0.9926565782209,1.0,3/33,9.16%,PPARGC1A;PAF1;TET1
prerank,cellular lipid catabolic process (GO:0044242),0.2773313055506574,0.7152902795029547,0.812051649928264,0.9921772041046314,1.0,4/27,10.29%,CEL;MGST2;ABHD12;ACOT8
prerank,regulation of postsynaptic membrane potential (GO:0060078),-0.21623274365998107,-0.7151740688930827,0.9302325581395349,0.9715686001449408,1.0,6/34,11.97%,GRIN2B;GABRA2;AKT1;GRIN1;LRRK2;GSK3A
prerank,positive regulation of JNK cascade (GO:0046330),0.2328689307825791,0.715014791172673,0.8580645161290322,0.9920381906719393,1.0,10/70,12.05%,AXIN1;SH3RF2;MINK1;WNT16;SEMA3A;MAP3K5;HMGB1;RASSF2;MAPK8IP1;MTURN
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),-0.25184929451956817,-0.7149134149047877,0.8583333333333333,0.9710822539649694,1.0,4/17,22.83%,WASF3;FCHSD2;PICK1;CORO1B
prerank,metal ion transport (GO:0030001),0.23266988888811524,0.7143816162846542,0.8890229191797346,0.992422635819482,1.0,4/86,4.37%,CAV1;SLC24A1;TRPV4;SLC30A9
prerank,entry into host (GO:0044409),0.3126090452966297,0.7138635286593157,0.7937293729372937,0.992639021827692,1.0,3/13,15.39%,SRC;CCR5;CDH1
prerank,regulation of mast cell activation (GO:0033003),-0.2972531979590286,-0.7136136830945715,0.8382022471910112,0.9717278187906457,1.0,7/10,42.19%,LYN;CRLF2;MILR1;CD300LF;CD84;TSLP;CD226
prerank,vitamin D metabolic process (GO:0042359),0.3149746505413251,0.7135461801754452,0.7775891341256367,0.9925851799951656,1.0,2/13,10.15%,CUBN;GC
prerank,neutrophil activation involved in immune response (GO:0002283),0.20335877114233475,0.7135124955606811,0.9795081967213115,0.9921447196522166,1.0,79/428,19.51%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;SYK;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.2983207600663537,0.7133973419317552,0.8089171974522293,0.9918070131249929,1.0,7/19,20.41%,HDAC6;HTRA2;HTT;FBXW7;CSNK2A2;PINK1;PRKN
prerank,atrioventricular valve development (GO:0003171),-0.2773012274829363,-0.7131663432387371,0.8578680203045685,0.9714485310300263,1.0,5/14,25.08%,BMPR2;BMP2;TGFB2;APLNR;NOTCH1
prerank,positive regulation of insulin secretion (GO:0032024),0.263674164006323,0.712822499387729,0.831858407079646,0.9920925377322918,1.0,13/36,22.13%,GPLD1;ISL1;GCK;SOX4;GPER1;BAD;ADCY8;STX4;IRS2;GLUD1;TRPM4;TCF7L2;NLGN2
prerank,positive regulation of translation (GO:0045727),0.22541606355001328,0.7127616710879926,0.900709219858156,0.9916827109784716,1.0,26/94,23.75%,BCL3;FXR2;PIWIL2;RMND1;FASTKD2;METTL5;PLD1;UPF3B;NSUN5;MPV17L2;SOX4;FXR1;PYM1;CPEB3;ERBB2;RPUSD4;DHX9;YBX3;HNRNPD;LARP4;IL6;HABP4;ELAVL1;PKM;NIBAN1;MTOR
prerank,regulation of autophagosome assembly (GO:2000785),0.26690689957970615,0.712617837211778,0.8272859216255443,0.9913726688667581,1.0,6/33,10.71%,LRSAM1;PIP4K2B;RAB3GAP2;MTMR3;CHMP4A;CHMP4B
prerank,phagosome acidification (GO:0090383),-0.23102272222533468,-0.7121324132836416,0.8997214484679665,0.9718483663162737,1.0,8/26,24.02%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;ATP6V1F;RAB7A;ATP6V1E1;RAB38
prerank,regulation of intracellular transport (GO:0032386),0.2569599289291482,0.7118840040837461,0.8415841584158416,0.9918998112491861,1.0,10/38,21.28%,RINT1;INPP5F;ATP9A;LAMP1;WWC1;TTC21B;ATPSCKMT;LCP1;DNAJC30;GRIPAP1
prerank,coenzyme A metabolic process (GO:0015936),-0.26843219095829457,-0.7118433344543353,0.8595641646489104,0.9713860551589598,1.0,6/14,24.11%,ACOT7;PANK1;ACLY;PPCDC;PANK3;DCAKD
prerank,cellular response to lectin (GO:1990858),0.21885619065476206,0.7115941786981189,0.9250614250614251,0.991300370691508,1.0,23/104,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.21885619065476206,0.7115941786981189,0.9250614250614251,0.991300370691508,1.0,23/104,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,cellular response to tumor necrosis factor (GO:0071356),0.21311965223862103,0.7114939303790748,0.9382022471910112,0.9909429288465935,1.0,35/175,22.11%,EDA;TNFSF8;ADAMTS12;FOXO3;PSME3;TRADD;ACOD1;PSMB5;NFE2L2;CDIP1;TNFRSF11B;ZFP36L2;TXNDC17;PSMB2;PSMA2;PSMA6;GPER1;TNFRSF14;PSMD13;PSMA7;PSME4;ASAH1;PSMC4;PSMB6;PSMD12;PSMD14;DHX9;YBX3;CCL14;ST18;TRAF3;TRAF5;PSMB3;CX3CL1;LTBR
prerank,nuclear export (GO:0051168),0.22909409855960217,0.7112963296801579,0.8851851851851852,0.9907299081569333,1.0,21/80,21.77%,RBM8A;SRSF4;NUP62;EIF4E;TPR;UPF3B;CSE1L;NUP153;PKD1;THOC3;LSG1;RAN;THOC5;CHP1;XPO5;SLU7;SRSF3;DHX38;SRSF11;STRADB;XPO4
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),0.23040879797788355,0.7106424550006598,0.9016189290161893,0.991118552301346,1.0,5/77,6.97%,ITGA6;SRC;PSME3;NDUFS3;MCL1
prerank,DNA replication initiation (GO:0006270),-0.21016217687002753,-0.7105283763433148,0.9006849315068494,0.9721172859076331,1.0,17/37,32.05%,PRIM2;POLE4;MCM6;ORC2;POLA1;LRWD1;CDC7;TOPBP1;CDC45;POLA2;CDK2;MCM3;MCM7;POLE3;MCM5;MCM10;MCM2
prerank,positive regulation of T-helper cell differentiation (GO:0045624),0.31535910592344685,0.7103705232536354,0.8169491525423729,0.9910111701352146,1.0,2/14,7.46%,SOCS5;RARA
prerank,protein localization to mitochondrion (GO:0070585),0.32863560857315166,0.7100654242964803,0.8177083333333334,0.990943211177798,1.0,1/11,1.86%,HK2
prerank,release of cytochrome c from mitochondria (GO:0001836),0.30213696541392565,0.709972478868766,0.7888888888888889,0.990570644145561,1.0,8/17,27.22%,FIS1;SFN;FZD9;BAD;BAX;DNM1L;MFF;BCL2L1
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2502158732349383,0.7099341866459243,0.8598901098901099,0.9901314392479065,1.0,14/45,23.66%,FOXO3;GCNT2;EIF4E;ATXN2;EIF2B4;PUM2;SPOUT1;LARP4;NUDT21;ATG14;PUM1;DDX25;YTHDC1;ZC3H7B
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.2883082860493246,-0.7094415754243677,0.8348623853211009,0.9725147142402092,1.0,5/11,32.17%,SMARCD1;SERTAD1;ZMIZ2;CDCA4;ZMIZ1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.24959959015951838,-0.7094112903471712,0.8409703504043127,0.9717640901415343,1.0,1/18,0.68%,SMAD3
prerank,innate immune response in mucosa (GO:0002227),0.332283462367789,0.7093967411766128,0.8014311270125224,0.9903531468631491,1.0,2/10,18.92%,DEFA6;RNASE3
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.3040701627650775,-0.7092224754455894,0.8235294117647058,0.9711875037299916,1.0,2/10,4.89%,HOXB4;ACE
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.3114980223873981,0.7091455847852999,0.818815331010453,0.9902062419882289,1.0,3/15,9.57%,TMEM129;SELENOS;NPLOC4
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.2400493625406259,0.7087441739273506,0.8660477453580901,0.9902537394369716,1.0,21/59,25.71%,CAMK2D;PRKCA;HIPK1;DYRK1A;CAD;GSK3B;CIT;TBK1;LMTK2;DYRK2;CSNK2A2;PDPK1;CDC42BPG;ACVR1;MAPK8;MAPK1;PRKCD;HIPK2;ROCK1;TNKS;TAF1
prerank,peptidyl-arginine modification (GO:0018195),-0.26301043306863,-0.7087381452054685,0.8875,0.9709111195959504,1.0,11/15,50.67%,ART3;PRMT7;KRTCAP2;PRMT1;PADI2;PARK7;ART1;PADI1;PADI4;ART4;ART5
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21776823038354054,0.7086526819618841,0.9277845777233782,0.9898713579683075,1.0,23/105,18.93%,SRC;PSME3;NRAS;KRAS;PSMB5;TAB2;CREBBP;PRKACB;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;RELB;SYK;PAK3;PSME4;PSMC4;PSMB6;PSMD12;PDPK1;PSMD14;RAF1
prerank,cardiac muscle cell action potential (GO:0086001),0.2729497302686624,0.7082054057294792,0.834061135371179,0.9899406386835731,1.0,3/30,5.19%,SCN10A;SLC4A3;ATP1A2
prerank,protein oxidation (GO:0018158),-0.2864764202507665,-0.7081617330520523,0.8431818181818181,0.970795086914063,1.0,2/11,12.25%,LOXL1;LOXL3
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.30710563756454423,0.7076678341220823,0.8047138047138047,0.9901342513306819,1.0,2/15,7.89%,FAP;DPP4
prerank,histone modification (GO:0016570),0.2226177146429608,0.7074434539927563,0.9057714958775029,0.9899399207695209,1.0,19/109,15.99%,EYA1;KAT6B;HDAC4;TAF10;RCOR3;SIN3B;MSL3;SIRT7;HDAC2;TRRAP;HDAC6;PHF20L1;CREBBP;BAZ2A;KAT8;BRD8;PRMT6;MORF4L2;NEK11
prerank,neutrophil degranulation (GO:0043312),0.20187371117783207,0.70736973207175,0.9825462012320328,0.9895501581487083,1.0,78/425,19.51%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,spindle assembly (GO:0051225),0.23761914950269727,0.7072526110425902,0.879021879021879,0.9892316273518442,1.0,21/67,26.17%,KIF2A;SMC3;NEK7;NCOR1;TUBGCP5;MAP9;INO80;MAPRE2;ARHGEF10;PIBF1;OFD1;RHOA;HDAC3;TUBGCP6;HAUS8;HAUS3;HAUS7;NEK6;CSNK1D;TNKS;CLASP2
prerank,protein import into peroxisome matrix (GO:0016558),-0.28436801228769615,-0.7070090976685062,0.817351598173516,0.9712623952393818,1.0,4/12,19.50%,PEX26;PEX6;PEX1;PEX10
prerank,TOR signaling (GO:0031929),0.2774144035892079,0.7069510736429929,0.8377192982456141,0.989156662777818,1.0,3/26,10.01%,PRR5;SYAP1;MAPKAP1
prerank,JNK cascade (GO:0007254),0.2533583442939909,0.7063280608405323,0.8394886363636364,0.9894747402377615,1.0,6/40,12.01%,MINK1;MAPK10;MAP3K5;PTGER4;TAB2;ARHGEF6
prerank,autophagy of peroxisome (GO:0030242),-0.2861751241169949,-0.7062519644764282,0.8542713567839196,0.9712896845772147,1.0,4/12,15.58%,SQSTM1;NBR1;ACBD5;USP30
prerank,mitochondrial translational elongation (GO:0070125),0.22755703467575653,0.7061982981877734,0.909310761789601,0.9891695769443257,1.0,34/88,27.92%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;MRPL40;MRPL22;GADD45GIP1;MRPL4;MRPL2;MRPL34;GFM1;TSFM;MRPS7;MRPL11;MRPL19;MRPL39;MRPS18A;MRPL1;MRPL13;MRPL47;MRPL21;DAP3;MRPL57;MRPL46;GFM2
prerank,translational termination (GO:0006415),0.22603039302532174,0.705695706158448,0.9186893203883495,0.9893307623777376,1.0,21/95,18.18%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;ETF1;CHCHD1;MRPL16;MTRF1L;MRPL40;MRPL22;MRRF;GADD45GIP1;MRPL4;MRPL2
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.33448990980075183,0.7054855365062023,0.7923875432525952,0.9891361130964064,1.0,3/11,21.16%,HMGB1;CBFB;RUNX1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),-0.22832654118051765,-0.7050861717965775,0.9053254437869822,0.9717711730364186,1.0,10/24,27.21%,RBPJ;HIF1A;KLF2;HSF1;CEBPB;ATF4;ATF6;NOTCH1;ATF3;ATF6B
prerank,negative regulation of cellular catabolic process (GO:0031330),0.23934699687998018,0.70501414904949,0.8876117496807152,0.9892622950712245,1.0,9/63,11.08%,LEPR;GPLD1;FOXK1;PTPN22;MCL1;FOXK2;EIF4E;RIC1;TAB2
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.28695486112533025,0.704882084023981,0.8206785137318255,0.9889504960384888,1.0,3/21,6.60%,EIF2AK3;CREB3L1;SELENOS
prerank,telomere capping (GO:0016233),0.30395256408302535,0.7047841184666707,0.8026981450252951,0.9885904253126446,1.0,4/16,19.02%,STN1;NBN;TERF2;MRE11
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.27436368420466695,-0.7042722686903745,0.8192488262910798,0.9718520461241338,1.0,4/13,17.74%,ZC3HAV1;ZC3H12A;MOV10;RC3H1
prerank,serine family amino acid metabolic process (GO:0009069),-0.2599457630261595,-0.7040932407269633,0.8670360110803325,0.9712309167539905,1.0,9/16,34.20%,PSPH;CBS;GCLC;SEPHS2;CTH;THNSL2;SHMT2;CDO1;SHMT1
prerank,urogenital system development (GO:0001655),0.32977929810091866,0.7040657765308994,0.8236272878535774,0.9890304477919902,1.0,2/11,6.39%,SOX9;EPHB2
prerank,pentose-phosphate shunt (GO:0006098),-0.2845583923470894,-0.7039262789003702,0.8359550561797753,0.9706242640432171,1.0,4/11,19.24%,RPIA;PGLS;PGD;RBKS
prerank,positive regulation of RNA splicing (GO:0033120),0.2677248789325013,0.7035574355381816,0.8476621417797888,0.9892219031907332,1.0,7/29,14.85%,SLC38A2;RBM22;DYRK1A;CELF4;RBMXL1;ERN1;TRA2B
prerank,cGMP biosynthetic process (GO:0006182),-0.2990009050130346,-0.7034506703547991,0.8109339407744874,0.9703276286338133,1.0,1/10,4.51%,NPR1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.23858796695884502,0.7033735855749028,0.892904953145917,0.9889953871265283,1.0,17/53,24.50%,PSME3;BCKDK;PSMB5;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;PSMB3;OAZ2;AZIN1;PSMD2
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.27920299652232505,0.7032668497969434,0.8293838862559242,0.9886501749663014,1.0,5/23,14.66%,DFFB;HMGB1;EXOG;DICER1;REXO4
prerank,neural crest cell migration (GO:0001755),0.26180416551726243,0.7032221949155947,0.854493580599144,0.9882239264415718,1.0,9/36,18.70%,FOLR1;SEMA4B;FN1;SEMA3A;SEMA4D;SEMA6C;ERBB4;SEMA4C;SEMA4A
prerank,retrograde axonal transport (GO:0008090),0.29561039986808113,0.7027908929026129,0.827140549273021,0.9883075668274718,1.0,6/16,22.15%,ACTR10;PAFAH1B1;KIF5A;KIF5B;DLG2;FBXW11
prerank,cellular response to glucose stimulus (GO:0071333),0.26497804753338317,0.7025151587159064,0.8512160228898427,0.9882075304469311,1.0,8/30,15.57%,ZBTB20;RAB11FIP5;ERN1;SOX4;UNC13B;TRA2B;GPER1;ADCY8
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.30833684485353324,0.702404494824615,0.8094462540716613,0.9878706768285366,1.0,1/15,1.39%,AK5
prerank,oligodendrocyte differentiation (GO:0048709),0.29011386724519705,0.702018153525443,0.827140549273021,0.9878836465310622,1.0,4/19,13.10%,EIF2B3;SOX9;EIF2B4;NSUN5
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.2360297737115978,-0.7014010119719818,0.8756345177664975,0.9716733405784512,1.0,4/22,14.99%,B2M;TRAF6;CYRIB;ZBTB1
prerank,histone H3 acetylation (GO:0043966),-0.20436293362518254,-0.7011519322825842,0.9283387622149837,0.9711556865954977,1.0,10/40,18.35%,LEF1;JADE1;TRIM16;KAT14;PHF14;SGF29;DR1;KAT2B;KAT2A;JADE2
prerank,tRNA modification (GO:0006400),0.2410834808874596,0.7010969653488596,0.859395532194481,0.9885537560251229,1.0,19/62,22.37%,TARBP1;PUS7;PUS3;WDR4;CDKAL1;THADA;FTSJ1;TRMT5;ALKBH1;ANKRD16;URM1;TYW5;THUMPD3;METTL2B;METTL2A;OSGEP;TRMO;THG1L;TRMT1
prerank,sodium ion import across plasma membrane (GO:0098719),0.3001249690407365,0.7010177478120574,0.8100840336134454,0.9881702758381775,1.0,3/17,11.18%,SLC12A2;SLC9A7;SLC9A6
prerank,centromere complex assembly (GO:0034508),-0.20791681432862164,-0.7008222641606192,0.9265734265734266,0.9707159336564208,1.0,16/36,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPE;CENPX;CENPI;MIS18A;CENPN;CENPF;CENPA
prerank,lipid biosynthetic process (GO:0008610),0.2260825696043121,0.7003236839991175,0.8983890954151177,0.9885694269466742,1.0,15/77,20.42%,HSD17B3;AGPAT4;CLN8;SCD5;ACACA;AGPAT5;PRLR;LSS;SCD;LPL;STAR;AGPS;FADS1;GGPS1;DOLPP1
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.26120636256884505,0.7002528333484375,0.8516886930983847,0.9881840344097711,1.0,10/31,22.62%,DCP1B;EXOSC5;DIS3L2;CNOT7;DDX6;CNOT8;LSM3;EXOSC7;DCPS;LSM2
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.29666177723400816,0.699523897504386,0.8071065989847716,0.9886378653887372,1.0,6/17,21.89%,TMEM129;SELENOS;NPLOC4;HM13;SEL1L;DERL1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.3166479416551217,0.6993815299155342,0.8175787728026535,0.9883374309980386,1.0,2/13,7.60%,BMS1;NOP14
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.30357199479185565,0.6991562374416339,0.8097560975609757,0.9881377793964737,1.0,1/15,1.84%,KCNA5
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.28796668505538164,0.698413701538014,0.8290322580645161,0.9885855195374549,1.0,4/18,14.35%,SEC14L1;NPLOC4;USP15;PUM2
prerank,negative regulation of cell cycle process (GO:0010948),0.23516241913585478,0.6983468443395968,0.8701298701298701,0.9881846980763253,1.0,18/61,24.76%,FBXO43;TOM1L1;FBXO5;CCP110;TOM1L2;CHMP4C;GPER1;E2F1;TERF2;FOXO4;RBBP4;CHMP2A;RBBP7;TFDP1;NME6;BMP7;APAF1;CBX3
prerank,neurogenesis (GO:0022008),0.25177126309104747,0.6982928314773965,0.8614540466392319,0.98778063201654,1.0,6/43,13.55%,LPAR1;NTN5;BTBD2;ERCC6;WDR62;CIT
prerank,purine ribonucleotide catabolic process (GO:0009154),0.2836977775625918,0.6980152820875096,0.8422712933753943,0.9876592414334624,1.0,5/21,12.50%,PDE4D;ACAT1;NT5E;NT5C2;NUDT18
prerank,histone exchange (GO:0043486),-0.20691483951330306,-0.6978816811046865,0.9506578947368421,0.9730163748904658,1.0,16/37,31.96%,NPM1;RUVBL1;SMARCA5;ANP32E;CENPT;RNF8;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,negative regulation of myotube differentiation (GO:0010832),-0.27976067121931736,-0.6966262224948004,0.8490566037735849,0.9734930575713621,1.0,5/12,25.08%,CCN3;HDAC1;BDNF;XBP1;NOTCH1
prerank,positive regulation of type I interferon production (GO:0032481),-0.17658169356043574,-0.6963232615934011,0.9641025641025641,0.9730355093491904,1.0,17/73,21.44%,EP300;POLR3E;POLR3B;IRF1;GAPDH;POLR3A;DHX33;POLR3H;ISG15;DHX36;POLR2F;FLOT1;POLR2K;CGAS;TLR3;POLR1C;RIOK3
prerank,axon extension (GO:0048675),0.28080046065243053,0.6961180832018151,0.8307210031347962,0.9895556457948925,1.0,7/23,21.72%,NRP2;SEMA3A;SLC9A6;AUTS2;USP9X;SPG11;NLGN3
prerank,regulation of secretion (GO:0051046),-0.2721916047274601,-0.6957849559308987,0.8486352357320099,0.9728020420791891,1.0,2/13,2.67%,ACSL3;MYO6
prerank,"transcription, DNA-templated (GO:0006351)",0.2043974310425677,0.6953898118332715,0.9603429796355841,0.9900025262691985,1.0,38/207,18.15%,DTX1;BCL3;MLLT3;FOXO3;TAF10;LEO1;GTF3C6;TAF4B;CDK7;PAF1;RREB1;SMN1;POLR3G;ELL;NELFB;SUPT4H1;TFB2M;ERCC6;NAT14;NFKBIB;GTF2F2;TAF15;BRF2;GTF2H1;TRIP11;GTF3C5;MBD1;BAZ2A;CBFB;TEFM;TAF5;CRCP;ELOA;E2F1;RTF1;TCEA1;TSC22D1;GTF2H3
prerank,regulation of telomere maintenance (GO:0032204),0.27421886765942505,0.6953844693865457,0.8516819571865444,0.9895308395832167,1.0,12/26,28.08%,NBN;ERCC1;TERF2;MRE11;HNRNPD;SMG6;ATRX;PML;YLPM1;RAD50;SMG5;TERF2IP
prerank,natural killer cell mediated immunity (GO:0002228),-0.2614004749309272,-0.6949186439232988,0.8552971576227391,0.9728912157123335,1.0,4/15,21.88%,CEBPG;TUBB4B;PLEKHM2;RAET1E
prerank,regulation of transcription by RNA polymerase I (GO:0006356),0.29112781193435044,0.694606503828437,0.82,0.9900357322328621,1.0,3/18,9.58%,EIF2AK3;UTP15;SIRT7
prerank,long-term memory (GO:0007616),0.2868178371852794,0.6937241657669834,0.8206785137318255,0.9906487951984783,1.0,4/19,15.60%,RGS14;SGK1;NFATC4;CPEB3
prerank,cellular response to misfolded protein (GO:0071218),0.27999647816788,0.6918050175266318,0.8381877022653722,0.9925455215579937,1.0,10/20,30.01%,CUL3;RNF185;KLHL15;UBE2W;DERL1;STUB1;UGGT1;UGGT2;DNAJB12;DNAJC18
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.21767707664612912,0.6917687712287354,0.9288214702450408,0.9921097028406343,1.0,10/104,8.84%,TRIB2;CCND3;SRC;SLC27A1;TSG101;CCNG1;CDK7;SYAP1;CCNJ;IRGM
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),-0.26122187515155626,-0.6913110933044996,0.8839050131926122,0.9755813585892671,1.0,6/15,21.80%,ATF2;TIPIN;MUS81;RAD17;RAD9B;FANCD2
prerank,osteoclast differentiation (GO:0030316),0.2824130477262568,0.691134931452646,0.829073482428115,0.9923935712857317,1.0,4/22,11.78%,SRC;SNX10;GAB2;GPR183
prerank,regulation of mitochondrial membrane permeability (GO:0046902),0.29781520146278234,0.6908259220289119,0.824212271973466,0.9922980496564808,1.0,9/18,29.30%,NAIF1;BAD;BNIP3;MUL1;BCL2L1;SLC25A5;SPG7;PPIF;BCL2
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.2671653577167741,-0.6897464079731501,0.8729411764705882,0.9763812428100058,1.0,5/13,22.42%,FLNA;SUFU;DBN1;GOPC;GET4
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.30263185858205843,0.6896725369495352,0.8501683501683501,0.9931976047468482,1.0,2/14,12.38%,RAB29;CD81
prerank,positive regulation of chromosome organization (GO:2001252),0.29740375198699226,0.6895917685132993,0.8473520249221184,0.9928070027285902,1.0,7/15,26.71%,NBN;SHCBP1L;MRE11;DDX11;ATRX;PML;RAD50
prerank,translational elongation (GO:0006414),0.2179354067224575,0.6891488888723298,0.9219858156028369,0.9928815284042121,1.0,28/101,22.52%,MRPL37;MRPL43;MRPL33;MRPS28;MRPS35;EEFSEC;PTCD3;MRPL41;MRPS22;MRPS15;MRPS33;MRPL3;CHCHD1;MRPL16;LTN1;MRPL40;MRPL22;GADD45GIP1;MRPL4;GTPBP1;MRPL2;MRPL34;EEF1G;GFM1;TSFM;MRPS7;MRPL11;GTPBP2
prerank,positive regulation of transporter activity (GO:0032411),0.3008253914196009,0.6890925902686227,0.8303425774877651,0.9924806296994323,1.0,2/13,11.96%,KMT2A;SGK1
prerank,negative regulation of immune system process (GO:0002683),0.2950679484474156,0.6883822931124641,0.8081967213114755,0.9928545599255795,1.0,2/16,6.65%,SOX9;COL3A1
prerank,DNA-dependent DNA replication (GO:0006261),0.20965306804515466,0.6883405480548602,0.9417142857142857,0.9924247723156614,1.0,32/128,18.75%,PSME3;RFC3;ORC5;GINS4;PSMB5;SIRT7;ORC3;SRPK2;CDK2AP1;CDC6;PSMB2;TEFM;POLG2;POLB;PSMA2;PSMA6;REV3L;RECQL5;PSMD13;POLE;PSMA7;GMNN;PSME4;GINS3;NOC3L;ORC1;RFC1;ORC6;PSMC4;PSMB6;PSMD12;PSMD14
prerank,positive regulation of lipid storage (GO:0010884),-0.23359448503831004,-0.6880108371245467,0.889487870619946,0.9771923328584817,1.0,6/21,25.18%,OSBPL11;ZC3H12A;PLIN3;FITM2;C3;SCARB1
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3351415604936169,0.6875091523988319,0.8213660245183888,0.9929253690706196,1.0,2/10,11.15%,RACGAP1;APC
prerank,pinocytosis (GO:0006907),0.32643865224711704,0.6873678032128069,0.8014705882352942,0.9926075928970204,1.0,3/10,15.49%,DOCK2;RAB34;SNX5
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.22007777659809385,0.687017823834458,0.9201474201474201,0.9925645712601157,1.0,22/88,18.75%,FBXL15;PSME3;FBXO31;PSMB5;FBXL5;FBXL17;FBXO38;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;FBXL12;DMAC2;FBXW7;FBXL3;CUL4B;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,membrane repolarization (GO:0086009),-0.26027727570891224,-0.6869602395408521,0.8848167539267016,0.9773560742472507,1.0,7/15,30.78%,KCNJ2;ATP1B1;ATP1B2;KCNE4;KCNH2;ATP1A1;KCNQ1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.2070840668115061,-0.6868242369175972,0.9548387096774194,0.9767263899179502,1.0,11/32,23.85%,MNAT1;TAF1D;ERCC2;CCNH;POLR2F;TAF1C;GTF2H4;POLR2K;POLR1C;POLR1F;RRN3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),-0.2148583732902629,-0.6861060439838802,0.9074626865671642,0.9766636725123043,1.0,10/28,29.85%,ITPR1;TMEM117;CEBPB;CASP4;ATF4;BBC3;AIFM1;TRIB3;TRAF2;PPP1R15A
prerank,neutrophil mediated immunity (GO:0002446),0.19551442615784975,0.6860068776257898,0.9938524590163934,0.9932842858245087,1.0,78/432,19.51%,DYNLL1;NAPRT;CEACAM1;ARG1;RAP1A;ARHGAP9;ANO6;CD55;ITGAX;PTPRC;NIT2;CD53;DOCK2;CDK13;NCSTN;ADAM10;PPIE;NRAS;NEU1;ACTR10;RAB3A;DSN1;ILF2;YPEL5;FRMPD3;PGM1;PTPRJ;ATP6V0A1;HMGB1;LAMP1;IST1;CANT1;S100A9;MME;MANBA;PAFAH1B2;PLD1;VAMP8;LAIR1;CEP290;CCT2;PGRMC1;TSPAN14;LTA4H;MVP;DERA;ATG7;MLEC;TMEM30A;GSDMD;HEXB;PSMA2;TMEM63A;PTPN6;PSMD13;TICAM2;ATP8B4;AP2A2;HGSNAT;GLIPR1;CTSB;CREG1;CRACR2A;ASAH1;CYBB;ERP44;PSMD12;ATP6AP2;SNAP23;RHOA;PRDX6;PSMD14;SNAP29;RNASE3;PTGES2;XRCC6;AP1M1;LAMP2
prerank,heme catabolic process (GO:0042167),-0.2569221069366713,-0.6844904563140224,0.8797169811320755,0.9765686950817593,1.0,1/14,2.64%,ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.2569221069366713,-0.6844904563140224,0.8797169811320755,0.9765686950817593,1.0,1/14,2.64%,ABCG2
prerank,purine-containing compound biosynthetic process (GO:0072522),0.2693561876555067,0.6843506765035374,0.8475609756097561,0.9948015996528586,1.0,8/25,20.46%,MTHFD1;PPAT;PRPSAP2;PRPS1;PRPS1L1;DCK;GART;ADSL
prerank,I-kappaB phosphorylation (GO:0007252),0.32718505837015743,0.6829178588914013,0.8242753623188406,0.9960276805765381,1.0,1/10,5.70%,TLR7
prerank,chromatin remodeling at centromere (GO:0031055),-0.20984001575489747,-0.682721278958381,0.9171974522292994,0.9774680013535144,1.0,14/31,31.96%,NPM1;RUVBL1;SMARCA5;CENPT;CENPP;CENPC;CENPQ;MIS18BP1;CENPO;CENPX;CENPI;MIS18A;CENPN;CENPA
prerank,NIK/NF-kappaB signaling (GO:0038061),0.22221948472857983,0.6826510649107934,0.9159120310478654,0.9958685954087323,1.0,16/72,18.75%,REL;PSME3;CARD10;PSMB5;PSMB2;PSMA2;PSMA6;DICER1;PSMD13;PSMA7;RELB;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,cellular response to UV-A (GO:0071492),-0.28217009293670825,-0.6826391317095236,0.9097222222222222,0.9767760435107644,1.0,2/11,11.42%,MMP2;MMP1
prerank,inositol phosphate catabolic process (GO:0071545),-0.2744191263272819,-0.682408444363948,0.8476190476190476,0.9762258887838066,1.0,6/12,29.35%,NUDT3;IMPA1;INPP5A;INPP5B;SYNJ1;INPP5J
prerank,positive regulation of T cell migration (GO:2000406),0.28292574635898965,0.6819410201244376,0.8390092879256966,0.9962222399235564,1.0,5/20,18.90%,WNT5A;ADAM10;TNFRSF14;RHOA;DOCK8
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2930089124200311,0.6815727108432945,0.8358458961474037,0.9961753706958675,1.0,2/17,10.37%,GPLD1;ADRA2A
prerank,positive regulation of viral life cycle (GO:1903902),0.2758868022529795,0.6815510522032824,0.8487261146496815,0.9957294586278701,1.0,4/22,14.09%,TSG101;KPNA2;AXL;P4HB
prerank,negative regulation of mRNA processing (GO:0050686),0.2940504737777557,0.6813877994302047,0.824793388429752,0.9954287407067245,1.0,6/15,24.10%,SRSF4;SFSWAP;SAP18;SRSF12;SRSF10;RBMX
prerank,regulation of immunoglobulin production (GO:0002637),0.2728377183651629,0.6809950906522841,0.8823529411764706,0.9954096444375174,1.0,2/23,6.39%,PTPRC;EPHB2
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.28669179752449264,-0.6808900967426077,0.8555555555555555,0.9768545150600819,1.0,6/10,34.14%,COMT;SARDH;CHDH;SLC44A1;DMGDH;HNMT
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.25600307969025415,-0.6806319194827226,0.87,0.9763113459353141,1.0,5/15,25.78%,FKBP1A;LEMD3;CSNK2B;FSTL3;ACVR1B
prerank,protein catabolic process (GO:0030163),0.22890268501020836,0.6803734552875789,0.9094488188976378,0.9956444526894883,1.0,5/59,7.41%,CEACAM1;LRSAM1;CLN8;SOCS6;SIAH1
prerank,microtubule bundle formation (GO:0001578),0.24535066752673151,0.6802526034057795,0.8806584362139918,0.9953079533414104,1.0,5/42,9.41%,NCKAP5L;SPEF1;CAPN6;SPAST;FOXJ1
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.24988163736925298,0.6800921326548065,0.8702623906705539,0.995013377803242,1.0,6/33,13.19%,WEE1;DACT1;KANK2;APC;PTEN;FHL1
prerank,regulation of cytoplasmic transport (GO:1903649),0.3131134489113917,0.6800652414815244,0.8374384236453202,0.994568846838988,1.0,2/11,9.27%,SRC;ATP9A
prerank,positive regulation of protein transport (GO:0051222),0.22968333170651048,0.6799810689753693,0.9247448979591837,0.9941850732153181,1.0,12/67,14.28%,RAB29;KIF20B;IL1A;FRMD4A;CEP131;ARHGEF5;RIPOR1;ARF6;TPR;CEP290;PCM1;UNC13B
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.30509752471072493,0.679790386997744,0.8452380952380952,0.9939593520061684,1.0,1/12,2.29%,JAG1
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.3192794830545078,0.679339574826395,0.8549488054607508,0.9939847746997557,1.0,2/10,9.57%,SEC14L1;NPLOC4
prerank,lysosome localization (GO:0032418),0.2522876119088354,0.6782909454058014,0.8645533141210374,0.9947286853195222,1.0,8/37,14.20%,RAB3A;TFEB;BORCS6;HDAC6;SPAG9;ARL8B;KIF5B;RAB34
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.3030822210306629,0.6781081715092012,0.8184931506849316,0.9944695724329972,1.0,4/13,18.11%,TYK2;IL6ST;JAK1;OAS2
prerank,cardiac muscle cell contraction (GO:0086003),0.2836028095718868,0.677715739583777,0.8460342146189735,0.9944675192455266,1.0,1/19,1.42%,CAMK2D
prerank,integrated stress response signaling (GO:0140467),0.2881446595954453,0.6771354007033171,0.833904109589041,0.9946174329809044,1.0,6/14,24.33%,EIF2AK3;NFE2L2;QRICH1;DDIT3;IMPACT;HSPA5
prerank,tRNA 5'-leader removal (GO:0001682),0.30132665673187164,0.676897393040252,0.8414023372287145,0.9944041760518443,1.0,6/13,24.93%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,phosphate ion transmembrane transport (GO:0035435),-0.26821788038218297,-0.6765321404715956,0.8737623762376238,0.9791701095038825,1.0,5/12,29.54%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,glutathione metabolic process (GO:0006749),-0.20436942926727697,-0.6761796992768935,0.9473684210526315,0.9787053816898408,1.0,12/38,25.82%,GCLM;CTNS;ETHE1;GLRX2;CNDP2;GGCT;GSTT2;HPGDS;GCLC;GSTT1;GSR;GGT5
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.31466086139538196,0.6752568375845653,0.8075601374570447,0.9957894693993646,1.0,3/10,23.12%,CRTAM;SCRIB;PRNP
prerank,N-terminal protein amino acid modification (GO:0031365),0.29809112521606596,0.6751239149273586,0.8445229681978799,0.995464161172609,1.0,4/14,19.22%,NAA35;NAA10;NAA40;NAA60
prerank,telomere organization (GO:0032200),-0.1897689517442848,-0.6749271915917647,0.9490445859872612,0.9790471256991912,1.0,13/43,29.83%,SP100;WRN;BLM;DCLRE1B;PARP1;ERCC4;POLD2;ACD;PARP3;ATM;CTC1;PTGES3;TINF2
prerank,regulation of synapse maturation (GO:0090128),0.31610317323948556,0.674523995509293,0.8374558303886925,0.9956795936075274,1.0,3/10,13.85%,CDC20;RELN;ANAPC2
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2676985277074906,-0.6743285030972633,0.8764568764568764,0.9788289826521541,1.0,7/12,44.42%,HDAC1;POU2F3;HMGA2;TFAP4;CCL5;CCL4;TARDBP
prerank,positive regulation of TOR signaling (GO:0032008),-0.19551447788812198,-0.6738442697964201,0.9598540145985401,0.9784870739012692,1.0,15/40,28.17%,FNIP1;LAMTOR3;SEH1L;RRAGC;GPR137B;RICTOR;RRAGD;LAMTOR2;NCKAP1L;PIP4P1;SLC38A9;FLCN;MLST8;RHEB;LAMTOR4
prerank,heterochromatin assembly (GO:0031507),0.2754275793997468,0.673559729422447,0.8612804878048781,0.9962953971236036,1.0,7/20,24.47%,BEND3;SUV39H1;BAZ2A;ZNFX1;SIRT2;EZH1;CENPV
prerank,protein targeting to lysosome (GO:0006622),0.2802855099571344,0.6734836133143034,0.873015873015873,0.9959094315041266,1.0,7/20,19.51%,ZFYVE16;M6PR;GCC2;NEDD4;AP3M1;SCARB2;LAMP2
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.19331753704873378,0.673154409115388,0.9844559585492227,0.9958103200452928,1.0,77/314,22.15%,NEDD4L;FBXL15;RNF122;PCBP2;SPSB4;PSME3;TMEM129;SELENOS;SIAH1;FBXO31;FBXO5;CUL3;CDC20;AMFR;PSMB5;ANAPC5;ANAPC7;SIAH3;NPLOC4;UBE3D;SHARPIN;ANAPC11;FBXL19;NEDD4;SPOPL;BUB3;FBXL5;FBXL17;FAF1;NFE2L2;RNF185;FBXO38;ANAPC2;PSMB2;UBE2J2;UBE2D3;UBE2D1;PSMA2;KLHL22;KLHL15;FEM1C;PSMA6;ANAPC4;WWP2;FZR1;PSMD13;PSMA7;PLAA;FBXL12;LTN1;DMAC2;FBXW7;UBQLN1;FBXL3;ITCH;CUL4B;PSME4;ANAPC16;WFS1;PSMC4;CDC23;PSMB6;PSMD12;PSMD14;KBTBD7;GID4;SEL1L;UBE2W;DDIT3;PRKN;PPP2R5C;ZNRF1;PSMB3;DERL1;GID8;CUL5;FBXW11
prerank,cellular response to virus (GO:0098586),-0.20677691976033963,-0.6729862663683579,0.9306930693069307,0.9784684740857279,1.0,10/30,32.37%,GSDME;HIF1A;ZC3H12A;LGALS9;RIOK3;CCL19;DDX3X;VWCE;EIF5A;CXCL10
prerank,ruffle organization (GO:0031529),-0.24498421902319262,-0.672945611770726,0.9158163265306123,0.9777424583426456,1.0,5/16,22.83%,TPM1;AIF1L;PIP5K1A;CARMIL1;CORO1B
prerank,amino sugar biosynthetic process (GO:0046349),0.3071234639578726,0.6726669304967592,0.8519134775374376,0.9958777868393076,1.0,8/12,31.21%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,carbohydrate transport (GO:0008643),0.3090805106418737,0.6714644724266183,0.837171052631579,0.9966920189308112,1.0,2/11,12.99%,SLC2A2;AQP1
prerank,protein localization to chromosome (GO:0034502),-0.20076594598953604,-0.6712161506734797,0.9380804953560371,0.9784656083579075,1.0,13/34,31.96%,SLF2;TPP1;SLF1;ESR1;PINX1;XRCC4;ACD;TNKS2;PARP3;CHMP7;MCM9;TINF2;CENPA
prerank,transcription by RNA polymerase III (GO:0006383),-0.21403646193042297,-0.6711551768705658,0.939873417721519,0.9777503758649376,1.0,8/27,19.34%,BRF1;SNAPC1;ZC3H8;GTF3C4;IVNS1ABP;POLR3H;SNAPC5;POLR2K
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.21087471322454057,0.6711471331283908,0.9184914841849149,0.9965700576568826,1.0,24/86,21.95%,PSME3;EGLN3;ANKRD2;MAPK7;BAG3;PSMB5;INO80;NFE2L2;CREBBP;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;BACH1;PSMC4;PSMB6;PSMD12;PSMD14;GCN1;DDIT3;PSMB3;IMPACT
prerank,organelle fission (GO:0048285),0.26665436005057275,0.6710861656871208,0.853030303030303,0.9961760072932891,1.0,4/24,10.29%,DNM1;FIS1;MIEF1;ACOT8
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.1976160805212555,-0.6710473748919178,0.9321428571428572,0.9770853536856606,1.0,16/38,29.94%,NPM1;HIRA;RUVBL1;SMARCA5;CENPT;CENPP;UBN1;CENPC;CENPQ;MIS18BP1;CENPO;IPO4;CENPX;CENPI;MIS18A;CENPN
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),-0.20868005811096063,-0.6705320674708686,0.9423728813559322,0.9767393827521632,1.0,5/32,12.85%,RPS19;RPL30;PGLYRP1;GAPDH;CCL13
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.29124047170305806,0.6699850434041158,0.8384353741496599,0.9968927881994539,1.0,8/15,28.94%,RAB3GAP2;SEC61G;RAB3GAP1;SRPRA;SEC61A1;ZFAND2B;SRPRB;SPCS3
prerank,cellular biogenic amine metabolic process (GO:0006576),0.3045469901077051,0.6698405753205257,0.8542024013722127,0.9965684944906159,1.0,2/12,4.89%,SLC29A4;SLC22A3
prerank,nucleosome assembly (GO:0006334),0.2524059851643678,0.6689094458024142,0.8874643874643875,0.9970958229400334,1.0,3/31,4.43%,SOX9;HAT1;KAT6B
prerank,central nervous system myelination (GO:0022010),0.3062381052628341,0.6685407576703536,0.8656462585034014,0.9970226330673706,1.0,2/11,12.80%,CNTNAP1;PTEN
prerank,regulation of microtubule nucleation (GO:0010968),0.3174470007044105,0.6675211615042793,0.8447653429602888,0.9976735325465204,1.0,3/10,16.89%,CKAP5;MECP2;ARHGEF7
prerank,protein localization to vacuole (GO:0072665),-0.2546217918149023,-0.6661536129180322,0.8793969849246231,0.9796171885186823,1.0,3/13,13.94%,SH3GLB1;GLMP;LMBRD1
prerank,lipoxygenase pathway (GO:0019372),0.2860290041543398,0.6649909551291644,0.842560553633218,0.9999780693354877,1.0,3/14,21.55%,ALOXE3;HPGD;PON3
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.22838634245093753,0.6649677977534323,0.9295392953929539,0.9990585548695741,1.0,13/56,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.22838634245093753,0.6649677977534323,0.9295392953929539,0.9990585548695741,1.0,13/56,18.16%,NDUFA6;NDUFB10;NDUFS3;NDUFS6;NDUFA3;NDUFV2;NDUFV1;NDUFAF5;BCS1L;NDUFA7;DMAC2;NDUFAF6;NDUFS2
prerank,heart looping (GO:0001947),0.24165573950792152,0.6649121310643923,0.9012517385257302,0.9986464611180483,1.0,4/39,7.30%,FOLR1;STIL;TBX2;CCDC39
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.22654291481993472,-0.6641437028543783,0.9220055710306406,0.9797174423537215,1.0,9/21,27.84%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5;GTF2H5;DDB1
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.22654291481993472,-0.6641437028543783,0.9220055710306406,0.9797174423537215,1.0,9/21,27.84%,RBX1;ERCC2;XPA;GTF2H4;PARP1;ERCC4;ERCC5;GTF2H5;DDB1
prerank,global genome nucleotide-excision repair (GO:0070911),0.261410548625238,0.6637446277098398,0.8924731182795699,0.9993996421859295,1.0,8/26,18.15%,ERCC1;CETN2;GTF2H1;DDB2;CHD1L;USP45;CUL4B;GTF2H3
prerank,peptidyl-methionine modification (GO:0018206),-0.2579310977089066,-0.6624887389060393,0.877030162412993,0.9802901660012127,1.0,1/12,5.91%,NAA15
prerank,polarized epithelial cell differentiation (GO:0030859),0.29745105894622675,0.662303089853479,0.8473154362416108,1.0,1.0,5/13,18.52%,OPHN1;ZDHHC7;EZR;SCRIB;RHOA
prerank,protein-DNA complex assembly (GO:0065004),0.20441409488952303,0.6616522754746169,0.9599528857479388,1.0,1.0,34/116,21.63%,SOX9;KAT6B;PSME3;ORC5;CDK7;PSMB5;ORC3;CETN2;CDC6;GTF2H1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;DDB2;CHD1L;GMNN;CUL4B;PSME4;ORC1;ORC6;NAP1L1;GTF2H3;PSMC4;PSMB6;PSMD12;PSMD14;SPTY2D1;NAA60;DAXX;RSF1;RPA3;PSMB3
prerank,mitochondrial protein processing (GO:0034982),-0.265975909519804,-0.6614364237354922,0.8844339622641509,0.9802991145177262,1.0,1/11,1.45%,OMA1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.28188665123085144,0.6607768849230282,0.8587301587301587,1.0,1.0,3/17,8.58%,SRC;ATP1A2;ACOD1
prerank,magnesium ion transport (GO:0015693),0.30424376704679984,0.6606403503776337,0.8197278911564626,1.0,1.0,3/12,12.90%,NIPA2;MRS2;TUSC3
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.3031262541672055,0.6605633002262681,0.8609715242881072,1.0,1.0,2/11,9.89%,SELENOS;AXL
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.20574404650746883,-0.660240630058519,0.9251497005988024,0.9804449566716023,1.0,16/29,37.90%,IKBKB;CASP8;CD40;TLR3;IKBKG;RIPK1;BIRC3;LY96;UBB;TANK;CD300LF;IKBKE;TLR6;RPS27A;UBC;CD14
prerank,negative regulation of translation (GO:0017148),0.21287646228055188,0.6599708153384235,0.9552058111380145,1.0,1.0,11/87,11.01%,FXR2;GIGYF2;EIF2AK3;CNOT10;CELF1;SAMD4B;PUS7;IGF2BP2;CNOT7;TPR;ILF3
prerank,axonemal dynein complex assembly (GO:0070286),0.2573666759861598,0.6599299599659595,0.8829787234042553,1.0,1.0,7/27,22.54%,CFAP73;CCDC39;DNAH5;CCDC40;ODAD1;DNAI4;CFAP100
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.27485181738405434,-0.659797425376818,0.8846153846153846,0.9800363958045473,1.0,2/10,17.74%,ZC3H12A;RC3H1
prerank,regulation of sensory perception of pain (GO:0051930),-0.27142612252332854,-0.6593279694357853,0.8936170212765957,0.9796450082838204,1.0,4/11,31.41%,CCN3;ACP3;SPX;F2R
prerank,glycerophospholipid metabolic process (GO:0006650),0.21856451791495454,0.6587451225065244,0.9307411907654921,1.0,1.0,8/75,9.37%,PLCB3;GPLD1;ACP6;PAFAH1B1;PIGB;ABHD12;PLEK;PIGA
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.2739856783042377,-0.6586006914255866,0.8899082568807339,0.9787006074852185,1.0,1/10,4.40%,AP2A1
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.2739856783042377,-0.6586006914255866,0.8899082568807339,0.9787006074852185,1.0,1/10,4.40%,AP2A1
prerank,pyroptosis (GO:0070269),-0.24506007823260176,-0.6585951355933096,0.9052369077306733,0.9779515246333613,1.0,6/15,32.87%,GSDME;CASP8;CASP4;ZBP1;CASP1;TREM2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.22394734731544214,0.657660575442881,0.928388746803069,1.0,1.0,17/60,21.70%,RUNX2;SOX9;MED7;AGO1;MED13;MECP2;MED23;PTEN;CBFB;MED8;MED12;MED31;BAX;MED15;IL6;MED16;TCF7L2
prerank,positive regulation of defense response to virus by host (GO:0002230),0.26375209299479785,0.6570784621875769,0.8878357030015798,1.0,1.0,2/24,6.13%,PTPN22;ZDHHC1
prerank,anterograde axonal transport (GO:0008089),0.2434596470613337,0.6569596133970443,0.915041782729805,1.0,1.0,12/37,24.61%,SPAST;KIF5A;KIF5B;AP3M1;AP3B1;RAB21;AP3S2;RAB27B;DLG2;BLOC1S2;MAPK8IP3;BLOC1S4
prerank,negative regulation of leukocyte migration (GO:0002686),0.3142606182610658,0.6560566283566869,0.8544520547945206,1.0,1.0,2/10,9.01%,BMP5;CD200R1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.2722744352863045,-0.6558478424942771,0.9025974025974026,0.9792911278981494,1.0,4/10,18.90%,UBA2;PIAS3;RWDD3;GNL3
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.24568452049042347,0.6554180096932013,0.8896952104499274,1.0,1.0,6/34,9.65%,IRAK3;TNFAIP3;ACOD1;SARM1;NLRP2B;TICAM1
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2745813173800852,0.6551221513936901,0.8949044585987261,1.0,1.0,2/17,7.80%,EMC9;EMC7
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.28089743311251364,0.6547881721043893,0.8813291139240507,1.0,1.0,5/18,20.41%,MAPK7;NFE2L2;HTRA2;PINK1;PRKN
prerank,tRNA methylation (GO:0030488),0.2431347215628844,0.6546602542531507,0.8973607038123167,1.0,1.0,13/34,25.35%,TARBP1;THADA;FTSJ1;TRMT5;THUMPD3;METTL2B;METTL2A;TRMT1L;TRMO;TRMT1;THUMPD2;PRORP;MTO1
prerank,nuclear migration (GO:0007097),0.2910014599721998,0.6545570411353069,0.8708053691275168,1.0,1.0,5/13,14.24%,PAFAH1B1;DOCK7;HOOK3;PCM1;CLMN
prerank,sphingoid biosynthetic process (GO:0046520),0.296093542323874,0.6530305553643109,0.8386023294509152,1.0,1.0,1/11,2.60%,ACER3
prerank,sphingosine biosynthetic process (GO:0046512),0.296093542323874,0.6530305553643109,0.8386023294509152,1.0,1.0,1/11,2.60%,ACER3
prerank,regulation of cellular amine metabolic process (GO:0033238),0.22311684889846023,0.6523481769085452,0.9406207827260459,1.0,1.0,16/50,24.50%,PSME3;PSMB5;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14;PSMB3;OAZ2;AZIN1;PSMD2
prerank,protein localization to cell junction (GO:1902414),0.26255440318648104,0.6522456254849514,0.8877086494688923,1.0,1.0,6/22,22.13%,TJP2;CGNL1;FERMT2;JAK1;ARHGEF18;NLGN2
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.25025600170957085,-0.6518585855823177,0.8987654320987655,0.9814673801181775,1.0,5/14,29.83%,TPP1;PINX1;ACD;TNKS2;TINF2
prerank,programmed necrotic cell death (GO:0097300),-0.22991115490982128,-0.6516415032819657,0.9144385026737968,0.9808660977977237,1.0,6/18,25.91%,PGAM5;IPMK;TRPM7;TLR3;RIPK1;LY96
prerank,phosphate ion transport (GO:0006817),-0.22921867887769806,-0.6512629354043915,0.8974358974358975,0.9803843802483595,1.0,5/16,29.54%,SLC25A30;SLC25A11;SLC37A1;SLC37A2;SLC37A3
prerank,positive regulation of T cell differentiation (GO:0045582),-0.19640702083650358,-0.6512349583640656,0.9639344262295082,0.9796550504408066,1.0,3/36,5.06%,LEF1;GLI3;DUSP10
prerank,positive regulation of chemokine production (GO:0032722),0.22793531230656613,0.6508469180971328,0.9157608695652174,1.0,1.0,10/44,21.62%,WNT5A;IL17RA;TLR7;HMGB1;EGR1;IL7;SYK;LPL;IL6;TWIST1
prerank,positive regulation of telomere capping (GO:1904355),0.2755216619007954,0.6507788046055794,0.8796875,1.0,1.0,4/17,25.70%,NEK7;HNRNPD;MAPK1;TNKS
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.2967084410763974,0.6501631718840457,0.8617200674536256,1.0,1.0,1/12,4.05%,SOX9
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.2623826915294193,0.6495666151609798,0.8835098335854765,1.0,1.0,2/21,8.37%,KCNA5;NOS1AP
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),-0.24420036097086806,-0.6492603672176971,0.9223529411764706,0.9803492233468649,1.0,3/15,11.04%,CCT7;RUVBL1;CCT8
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.2514331647907995,0.6490804198013578,0.8942598187311178,1.0,1.0,8/25,22.32%,B3GALT1;B4GAT1;NDST1;EXT1;EXT2;B3GNT8;NDST4;HS2ST1
prerank,regulation of myelination (GO:0031641),0.2486928629650792,0.6487361068655958,0.9072164948453608,1.0,1.0,5/25,14.63%,ITGAX;EIF2AK3;NCMAP;NSUN5;DICER1
prerank,autophagy of nucleus (GO:0044804),-0.2327932031242732,-0.6484479746775988,0.9238329238329238,0.9802051078637364,1.0,7/16,24.51%,WIPI1;ULK2;ATG13;WIPI2;ATG12;WDR45B;WDR45
prerank,regulation of microglial cell activation (GO:1903978),-0.23697133144495441,-0.6482175308995178,0.8911392405063291,0.9796191784400242,1.0,3/15,13.41%,LDLR;TTBK1;SPHK1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.2199316366480547,-0.6481188395533843,0.9352112676056338,0.9789418372611868,1.0,7/22,20.52%,WDR12;NOP9;RPS21;EXOSC3;NOL9;KRI1;ERI3
prerank,positive regulation of bone resorption (GO:0045780),0.2994812678739619,0.6479516445201501,0.8540925266903915,1.0,1.0,1/11,4.28%,PRKCA
prerank,snRNA metabolic process (GO:0016073),0.27361291726330134,0.6474693725213814,0.8876221498371335,1.0,1.0,2/17,5.85%,INTS10;TUT1
prerank,mitotic metaphase plate congression (GO:0007080),0.2284345569307615,0.6474172126435414,0.9387186629526463,1.0,1.0,15/51,22.27%,NUP62;CUL3;CHMP5;PDCD6IP;CHMP4A;CHMP4B;CHMP4C;ZW10;PIBF1;MAD1L1;CDC23;DCTN2;RRS1;CHMP2A;MIS12
prerank,endoderm formation (GO:0001706),0.23682917812775733,0.6471698735046307,0.907563025210084,1.0,1.0,3/35,5.16%,MMP15;ITGA7;FN1
prerank,DNA geometric change (GO:0032392),-0.21215585978727897,-0.647034389512043,0.9756838905775076,0.9789784293579891,1.0,6/24,18.89%,WRN;BLM;ANXA1;ZRANB3;DHX36;DDX1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.250824546212264,0.6469928613770696,0.907185628742515,1.0,1.0,7/28,20.41%,AXIN1;DDRGK1;PTEN;FBXW7;BAG2;TMTC3;PRKN
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.2582167079978251,0.6468051524804042,0.8900928792569659,1.0,1.0,7/25,21.38%,ZNF326;ELL;SUPT4H1;ERCC6;THOC5;TSFM;CCAR2
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.25403906481394456,-0.6466714624271013,0.9090909090909091,0.978476608439859,1.0,7/12,28.39%,PARP2;PARP10;PARP1;TNKS2;PARP3;PARP12;PARP16
prerank,negative regulation of calcium ion transport (GO:0051926),0.27622751605557805,0.6459911456558869,0.867330016583748,1.0,1.0,4/15,21.05%,ATP1A2;ADRA2A;PACSIN3;CBARP
prerank,cell cycle G1/S phase transition (GO:0044843),0.21578822975441736,0.6458423357279063,0.9321148825065274,1.0,1.0,9/61,17.29%,PLK2;CDK7;CUL3;EIF4E;CRLF3;POLE;E2F1;USP37;CUL4B
prerank,ESCRT complex disassembly (GO:1904896),0.30379557613257424,0.6451799228477972,0.8625,1.0,1.0,2/10,9.92%,CHMP5;IST1
prerank,ESCRT III complex disassembly (GO:1904903),0.30379557613257424,0.6451799228477972,0.8625,1.0,1.0,2/10,9.92%,CHMP5;IST1
prerank,positive regulation of heart contraction (GO:0045823),0.27205762456959565,0.644932453035112,0.8775193798449612,1.0,1.0,2/19,5.62%,ATP1A2;APLN
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.22314070312275508,-0.6445826096892704,0.9495548961424333,0.9791598960970378,1.0,7/22,21.74%,RNF115;VPS4A;MVB12A;VPS37C;UBAP1;VPS28;RNF126
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),0.22109058412171545,0.6438105010091392,0.9423328964613368,1.0,1.0,13/56,18.52%,RACGAP1;SON;USP8;SPAST;PDCD6IP;IST1;CHMP4B;APC;CIT;STAMBP;RTKN;SPTBN1;RHOA
prerank,regulation of endocytic recycling (GO:2001135),0.30150283166807157,0.6434229143943826,0.8461538461538461,1.0,1.0,3/11,9.27%,EHD2;INPP5F;ATP9A
prerank,cardiac left ventricle morphogenesis (GO:0003214),-0.2470502646221262,-0.6432289645790346,0.9054373522458629,0.9793261071337382,1.0,3/13,17.04%,RBPJ;GSK3A;SMAD4
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.27733700980692033,0.6431856321751971,0.8683760683760684,1.0,1.0,2/16,8.76%,KMT5C;WRAP53
prerank,B cell proliferation (GO:0042100),-0.2321003649578477,-0.6428677987793158,0.9292929292929293,0.9788243085982389,1.0,1/17,1.74%,CTPS1
prerank,lipid homeostasis (GO:0055088),0.22264307232061492,0.6423501918715973,0.9319640564826701,1.0,1.0,11/57,17.63%,ZBTB20;CLN8;USF2;TLCD3A;ABCA1;THADA;ABCD1;PNPLA8;FBXW7;PPARG;IRS2
prerank,outer dynein arm assembly (GO:0036158),-0.24149865171970303,-0.6418602760283618,0.9230769230769231,0.9787406259966671,1.0,8/14,40.56%,LRRC49;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.2237073686215281,0.6417326530246626,0.9359477124183007,1.0,1.0,6/55,8.67%,COQ7;MPV17;RAC2;DHRS4;ACOD1;AATF
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.26403936569025316,0.6414844418951793,0.9016666666666666,1.0,1.0,9/20,25.78%,AGO1;PUM2;DICER1;SPOUT1;TSNAX;PRKRA;PUM1;ZC3H7B;AGO2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3026089019682928,0.6408628033343894,0.8608247422680413,1.0,1.0,1/10,3.05%,IL4I1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),0.26782319742526217,0.6404874311268566,0.8715890850722311,1.0,1.0,2/15,10.37%,GPLD1;ADRA2A
prerank,macrophage activation (GO:0042116),0.24036055889976493,0.6403887437315267,0.9164222873900293,1.0,1.0,1/34,0.73%,LBP
prerank,defense response to Gram-positive bacterium (GO:0050830),0.23387411181913761,0.6402689310466106,0.9252199413489736,1.0,1.0,1/40,0.73%,LBP
prerank,telomere maintenance (GO:0000723),-0.17559130384046825,-0.6401242204863891,0.9848484848484849,0.9791230169393041,1.0,18/50,30.41%,SP100;WRN;BLM;DCLRE1B;SMC6;TPRKB;PARP1;ERCC4;POLD2;ACD;RAD51;PARP3;ATM;CTC1;PTGES3;TINF2;XRCC3;TEN1
prerank,regulation of protein targeting to membrane (GO:0090313),-0.20542830042964982,-0.6398047496362017,0.9536231884057971,0.9785985082073249,1.0,10/28,26.51%,KCNB1;C2CD5;ANK3;MTCL1;MIEF2;TCAF2;HRAS;ITGB2;CIB1;ITGAM
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.2852498154987828,0.6397115062372866,0.8609625668449198,1.0,1.0,4/12,20.64%,WRAP53;CCT2;GNL3L;CCT3
prerank,regulation of interleukin-1 beta production (GO:0032651),0.2109397086118735,0.6397040026249923,0.9509677419354838,0.9997898403642036,1.0,7/66,11.42%,USP50;WNT5A;TNFAIP3;NLRC4;ISL1;NLRP2B;EGR1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.2336353742057875,0.6389756544116092,0.9220963172804533,0.999959933032861,1.0,9/40,15.67%,BOD1L1;DONSON;GEN1;RFWD3;NUCKS1;ETAA1;EME2;FAM111A;POLE
prerank,pancreas development (GO:0031016),0.2915984170594469,0.6388396710341164,0.8787878787878788,0.9996255020167428,1.0,4/12,15.14%,CCDC39;ISL1;FOXF1;CCDC40
prerank,regulation of mRNA catabolic process (GO:0061013),0.19548721544493963,0.6382215861061055,0.976027397260274,0.9997188818745589,1.0,30/121,22.22%,FXR2;PRKCA;PSME3;SAMD4B;EXOSC5;IGF2BP2;PSMB5;CNOT7;ZFP36L2;PSMB2;FXR1;PSMA2;PUM2;PSMA6;PSMD13;PSMA7;PSME4;CNOT8;GTPBP1;PSMC4;PSMB6;PSMD12;PSMD14;CNOT1;HNRNPD;EXOSC7;PUM1;PSMB3;ELAVL1;YWHAB
prerank,regulation of microtubule depolymerization (GO:0031114),0.2507016179384868,0.6381697976336701,0.8956521739130435,0.9993061194461672,1.0,2/25,3.32%,SPEF1;TRPV4
prerank,establishment of mitotic spindle localization (GO:0040001),0.2461905713475615,0.6379428176202887,0.8957142857142857,0.9990533110114919,1.0,8/28,22.15%,SAPCD2;PAFAH1B1;NDE1;HTT;ZW10;ITGB1;GPSM2;FBXW11
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.2454888626510414,0.6368779689345632,0.9050445103857567,0.9995397770533134,1.0,4/28,10.74%,KMT5C;WRAP53;SIRT7;ERCC6
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.20045594483809842,-0.6368220166234007,0.9555555555555556,0.9798355059284913,1.0,11/29,27.84%,RBX1;MNAT1;ERCC2;XPA;CCNH;GTF2H4;PARP1;ERCC5;UBB;GTF2H5;DDB1
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.234368459537874,-0.636501839945223,0.9211195928753181,0.9793223823892848,1.0,5/15,29.81%,ARMC10;KDM1A;MIF;TAF9;TRIAP1
prerank,regulation of cell cycle (GO:0051726),0.18463880185846557,0.6359621489503821,0.9947916666666666,0.9998818383359911,1.0,50/271,18.32%,FAP;MYBBP1A;PPP1R13B;KIF20B;SOX9;MFN2;PTPRC;SON;RPRD1B;NEK7;NBN;ADAM10;TRIM21;CDK7;LIN54;RARA;FBXO5;BRINP1;E4F1;PES1;NLRP2B;MASTL;POU4F1;TRNP1;SRPK2;APC;ZBTB49;FBXL17;MEN1;NF2;DHCR24;CRLF3;PKD1;ERN1;HTRA2;TTC28;SIPA1;FZD9;GPER1;FBXL12;HPGD;CDC14A;FBXL3;RGCC;GMNN;LIN37;GADD45GIP1;CSNK2A2;FGF10;FOXO4
prerank,B cell mediated immunity (GO:0019724),0.2968138663684315,0.6357507586147778,0.8515901060070671,0.9996235295971309,1.0,1/10,7.45%,MSH2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.2800414649399734,0.635150452246539,0.8867924528301887,0.9997072086614098,1.0,2/14,6.60%,CREB3L1;SELENOS
prerank,regulation of cellular pH (GO:0030641),0.23907906251697703,0.635056478132144,0.9174041297935103,0.9993243363382587,1.0,4/29,11.18%,SLC4A3;SLC4A4;SLC9A7;SLC9A6
prerank,DNA methylation (GO:0006306),0.2509545870942499,0.6350076407060935,0.8901639344262295,0.9989135037138331,1.0,4/23,13.94%,BEND3;TEX15;ZFP57;BAZ2A
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.23622583231449318,0.6349756872322538,0.9286733238231099,0.9984910415170211,1.0,9/37,18.15%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,glycosphingolipid metabolic process (GO:0006687),0.229082789234672,0.6349045726025716,0.9325997248968363,0.9981023921744301,1.0,8/42,14.23%,A4GALT;SUMF1;CERK;NEU1;HEXA;ST8SIA5;ST8SIA3;HEXB
prerank,male meiosis I (GO:0007141),-0.22859312685275968,-0.6336603064099188,0.941025641025641,0.9804833831613239,1.0,2/16,8.93%,FOXJ3;MYBL1
prerank,rRNA catabolic process (GO:0016075),0.2687940504586922,0.6330871336956823,0.8954041204437401,0.9992471846181858,1.0,2/16,9.57%,EXOSC5;EXOSC10
prerank,mitochondrial membrane organization (GO:0007006),0.2385307893021621,0.6307079242681547,0.9200581395348837,1.0,1.0,15/32,29.89%,MFN2;MICOS10;MTX1;CHCHD6;BAD;BNIP3;CHCHD3;HSPA9;APOOL;BCL2L1;SLC25A5;SPG7;PPIF;BCL2;APOO
prerank,regulation of lipid catabolic process (GO:0050994),0.2619284382304555,0.6302678322844478,0.9025210084033614,1.0,1.0,4/19,20.90%,ADRA2A;ABCD1;TYSND1;ALK
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.2963009769166857,0.6295861132949526,0.8689407540394973,1.0,1.0,4/11,24.22%,ATL2;RTN4;VCPIP1;VAPB
prerank,sensory perception (GO:0007600),0.22280471095136237,0.6294662636232342,0.9333333333333333,1.0,1.0,7/45,13.89%,SCN10A;ALOXE3;GNAL;MME;TMEM150C;TRPV2;KCNK4
prerank,mRNA destabilization (GO:0061157),0.22914759097240955,0.6288768074696781,0.9251412429378532,1.0,1.0,4/38,7.87%,DND1;GIGYF2;CELF1;DIS3L2
prerank,nucleoside salvage (GO:0043174),0.28872545626314283,0.6276135169728657,0.8771929824561403,1.0,1.0,1/10,4.03%,UPP2
prerank,B cell activation (GO:0042113),0.207035078323399,0.6275993655387755,0.96248382923674,1.0,1.0,7/68,8.21%,TPD52;HDAC4;PTPRC;BANK1;EPHB2;MSH2;PTPRJ
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.25084935938598446,0.6274176609142563,0.9103139013452914,1.0,1.0,7/24,18.70%,SEMA4B;DSCAM;SEMA3A;SEMA4D;SEMA6C;SEMA4C;SEMA4A
prerank,regulation of response to oxidative stress (GO:1902882),0.28472667077527175,0.6273078594173298,0.8797250859106529,1.0,1.0,4/11,20.41%,ABCD1;AIFM2;PINK1;PRKN
prerank,negative regulation of interferon-gamma production (GO:0032689),0.2544792433441811,0.6271587272487025,0.9126365054602185,0.9997422655763484,1.0,3/23,9.89%,RARA;HMGB1;AXL
prerank,AMP metabolic process (GO:0046033),-0.23801775042624462,-0.6266644215787563,0.9343434343434344,0.9841250973273784,1.0,3/13,18.92%,XDH;NUDT2;NT5C1A
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.29284759454702414,0.6262226439615113,0.8707964601769912,1.0,1.0,1/11,4.96%,WNT5A
prerank,phagosome maturation (GO:0090382),-0.18365246428715407,-0.6259449179111802,0.9817073170731707,0.9838046491859802,1.0,9/35,24.02%,ATP6V0A4;ATP6V0C;ATP6V1C1;ATP6V1D;RAB32;ATP6V1F;RAB7A;ATP6V1E1;RAB38
prerank,negative regulation of ion transport (GO:0043271),-0.20364571788048047,-0.6251150685286896,0.9320113314447592,0.9835836979432924,1.0,14/24,43.08%,ACTN2;PXK;NOS1;GPM6B;PLN;WNK1;WNK2;STC1;LILRB1;SNCA;HTR1B;CD33;HRH3;VIP
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.24785033963947872,0.6245491021068397,0.8963963963963963,1.0,1.0,4/23,13.61%,HOOK2;HOOK3;KIF5A;KIF5B
prerank,positive regulation of response to external stimulus (GO:0032103),0.19074473845819825,0.6242696509567276,0.9827188940092166,1.0,1.0,23/128,17.74%,PRKCA;MGST2;LRSAM1;WNT5A;ABCC1;IL17RA;TLR7;TRADD;POLR3G;PTGER4;TNIP1;ACOD1;PLSCR1;S100A9;POLR3D;USP15;PUM2;PLG;IL15;NFKBIZ;MDK;STX4;LPL
prerank,regulation of viral genome replication (GO:0045069),0.2109764851461371,0.6240560684280043,0.9437908496732026,1.0,1.0,8/56,11.01%,PPIE;N4BP1;SRPK1;TNIP1;PLSCR1;CNOT7;SRPK2;ILF3
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.24383193938652495,-0.6240176825603246,0.9416243654822335,0.9835643668793258,1.0,8/14,32.62%,WDR12;NOL9;RPF2;RPL7;ZNHIT3;RPL7L1;DDX18;FTSJ3
prerank,positive regulation of interleukin-8 production (GO:0032757),0.21667403031873106,0.6239610812957332,0.9390243902439024,1.0,1.0,3/49,9.49%,LBP;TLR7;HMGB1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.27324514196204436,0.6238307091756977,0.8877887788778878,0.9998301485545517,1.0,6/13,27.69%,DYRK1A;YJU2;TWIST1;PTTG1IP;MDM2;SNAI1
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2671928699234061,0.6237482274585858,0.8789915966386554,0.999438535312536,1.0,3/16,15.60%,DND1;ZFP36L2;CPEB3
prerank,water transport (GO:0006833),-0.24935932417706924,-0.6237140623524507,0.9166666666666666,0.982999616516259,1.0,3/12,31.14%,AQP11;AQP4;PDPN
prerank,negative regulation of translational initiation (GO:0045947),-0.2390511512664708,-0.6236699339632911,0.9358669833729216,0.9822798721348877,1.0,2/13,10.27%,PAIP2;EIF2AK4
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.20894108199508368,0.6223702827951808,0.9624664879356568,1.0,1.0,14/55,18.75%,PSME3;PSMB5;USP47;FHL1;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;PSMC4;PSMB6;PSMD12;PSMD14
prerank,protein acetylation (GO:0006473),0.2334963287028938,0.6216580997167158,0.9200603318250377,1.0,1.0,8/30,19.22%,HAT1;NAA35;CREBBP;NAT9;NAA10;DSCC1;NAA40;NAA60
prerank,regulation of neuroblast proliferation (GO:1902692),0.2676965556729365,0.6202486375794897,0.9197952218430034,1.0,1.0,4/15,21.68%,NF1;FZD3;CX3CR1;CX3CL1
prerank,synaptic vesicle localization (GO:0097479),0.2789807803375778,0.6202150928839871,0.8920741989881956,1.0,1.0,4/13,19.71%,KIF5A;KIF5B;TMEM230;SPG11
prerank,negative regulation of cation channel activity (GO:2001258),0.24194220228654773,0.6201276238673682,0.9174041297935103,1.0,1.0,4/26,10.76%,FKBP1B;EPHB2;CASQ2;KCNAB1
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.26964878939485715,0.6200865076799961,0.9067796610169492,0.9996634613763599,1.0,5/14,23.44%,USP15;PUM2;PUM1;ZDHHC5;DHX58
prerank,histone ubiquitination (GO:0016574),0.25235585441851804,0.6200333014677182,0.9020866773675762,0.9992612969743758,1.0,2/21,6.82%,LEO1;PAF1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.19997334035916484,0.6189598763714048,0.9694267515923567,0.9996756257272019,1.0,17/70,18.75%,PSME3;TAPBP;PSMB5;LNPEP;VAMP8;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;CYBB;PSMC4;PSMB6;PSMD12;SNAP23;PSMD14
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.2815471665989132,0.6180103814235962,0.9,0.9999765508812585,1.0,3/12,18.69%,CACNA1H;STARD3;STAR
prerank,regulation of T cell mediated immunity (GO:0002709),-0.259252226337376,-0.617477636030508,0.9322429906542056,0.9851285123472998,1.0,4/10,29.78%,TNFRSF1B;ZBTB1;AGER;CCR2
prerank,DNA alkylation (GO:0006305),0.2521068491161584,0.617193647206843,0.9067796610169492,0.9997333770692083,1.0,3/19,13.94%,BEND3;TEX15;BAZ2A
prerank,DNA methylation or demethylation (GO:0044728),0.2521068491161584,0.617193647206843,0.9067796610169492,0.9997333770692083,1.0,3/19,13.94%,BEND3;TEX15;BAZ2A
prerank,negative regulation of dephosphorylation (GO:0035305),0.2612497546371506,0.6171750580625401,0.9162640901771336,0.9992957295373249,1.0,4/18,17.14%,SH3RF2;ENSA;PTPA;CHP1
prerank,regulation of protein modification process (GO:0031399),0.21622343991212623,0.6168403484142064,0.9549071618037135,0.9990946928791788,1.0,14/50,21.48%,CDH5;SPRED1;FN1;FER;STAT2;ATG7;SPRED2;SOCS1;WARS1;RABL3;PPP2CA;PIN1;CCAR2;ATG14
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.23884340287964131,-0.6165934814064719,0.9320388349514563,0.9848793348843863,1.0,3/14,18.16%,SCAP;SEC23A;SEC31A
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.2886647537239601,0.6149188861682612,0.9076376554174067,1.0,1.0,6/11,25.00%,FXR1;PUM2;XPO5;DHX9;PUM1;FMR1
prerank,cholesterol efflux (GO:0033344),-0.21365385307585266,-0.6147607425781341,0.9287531806615776,0.9851564946509805,1.0,8/20,32.70%,APOE;STX12;ABCG1;TSKU;ABCG4;SCARB1;SOAT2;APOC1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",0.22594609039741648,0.614634546485025,0.9530583214793741,0.9998866935218856,1.0,9/39,18.15%,NTHL1;RFC3;ERCC1;GTF2H1;DDB2;CHD1L;CUL4B;RFC1;GTF2H3
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.29050486919389873,0.6125903922325985,0.8966725043782837,1.0,1.0,3/10,18.34%,FN1;LAPTM4B;CDH3
prerank,regulation of interferon-beta production (GO:0032648),0.21687143680058182,0.6122742735663247,0.9524456521739131,1.0,1.0,14/46,24.67%,REL;TLR7;POLR3G;POLR3D;TBK1;RELB;OAS2;DHX9;TRAF3;IFIH1;DHX58;POLR3C;RIPK2;YY1
prerank,anterograde synaptic vesicle transport (GO:0048490),0.26496960851111384,0.6119168592786766,0.9031746031746032,1.0,1.0,5/15,24.61%,AP3M1;AP3B1;AP3S2;BLOC1S2;BLOC1S4
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.26496960851111384,0.6119168592786766,0.9031746031746032,1.0,1.0,5/15,24.61%,AP3M1;AP3B1;AP3S2;BLOC1S2;BLOC1S4
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.22405679659946848,0.6116503339244918,0.9310344827586207,0.9998816871206938,1.0,6/36,15.63%,TXK;WNT5A;IRGM;AXL;IL7;TICAM2
prerank,regulation of chromatin binding (GO:0035561),-0.24973096406223144,-0.6108688066594763,0.9299516908212561,0.9865820112719123,1.0,3/10,26.41%,MED25;KDM4D;BTAF1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.1955882573166735,-0.6106202835816135,0.9788519637462235,0.9859810577544459,1.0,11/25,32.45%,HSPA8;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;DNAJB1;PTGES3;HSPA1B;HSPA2;SDF2L1
prerank,protein export from nucleus (GO:0006611),0.23711493722745874,0.6100594129173734,0.9311377245508982,1.0,1.0,9/27,21.77%,STYX;TPR;CSE1L;PKD1;RAN;CHP1;XPO5;STRADB;XPO4
prerank,double-strand break repair via homologous recombination (GO:0000724),0.19072566304177463,0.6098780039026716,0.9841656516443362,1.0,1.0,19/95,19.02%,SMC5;NBN;PALB2;SWI5;GINS4;ZSWIM7;ZFYVE26;INO80;GEN1;RFWD3;NUCKS1;SFPQ;RAD51AP2;REV3L;RECQL5;REC8;SFR1;PSMD14;MRE11
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.24435590367911333,-0.6098157127648326,0.9441860465116279,0.9856463627178292,1.0,2/12,13.12%,ACSL3;MFSD2A
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2814897930880639,0.6095837063592708,0.9023972602739726,1.0,1.0,1/11,4.21%,HAT1
prerank,T cell differentiation in thymus (GO:0033077),-0.23087989878701512,-0.6079824776136935,0.9367088607594937,0.9858704385065257,1.0,1/14,1.43%,GLI3
prerank,phosphatidylglycerol metabolic process (GO:0046471),0.24558891847505826,0.6079621944196205,0.9525993883792049,1.0,1.0,3/24,12.76%,SLC27A1;CDS2;PNPLA8
prerank,regulation of hemopoiesis (GO:1903706),0.2845501778189947,0.6079445395237023,0.8915441176470589,1.0,1.0,4/10,26.73%,CREBBP;CBFB;RUNX1;MYSM1
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.2446840541934057,0.6074513116937952,0.9236641221374046,1.0,1.0,5/20,18.94%,CELF1;AGO1;CNOT7;CNOT8;CNOT1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2676207772523944,0.6062181298325691,0.9201954397394136,1.0,1.0,4/14,22.73%,TUT1;ERN1;NUDT21;CPSF2
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.27943691032575857,0.605830828531696,0.898936170212766,1.0,1.0,3/10,20.64%,WRAP53;CCT2;CCT3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.21470104713959365,-0.6056719231910616,0.9546666666666667,0.9863379727084135,1.0,3/18,9.06%,NPHP3;RFX3;SPEF2
prerank,regulation of response to stress (GO:0080134),0.2894013056606628,0.6054182417099156,0.890652557319224,1.0,1.0,1/10,3.15%,SLC38A2
prerank,regulation of cAMP-mediated signaling (GO:0043949),-0.19786816582721056,-0.6045795166528573,0.9716713881019831,0.986131489856526,1.0,3/24,12.17%,RAPGEF2;PDE2A;PRKAR2B
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.29612969992592414,0.6038521862776438,0.8861209964412812,1.0,1.0,3/10,20.76%,HDAC6;PRKN;ETFBKMT
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.22277215925610658,-0.6038451848611238,0.9365482233502538,0.985730910938158,1.0,4/16,16.56%,TRA2A;SNW1;NCL;NCBP1
prerank,cellular response to nutrient levels (GO:0031669),0.20042726398103775,0.6032406494690573,0.9534883720930233,1.0,1.0,8/62,13.76%,INHBB;KLF10;PDK4;RIPOR1;STK24;TFEB;ATG7;RRAGB
prerank,positive regulation of TORC1 signaling (GO:1904263),0.26081946683921436,0.6028212610251819,0.9156626506024096,1.0,1.0,7/16,24.89%,SIK3;RRAGB;KLHL22;GPR137C;LAMTOR5;RRAGA;CLEC16A
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.19606097451164828,0.6012820889394503,0.9804639804639804,1.0,1.0,17/84,18.94%,FXR2;GIGYF2;EIF2AK3;CNOT10;SAMD4B;PUS7;IGF2BP2;CNOT7;ILF3;DDX6;FXR1;RTN4;CPEB3;SYNCRIP;CNOT8;CHRNA7;CNOT1
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.2712251919676863,0.6011495978036311,0.9154929577464789,1.0,1.0,3/11,20.64%,WRAP53;CCT2;CCT3
prerank,ribonucleoprotein complex assembly (GO:0022618),0.18584219159513707,0.6007879931212017,0.9895591647331786,1.0,1.0,13/132,11.36%,RPSA;SF3B1;CELF1;ZRSR2;SNRPF;SMN1;SRPK1;RBM5;NAF1;CELF2;CELF4;SRPK2;LUC7L2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.28540500447745587,0.6007816888285467,0.9019963702359347,1.0,1.0,2/10,18.27%,HMGB1;PSMC4
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.21924233870231186,-0.6003757262817637,0.9526184538653366,0.986678081802915,1.0,2/15,7.39%,BCL2L11;ANXA1
prerank,N-acetylneuraminate metabolic process (GO:0006054),0.28459837102431207,0.6001059556951915,0.9242424242424242,1.0,1.0,3/10,14.46%,ST6GAL1;NAGK;GNPDA2
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2528773795231045,-0.5984773962115916,0.9344262295081968,0.9868245900593442,1.0,5/10,35.92%,SMYD2;SETD6;EHMT1;SETD7;METTL18
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),0.27341562407952247,0.5984668869535258,0.9137055837563451,1.0,1.0,4/13,18.77%,GCC2;CD81;TMEM30A;TM9SF4
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2474070418021928,0.5984321884826401,0.9333333333333333,1.0,1.0,1/18,2.89%,GPLD1
prerank,rRNA 3'-end processing (GO:0031125),-0.25484510798888826,-0.5978991353835836,0.9338235294117647,0.9863577669753333,1.0,3/10,20.52%,RPS21;EXOSC3;ERI3
prerank,exit from mitosis (GO:0010458),0.27723985493456316,0.5974761825641296,0.9,1.0,1.0,3/12,10.71%,SPAST;SIRT7;CHMP4B
prerank,cranial nerve development (GO:0021545),-0.23886685872611133,-0.5972830483891743,0.9505882352941176,0.9859388332527154,1.0,3/11,16.64%,CHD7;SALL1;TMEM126A
prerank,regulation of oxidoreductase activity (GO:0051341),0.274359744257843,0.5966907899786363,0.9151414309484193,1.0,1.0,2/13,11.27%,ABL2;HDAC6
prerank,establishment of vesicle localization (GO:0051650),0.25186391352586124,0.5965528376865525,0.9189627228525121,1.0,1.0,5/18,19.71%,LIMK2;KIF5A;KIF5B;TMEM230;SPG11
prerank,stress granule assembly (GO:0034063),0.242928986613599,0.5962641905148098,0.9080824088748018,1.0,1.0,5/20,19.09%,ATXN2;CSDE1;UBAP2L;DDX6;G3BP1
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.2576477603711196,0.595947403142118,0.912828947368421,1.0,1.0,2/15,9.65%,IL17RA;TICAM1
prerank,gene silencing by miRNA (GO:0035195),0.22619584972847034,0.5959315743849303,0.9458272327964861,0.999605381133483,1.0,10/32,18.94%,AGO1;CNOT7;PUM2;DICER1;RAN;SPOUT1;PRKRA;XPO5;CNOT8;CNOT1
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.22696969210952267,-0.5951066906634608,0.9467312348668281,0.9862615613673233,1.0,3/13,12.42%,SEC16A;SEC16B;SAR1B
prerank,protein methylation (GO:0006479),0.21515687825895496,0.5947001653832905,0.9678770949720671,0.9999888382342619,1.0,12/40,25.77%,ETF1;ATPSCKMT;LCMT1;METTL22;PRMT6;CAMKMT;ICMT;ETFBKMT;VCPKMT;EEF2KMT;PRMT8;PRMT3
prerank,chromatin organization involved in regulation of transcription (GO:0034401),0.2641121034091769,0.5942722371985527,0.9013840830449827,0.9998338100489078,1.0,4/13,21.53%,SPI1;ARID1B;SERTAD2;ARID1A
prerank,microtubule anchoring at centrosome (GO:0034454),0.2794907766821151,0.5932320170854545,0.9141856392294221,1.0,1.0,3/10,15.04%,HOOK3;PCM1;CCDC120
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.24275301271735636,0.5927955411281487,0.9405320813771518,0.9999175410821602,1.0,4/18,17.64%,RFC3;GINS4;POLE;GINS3
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),0.2581116517162828,0.5904910839416988,0.9168053244592346,1.0,1.0,2/16,9.37%,PIGB;PIGA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.24595827092499495,-0.5885352522009814,0.9123595505617977,0.9885090664612816,1.0,4/10,29.08%,SSBP1;CDC7;WIZ;E2F7
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),0.26628006126998954,0.5871382358204029,0.9327731092436975,1.0,1.0,8/13,31.21%,NAGK;GNPDA2;GFPT1;GFPT2;AMDHD2;RENBP;GNPNAT1;GNPDA1
prerank,P-body assembly (GO:0033962),-0.23576500610472997,-0.5871301220028083,0.9364705882352942,0.9883879615681797,1.0,7/12,36.14%,EDC3;RC3H1;LIMD1;LSM4;DYNC1H1;EIF4ENIF1;PATL2
prerank,protein ADP-ribosylation (GO:0006471),-0.18561110158120164,-0.5849880117341373,0.9834437086092715,0.9885947173435631,1.0,10/28,29.27%,ART3;ZC3HAV1;PARP2;PARP10;PARP1;TNKS2;PARP3;PARP12;PARP16;SIRT6
prerank,positive regulation of interferon-beta production (GO:0032728),0.22076698346702506,0.5844442351889495,0.9597014925373134,1.0,1.0,10/33,24.19%,TLR7;POLR3G;POLR3D;TBK1;OAS2;DHX9;IFIH1;DHX58;POLR3C;RIPK2
prerank,tRNA 5'-end processing (GO:0099116),0.251048586403898,0.5835792177766843,0.9395424836601307,1.0,1.0,6/15,24.93%,POP4;POP7;RPP14;RPP21;RPP30;PRORP
prerank,modulation by symbiont of host process (GO:0044003),-0.24223618996625165,-0.5832242521945601,0.9596199524940617,0.9886122597684383,1.0,1/10,4.53%,B2M
prerank,histone lysine methylation (GO:0034968),0.21299329970736774,0.5825997390575174,0.9656160458452722,1.0,1.0,8/33,21.36%,KMT2A;SUV39H1;MEN1;DYDC2;KMT2D;SUV39H2;ASH2L;SETDB1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.27243399350239195,0.5825732969044516,0.9125874125874126,1.0,1.0,3/11,15.34%,COASY;ACAT1;PANK2
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.27243399350239195,0.5825732969044516,0.9125874125874126,1.0,1.0,3/11,15.34%,COASY;ACAT1;PANK2
prerank,coenzyme A biosynthetic process (GO:0015937),0.27243399350239195,0.5825732969044516,0.9125874125874126,1.0,1.0,3/11,15.34%,COASY;ACAT1;PANK2
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.1887027352060449,0.5819832353132136,0.9769526248399488,1.0,1.0,16/67,18.75%,PSME3;TAPBP;PSMB5;VAMP8;PSMB2;PSMA2;PSMA6;PSMD13;PSMA7;PSME4;CYBB;PSMC4;PSMB6;PSMD12;SNAP23;PSMD14
prerank,regulation of mitotic sister chromatid separation (GO:0010965),-0.21528883654271722,-0.5799143506715674,0.9416445623342176,0.9892053003138916,1.0,5/15,24.84%,HECW2;ANAPC1;PTTG1;CENPE;TACC3
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),0.2708678894424785,0.5797024906474971,0.9171171171171171,1.0,1.0,1/10,4.33%,DIP2A
prerank,intracellular sterol transport (GO:0032366),0.25981049800797684,0.5795586628106706,0.9228070175438596,1.0,1.0,7/13,26.12%,ABCA1;OSBPL2;STAR;NPC1;RELCH;STARD4;NPC2
prerank,regulation of interferon-alpha production (GO:0032647),0.236232066863525,0.5792486559316047,0.9380804953560371,1.0,1.0,8/23,28.83%,TLR7;TBK1;SETD2;DHX9;IFIH1;RIPK2;HAVCR2;MAVS
prerank,protein targeting to mitochondrion (GO:0006626),0.19935107682341804,0.5792032716171156,0.973404255319149,1.0,1.0,9/52,19.36%,TOMM34;MFN2;FIS1;IMMP2L;TOMM40;MIPEP;HSPA4;DNAJC19;GRPEL2
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.22049078232580896,0.5787368993844549,0.9491778774289985,1.0,1.0,7/27,21.52%,EGFR;DDX6;FXR1;PUM2;DHX9;IL6;PUM1
prerank,cellular response to topologically incorrect protein (GO:0035967),0.21775683503384308,0.5782194213650966,0.9598853868194842,1.0,1.0,13/31,30.01%,BAG3;HDAC6;ERN1;BAX;UBE2W;PRKN;DAXX;HSPA9;HSPA5;STUB1;RHBDD1;DNAJB12;DNAJC18
prerank,hyaluronan metabolic process (GO:0030212),0.23070398004813875,0.5778936862458198,0.9544764795144158,1.0,1.0,7/23,24.71%,HEXA;CEMIP2;HEXB;CHP1;CEMIP;GUSB;FGF2
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.1936960741920753,-0.5778067818584466,0.9622641509433962,0.9893162563714961,1.0,10/23,36.82%,RBX1;XPA;COPS6;PARP1;GPS1;UBB;DDB1;COPS8;RPS27A;UBC
prerank,replication fork processing (GO:0031297),0.20937707821905138,0.576848023838801,0.9683195592286501,1.0,1.0,15/38,27.59%,BOD1L1;GEN1;RFWD3;NUCKS1;ETAA1;EME2;FAM111A;MRE11;ATR;DDX11;PRIMPOL;ATRX;FBH1;FANCM;BRCA2
prerank,cellular response to unfolded protein (GO:0034620),-0.18175028418525263,-0.5763941639848671,0.9738372093023255,0.9891531162187995,1.0,12/26,36.75%,HSPA8;HSF1;OPTN;ABCB10;TMBIM6;HSPA1A;HSPA14;HSPA1B;HSPD1;HSPA2;PACRG;DAB2IP
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.2232073293050703,-0.5752962082277205,0.9621749408983451,0.9888788852163664,1.0,2/14,15.72%,TRAF6;CSF1
prerank,production of siRNA involved in RNA interference (GO:0030422),0.26388177853348327,0.5747956833979605,0.9104477611940298,1.0,1.0,3/10,16.65%,DICER1;TSNAX;PRKRA
prerank,nucleotide-excision repair (GO:0006289),0.18225071369539872,0.5746736479621063,0.987012987012987,1.0,1.0,20/101,18.15%,SLC30A9;FANCC;RFC3;PPIE;CDK7;ERCC6;ERCC1;CETN2;GTF2H1;POLB;COPS5;POLE;DDB2;CHD1L;USP45;TCEA1;CUL4B;BRIP1;RFC1;GTF2H3
prerank,positive regulation of lipid catabolic process (GO:0050996),0.23146598530722717,0.5743288186949436,0.9512987012987013,1.0,1.0,6/19,24.59%,ABCD1;IRS2;AKT2;TWIST1;PRKCD;DAGLB
prerank,positive regulation of chromatin organization (GO:1905269),-0.23158738431753495,-0.5743092754346437,0.9513381995133819,0.9885197409525373,1.0,4/12,29.83%,UBE2N;TAL1;ACD;TINF2
prerank,peptidyl-lysine methylation (GO:0018022),0.2226636060229548,0.5740024194575428,0.9571639586410635,1.0,1.0,8/26,22.65%,SUV39H1;ATPSCKMT;SETD2;SUV39H2;ETFBKMT;KMT5A;VCPKMT;EEF2KMT
prerank,regulation of response to cytokine stimulus (GO:0060759),0.23581583425773628,0.5717067271666116,0.9420062695924765,1.0,1.0,6/19,22.89%,WNT5A;MAPK7;CBFB;DHX9;RUNX1;IFIH1
prerank,regulation of protein sumoylation (GO:0033233),0.23763486271669426,0.5708178499246765,0.930976430976431,1.0,1.0,6/17,25.06%,HDAC4;EGR1;GNL3L;MUL1;SAE1;PIAS1
prerank,N-terminal protein amino acid acetylation (GO:0006474),0.24318277329931723,0.5684726017236683,0.934453781512605,1.0,1.0,5/16,19.22%,NAA35;CREBBP;NAA10;NAA40;NAA60
prerank,insulin secretion (GO:0030073),0.23787673140167412,0.5683959640152756,0.9481946624803768,1.0,1.0,4/19,18.74%,RIMS2;RAB11FIP5;CAMK2G;RAB11FIP2
prerank,homologous chromosome segregation (GO:0045143),-0.19895404651630041,-0.5679806717007102,0.972972972972973,0.99010364257842,1.0,15/20,50.59%,TERB1;PTTG1;CENPC;FANCD2;ZCWPW1;SGO1;MAJIN;MEIOB;IHO1;PRDM9;FMN2;RNF212B;MEIKIN;ANKRD31;TERB2
prerank,mitotic nuclear membrane disassembly (GO:0007077),0.25907584197303263,0.5654487818891913,0.9312169312169312,1.0,1.0,1/12,4.28%,PRKCA
prerank,histone monoubiquitination (GO:0010390),0.22210165098137452,0.5651407628909617,0.9525267993874426,1.0,1.0,8/24,23.23%,LEO1;PAF1;DDB2;CUL4B;CDC73;PCGF1;RNF20;DTX3L
prerank,renal absorption (GO:0070293),0.2718354254801981,0.5649332253631661,0.9372822299651568,1.0,1.0,2/10,11.96%,MAGED2;SGK1
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.207500035168396,0.5646728301520186,0.964963503649635,1.0,1.0,7/33,19.02%,STN1;WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21428663115698898,0.5642920135264753,0.9522388059701492,1.0,1.0,3/30,6.71%,CAVIN1;CDK7;POLR1E
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.23300932716178296,0.5641758337591218,0.9490131578947368,1.0,1.0,5/18,20.64%,NAF1;EXOSC10;CCT2;RUVBL2;CCT3
prerank,regulation of intracellular pH (GO:0051453),0.20617655414880365,0.5638541972259751,0.977110157367668,1.0,1.0,4/34,11.18%,SLC4A3;SLC4A4;SLC9A7;SLC9A6
prerank,DNA replication (GO:0006260),0.17915003078870173,0.5632454307639198,0.9954285714285714,1.0,1.0,29/105,22.79%,RFC3;ORC5;NBN;PTMS;ORC3;TOP1;CDK2AP1;DONSON;CDC6;POLG2;POLB;REV3L;RECQL5;FAM111A;POLE;RHNO1;BRIP1;ORC1;RFC1;ORC6;NAP1L1;MRE11;RPAIN;ATR;RAD9A;RPA3;HELB;POLE2;MCM4
prerank,ATP transport (GO:0015867),-0.23827810687912387,-0.5632337690537438,0.9568345323741008,0.991099702746828,1.0,3/10,27.27%,ABCC6;SLC25A24;SLC25A42
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2208574158940446,0.5622941274934491,0.9615384615384616,1.0,1.0,1/27,1.39%,AK5
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.25238717606951666,0.5610195157044598,0.9205298013245033,1.0,1.0,3/13,13.64%,TPR;GEN1;LCMT1
prerank,protein localization to chromatin (GO:0071168),0.22893758414741566,0.5600742212509208,0.9538714991762768,1.0,1.0,4/18,18.67%,MSH2;PPHLN1;LEMD2;RUVBL2
prerank,regulation of leukocyte migration (GO:0002685),0.24171578762771148,0.5591520002201464,0.9517684887459807,1.0,1.0,2/16,12.38%,RAC2;CD81
prerank,protein localization to kinetochore (GO:0034501),0.24944686111161637,0.5585017242455758,0.9362041467304625,1.0,1.0,3/14,14.75%,BUB3;ZWILCH;ZW10
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.2039367864385362,-0.5584524024117213,0.9848101265822785,0.9920108281676061,1.0,6/16,26.75%,MUS81;ERCC4;TOP2B;TOP2A;CENPX;RMI1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.21278584053697,0.5573697427307263,0.9662261380323054,1.0,1.0,7/31,19.95%,AXIN1;CDC20;PTEN;FZR1;FBXW7;PINK1;PIN1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.2490809430990134,0.5561991208358411,0.931899641577061,1.0,1.0,4/13,24.33%,DDRGK1;WFS1;NCK1;HSPA5
prerank,cytoplasmic translational initiation (GO:0002183),0.2280201766498247,0.5554495821040798,0.9486754966887417,1.0,1.0,1/17,3.60%,EIF2B3
prerank,detection of calcium ion (GO:0005513),-0.21285401304102786,-0.5547451888965871,0.948849104859335,0.992456904991287,1.0,8/13,46.95%,CALM1;CALM3;SYT1;RYR2;KCNMB2;KCNMB1;CASR;KCNIP2
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.21938692428610565,0.5533403564476986,0.9643962848297214,1.0,1.0,5/22,21.09%,PPM1A;DUSP8;PPP1CA;PPP2CA;PPM1E
prerank,sulfur amino acid catabolic process (GO:0000098),0.2619389708880755,0.5528933380693153,0.9265734265734266,1.0,1.0,2/10,15.15%,BLMH;TXN2
prerank,DNA biosynthetic process (GO:0071897),-0.20258369000107201,-0.5527856000490166,0.974937343358396,0.9923072895586582,1.0,6/16,35.08%,WRN;POLA1;POLD2;CDKN2D;POLL;TYMS
prerank,sensory perception of pain (GO:0019233),0.21836452723426447,0.5507555585060732,0.9658914728682171,1.0,1.0,3/21,13.89%,ALOXE3;MME;KCNK4
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.24405978924711658,0.5490647084229178,0.9243986254295533,1.0,1.0,4/13,25.21%,ALG9;DPAGT1;ALG12;ALG14
prerank,positive regulation of type 2 immune response (GO:0002830),-0.20529746301903712,-0.5486790931077327,0.9734939759036144,0.9928141137861923,1.0,4/14,23.42%,IL18;PRKCZ;RSAD2;NOD2
prerank,RNA biosynthetic process (GO:0032774),0.2049425227455478,0.5484162591533479,0.9691176470588235,1.0,1.0,5/31,15.64%,TAF10;SMN1;NAT14;BRF2;TAF5
prerank,lipid droplet formation (GO:0140042),-0.23005171857633733,-0.5483145752394425,0.9593679458239278,0.9921809759394222,1.0,5/10,35.91%,FITM2;AUP1;BSCL2;SQLE;CDS1
prerank,skeletal muscle contraction (GO:0003009),0.22697235959293066,0.5480745148311518,0.948220064724919,1.0,1.0,3/19,16.68%,TNNI1;TNNI3;RCSD1
prerank,organelle transport along microtubule (GO:0072384),0.2067183165738145,0.5475150424623417,0.968705547652916,1.0,1.0,8/31,22.77%,PAFAH1B1;NDE1;COPG1;KIF5B;HTT;DYNC1I1;FBXW11;RHOT2
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.24771323993296335,0.5458785185425149,0.9511784511784511,1.0,1.0,3/12,15.38%,CDC20;PTEN;FZR1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.20473725023693162,0.5456033607377615,0.9808823529411764,1.0,1.0,11/29,28.08%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;SHQ1;TERF2IP
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.22525077284116968,0.5454924964819284,0.9654631083202512,1.0,1.0,6/18,24.54%,ITGB7;PODXL2;ITGB1;CX3CR1;GOLPH3;ROCK1
prerank,protein deneddylation (GO:0000338),-0.2240506961629294,-0.5441489786665303,0.9674418604651163,0.992635590938452,1.0,4/10,32.50%,COPS6;GPS1;COPS8;TOR1A
prerank,central nervous system neuron axonogenesis (GO:0021955),0.2513251981035801,0.543223262609419,0.9581239530988275,1.0,1.0,2/12,12.80%,EPHB2;PTEN
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.260498801843847,0.5431842409602853,0.9466437177280551,1.0,1.0,2/10,11.18%,GABRG2;GABRG1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.18004557075668814,-0.5430116408154466,0.980225988700565,0.9922145720394189,1.0,7/24,21.22%,JARID2;BMI1;SUZ12;DNMT3B;EED;TASOR;DNMT3A
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.2602222169542414,0.5429244542148466,0.9517625231910947,1.0,1.0,4/10,27.79%,FZD3;CX3CR1;CX3CL1;SMARCD3
prerank,telomere maintenance via telomerase (GO:0007004),0.20549165723798582,0.541955753339413,0.9805680119581465,1.0,1.0,11/28,28.08%,WRAP53;TNKS1BP1;PPP6R3;TERF2;RFC1;MRE11;PPP6C;RAD50;RPA1;SHQ1;TERF2IP
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.24805423047953795,0.5418601333601358,0.9481865284974094,1.0,1.0,11/11,75.21%,RTP3;RTP2;TAS1R3;PIGR;GNAT2;GNAT3;TAS1R2;LPO;RTP4;PKD1L3;PKD2L1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.25092756321615556,0.5402141901374932,0.9395604395604396,1.0,1.0,4/11,24.33%,CREB3L1;DDIT3;MBTPS2;HSPA5
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.16647823409667062,-0.5393479774789279,0.9902912621359223,0.9924849939028401,1.0,12/30,32.45%,HSPA8;ENTPD5;DNAJB5;SDF2;BAG1;HSPA1A;HSPA14;DNAJB1;PTGES3;HSPA1B;HSPA2;SDF2L1
prerank,regulation of RNA export from nucleus (GO:0046831),0.2501909731790248,0.5381727474669347,0.9342806394316163,1.0,1.0,5/11,24.04%,TPR;NUP153;SETD2;DHX9;IWS1
prerank,antibacterial humoral response (GO:0019731),0.22714001334602016,0.538161271697838,0.9464882943143813,1.0,1.0,15/16,65.36%,DEFA6;RNASE3;ANG;DMBT1;PLA2G1B;WFDC2;LTF;DEFB1;RNASE7;WFDC3;RNASE6;CAMP;JCHAIN;SLPI;PLA2G6
prerank,inorganic ion transmembrane transport (GO:0098660),0.24055626177620937,0.5373024025904515,0.9484536082474226,1.0,1.0,1/12,4.79%,CACNA1H
prerank,regulation of macrophage migration (GO:1905521),0.2544577658935637,0.5369487657994151,0.95,1.0,1.0,2/10,12.38%,CD200R1;CD81
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",-0.19764039972813277,-0.5367676510319549,0.9794871794871794,0.9924870238982106,1.0,9/16,34.30%,CACTIN;SRSF1;WBP4;WBP11;DDX23;SNRPC;SART1;NCBP2;CWC15
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.20852350800110397,-0.536554378265346,0.9770992366412213,0.991814168603467,1.0,4/13,22.44%,NCBP1;CPSF1;CPSF7;CPSF6
prerank,cell differentiation in hindbrain (GO:0021533),0.24078762509937432,0.5359465284777963,0.9576719576719577,1.0,1.0,1/11,3.66%,OPHN1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.24447187073477575,0.5351923397111258,0.9468267581475128,1.0,1.0,3/12,15.04%,HOOK3;PCM1;CCDC120
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.20571064073947265,0.5340912644351484,0.982089552238806,1.0,1.0,2/29,7.63%,AXIN1;FBXO5
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),0.2472097768817213,0.5335876246003485,0.9555160142348754,1.0,1.0,1/10,6.35%,SIRT3
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),0.2472097768817213,0.5335876246003485,0.9555160142348754,1.0,1.0,1/10,6.35%,SIRT3
prerank,regulation of nervous system development (GO:0051960),0.19445750368503986,0.5326365237131025,0.9831697054698457,1.0,1.0,9/37,22.93%,HEYL;BHLHE40;DOCK7;NSUN5;YAP1;GBX1;CX3CR1;CX3CL1;SIRT2
prerank,positive regulation of viral genome replication (GO:0045070),0.20276556551818822,0.5325083028937523,0.9659574468085106,0.9999983276603536,1.0,4/29,10.90%,PPIE;SRPK1;CNOT7;SRPK2
prerank,intracellular pH reduction (GO:0051452),0.19656633898828485,0.5324237402778187,0.9665697674418605,0.9996063342619772,1.0,4/33,11.51%,ATP6V0D2;DMXL1;ATP6V0A1;DMXL2
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.23443482563946513,0.5314555429411014,0.9501607717041801,0.999547417801601,1.0,8/15,30.78%,CNOT7;CPEB3;CNOT1;TENT4B;AGO2;TENT4A;POLR2G;TOB1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.23452092451983592,0.5285634410116242,0.9583333333333334,1.0,1.0,5/14,21.62%,ABCD1;TYSND1;IRS2;AKT2;TWIST1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.21340266288121043,0.528231219029267,0.9755351681957186,0.9997871753988199,1.0,6/22,18.15%,CETN2;GTF2H1;DDB2;CHD1L;CUL4B;GTF2H3
prerank,steroid catabolic process (GO:0006706),0.2449005209314003,0.5255068389069348,0.9450354609929078,1.0,1.0,10/10,75.53%,HSD17B11;HSD11B1;SPP1;HSD17B6;CYP19A1;FGF23;CYP24A1;CYP27B1;HSD17B14;YWHAH
prerank,error-free translesion synthesis (GO:0070987),0.2113531206573209,0.5210387945353051,0.9684684684684685,1.0,1.0,3/22,10.64%,RFC3;NPLOC4;RCHY1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.19448972607185777,-0.5202908098686081,0.9873417721518988,0.9951041166700232,1.0,7/16,29.83%,PINX1;DHX36;PARP1;ERCC4;TNKS2;ATM;TINF2
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.2024896812222602,-0.520207408124412,0.9705882352941176,0.9943955577518496,1.0,2/13,15.54%,LRRK2;OPA1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.22933321521803884,0.5199905537681272,0.9616666666666667,1.0,1.0,4/15,18.94%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.22933321521803884,0.5199905537681272,0.9616666666666667,1.0,1.0,4/15,18.94%,CNOT7;ZFP36L2;CPEB3;CNOT1
prerank,acylglycerol catabolic process (GO:0046464),0.1976536575606257,0.5187085547525171,0.9788434414668548,1.0,1.0,5/30,20.02%,ABHD12;LIPE;LPL;FAAH;LYPLA2
prerank,histone methylation (GO:0016571),0.2012161709002327,0.5158316048082031,0.9850299401197605,1.0,1.0,5/26,17.48%,SUV39H1;SIRT7;CREBBP;PRMT6;SUV39H2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.2452246168806848,0.5153916994773741,0.9559082892416225,1.0,1.0,1/10,11.42%,EGR1
prerank,response to peptide (GO:1901652),0.19168709619229285,0.5151602493248935,0.9817905918057663,1.0,1.0,4/33,12.28%,EIF2B3;MMP12;EIF2B4;STAT2
prerank,peptide hormone secretion (GO:0030072),0.20224545602324645,0.5149958121143801,0.9786910197869102,1.0,1.0,2/26,6.97%,RIMS2;LTBP4
prerank,phagosome-lysosome fusion (GO:0090385),0.24057778545557024,0.5149528628452094,0.9688041594454073,0.9998037433698623,1.0,3/10,18.86%,ARL8B;RAB34;RAB39A
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.19080766635925098,0.5101396281410169,0.984149855907781,1.0,1.0,6/32,23.05%,NEK7;NAF1;CCT2;ATR;CCT3;MAPK1
prerank,inositol phosphate dephosphorylation (GO:0046855),0.2359570094104826,0.5077151513887938,0.958904109589041,1.0,1.0,2/11,12.80%,OCRL;PTEN
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.2359570094104826,0.5077151513887938,0.958904109589041,1.0,1.0,2/11,12.80%,OCRL;PTEN
prerank,immunoglobulin mediated immune response (GO:0016064),0.23874976463942768,0.5056799374084776,0.9625468164794008,1.0,1.0,10/10,76.14%,CD81;ZP3;GAPT;CD19;CARD9;CD74;TLR8;FCER1G;FCGR2B;CD27
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.23231607722753184,0.5040397329819195,0.9645390070921985,1.0,1.0,2/11,15.10%,EFNB2;GPER1
prerank,negative regulation of interleukin-12 production (GO:0032695),0.22181445536654004,0.5024512795201913,0.9656357388316151,1.0,1.0,2/14,15.87%,IRAK3;PIBF1
prerank,negative regulation of interferon-beta production (GO:0032688),0.2390982530625573,0.5001794077693353,0.9621342512908778,1.0,1.0,1/10,4.50%,REL
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.209282065541879,0.5000379430027253,0.9706362153344209,1.0,1.0,8/18,28.37%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;UGGT1;UGGT2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.21755344250802022,0.49994802867316823,0.9696969696969697,1.0,1.0,1/14,5.17%,CARD10
prerank,regulation of double-strand break repair (GO:2000779),0.1828141435637685,0.49946135665469044,0.9958333333333333,0.9998053871537997,1.0,10/39,22.70%,OTUB2;UBR5;WRAP53;SIRT7;MGMT;PPP4C;SETD2;DDX11;TWIST1;SPIDR
prerank,striated muscle contraction (GO:0006941),0.17168100504713443,0.4987650410003156,0.9959785522788204,0.9995620525275994,1.0,8/53,16.68%,CSRP3;ATP1A2;CASQ2;SCN2B;TNNI1;TNNI3;ARHGEF11;RCSD1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),-0.20452096614091486,-0.49623618437834077,0.9814385150812065,0.9982123786276272,1.0,3/11,28.12%,JAK2;XBP1;CIITA
prerank,positive regulation of immune response (GO:0050778),0.16743049673067223,0.49491362095650293,0.9986893840104849,1.0,1.0,9/64,17.17%,PTPRC;POLR3G;PLSCR1;KARS1;IL6ST;CD81;POLR3D;IL15;STX4
prerank,cellular response to radiation (GO:0071478),0.1773580299066494,0.49436494329922526,0.9928263988522238,0.9998118231735611,1.0,9/40,22.70%,OPN1MW;OPN1MW3;SWI5;INO80;TNKS1BP1;RHNO1;GPR52;RAD9A;SPIDR
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.20408876396323727,-0.487497936785195,0.988009592326139,0.9988938565649412,1.0,5/10,35.96%,AKT1;MYD88;TREM2;CD36;TLR6
prerank,sensory perception of smell (GO:0007608),0.22402871367410326,0.4845599409535475,0.9671848013816926,1.0,1.0,10/11,48.40%,ADCY3;UBR3;SLC24A4;OBP2B;GFY;DRD2;OMP;BEST2;SYT10;BBS4
prerank,negative regulation of cellular metabolic process (GO:0031324),0.18196072090582877,0.48406984954843435,0.9930362116991643,1.0,1.0,8/37,22.93%,NCOR1;AATF;ATXN2;ANKRD13B;PINK1;PRKN;PAX2;SIRT2
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.21063925832862027,0.4833737291567983,0.9722222222222222,1.0,1.0,4/14,24.33%,DDRGK1;COPS5;BAX;HSPA5
prerank,T cell activation involved in immune response (GO:0002286),-0.1953570636758757,-0.48163090499264827,0.9860788863109049,0.9990233553823469,1.0,10/12,52.69%,EIF2AK4;ICAM1;SLC11A1;LILRB1;FCER1G;CD74;ITGAL;F2RL1;IFNK;TNFSF18
prerank,serine family amino acid catabolic process (GO:0009071),-0.19986182147740678,-0.481354411127997,0.985981308411215,0.9983247336642903,1.0,5/10,34.20%,CBS;GCSH;THNSL2;SHMT2;SHMT1
prerank,nuclear membrane disassembly (GO:0051081),0.21354345385858098,0.48069530423457835,0.9773913043478261,1.0,1.0,1/14,4.28%,PRKCA
prerank,lipid droplet organization (GO:0034389),0.19169650147603812,0.47866586563504815,0.9877675840978594,1.0,1.0,22/22,80.86%,HILPDA;CDS2;RAB18;RAB3GAP1;PLA2G4C;FAF2;ZFYVE1;PPIA;FITM1;CIDEC;TSPO2;HSD17B13;SMIM22;CIDEA;PLIN5;CDS1;SQLE;BSCL2;PPID;AUP1;FITM2;PNPLA3
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",0.20525655916080696,0.4777483451495597,0.9778534923339012,1.0,1.0,4/15,23.67%,POP7;DICER1;RPP30;RNASEH1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.18901560828485642,0.4774676316438066,0.9821958456973294,1.0,1.0,5/24,21.54%,RFC3;POLB;POLE;RFC1;RPA3
prerank,regulation of mast cell degranulation (GO:0043304),0.2134611296020204,0.4760992850457669,0.9876325088339223,1.0,1.0,3/14,16.49%,FER;GAB2;SYK
prerank,glycine metabolic process (GO:0006544),0.2156801205197415,0.4744832008472848,0.9778534923339012,1.0,1.0,12/12,78.45%,GLDC;DLD;SDSL;SDS;BAAT;AMT;GLYAT;SHMT1;GCAT;SHMT2;GCSH;RIDA
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.18847741954831995,0.4741049704105726,0.9800918836140888,0.9998074635301604,1.0,2/23,9.55%,CRTAM;LAMP1
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.18698321166635512,0.473459492216959,0.9878603945371776,0.9995090676346694,1.0,6/25,19.72%,CIDEB;GPER1;BAD;BNIP3;PINK1;BAX
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.1975702253895979,0.47180740085658845,0.9795275590551181,0.9993721097172776,1.0,3/18,13.32%,ISL1;AQP1;ZFP36L2
prerank,positive regulation of T cell activation (GO:0050870),0.1618545388210145,0.4686922018686469,1.0,0.9994928173137151,1.0,13/62,21.79%,FLOT2;PTPRC;NCK2;IL6ST;CD276;CD81;IL7;IL15;MDK;DOCK8;IL6;NCK1;CCDC88B
prerank,phospholipid homeostasis (GO:0055091),-0.1936546098815426,-0.46343542547141175,0.9825870646766169,0.9997082331643274,1.0,4/11,34.57%,ABCG1;RCN3;FABP3;TLCD2
prerank,neural crest cell differentiation (GO:0014033),0.19341088377218088,0.46252670241390104,0.9871794871794872,1.0,1.0,2/18,11.87%,CDH2;FBXL17
prerank,negative regulation of interleukin-17 production (GO:0032700),0.22174104060754413,0.4625220008603385,0.9731663685152058,0.9996494708567272,1.0,10/10,77.84%,DDIT3;PRNP;VSIR;IFNG;TNFSF4;IL12B;FOXP3;TLR4;IL12A;NCKAP1L
prerank,regulation of response to interferon-gamma (GO:0060330),0.20476109036823026,0.4609002305732062,0.9810671256454389,0.999475032878891,1.0,5/14,26.57%,SOCS1;JAK1;SUMO1;PIAS1;PTPN2
prerank,ER-associated misfolded protein catabolic process (GO:0071712),-0.18110302374013976,-0.459577780696871,0.9929411764705882,0.9993587890364352,1.0,5/11,37.95%,VCP;AUP1;TOR1A;POMT2;UFD1
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.21010358642437257,0.4570586788822231,0.9747899159663865,0.9996588805400494,1.0,3/13,18.94%,CNOT7;CPEB3;CNOT1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.20734318596827817,0.4533655009579409,0.9901153212520593,0.9997800044859726,1.0,1/12,8.28%,GCNT2
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.18600933741495299,0.4506866048356553,0.990726429675425,0.9997573375803644,1.0,7/19,26.09%,NAGK;GNPDA2;PMM1;GFPT1;GFPT2;PMM2;AMDHD2
prerank,protein homotrimerization (GO:0070207),-0.17449255324445054,-0.4494226992986653,0.9946949602122016,0.9988540229291268,1.0,1/14,3.29%,SCARA5
prerank,protein trimerization (GO:0070206),-0.17449255324445054,-0.4494226992986653,0.9946949602122016,0.9988540229291268,1.0,1/14,3.29%,SCARA5
prerank,regulation of AMPA receptor activity (GO:2000311),0.17806786392490614,0.44776172716035423,0.992412746585736,0.9997319200988752,1.0,2/25,10.52%,MINK1;RELN
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),0.18652399594999952,0.44579176944248555,0.9935379644588045,0.9995783810780051,1.0,7/17,27.69%,DYRK1A;YJU2;PRKN;TWIST1;PTTG1IP;MDM2;SNAI1
prerank,spermatid development (GO:0007286),0.16805604395157325,0.4440819147407639,0.9911373707533235,0.9993708103248933,1.0,6/32,23.55%,TDRD5;IQCG;CEP57;CDYL;DDX25;SYCP3
prerank,spliceosomal snRNP assembly (GO:0000387),0.16250157389337175,0.4437175551867661,0.9971870604781997,0.9990006043641235,1.0,3/38,7.37%,SNRPF;PRPF3;SMN1
prerank,phagolysosome assembly (GO:0001845),0.1968180920780608,0.4418907752994917,0.9882747068676717,0.9987926614986944,1.0,3/12,18.86%,ARL8B;RAB34;RAB39A
prerank,negative regulation of receptor internalization (GO:0002091),0.20090429841486696,0.44067832457528683,0.9833610648918469,0.9985248783081511,1.0,2/12,15.17%,ATXN2;ANKRD13B
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.1758937364808671,0.4338849920505779,0.9919484702093397,0.998859194190094,1.0,9/22,28.37%,AMFR;RNF185;EDEM2;SEL1L;RNF103;MAN1B1;UGGT1;MAN1C1;UGGT2
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.15870427124408065,0.431088674503916,0.9985775248933144,0.9987415202387302,1.0,3/35,12.07%,NEK7;NAF1;CCT2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.19548533102810767,0.42801955762190347,0.9913644214162349,0.9986361697044819,1.0,2/13,21.31%,NEDD4;EPN2
prerank,cell-cell junction maintenance (GO:0045217),-0.17148396331113563,-0.4267663651901448,1.0,0.9996573905804201,1.0,1/11,6.24%,MYADM
prerank,regulation of superoxide anion generation (GO:0032928),0.18897471989978423,0.4248359300461861,0.9965694682675815,0.998514352350521,1.0,2/14,16.49%,AATF;SYK
prerank,regulation of lipid storage (GO:0010883),0.1692512090594708,0.4239412641512712,0.9936204146730463,0.9981719924485577,1.0,4/22,20.68%,HILPDA;FBXW7;LPL;IL6
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.16497175141242937,-0.4185805019860611,1.0,0.9993353006475768,1.0,13/13,83.52%,MAPT;ITGB2;ITGAM;TGFB1;CRP;GSTP1;F2RL1;CD177;FPR2;TYROBP;SOD1;PRKCD;SYK
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.18726566738406758,0.41662263991940107,0.9948275862068966,0.998352549918098,1.0,3/11,23.75%,SIRT7;DDX11;MTOR
prerank,regulation of chromosome organization (GO:0033044),0.16382377604866558,0.4096863811422117,0.9938837920489296,0.9984727231669964,1.0,10/22,31.16%,SHCBP1L;TERF2;HNRNPD;SMG6;CENPV;YLPM1;SMG5;TERF2IP;XRCC5;WAPL
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.17273707987276787,0.40375701463413616,0.9911816578483245,0.9984609687813522,1.0,2/14,19.90%,NLRP2B;CCDC3
prerank,positive regulation of lymphocyte migration (GO:2000403),0.18375615022975728,0.3984705192229114,0.9965217391304347,0.9983579674916039,1.0,3/12,18.90%,TNFRSF14;RHOA;DOCK8
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.1555056426866471,-0.37979177883395526,0.9977477477477478,0.999655896529154,1.0,6/11,42.67%,JAK2;STAT3;IL12RB2;STAT4;IL27RA;IL12A
prerank,secretory granule organization (GO:0033363),0.17267752136117837,0.3561655770238,0.9982456140350877,0.9994770662077431,1.0,1/10,9.72%,ABCA1
